Sentence	entity_1	entity_2	entity_3	entity_4	json	split
Leukemic K562, U937 and HL60 cells expressed Glut - 1 transporter protein.	Leukemic K562,0,13,Cell	U937,15,19,Cell	HL60 cells,24,34,Cell	Glut - 1,45,53,Gene_or_gene_product	"[{""token"": ""Leukemic K562"", ""start_span"": 0, ""end_span"": 13, ""type"": ""Cell""}, {""token"": ""U937"", ""start_span"": 15, ""end_span"": 19, ""type"": ""Cell""}, {""token"": ""HL60 cells"", ""start_span"": 24, ""end_span"": 34, ""type"": ""Cell""}, {""token"": ""Glut - 1"", ""start_span"": 45, ""end_span"": 53, ""type"": ""Gene_or_gene_product""}]"	train
With K562 cells Glut - 1 appeared as a broad band of 50 - 60 kDa, whereas with U937 and HL60 cells a diffuse band was observed at approximately 55 kDa.	K562 cells,5,15,Cell	Glut - 1,16,24,Gene_or_gene_product	U937,79,83,Cell	HL60 cells,88,98,Cell	"[{""token"": ""K562 cells"", ""start_span"": 5, ""end_span"": 15, ""type"": ""Cell""}, {""token"": ""Glut - 1"", ""start_span"": 16, ""end_span"": 24, ""type"": ""Gene_or_gene_product""}, {""token"": ""U937"", ""start_span"": 79, ""end_span"": 83, ""type"": ""Cell""}, {""token"": ""HL60 cells"", ""start_span"": 88, ""end_span"": 98, ""type"": ""Cell""}]"	train
Immunohistochemical analysis of nm23 - H1 gene product in node - positive lung cancer and lymph nodes.	nm23 - H1,32,41,Gene_or_gene_product	node,58,62,Multi	lung cancer,74,85,Cancer	lymph nodes,90,101,Multi	"[{""token"": ""nm23 - H1"", ""start_span"": 32, ""end_span"": 41, ""type"": ""Gene_or_gene_product""}, {""token"": ""node"", ""start_span"": 58, ""end_span"": 62, ""type"": ""Multi""}, {""token"": ""lung cancer"", ""start_span"": 74, ""end_span"": 85, ""type"": ""Cancer""}, {""token"": ""lymph nodes"", ""start_span"": 90, ""end_span"": 101, ""type"": ""Multi""}]"	train
We tested the hypothesis that vascular endothelial growth factor ( VEGF), an endothelial cell mitogen and a major regulator of angiogenesis, is upregulated in response to low heart rate and consequential increased stroke volume.	vascular endothelial growth factor,30,64,Gene_or_gene_product	VEGF,67,71,Gene_or_gene_product	endothelial cell,77,93,Cell	heart,175,180,Organ	"[{""token"": ""vascular endothelial growth factor"", ""start_span"": 30, ""end_span"": 64, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF"", ""start_span"": 67, ""end_span"": 71, ""type"": ""Gene_or_gene_product""}, {""token"": ""endothelial cell"", ""start_span"": 77, ""end_span"": 93, ""type"": ""Cell""}, {""token"": ""heart"", ""start_span"": 175, ""end_span"": 180, ""type"": ""Organ""}]"	train
Increased serum levels of vascular endothelial growth factor in patients with renal cell carcinoma.	serum,10,15,Organism_substance	vascular endothelial growth factor,26,60,Gene_or_gene_product	patients,64,72,Organism	renal cell carcinoma,78,98,Cancer	"[{""token"": ""serum"", ""start_span"": 10, ""end_span"": 15, ""type"": ""Organism_substance""}, {""token"": ""vascular endothelial growth factor"", ""start_span"": 26, ""end_span"": 60, ""type"": ""Gene_or_gene_product""}, {""token"": ""patients"", ""start_span"": 64, ""end_span"": 72, ""type"": ""Organism""}, {""token"": ""renal cell carcinoma"", ""start_span"": 78, ""end_span"": 98, ""type"": ""Cancer""}]"	train
In 20 RCC patients, serum samples were obtained separately from the bilateral renal veins.	RCC,6,9,Cancer	patients,10,18,Organism	serum samples,20,33,Organism_substance	bilateral renal veins,68,89,Multi	"[{""token"": ""RCC"", ""start_span"": 6, ""end_span"": 9, ""type"": ""Cancer""}, {""token"": ""patients"", ""start_span"": 10, ""end_span"": 18, ""type"": ""Organism""}, {""token"": ""serum samples"", ""start_span"": 20, ""end_span"": 33, ""type"": ""Organism_substance""}, {""token"": ""bilateral renal veins"", ""start_span"": 68, ""end_span"": 89, ""type"": ""Multi""}]"	train
Conditioned media from insulin - treated RPE cells were assayed for VEGF protein and capillary endothelial cell proliferation.	insulin,23,30,Gene_or_gene_product	RPE cells,41,50,Cell	VEGF,68,72,Gene_or_gene_product	capillary endothelial cell,85,111,Cell	"[{""token"": ""insulin"", ""start_span"": 23, ""end_span"": 30, ""type"": ""Gene_or_gene_product""}, {""token"": ""RPE cells"", ""start_span"": 41, ""end_span"": 50, ""type"": ""Cell""}, {""token"": ""VEGF"", ""start_span"": 68, ""end_span"": 72, ""type"": ""Gene_or_gene_product""}, {""token"": ""capillary endothelial cell"", ""start_span"": 85, ""end_span"": 111, ""type"": ""Cell""}]"	train
The insulin - conditioned RPE cell media stimulated capillary endothelial cell proliferation, an effect that was completely blocked by anti - VEGF neutralizing antibody.	insulin,4,11,Gene_or_gene_product	RPE cell,26,34,Cell	capillary endothelial cell,52,78,Cell	VEGF,142,146,Gene_or_gene_product	"[{""token"": ""insulin"", ""start_span"": 4, ""end_span"": 11, ""type"": ""Gene_or_gene_product""}, {""token"": ""RPE cell"", ""start_span"": 26, ""end_span"": 34, ""type"": ""Cell""}, {""token"": ""capillary endothelial cell"", ""start_span"": 52, ""end_span"": 78, ""type"": ""Cell""}, {""token"": ""VEGF"", ""start_span"": 142, ""end_span"": 146, ""type"": ""Gene_or_gene_product""}]"	train
CONCLUSIONS: Insulin increases VEGF mRNA and secreted protein levels in RPE cells through enhanced transcription of the VEGF gene.	Insulin,13,20,Gene_or_gene_product	VEGF,31,35,Gene_or_gene_product	RPE cells,72,81,Cell	VEGF,120,124,Gene_or_gene_product	"[{""token"": ""Insulin"", ""start_span"": 13, ""end_span"": 20, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF"", ""start_span"": 31, ""end_span"": 35, ""type"": ""Gene_or_gene_product""}, {""token"": ""RPE cells"", ""start_span"": 72, ""end_span"": 81, ""type"": ""Cell""}, {""token"": ""VEGF"", ""start_span"": 120, ""end_span"": 124, ""type"": ""Gene_or_gene_product""}]"	train
Intensive insulin therapy may cause a transient worsening of retinopathy in patients with diabetes through increased retinal VEGF gene expression.	insulin,10,17,Gene_or_gene_product	patients,76,84,Organism	retinal,117,124,Multi	VEGF,125,129,Gene_or_gene_product	"[{""token"": ""insulin"", ""start_span"": 10, ""end_span"": 17, ""type"": ""Gene_or_gene_product""}, {""token"": ""patients"", ""start_span"": 76, ""end_span"": 84, ""type"": ""Organism""}, {""token"": ""retinal"", ""start_span"": 117, ""end_span"": 124, ""type"": ""Multi""}, {""token"": ""VEGF"", ""start_span"": 125, ""end_span"": 129, ""type"": ""Gene_or_gene_product""}]"	train
Furthermore, LMP1 cooperates with a p16 - insensitive CDK4 ( R24C) oncogene in transforming MEF cells.	LMP1,13,17,Gene_or_gene_product	p16,36,39,Gene_or_gene_product	CDK4,54,58,Gene_or_gene_product	MEF cells,92,101,Cell	"[{""token"": ""LMP1"", ""start_span"": 13, ""end_span"": 17, ""type"": ""Gene_or_gene_product""}, {""token"": ""p16"", ""start_span"": 36, ""end_span"": 39, ""type"": ""Gene_or_gene_product""}, {""token"": ""CDK4"", ""start_span"": 54, ""end_span"": 58, ""type"": ""Gene_or_gene_product""}, {""token"": ""MEF cells"", ""start_span"": 92, ""end_span"": 101, ""type"": ""Cell""}]"	train
Our results provide the first evidence of the abilities of the LMP1 gene, acting alone, to effectively induce the proliferation of primary MEF cells and of its cooperativity with another cellular oncogene in transforming primary cells.	LMP1,63,67,Gene_or_gene_product	MEF cells,139,148,Cell	cellular,187,195,Cell	cells,229,234,Cell	"[{""token"": ""LMP1"", ""start_span"": 63, ""end_span"": 67, ""type"": ""Gene_or_gene_product""}, {""token"": ""MEF cells"", ""start_span"": 139, ""end_span"": 148, ""type"": ""Cell""}, {""token"": ""cellular"", ""start_span"": 187, ""end_span"": 195, ""type"": ""Cell""}, {""token"": ""cells"", ""start_span"": 229, ""end_span"": 234, ""type"": ""Cell""}]"	train
In order to study whether ATX expression affects motility - dependent processes such as invasion and metastasis, we stably transfected full - length ATX cDNA into two non - expressing cell lines, parental and ras - transformed NIH3T3 ( clone7) cells.	ATX,26,29,Gene_or_gene_product	ATX,149,152,Gene_or_gene_product	cell lines,184,194,Cell	ras,209,212,Gene_or_gene_product	"[{""token"": ""ATX"", ""start_span"": 26, ""end_span"": 29, ""type"": ""Gene_or_gene_product""}, {""token"": ""ATX"", ""start_span"": 149, ""end_span"": 152, ""type"": ""Gene_or_gene_product""}, {""token"": ""cell lines"", ""start_span"": 184, ""end_span"": 194, ""type"": ""Cell""}, {""token"": ""ras"", ""start_span"": 209, ""end_span"": 212, ""type"": ""Gene_or_gene_product""}]"	train
A number of epidermal growth factor receptor ( EGFR) deletion mutants have been identified in gliomas, in which the EGFR gene is frequently amplified and rearranged.	epidermal growth factor receptor,12,44,Gene_or_gene_product	EGFR,47,51,Gene_or_gene_product	gliomas,94,101,Cancer	EGFR,116,120,Gene_or_gene_product	"[{""token"": ""epidermal growth factor receptor"", ""start_span"": 12, ""end_span"": 44, ""type"": ""Gene_or_gene_product""}, {""token"": ""EGFR"", ""start_span"": 47, ""end_span"": 51, ""type"": ""Gene_or_gene_product""}, {""token"": ""gliomas"", ""start_span"": 94, ""end_span"": 101, ""type"": ""Cancer""}, {""token"": ""EGFR"", ""start_span"": 116, ""end_span"": 120, ""type"": ""Gene_or_gene_product""}]"	train
The second most prevalent urological malignancy in middle aged and elderly men is bladder cancer, with 90% of the cases being transitional cell carcinomas.	urological malignancy,26,47,Cancer	men,75,78,Organism	bladder cancer,82,96,Cancer	transitional cell carcinomas,126,154,Cancer	"[{""token"": ""urological malignancy"", ""start_span"": 26, ""end_span"": 47, ""type"": ""Cancer""}, {""token"": ""men"", ""start_span"": 75, ""end_span"": 78, ""type"": ""Organism""}, {""token"": ""bladder cancer"", ""start_span"": 82, ""end_span"": 96, ""type"": ""Cancer""}, {""token"": ""transitional cell carcinomas"", ""start_span"": 126, ""end_span"": 154, ""type"": ""Cancer""}]"	train
Our experimental data confirm previous studies showing the in vitro cell growth inhibition of the transitional cell carcinoma of the bladder cell line HTB9 and further showed the induction of cell cycle arrest at the S / G2 - M checkpoints.	cell,68,72,Cell	transitional cell carcinoma,98,125,Cancer	bladder cell line HTB9,133,155,Cell	cell,192,196,Cell	"[{""token"": ""cell"", ""start_span"": 68, ""end_span"": 72, ""type"": ""Cell""}, {""token"": ""transitional cell carcinoma"", ""start_span"": 98, ""end_span"": 125, ""type"": ""Cancer""}, {""token"": ""bladder cell line HTB9"", ""start_span"": 133, ""end_span"": 155, ""type"": ""Cell""}, {""token"": ""cell"", ""start_span"": 192, ""end_span"": 196, ""type"": ""Cell""}]"	train
There was also an up - regulation of Bax, which altered the Bax: Bcl - 2 ratio, which may be responsible for mitochondrial depolarization reported to be involved prior to the induction of apoptosis.	Bax,37,40,Gene_or_gene_product	Bax,60,63,Gene_or_gene_product	Bcl - 2,65,72,Gene_or_gene_product	mitochondrial,109,122,Cellular_component	"[{""token"": ""Bax"", ""start_span"": 37, ""end_span"": 40, ""type"": ""Gene_or_gene_product""}, {""token"": ""Bax"", ""start_span"": 60, ""end_span"": 63, ""type"": ""Gene_or_gene_product""}, {""token"": ""Bcl - 2"", ""start_span"": 65, ""end_span"": 72, ""type"": ""Gene_or_gene_product""}, {""token"": ""mitochondrial"", ""start_span"": 109, ""end_span"": 122, ""type"": ""Cellular_component""}]"	train
NOS activities were measured by the L - citrulline assay in peritoneal biopsies from seven control subjects, eight uremic patients immediately before the onset of PD, and 13 uremic patients on short - term ( less than 18 mo, n = 6) or long - term ( greater than 18 mo, n = 7) PD.	NOS,0,3,Gene_or_gene_product	peritoneal biopsies,60,79,Multi	patients,122,130,Organism	patients,181,189,Organism	"[{""token"": ""NOS"", ""start_span"": 0, ""end_span"": 3, ""type"": ""Gene_or_gene_product""}, {""token"": ""peritoneal biopsies"", ""start_span"": 60, ""end_span"": 79, ""type"": ""Multi""}, {""token"": ""patients"", ""start_span"": 122, ""end_span"": 130, ""type"": ""Organism""}, {""token"": ""patients"", ""start_span"": 181, ""end_span"": 189, ""type"": ""Organism""}]"	train
After the completion of skin development, angiogenesis, i. e., the growth of new capillaries from pre - existing blood vessels, is held to occur in the skin only under pathologic conditions.	skin,24,28,Organ	capillaries,81,92,Tissue	blood vessels,113,126,Multi	skin,152,156,Organ	"[{""token"": ""skin"", ""start_span"": 24, ""end_span"": 28, ""type"": ""Organ""}, {""token"": ""capillaries"", ""start_span"": 81, ""end_span"": 92, ""type"": ""Tissue""}, {""token"": ""blood vessels"", ""start_span"": 113, ""end_span"": 126, ""type"": ""Multi""}, {""token"": ""skin"", ""start_span"": 152, ""end_span"": 156, ""type"": ""Organ""}]"	train
MATERIALS AND METHODS: Human neuroblastoma cells and human Chang hepatocytes are grown in a noncontact, coculture system.	Human,23,28,Organism	neuroblastoma cells,29,48,Cell	human,53,58,Organism	Chang hepatocytes,59,76,Cell	"[{""token"": ""Human"", ""start_span"": 23, ""end_span"": 28, ""type"": ""Organism""}, {""token"": ""neuroblastoma cells"", ""start_span"": 29, ""end_span"": 48, ""type"": ""Cell""}, {""token"": ""human"", ""start_span"": 53, ""end_span"": 58, ""type"": ""Organism""}, {""token"": ""Chang hepatocytes"", ""start_span"": 59, ""end_span"": 76, ""type"": ""Cell""}]"	train
Tumor necrosis factor alpha ( TNF - alpha), Fas ligand, and Bcl - 2, are measured with immunohistochemistry.	Tumor necrosis factor alpha,0,27,Gene_or_gene_product	TNF - alpha,30,41,Gene_or_gene_product	Fas ligand,44,54,Gene_or_gene_product	Bcl - 2,60,67,Gene_or_gene_product	"[{""token"": ""Tumor necrosis factor alpha"", ""start_span"": 0, ""end_span"": 27, ""type"": ""Gene_or_gene_product""}, {""token"": ""TNF - alpha"", ""start_span"": 30, ""end_span"": 41, ""type"": ""Gene_or_gene_product""}, {""token"": ""Fas ligand"", ""start_span"": 44, ""end_span"": 54, ""type"": ""Gene_or_gene_product""}, {""token"": ""Bcl - 2"", ""start_span"": 60, ""end_span"": 67, ""type"": ""Gene_or_gene_product""}]"	train
Previously we demonstrated that N1 ( ic) and N2 ( ic) could transform E1A immortalized baby rat kidney cells ( RKE) in vitro.	E1A,70,73,Gene_or_gene_product	rat,92,95,Organism	kidney cells,96,108,Cell	RKE,111,114,Cell	"[{""token"": ""E1A"", ""start_span"": 70, ""end_span"": 73, ""type"": ""Gene_or_gene_product""}, {""token"": ""rat"", ""start_span"": 92, ""end_span"": 95, ""type"": ""Organism""}, {""token"": ""kidney cells"", ""start_span"": 96, ""end_span"": 108, ""type"": ""Cell""}, {""token"": ""RKE"", ""start_span"": 111, ""end_span"": 114, ""type"": ""Cell""}]"	train
alpha - MSH also induces activation of NF - kappa B but does not modulate DNA binding on costimulation with IL - 1 beta.	alpha - MSH,0,11,Gene_or_gene_product	NF - kappa B,39,51,Gene_or_gene_product	DNA,74,77,Cellular_component	IL - 1 beta,108,119,Gene_or_gene_product	"[{""token"": ""alpha - MSH"", ""start_span"": 0, ""end_span"": 11, ""type"": ""Gene_or_gene_product""}, {""token"": ""NF - kappa B"", ""start_span"": 39, ""end_span"": 51, ""type"": ""Gene_or_gene_product""}, {""token"": ""DNA"", ""start_span"": 74, ""end_span"": 77, ""type"": ""Cellular_component""}, {""token"": ""IL - 1 beta"", ""start_span"": 108, ""end_span"": 119, ""type"": ""Gene_or_gene_product""}]"	train
alpha - MSH alone had little effect, whereas coincubation with IL - 1 beta led to marked downregulation of IL - 8 secretion ( at most 288 + / - 152 ng / mL) when compared to treatment with IL - 1 beta alone ( 919 + / - 157 ng / mL).	alpha - MSH,0,11,Gene_or_gene_product	IL - 1 beta,63,74,Gene_or_gene_product	IL - 8,107,113,Gene_or_gene_product	IL - 1 beta,189,200,Gene_or_gene_product	"[{""token"": ""alpha - MSH"", ""start_span"": 0, ""end_span"": 11, ""type"": ""Gene_or_gene_product""}, {""token"": ""IL - 1 beta"", ""start_span"": 63, ""end_span"": 74, ""type"": ""Gene_or_gene_product""}, {""token"": ""IL - 8"", ""start_span"": 107, ""end_span"": 113, ""type"": ""Gene_or_gene_product""}, {""token"": ""IL - 1 beta"", ""start_span"": 189, ""end_span"": 200, ""type"": ""Gene_or_gene_product""}]"	train
RESULTS: No correlation was found between tumor prognosis and EGFR, ICAM - 1 or Fas.	tumor,42,47,Cancer	EGFR,62,66,Gene_or_gene_product	ICAM - 1,68,76,Gene_or_gene_product	Fas,80,83,Gene_or_gene_product	"[{""token"": ""tumor"", ""start_span"": 42, ""end_span"": 47, ""type"": ""Cancer""}, {""token"": ""EGFR"", ""start_span"": 62, ""end_span"": 66, ""type"": ""Gene_or_gene_product""}, {""token"": ""ICAM - 1"", ""start_span"": 68, ""end_span"": 76, ""type"": ""Gene_or_gene_product""}, {""token"": ""Fas"", ""start_span"": 80, ""end_span"": 83, ""type"": ""Gene_or_gene_product""}]"	train
Recently serum S - 100beta has shown promise as a tumour marker in melanoma; however, its use as a prognostic marker in the advanced stage needs to be confirmed.	serum,9,14,Organism_substance	S - 100beta,15,26,Gene_or_gene_product	tumour,50,56,Cancer	melanoma,67,75,Cancer	"[{""token"": ""serum"", ""start_span"": 9, ""end_span"": 14, ""type"": ""Organism_substance""}, {""token"": ""S - 100beta"", ""start_span"": 15, ""end_span"": 26, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumour"", ""start_span"": 50, ""end_span"": 56, ""type"": ""Cancer""}, {""token"": ""melanoma"", ""start_span"": 67, ""end_span"": 75, ""type"": ""Cancer""}]"	train
TEL is a member of the ETS family of transcription factors that interacts with the mSin3 and SMRT corepressors to regulate transcription.	TEL,0,3,Gene_or_gene_product	ETS,23,26,Gene_or_gene_product	mSin3,83,88,Gene_or_gene_product	SMRT,93,97,Gene_or_gene_product	"[{""token"": ""TEL"", ""start_span"": 0, ""end_span"": 3, ""type"": ""Gene_or_gene_product""}, {""token"": ""ETS"", ""start_span"": 23, ""end_span"": 26, ""type"": ""Gene_or_gene_product""}, {""token"": ""mSin3"", ""start_span"": 83, ""end_span"": 88, ""type"": ""Gene_or_gene_product""}, {""token"": ""SMRT"", ""start_span"": 93, ""end_span"": 97, ""type"": ""Gene_or_gene_product""}]"	train
TEL is biallelically disrupted in acute leukemia, and loss of heterozygosity at the TEL locus has been observed in various cancers.	TEL,0,3,Gene_or_gene_product	acute leukemia,34,48,Cancer	TEL,84,87,Gene_or_gene_product	cancers,123,130,Cancer	"[{""token"": ""TEL"", ""start_span"": 0, ""end_span"": 3, ""type"": ""Gene_or_gene_product""}, {""token"": ""acute leukemia"", ""start_span"": 34, ""end_span"": 48, ""type"": ""Cancer""}, {""token"": ""TEL"", ""start_span"": 84, ""end_span"": 87, ""type"": ""Gene_or_gene_product""}, {""token"": ""cancers"", ""start_span"": 123, ""end_span"": 130, ""type"": ""Cancer""}]"	train
Here we show that expression of TEL in Ras - transformed NIH 3T3 cells inhibits cell growth in soft agar and in normal cultures.	TEL,32,35,Gene_or_gene_product	Ras,39,42,Gene_or_gene_product	NIH 3T3 cells,57,70,Cell	cell,80,84,Cell	"[{""token"": ""TEL"", ""start_span"": 32, ""end_span"": 35, ""type"": ""Gene_or_gene_product""}, {""token"": ""Ras"", ""start_span"": 39, ""end_span"": 42, ""type"": ""Gene_or_gene_product""}, {""token"": ""NIH 3T3 cells"", ""start_span"": 57, ""end_span"": 70, ""type"": ""Cell""}, {""token"": ""cell"", ""start_span"": 80, ""end_span"": 84, ""type"": ""Cell""}]"	train
Caspase - 3 is essential for procaspase - 9 processing and cisplatin - induced apoptosis of MCF - 7 breast cancer cells.	Caspase - 3,0,11,Gene_or_gene_product	procaspase - 9,29,43,Gene_or_gene_product	cisplatin,59,68,Chemical	MCF - 7 breast cancer cells,92,119,Cell	"[{""token"": ""Caspase - 3"", ""start_span"": 0, ""end_span"": 11, ""type"": ""Gene_or_gene_product""}, {""token"": ""procaspase - 9"", ""start_span"": 29, ""end_span"": 43, ""type"": ""Gene_or_gene_product""}, {""token"": ""cisplatin"", ""start_span"": 59, ""end_span"": 68, ""type"": ""Chemical""}, {""token"": ""MCF - 7 breast cancer cells"", ""start_span"": 92, ""end_span"": 119, ""type"": ""Cell""}]"	train
Together, our data define caspase - 3 as an important integrator of the apoptotic process in MCF - 7 breast cancer cells and reveal an essential function of caspase - 3 for procaspase - 9 processing.	caspase - 3,26,37,Gene_or_gene_product	MCF - 7 breast cancer cells,93,120,Cell	caspase - 3,157,168,Gene_or_gene_product	procaspase - 9,173,187,Gene_or_gene_product	"[{""token"": ""caspase - 3"", ""start_span"": 26, ""end_span"": 37, ""type"": ""Gene_or_gene_product""}, {""token"": ""MCF - 7 breast cancer cells"", ""start_span"": 93, ""end_span"": 120, ""type"": ""Cell""}, {""token"": ""caspase - 3"", ""start_span"": 157, ""end_span"": 168, ""type"": ""Gene_or_gene_product""}, {""token"": ""procaspase - 9"", ""start_span"": 173, ""end_span"": 187, ""type"": ""Gene_or_gene_product""}]"	train
Vasodilator - stimulated phosphoprotein is involved in stress - fiber and membrane ruffle formation in endothelial cells.	Vasodilator - stimulated phosphoprotein,0,39,Gene_or_gene_product	stress - fiber,55,69,Cellular_component	membrane ruffle,74,89,Cellular_component	endothelial cells,103,120,Cell	"[{""token"": ""Vasodilator - stimulated phosphoprotein"", ""start_span"": 0, ""end_span"": 39, ""type"": ""Gene_or_gene_product""}, {""token"": ""stress - fiber"", ""start_span"": 55, ""end_span"": 69, ""type"": ""Cellular_component""}, {""token"": ""membrane ruffle"", ""start_span"": 74, ""end_span"": 89, ""type"": ""Cellular_component""}, {""token"": ""endothelial cells"", ""start_span"": 103, ""end_span"": 120, ""type"": ""Cell""}]"	train
In a variety of cell types, the glycolipid - anchored urokinase receptor ( uPAR) is colocalized pericellularly with components of the plasminogen activation system and endocytosis receptors.	cell,16,20,Cell	glycolipid - anchored urokinase receptor,32,72,Gene_or_gene_product	uPAR,75,79,Gene_or_gene_product	plasminogen,134,145,Gene_or_gene_product	"[{""token"": ""cell"", ""start_span"": 16, ""end_span"": 20, ""type"": ""Cell""}, {""token"": ""glycolipid - anchored urokinase receptor"", ""start_span"": 32, ""end_span"": 72, ""type"": ""Gene_or_gene_product""}, {""token"": ""uPAR"", ""start_span"": 75, ""end_span"": 79, ""type"": ""Gene_or_gene_product""}, {""token"": ""plasminogen"", ""start_span"": 134, ""end_span"": 145, ""type"": ""Gene_or_gene_product""}]"	train
However, additional transfection of TrkA into SY5Y - p75 cells resulted in a significantly reduced rate of apoptosis even in the absence of NGF.	TrkA,36,40,Gene_or_gene_product	SY5Y,46,50,Gene_or_gene_product	p75,53,56,Gene_or_gene_product	NGF,140,143,Gene_or_gene_product	"[{""token"": ""TrkA"", ""start_span"": 36, ""end_span"": 40, ""type"": ""Gene_or_gene_product""}, {""token"": ""SY5Y"", ""start_span"": 46, ""end_span"": 50, ""type"": ""Gene_or_gene_product""}, {""token"": ""p75"", ""start_span"": 53, ""end_span"": 56, ""type"": ""Gene_or_gene_product""}, {""token"": ""NGF"", ""start_span"": 140, ""end_span"": 143, ""type"": ""Gene_or_gene_product""}]"	train
Onconase similarly inhibited proliferation in all three cell lines ( IC ( 50) = 0. 3 - 1. 0 microM) while ( - 4) rhEDN was more effective on immortalized HUVEC cell lines ( IC ( 50) = 0. 02 - 0. 06 microM) than on primary HUVECs ( IC ( 50) > 0. 1 microM).	Onconase,0,8,Chemical	cell lines,56,66,Cell	HUVEC cell lines,154,170,Cell	HUVECs,222,228,Cell	"[{""token"": ""Onconase"", ""start_span"": 0, ""end_span"": 8, ""type"": ""Chemical""}, {""token"": ""cell lines"", ""start_span"": 56, ""end_span"": 66, ""type"": ""Cell""}, {""token"": ""HUVEC cell lines"", ""start_span"": 154, ""end_span"": 170, ""type"": ""Cell""}, {""token"": ""HUVECs"", ""start_span"": 222, ""end_span"": 228, ""type"": ""Cell""}]"	train
TES2 mediates the interaction with tumor necrosis factor receptor - associated death domain protein ( TRADD) and plays a key role in transactivating NF - kappa B and AP - 1.	tumor necrosis factor receptor - associated death domain,35,91,Gene_or_gene_product	TRADD,102,107,Gene_or_gene_product	NF - kappa B,149,161,Gene_or_gene_product	AP - 1,166,172,Gene_or_gene_product	"[{""token"": ""tumor necrosis factor receptor - associated death domain"", ""start_span"": 35, ""end_span"": 91, ""type"": ""Gene_or_gene_product""}, {""token"": ""TRADD"", ""start_span"": 102, ""end_span"": 107, ""type"": ""Gene_or_gene_product""}, {""token"": ""NF - kappa B"", ""start_span"": 149, ""end_span"": 161, ""type"": ""Gene_or_gene_product""}, {""token"": ""AP - 1"", ""start_span"": 166, ""end_span"": 172, ""type"": ""Gene_or_gene_product""}]"	train
IL - 12 inhibition of endothelial cell functions and angiogenesis depends on lymphocyte - endothelial cell cross - talk.	IL - 12,0,7,Gene_or_gene_product	endothelial cell,22,38,Cell	lymphocyte,77,87,Cell	endothelial cell,90,106,Cell	"[{""token"": ""IL - 12"", ""start_span"": 0, ""end_span"": 7, ""type"": ""Gene_or_gene_product""}, {""token"": ""endothelial cell"", ""start_span"": 22, ""end_span"": 38, ""type"": ""Cell""}, {""token"": ""lymphocyte"", ""start_span"": 77, ""end_span"": 87, ""type"": ""Cell""}, {""token"": ""endothelial cell"", ""start_span"": 90, ""end_span"": 106, ""type"": ""Cell""}]"	train
These effects do not require direct cell - cell contact, yet result from continuous interaction between activated lymphoid cells and EC.	cell,36,40,Cell	cell,43,47,Cell	lymphoid cells,114,128,Cell	EC,133,135,Cell	"[{""token"": ""cell"", ""start_span"": 36, ""end_span"": 40, ""type"": ""Cell""}, {""token"": ""cell"", ""start_span"": 43, ""end_span"": 47, ""type"": ""Cell""}, {""token"": ""lymphoid cells"", ""start_span"": 114, ""end_span"": 128, ""type"": ""Cell""}, {""token"": ""EC"", ""start_span"": 133, ""end_span"": 135, ""type"": ""Cell""}]"	train
The result showed that the mechanism of the FPC antineoplastic effect had an intimate relation with its induction to apoptosis and that the result of FPC inducing tumor cell apoptosis had the character of P53 independence.	FPC,44,47,Chemical	FPC,150,153,Chemical	tumor cell,163,173,Cell	P53,205,208,Gene_or_gene_product	"[{""token"": ""FPC"", ""start_span"": 44, ""end_span"": 47, ""type"": ""Chemical""}, {""token"": ""FPC"", ""start_span"": 150, ""end_span"": 153, ""type"": ""Chemical""}, {""token"": ""tumor cell"", ""start_span"": 163, ""end_span"": 173, ""type"": ""Cell""}, {""token"": ""P53"", ""start_span"": 205, ""end_span"": 208, ""type"": ""Gene_or_gene_product""}]"	train
Vinculin staining showed that the leading edge of ECs on 15 - microm wide strips had focal adhesions that were oriented with their lamellipodial protrusion and the direction of cell migration; this arrangement of the focal adhesions may promote EC migration.	Vinculin,0,8,Gene_or_gene_product	ECs,50,53,Cell	cell,177,181,Cell	EC,245,247,Cell	"[{""token"": ""Vinculin"", ""start_span"": 0, ""end_span"": 8, ""type"": ""Gene_or_gene_product""}, {""token"": ""ECs"", ""start_span"": 50, ""end_span"": 53, ""type"": ""Cell""}, {""token"": ""cell"", ""start_span"": 177, ""end_span"": 181, ""type"": ""Cell""}, {""token"": ""EC"", ""start_span"": 245, ""end_span"": 247, ""type"": ""Cell""}]"	train
The present study provides direct evidence on the role of cell morphology in EC migration, and will help us to understand the mechanisms of EC migration during angiogenesis and wound healing.	cell,58,62,Cell	EC,77,79,Cell	EC,140,142,Cell	wound,177,182,Pathological_formation	"[{""token"": ""cell"", ""start_span"": 58, ""end_span"": 62, ""type"": ""Cell""}, {""token"": ""EC"", ""start_span"": 77, ""end_span"": 79, ""type"": ""Cell""}, {""token"": ""EC"", ""start_span"": 140, ""end_span"": 142, ""type"": ""Cell""}, {""token"": ""wound"", ""start_span"": 177, ""end_span"": 182, ""type"": ""Pathological_formation""}]"	train
The angiogenic switch occurred in early stages of pre - malignant tumor formation, and tumor angiogenesis was significantly enhanced in TSP - 2 - deficient mice.	pre - malignant tumor,50,71,Pathological_formation	tumor,87,92,Cancer	TSP - 2,136,143,Gene_or_gene_product	mice,156,160,Organism	"[{""token"": ""pre - malignant tumor"", ""start_span"": 50, ""end_span"": 71, ""type"": ""Pathological_formation""}, {""token"": ""tumor"", ""start_span"": 87, ""end_span"": 92, ""type"": ""Cancer""}, {""token"": ""TSP - 2"", ""start_span"": 136, ""end_span"": 143, ""type"": ""Gene_or_gene_product""}, {""token"": ""mice"", ""start_span"": 156, ""end_span"": 160, ""type"": ""Organism""}]"	train
The interval between primary surgery and the appearance of gastric cancer in the remnant stomach was significantly shorter in the RSCM group than in the RSCB group.	gastric cancer,59,73,Cancer	remnant stomach,81,96,Organ	RSCM,130,134,Cancer	RSCB,153,157,Cancer	"[{""token"": ""gastric cancer"", ""start_span"": 59, ""end_span"": 73, ""type"": ""Cancer""}, {""token"": ""remnant stomach"", ""start_span"": 81, ""end_span"": 96, ""type"": ""Organ""}, {""token"": ""RSCM"", ""start_span"": 130, ""end_span"": 134, ""type"": ""Cancer""}, {""token"": ""RSCB"", ""start_span"": 153, ""end_span"": 157, ""type"": ""Cancer""}]"	train
Furthermore, p53 overexpression by tumors was almost twice as common in the RSCM group as in the RSCB group.	p53,13,16,Gene_or_gene_product	tumors,35,41,Cancer	RSCM,76,80,Cancer	RSCB,97,101,Cancer	"[{""token"": ""p53"", ""start_span"": 13, ""end_span"": 16, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumors"", ""start_span"": 35, ""end_span"": 41, ""type"": ""Cancer""}, {""token"": ""RSCM"", ""start_span"": 76, ""end_span"": 80, ""type"": ""Cancer""}, {""token"": ""RSCB"", ""start_span"": 97, ""end_span"": 101, ""type"": ""Cancer""}]"	train
These results indicate that specific HDAc inhibitors may be useful in the treatment of Evi - 1 - induced neoplastic tumors, including myeloid leukemias.	HDAc,37,41,Gene_or_gene_product	Evi - 1,87,94,Gene_or_gene_product	neoplastic tumors,105,122,Cancer	myeloid leukemias,134,151,Cancer	"[{""token"": ""HDAc"", ""start_span"": 37, ""end_span"": 41, ""type"": ""Gene_or_gene_product""}, {""token"": ""Evi - 1"", ""start_span"": 87, ""end_span"": 94, ""type"": ""Gene_or_gene_product""}, {""token"": ""neoplastic tumors"", ""start_span"": 105, ""end_span"": 122, ""type"": ""Cancer""}, {""token"": ""myeloid leukemias"", ""start_span"": 134, ""end_span"": 151, ""type"": ""Cancer""}]"	train
Invasion of the human melanoma cell line, BLM, was also attenuated by the anti - PAI - 1 monoclonal antibody MAI - 12.	human,16,21,Organism	melanoma cell line,22,40,Cell	BLM,42,45,Cell	PAI - 1,81,88,Gene_or_gene_product	"[{""token"": ""human"", ""start_span"": 16, ""end_span"": 21, ""type"": ""Organism""}, {""token"": ""melanoma cell line"", ""start_span"": 22, ""end_span"": 40, ""type"": ""Cell""}, {""token"": ""BLM"", ""start_span"": 42, ""end_span"": 45, ""type"": ""Cell""}, {""token"": ""PAI - 1"", ""start_span"": 81, ""end_span"": 88, ""type"": ""Gene_or_gene_product""}]"	train
Although antibodies to PAI - 1 did not affect the adhesion of HT1080 cells to vitronectin, the antibody to uPA reduced their attachment.	PAI - 1,23,30,Gene_or_gene_product	HT1080 cells,62,74,Cell	vitronectin,78,89,Gene_or_gene_product	uPA,107,110,Gene_or_gene_product	"[{""token"": ""PAI - 1"", ""start_span"": 23, ""end_span"": 30, ""type"": ""Gene_or_gene_product""}, {""token"": ""HT1080 cells"", ""start_span"": 62, ""end_span"": 74, ""type"": ""Cell""}, {""token"": ""vitronectin"", ""start_span"": 78, ""end_span"": 89, ""type"": ""Gene_or_gene_product""}, {""token"": ""uPA"", ""start_span"": 107, ""end_span"": 110, ""type"": ""Gene_or_gene_product""}]"	train
Addition of exogenous PAI - 1, however, prevented HT1080 cell adhesion ( IC50 180 nM) and promoted cell detachment from vitronectin.	PAI - 1,22,29,Gene_or_gene_product	HT1080 cell,50,61,Cell	cell,99,103,Cell	vitronectin,120,131,Gene_or_gene_product	"[{""token"": ""PAI - 1"", ""start_span"": 22, ""end_span"": 29, ""type"": ""Gene_or_gene_product""}, {""token"": ""HT1080 cell"", ""start_span"": 50, ""end_span"": 61, ""type"": ""Cell""}, {""token"": ""cell"", ""start_span"": 99, ""end_span"": 103, ""type"": ""Cell""}, {""token"": ""vitronectin"", ""start_span"": 120, ""end_span"": 131, ""type"": ""Gene_or_gene_product""}]"	train
Furthermore melanoma cells transfected with a uPA variant, which had an impaired interaction with PAI - 1, were not invasive and had impaired binding to vitronectin.	melanoma cells,12,26,Cell	uPA,46,49,Gene_or_gene_product	PAI - 1,98,105,Gene_or_gene_product	vitronectin,153,164,Gene_or_gene_product	"[{""token"": ""melanoma cells"", ""start_span"": 12, ""end_span"": 26, ""type"": ""Cell""}, {""token"": ""uPA"", ""start_span"": 46, ""end_span"": 49, ""type"": ""Gene_or_gene_product""}, {""token"": ""PAI - 1"", ""start_span"": 98, ""end_span"": 105, ""type"": ""Gene_or_gene_product""}, {""token"": ""vitronectin"", ""start_span"": 153, ""end_span"": 164, ""type"": ""Gene_or_gene_product""}]"	train
These data also suggest that uPA and PAI - 1 may co - operate in the migratory process by respectively facilitating the attachment to, and subsequent detachment from, vitronectin in the extracellular matrix.	uPA,29,32,Gene_or_gene_product	PAI - 1,37,44,Gene_or_gene_product	vitronectin,167,178,Gene_or_gene_product	extracellular matrix,186,206,Cellular_component	"[{""token"": ""uPA"", ""start_span"": 29, ""end_span"": 32, ""type"": ""Gene_or_gene_product""}, {""token"": ""PAI - 1"", ""start_span"": 37, ""end_span"": 44, ""type"": ""Gene_or_gene_product""}, {""token"": ""vitronectin"", ""start_span"": 167, ""end_span"": 178, ""type"": ""Gene_or_gene_product""}, {""token"": ""extracellular matrix"", ""start_span"": 186, ""end_span"": 206, ""type"": ""Cellular_component""}]"	train
Prognostic significance of heat shock protein 27 ( HSP27) in patients with oral squamous cell carcinoma.	heat shock protein 27,27,48,Gene_or_gene_product	HSP27,51,56,Gene_or_gene_product	patients,61,69,Organism	oral squamous cell carcinoma,75,103,Cancer	"[{""token"": ""heat shock protein 27"", ""start_span"": 27, ""end_span"": 48, ""type"": ""Gene_or_gene_product""}, {""token"": ""HSP27"", ""start_span"": 51, ""end_span"": 56, ""type"": ""Gene_or_gene_product""}, {""token"": ""patients"", ""start_span"": 61, ""end_span"": 69, ""type"": ""Organism""}, {""token"": ""oral squamous cell carcinoma"", ""start_span"": 75, ""end_span"": 103, ""type"": ""Cancer""}]"	train
Vascular endothelial growth factor ( VEGF) is a major regulator of angiogenesis that binds to tyrosine kinase receptors Flt - 1 and KDR.	Vascular endothelial growth factor,0,34,Gene_or_gene_product	VEGF,37,41,Gene_or_gene_product	Flt - 1,120,127,Gene_or_gene_product	KDR,132,135,Gene_or_gene_product	"[{""token"": ""Vascular endothelial growth factor"", ""start_span"": 0, ""end_span"": 34, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF"", ""start_span"": 37, ""end_span"": 41, ""type"": ""Gene_or_gene_product""}, {""token"": ""Flt - 1"", ""start_span"": 120, ""end_span"": 127, ""type"": ""Gene_or_gene_product""}, {""token"": ""KDR"", ""start_span"": 132, ""end_span"": 135, ""type"": ""Gene_or_gene_product""}]"	train
VEGF - A ( 165), B, C, Flt - 1, and KDR were analyzed.	B,17,18,Gene_or_gene_product	C,20,21,Gene_or_gene_product	Flt - 1,23,30,Gene_or_gene_product	KDR,36,39,Gene_or_gene_product	"[{""token"": ""B"", ""start_span"": 17, ""end_span"": 18, ""type"": ""Gene_or_gene_product""}, {""token"": ""C"", ""start_span"": 20, ""end_span"": 21, ""type"": ""Gene_or_gene_product""}, {""token"": ""Flt - 1"", ""start_span"": 23, ""end_span"": 30, ""type"": ""Gene_or_gene_product""}, {""token"": ""KDR"", ""start_span"": 36, ""end_span"": 39, ""type"": ""Gene_or_gene_product""}]"	train
CONCLUSIONS: VEGF - A ( 165) is one of the major angiogenesis regulators among the ligands ' family of VEGF, whereas its receptors KDR, and most probably Flt - 1, may contribute to a poor prognosis ( angiogenic) phenotype, as indicated by their upregulated MRNA levels in stage III neuroblastoma.	VEGF,13,17,Gene_or_gene_product	KDR,131,134,Gene_or_gene_product	Flt - 1,154,161,Gene_or_gene_product	stage III neuroblastoma,272,295,Cancer	"[{""token"": ""VEGF"", ""start_span"": 13, ""end_span"": 17, ""type"": ""Gene_or_gene_product""}, {""token"": ""KDR"", ""start_span"": 131, ""end_span"": 134, ""type"": ""Gene_or_gene_product""}, {""token"": ""Flt - 1"", ""start_span"": 154, ""end_span"": 161, ""type"": ""Gene_or_gene_product""}, {""token"": ""stage III neuroblastoma"", ""start_span"": 272, ""end_span"": 295, ""type"": ""Cancer""}]"	train
Lactate and pyruvate, the end products of glycolysis, are highly produced by cancer cells even in the presence of oxygen.	Lactate,0,7,Chemical	pyruvate,12,20,Chemical	cancer cells,77,89,Cell	oxygen,114,120,Chemical	"[{""token"": ""Lactate"", ""start_span"": 0, ""end_span"": 7, ""type"": ""Chemical""}, {""token"": ""pyruvate"", ""start_span"": 12, ""end_span"": 20, ""type"": ""Chemical""}, {""token"": ""cancer cells"", ""start_span"": 77, ""end_span"": 89, ""type"": ""Cell""}, {""token"": ""oxygen"", ""start_span"": 114, ""end_span"": 120, ""type"": ""Chemical""}]"	train
Here we provide evidence that lactate and pyruvate regulate hypoxia - inducible gene expression independently of hypoxia by stimulating the accumulation of hypoxia - inducible Factor 1alpha ( HIF - 1alpha).	lactate,30,37,Chemical	pyruvate,42,50,Chemical	hypoxia - inducible Factor 1alpha,156,189,Gene_or_gene_product	HIF - 1alpha,192,204,Gene_or_gene_product	"[{""token"": ""lactate"", ""start_span"": 30, ""end_span"": 37, ""type"": ""Chemical""}, {""token"": ""pyruvate"", ""start_span"": 42, ""end_span"": 50, ""type"": ""Chemical""}, {""token"": ""hypoxia - inducible Factor 1alpha"", ""start_span"": 156, ""end_span"": 189, ""type"": ""Gene_or_gene_product""}, {""token"": ""HIF - 1alpha"", ""start_span"": 192, ""end_span"": 204, ""type"": ""Gene_or_gene_product""}]"	train
To address this, the Severe Chronic Neutropenia International Registry ( SCNIR) used its large database of chronic neutropenia patients treated with G - CSF to determine the incidence of malignant myeloid transformation in the two disorders, and its relationship to treatment and to other patient characteristics.	patients,127,135,Organism	G - CSF,149,156,Gene_or_gene_product	malignant myeloid,187,204,Cell	patient,289,296,Organism	"[{""token"": ""patients"", ""start_span"": 127, ""end_span"": 135, ""type"": ""Organism""}, {""token"": ""G - CSF"", ""start_span"": 149, ""end_span"": 156, ""type"": ""Gene_or_gene_product""}, {""token"": ""malignant myeloid"", ""start_span"": 187, ""end_span"": 204, ""type"": ""Cell""}, {""token"": ""patient"", ""start_span"": 289, ""end_span"": 296, ""type"": ""Organism""}]"	train
No statistically significant relationships were found between age at onset of MDS or AML and patient gender, G - CSF dose, or duration of G - CSF therapy.	AML,85,88,Cancer	patient,93,100,Organism	G - CSF,109,116,Gene_or_gene_product	G - CSF,138,145,Gene_or_gene_product	"[{""token"": ""AML"", ""start_span"": 85, ""end_span"": 88, ""type"": ""Cancer""}, {""token"": ""patient"", ""start_span"": 93, ""end_span"": 100, ""type"": ""Organism""}, {""token"": ""G - CSF"", ""start_span"": 109, ""end_span"": 116, ""type"": ""Gene_or_gene_product""}, {""token"": ""G - CSF"", ""start_span"": 138, ""end_span"": 145, ""type"": ""Gene_or_gene_product""}]"	train
Increased VEGF expression by malignant tumors has been associated with high vascularity, increased cancer cell growth, and lymph node metastasis.	VEGF,10,14,Gene_or_gene_product	malignant tumors,29,45,Cancer	cancer cell,99,110,Cell	lymph node,123,133,Multi	"[{""token"": ""VEGF"", ""start_span"": 10, ""end_span"": 14, ""type"": ""Gene_or_gene_product""}, {""token"": ""malignant tumors"", ""start_span"": 29, ""end_span"": 45, ""type"": ""Cancer""}, {""token"": ""cancer cell"", ""start_span"": 99, ""end_span"": 110, ""type"": ""Cell""}, {""token"": ""lymph node"", ""start_span"": 123, ""end_span"": 133, ""type"": ""Multi""}]"	train
Reduced oxygen tension has been shown to increase VEGF production by induction of the transcription factor hypoxia inducible factor 1 alpha ( HIF - 1alpha).	oxygen,8,14,Chemical	VEGF,50,54,Gene_or_gene_product	hypoxia inducible factor 1 alpha,107,139,Gene_or_gene_product	HIF - 1alpha,142,154,Gene_or_gene_product	"[{""token"": ""oxygen"", ""start_span"": 8, ""end_span"": 14, ""type"": ""Chemical""}, {""token"": ""VEGF"", ""start_span"": 50, ""end_span"": 54, ""type"": ""Gene_or_gene_product""}, {""token"": ""hypoxia inducible factor 1 alpha"", ""start_span"": 107, ""end_span"": 139, ""type"": ""Gene_or_gene_product""}, {""token"": ""HIF - 1alpha"", ""start_span"": 142, ""end_span"": 154, ""type"": ""Gene_or_gene_product""}]"	train
To determine if hypoxic activation of these stress activated protein kinases regulated HIF - 1alpha and VEGF expression, we assayed JNK1 and p38 activity in squamous cell carcinoma ( SCC) lines grown under normoxic or hypoxic conditions.	HIF - 1alpha,87,99,Gene_or_gene_product	VEGF,104,108,Gene_or_gene_product	JNK1,132,136,Gene_or_gene_product	p38,141,144,Gene_or_gene_product	"[{""token"": ""HIF - 1alpha"", ""start_span"": 87, ""end_span"": 99, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF"", ""start_span"": 104, ""end_span"": 108, ""type"": ""Gene_or_gene_product""}, {""token"": ""JNK1"", ""start_span"": 132, ""end_span"": 136, ""type"": ""Gene_or_gene_product""}, {""token"": ""p38"", ""start_span"": 141, ""end_span"": 144, ""type"": ""Gene_or_gene_product""}]"	train
This activation correlated with induction of HIF - 1alpha expression and DNA binding activity which was blocked by the p38 inhibitor SB203580.	HIF - 1alpha,45,57,Gene_or_gene_product	DNA,73,76,Cellular_component	p38,119,122,Gene_or_gene_product	SB203580,133,141,Chemical	"[{""token"": ""HIF - 1alpha"", ""start_span"": 45, ""end_span"": 57, ""type"": ""Gene_or_gene_product""}, {""token"": ""DNA"", ""start_span"": 73, ""end_span"": 76, ""type"": ""Cellular_component""}, {""token"": ""p38"", ""start_span"": 119, ""end_span"": 122, ""type"": ""Gene_or_gene_product""}, {""token"": ""SB203580"", ""start_span"": 133, ""end_span"": 141, ""type"": ""Chemical""}]"	train
Overexpression of JNK1 or p38 was sufficient to induce HIF - 1alpha and VEGF expression.	JNK1,18,22,Gene_or_gene_product	p38,26,29,Gene_or_gene_product	HIF - 1alpha,55,67,Gene_or_gene_product	VEGF,72,76,Gene_or_gene_product	"[{""token"": ""JNK1"", ""start_span"": 18, ""end_span"": 22, ""type"": ""Gene_or_gene_product""}, {""token"": ""p38"", ""start_span"": 26, ""end_span"": 29, ""type"": ""Gene_or_gene_product""}, {""token"": ""HIF - 1alpha"", ""start_span"": 55, ""end_span"": 67, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF"", ""start_span"": 72, ""end_span"": 76, ""type"": ""Gene_or_gene_product""}]"	train
These results indicate that induction of SAPKs by hypoxia regulates HIF - 1alpha and VEGF expression in head and neck carcinoma cell lines.	SAPKs,41,46,Gene_or_gene_product	HIF - 1alpha,68,80,Gene_or_gene_product	VEGF,85,89,Gene_or_gene_product	head and neck carcinoma cell lines,104,138,Cell	"[{""token"": ""SAPKs"", ""start_span"": 41, ""end_span"": 46, ""type"": ""Gene_or_gene_product""}, {""token"": ""HIF - 1alpha"", ""start_span"": 68, ""end_span"": 80, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF"", ""start_span"": 85, ""end_span"": 89, ""type"": ""Gene_or_gene_product""}, {""token"": ""head and neck carcinoma cell lines"", ""start_span"": 104, ""end_span"": 138, ""type"": ""Cell""}]"	train
Simian virus 40 large T antigen and two independent T - antigen segments sensitize cells to apoptosis following genotoxic damage.	Simian virus 40,0,15,Organism	large T antigen,16,31,Gene_or_gene_product	T - antigen,52,63,Gene_or_gene_product	cells,83,88,Cell	"[{""token"": ""Simian virus 40"", ""start_span"": 0, ""end_span"": 15, ""type"": ""Organism""}, {""token"": ""large T antigen"", ""start_span"": 16, ""end_span"": 31, ""type"": ""Gene_or_gene_product""}, {""token"": ""T - antigen"", ""start_span"": 52, ""end_span"": 63, ""type"": ""Gene_or_gene_product""}, {""token"": ""cells"", ""start_span"": 83, ""end_span"": 88, ""type"": ""Cell""}]"	train
The simian virus 40 ( SV40) large tumor ( T) antigen is sufficient to transform cells in cultures and induce tumors in experimental animals.	simian virus 40,4,19,Organism	SV40,22,26,Organism	cells,80,85,Cell	tumors,109,115,Cancer	"[{""token"": ""simian virus 40"", ""start_span"": 4, ""end_span"": 19, ""type"": ""Organism""}, {""token"": ""SV40"", ""start_span"": 22, ""end_span"": 26, ""type"": ""Organism""}, {""token"": ""cells"", ""start_span"": 80, ""end_span"": 85, ""type"": ""Cell""}, {""token"": ""tumors"", ""start_span"": 109, ""end_span"": 115, ""type"": ""Cancer""}]"	train
The study presented here examined the ability of specific regions and activities of T antigen to modulate apoptosis in cells treated with the genotoxic agent 5 - fluorouracil ( 5 - FU).	T antigen,84,93,Gene_or_gene_product	cells,119,124,Cell	5 - fluorouracil,158,174,Chemical	5 - FU,177,183,Chemical	"[{""token"": ""T antigen"", ""start_span"": 84, ""end_span"": 93, ""type"": ""Gene_or_gene_product""}, {""token"": ""cells"", ""start_span"": 119, ""end_span"": 124, ""type"": ""Cell""}, {""token"": ""5 - fluorouracil"", ""start_span"": 158, ""end_span"": 174, ""type"": ""Chemical""}, {""token"": ""5 - FU"", ""start_span"": 177, ""end_span"": 183, ""type"": ""Chemical""}]"	train
T - antigen - mediated sensitization occurred independently of retinoblastoma protein or p53 and p300 binding.	T - antigen,0,11,Gene_or_gene_product	retinoblastoma protein,63,85,Gene_or_gene_product	p53,89,92,Gene_or_gene_product	p300,97,101,Gene_or_gene_product	"[{""token"": ""T - antigen"", ""start_span"": 0, ""end_span"": 11, ""type"": ""Gene_or_gene_product""}, {""token"": ""retinoblastoma protein"", ""start_span"": 63, ""end_span"": 85, ""type"": ""Gene_or_gene_product""}, {""token"": ""p53"", ""start_span"": 89, ""end_span"": 92, ""type"": ""Gene_or_gene_product""}, {""token"": ""p300"", ""start_span"": 97, ""end_span"": 101, ""type"": ""Gene_or_gene_product""}]"	train
A C - terminal segment consisting of T - antigen amino acids 251 to 708 ( T251 - 708) also sensitized cells to 5 - FU - induced apoptosis.	T - antigen,37,48,Gene_or_gene_product	amino acids,49,60,Amino_acid	cells,102,107,Cell	5 - FU,111,117,Chemical	"[{""token"": ""T - antigen"", ""start_span"": 37, ""end_span"": 48, ""type"": ""Gene_or_gene_product""}, {""token"": ""amino acids"", ""start_span"": 49, ""end_span"": 60, ""type"": ""Amino_acid""}, {""token"": ""cells"", ""start_span"": 102, ""end_span"": 107, ""type"": ""Cell""}, {""token"": ""5 - FU"", ""start_span"": 111, ""end_span"": 117, ""type"": ""Chemical""}]"	train
Possible mechanisms involved in sensitizing cells to a p53 - dependent apoptosis pathway in spite of the ability of T antigen to bind and inactivate the transcriptional transactivating activity of p53 are discussed.	cells,44,49,Cell	p53,55,58,Gene_or_gene_product	T antigen,116,125,Gene_or_gene_product	p53,197,200,Gene_or_gene_product	"[{""token"": ""cells"", ""start_span"": 44, ""end_span"": 49, ""type"": ""Cell""}, {""token"": ""p53"", ""start_span"": 55, ""end_span"": 58, ""type"": ""Gene_or_gene_product""}, {""token"": ""T antigen"", ""start_span"": 116, ""end_span"": 125, ""type"": ""Gene_or_gene_product""}, {""token"": ""p53"", ""start_span"": 197, ""end_span"": 200, ""type"": ""Gene_or_gene_product""}]"	train
Based on these optimized parameters, a prototype diagnostic / treatment system was designed that captures high - speed indocyanine green ( ICG) angiogram images and facilitates analysis of the images by enhancing visualization of dye movement through CNV feeder vessels ( FVs).	indocyanine green,119,136,Chemical	ICG,139,142,Chemical	feeder vessels,255,269,Multi	FVs,272,275,Multi	"[{""token"": ""indocyanine green"", ""start_span"": 119, ""end_span"": 136, ""type"": ""Chemical""}, {""token"": ""ICG"", ""start_span"": 139, ""end_span"": 142, ""type"": ""Chemical""}, {""token"": ""feeder vessels"", ""start_span"": 255, ""end_span"": 269, ""type"": ""Multi""}, {""token"": ""FVs"", ""start_span"": 272, ""end_span"": 275, ""type"": ""Multi""}]"	train
Target FVs are tracked by a joy - stick controlled laser aiming beam until an intravenously - injected high - concentration ICG dye bolus is observed to enter the target vessel, at which time the laser is fired.	FVs,7,10,Multi	intravenously,78,91,Immaterial_anatomical_entity	ICG dye,124,131,Chemical	vessel,170,176,Multi	"[{""token"": ""FVs"", ""start_span"": 7, ""end_span"": 10, ""type"": ""Multi""}, {""token"": ""intravenously"", ""start_span"": 78, ""end_span"": 91, ""type"": ""Immaterial_anatomical_entity""}, {""token"": ""ICG dye"", ""start_span"": 124, ""end_span"": 131, ""type"": ""Chemical""}, {""token"": ""vessel"", ""start_span"": 170, ""end_span"": 176, ""type"": ""Multi""}]"	train
RESULTS: Using ICG - DEP, CNV feeder vessels were closed with single pulse laser energy, delivering as little as 0. 6 to 1. 8 J of energy to the fundus, producing no visible change in the fundus.	ICG,15,18,Chemical	feeder vessels,30,44,Multi	fundus,145,151,Multi	fundus,188,194,Multi	"[{""token"": ""ICG"", ""start_span"": 15, ""end_span"": 18, ""type"": ""Chemical""}, {""token"": ""feeder vessels"", ""start_span"": 30, ""end_span"": 44, ""type"": ""Multi""}, {""token"": ""fundus"", ""start_span"": 145, ""end_span"": 151, ""type"": ""Multi""}, {""token"": ""fundus"", ""start_span"": 188, ""end_span"": 194, ""type"": ""Multi""}]"	train
Dietary conjugated linoleic acid ( CLA) has been shown previously to inhibit rat mammary carcinogenesis.	conjugated linoleic acid,8,32,Chemical	CLA,35,38,Chemical	rat,77,80,Organism	mammary,81,88,Organ	"[{""token"": ""conjugated linoleic acid"", ""start_span"": 8, ""end_span"": 32, ""type"": ""Chemical""}, {""token"": ""CLA"", ""start_span"": 35, ""end_span"": 38, ""type"": ""Chemical""}, {""token"": ""rat"", ""start_span"": 77, ""end_span"": 80, ""type"": ""Organism""}, {""token"": ""mammary"", ""start_span"": 81, ""end_span"": 88, ""type"": ""Organ""}]"	train
In addition to direct effects on mammary epithelial cells, including decreased proliferation and induction of apoptosis, CLA may exert its effects indirectly by inhibiting the differentiation of mammary stromal cells to an endothelial cell type.	mammary epithelial cells,33,57,Cell	CLA,121,124,Chemical	mammary stromal cells,195,216,Cell	endothelial cell type,223,244,Cell	"[{""token"": ""mammary epithelial cells"", ""start_span"": 33, ""end_span"": 57, ""type"": ""Cell""}, {""token"": ""CLA"", ""start_span"": 121, ""end_span"": 124, ""type"": ""Chemical""}, {""token"": ""mammary stromal cells"", ""start_span"": 195, ""end_span"": 216, ""type"": ""Cell""}, {""token"": ""endothelial cell type"", ""start_span"": 223, ""end_span"": 244, ""type"": ""Cell""}]"	train
Specifically, CLA was found to decrease the ability of mammary stromal cells to form complex anastomosing microcapillary networks in vitro on Engelbreth - Holm - Swarm - derived reconstituted basement membrane.	CLA,14,17,Chemical	mammary stromal cells,55,76,Cell	microcapillary networks,106,129,Multi	basement membrane,192,209,Cellular_component	"[{""token"": ""CLA"", ""start_span"": 14, ""end_span"": 17, ""type"": ""Chemical""}, {""token"": ""mammary stromal cells"", ""start_span"": 55, ""end_span"": 76, ""type"": ""Cell""}, {""token"": ""microcapillary networks"", ""start_span"": 106, ""end_span"": 129, ""type"": ""Multi""}, {""token"": ""basement membrane"", ""start_span"": 192, ""end_span"": 209, ""type"": ""Cellular_component""}]"	train
Both cis - 9, trans - 11 and trans - 10, cis - 12 CLA isomers were effective in inhibiting angiogenesis in vitro in a dose - dependent fashion.	cis - 9,5,12,Chemical	trans - 11,14,24,Chemical	trans - 10,29,39,Chemical	cis - 12 CLA isomers,41,61,Chemical	"[{""token"": ""cis - 9"", ""start_span"": 5, ""end_span"": 12, ""type"": ""Chemical""}, {""token"": ""trans - 11"", ""start_span"": 14, ""end_span"": 24, ""type"": ""Chemical""}, {""token"": ""trans - 10"", ""start_span"": 29, ""end_span"": 39, ""type"": ""Chemical""}, {""token"": ""cis - 12 CLA isomers"", ""start_span"": 41, ""end_span"": 61, ""type"": ""Chemical""}]"	train
ELISA found the presence of vascular endothelial growth factors ( VEGF) both in the tested oral cancer cells and NOK.	vascular endothelial growth factors,28,63,Gene_or_gene_product	VEGF,66,70,Gene_or_gene_product	oral cancer cells,91,108,Cell	NOK,113,116,Cell	"[{""token"": ""vascular endothelial growth factors"", ""start_span"": 28, ""end_span"": 63, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF"", ""start_span"": 66, ""end_span"": 70, ""type"": ""Gene_or_gene_product""}, {""token"": ""oral cancer cells"", ""start_span"": 91, ""end_span"": 108, ""type"": ""Cell""}, {""token"": ""NOK"", ""start_span"": 113, ""end_span"": 116, ""type"": ""Cell""}]"	train
This effect appears to be mediated, in part, by decreased expression of vascular endothelial ( VE) - cadherin by endothelial cells in the presence of TIMP - 3 as seen both in an in vitro assay and in TIMP - 3 - overexpressing tumors.	endothelial cells,113,130,Cell	TIMP - 3,150,158,Gene_or_gene_product	TIMP - 3,200,208,Gene_or_gene_product	tumors,226,232,Cancer	"[{""token"": ""endothelial cells"", ""start_span"": 113, ""end_span"": 130, ""type"": ""Cell""}, {""token"": ""TIMP - 3"", ""start_span"": 150, ""end_span"": 158, ""type"": ""Gene_or_gene_product""}, {""token"": ""TIMP - 3"", ""start_span"": 200, ""end_span"": 208, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumors"", ""start_span"": 226, ""end_span"": 232, ""type"": ""Cancer""}]"	train
Taken together, these results demonstrate that overexpression of TIMP - 3 can inhibit angiogenesis and associated tumor growth, and that the antiangiogenic effects of TIMP - 3 appear to be mediated through the inhibition of functional capillary morphogenesis.	TIMP - 3,65,73,Gene_or_gene_product	tumor,114,119,Cancer	TIMP - 3,167,175,Gene_or_gene_product	capillary,235,244,Tissue	"[{""token"": ""TIMP - 3"", ""start_span"": 65, ""end_span"": 73, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumor"", ""start_span"": 114, ""end_span"": 119, ""type"": ""Cancer""}, {""token"": ""TIMP - 3"", ""start_span"": 167, ""end_span"": 175, ""type"": ""Gene_or_gene_product""}, {""token"": ""capillary"", ""start_span"": 235, ""end_span"": 244, ""type"": ""Tissue""}]"	train
However, recent works demonstrate that Brn - 3a expression is not restricted to neuronal cells, as its activity was detected also in cancer cells of non - neuronal nature.	Brn - 3a,39,47,Gene_or_gene_product	neuronal cells,80,94,Cell	cancer cells,133,145,Cell	neuronal,155,163,Cell	"[{""token"": ""Brn - 3a"", ""start_span"": 39, ""end_span"": 47, ""type"": ""Gene_or_gene_product""}, {""token"": ""neuronal cells"", ""start_span"": 80, ""end_span"": 94, ""type"": ""Cell""}, {""token"": ""cancer cells"", ""start_span"": 133, ""end_span"": 145, ""type"": ""Cell""}, {""token"": ""neuronal"", ""start_span"": 155, ""end_span"": 163, ""type"": ""Cell""}]"	train
Identification of Dss1 as a 12 - O - tetradecanoylphorbol - 13 - acetate - responsive gene expressed in keratinocyte progenitor cells, with possible involvement in early skin tumorigenesis.	Dss1,18,22,Gene_or_gene_product	12 - O - tetradecanoylphorbol - 13 - acetate,28,72,Chemical	keratinocyte progenitor cells,104,133,Cell	skin,170,174,Organ	"[{""token"": ""Dss1"", ""start_span"": 18, ""end_span"": 22, ""type"": ""Gene_or_gene_product""}, {""token"": ""12 - O - tetradecanoylphorbol - 13 - acetate"", ""start_span"": 28, ""end_span"": 72, ""type"": ""Chemical""}, {""token"": ""keratinocyte progenitor cells"", ""start_span"": 104, ""end_span"": 133, ""type"": ""Cell""}, {""token"": ""skin"", ""start_span"": 170, ""end_span"": 174, ""type"": ""Organ""}]"	train
This study identifies genes expressed early in 12 - O - tetradecanoylphorbol - 13 - acetate ( TPA) - induced skin carcinogenesis in genetically initiated Tg. AC v - Ha - ras transgenic mice.	12 - O - tetradecanoylphorbol - 13 - acetate,47,91,Chemical	TPA,94,97,Chemical	skin,109,113,Organ	v - Ha - ras,161,173,Gene_or_gene_product	"[{""token"": ""12 - O - tetradecanoylphorbol - 13 - acetate"", ""start_span"": 47, ""end_span"": 91, ""type"": ""Chemical""}, {""token"": ""TPA"", ""start_span"": 94, ""end_span"": 97, ""type"": ""Chemical""}, {""token"": ""skin"", ""start_span"": 109, ""end_span"": 113, ""type"": ""Organ""}, {""token"": ""v - Ha - ras"", ""start_span"": 161, ""end_span"": 173, ""type"": ""Gene_or_gene_product""}]"	train
Dss1 overexpression was detected by Northern blot analysis in early TPA - treated hyperplastic skins and in JB6 Cl 41 - 5a epidermal cells.	Dss1,0,4,Gene_or_gene_product	TPA,68,71,Chemical	skins,95,100,Organ	JB6 Cl 41 - 5a epidermal cells,108,138,Cell	"[{""token"": ""Dss1"", ""start_span"": 0, ""end_span"": 4, ""type"": ""Gene_or_gene_product""}, {""token"": ""TPA"", ""start_span"": 68, ""end_span"": 71, ""type"": ""Chemical""}, {""token"": ""skins"", ""start_span"": 95, ""end_span"": 100, ""type"": ""Organ""}, {""token"": ""JB6 Cl 41 - 5a epidermal cells"", ""start_span"": 108, ""end_span"": 138, ""type"": ""Cell""}]"	train
Interestingly, Dss1 expression was also shown to be elevated in skin papillomas relative to normal skins, and further increased in squamous cell malignancies.	Dss1,15,19,Gene_or_gene_product	skin papillomas,64,79,Organ	skins,99,104,Organ	squamous cell malignancies,131,157,Cell	"[{""token"": ""Dss1"", ""start_span"": 15, ""end_span"": 19, ""type"": ""Gene_or_gene_product""}, {""token"": ""skin papillomas"", ""start_span"": 64, ""end_span"": 79, ""type"": ""Organ""}, {""token"": ""skins"", ""start_span"": 99, ""end_span"": 104, ""type"": ""Organ""}, {""token"": ""squamous cell malignancies"", ""start_span"": 131, ""end_span"": 157, ""type"": ""Cell""}]"	train
Functional studies by ectopically constitutive expression of Dss1 in JB6 Cl 41 - 5a preneoplastic cells strongly increased focus formation and proliferation of these cells and enhanced efficiency of neoplastic transformation of the cells in soft agar.	Dss1,61,65,Gene_or_gene_product	JB6 Cl 41 - 5a preneoplastic cells,69,103,Cell	cells,166,171,Cell	cells,232,237,Cell	"[{""token"": ""Dss1"", ""start_span"": 61, ""end_span"": 65, ""type"": ""Gene_or_gene_product""}, {""token"": ""JB6 Cl 41 - 5a preneoplastic cells"", ""start_span"": 69, ""end_span"": 103, ""type"": ""Cell""}, {""token"": ""cells"", ""start_span"": 166, ""end_span"": 171, ""type"": ""Cell""}, {""token"": ""cells"", ""start_span"": 232, ""end_span"": 237, ""type"": ""Cell""}]"	train
In contrast, CH - 11 binds to Fas, but is unable to transmit the death signal beyond the plasma membrane suggesting a block at the DISC ( death inducing signaling complex).	Fas,30,33,Gene_or_gene_product	plasma membrane,89,104,Cellular_component	DISC,131,135,Gene_or_gene_product	death inducing signaling complex,138,170,Gene_or_gene_product	"[{""token"": ""Fas"", ""start_span"": 30, ""end_span"": 33, ""type"": ""Gene_or_gene_product""}, {""token"": ""plasma membrane"", ""start_span"": 89, ""end_span"": 104, ""type"": ""Cellular_component""}, {""token"": ""DISC"", ""start_span"": 131, ""end_span"": 135, ""type"": ""Gene_or_gene_product""}, {""token"": ""death inducing signaling complex"", ""start_span"": 138, ""end_span"": 170, ""type"": ""Gene_or_gene_product""}]"	train
Topoisomerase I ( topo I) is an important target for the treatment of malignant disease, especially colorectal cancer.	Topoisomerase I,0,15,Gene_or_gene_product	topo I,18,24,Gene_or_gene_product	malignant disease,70,87,Cancer	colorectal cancer,100,117,Cancer	"[{""token"": ""Topoisomerase I"", ""start_span"": 0, ""end_span"": 15, ""type"": ""Gene_or_gene_product""}, {""token"": ""topo I"", ""start_span"": 18, ""end_span"": 24, ""type"": ""Gene_or_gene_product""}, {""token"": ""malignant disease"", ""start_span"": 70, ""end_span"": 87, ""type"": ""Cancer""}, {""token"": ""colorectal cancer"", ""start_span"": 100, ""end_span"": 117, ""type"": ""Cancer""}]"	train
Immunohistochemistry assay was performed for topo I protein expression in 249 primary human colorectal cancer and 42 paired lymph node metastasis samples.	topo I,45,51,Gene_or_gene_product	human,86,91,Organism	colorectal cancer,92,109,Cancer	lymph node metastasis samples,124,153,Cancer	"[{""token"": ""topo I"", ""start_span"": 45, ""end_span"": 51, ""type"": ""Gene_or_gene_product""}, {""token"": ""human"", ""start_span"": 86, ""end_span"": 91, ""type"": ""Organism""}, {""token"": ""colorectal cancer"", ""start_span"": 92, ""end_span"": 109, ""type"": ""Cancer""}, {""token"": ""lymph node metastasis samples"", ""start_span"": 124, ""end_span"": 153, ""type"": ""Cancer""}]"	train
Patients with rectal cancer had greater topo I expression than those with colon tumors ( P =. 029).	Patients,0,8,Organism	rectal cancer,14,27,Cancer	topo I,40,46,Gene_or_gene_product	colon tumors,74,86,Cancer	"[{""token"": ""Patients"", ""start_span"": 0, ""end_span"": 8, ""type"": ""Organism""}, {""token"": ""rectal cancer"", ""start_span"": 14, ""end_span"": 27, ""type"": ""Cancer""}, {""token"": ""topo I"", ""start_span"": 40, ""end_span"": 46, ""type"": ""Gene_or_gene_product""}, {""token"": ""colon tumors"", ""start_span"": 74, ""end_span"": 86, ""type"": ""Cancer""}]"	train
p53 and PCNA status do not appear to influence topo I expression, and topo I has no apparent association with the acquisition of a metastatic phenotype.	p53,0,3,Gene_or_gene_product	PCNA,8,12,Gene_or_gene_product	topo I,47,53,Gene_or_gene_product	topo I,70,76,Gene_or_gene_product	"[{""token"": ""p53"", ""start_span"": 0, ""end_span"": 3, ""type"": ""Gene_or_gene_product""}, {""token"": ""PCNA"", ""start_span"": 8, ""end_span"": 12, ""type"": ""Gene_or_gene_product""}, {""token"": ""topo I"", ""start_span"": 47, ""end_span"": 53, ""type"": ""Gene_or_gene_product""}, {""token"": ""topo I"", ""start_span"": 70, ""end_span"": 76, ""type"": ""Gene_or_gene_product""}]"	train
METHODS: Immunohistochemical and PCR - SSCP techniques were used to detect c - kit protein expression and c - kit gene exon 11 mutation in 82 patients with GIST.	c - kit,75,82,Gene_or_gene_product	c - kit,106,113,Gene_or_gene_product	patients,142,150,Organism	GIST,156,160,Cancer	"[{""token"": ""c - kit"", ""start_span"": 75, ""end_span"": 82, ""type"": ""Gene_or_gene_product""}, {""token"": ""c - kit"", ""start_span"": 106, ""end_span"": 113, ""type"": ""Gene_or_gene_product""}, {""token"": ""patients"", ""start_span"": 142, ""end_span"": 150, ""type"": ""Organism""}, {""token"": ""GIST"", ""start_span"": 156, ""end_span"": 160, ""type"": ""Cancer""}]"	train
Correlating the results of these two methods and clinicopathological factors, the c - kit expression and c - kit gene mutation rates were 95. 0% ( 19 / 20) and 0 in benign GIST, and were 98. 4% ( 61 / 62), 54. 8% ( 34 / 62) in malignant GIST.	c - kit,82,89,Gene_or_gene_product	c - kit,105,112,Gene_or_gene_product	benign GIST,165,176,Cancer	malignant GIST,227,241,Cancer	"[{""token"": ""c - kit"", ""start_span"": 82, ""end_span"": 89, ""type"": ""Gene_or_gene_product""}, {""token"": ""c - kit"", ""start_span"": 105, ""end_span"": 112, ""type"": ""Gene_or_gene_product""}, {""token"": ""benign GIST"", ""start_span"": 165, ""end_span"": 176, ""type"": ""Cancer""}, {""token"": ""malignant GIST"", ""start_span"": 227, ""end_span"": 241, ""type"": ""Cancer""}]"	train
Inhibition of glucose metabolism sensitizes tumor cells to death receptor - triggered apoptosis through enhancement of death - inducing signaling complex formation and apical procaspase - 8 processing.	glucose,14,21,Chemical	tumor cells,44,55,Cell	death - inducing signaling complex,119,153,Gene_or_gene_product	procaspase - 8,175,189,Gene_or_gene_product	"[{""token"": ""glucose"", ""start_span"": 14, ""end_span"": 21, ""type"": ""Chemical""}, {""token"": ""tumor cells"", ""start_span"": 44, ""end_span"": 55, ""type"": ""Cell""}, {""token"": ""death - inducing signaling complex"", ""start_span"": 119, ""end_span"": 153, ""type"": ""Gene_or_gene_product""}, {""token"": ""procaspase - 8"", ""start_span"": 175, ""end_span"": 189, ""type"": ""Gene_or_gene_product""}]"	train
Inhibition of glucose metabolism enhanced killing of myeloid leukemia U937, cervical carcinoma HeLa, and breast carcinoma MCF - 7 cells upon death receptor ligation.	glucose,14,21,Chemical	myeloid leukemia U937,53,74,Cell	cervical carcinoma HeLa,76,99,Cell	breast carcinoma MCF - 7 cells,105,135,Cell	"[{""token"": ""glucose"", ""start_span"": 14, ""end_span"": 21, ""type"": ""Chemical""}, {""token"": ""myeloid leukemia U937"", ""start_span"": 53, ""end_span"": 74, ""type"": ""Cell""}, {""token"": ""cervical carcinoma HeLa"", ""start_span"": 76, ""end_span"": 99, ""type"": ""Cell""}, {""token"": ""breast carcinoma MCF - 7 cells"", ""start_span"": 105, ""end_span"": 135, ""type"": ""Cell""}]"	train
Altogether, these results suggest that the glycolytic pathway may be an important target for therapeutic intervention to sensitize tumor cells to selectively toxic soluble death ligands or death ligand - expressing cells of the immune system by facilitating the activation of initiator caspase - 8.	tumor cells,131,142,Cell	cells,215,220,Cell	immune system,228,241,Anatomical_system	caspase - 8,286,297,Gene_or_gene_product	"[{""token"": ""tumor cells"", ""start_span"": 131, ""end_span"": 142, ""type"": ""Cell""}, {""token"": ""cells"", ""start_span"": 215, ""end_span"": 220, ""type"": ""Cell""}, {""token"": ""immune system"", ""start_span"": 228, ""end_span"": 241, ""type"": ""Anatomical_system""}, {""token"": ""caspase - 8"", ""start_span"": 286, ""end_span"": 297, ""type"": ""Gene_or_gene_product""}]"	train
In patients with atherosclerotic vascular diseases, collateral vessels bypassing major arterial obstructions have frequently been observed.	patients,3,11,Organism	vascular,33,41,Multi	collateral vessels,52,70,Multi	arterial obstructions,87,108,Pathological_formation	"[{""token"": ""patients"", ""start_span"": 3, ""end_span"": 11, ""type"": ""Organism""}, {""token"": ""vascular"", ""start_span"": 33, ""end_span"": 41, ""type"": ""Multi""}, {""token"": ""collateral vessels"", ""start_span"": 52, ""end_span"": 70, ""type"": ""Multi""}, {""token"": ""arterial obstructions"", ""start_span"": 87, ""end_span"": 108, ""type"": ""Pathological_formation""}]"	train
These results suggest the possibility that BV may exert an anti - tumor effect on human lung cancer.	BV,43,45,Organism_substance	tumor,66,71,Cancer	human,82,87,Organism	lung cancer,88,99,Cancer	"[{""token"": ""BV"", ""start_span"": 43, ""end_span"": 45, ""type"": ""Organism_substance""}, {""token"": ""tumor"", ""start_span"": 66, ""end_span"": 71, ""type"": ""Cancer""}, {""token"": ""human"", ""start_span"": 82, ""end_span"": 87, ""type"": ""Organism""}, {""token"": ""lung cancer"", ""start_span"": 88, ""end_span"": 99, ""type"": ""Cancer""}]"	train
In contrast, a selective COX - I inhibitor, SC - 560, had no effect on serum progesterone concentrations.	COX - I,25,32,Gene_or_gene_product	SC - 560,44,52,Chemical	serum,71,76,Organism_substance	progesterone,77,89,Chemical	"[{""token"": ""COX - I"", ""start_span"": 25, ""end_span"": 32, ""type"": ""Gene_or_gene_product""}, {""token"": ""SC - 560"", ""start_span"": 44, ""end_span"": 52, ""type"": ""Chemical""}, {""token"": ""serum"", ""start_span"": 71, ""end_span"": 76, ""type"": ""Organism_substance""}, {""token"": ""progesterone"", ""start_span"": 77, ""end_span"": 89, ""type"": ""Chemical""}]"	train
All of these parameters were reduced by the COX - II inhibitors, suggesting that changes in the vasculature are responsible for the decrease in serum progesterone.	COX - II,44,52,Gene_or_gene_product	vasculature,96,107,Multi	serum,144,149,Organism_substance	progesterone,150,162,Chemical	"[{""token"": ""COX - II"", ""start_span"": 44, ""end_span"": 52, ""type"": ""Gene_or_gene_product""}, {""token"": ""vasculature"", ""start_span"": 96, ""end_span"": 107, ""type"": ""Multi""}, {""token"": ""serum"", ""start_span"": 144, ""end_span"": 149, ""type"": ""Organism_substance""}, {""token"": ""progesterone"", ""start_span"": 150, ""end_span"": 162, ""type"": ""Chemical""}]"	train
Histological examination of ovarian corrosion casts indicated that NS - 398 inhibited the establishment of luteal capillary vessels following the injection of hCG.	ovarian,28,35,Organ	NS - 398,67,75,Chemical	luteal capillary vessels,107,131,Multi	hCG,159,162,Gene_or_gene_product	"[{""token"": ""ovarian"", ""start_span"": 28, ""end_span"": 35, ""type"": ""Organ""}, {""token"": ""NS - 398"", ""start_span"": 67, ""end_span"": 75, ""type"": ""Chemical""}, {""token"": ""luteal capillary vessels"", ""start_span"": 107, ""end_span"": 131, ""type"": ""Multi""}, {""token"": ""hCG"", ""start_span"": 159, ""end_span"": 162, ""type"": ""Gene_or_gene_product""}]"	train
Tumor angiogenesis modulates leukocyte - vessel wall interactions in vivo by reducing endothelial adhesion molecule expression.	Tumor,0,5,Cancer	leukocyte,29,38,Cell	vessel wall,41,52,Multi	endothelial adhesion molecule,86,115,Gene_or_gene_product	"[{""token"": ""Tumor"", ""start_span"": 0, ""end_span"": 5, ""type"": ""Cancer""}, {""token"": ""leukocyte"", ""start_span"": 29, ""end_span"": 38, ""type"": ""Cell""}, {""token"": ""vessel wall"", ""start_span"": 41, ""end_span"": 52, ""type"": ""Multi""}, {""token"": ""endothelial adhesion molecule"", ""start_span"": 86, ""end_span"": 115, ""type"": ""Gene_or_gene_product""}]"	train
Surprisingly, the level of leukocyte adhesion in ear venules of mice with a large flank tumor was also reduced significantly.	leukocyte,27,36,Cell	ear venules,49,60,Multi	mice,64,68,Organism	flank tumor,82,93,Cancer	"[{""token"": ""leukocyte"", ""start_span"": 27, ""end_span"": 36, ""type"": ""Cell""}, {""token"": ""ear venules"", ""start_span"": 49, ""end_span"": 60, ""type"": ""Multi""}, {""token"": ""mice"", ""start_span"": 64, ""end_span"": 68, ""type"": ""Organism""}, {""token"": ""flank tumor"", ""start_span"": 82, ""end_span"": 93, ""type"": ""Cancer""}]"	train
Leukocyte rolling, i. e., the step preceding adhesion, was not influenced by the presence of a tumor in nude mice, but was down - regulated in immune - competent C57Bl / 6 mice.	Leukocyte,0,9,Cell	tumor,95,100,Cancer	nude mice,104,113,Organism	C57Bl / 6 mice,162,176,Organism	"[{""token"": ""Leukocyte"", ""start_span"": 0, ""end_span"": 9, ""type"": ""Cell""}, {""token"": ""tumor"", ""start_span"": 95, ""end_span"": 100, ""type"": ""Cancer""}, {""token"": ""nude mice"", ""start_span"": 104, ""end_span"": 113, ""type"": ""Organism""}, {""token"": ""C57Bl / 6 mice"", ""start_span"": 162, ""end_span"": 176, ""type"": ""Organism""}]"	train
For efficacy studies, nude mice bearing orthotopically implanted tumors derived from breast cancer cell line MDA - MB - 435 were treated with galectin - 3C or a vehicle control i. m. twice daily for 90 days.	nude mice,22,31,Organism	tumors,65,71,Cancer	breast cancer cell line MDA - MB - 435,85,123,Cell	galectin - 3C,142,155,Gene_or_gene_product	"[{""token"": ""nude mice"", ""start_span"": 22, ""end_span"": 31, ""type"": ""Organism""}, {""token"": ""tumors"", ""start_span"": 65, ""end_span"": 71, ""type"": ""Cancer""}, {""token"": ""breast cancer cell line MDA - MB - 435"", ""start_span"": 85, ""end_span"": 123, ""type"": ""Cell""}, {""token"": ""galectin - 3C"", ""start_span"": 142, ""end_span"": 155, ""type"": ""Gene_or_gene_product""}]"	train
Prognostic value of p53 protein expression and vascular endothelial growth factor expression in resected squamous cell carcinoma of the esophagus.	p53,20,23,Gene_or_gene_product	vascular endothelial growth factor,47,81,Gene_or_gene_product	squamous cell carcinoma,105,128,Cancer	esophagus,136,145,Organ	"[{""token"": ""p53"", ""start_span"": 20, ""end_span"": 23, ""type"": ""Gene_or_gene_product""}, {""token"": ""vascular endothelial growth factor"", ""start_span"": 47, ""end_span"": 81, ""type"": ""Gene_or_gene_product""}, {""token"": ""squamous cell carcinoma"", ""start_span"": 105, ""end_span"": 128, ""type"": ""Cancer""}, {""token"": ""esophagus"", ""start_span"": 136, ""end_span"": 145, ""type"": ""Organ""}]"	train
Forty - seven specimens resected from patients with stage II and III squamous cell carcinoma ( SCC) of the esophagus were studied using immunohistochemical staining.	patients,38,46,Organism	squamous cell carcinoma,69,92,Cancer	SCC,95,98,Cancer	esophagus,107,116,Organ	"[{""token"": ""patients"", ""start_span"": 38, ""end_span"": 46, ""type"": ""Organism""}, {""token"": ""squamous cell carcinoma"", ""start_span"": 69, ""end_span"": 92, ""type"": ""Cancer""}, {""token"": ""SCC"", ""start_span"": 95, ""end_span"": 98, ""type"": ""Cancer""}, {""token"": ""esophagus"", ""start_span"": 107, ""end_span"": 116, ""type"": ""Organ""}]"	train
Therapeutic targeting of the survivin pathway in cancer: initiation of mitochondrial apoptosis and suppression of tumor - associated angiogenesis.	survivin,29,37,Gene_or_gene_product	cancer,49,55,Cancer	mitochondrial,71,84,Cellular_component	tumor,114,119,Cancer	"[{""token"": ""survivin"", ""start_span"": 29, ""end_span"": 37, ""type"": ""Gene_or_gene_product""}, {""token"": ""cancer"", ""start_span"": 49, ""end_span"": 55, ""type"": ""Cancer""}, {""token"": ""mitochondrial"", ""start_span"": 71, ""end_span"": 84, ""type"": ""Cellular_component""}, {""token"": ""tumor"", ""start_span"": 114, ""end_span"": 119, ""type"": ""Cancer""}]"	train
PURPOSE: Molecular antagonists of the inhibitor of apoptosis protein survivin have shown promise as novel anticancer strategies for triggering tumor cell apoptosis, dysregulating mitotic progression, and inhibiting tumor growth in preclinical models.	survivin,69,77,Gene_or_gene_product	anticancer,106,116,Cancer	tumor cell,143,153,Cell	tumor,215,220,Cancer	"[{""token"": ""survivin"", ""start_span"": 69, ""end_span"": 77, ""type"": ""Gene_or_gene_product""}, {""token"": ""anticancer"", ""start_span"": 106, ""end_span"": 116, ""type"": ""Cancer""}, {""token"": ""tumor cell"", ""start_span"": 143, ""end_span"": 153, ""type"": ""Cell""}, {""token"": ""tumor"", ""start_span"": 215, ""end_span"": 220, ""type"": ""Cancer""}]"	train
However, how survivin couples to the cell death machinery has remained elusive, and the relevant cellular targets of survivin antagonists have not been completely elucidated.	survivin,13,21,Gene_or_gene_product	cell,37,41,Cell	cellular,97,105,Cell	survivin,117,125,Gene_or_gene_product	"[{""token"": ""survivin"", ""start_span"": 13, ""end_span"": 21, ""type"": ""Gene_or_gene_product""}, {""token"": ""cell"", ""start_span"": 37, ""end_span"": 41, ""type"": ""Cell""}, {""token"": ""cellular"", ""start_span"": 97, ""end_span"": 105, ""type"": ""Cell""}, {""token"": ""survivin"", ""start_span"": 117, ""end_span"": 125, ""type"": ""Gene_or_gene_product""}]"	train
Conversely, expression of pAd - T34A caused apoptosis in umbilical vein and dermal microvascular endothelial cells and resulted in caspase - 3 activity.	pAd - T34A,26,36,Gene_or_gene_product	umbilical vein,57,71,Cell	dermal microvascular endothelial cells,76,114,Cell	caspase - 3,131,142,Gene_or_gene_product	"[{""token"": ""pAd - T34A"", ""start_span"": 26, ""end_span"": 36, ""type"": ""Gene_or_gene_product""}, {""token"": ""umbilical vein"", ""start_span"": 57, ""end_span"": 71, ""type"": ""Cell""}, {""token"": ""dermal microvascular endothelial cells"", ""start_span"": 76, ""end_span"": 114, ""type"": ""Cell""}, {""token"": ""caspase - 3"", ""start_span"": 131, ""end_span"": 142, ""type"": ""Gene_or_gene_product""}]"	train
CONCLUSIONS: Survivin functions as a novel upstream regulator of mitochondrial - dependent apoptosis, and molecular targeting of this pathway results in anticancer activity via a dual mechanism of induction of tumor cell apoptosis and suppression of angiogenesis.	Survivin,13,21,Gene_or_gene_product	mitochondrial,65,78,Cellular_component	anticancer,153,163,Cancer	tumor cell,210,220,Cell	"[{""token"": ""Survivin"", ""start_span"": 13, ""end_span"": 21, ""type"": ""Gene_or_gene_product""}, {""token"": ""mitochondrial"", ""start_span"": 65, ""end_span"": 78, ""type"": ""Cellular_component""}, {""token"": ""anticancer"", ""start_span"": 153, ""end_span"": 163, ""type"": ""Cancer""}, {""token"": ""tumor cell"", ""start_span"": 210, ""end_span"": 220, ""type"": ""Cell""}]"	train
To determine whether lipofection in other organs could be enhanced by increasing the degree of vascularization, we used a transgenic mouse model with tissue - specific angiogenesis in liver.	organs,42,48,Organ	mouse,133,138,Organism	tissue,150,156,Tissue	liver,184,189,Organ	"[{""token"": ""organs"", ""start_span"": 42, ""end_span"": 48, ""type"": ""Organ""}, {""token"": ""mouse"", ""start_span"": 133, ""end_span"": 138, ""type"": ""Organism""}, {""token"": ""tissue"", ""start_span"": 150, ""end_span"": 156, ""type"": ""Tissue""}, {""token"": ""liver"", ""start_span"": 184, ""end_span"": 189, ""type"": ""Organ""}]"	train
Proliferative diabetic retinopathy is associated with a low level of the natural ocular anti - angiogenic agent pigment epithelium - derived factor ( PEDF) in aqueous humor.	ocular,81,87,Organ	pigment epithelium - derived factor,112,147,Gene_or_gene_product	PEDF,150,154,Gene_or_gene_product	aqueous humor,159,172,Organism_substance	"[{""token"": ""ocular"", ""start_span"": 81, ""end_span"": 87, ""type"": ""Organ""}, {""token"": ""pigment epithelium - derived factor"", ""start_span"": 112, ""end_span"": 147, ""type"": ""Gene_or_gene_product""}, {""token"": ""PEDF"", ""start_span"": 150, ""end_span"": 154, ""type"": ""Gene_or_gene_product""}, {""token"": ""aqueous humor"", ""start_span"": 159, ""end_span"": 172, ""type"": ""Organism_substance""}]"	train
Levels of pro - angiogenic vascular endothelial growth factor ( VEGF) and angiogenic inhibitor pigment epithelium - derived factor ( PEDF) were determined.	vascular endothelial growth factor,27,61,Gene_or_gene_product	VEGF,64,68,Gene_or_gene_product	pigment epithelium - derived factor,95,130,Gene_or_gene_product	PEDF,133,137,Gene_or_gene_product	"[{""token"": ""vascular endothelial growth factor"", ""start_span"": 27, ""end_span"": 61, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF"", ""start_span"": 64, ""end_span"": 68, ""type"": ""Gene_or_gene_product""}, {""token"": ""pigment epithelium - derived factor"", ""start_span"": 95, ""end_span"": 130, ""type"": ""Gene_or_gene_product""}, {""token"": ""PEDF"", ""start_span"": 133, ""end_span"": 137, ""type"": ""Gene_or_gene_product""}]"	train
In seven diabetic patients with proliferative retinopathy, the most profound finding was a significant decrease of the PEDF level ( mean value: 237 ng / ml), whereas VEGF levels were comparable to diabetic patients without proliferation ( mean value: 3153; p = 0. 003).	patients,18,26,Organism	PEDF,119,123,Gene_or_gene_product	VEGF,166,170,Gene_or_gene_product	patients,206,214,Organism	"[{""token"": ""patients"", ""start_span"": 18, ""end_span"": 26, ""type"": ""Organism""}, {""token"": ""PEDF"", ""start_span"": 119, ""end_span"": 123, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF"", ""start_span"": 166, ""end_span"": 170, ""type"": ""Gene_or_gene_product""}, {""token"": ""patients"", ""start_span"": 206, ""end_span"": 214, ""type"": ""Organism""}]"	train
Expression of osteoprotegerin and RANK ligand in breast cancer bone metastasis.	osteoprotegerin,14,29,Gene_or_gene_product	RANK ligand,34,45,Gene_or_gene_product	breast cancer,49,62,Cancer	bone,63,67,Tissue	"[{""token"": ""osteoprotegerin"", ""start_span"": 14, ""end_span"": 29, ""type"": ""Gene_or_gene_product""}, {""token"": ""RANK ligand"", ""start_span"": 34, ""end_span"": 45, ""type"": ""Gene_or_gene_product""}, {""token"": ""breast cancer"", ""start_span"": 49, ""end_span"": 62, ""type"": ""Cancer""}, {""token"": ""bone"", ""start_span"": 63, ""end_span"": 67, ""type"": ""Tissue""}]"	train
These experiments demonstrate that direct interactions between breast cancer and stromal or osteoblastic cells induce osteoclastogenesis in vitro through modulating RANKL expression.	breast cancer,63,76,Cancer	stromal,81,88,Cell	osteoblastic cells,92,110,Cell	RANKL,165,170,Gene_or_gene_product	"[{""token"": ""breast cancer"", ""start_span"": 63, ""end_span"": 76, ""type"": ""Cancer""}, {""token"": ""stromal"", ""start_span"": 81, ""end_span"": 88, ""type"": ""Cell""}, {""token"": ""osteoblastic cells"", ""start_span"": 92, ""end_span"": 110, ""type"": ""Cell""}, {""token"": ""RANKL"", ""start_span"": 165, ""end_span"": 170, ""type"": ""Gene_or_gene_product""}]"	train
Interleukin - 1 ( IL - 1) synthesis in the brain is stimulated by mechanical injury and IL - 1 mimics some effects of injury, such as gliosis and neovascularization.	Interleukin - 1,0,15,Gene_or_gene_product	IL - 1,18,24,Gene_or_gene_product	brain,43,48,Organ	IL - 1,88,94,Gene_or_gene_product	"[{""token"": ""Interleukin - 1"", ""start_span"": 0, ""end_span"": 15, ""type"": ""Gene_or_gene_product""}, {""token"": ""IL - 1"", ""start_span"": 18, ""end_span"": 24, ""type"": ""Gene_or_gene_product""}, {""token"": ""brain"", ""start_span"": 43, ""end_span"": 48, ""type"": ""Organ""}, {""token"": ""IL - 1"", ""start_span"": 88, ""end_span"": 94, ""type"": ""Gene_or_gene_product""}]"	train
These data indicate that endogenous IL - 1 is a mediator of ischaemic and excitotoxic brain damage, and that inhibitors of IL - 1 action may be of therapeutic value in the treatment of acute or chronic neuronal death.	IL - 1,36,42,Gene_or_gene_product	brain,86,91,Organ	IL - 1,123,129,Gene_or_gene_product	neuronal,202,210,Cell	"[{""token"": ""IL - 1"", ""start_span"": 36, ""end_span"": 42, ""type"": ""Gene_or_gene_product""}, {""token"": ""brain"", ""start_span"": 86, ""end_span"": 91, ""type"": ""Organ""}, {""token"": ""IL - 1"", ""start_span"": 123, ""end_span"": 129, ""type"": ""Gene_or_gene_product""}, {""token"": ""neuronal"", ""start_span"": 202, ""end_span"": 210, ""type"": ""Cell""}]"	train
The interaction between the vascular endothelium and hemodynamic forces ( and more specifically, fluid shear stress), induced by the flow of blood, plays a major role in vascular remodeling and in new blood vessels formation via a process termed arteriogenesis.	vascular endothelium,28,48,Tissue	blood,141,146,Organism_substance	vascular,170,178,Multi	blood vessels,201,214,Multi	"[{""token"": ""vascular endothelium"", ""start_span"": 28, ""end_span"": 48, ""type"": ""Tissue""}, {""token"": ""blood"", ""start_span"": 141, ""end_span"": 146, ""type"": ""Organism_substance""}, {""token"": ""vascular"", ""start_span"": 170, ""end_span"": 178, ""type"": ""Multi""}, {""token"": ""blood vessels"", ""start_span"": 201, ""end_span"": 214, ""type"": ""Multi""}]"	train
The rapid down - regulation of Tie1 by shear stress changes and its rapid binding to Tie2 may be required for destabilization of endothelial cells in order to initiate the process of vascular restructuring.	Tie1,31,35,Gene_or_gene_product	Tie2,85,89,Gene_or_gene_product	endothelial cells,129,146,Cell	vascular,183,191,Multi	"[{""token"": ""Tie1"", ""start_span"": 31, ""end_span"": 35, ""type"": ""Gene_or_gene_product""}, {""token"": ""Tie2"", ""start_span"": 85, ""end_span"": 89, ""type"": ""Gene_or_gene_product""}, {""token"": ""endothelial cells"", ""start_span"": 129, ""end_span"": 146, ""type"": ""Cell""}, {""token"": ""vascular"", ""start_span"": 183, ""end_span"": 191, ""type"": ""Multi""}]"	train
Ischemia, involving restricted blood flow to tissues is the most common consequence of vessel dysfunction resulting in the disruption of oxygen and nutrient delivery and the accumulation of waste metabolites.	blood,31,36,Organism_substance	tissues,45,52,Tissue	vessel,87,93,Multi	oxygen,137,143,Chemical	"[{""token"": ""blood"", ""start_span"": 31, ""end_span"": 36, ""type"": ""Organism_substance""}, {""token"": ""tissues"", ""start_span"": 45, ""end_span"": 52, ""type"": ""Tissue""}, {""token"": ""vessel"", ""start_span"": 87, ""end_span"": 93, ""type"": ""Multi""}, {""token"": ""oxygen"", ""start_span"": 137, ""end_span"": 143, ""type"": ""Chemical""}]"	train
Expression, regulation, and function of IGF - 1, IGF - 1R, and IGF - 1 binding proteins in blood vessels.	IGF - 1,40,47,Gene_or_gene_product	IGF - 1R,49,57,Gene_or_gene_product	IGF - 1 binding proteins,63,87,Gene_or_gene_product	blood vessels,91,104,Multi	"[{""token"": ""IGF - 1"", ""start_span"": 40, ""end_span"": 47, ""type"": ""Gene_or_gene_product""}, {""token"": ""IGF - 1R"", ""start_span"": 49, ""end_span"": 57, ""type"": ""Gene_or_gene_product""}, {""token"": ""IGF - 1 binding proteins"", ""start_span"": 63, ""end_span"": 87, ""type"": ""Gene_or_gene_product""}, {""token"": ""blood vessels"", ""start_span"": 91, ""end_span"": 104, ""type"": ""Multi""}]"	train
The vascular insulin - like growth factor ( IGF) - 1 system includes the IGFs, the IGF - 1 receptor ( IGF - 1R), and multiple binding proteins.	vascular,4,12,Multi	IGFs,73,77,Gene_or_gene_product	IGF - 1 receptor,83,99,Gene_or_gene_product	IGF - 1R,102,110,Gene_or_gene_product	"[{""token"": ""vascular"", ""start_span"": 4, ""end_span"": 12, ""type"": ""Multi""}, {""token"": ""IGFs"", ""start_span"": 73, ""end_span"": 77, ""type"": ""Gene_or_gene_product""}, {""token"": ""IGF - 1 receptor"", ""start_span"": 83, ""end_span"": 99, ""type"": ""Gene_or_gene_product""}, {""token"": ""IGF - 1R"", ""start_span"": 102, ""end_span"": 110, ""type"": ""Gene_or_gene_product""}]"	train
The roles of miscrovascularity density ( MVD) and VEGF expression in the progression of oral squamous cell carcinoma ( OSCC) have been controversial.	miscrovascularity,13,30,Tissue	VEGF,50,54,Gene_or_gene_product	oral squamous cell carcinoma,88,116,Cancer	OSCC,119,123,Cancer	"[{""token"": ""miscrovascularity"", ""start_span"": 13, ""end_span"": 30, ""type"": ""Tissue""}, {""token"": ""VEGF"", ""start_span"": 50, ""end_span"": 54, ""type"": ""Gene_or_gene_product""}, {""token"": ""oral squamous cell carcinoma"", ""start_span"": 88, ""end_span"": 116, ""type"": ""Cancer""}, {""token"": ""OSCC"", ""start_span"": 119, ""end_span"": 123, ""type"": ""Cancer""}]"	train
The purpose of the present study was to measure the MVD and VEGF expression in a cohort of patients with betel - associated OSCC and to evaluate for possible clinicopathologic correlations.	VEGF,60,64,Gene_or_gene_product	patients,91,99,Organism	betel,105,110,Organism_subdivision	OSCC,124,128,Cancer	"[{""token"": ""VEGF"", ""start_span"": 60, ""end_span"": 64, ""type"": ""Gene_or_gene_product""}, {""token"": ""patients"", ""start_span"": 91, ""end_span"": 99, ""type"": ""Organism""}, {""token"": ""betel"", ""start_span"": 105, ""end_span"": 110, ""type"": ""Organism_subdivision""}, {""token"": ""OSCC"", ""start_span"": 124, ""end_span"": 128, ""type"": ""Cancer""}]"	train
The age and oral habits of patients, as well as the tumor site and size, did not appear to be correlated with h - MVD or VEGF immunoreactivity.	oral,12,16,Organism_subdivision	patients,27,35,Organism	tumor,52,57,Cancer	VEGF,121,125,Gene_or_gene_product	"[{""token"": ""oral"", ""start_span"": 12, ""end_span"": 16, ""type"": ""Organism_subdivision""}, {""token"": ""patients"", ""start_span"": 27, ""end_span"": 35, ""type"": ""Organism""}, {""token"": ""tumor"", ""start_span"": 52, ""end_span"": 57, ""type"": ""Cancer""}, {""token"": ""VEGF"", ""start_span"": 121, ""end_span"": 125, ""type"": ""Gene_or_gene_product""}]"	train
Here we show that heterozygous disruption of beclin 1 increases the frequency of spontaneous malignancies and accelerates the development of hepatitis B virus - induced premalignant lesions.	beclin 1,45,53,Gene_or_gene_product	malignancies,93,105,Cancer	hepatitis B virus,141,158,Organism	premalignant lesions,169,189,Pathological_formation	"[{""token"": ""beclin 1"", ""start_span"": 45, ""end_span"": 53, ""type"": ""Gene_or_gene_product""}, {""token"": ""malignancies"", ""start_span"": 93, ""end_span"": 105, ""type"": ""Cancer""}, {""token"": ""hepatitis B virus"", ""start_span"": 141, ""end_span"": 158, ""type"": ""Organism""}, {""token"": ""premalignant lesions"", ""start_span"": 169, ""end_span"": 189, ""type"": ""Pathological_formation""}]"	train
These findings demonstrate that beclin 1 is a haplo - insufficient tumor - suppressor gene and provide genetic evidence that autophagy is a novel mechanism of cell - growth control and tumor suppression.	beclin 1,32,40,Gene_or_gene_product	tumor,67,72,Cancer	cell,159,163,Cell	tumor,185,190,Cancer	"[{""token"": ""beclin 1"", ""start_span"": 32, ""end_span"": 40, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumor"", ""start_span"": 67, ""end_span"": 72, ""type"": ""Cancer""}, {""token"": ""cell"", ""start_span"": 159, ""end_span"": 163, ""type"": ""Cell""}, {""token"": ""tumor"", ""start_span"": 185, ""end_span"": 190, ""type"": ""Cancer""}]"	train
The interleukin ( IL) 2 - and beta ( 2) - microglobulin ( beta ( 2) m) - deficient ( IL - 2 ( null) x beta ( 2) m ( null)) mice spontaneously develop colon cancer in the setting of chronic UC.	IL - 2,85,91,Gene_or_gene_product	mice,123,127,Organism	colon cancer,150,162,Cancer	UC,189,191,Pathological_formation	"[{""token"": ""IL - 2"", ""start_span"": 85, ""end_span"": 91, ""type"": ""Gene_or_gene_product""}, {""token"": ""mice"", ""start_span"": 123, ""end_span"": 127, ""type"": ""Organism""}, {""token"": ""colon cancer"", ""start_span"": 150, ""end_span"": 162, ""type"": ""Cancer""}, {""token"": ""UC"", ""start_span"": 189, ""end_span"": 191, ""type"": ""Pathological_formation""}]"	train
However, the high mortality observed in the folate - deficient group precludes a definitive conclusion concerning the effect of folate deficiency on UC - associated colorectal carcinogenesis in this model.	folate,44,50,Chemical	folate,128,134,Chemical	UC,149,151,Pathological_formation	colorectal,165,175,Multi	"[{""token"": ""folate"", ""start_span"": 44, ""end_span"": 50, ""type"": ""Chemical""}, {""token"": ""folate"", ""start_span"": 128, ""end_span"": 134, ""type"": ""Chemical""}, {""token"": ""UC"", ""start_span"": 149, ""end_span"": 151, ""type"": ""Pathological_formation""}, {""token"": ""colorectal"", ""start_span"": 165, ""end_span"": 175, ""type"": ""Multi""}]"	train
We have recently found that sodium fluoride ( NaF) induced apoptotic cell death in tumor cell lines.	sodium fluoride,28,43,Chemical	NaF,46,49,Chemical	cell,69,73,Cell	tumor cell lines,83,99,Cell	"[{""token"": ""sodium fluoride"", ""start_span"": 28, ""end_span"": 43, ""type"": ""Chemical""}, {""token"": ""NaF"", ""start_span"": 46, ""end_span"": 49, ""type"": ""Chemical""}, {""token"": ""cell"", ""start_span"": 69, ""end_span"": 73, ""type"": ""Cell""}, {""token"": ""tumor cell lines"", ""start_span"": 83, ""end_span"": 99, ""type"": ""Cell""}]"	train
NaF and Group I compounds induced internucleosomal DNA fragmentation in HL - 60 cells, whereas Group II compounds were inactive even in the presence of NaF.	NaF,0,3,Chemical	DNA,51,54,Cellular_component	HL - 60 cells,72,85,Cell	NaF,152,155,Chemical	"[{""token"": ""NaF"", ""start_span"": 0, ""end_span"": 3, ""type"": ""Chemical""}, {""token"": ""DNA"", ""start_span"": 51, ""end_span"": 54, ""type"": ""Cellular_component""}, {""token"": ""HL - 60 cells"", ""start_span"": 72, ""end_span"": 85, ""type"": ""Cell""}, {""token"": ""NaF"", ""start_span"": 152, ""end_span"": 155, ""type"": ""Chemical""}]"	train
Caspase 8 ( involved in non - mitochondrial extrinsic pathway) and caspase 9 ( involved in mitochondrial intrinsic pathway) were also activated, but to a much lesser extent.	Caspase 8,0,9,Gene_or_gene_product	mitochondrial,30,43,Cellular_component	caspase 9,67,76,Gene_or_gene_product	mitochondrial,91,104,Cellular_component	"[{""token"": ""Caspase 8"", ""start_span"": 0, ""end_span"": 9, ""type"": ""Gene_or_gene_product""}, {""token"": ""mitochondrial"", ""start_span"": 30, ""end_span"": 43, ""type"": ""Cellular_component""}, {""token"": ""caspase 9"", ""start_span"": 67, ""end_span"": 76, ""type"": ""Gene_or_gene_product""}, {""token"": ""mitochondrial"", ""start_span"": 91, ""end_span"": 104, ""type"": ""Cellular_component""}]"	train
Gliomas are the most common primary tumours of the central nervous system, with nearly 15, 000 diagnosed annually in the United States and a lethality approaching 80% within the first year of glioblastoma diagnosis.	Gliomas,0,7,Cancer	tumours,36,43,Cancer	central nervous system,51,73,Anatomical_system	glioblastoma,192,204,Cancer	"[{""token"": ""Gliomas"", ""start_span"": 0, ""end_span"": 7, ""type"": ""Cancer""}, {""token"": ""tumours"", ""start_span"": 36, ""end_span"": 43, ""type"": ""Cancer""}, {""token"": ""central nervous system"", ""start_span"": 51, ""end_span"": 73, ""type"": ""Anatomical_system""}, {""token"": ""glioblastoma"", ""start_span"": 192, ""end_span"": 204, ""type"": ""Cancer""}]"	train
However many human carcinomas overexpress TGFbeta1 and this is associated with poor patient prognosis and increased frequency of metastasis.	human,13,18,Organism	carcinomas,19,29,Cancer	TGFbeta1,42,50,Gene_or_gene_product	patient,84,91,Organism	"[{""token"": ""human"", ""start_span"": 13, ""end_span"": 18, ""type"": ""Organism""}, {""token"": ""carcinomas"", ""start_span"": 19, ""end_span"": 29, ""type"": ""Cancer""}, {""token"": ""TGFbeta1"", ""start_span"": 42, ""end_span"": 50, ""type"": ""Gene_or_gene_product""}, {""token"": ""patient"", ""start_span"": 84, ""end_span"": 91, ""type"": ""Organism""}]"	train
Thrombin greatly potentiates vascular endothelial growth factor - ( VEGF -) induced endothelial cell proliferation.	Thrombin,0,8,Gene_or_gene_product	vascular endothelial growth factor,29,63,Gene_or_gene_product	VEGF,68,72,Gene_or_gene_product	endothelial cell,84,100,Cell	"[{""token"": ""Thrombin"", ""start_span"": 0, ""end_span"": 8, ""type"": ""Gene_or_gene_product""}, {""token"": ""vascular endothelial growth factor"", ""start_span"": 29, ""end_span"": 63, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF"", ""start_span"": 68, ""end_span"": 72, ""type"": ""Gene_or_gene_product""}, {""token"": ""endothelial cell"", ""start_span"": 84, ""end_span"": 100, ""type"": ""Cell""}]"	train
We have demonstrated recently that lactoferrin enhances the expression of a member of the tumor necrosis factor receptor family, Fas, in the colon mucosa during both early and late stages of carcinogenesis.	lactoferrin,35,46,Gene_or_gene_product	tumor necrosis factor receptor,90,120,Gene_or_gene_product	Fas,129,132,Gene_or_gene_product	colon mucosa,141,153,Multi	"[{""token"": ""lactoferrin"", ""start_span"": 35, ""end_span"": 46, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumor necrosis factor receptor"", ""start_span"": 90, ""end_span"": 120, ""type"": ""Gene_or_gene_product""}, {""token"": ""Fas"", ""start_span"": 129, ""end_span"": 132, ""type"": ""Gene_or_gene_product""}, {""token"": ""colon mucosa"", ""start_span"": 141, ""end_span"": 153, ""type"": ""Multi""}]"	train
Thus, Fas could be involved in bovine lactoferrin - mediated inhibition of tumor development.	Fas,6,9,Gene_or_gene_product	bovine,31,37,Organism	lactoferrin,38,49,Gene_or_gene_product	tumor,75,80,Cancer	"[{""token"": ""Fas"", ""start_span"": 6, ""end_span"": 9, ""type"": ""Gene_or_gene_product""}, {""token"": ""bovine"", ""start_span"": 31, ""end_span"": 37, ""type"": ""Organism""}, {""token"": ""lactoferrin"", ""start_span"": 38, ""end_span"": 49, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumor"", ""start_span"": 75, ""end_span"": 80, ""type"": ""Cancer""}]"	train
We identified dynein light chain 1 ( DLC1) as a physiologic substrate of p21 - activated kinase 1 ( Pak1).	dynein light chain 1,14,34,Gene_or_gene_product	DLC1,37,41,Gene_or_gene_product	p21 - activated kinase 1,73,97,Gene_or_gene_product	Pak1,100,104,Gene_or_gene_product	"[{""token"": ""dynein light chain 1"", ""start_span"": 14, ""end_span"": 34, ""type"": ""Gene_or_gene_product""}, {""token"": ""DLC1"", ""start_span"": 37, ""end_span"": 41, ""type"": ""Gene_or_gene_product""}, {""token"": ""p21 - activated kinase 1"", ""start_span"": 73, ""end_span"": 97, ""type"": ""Gene_or_gene_product""}, {""token"": ""Pak1"", ""start_span"": 100, ""end_span"": 104, ""type"": ""Gene_or_gene_product""}]"	train
The regulation of cell survival functions by Pak1 - DLC1 interaction represents a novel mechanism by which a signaling kinase might regulate the cancerous phenotypes.	cell,18,22,Cell	Pak1,45,49,Gene_or_gene_product	DLC1,52,56,Gene_or_gene_product	cancerous,145,154,Cancer	"[{""token"": ""cell"", ""start_span"": 18, ""end_span"": 22, ""type"": ""Cell""}, {""token"": ""Pak1"", ""start_span"": 45, ""end_span"": 49, ""type"": ""Gene_or_gene_product""}, {""token"": ""DLC1"", ""start_span"": 52, ""end_span"": 56, ""type"": ""Gene_or_gene_product""}, {""token"": ""cancerous"", ""start_span"": 145, ""end_span"": 154, ""type"": ""Cancer""}]"	train
The later expression of matrix metalloproteinase - 2 and - 9 in fibroblasts suggests a role in extracellular matrix remodeling.	matrix metalloproteinase - 2,24,52,Gene_or_gene_product	- 9,57,60,Gene_or_gene_product	fibroblasts,64,75,Cell	extracellular matrix,95,115,Cellular_component	"[{""token"": ""matrix metalloproteinase - 2"", ""start_span"": 24, ""end_span"": 52, ""type"": ""Gene_or_gene_product""}, {""token"": ""- 9"", ""start_span"": 57, ""end_span"": 60, ""type"": ""Gene_or_gene_product""}, {""token"": ""fibroblasts"", ""start_span"": 64, ""end_span"": 75, ""type"": ""Cell""}, {""token"": ""extracellular matrix"", ""start_span"": 95, ""end_span"": 115, ""type"": ""Cellular_component""}]"	train
Most of the studies focusing on the mechanisms of p53 activity have been performed in cultured cells upon treatment with well - established p53 - activating inputs, such as high doses of radiations, DNA - damaging drugs and activated oncogenes.	p53,50,53,Gene_or_gene_product	cells,95,100,Cell	p53,140,143,Gene_or_gene_product	DNA,199,202,Cellular_component	"[{""token"": ""p53"", ""start_span"": 50, ""end_span"": 53, ""type"": ""Gene_or_gene_product""}, {""token"": ""cells"", ""start_span"": 95, ""end_span"": 100, ""type"": ""Cell""}, {""token"": ""p53"", ""start_span"": 140, ""end_span"": 143, ""type"": ""Gene_or_gene_product""}, {""token"": ""DNA"", ""start_span"": 199, ""end_span"": 202, ""type"": ""Cellular_component""}]"	train
Intriguingly, two recent papers have shed new light into this unexplored field, indicating that p53 plays a key role in TGF - beta - induced growth arrest and, unexpectedly, in the developmental effects of TGF - beta in early embryos.	p53,96,99,Gene_or_gene_product	TGF - beta,120,130,Gene_or_gene_product	TGF - beta,206,216,Gene_or_gene_product	embryos,226,233,Developing_anatomical_structure	"[{""token"": ""p53"", ""start_span"": 96, ""end_span"": 99, ""type"": ""Gene_or_gene_product""}, {""token"": ""TGF - beta"", ""start_span"": 120, ""end_span"": 130, ""type"": ""Gene_or_gene_product""}, {""token"": ""TGF - beta"", ""start_span"": 206, ""end_span"": 216, ""type"": ""Gene_or_gene_product""}, {""token"": ""embryos"", ""start_span"": 226, ""end_span"": 233, ""type"": ""Developing_anatomical_structure""}]"	train
These effects translated into a 2. 2 - to 229. 0 - fold increase in the cytotoxic activity of ara - C against clonogenic leukemic cells after GM - CSF or IL - 3 pretreatment.	ara - C,94,101,Chemical	clonogenic leukemic cells,110,135,Cell	GM - CSF,142,150,Gene_or_gene_product	IL - 3,154,160,Gene_or_gene_product	"[{""token"": ""ara - C"", ""start_span"": 94, ""end_span"": 101, ""type"": ""Chemical""}, {""token"": ""clonogenic leukemic cells"", ""start_span"": 110, ""end_span"": 135, ""type"": ""Cell""}, {""token"": ""GM - CSF"", ""start_span"": 142, ""end_span"": 150, ""type"": ""Gene_or_gene_product""}, {""token"": ""IL - 3"", ""start_span"": 154, ""end_span"": 160, ""type"": ""Gene_or_gene_product""}]"	train
METHODS: We quantified expression of MCT isoforms in human glioblastoma multiforme and glioma - derived cells lines by Western blot analysis.	MCT,37,40,Gene_or_gene_product	human,53,58,Organism	glioblastoma multiforme,59,82,Cell	glioma - derived cells lines,87,115,Cell	"[{""token"": ""MCT"", ""start_span"": 37, ""end_span"": 40, ""type"": ""Gene_or_gene_product""}, {""token"": ""human"", ""start_span"": 53, ""end_span"": 58, ""type"": ""Organism""}, {""token"": ""glioblastoma multiforme"", ""start_span"": 59, ""end_span"": 82, ""type"": ""Cell""}, {""token"": ""glioma - derived cells lines"", ""start_span"": 87, ""end_span"": 115, ""type"": ""Cell""}]"	train
Proteome analysis of NIH3T3 cells transformed by activated Galpha12: regulation of leukemia - associated protein SET.	NIH3T3 cells,21,33,Cell	Galpha12,59,67,Gene_or_gene_product	leukemia,83,91,Cancer	SET,113,116,Gene_or_gene_product	"[{""token"": ""NIH3T3 cells"", ""start_span"": 21, ""end_span"": 33, ""type"": ""Cell""}, {""token"": ""Galpha12"", ""start_span"": 59, ""end_span"": 67, ""type"": ""Gene_or_gene_product""}, {""token"": ""leukemia"", ""start_span"": 83, ""end_span"": 91, ""type"": ""Cancer""}, {""token"": ""SET"", ""start_span"": 113, ""end_span"": 116, ""type"": ""Gene_or_gene_product""}]"	train
To identify the underlying mechanism involved in such growth - factor / serum independent growth of Galpha ( 12) QL - transformed NIH3T3, we carried out a two - dimensional differential proteome analysis of Galpha ( 12) QL - transformed NIH3T3 cells and cells expressing vector control.	serum,72,77,Organism_substance	NIH3T3,130,136,Cell	NIH3T3 cells,237,249,Cell	cells,254,259,Cell	"[{""token"": ""serum"", ""start_span"": 72, ""end_span"": 77, ""type"": ""Organism_substance""}, {""token"": ""NIH3T3"", ""start_span"": 130, ""end_span"": 136, ""type"": ""Cell""}, {""token"": ""NIH3T3 cells"", ""start_span"": 237, ""end_span"": 249, ""type"": ""Cell""}, {""token"": ""cells"", ""start_span"": 254, ""end_span"": 259, ""type"": ""Cell""}]"	train
Two of these spots were identified by MALDI - MS analysis as proliferating cell nuclear antigen ( PCNA) and myeloid - leukemia - associated SET protein.	proliferating cell nuclear antigen,61,95,Gene_or_gene_product	PCNA,98,102,Gene_or_gene_product	myeloid - leukemia,108,126,Cancer	SET,140,143,Gene_or_gene_product	"[{""token"": ""proliferating cell nuclear antigen"", ""start_span"": 61, ""end_span"": 95, ""type"": ""Gene_or_gene_product""}, {""token"": ""PCNA"", ""start_span"": 98, ""end_span"": 102, ""type"": ""Gene_or_gene_product""}, {""token"": ""myeloid - leukemia"", ""start_span"": 108, ""end_span"": 126, ""type"": ""Cancer""}, {""token"": ""SET"", ""start_span"": 140, ""end_span"": 143, ""type"": ""Gene_or_gene_product""}]"	train
As SET has been previously reported to be an inhibitor of phosphatase PP2A, the nuclear phosphatase activity was monitored in cells expressing activated Galpha ( 12).	SET,3,6,Gene_or_gene_product	PP2A,70,74,Gene_or_gene_product	nuclear,80,87,Cellular_component	cells,126,131,Cell	"[{""token"": ""SET"", ""start_span"": 3, ""end_span"": 6, ""type"": ""Gene_or_gene_product""}, {""token"": ""PP2A"", ""start_span"": 70, ""end_span"": 74, ""type"": ""Gene_or_gene_product""}, {""token"": ""nuclear"", ""start_span"": 80, ""end_span"": 87, ""type"": ""Cellular_component""}, {""token"": ""cells"", ""start_span"": 126, ""end_span"": 131, ""type"": ""Cell""}]"	train
RESULTS: 2ME2 exhibited antiproliferative and cytotoxic effects in a panel of five head and neck squamous cell carcinoma cell lines in the 0. 5 to 10 micromol / L range, including induction of G2 - M blockade, caspase - 3 / 7 activation, and apoptosis at 48 hours.	2ME2,9,13,Chemical	head and neck squamous cell carcinoma cell lines,83,131,Cell	caspase - 3,210,221,Gene_or_gene_product	7,224,225,Gene_or_gene_product	"[{""token"": ""2ME2"", ""start_span"": 9, ""end_span"": 13, ""type"": ""Chemical""}, {""token"": ""head and neck squamous cell carcinoma cell lines"", ""start_span"": 83, ""end_span"": 131, ""type"": ""Cell""}, {""token"": ""caspase - 3"", ""start_span"": 210, ""end_span"": 221, ""type"": ""Gene_or_gene_product""}, {""token"": ""7"", ""start_span"": 224, ""end_span"": 225, ""type"": ""Gene_or_gene_product""}]"	train
The up - regulation of Bid ( 57. 5% at 12 hours, P less than 0. 0006) and inhibition of vascular endothelial growth factor secretion ( 57. 7% at 24 hours, P less than 0. 015; and 50. 3% at 48 hours, P less than 0. 0006) could be partially attributed to the effects on HIF - 1alpha, because HIF - 1alpha small interfering RNAs produced similar effects.	Bid,23,26,Gene_or_gene_product	vascular endothelial growth factor,88,122,Gene_or_gene_product	HIF - 1alpha,268,280,Gene_or_gene_product	HIF - 1alpha,290,302,Gene_or_gene_product	"[{""token"": ""Bid"", ""start_span"": 23, ""end_span"": 26, ""type"": ""Gene_or_gene_product""}, {""token"": ""vascular endothelial growth factor"", ""start_span"": 88, ""end_span"": 122, ""type"": ""Gene_or_gene_product""}, {""token"": ""HIF - 1alpha"", ""start_span"": 268, ""end_span"": 280, ""type"": ""Gene_or_gene_product""}, {""token"": ""HIF - 1alpha"", ""start_span"": 290, ""end_span"": 302, ""type"": ""Gene_or_gene_product""}]"	train
Here, we demonstrate that HIF - 2alpha protein is selectively present in human fetal week 8. 5 SNS paraganglia.	HIF - 2alpha,26,38,Gene_or_gene_product	human,73,78,Organism	fetal,79,84,Developing_anatomical_structure	SNS paraganglia,95,110,Cell	"[{""token"": ""HIF - 2alpha"", ""start_span"": 26, ""end_span"": 38, ""type"": ""Gene_or_gene_product""}, {""token"": ""human"", ""start_span"": 73, ""end_span"": 78, ""type"": ""Organism""}, {""token"": ""fetal"", ""start_span"": 79, ""end_span"": 84, ""type"": ""Developing_anatomical_structure""}, {""token"": ""SNS paraganglia"", ""start_span"": 95, ""end_span"": 110, ""type"": ""Cell""}]"	train
In a subset of neuroblastomas, a spontaneous neuronal to neuroendocrine differentiation occurs in areas adjacent to necrotic zones.	neuroblastomas,15,29,Cancer	neuronal,45,53,Cell	neuroendocrine,57,71,Cell	necrotic zones,116,130,Tissue	"[{""token"": ""neuroblastomas"", ""start_span"": 15, ""end_span"": 29, ""type"": ""Cancer""}, {""token"": ""neuronal"", ""start_span"": 45, ""end_span"": 53, ""type"": ""Cell""}, {""token"": ""neuroendocrine"", ""start_span"": 57, ""end_span"": 71, ""type"": ""Cell""}, {""token"": ""necrotic zones"", ""start_span"": 116, ""end_span"": 130, ""type"": ""Tissue""}]"	train
As HIF - 2alpha activity has been associated not only with hypoxic but also with hypoglycemic conditions, we have investigated putative effects of hypoxia, glucose depletion, and HIF - 2alpha on the neuroblastoma phenotype.	HIF - 2alpha,3,15,Gene_or_gene_product	glucose,156,163,Chemical	HIF - 2alpha,179,191,Gene_or_gene_product	neuroblastoma,199,212,Cancer	"[{""token"": ""HIF - 2alpha"", ""start_span"": 3, ""end_span"": 15, ""type"": ""Gene_or_gene_product""}, {""token"": ""glucose"", ""start_span"": 156, ""end_span"": 163, ""type"": ""Chemical""}, {""token"": ""HIF - 2alpha"", ""start_span"": 179, ""end_span"": 191, ""type"": ""Gene_or_gene_product""}, {""token"": ""neuroblastoma"", ""start_span"": 199, ""end_span"": 212, ""type"": ""Cancer""}]"	train
HIF - 2alpha was detected in hypoxic and in well - oxygenized neuroblastoma cells and tissue, presumably reflecting their embryonic features.	HIF - 2alpha,0,12,Gene_or_gene_product	neuroblastoma cells,62,81,Cell	tissue,86,92,Tissue	embryonic,122,131,Developing_anatomical_structure	"[{""token"": ""HIF - 2alpha"", ""start_span"": 0, ""end_span"": 12, ""type"": ""Gene_or_gene_product""}, {""token"": ""neuroblastoma cells"", ""start_span"": 62, ""end_span"": 81, ""type"": ""Cell""}, {""token"": ""tissue"", ""start_span"": 86, ""end_span"": 92, ""type"": ""Tissue""}, {""token"": ""embryonic"", ""start_span"": 122, ""end_span"": 131, ""type"": ""Developing_anatomical_structure""}]"	train
Treatment of NIH3T3 / KDR cells with TKI - 31 blocked VEGF - induced phosphorylation of KDR in a dose - dependent manner.	NIH3T3 / KDR cells,13,31,Cell	TKI - 31,37,45,Chemical	VEGF,54,58,Gene_or_gene_product	KDR,88,91,Gene_or_gene_product	"[{""token"": ""NIH3T3 / KDR cells"", ""start_span"": 13, ""end_span"": 31, ""type"": ""Cell""}, {""token"": ""TKI - 31"", ""start_span"": 37, ""end_span"": 45, ""type"": ""Chemical""}, {""token"": ""VEGF"", ""start_span"": 54, ""end_span"": 58, ""type"": ""Gene_or_gene_product""}, {""token"": ""KDR"", ""start_span"": 88, ""end_span"": 91, ""type"": ""Gene_or_gene_product""}]"	train
This study suggests that angiogenin may be important in breast cancer progression and that, through its relationship with ER, it may be a target for tamoxifen.	angiogenin,25,35,Gene_or_gene_product	breast cancer,56,69,Cancer	ER,122,124,Gene_or_gene_product	tamoxifen,149,158,Chemical	"[{""token"": ""angiogenin"", ""start_span"": 25, ""end_span"": 35, ""type"": ""Gene_or_gene_product""}, {""token"": ""breast cancer"", ""start_span"": 56, ""end_span"": 69, ""type"": ""Cancer""}, {""token"": ""ER"", ""start_span"": 122, ""end_span"": 124, ""type"": ""Gene_or_gene_product""}, {""token"": ""tamoxifen"", ""start_span"": 149, ""end_span"": 158, ""type"": ""Chemical""}]"	train
Germline succinate dehydrogenase subunit A ( SDHA) mutations have been reported in a few patients with a classical mitochondrial neurodegenerative disease.	succinate dehydrogenase subunit A,9,42,Gene_or_gene_product	SDHA,45,49,Gene_or_gene_product	patients,89,97,Organism	mitochondrial,115,128,Cellular_component	"[{""token"": ""succinate dehydrogenase subunit A"", ""start_span"": 9, ""end_span"": 42, ""type"": ""Gene_or_gene_product""}, {""token"": ""SDHA"", ""start_span"": 45, ""end_span"": 49, ""type"": ""Gene_or_gene_product""}, {""token"": ""patients"", ""start_span"": 89, ""end_span"": 97, ""type"": ""Organism""}, {""token"": ""mitochondrial"", ""start_span"": 115, ""end_span"": 128, ""type"": ""Cellular_component""}]"	train
Mouse p10, an alternative spliced form of p15INK4b, inhibits cell cycle progression and malignant transformation.	Mouse,0,5,Organism	p10,6,9,Gene_or_gene_product	p15INK4b,42,50,Gene_or_gene_product	cell,61,65,Cell	"[{""token"": ""Mouse"", ""start_span"": 0, ""end_span"": 5, ""type"": ""Organism""}, {""token"": ""p10"", ""start_span"": 6, ""end_span"": 9, ""type"": ""Gene_or_gene_product""}, {""token"": ""p15INK4b"", ""start_span"": 42, ""end_span"": 50, ""type"": ""Gene_or_gene_product""}, {""token"": ""cell"", ""start_span"": 61, ""end_span"": 65, ""type"": ""Cell""}]"	train
Importantly, we show that mouse p10 is able to induce cell cycle arrest in a p53 - dependent manner.	mouse,26,31,Organism	p10,32,35,Gene_or_gene_product	cell,54,58,Cell	p53,77,80,Gene_or_gene_product	"[{""token"": ""mouse"", ""start_span"": 26, ""end_span"": 31, ""type"": ""Organism""}, {""token"": ""p10"", ""start_span"": 32, ""end_span"": 35, ""type"": ""Gene_or_gene_product""}, {""token"": ""cell"", ""start_span"": 54, ""end_span"": 58, ""type"": ""Cell""}, {""token"": ""p53"", ""start_span"": 77, ""end_span"": 80, ""type"": ""Gene_or_gene_product""}]"	train
Cyclooxygenase - 2 ( COX - 2) inhibitors are anti - inflammatory agents, which have potent anti - inflammatory, anti - angiogenic and analgesic properties yet do not affect platelet function in the manner of traditional non - steroidal anti - inflammatory drugs.	Cyclooxygenase - 2,0,18,Gene_or_gene_product	COX - 2,21,28,Gene_or_gene_product	platelet,173,181,Cell	non - steroidal anti - inflammatory drugs,220,261,Chemical	"[{""token"": ""Cyclooxygenase - 2"", ""start_span"": 0, ""end_span"": 18, ""type"": ""Gene_or_gene_product""}, {""token"": ""COX - 2"", ""start_span"": 21, ""end_span"": 28, ""type"": ""Gene_or_gene_product""}, {""token"": ""platelet"", ""start_span"": 173, ""end_span"": 181, ""type"": ""Cell""}, {""token"": ""non - steroidal anti - inflammatory drugs"", ""start_span"": 220, ""end_span"": 261, ""type"": ""Chemical""}]"	train
After tumors developed, mice were treated with angiostatin 20 mg / kg / day or thalidomide 200 mg / kg / day for 30 days.	tumors,6,12,Cancer	mice,24,28,Organism	angiostatin,47,58,Gene_or_gene_product	thalidomide,79,90,Chemical	"[{""token"": ""tumors"", ""start_span"": 6, ""end_span"": 12, ""type"": ""Cancer""}, {""token"": ""mice"", ""start_span"": 24, ""end_span"": 28, ""type"": ""Organism""}, {""token"": ""angiostatin"", ""start_span"": 47, ""end_span"": 58, ""type"": ""Gene_or_gene_product""}, {""token"": ""thalidomide"", ""start_span"": 79, ""end_span"": 90, ""type"": ""Chemical""}]"	train
Green fluorescence protein transfected cancer cells were injected into the mammary fat pad of young female mice.	Green fluorescence protein,0,26,Gene_or_gene_product	cancer cells,39,51,Cell	mammary fat pad,75,90,Tissue	mice,107,111,Organism	"[{""token"": ""Green fluorescence protein"", ""start_span"": 0, ""end_span"": 26, ""type"": ""Gene_or_gene_product""}, {""token"": ""cancer cells"", ""start_span"": 39, ""end_span"": 51, ""type"": ""Cell""}, {""token"": ""mammary fat pad"", ""start_span"": 75, ""end_span"": 90, ""type"": ""Tissue""}, {""token"": ""mice"", ""start_span"": 107, ""end_span"": 111, ""type"": ""Organism""}]"	train
Mice that received either IR or TEMF had significantly fewer lung metastatic sites and slower tumor growth than did untreated mice.	Mice,0,4,Organism	lung,61,65,Organ	tumor,94,99,Cancer	mice,126,130,Organism	"[{""token"": ""Mice"", ""start_span"": 0, ""end_span"": 4, ""type"": ""Organism""}, {""token"": ""lung"", ""start_span"": 61, ""end_span"": 65, ""type"": ""Organ""}, {""token"": ""tumor"", ""start_span"": 94, ""end_span"": 99, ""type"": ""Cancer""}, {""token"": ""mice"", ""start_span"": 126, ""end_span"": 130, ""type"": ""Organism""}]"	train
The adenomatous polyposis coli ( APC) gene, whose mutations are responsible for familial adenomatous polyposis, is a major negative controller of the Wnt / beta - catenin pathway.	adenomatous polyposis coli,4,30,Gene_or_gene_product	APC,33,36,Gene_or_gene_product	Wnt,150,153,Gene_or_gene_product	beta - catenin,156,170,Gene_or_gene_product	"[{""token"": ""adenomatous polyposis coli"", ""start_span"": 4, ""end_span"": 30, ""type"": ""Gene_or_gene_product""}, {""token"": ""APC"", ""start_span"": 33, ""end_span"": 36, ""type"": ""Gene_or_gene_product""}, {""token"": ""Wnt"", ""start_span"": 150, ""end_span"": 153, ""type"": ""Gene_or_gene_product""}, {""token"": ""beta - catenin"", ""start_span"": 156, ""end_span"": 170, ""type"": ""Gene_or_gene_product""}]"	train
To investigate the dose - dependent effects of APC protein in suppressing intestinal tumorigenesis, we constructed mutant mice carrying hypomorphic Apc alleles Apc ( neoR) and Apc ( neoF) whose expression levels were reduced to 20% and 10% of the wild type, respectively.	APC,47,50,Gene_or_gene_product	intestinal,74,84,Organ	mice,122,126,Organism	Apc,148,151,Gene_or_gene_product	"[{""token"": ""APC"", ""start_span"": 47, ""end_span"": 50, ""type"": ""Gene_or_gene_product""}, {""token"": ""intestinal"", ""start_span"": 74, ""end_span"": 84, ""type"": ""Organ""}, {""token"": ""mice"", ""start_span"": 122, ""end_span"": 126, ""type"": ""Organism""}, {""token"": ""Apc"", ""start_span"": 148, ""end_span"": 151, ""type"": ""Gene_or_gene_product""}]"	train
These results suggest that the reduced APC protein level increases intestinal polyp multiplicity through quantitative stimulation of the beta - catenin / T - cell factor transcription.	APC,39,42,Gene_or_gene_product	intestinal polyp,67,83,Pathological_formation	beta - catenin,137,151,Gene_or_gene_product	T - cell factor,154,169,Gene_or_gene_product	"[{""token"": ""APC"", ""start_span"": 39, ""end_span"": 42, ""type"": ""Gene_or_gene_product""}, {""token"": ""intestinal polyp"", ""start_span"": 67, ""end_span"": 83, ""type"": ""Pathological_formation""}, {""token"": ""beta - catenin"", ""start_span"": 137, ""end_span"": 151, ""type"": ""Gene_or_gene_product""}, {""token"": ""T - cell factor"", ""start_span"": 154, ""end_span"": 169, ""type"": ""Gene_or_gene_product""}]"	train
Both HKa and D5 decrease the speed of BPAE cell migration and alter the morphology in live, time - lapse microscopy after stimulation with S1P or VEGF.	HKa,5,8,Gene_or_gene_product	BPAE cell,38,47,Cell	S1P,139,142,Gene_or_gene_product	VEGF,146,150,Gene_or_gene_product	"[{""token"": ""HKa"", ""start_span"": 5, ""end_span"": 8, ""type"": ""Gene_or_gene_product""}, {""token"": ""BPAE cell"", ""start_span"": 38, ""end_span"": 47, ""type"": ""Cell""}, {""token"": ""S1P"", ""start_span"": 139, ""end_span"": 142, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF"", ""start_span"": 146, ""end_span"": 150, ""type"": ""Gene_or_gene_product""}]"	train
Activation of protein kinase C ( PKC) induces phenotypic changes in the morphology of microvascular endothelial cells that affect major functions of the microvasculature.	protein kinase C,14,30,Gene_or_gene_product	PKC,33,36,Gene_or_gene_product	microvascular endothelial cells,86,117,Cell	microvasculature,153,169,Tissue	"[{""token"": ""protein kinase C"", ""start_span"": 14, ""end_span"": 30, ""type"": ""Gene_or_gene_product""}, {""token"": ""PKC"", ""start_span"": 33, ""end_span"": 36, ""type"": ""Gene_or_gene_product""}, {""token"": ""microvascular endothelial cells"", ""start_span"": 86, ""end_span"": 117, ""type"": ""Cell""}, {""token"": ""microvasculature"", ""start_span"": 153, ""end_span"": 169, ""type"": ""Tissue""}]"	train
The differential regulation of human telomerase reverse transcriptase and vascular endothelial growth factor may contribute to the clinically more aggressive behavior of p63 - positive breast carcinomas.	human,31,36,Organism	telomerase reverse transcriptase,37,69,Gene_or_gene_product	vascular endothelial growth factor,74,108,Gene_or_gene_product	p63,170,173,Gene_or_gene_product	"[{""token"": ""human"", ""start_span"": 31, ""end_span"": 36, ""type"": ""Organism""}, {""token"": ""telomerase reverse transcriptase"", ""start_span"": 37, ""end_span"": 69, ""type"": ""Gene_or_gene_product""}, {""token"": ""vascular endothelial growth factor"", ""start_span"": 74, ""end_span"": 108, ""type"": ""Gene_or_gene_product""}, {""token"": ""p63"", ""start_span"": 170, ""end_span"": 173, ""type"": ""Gene_or_gene_product""}]"	train
Thus, the differential regulation of hTERT and VEGF in p63 - positive breast carcinomas may contribute to the clinically more aggressive behavior of these neoplasms.	hTERT,37,42,Gene_or_gene_product	VEGF,47,51,Gene_or_gene_product	p63,55,58,Gene_or_gene_product	neoplasms,155,164,Cancer	"[{""token"": ""hTERT"", ""start_span"": 37, ""end_span"": 42, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF"", ""start_span"": 47, ""end_span"": 51, ""type"": ""Gene_or_gene_product""}, {""token"": ""p63"", ""start_span"": 55, ""end_span"": 58, ""type"": ""Gene_or_gene_product""}, {""token"": ""neoplasms"", ""start_span"": 155, ""end_span"": 164, ""type"": ""Cancer""}]"	train
In addition, activation of transforming growth factor beta ( TGF - beta) by TSP - 1 plays a crucial role in the regulation of tumor progression.	transforming growth factor beta,27,58,Gene_or_gene_product	TGF - beta,61,71,Gene_or_gene_product	TSP - 1,76,83,Gene_or_gene_product	tumor,126,131,Cancer	"[{""token"": ""transforming growth factor beta"", ""start_span"": 27, ""end_span"": 58, ""type"": ""Gene_or_gene_product""}, {""token"": ""TGF - beta"", ""start_span"": 61, ""end_span"": 71, ""type"": ""Gene_or_gene_product""}, {""token"": ""TSP - 1"", ""start_span"": 76, ""end_span"": 83, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumor"", ""start_span"": 126, ""end_span"": 131, ""type"": ""Cancer""}]"	train
Human LRP - 1 reversed the changes in protein expression associated with LRP - 1 deficiency; however, the endocytic activity of LRP - 1 was not involved.	Human,0,5,Organism	LRP - 1,6,13,Gene_or_gene_product	LRP - 1,73,80,Gene_or_gene_product	LRP - 1,128,135,Gene_or_gene_product	"[{""token"": ""Human"", ""start_span"": 0, ""end_span"": 5, ""type"": ""Organism""}, {""token"": ""LRP - 1"", ""start_span"": 6, ""end_span"": 13, ""type"": ""Gene_or_gene_product""}, {""token"": ""LRP - 1"", ""start_span"": 73, ""end_span"": 80, ""type"": ""Gene_or_gene_product""}, {""token"": ""LRP - 1"", ""start_span"": 128, ""end_span"": 135, ""type"": ""Gene_or_gene_product""}]"	train
L - Carnitine ameliorates methotrexate - induced oxidative organ injury and inhibits leukocyte death.	L - Carnitine,0,13,Chemical	methotrexate,26,38,Chemical	organ,59,64,Organ	leukocyte,85,94,Cell	"[{""token"": ""L - Carnitine"", ""start_span"": 0, ""end_span"": 13, ""type"": ""Chemical""}, {""token"": ""methotrexate"", ""start_span"": 26, ""end_span"": 38, ""type"": ""Chemical""}, {""token"": ""organ"", ""start_span"": 59, ""end_span"": 64, ""type"": ""Organ""}, {""token"": ""leukocyte"", ""start_span"": 85, ""end_span"": 94, ""type"": ""Cell""}]"	train
The elevated serum TNF - alpha level observed following MTX treatment was depressed with L - Car.	serum,13,18,Organism_substance	TNF - alpha,19,30,Gene_or_gene_product	MTX,56,59,Chemical	L - Car,89,96,Chemical	"[{""token"": ""serum"", ""start_span"": 13, ""end_span"": 18, ""type"": ""Organism_substance""}, {""token"": ""TNF - alpha"", ""start_span"": 19, ""end_span"": 30, ""type"": ""Gene_or_gene_product""}, {""token"": ""MTX"", ""start_span"": 56, ""end_span"": 59, ""type"": ""Chemical""}, {""token"": ""L - Car"", ""start_span"": 89, ""end_span"": 96, ""type"": ""Chemical""}]"	train
These results suggest that L - Car, possibly via its free radical scavenging and antioxidant properties, ameliorates MTX - induced oxidative organ injury and inhibits leukocyte apoptosis.	L - Car,27,34,Chemical	MTX,117,120,Chemical	organ,141,146,Organ	leukocyte,167,176,Cell	"[{""token"": ""L - Car"", ""start_span"": 27, ""end_span"": 34, ""type"": ""Chemical""}, {""token"": ""MTX"", ""start_span"": 117, ""end_span"": 120, ""type"": ""Chemical""}, {""token"": ""organ"", ""start_span"": 141, ""end_span"": 146, ""type"": ""Organ""}, {""token"": ""leukocyte"", ""start_span"": 167, ""end_span"": 176, ""type"": ""Cell""}]"	train
Consistent with a role for NF - kappaB in oncogenesis are observations that inhibition of NF - kappaB alone or in combination with cancer therapies leads to tumor cell death or growth inhibition.	NF - kappaB,27,38,Gene_or_gene_product	NF - kappaB,90,101,Gene_or_gene_product	cancer,131,137,Cancer	tumor cell,157,167,Cell	"[{""token"": ""NF - kappaB"", ""start_span"": 27, ""end_span"": 38, ""type"": ""Gene_or_gene_product""}, {""token"": ""NF - kappaB"", ""start_span"": 90, ""end_span"": 101, ""type"": ""Gene_or_gene_product""}, {""token"": ""cancer"", ""start_span"": 131, ""end_span"": 137, ""type"": ""Cancer""}, {""token"": ""tumor cell"", ""start_span"": 157, ""end_span"": 167, ""type"": ""Cell""}]"	train
Analysis of Runx2 - expressing lymphomas reveals a consistently low rate of apoptosis, in contrast to lymphomas of MYC mice which are often highly apoptotic.	Runx2,12,17,Gene_or_gene_product	lymphomas,31,40,Cancer	lymphomas,102,111,Cancer	MYC,115,118,Gene_or_gene_product	"[{""token"": ""Runx2"", ""start_span"": 12, ""end_span"": 17, ""type"": ""Gene_or_gene_product""}, {""token"": ""lymphomas"", ""start_span"": 31, ""end_span"": 40, ""type"": ""Cancer""}, {""token"": ""lymphomas"", ""start_span"": 102, ""end_span"": 111, ""type"": ""Cancer""}, {""token"": ""MYC"", ""start_span"": 115, ""end_span"": 118, ""type"": ""Gene_or_gene_product""}]"	train
The role of the p53 pathway in Runx2 / MYC tumors was explored on a p53 heterozygote background.	p53,16,19,Gene_or_gene_product	Runx2,31,36,Gene_or_gene_product	MYC,39,42,Gene_or_gene_product	p53,68,71,Gene_or_gene_product	"[{""token"": ""p53"", ""start_span"": 16, ""end_span"": 19, ""type"": ""Gene_or_gene_product""}, {""token"": ""Runx2"", ""start_span"": 31, ""end_span"": 36, ""type"": ""Gene_or_gene_product""}, {""token"": ""MYC"", ""start_span"": 39, ""end_span"": 42, ""type"": ""Gene_or_gene_product""}, {""token"": ""p53"", ""start_span"": 68, ""end_span"": 71, ""type"": ""Gene_or_gene_product""}]"	train
In addition, we showed that paclitaxel downregulated the phosphorylation of Akt in both HeLa and CaSki cells.	paclitaxel,28,38,Chemical	Akt,76,79,Gene_or_gene_product	HeLa,88,92,Cell	CaSki cells,97,108,Cell	"[{""token"": ""paclitaxel"", ""start_span"": 28, ""end_span"": 38, ""type"": ""Chemical""}, {""token"": ""Akt"", ""start_span"": 76, ""end_span"": 79, ""type"": ""Gene_or_gene_product""}, {""token"": ""HeLa"", ""start_span"": 88, ""end_span"": 92, ""type"": ""Cell""}, {""token"": ""CaSki cells"", ""start_span"": 97, ""end_span"": 108, ""type"": ""Cell""}]"	train
Interestingly, in CaSki cells, which were more suggestive of a resistant phenotype, paclitaxel induced the activation of mTOR as a downstream target of Akt.	CaSki cells,18,29,Cell	paclitaxel,84,94,Chemical	mTOR,121,125,Gene_or_gene_product	Akt,152,155,Gene_or_gene_product	"[{""token"": ""CaSki cells"", ""start_span"": 18, ""end_span"": 29, ""type"": ""Cell""}, {""token"": ""paclitaxel"", ""start_span"": 84, ""end_span"": 94, ""type"": ""Chemical""}, {""token"": ""mTOR"", ""start_span"": 121, ""end_span"": 125, ""type"": ""Gene_or_gene_product""}, {""token"": ""Akt"", ""start_span"": 152, ""end_span"": 155, ""type"": ""Gene_or_gene_product""}]"	train
A novel method of assessing vascular endothelial function in cancer is via the quantification of circulating endothelial cells ( CEC).	vascular endothelial,28,48,Tissue	cancer,61,67,Cancer	circulating endothelial cells,97,126,Cell	CEC,129,132,Cell	"[{""token"": ""vascular endothelial"", ""start_span"": 28, ""end_span"": 48, ""type"": ""Tissue""}, {""token"": ""cancer"", ""start_span"": 61, ""end_span"": 67, ""type"": ""Cancer""}, {""token"": ""circulating endothelial cells"", ""start_span"": 97, ""end_span"": 126, ""type"": ""Cell""}, {""token"": ""CEC"", ""start_span"": 129, ""end_span"": 132, ""type"": ""Cell""}]"	train
Another interesting cell type is the endothelial progenitor cell ( EPC), whose numbers increase in the presence of vascular damage.	cell,20,24,Cell	endothelial progenitor cell,37,64,Cell	EPC,67,70,Cell	vascular,115,123,Multi	"[{""token"": ""cell"", ""start_span"": 20, ""end_span"": 24, ""type"": ""Cell""}, {""token"": ""endothelial progenitor cell"", ""start_span"": 37, ""end_span"": 64, ""type"": ""Cell""}, {""token"": ""EPC"", ""start_span"": 67, ""end_span"": 70, ""type"": ""Cell""}, {""token"": ""vascular"", ""start_span"": 115, ""end_span"": 123, ""type"": ""Multi""}]"	train
RAGE ( receptor for AGE) is the best characterized signal transduction receptor for AGEs and is expressed on mesothelial cells.	RAGE,0,4,Gene_or_gene_product	receptor for AGE,7,23,Gene_or_gene_product	AGEs,84,88,Chemical	mesothelial cells,109,126,Cell	"[{""token"": ""RAGE"", ""start_span"": 0, ""end_span"": 4, ""type"": ""Gene_or_gene_product""}, {""token"": ""receptor for AGE"", ""start_span"": 7, ""end_span"": 23, ""type"": ""Gene_or_gene_product""}, {""token"": ""AGEs"", ""start_span"": 84, ""end_span"": 88, ""type"": ""Chemical""}, {""token"": ""mesothelial cells"", ""start_span"": 109, ""end_span"": 126, ""type"": ""Cell""}]"	train
Further investigations of this pathway with regard to preventing peritoneal fibrosis should be performed to maintain the integrity of the peritoneal membrane in peritoneal dialysis patients.	peritoneal,65,75,Multi	peritoneal membrane,138,157,Multi	peritoneal,161,171,Multi	patients,181,189,Organism	"[{""token"": ""peritoneal"", ""start_span"": 65, ""end_span"": 75, ""type"": ""Multi""}, {""token"": ""peritoneal membrane"", ""start_span"": 138, ""end_span"": 157, ""type"": ""Multi""}, {""token"": ""peritoneal"", ""start_span"": 161, ""end_span"": 171, ""type"": ""Multi""}, {""token"": ""patients"", ""start_span"": 181, ""end_span"": 189, ""type"": ""Organism""}]"	train
METHODS: Preoperative plasma fibrinogen levels were retrospectively examined in 405 patients who underwent surgery for advanced gastric cancer.	plasma,22,28,Organism_substance	fibrinogen,29,39,Gene_or_gene_product	patients,84,92,Organism	gastric cancer,128,142,Cancer	"[{""token"": ""plasma"", ""start_span"": 22, ""end_span"": 28, ""type"": ""Organism_substance""}, {""token"": ""fibrinogen"", ""start_span"": 29, ""end_span"": 39, ""type"": ""Gene_or_gene_product""}, {""token"": ""patients"", ""start_span"": 84, ""end_span"": 92, ""type"": ""Organism""}, {""token"": ""gastric cancer"", ""start_span"": 128, ""end_span"": 142, ""type"": ""Cancer""}]"	train
However, monolayer cultures differ greatly from the complex environmental conditions generated in solid tumors that develop inhomogeneous hypoxic and necrotic regions.	monolayer cultures,9,27,Cell	solid tumors,98,110,Cancer	inhomogeneous hypoxic,124,145,Pathological_formation	necrotic regions,150,166,Pathological_formation	"[{""token"": ""monolayer cultures"", ""start_span"": 9, ""end_span"": 27, ""type"": ""Cell""}, {""token"": ""solid tumors"", ""start_span"": 98, ""end_span"": 110, ""type"": ""Cancer""}, {""token"": ""inhomogeneous hypoxic"", ""start_span"": 124, ""end_span"": 145, ""type"": ""Pathological_formation""}, {""token"": ""necrotic regions"", ""start_span"": 150, ""end_span"": 166, ""type"": ""Pathological_formation""}]"	train
In contrast, multicellular spheroids mimic heterogeneous cellular behavior and the consequent functional characteristics of in vivo solid tumors, and serve as important in vitro model to investigate tumor biology and responses to potential therapeutic agents.	multicellular spheroids,13,36,Cell	cellular,57,65,Cell	solid tumors,132,144,Cancer	tumor,199,204,Cancer	"[{""token"": ""multicellular spheroids"", ""start_span"": 13, ""end_span"": 36, ""type"": ""Cell""}, {""token"": ""cellular"", ""start_span"": 57, ""end_span"": 65, ""type"": ""Cell""}, {""token"": ""solid tumors"", ""start_span"": 132, ""end_span"": 144, ""type"": ""Cancer""}, {""token"": ""tumor"", ""start_span"": 199, ""end_span"": 204, ""type"": ""Cancer""}]"	train
In spheroids, the glucose consumption ( 2. 1 p mole / cell / h) and lactate production ( 3. 67 p mole / cell / h) was nearly 2 - 3 fold higher than in monolayer cells ( 0. 83 and 1. 43 p mole / cell / h respectively).	spheroids,3,12,Cell	glucose,18,25,Chemical	lactate,68,75,Chemical	monolayer cells,151,166,Cell	"[{""token"": ""spheroids"", ""start_span"": 3, ""end_span"": 12, ""type"": ""Cell""}, {""token"": ""glucose"", ""start_span"": 18, ""end_span"": 25, ""type"": ""Chemical""}, {""token"": ""lactate"", ""start_span"": 68, ""end_span"": 75, ""type"": ""Chemical""}, {""token"": ""monolayer cells"", ""start_span"": 151, ""end_span"": 166, ""type"": ""Cell""}]"	train
Under these conditions, 2 - DG drastically enhanced the radiation - induced cell death of spheroids ( by 2 - 3 folds); while a 40% increase was observed in monolayer cells.	2 - DG,24,30,Chemical	cell,76,80,Cell	spheroids,90,99,Cell	monolayer cells,156,171,Cell	"[{""token"": ""2 - DG"", ""start_span"": 24, ""end_span"": 30, ""type"": ""Chemical""}, {""token"": ""cell"", ""start_span"": 76, ""end_span"": 80, ""type"": ""Cell""}, {""token"": ""spheroids"", ""start_span"": 90, ""end_span"": 99, ""type"": ""Cell""}, {""token"": ""monolayer cells"", ""start_span"": 156, ""end_span"": 171, ""type"": ""Cell""}]"	train
Radiosensitization by 2 - DG in monolayer cells was primarily due to an increase in mitotic death ( 23%) linked to cytogenetic damage ( micronuclei), whereas a profound induction of apoptosis ( 40%) accounted for the sensitization in spheroids.	2 - DG,22,28,Chemical	monolayer cells,32,47,Cell	micronuclei,136,147,Cellular_component	spheroids,234,243,Cell	"[{""token"": ""2 - DG"", ""start_span"": 22, ""end_span"": 28, ""type"": ""Chemical""}, {""token"": ""monolayer cells"", ""start_span"": 32, ""end_span"": 47, ""type"": ""Cell""}, {""token"": ""micronuclei"", ""start_span"": 136, ""end_span"": 147, ""type"": ""Cellular_component""}, {""token"": ""spheroids"", ""start_span"": 234, ""end_span"": 243, ""type"": ""Cell""}]"	train
2 - DG did not induce a significant cell cycle delay in monolayers, while a transient G ( 2) delay was apparent in spheroids.	2 - DG,0,6,Chemical	cell,36,40,Cell	monolayers,56,66,Cell	spheroids,115,124,Cell	"[{""token"": ""2 - DG"", ""start_span"": 0, ""end_span"": 6, ""type"": ""Chemical""}, {""token"": ""cell"", ""start_span"": 36, ""end_span"": 40, ""type"": ""Cell""}, {""token"": ""monolayers"", ""start_span"": 56, ""end_span"": 66, ""type"": ""Cell""}, {""token"": ""spheroids"", ""start_span"": 115, ""end_span"": 124, ""type"": ""Cell""}]"	train
[ Autologous bone marrow stem cell or peripheral blood endothelial progenitor cell therapy in patients with peripheral limb ischaemia]	bone marrow stem cell,13,34,Cell	peripheral blood endothelial progenitor cell,38,82,Cell	patients,94,102,Organism	limb,119,123,Organism_subdivision	"[{""token"": ""bone marrow stem cell"", ""start_span"": 13, ""end_span"": 34, ""type"": ""Cell""}, {""token"": ""peripheral blood endothelial progenitor cell"", ""start_span"": 38, ""end_span"": 82, ""type"": ""Cell""}, {""token"": ""patients"", ""start_span"": 94, ""end_span"": 102, ""type"": ""Organism""}, {""token"": ""limb"", ""start_span"": 119, ""end_span"": 123, ""type"": ""Organism_subdivision""}]"	train
No effective medical therapies have been developed sofar to enhance blood flow in the legs of patients with peripheral arterial disease ( PAD).	blood,68,73,Organism_substance	legs,86,90,Organism_subdivision	patients,94,102,Organism	peripheral arterial,108,127,Multi	"[{""token"": ""blood"", ""start_span"": 68, ""end_span"": 73, ""type"": ""Organism_substance""}, {""token"": ""legs"", ""start_span"": 86, ""end_span"": 90, ""type"": ""Organism_subdivision""}, {""token"": ""patients"", ""start_span"": 94, ""end_span"": 102, ""type"": ""Organism""}, {""token"": ""peripheral arterial"", ""start_span"": 108, ""end_span"": 127, ""type"": ""Multi""}]"	train
Formation of new bone during vertical distraction osteogenesis of the human mandible is related to the presence of blood vessels.	bone,17,21,Tissue	human,70,75,Organism	mandible,76,84,Organ	blood vessels,115,128,Multi	"[{""token"": ""bone"", ""start_span"": 17, ""end_span"": 21, ""type"": ""Tissue""}, {""token"": ""human"", ""start_span"": 70, ""end_span"": 75, ""type"": ""Organism""}, {""token"": ""mandible"", ""start_span"": 76, ""end_span"": 84, ""type"": ""Organ""}, {""token"": ""blood vessels"", ""start_span"": 115, ""end_span"": 128, ""type"": ""Multi""}]"	train
A positive correlation between blood vessel volume and bone volume density was found in the younger new - bone area but not in the oldest new - bone area.	blood vessel,31,43,Multi	bone,55,59,Tissue	bone,106,110,Tissue	bone,144,148,Tissue	"[{""token"": ""blood vessel"", ""start_span"": 31, ""end_span"": 43, ""type"": ""Multi""}, {""token"": ""bone"", ""start_span"": 55, ""end_span"": 59, ""type"": ""Tissue""}, {""token"": ""bone"", ""start_span"": 106, ""end_span"": 110, ""type"": ""Tissue""}, {""token"": ""bone"", ""start_span"": 144, ""end_span"": 148, ""type"": ""Tissue""}]"	train
Our data suggest that the lower blood vessel density found in the patients with 1 mm / day distraction rate may be related to disruption of angiogenesis in the soft connective tissue of the gap or to a less optimal mechanical stimulation of cells involved in angiogenesis.	blood vessel,32,44,Multi	patients,66,74,Organism	soft connective tissue,160,182,Tissue	cells,241,246,Cell	"[{""token"": ""blood vessel"", ""start_span"": 32, ""end_span"": 44, ""type"": ""Multi""}, {""token"": ""patients"", ""start_span"": 66, ""end_span"": 74, ""type"": ""Organism""}, {""token"": ""soft connective tissue"", ""start_span"": 160, ""end_span"": 182, ""type"": ""Tissue""}, {""token"": ""cells"", ""start_span"": 241, ""end_span"": 246, ""type"": ""Cell""}]"	train
It is synthesised and secreted by the ciliary body epithelium ( CBE) from the initiation of CBE development in the embryo, and production continues throughout life.	ciliary body epithelium,38,61,Tissue	CBE,64,67,Tissue	CBE,92,95,Tissue	embryo,115,121,Developing_anatomical_structure	"[{""token"": ""ciliary body epithelium"", ""start_span"": 38, ""end_span"": 61, ""type"": ""Tissue""}, {""token"": ""CBE"", ""start_span"": 64, ""end_span"": 67, ""type"": ""Tissue""}, {""token"": ""CBE"", ""start_span"": 92, ""end_span"": 95, ""type"": ""Tissue""}, {""token"": ""embryo"", ""start_span"": 115, ""end_span"": 121, ""type"": ""Developing_anatomical_structure""}]"	train
p18Ink4c, but not p27Kip1, collaborates with Men1 to suppress neuroendocrine organ tumors.	p18Ink4c,0,8,Gene_or_gene_product	p27Kip1,18,25,Gene_or_gene_product	Men1,45,49,Gene_or_gene_product	neuroendocrine organ tumors,62,89,Cancer	"[{""token"": ""p18Ink4c"", ""start_span"": 0, ""end_span"": 8, ""type"": ""Gene_or_gene_product""}, {""token"": ""p27Kip1"", ""start_span"": 18, ""end_span"": 25, ""type"": ""Gene_or_gene_product""}, {""token"": ""Men1"", ""start_span"": 45, ""end_span"": 49, ""type"": ""Gene_or_gene_product""}, {""token"": ""neuroendocrine organ tumors"", ""start_span"": 62, ""end_span"": 89, ""type"": ""Cancer""}]"	train
Recombinant human prothrombin kringle - 2 inhibits B16F10 melanoma metastasis through inhibition of neovascularization and reduction of matrix metalloproteinase expression.	human,12,17,Organism	prothrombin kringle - 2,18,41,Gene_or_gene_product	B16F10 melanoma,51,66,Cancer	matrix metalloproteinase,136,160,Gene_or_gene_product	"[{""token"": ""human"", ""start_span"": 12, ""end_span"": 17, ""type"": ""Organism""}, {""token"": ""prothrombin kringle - 2"", ""start_span"": 18, ""end_span"": 41, ""type"": ""Gene_or_gene_product""}, {""token"": ""B16F10 melanoma"", ""start_span"": 51, ""end_span"": 66, ""type"": ""Cancer""}, {""token"": ""matrix metalloproteinase"", ""start_span"": 136, ""end_span"": 160, ""type"": ""Gene_or_gene_product""}]"	train
Angiogenesis, a multi - step process which involves endothelial cell proliferation, adhesion, migration, and basement membrane ( BM) degradation, is essential for tumor metastasis.	endothelial cell,52,68,Cell	basement membrane,109,126,Cellular_component	BM,129,131,Cellular_component	tumor,163,168,Cancer	"[{""token"": ""endothelial cell"", ""start_span"": 52, ""end_span"": 68, ""type"": ""Cell""}, {""token"": ""basement membrane"", ""start_span"": 109, ""end_span"": 126, ""type"": ""Cellular_component""}, {""token"": ""BM"", ""start_span"": 129, ""end_span"": 131, ""type"": ""Cellular_component""}, {""token"": ""tumor"", ""start_span"": 163, ""end_span"": 168, ""type"": ""Cancer""}]"	train
Because tumor metastasis requires angiogenesis, we examined whether rk - 2 could inhibit metastases induced by injection of B16F10 melanoma cells into mice.	tumor,8,13,Cancer	rk - 2,68,74,Gene_or_gene_product	B16F10 melanoma cells,124,145,Cell	mice,151,155,Organism	"[{""token"": ""tumor"", ""start_span"": 8, ""end_span"": 13, ""type"": ""Cancer""}, {""token"": ""rk - 2"", ""start_span"": 68, ""end_span"": 74, ""type"": ""Gene_or_gene_product""}, {""token"": ""B16F10 melanoma cells"", ""start_span"": 124, ""end_span"": 145, ""type"": ""Cell""}, {""token"": ""mice"", ""start_span"": 151, ""end_span"": 155, ""type"": ""Organism""}]"	train
In immunohistochemical analysis, rk - 2 reduced expression of vascular endothelial growth factor, which is a potent angiogenic activator and neovascularization in the mouse lung.	rk - 2,33,39,Gene_or_gene_product	vascular endothelial growth factor,62,96,Gene_or_gene_product	mouse,167,172,Organism	lung,173,177,Organ	"[{""token"": ""rk - 2"", ""start_span"": 33, ""end_span"": 39, ""type"": ""Gene_or_gene_product""}, {""token"": ""vascular endothelial growth factor"", ""start_span"": 62, ""end_span"": 96, ""type"": ""Gene_or_gene_product""}, {""token"": ""mouse"", ""start_span"": 167, ""end_span"": 172, ""type"": ""Organism""}, {""token"": ""lung"", ""start_span"": 173, ""end_span"": 177, ""type"": ""Organ""}]"	train
Activation of vascular endothelial growth factor through reactive oxygen species mediates 20 - hydroxyeicosatetraenoic acid - induced endothelial cell proliferation.	vascular endothelial growth factor,14,48,Gene_or_gene_product	reactive oxygen species,57,80,Chemical	20 - hydroxyeicosatetraenoic acid,90,123,Chemical	endothelial cell,134,150,Cell	"[{""token"": ""vascular endothelial growth factor"", ""start_span"": 14, ""end_span"": 48, ""type"": ""Gene_or_gene_product""}, {""token"": ""reactive oxygen species"", ""start_span"": 57, ""end_span"": 80, ""type"": ""Chemical""}, {""token"": ""20 - hydroxyeicosatetraenoic acid"", ""start_span"": 90, ""end_span"": 123, ""type"": ""Chemical""}, {""token"": ""endothelial cell"", ""start_span"": 134, ""end_span"": 150, ""type"": ""Cell""}]"	train
Polyethylene glycol - superoxide dismutase ( PEG - SOD) markedly inhibited both the increases in VEGF expression and the proliferative effects of 20 - HETE.	Polyethylene glycol - superoxide dismutase,0,42,Chemical	PEG - SOD,45,54,Chemical	VEGF,97,101,Gene_or_gene_product	20 - HETE,146,155,Chemical	"[{""token"": ""Polyethylene glycol - superoxide dismutase"", ""start_span"": 0, ""end_span"": 42, ""type"": ""Chemical""}, {""token"": ""PEG - SOD"", ""start_span"": 45, ""end_span"": 54, ""type"": ""Chemical""}, {""token"": ""VEGF"", ""start_span"": 97, ""end_span"": 101, ""type"": ""Gene_or_gene_product""}, {""token"": ""20 - HETE"", ""start_span"": 146, ""end_span"": 155, ""type"": ""Chemical""}]"	train
To understand the molecular pathway in Hoxa9 / Meis1 - induced leukemogenesis, retroviral insertional mutagenesis was applied using retrovirus - mediated gene transfer.	Hoxa9,39,44,Gene_or_gene_product	Meis1,47,52,Gene_or_gene_product	retroviral,79,89,Organism	retrovirus,132,142,Organism	"[{""token"": ""Hoxa9"", ""start_span"": 39, ""end_span"": 44, ""type"": ""Gene_or_gene_product""}, {""token"": ""Meis1"", ""start_span"": 47, ""end_span"": 52, ""type"": ""Gene_or_gene_product""}, {""token"": ""retroviral"", ""start_span"": 79, ""end_span"": 89, ""type"": ""Organism""}, {""token"": ""retrovirus"", ""start_span"": 132, ""end_span"": 142, ""type"": ""Organism""}]"	train
Pro / antioxidant status and AP - 1 transcription factor in murine skin following topical exposure to cumene hydroperoxide.	AP - 1,29,35,Gene_or_gene_product	murine,60,66,Organism	skin,67,71,Organ	cumene hydroperoxide,102,122,Chemical	"[{""token"": ""AP - 1"", ""start_span"": 29, ""end_span"": 35, ""type"": ""Gene_or_gene_product""}, {""token"": ""murine"", ""start_span"": 60, ""end_span"": 66, ""type"": ""Organism""}, {""token"": ""skin"", ""start_span"": 67, ""end_span"": 71, ""type"": ""Organ""}, {""token"": ""cumene hydroperoxide"", ""start_span"": 102, ""end_span"": 122, ""type"": ""Chemical""}]"	train
Activation of AP - 1 in skin was detected as early as 2 weeks following Cum - OOH or TPA exposure.	AP - 1,14,20,Gene_or_gene_product	skin,24,28,Organ	Cum - OOH,72,81,Chemical	TPA,85,88,Chemical	"[{""token"": ""AP - 1"", ""start_span"": 14, ""end_span"": 20, ""type"": ""Gene_or_gene_product""}, {""token"": ""skin"", ""start_span"": 24, ""end_span"": 28, ""type"": ""Organ""}, {""token"": ""Cum - OOH"", ""start_span"": 72, ""end_span"": 81, ""type"": ""Chemical""}, {""token"": ""TPA"", ""start_span"": 85, ""end_span"": 88, ""type"": ""Chemical""}]"	train
Hyperforin blocks neutrophil activation of matrix metalloproteinase - 9, motility and recruitment, and restrains inflammation - triggered angiogenesis and lung fibrosis.	Hyperforin,0,10,Chemical	neutrophil,18,28,Cell	matrix metalloproteinase - 9,43,71,Gene_or_gene_product	lung,155,159,Organ	"[{""token"": ""Hyperforin"", ""start_span"": 0, ""end_span"": 10, ""type"": ""Chemical""}, {""token"": ""neutrophil"", ""start_span"": 18, ""end_span"": 28, ""type"": ""Cell""}, {""token"": ""matrix metalloproteinase - 9"", ""start_span"": 43, ""end_span"": 71, ""type"": ""Gene_or_gene_product""}, {""token"": ""lung"", ""start_span"": 155, ""end_span"": 159, ""type"": ""Organ""}]"	train
We tested whether as well as inhibiting leukocyte elastase ( LE) activity, Hyp might be effective in containing both polymorphonuclear neutrophil ( PMN) leukocyte recruitment and unfavorable eventual tissue responses.	leukocyte elastase,40,58,Gene_or_gene_product	LE,61,63,Gene_or_gene_product	Hyp,75,78,Chemical	tissue,200,206,Tissue	"[{""token"": ""leukocyte elastase"", ""start_span"": 40, ""end_span"": 58, ""type"": ""Gene_or_gene_product""}, {""token"": ""LE"", ""start_span"": 61, ""end_span"": 63, ""type"": ""Gene_or_gene_product""}, {""token"": ""Hyp"", ""start_span"": 75, ""end_span"": 78, ""type"": ""Chemical""}, {""token"": ""tissue"", ""start_span"": 200, ""end_span"": 206, ""type"": ""Tissue""}]"	train
PMN - triggered angiogenesis is also blocked by both local injection and daily i. p. administration of the Hyp salt in an interleukin - 8 - induced murine model.	PMN,0,3,Cell	Hyp,107,110,Chemical	interleukin - 8,122,137,Gene_or_gene_product	murine,148,154,Organism	"[{""token"": ""PMN"", ""start_span"": 0, ""end_span"": 3, ""type"": ""Cell""}, {""token"": ""Hyp"", ""start_span"": 107, ""end_span"": 110, ""type"": ""Chemical""}, {""token"": ""interleukin - 8"", ""start_span"": 122, ""end_span"": 137, ""type"": ""Gene_or_gene_product""}, {""token"": ""murine"", ""start_span"": 148, ""end_span"": 154, ""type"": ""Organism""}]"	train
Furthermore, i. p. treatment with Hyp reduces acute PMN recruitment and enhances resolution in a pulmonary bleomycin - induced inflammation model, significantly reducing consequent fibrosis.	Hyp,34,37,Chemical	PMN,52,55,Cell	pulmonary,97,106,Organ	bleomycin,107,116,Chemical	"[{""token"": ""Hyp"", ""start_span"": 34, ""end_span"": 37, ""type"": ""Chemical""}, {""token"": ""PMN"", ""start_span"": 52, ""end_span"": 55, ""type"": ""Cell""}, {""token"": ""pulmonary"", ""start_span"": 97, ""end_span"": 106, ""type"": ""Organ""}, {""token"": ""bleomycin"", ""start_span"": 107, ""end_span"": 116, ""type"": ""Chemical""}]"	train
Impaired apoptosis of pulmonary endothelial cells is associated with intimal proliferation and irreversibility of pulmonary hypertension in congenital heart disease.	pulmonary endothelial cells,22,49,Cell	intimal,69,76,Tissue	pulmonary,114,123,Organ	heart,151,156,Organ	"[{""token"": ""pulmonary endothelial cells"", ""start_span"": 22, ""end_span"": 49, ""type"": ""Cell""}, {""token"": ""intimal"", ""start_span"": 69, ""end_span"": 76, ""type"": ""Tissue""}, {""token"": ""pulmonary"", ""start_span"": 114, ""end_span"": 123, ""type"": ""Organ""}, {""token"": ""heart"", ""start_span"": 151, ""end_span"": 156, ""type"": ""Organ""}]"	train
Notch receptors and ligands ( Jagged and Delta - like) play a critical role in this process in addition to VEGF.	Notch,0,5,Gene_or_gene_product	Jagged,30,36,Gene_or_gene_product	Delta,41,46,Gene_or_gene_product	VEGF,107,111,Gene_or_gene_product	"[{""token"": ""Notch"", ""start_span"": 0, ""end_span"": 5, ""type"": ""Gene_or_gene_product""}, {""token"": ""Jagged"", ""start_span"": 30, ""end_span"": 36, ""type"": ""Gene_or_gene_product""}, {""token"": ""Delta"", ""start_span"": 41, ""end_span"": 46, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF"", ""start_span"": 107, ""end_span"": 111, ""type"": ""Gene_or_gene_product""}]"	train
In the current study, we have shown that loss of function by either targeted allele deletion or use of a soluble form of Dll4 extracellular domain leads to inhibition of Notch signaling, resulting in increased vascular proliferation but defective maturation.	Dll4,121,125,Gene_or_gene_product	extracellular,126,139,Immaterial_anatomical_entity	Notch,170,175,Gene_or_gene_product	vascular,210,218,Multi	"[{""token"": ""Dll4"", ""start_span"": 121, ""end_span"": 125, ""type"": ""Gene_or_gene_product""}, {""token"": ""extracellular"", ""start_span"": 126, ""end_span"": 139, ""type"": ""Immaterial_anatomical_entity""}, {""token"": ""Notch"", ""start_span"": 170, ""end_span"": 175, ""type"": ""Gene_or_gene_product""}, {""token"": ""vascular"", ""start_span"": 210, ""end_span"": 218, ""type"": ""Multi""}]"	train
sDll4 similarly induced defective vascular response in tumor implants leading to reduced tumor growth.	sDll4,0,5,Gene_or_gene_product	vascular,34,42,Multi	tumor,55,60,Cancer	tumor,89,94,Cancer	"[{""token"": ""sDll4"", ""start_span"": 0, ""end_span"": 5, ""type"": ""Gene_or_gene_product""}, {""token"": ""vascular"", ""start_span"": 34, ""end_span"": 42, ""type"": ""Multi""}, {""token"": ""tumor"", ""start_span"": 55, ""end_span"": 60, ""type"": ""Cancer""}, {""token"": ""tumor"", ""start_span"": 89, ""end_span"": 94, ""type"": ""Cancer""}]"	train
SWAP - 70 is required for oncogenic transformation by v - Src in mouse embryo fibroblasts.	SWAP - 70,0,9,Gene_or_gene_product	v - Src,54,61,Gene_or_gene_product	mouse,65,70,Organism	embryo fibroblasts,71,89,Cell	"[{""token"": ""SWAP - 70"", ""start_span"": 0, ""end_span"": 9, ""type"": ""Gene_or_gene_product""}, {""token"": ""v - Src"", ""start_span"": 54, ""end_span"": 61, ""type"": ""Gene_or_gene_product""}, {""token"": ""mouse"", ""start_span"": 65, ""end_span"": 70, ""type"": ""Organism""}, {""token"": ""embryo fibroblasts"", ""start_span"": 71, ""end_span"": 89, ""type"": ""Cell""}]"	train
These results suggest that SWAP - 70 may be required for oncogenic transformation and contributes to cell growth in MEFs transformed by v - Src.	SWAP - 70,27,36,Gene_or_gene_product	cell,101,105,Cell	MEFs,116,120,Cell	v - Src,136,143,Gene_or_gene_product	"[{""token"": ""SWAP - 70"", ""start_span"": 27, ""end_span"": 36, ""type"": ""Gene_or_gene_product""}, {""token"": ""cell"", ""start_span"": 101, ""end_span"": 105, ""type"": ""Cell""}, {""token"": ""MEFs"", ""start_span"": 116, ""end_span"": 120, ""type"": ""Cell""}, {""token"": ""v - Src"", ""start_span"": 136, ""end_span"": 143, ""type"": ""Gene_or_gene_product""}]"	train
Based on this observation, we generated the first transgenic mouse model with a targeted overexpression of Tsg101 in the developing mammary gland to test whether exogenous Tsg101 is capable of initiating tumorigenesis.	mouse,61,66,Organism	Tsg101,107,113,Gene_or_gene_product	mammary gland,132,145,Organ	Tsg101,172,178,Gene_or_gene_product	"[{""token"": ""mouse"", ""start_span"": 61, ""end_span"": 66, ""type"": ""Organism""}, {""token"": ""Tsg101"", ""start_span"": 107, ""end_span"": 113, ""type"": ""Gene_or_gene_product""}, {""token"": ""mammary gland"", ""start_span"": 132, ""end_span"": 145, ""type"": ""Organ""}, {""token"": ""Tsg101"", ""start_span"": 172, ""end_span"": 178, ""type"": ""Gene_or_gene_product""}]"	train
Normal functionality of exogenous Tsg101 was tested by rescuing the survival of Tsg101 - deficient mammary epithelial cells in conditional knockout mice.	Tsg101,34,40,Gene_or_gene_product	Tsg101,80,86,Gene_or_gene_product	mammary epithelial cells,99,123,Cell	mice,148,152,Organism	"[{""token"": ""Tsg101"", ""start_span"": 34, ""end_span"": 40, ""type"": ""Gene_or_gene_product""}, {""token"": ""Tsg101"", ""start_span"": 80, ""end_span"": 86, ""type"": ""Gene_or_gene_product""}, {""token"": ""mammary epithelial cells"", ""start_span"": 99, ""end_span"": 123, ""type"": ""Cell""}, {""token"": ""mice"", ""start_span"": 148, ""end_span"": 152, ""type"": ""Organism""}]"	train
The aim of this study was the assessment of correlations among proteins involved in apoptosis - Bcl - xL, Bax, and p53 - as well as relationships of these proteins with selected clinicopathological features in oral squamous cell carcinoma.	Bcl - xL,96,104,Gene_or_gene_product	Bax,106,109,Gene_or_gene_product	p53,115,118,Gene_or_gene_product	oral squamous cell carcinoma,210,238,Cancer	"[{""token"": ""Bcl - xL"", ""start_span"": 96, ""end_span"": 104, ""type"": ""Gene_or_gene_product""}, {""token"": ""Bax"", ""start_span"": 106, ""end_span"": 109, ""type"": ""Gene_or_gene_product""}, {""token"": ""p53"", ""start_span"": 115, ""end_span"": 118, ""type"": ""Gene_or_gene_product""}, {""token"": ""oral squamous cell carcinoma"", ""start_span"": 210, ""end_span"": 238, ""type"": ""Cancer""}]"	train
The antibody also blocks ligand - stimulated activation of PDGFRbeta and downstream signaling molecules, including Akt and MAPK p42 / 44, in tumor cells.	PDGFRbeta,59,68,Gene_or_gene_product	Akt,115,118,Gene_or_gene_product	MAPK p42 / 44,123,136,Gene_or_gene_product	tumor cells,141,152,Cell	"[{""token"": ""PDGFRbeta"", ""start_span"": 59, ""end_span"": 68, ""type"": ""Gene_or_gene_product""}, {""token"": ""Akt"", ""start_span"": 115, ""end_span"": 118, ""type"": ""Gene_or_gene_product""}, {""token"": ""MAPK p42 / 44"", ""start_span"": 123, ""end_span"": 136, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumor cells"", ""start_span"": 141, ""end_span"": 152, ""type"": ""Cell""}]"	train
Our results show that caffeine significantly inhibits adenosine - induced HIF - 1alpha protein accumulation in cancer cells.	caffeine,22,30,Chemical	adenosine,54,63,Chemical	HIF - 1alpha,74,86,Gene_or_gene_product	cancer cells,111,123,Cell	"[{""token"": ""caffeine"", ""start_span"": 22, ""end_span"": 30, ""type"": ""Chemical""}, {""token"": ""adenosine"", ""start_span"": 54, ""end_span"": 63, ""type"": ""Chemical""}, {""token"": ""HIF - 1alpha"", ""start_span"": 74, ""end_span"": 86, ""type"": ""Gene_or_gene_product""}, {""token"": ""cancer cells"", ""start_span"": 111, ""end_span"": 123, ""type"": ""Cell""}]"	train
From a functional perspective, we observe that caffeine also significantly inhibits the A3 receptor - stimulated cell migration of colon cancer cells.	caffeine,47,55,Chemical	A3 receptor,88,99,Gene_or_gene_product	cell,113,117,Cell	colon cancer cells,131,149,Cell	"[{""token"": ""caffeine"", ""start_span"": 47, ""end_span"": 55, ""type"": ""Chemical""}, {""token"": ""A3 receptor"", ""start_span"": 88, ""end_span"": 99, ""type"": ""Gene_or_gene_product""}, {""token"": ""cell"", ""start_span"": 113, ""end_span"": 117, ""type"": ""Cell""}, {""token"": ""colon cancer cells"", ""start_span"": 131, ""end_span"": 149, ""type"": ""Cell""}]"	train
Medical therapy to improve symptoms, stabilise the underlying vascular disease and improve lower limb outcomes is an important and effective adjunct to lifestyle modification and surgical or endovascular interventions in patients with IC.	vascular,62,70,Multi	lower limb,91,101,Organism_subdivision	endovascular,191,203,Immaterial_anatomical_entity	patients,221,229,Organism	"[{""token"": ""vascular"", ""start_span"": 62, ""end_span"": 70, ""type"": ""Multi""}, {""token"": ""lower limb"", ""start_span"": 91, ""end_span"": 101, ""type"": ""Organism_subdivision""}, {""token"": ""endovascular"", ""start_span"": 191, ""end_span"": 203, ""type"": ""Immaterial_anatomical_entity""}, {""token"": ""patients"", ""start_span"": 221, ""end_span"": 229, ""type"": ""Organism""}]"	train
Randomised placebo controlled trials have shown that the phosphodiesterase III inhibitor cilostazol 100mg bid improves pain - free and maximum walking distance, as well as quality of life, in a range of patients with intermittent claudication in whom there is no evidence of tissue necrosis or rest pain.	phosphodiesterase III,57,78,Gene_or_gene_product	cilostazol,89,99,Chemical	patients,203,211,Organism	tissue,275,281,Tissue	"[{""token"": ""phosphodiesterase III"", ""start_span"": 57, ""end_span"": 78, ""type"": ""Gene_or_gene_product""}, {""token"": ""cilostazol"", ""start_span"": 89, ""end_span"": 99, ""type"": ""Chemical""}, {""token"": ""patients"", ""start_span"": 203, ""end_span"": 211, ""type"": ""Organism""}, {""token"": ""tissue"", ""start_span"": 275, ""end_span"": 281, ""type"": ""Tissue""}]"	train
Our results show CWR22Rv - 1 and PC3 tumor cell lines to be more metastatic than LAPC - 4, which in turn disseminates more readily than LAPC - 9.	CWR22Rv - 1,17,28,Cell	PC3 tumor cell lines,33,53,Cell	LAPC - 4,81,89,Cell	LAPC - 9,136,144,Cell	"[{""token"": ""CWR22Rv - 1"", ""start_span"": 17, ""end_span"": 28, ""type"": ""Cell""}, {""token"": ""PC3 tumor cell lines"", ""start_span"": 33, ""end_span"": 53, ""type"": ""Cell""}, {""token"": ""LAPC - 4"", ""start_span"": 81, ""end_span"": 89, ""type"": ""Cell""}, {""token"": ""LAPC - 9"", ""start_span"": 136, ""end_span"": 144, ""type"": ""Cell""}]"	train
In agreement, induced overexpression of VEGF - C in LAPC - 9 enhanced tumor lymphangiogenesis leading to the development of metastatic lesions.	VEGF - C,40,48,Gene_or_gene_product	LAPC - 9,52,60,Cell	tumor,70,75,Cancer	metastatic lesions,124,142,Cancer	"[{""token"": ""VEGF - C"", ""start_span"": 40, ""end_span"": 48, ""type"": ""Gene_or_gene_product""}, {""token"": ""LAPC - 9"", ""start_span"": 52, ""end_span"": 60, ""type"": ""Cell""}, {""token"": ""tumor"", ""start_span"": 70, ""end_span"": 75, ""type"": ""Cancer""}, {""token"": ""metastatic lesions"", ""start_span"": 124, ""end_span"": 142, ""type"": ""Cancer""}]"	train
CONCLUSION: This angiogenesis assay based on human fat tissue uses three - dimensionally intact human tissue.	human,45,50,Organism	fat tissue,51,61,Tissue	human,96,101,Organism	tissue,102,108,Tissue	"[{""token"": ""human"", ""start_span"": 45, ""end_span"": 50, ""type"": ""Organism""}, {""token"": ""fat tissue"", ""start_span"": 51, ""end_span"": 61, ""type"": ""Tissue""}, {""token"": ""human"", ""start_span"": 96, ""end_span"": 101, ""type"": ""Organism""}, {""token"": ""tissue"", ""start_span"": 102, ""end_span"": 108, ""type"": ""Tissue""}]"	train
Having identified the nucleolar localisation sequence in BAG - 1L, we showed that mutation of this sequence did not prevent BAG - 1L from potentiating VDR activity.	nucleolar,22,31,Cellular_component	BAG - 1L,57,65,Gene_or_gene_product	BAG - 1L,124,132,Gene_or_gene_product	VDR,151,154,Gene_or_gene_product	"[{""token"": ""nucleolar"", ""start_span"": 22, ""end_span"": 31, ""type"": ""Cellular_component""}, {""token"": ""BAG - 1L"", ""start_span"": 57, ""end_span"": 65, ""type"": ""Gene_or_gene_product""}, {""token"": ""BAG - 1L"", ""start_span"": 124, ""end_span"": 132, ""type"": ""Gene_or_gene_product""}, {""token"": ""VDR"", ""start_span"": 151, ""end_span"": 154, ""type"": ""Gene_or_gene_product""}]"	train
Transporters, enzymes, and enalapril removal in a rat ( CC531 - induced) liver metastatic model.	enalapril,27,36,Chemical	rat,50,53,Organism	CC531,56,61,Cell	liver,73,78,Organ	"[{""token"": ""enalapril"", ""start_span"": 27, ""end_span"": 36, ""type"": ""Chemical""}, {""token"": ""rat"", ""start_span"": 50, ""end_span"": 53, ""type"": ""Organism""}, {""token"": ""CC531"", ""start_span"": 56, ""end_span"": 61, ""type"": ""Cell""}, {""token"": ""liver"", ""start_span"": 73, ""end_span"": 78, ""type"": ""Organ""}]"	train
Temporal changes in physiological spaces, protein expression of transporters and enzymes, and enalapril removal were appraised in the metastatic liver tumor model developed from male Wag / Rij rats after the intraportal injection of CC531 colon adenocarcinoma cells; sham - operated preparations received PBS.	enalapril,94,103,Chemical	liver tumor,145,156,Cancer	Wag / Rij rats,183,197,Organism	CC531 colon adenocarcinoma cells,233,265,Cell	"[{""token"": ""enalapril"", ""start_span"": 94, ""end_span"": 103, ""type"": ""Chemical""}, {""token"": ""liver tumor"", ""start_span"": 145, ""end_span"": 156, ""type"": ""Cancer""}, {""token"": ""Wag / Rij rats"", ""start_span"": 183, ""end_span"": 197, ""type"": ""Organism""}, {""token"": ""CC531 colon adenocarcinoma cells"", ""start_span"": 233, ""end_span"": 265, ""type"": ""Cell""}]"	train
At week 4, however, the sinusoidal blood volume and albumin Disse space in tumor - bearing livers were slightly lower compared with those of shams.	sinusoidal blood,24,40,Multi	albumin,52,59,Gene_or_gene_product	tumor,75,80,Cancer	livers,91,97,Organ	"[{""token"": ""sinusoidal blood"", ""start_span"": 24, ""end_span"": 40, ""type"": ""Multi""}, {""token"": ""albumin"", ""start_span"": 52, ""end_span"": 59, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumor"", ""start_span"": 75, ""end_span"": 80, ""type"": ""Cancer""}, {""token"": ""livers"", ""start_span"": 91, ""end_span"": 97, ""type"": ""Organ""}]"	train
Wnt signaling, stem cells, and the cellular origin of breast cancer.	Wnt,0,3,Gene_or_gene_product	stem cells,15,25,Cell	cellular,35,43,Cell	breast cancer,54,67,Cancer	"[{""token"": ""Wnt"", ""start_span"": 0, ""end_span"": 3, ""type"": ""Gene_or_gene_product""}, {""token"": ""stem cells"", ""start_span"": 15, ""end_span"": 25, ""type"": ""Cell""}, {""token"": ""cellular"", ""start_span"": 35, ""end_span"": 43, ""type"": ""Cell""}, {""token"": ""breast cancer"", ""start_span"": 54, ""end_span"": 67, ""type"": ""Cancer""}]"	train
Ovarian cancers overexpress the antimicrobial protein hCAP - 18 and its derivative LL - 37 increases ovarian cancer cell proliferation and invasion.	Ovarian cancers,0,15,Cancer	hCAP - 18,54,63,Gene_or_gene_product	LL - 37,83,90,Gene_or_gene_product	ovarian cancer cell,101,120,Cell	"[{""token"": ""Ovarian cancers"", ""start_span"": 0, ""end_span"": 15, ""type"": ""Cancer""}, {""token"": ""hCAP - 18"", ""start_span"": 54, ""end_span"": 63, ""type"": ""Gene_or_gene_product""}, {""token"": ""LL - 37"", ""start_span"": 83, ""end_span"": 90, ""type"": ""Gene_or_gene_product""}, {""token"": ""ovarian cancer cell"", ""start_span"": 101, ""end_span"": 120, ""type"": ""Cell""}]"	train
The role of the pro - inflammatory peptide, LL - 37, and its pro - form, human cationic antimicrobial protein 18 ( hCAP - 18), in cancer development and progression is poorly understood.	LL - 37,44,51,Gene_or_gene_product	human cationic antimicrobial protein 18,73,112,Gene_or_gene_product	hCAP - 18,115,124,Gene_or_gene_product	cancer,130,136,Cancer	"[{""token"": ""LL - 37"", ""start_span"": 44, ""end_span"": 51, ""type"": ""Gene_or_gene_product""}, {""token"": ""human cationic antimicrobial protein 18"", ""start_span"": 73, ""end_span"": 112, ""type"": ""Gene_or_gene_product""}, {""token"": ""hCAP - 18"", ""start_span"": 115, ""end_span"": 124, ""type"": ""Gene_or_gene_product""}, {""token"": ""cancer"", ""start_span"": 130, ""end_span"": 136, ""type"": ""Cancer""}]"	train
It was demonstrated that ovarian tumor tissue lysates and ovarian cancer cell lines express hCAP - 18 / LL - 37.	ovarian tumor tissue lysates,25,53,Organism_substance	ovarian cancer cell lines,58,83,Cell	hCAP - 18,92,101,Gene_or_gene_product	LL - 37,104,111,Gene_or_gene_product	"[{""token"": ""ovarian tumor tissue lysates"", ""start_span"": 25, ""end_span"": 53, ""type"": ""Organism_substance""}, {""token"": ""ovarian cancer cell lines"", ""start_span"": 58, ""end_span"": 83, ""type"": ""Cell""}, {""token"": ""hCAP - 18"", ""start_span"": 92, ""end_span"": 101, ""type"": ""Gene_or_gene_product""}, {""token"": ""LL - 37"", ""start_span"": 104, ""end_span"": 111, ""type"": ""Gene_or_gene_product""}]"	train
This collection of reviews at the front - edge of scientific knowledge focuses on host - tumor cell interactions, the disastrous consequences they can produce and approaches the ways to break up these cellular conspiracies, to leave the tumor cells unattended and vulnerable.	host,82,86,Cell	tumor cell,89,99,Cell	cellular,201,209,Cell	tumor cells,237,248,Cell	"[{""token"": ""host"", ""start_span"": 82, ""end_span"": 86, ""type"": ""Cell""}, {""token"": ""tumor cell"", ""start_span"": 89, ""end_span"": 99, ""type"": ""Cell""}, {""token"": ""cellular"", ""start_span"": 201, ""end_span"": 209, ""type"": ""Cell""}, {""token"": ""tumor cells"", ""start_span"": 237, ""end_span"": 248, ""type"": ""Cell""}]"	train
Here, we demonstrate that Ang1 halts the ability of VEGF to induce the phosphorylation - dependent redistribution of the adhesion molecule VE - cadherin, thereby rescuing the endothelial barrier function.	Ang1,26,30,Gene_or_gene_product	VEGF,52,56,Gene_or_gene_product	VE - cadherin,139,152,Gene_or_gene_product	endothelial barrier,175,194,Tissue	"[{""token"": ""Ang1"", ""start_span"": 26, ""end_span"": 30, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF"", ""start_span"": 52, ""end_span"": 56, ""type"": ""Gene_or_gene_product""}, {""token"": ""VE - cadherin"", ""start_span"": 139, ""end_span"": 152, ""type"": ""Gene_or_gene_product""}, {""token"": ""endothelial barrier"", ""start_span"": 175, ""end_span"": 194, ""type"": ""Tissue""}]"	train
Two patients presented both RUNX1 mutations and RUNX1 - PRDM16 fusion.	patients,4,12,Organism	RUNX1,28,33,Gene_or_gene_product	RUNX1,48,53,Gene_or_gene_product	PRDM16,56,62,Gene_or_gene_product	"[{""token"": ""patients"", ""start_span"": 4, ""end_span"": 12, ""type"": ""Organism""}, {""token"": ""RUNX1"", ""start_span"": 28, ""end_span"": 33, ""type"": ""Gene_or_gene_product""}, {""token"": ""RUNX1"", ""start_span"": 48, ""end_span"": 53, ""type"": ""Gene_or_gene_product""}, {""token"": ""PRDM16"", ""start_span"": 56, ""end_span"": 62, ""type"": ""Gene_or_gene_product""}]"	train
Suppression of lung tumor growth and metastasis in mice by adeno - associated virus - mediated expression of vasostatin.	lung tumor,15,25,Cancer	mice,51,55,Organism	adeno - associated virus,59,83,Organism	vasostatin,109,119,Gene_or_gene_product	"[{""token"": ""lung tumor"", ""start_span"": 15, ""end_span"": 25, ""type"": ""Cancer""}, {""token"": ""mice"", ""start_span"": 51, ""end_span"": 55, ""type"": ""Organism""}, {""token"": ""adeno - associated virus"", ""start_span"": 59, ""end_span"": 83, ""type"": ""Organism""}, {""token"": ""vasostatin"", ""start_span"": 109, ""end_span"": 119, ""type"": ""Gene_or_gene_product""}]"	train
We hypothesized that signaling through multiple mitogen - activated protein kinase ( MAPK) kinase ( MKK) pathways is essential for the growth and vascularization of soft - tissue sarcomas, which are malignant tumors derived from mesenchymal tissues.	MKK,100,103,Gene_or_gene_product	soft - tissue sarcomas,165,187,Cancer	malignant tumors,199,215,Cancer	mesenchymal tissues,229,248,Tissue	"[{""token"": ""MKK"", ""start_span"": 100, ""end_span"": 103, ""type"": ""Gene_or_gene_product""}, {""token"": ""soft - tissue sarcomas"", ""start_span"": 165, ""end_span"": 187, ""type"": ""Cancer""}, {""token"": ""malignant tumors"", ""start_span"": 199, ""end_span"": 215, ""type"": ""Cancer""}, {""token"": ""mesenchymal tissues"", ""start_span"": 229, ""end_span"": 248, ""type"": ""Tissue""}]"	train
Similar results were obtained with cell lines derived from malignant fibrous histiocytomas, leiomyosarcomas, and liposarcomas.	cell lines,35,45,Cell	malignant fibrous histiocytomas,59,90,Cancer	leiomyosarcomas,92,107,Cancer	liposarcomas,113,125,Cancer	"[{""token"": ""cell lines"", ""start_span"": 35, ""end_span"": 45, ""type"": ""Cell""}, {""token"": ""malignant fibrous histiocytomas"", ""start_span"": 59, ""end_span"": 90, ""type"": ""Cancer""}, {""token"": ""leiomyosarcomas"", ""start_span"": 92, ""end_span"": 107, ""type"": ""Cancer""}, {""token"": ""liposarcomas"", ""start_span"": 113, ""end_span"": 125, ""type"": ""Cancer""}]"	train
Growth inhibition correlated with decreased cellular proliferation and extensive necrosis, and it was accompanied by a decrease in tumor mean vessel density as well as a reduction in serum expression of angioproliferative cytokines.	cellular,44,52,Cell	tumor,131,136,Cancer	vessel,142,148,Multi	serum,183,188,Organism_substance	"[{""token"": ""cellular"", ""start_span"": 44, ""end_span"": 52, ""type"": ""Cell""}, {""token"": ""tumor"", ""start_span"": 131, ""end_span"": 136, ""type"": ""Cancer""}, {""token"": ""vessel"", ""start_span"": 142, ""end_span"": 148, ""type"": ""Multi""}, {""token"": ""serum"", ""start_span"": 183, ""end_span"": 188, ""type"": ""Organism_substance""}]"	train
Vital imaging using high - resolution ultrasound enhanced with contrast microbubbles revealed that the effects of LeTx on tumor perfusion were remarkably rapid ( less than 24 h) and resulted in a marked reduction of perfusion within the tumor but not in nontumor tissues.	LeTx,114,118,Chemical	tumor,122,127,Cancer	tumor,237,242,Cancer	nontumor tissues,254,270,Tissue	"[{""token"": ""LeTx"", ""start_span"": 114, ""end_span"": 118, ""type"": ""Chemical""}, {""token"": ""tumor"", ""start_span"": 122, ""end_span"": 127, ""type"": ""Cancer""}, {""token"": ""tumor"", ""start_span"": 237, ""end_span"": 242, ""type"": ""Cancer""}, {""token"": ""nontumor tissues"", ""start_span"": 254, ""end_span"": 270, ""type"": ""Tissue""}]"	train
These results are consistent with our initial hypothesis and lead us to propose that MKK inhibition by LeTx is a broadly effective strategy for targeting neovascularization in fibrosarcomas and other similar proliferative lesions.	MKK,85,88,Gene_or_gene_product	LeTx,103,107,Chemical	fibrosarcomas,176,189,Cancer	proliferative lesions,208,229,Cancer	"[{""token"": ""MKK"", ""start_span"": 85, ""end_span"": 88, ""type"": ""Gene_or_gene_product""}, {""token"": ""LeTx"", ""start_span"": 103, ""end_span"": 107, ""type"": ""Chemical""}, {""token"": ""fibrosarcomas"", ""start_span"": 176, ""end_span"": 189, ""type"": ""Cancer""}, {""token"": ""proliferative lesions"", ""start_span"": 208, ""end_span"": 229, ""type"": ""Cancer""}]"	train
A 4. 0 kb mRNA of the murine UFO homolog is expressed in a variety of different mouse tissues.	murine,22,28,Organism	UFO,29,32,Gene_or_gene_product	mouse,80,85,Organism	tissues,86,93,Tissue	"[{""token"": ""murine"", ""start_span"": 22, ""end_span"": 28, ""type"": ""Organism""}, {""token"": ""UFO"", ""start_span"": 29, ""end_span"": 32, ""type"": ""Gene_or_gene_product""}, {""token"": ""mouse"", ""start_span"": 80, ""end_span"": 85, ""type"": ""Organism""}, {""token"": ""tissues"", ""start_span"": 86, ""end_span"": 93, ""type"": ""Tissue""}]"	train
RESULTS: Proteomic findings indicated that adenosine triphosphate synthase alpha chain was up - regulated, whereas annexin II, annexin V, beta ( 2) - tubulin, and profilin 1 were down - regulated.	adenosine triphosphate synthase alpha chain,43,86,Gene_or_gene_product	annexin II,115,125,Gene_or_gene_product	annexin V,127,136,Gene_or_gene_product	profilin 1,163,173,Gene_or_gene_product	"[{""token"": ""adenosine triphosphate synthase alpha chain"", ""start_span"": 43, ""end_span"": 86, ""type"": ""Gene_or_gene_product""}, {""token"": ""annexin II"", ""start_span"": 115, ""end_span"": 125, ""type"": ""Gene_or_gene_product""}, {""token"": ""annexin V"", ""start_span"": 127, ""end_span"": 136, ""type"": ""Gene_or_gene_product""}, {""token"": ""profilin 1"", ""start_span"": 163, ""end_span"": 173, ""type"": ""Gene_or_gene_product""}]"	train
PLAG1 overexpression in salivary glands has previously been shown to result in salivary gland tumors in 100% of mice within 5 weeks after birth.	PLAG1,0,5,Gene_or_gene_product	salivary glands,24,39,Organ	salivary gland tumors,79,100,Cancer	mice,112,116,Organism	"[{""token"": ""PLAG1"", ""start_span"": 0, ""end_span"": 5, ""type"": ""Gene_or_gene_product""}, {""token"": ""salivary glands"", ""start_span"": 24, ""end_span"": 39, ""type"": ""Organ""}, {""token"": ""salivary gland tumors"", ""start_span"": 79, ""end_span"": 100, ""type"": ""Cancer""}, {""token"": ""mice"", ""start_span"": 112, ""end_span"": 116, ""type"": ""Organism""}]"	train
Collectively, these results suggest an important role for furin in PLAG1 - induced salivary gland tumorigenesis in mice.	furin,58,63,Gene_or_gene_product	PLAG1,67,72,Gene_or_gene_product	salivary gland,83,97,Multi	mice,115,119,Organism	"[{""token"": ""furin"", ""start_span"": 58, ""end_span"": 63, ""type"": ""Gene_or_gene_product""}, {""token"": ""PLAG1"", ""start_span"": 67, ""end_span"": 72, ""type"": ""Gene_or_gene_product""}, {""token"": ""salivary gland"", ""start_span"": 83, ""end_span"": 97, ""type"": ""Multi""}, {""token"": ""mice"", ""start_span"": 115, ""end_span"": 119, ""type"": ""Organism""}]"	train
Furthermore, the expression of M2 - PK - binding peptide aptamers moderately reduced the growth of immortalized NIH3T3 cell populations by decelerating cell proliferation, but without affecting apoptotic cell death.	M2 - PK,31,38,Gene_or_gene_product	NIH3T3 cell populations,112,135,Cell	cell,152,156,Cell	cell,204,208,Cell	"[{""token"": ""M2 - PK"", ""start_span"": 31, ""end_span"": 38, ""type"": ""Gene_or_gene_product""}, {""token"": ""NIH3T3 cell populations"", ""start_span"": 112, ""end_span"": 135, ""type"": ""Cell""}, {""token"": ""cell"", ""start_span"": 152, ""end_span"": 156, ""type"": ""Cell""}, {""token"": ""cell"", ""start_span"": 204, ""end_span"": 208, ""type"": ""Cell""}]"	train
EXPERIMENTAL DESIGN: Both bone marrow and peripheral blood samples from 810 gastric cancer patients were collected at the Central Hospital, National Cancer Center ( Tokyo, Japan).	bone marrow,26,37,Multi	peripheral blood samples,42,66,Organism_substance	gastric cancer,76,90,Cancer	patients,91,99,Organism	"[{""token"": ""bone marrow"", ""start_span"": 26, ""end_span"": 37, ""type"": ""Multi""}, {""token"": ""peripheral blood samples"", ""start_span"": 42, ""end_span"": 66, ""type"": ""Organism_substance""}, {""token"": ""gastric cancer"", ""start_span"": 76, ""end_span"": 90, ""type"": ""Cancer""}, {""token"": ""patients"", ""start_span"": 91, ""end_span"": 99, ""type"": ""Organism""}]"	train
RESULTS: ITCs were observed in peripheral blood and bone marrow even in early stages of gastric cancer.	ITCs,9,13,Cell	peripheral blood,31,47,Organism_substance	bone marrow,52,63,Multi	gastric cancer,88,102,Cancer	"[{""token"": ""ITCs"", ""start_span"": 9, ""end_span"": 13, ""type"": ""Cell""}, {""token"": ""peripheral blood"", ""start_span"": 31, ""end_span"": 47, ""type"": ""Organism_substance""}, {""token"": ""bone marrow"", ""start_span"": 52, ""end_span"": 63, ""type"": ""Multi""}, {""token"": ""gastric cancer"", ""start_span"": 88, ""end_span"": 102, ""type"": ""Cancer""}]"	train
Acute ethanol exposure disrupts VEGF receptor cell signaling in endothelial cells.	ethanol,6,13,Chemical	VEGF receptor,32,45,Gene_or_gene_product	cell,46,50,Cell	endothelial cells,64,81,Cell	"[{""token"": ""ethanol"", ""start_span"": 6, ""end_span"": 13, ""type"": ""Chemical""}, {""token"": ""VEGF receptor"", ""start_span"": 32, ""end_span"": 45, ""type"": ""Gene_or_gene_product""}, {""token"": ""cell"", ""start_span"": 46, ""end_span"": 50, ""type"": ""Cell""}, {""token"": ""endothelial cells"", ""start_span"": 64, ""end_span"": 81, ""type"": ""Cell""}]"	train
In addition, ethanol exposure decreased expression of endothelial VEGF receptor - 2, as well as VEGF receptor - 2 phosphorylation in vitro.	ethanol,13,20,Chemical	endothelial,54,65,Cell	VEGF receptor - 2,66,83,Gene_or_gene_product	VEGF receptor - 2,96,113,Gene_or_gene_product	"[{""token"": ""ethanol"", ""start_span"": 13, ""end_span"": 20, ""type"": ""Chemical""}, {""token"": ""endothelial"", ""start_span"": 54, ""end_span"": 65, ""type"": ""Cell""}, {""token"": ""VEGF receptor - 2"", ""start_span"": 66, ""end_span"": 83, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF receptor - 2"", ""start_span"": 96, ""end_span"": 113, ""type"": ""Gene_or_gene_product""}]"	train
Inhibition of ethanol metabolism by 4 - methylpyrazole partially abrogated the effect of ethanol on endothelial cell cord formation.	ethanol,14,21,Chemical	4 - methylpyrazole,36,54,Chemical	ethanol,89,96,Chemical	endothelial cell cord,100,121,Tissue	"[{""token"": ""ethanol"", ""start_span"": 14, ""end_span"": 21, ""type"": ""Chemical""}, {""token"": ""4 - methylpyrazole"", ""start_span"": 36, ""end_span"": 54, ""type"": ""Chemical""}, {""token"": ""ethanol"", ""start_span"": 89, ""end_span"": 96, ""type"": ""Chemical""}, {""token"": ""endothelial cell cord"", ""start_span"": 100, ""end_span"": 121, ""type"": ""Tissue""}]"	train
These results suggest that products of ethanol metabolism are important factors in the development of ethanol - induced changes in endothelial cell responsiveness to VEGF.	ethanol,39,46,Chemical	ethanol,102,109,Chemical	endothelial cell,131,147,Cell	VEGF,166,170,Gene_or_gene_product	"[{""token"": ""ethanol"", ""start_span"": 39, ""end_span"": 46, ""type"": ""Chemical""}, {""token"": ""ethanol"", ""start_span"": 102, ""end_span"": 109, ""type"": ""Chemical""}, {""token"": ""endothelial cell"", ""start_span"": 131, ""end_span"": 147, ""type"": ""Cell""}, {""token"": ""VEGF"", ""start_span"": 166, ""end_span"": 170, ""type"": ""Gene_or_gene_product""}]"	train
Moreover, in vitro experiments demonstrated a direct effect of ethanol on the response to hypoxia in endothelial cells, as ethanol diminished nuclear hypoxia - inducible factor - 1alpha protein levels.	ethanol,63,70,Chemical	endothelial cells,101,118,Cell	ethanol,123,130,Chemical	hypoxia - inducible factor - 1alpha,150,185,Gene_or_gene_product	"[{""token"": ""ethanol"", ""start_span"": 63, ""end_span"": 70, ""type"": ""Chemical""}, {""token"": ""endothelial cells"", ""start_span"": 101, ""end_span"": 118, ""type"": ""Cell""}, {""token"": ""ethanol"", ""start_span"": 123, ""end_span"": 130, ""type"": ""Chemical""}, {""token"": ""hypoxia - inducible factor - 1alpha"", ""start_span"": 150, ""end_span"": 185, ""type"": ""Gene_or_gene_product""}]"	train
The epithelioid cells were entirely supported by proliferated capillaries and arteries together with collagenous stroma.	epithelioid cells,4,21,Cell	capillaries,62,73,Tissue	arteries,78,86,Multi	collagenous stroma,101,119,Tissue	"[{""token"": ""epithelioid cells"", ""start_span"": 4, ""end_span"": 21, ""type"": ""Cell""}, {""token"": ""capillaries"", ""start_span"": 62, ""end_span"": 73, ""type"": ""Tissue""}, {""token"": ""arteries"", ""start_span"": 78, ""end_span"": 86, ""type"": ""Multi""}, {""token"": ""collagenous stroma"", ""start_span"": 101, ""end_span"": 119, ""type"": ""Tissue""}]"	train
Platelet - derived endothelial cell growth - factor ( PD - ECGF) is similar to the pyrimidine enzyme thymidine phosphorylase ( TP).	Platelet - derived endothelial cell growth - factor,0,51,Gene_or_gene_product	PD - ECGF,54,63,Gene_or_gene_product	thymidine phosphorylase,101,124,Gene_or_gene_product	TP,127,129,Gene_or_gene_product	"[{""token"": ""Platelet - derived endothelial cell growth - factor"", ""start_span"": 0, ""end_span"": 51, ""type"": ""Gene_or_gene_product""}, {""token"": ""PD - ECGF"", ""start_span"": 54, ""end_span"": 63, ""type"": ""Gene_or_gene_product""}, {""token"": ""thymidine phosphorylase"", ""start_span"": 101, ""end_span"": 124, ""type"": ""Gene_or_gene_product""}, {""token"": ""TP"", ""start_span"": 127, ""end_span"": 129, ""type"": ""Gene_or_gene_product""}]"	train
TP is not only expressed in tumor cells but also in tumor surrounding tissues, such as tumor infiltrating macrophages.	TP,0,2,Gene_or_gene_product	tumor cells,28,39,Cell	tumor surrounding tissues,52,77,Tissue	tumor infiltrating macrophages,87,117,Cell	"[{""token"": ""TP"", ""start_span"": 0, ""end_span"": 2, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumor cells"", ""start_span"": 28, ""end_span"": 39, ""type"": ""Cell""}, {""token"": ""tumor surrounding tissues"", ""start_span"": 52, ""end_span"": 77, ""type"": ""Tissue""}, {""token"": ""tumor infiltrating macrophages"", ""start_span"": 87, ""end_span"": 117, ""type"": ""Cell""}]"	train
L - deoxyribose ( L - dR) and thymidine phosphorylase inhibitor ( TPI) can reverse these effects.	L - deoxyribose,0,15,Chemical	L - dR,18,24,Chemical	thymidine phosphorylase inhibitor,30,63,Chemical	TPI,66,69,Chemical	"[{""token"": ""L - deoxyribose"", ""start_span"": 0, ""end_span"": 15, ""type"": ""Chemical""}, {""token"": ""L - dR"", ""start_span"": 18, ""end_span"": 24, ""type"": ""Chemical""}, {""token"": ""thymidine phosphorylase inhibitor"", ""start_span"": 30, ""end_span"": 63, ""type"": ""Chemical""}, {""token"": ""TPI"", ""start_span"": 66, ""end_span"": 69, ""type"": ""Chemical""}]"	train
Bone marrow - derived mesenchymal stem cells ( BM - MSC) have been demonstrated to be an attractive therapeutic cell source for tissue regeneration and repair.	Bone marrow - derived mesenchymal stem cells,0,44,Cell	BM - MSC,47,55,Cell	cell,112,116,Cell	tissue,128,134,Tissue	"[{""token"": ""Bone marrow - derived mesenchymal stem cells"", ""start_span"": 0, ""end_span"": 44, ""type"": ""Cell""}, {""token"": ""BM - MSC"", ""start_span"": 47, ""end_span"": 55, ""type"": ""Cell""}, {""token"": ""cell"", ""start_span"": 112, ""end_span"": 116, ""type"": ""Cell""}, {""token"": ""tissue"", ""start_span"": 128, ""end_span"": 134, ""type"": ""Tissue""}]"	train
However, it remains unknown whether or not allogeneic transplantation of mesenchymal stem cells ( MSC) derived from fetal membranes ( FM), which are generally discarded as medical waste after delivery, has therapeutic potential.	mesenchymal stem cells,73,95,Cell	MSC,98,101,Cell	fetal membranes,116,131,Multi	FM,134,136,Multi	"[{""token"": ""mesenchymal stem cells"", ""start_span"": 73, ""end_span"": 95, ""type"": ""Cell""}, {""token"": ""MSC"", ""start_span"": 98, ""end_span"": 101, ""type"": ""Cell""}, {""token"": ""fetal membranes"", ""start_span"": 116, ""end_span"": 131, ""type"": ""Multi""}, {""token"": ""FM"", ""start_span"": 134, ""end_span"": 136, ""type"": ""Multi""}]"	train
Compared with BM - MSC, FM - MSC secreted a comparable amount of hepatocyte growth factor despite a small amount of vascular endothelial growth factor.	BM - MSC,14,22,Cell	FM - MSC,24,32,Cell	hepatocyte growth factor,65,89,Gene_or_gene_product	vascular endothelial growth factor,116,150,Gene_or_gene_product	"[{""token"": ""BM - MSC"", ""start_span"": 14, ""end_span"": 22, ""type"": ""Cell""}, {""token"": ""FM - MSC"", ""start_span"": 24, ""end_span"": 32, ""type"": ""Cell""}, {""token"": ""hepatocyte growth factor"", ""start_span"": 65, ""end_span"": 89, ""type"": ""Gene_or_gene_product""}, {""token"": ""vascular endothelial growth factor"", ""start_span"": 116, ""end_span"": 150, ""type"": ""Gene_or_gene_product""}]"	train
FM - MSC and BM - MSC both expressed major histocompatibility complex ( MHC) class I but not MHC class II antigens and did not elicit allogeneic lymphocyte proliferation in mixed lymphocyte culture.	FM - MSC,0,8,Cell	BM - MSC,13,21,Cell	lymphocyte,145,155,Cell	lymphocyte,179,189,Cell	"[{""token"": ""FM - MSC"", ""start_span"": 0, ""end_span"": 8, ""type"": ""Cell""}, {""token"": ""BM - MSC"", ""start_span"": 13, ""end_span"": 21, ""type"": ""Cell""}, {""token"": ""lymphocyte"", ""start_span"": 145, ""end_span"": 155, ""type"": ""Cell""}, {""token"": ""lymphocyte"", ""start_span"": 179, ""end_span"": 189, ""type"": ""Cell""}]"	train
[ ( 18) F] deoxyglucose uptake correlates with glucose transporter ( GLUT - 1) expression, which can be regulated by hypoxia - inducible factor 1 alpha ( HIF - 1alpha).	glucose transporter,47,66,Gene_or_gene_product	GLUT - 1,69,77,Gene_or_gene_product	hypoxia - inducible factor 1 alpha,117,151,Gene_or_gene_product	HIF - 1alpha,154,166,Gene_or_gene_product	"[{""token"": ""glucose transporter"", ""start_span"": 47, ""end_span"": 66, ""type"": ""Gene_or_gene_product""}, {""token"": ""GLUT - 1"", ""start_span"": 69, ""end_span"": 77, ""type"": ""Gene_or_gene_product""}, {""token"": ""hypoxia - inducible factor 1 alpha"", ""start_span"": 117, ""end_span"": 151, ""type"": ""Gene_or_gene_product""}, {""token"": ""HIF - 1alpha"", ""start_span"": 154, ""end_span"": 166, ""type"": ""Gene_or_gene_product""}]"	train
Intracerebral grafting of cultured autologous skin fibroblasts into the rat striatum: an assessment of graft size and ultrastructure.	skin fibroblasts,46,62,Cell	rat,72,75,Organism	striatum,76,84,Multi	graft,103,108,Tissue	"[{""token"": ""skin fibroblasts"", ""start_span"": 46, ""end_span"": 62, ""type"": ""Cell""}, {""token"": ""rat"", ""start_span"": 72, ""end_span"": 75, ""type"": ""Organism""}, {""token"": ""striatum"", ""start_span"": 76, ""end_span"": 84, ""type"": ""Multi""}, {""token"": ""graft"", ""start_span"": 103, ""end_span"": 108, ""type"": ""Tissue""}]"	train
It is concluded that primary skin fibroblasts are able to survive for at least 8 weeks following intracerebral implantation and continue to synthesize collagen and fibronectin in vivo.	skin fibroblasts,29,45,Cell	intracerebral,97,110,Immaterial_anatomical_entity	collagen,151,159,Gene_or_gene_product	fibronectin,164,175,Gene_or_gene_product	"[{""token"": ""skin fibroblasts"", ""start_span"": 29, ""end_span"": 45, ""type"": ""Cell""}, {""token"": ""intracerebral"", ""start_span"": 97, ""end_span"": 110, ""type"": ""Immaterial_anatomical_entity""}, {""token"": ""collagen"", ""start_span"": 151, ""end_span"": 159, ""type"": ""Gene_or_gene_product""}, {""token"": ""fibronectin"", ""start_span"": 164, ""end_span"": 175, ""type"": ""Gene_or_gene_product""}]"	train
RESULTS: Both SAT and VAT expressed angiogenic factors without significant difference for vascular endothelial growth factor ( VEGF) expression.	SAT,14,17,Tissue	VAT,22,25,Tissue	vascular endothelial growth factor,90,124,Gene_or_gene_product	VEGF,127,131,Gene_or_gene_product	"[{""token"": ""SAT"", ""start_span"": 14, ""end_span"": 17, ""type"": ""Tissue""}, {""token"": ""VAT"", ""start_span"": 22, ""end_span"": 25, ""type"": ""Tissue""}, {""token"": ""vascular endothelial growth factor"", ""start_span"": 90, ""end_span"": 124, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF"", ""start_span"": 127, ""end_span"": 131, ""type"": ""Gene_or_gene_product""}]"	train
Stimulation of angiogenesis by adipose tissue was nearly abolished by bevacizumab, which specifically targets human VEGF.	adipose tissue,31,45,Tissue	bevacizumab,70,81,Chemical	human,110,115,Organism	VEGF,116,120,Gene_or_gene_product	"[{""token"": ""adipose tissue"", ""start_span"": 31, ""end_span"": 45, ""type"": ""Tissue""}, {""token"": ""bevacizumab"", ""start_span"": 70, ""end_span"": 81, ""type"": ""Chemical""}, {""token"": ""human"", ""start_span"": 110, ""end_span"": 115, ""type"": ""Organism""}, {""token"": ""VEGF"", ""start_span"": 116, ""end_span"": 120, ""type"": ""Gene_or_gene_product""}]"	train
Previously, we reported that in vitro M - CSF induces the expression of biologically - active VEGF from human monocytes.	M - CSF,38,45,Gene_or_gene_product	VEGF,94,98,Gene_or_gene_product	human,104,109,Organism	monocytes,110,119,Cell	"[{""token"": ""M - CSF"", ""start_span"": 38, ""end_span"": 45, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF"", ""start_span"": 94, ""end_span"": 98, ""type"": ""Gene_or_gene_product""}, {""token"": ""human"", ""start_span"": 104, ""end_span"": 109, ""type"": ""Organism""}, {""token"": ""monocytes"", ""start_span"": 110, ""end_span"": 119, ""type"": ""Cell""}]"	train
Thus, inhibition of either ERK or Sp1 suppressed M - CSF - induced VEGF at the mRNA and protein level.	ERK,27,30,Gene_or_gene_product	Sp1,34,37,Gene_or_gene_product	M - CSF,49,56,Gene_or_gene_product	VEGF,67,71,Gene_or_gene_product	"[{""token"": ""ERK"", ""start_span"": 27, ""end_span"": 30, ""type"": ""Gene_or_gene_product""}, {""token"": ""Sp1"", ""start_span"": 34, ""end_span"": 37, ""type"": ""Gene_or_gene_product""}, {""token"": ""M - CSF"", ""start_span"": 49, ""end_span"": 56, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF"", ""start_span"": 67, ""end_span"": 71, ""type"": ""Gene_or_gene_product""}]"	train
M - CSF also induced the nuclear localization of Sp1, which was blocked by ERK inhibition.	M - CSF,0,7,Gene_or_gene_product	nuclear,25,32,Cellular_component	Sp1,49,52,Gene_or_gene_product	ERK,75,78,Gene_or_gene_product	"[{""token"": ""M - CSF"", ""start_span"": 0, ""end_span"": 7, ""type"": ""Gene_or_gene_product""}, {""token"": ""nuclear"", ""start_span"": 25, ""end_span"": 32, ""type"": ""Cellular_component""}, {""token"": ""Sp1"", ""start_span"": 49, ""end_span"": 52, ""type"": ""Gene_or_gene_product""}, {""token"": ""ERK"", ""start_span"": 75, ""end_span"": 78, ""type"": ""Gene_or_gene_product""}]"	train
Selective inhibition of PI3K / Akt suppressed the NF - kappaB - induced BMP - 2 promoter activity.	PI3K,24,28,Gene_or_gene_product	Akt,31,34,Gene_or_gene_product	NF - kappaB,50,61,Gene_or_gene_product	BMP - 2,72,79,Gene_or_gene_product	"[{""token"": ""PI3K"", ""start_span"": 24, ""end_span"": 28, ""type"": ""Gene_or_gene_product""}, {""token"": ""Akt"", ""start_span"": 31, ""end_span"": 34, ""type"": ""Gene_or_gene_product""}, {""token"": ""NF - kappaB"", ""start_span"": 50, ""end_span"": 61, ""type"": ""Gene_or_gene_product""}, {""token"": ""BMP - 2"", ""start_span"": 72, ""end_span"": 79, ""type"": ""Gene_or_gene_product""}]"	train
Based on ChIP analysis, the transcriptional regulation of BMP - 2 gene by NF - kappaB may be partially attributed to binding to kappab site on the BMP - 2 promoter.	BMP - 2,58,65,Gene_or_gene_product	NF - kappaB,74,85,Gene_or_gene_product	kappab,128,134,Gene_or_gene_product	BMP - 2,147,154,Gene_or_gene_product	"[{""token"": ""BMP - 2"", ""start_span"": 58, ""end_span"": 65, ""type"": ""Gene_or_gene_product""}, {""token"": ""NF - kappaB"", ""start_span"": 74, ""end_span"": 85, ""type"": ""Gene_or_gene_product""}, {""token"": ""kappab"", ""start_span"": 128, ""end_span"": 134, ""type"": ""Gene_or_gene_product""}, {""token"": ""BMP - 2"", ""start_span"": 147, ""end_span"": 154, ""type"": ""Gene_or_gene_product""}]"	train
The early closure of all wounds implies that the rabbit ear model may not be valid for chronic wound studies.	wounds,25,31,Pathological_formation	rabbit,49,55,Organism	ear,56,59,Organ	wound,95,100,Pathological_formation	"[{""token"": ""wounds"", ""start_span"": 25, ""end_span"": 31, ""type"": ""Pathological_formation""}, {""token"": ""rabbit"", ""start_span"": 49, ""end_span"": 55, ""type"": ""Organism""}, {""token"": ""ear"", ""start_span"": 56, ""end_span"": 59, ""type"": ""Organ""}, {""token"": ""wound"", ""start_span"": 95, ""end_span"": 100, ""type"": ""Pathological_formation""}]"	train
Ang - 1 has been shown to induce the migration and sprouting of endothelial cells, and coexpression of Ang - 1 and VEGF enhanced angiogenesis.	Ang - 1,0,7,Gene_or_gene_product	endothelial cells,64,81,Cell	Ang - 1,103,110,Gene_or_gene_product	VEGF,115,119,Gene_or_gene_product	"[{""token"": ""Ang - 1"", ""start_span"": 0, ""end_span"": 7, ""type"": ""Gene_or_gene_product""}, {""token"": ""endothelial cells"", ""start_span"": 64, ""end_span"": 81, ""type"": ""Cell""}, {""token"": ""Ang - 1"", ""start_span"": 103, ""end_span"": 110, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF"", ""start_span"": 115, ""end_span"": 119, ""type"": ""Gene_or_gene_product""}]"	train
Effect of transplanted mesenchymal stem cells from rats of different ages on the improvement of heart function after acute myocardial infarction.	mesenchymal stem cells,23,45,Cell	rats,51,55,Organism	heart,96,101,Organ	myocardial,123,133,Multi	"[{""token"": ""mesenchymal stem cells"", ""start_span"": 23, ""end_span"": 45, ""type"": ""Cell""}, {""token"": ""rats"", ""start_span"": 51, ""end_span"": 55, ""type"": ""Organism""}, {""token"": ""heart"", ""start_span"": 96, ""end_span"": 101, ""type"": ""Organ""}, {""token"": ""myocardial"", ""start_span"": 123, ""end_span"": 133, ""type"": ""Multi""}]"	train
Thus, our objective was to explore the expression of COUP - TFII in colorectal cancer as well as its association with clinicopathological features, and to evaluate the role of COUP - TFII as a prognostic indicator in colorectal cancer.	COUP - TFII,53,64,Gene_or_gene_product	colorectal cancer,68,85,Cancer	COUP - TFII,176,187,Gene_or_gene_product	colorectal cancer,217,234,Cancer	"[{""token"": ""COUP - TFII"", ""start_span"": 53, ""end_span"": 64, ""type"": ""Gene_or_gene_product""}, {""token"": ""colorectal cancer"", ""start_span"": 68, ""end_span"": 85, ""type"": ""Cancer""}, {""token"": ""COUP - TFII"", ""start_span"": 176, ""end_span"": 187, ""type"": ""Gene_or_gene_product""}, {""token"": ""colorectal cancer"", ""start_span"": 217, ""end_span"": 234, ""type"": ""Cancer""}]"	train
No significant correlation was found between COUP - TFII expression and age at surgery, gender, histopathologic differentiation, vessel invasion, carcinoembryonic antigen ( CEA), or nodal involvement.	COUP - TFII,45,56,Gene_or_gene_product	vessel,129,135,Multi	carcinoembryonic antigen,146,170,Gene_or_gene_product	CEA,173,176,Gene_or_gene_product	"[{""token"": ""COUP - TFII"", ""start_span"": 45, ""end_span"": 56, ""type"": ""Gene_or_gene_product""}, {""token"": ""vessel"", ""start_span"": 129, ""end_span"": 135, ""type"": ""Multi""}, {""token"": ""carcinoembryonic antigen"", ""start_span"": 146, ""end_span"": 170, ""type"": ""Gene_or_gene_product""}, {""token"": ""CEA"", ""start_span"": 173, ""end_span"": 176, ""type"": ""Gene_or_gene_product""}]"	train
It has been widely accepted that p53 acts in response to stresses and abnormalities in cell physiology by mobilizing the repair processes or by removing the diseased cells through initiating the cell death programs.	p53,33,36,Gene_or_gene_product	cell,87,91,Cell	cells,166,171,Cell	cell,195,199,Cell	"[{""token"": ""p53"", ""start_span"": 33, ""end_span"": 36, ""type"": ""Gene_or_gene_product""}, {""token"": ""cell"", ""start_span"": 87, ""end_span"": 91, ""type"": ""Cell""}, {""token"": ""cells"", ""start_span"": 166, ""end_span"": 171, ""type"": ""Cell""}, {""token"": ""cell"", ""start_span"": 195, ""end_span"": 199, ""type"": ""Cell""}]"	train
These novel functions of p53 help to align metabolic processes with the proliferation and energy status, to maintain optimal mode of glucose metabolism and to boost the energy efficient mitochondrial respiration in response to ATP deficiency.	p53,25,28,Gene_or_gene_product	glucose,133,140,Chemical	mitochondrial,186,199,Cellular_component	ATP,227,230,Chemical	"[{""token"": ""p53"", ""start_span"": 25, ""end_span"": 28, ""type"": ""Gene_or_gene_product""}, {""token"": ""glucose"", ""start_span"": 133, ""end_span"": 140, ""type"": ""Chemical""}, {""token"": ""mitochondrial"", ""start_span"": 186, ""end_span"": 199, ""type"": ""Cellular_component""}, {""token"": ""ATP"", ""start_span"": 227, ""end_span"": 230, ""type"": ""Chemical""}]"	train
The deficiency in the p53 - mediated regulation of glycolysis and mitochondrial respiration greatly accounts for the deficient respiration of the predominance of aerobic glycolysis in cancer cells ( the Warburg effect), while the deficiency in the p53 - modulated antioxidant defense mechanisms contributes to mutagenesis and additionally boosts the carcinogenesis process.	p53,22,25,Gene_or_gene_product	mitochondrial,66,79,Cellular_component	cancer cells,184,196,Cell	p53,248,251,Gene_or_gene_product	"[{""token"": ""p53"", ""start_span"": 22, ""end_span"": 25, ""type"": ""Gene_or_gene_product""}, {""token"": ""mitochondrial"", ""start_span"": 66, ""end_span"": 79, ""type"": ""Cellular_component""}, {""token"": ""cancer cells"", ""start_span"": 184, ""end_span"": 196, ""type"": ""Cell""}, {""token"": ""p53"", ""start_span"": 248, ""end_span"": 251, ""type"": ""Gene_or_gene_product""}]"	train
CONCLUSIONS: We reported here for the first time the involvement of PTEN promoter methylation in CCMs, particularly in familial CCMs, suggesting this epigenetic alteration as a potential pathomechanism of CCMs.	PTEN,68,72,Gene_or_gene_product	CCMs,97,101,Pathological_formation	CCMs,128,132,Pathological_formation	CCMs,205,209,Pathological_formation	"[{""token"": ""PTEN"", ""start_span"": 68, ""end_span"": 72, ""type"": ""Gene_or_gene_product""}, {""token"": ""CCMs"", ""start_span"": 97, ""end_span"": 101, ""type"": ""Pathological_formation""}, {""token"": ""CCMs"", ""start_span"": 128, ""end_span"": 132, ""type"": ""Pathological_formation""}, {""token"": ""CCMs"", ""start_span"": 205, ""end_span"": 209, ""type"": ""Pathological_formation""}]"	train
Aflibercept ( AVE0005): an alternative strategy for inhibiting tumour angiogenesis by vascular endothelial growth factors.	Aflibercept,0,11,Chemical	AVE0005,14,21,Chemical	tumour,63,69,Cancer	vascular endothelial growth factors,86,121,Gene_or_gene_product	"[{""token"": ""Aflibercept"", ""start_span"": 0, ""end_span"": 11, ""type"": ""Chemical""}, {""token"": ""AVE0005"", ""start_span"": 14, ""end_span"": 21, ""type"": ""Chemical""}, {""token"": ""tumour"", ""start_span"": 63, ""end_span"": 69, ""type"": ""Cancer""}, {""token"": ""vascular endothelial growth factors"", ""start_span"": 86, ""end_span"": 121, ""type"": ""Gene_or_gene_product""}]"	train
METHODS: This review outlines and compares the latest development of these strategies, with emphasis on aflibercept, a novel decoy fusion protein of domain 2 of VEGFR - 1 and domain 3 of VEGFR - 2 with the Fc fragment of IgG1.	aflibercept,104,115,Chemical	VEGFR - 1,161,170,Gene_or_gene_product	VEGFR - 2,187,196,Gene_or_gene_product	IgG1,221,225,Gene_or_gene_product	"[{""token"": ""aflibercept"", ""start_span"": 104, ""end_span"": 115, ""type"": ""Chemical""}, {""token"": ""VEGFR - 1"", ""start_span"": 161, ""end_span"": 170, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGFR - 2"", ""start_span"": 187, ""end_span"": 196, ""type"": ""Gene_or_gene_product""}, {""token"": ""IgG1"", ""start_span"": 221, ""end_span"": 225, ""type"": ""Gene_or_gene_product""}]"	train
Partial tissue oxygen tension ( PtO ( 2)) was measured with polarographic microprobes; epithelial metabolism was monitored by microdialysis inside the TET epithelium perfused with the medium underneath.	tissue,8,14,Tissue	oxygen,15,21,Chemical	epithelial,87,97,Cell	TET epithelium,151,165,Tissue	"[{""token"": ""tissue"", ""start_span"": 8, ""end_span"": 14, ""type"": ""Tissue""}, {""token"": ""oxygen"", ""start_span"": 15, ""end_span"": 21, ""type"": ""Chemical""}, {""token"": ""epithelial"", ""start_span"": 87, ""end_span"": 97, ""type"": ""Cell""}, {""token"": ""TET epithelium"", ""start_span"": 151, ""end_span"": 165, ""type"": ""Tissue""}]"	train
Tissue reaction of TET epithelial scaffolds immersed with the medium was evaluated on the chick embryo chorioallantoic membrane.	Tissue,0,6,Tissue	TET epithelial scaffolds,19,43,Tissue	chick,90,95,Organism	embryo chorioallantoic membrane,96,127,Multi	"[{""token"": ""Tissue"", ""start_span"": 0, ""end_span"": 6, ""type"": ""Tissue""}, {""token"": ""TET epithelial scaffolds"", ""start_span"": 19, ""end_span"": 43, ""type"": ""Tissue""}, {""token"": ""chick"", ""start_span"": 90, ""end_span"": 95, ""type"": ""Organism""}, {""token"": ""embryo chorioallantoic membrane"", ""start_span"": 96, ""end_span"": 127, ""type"": ""Multi""}]"	train
Chondrocyte - DegraPol in Oxygent group presented lower glycosaminoglycan value ( 0. 03 + / - 0. 00 vs. 0. 13 + / - 0. 00, p less than 0. 05); histology slides showed poor acid mucopolysaccharides formation.	Chondrocyte,0,11,Cell	Oxygent,26,33,Chemical	glycosaminoglycan,56,73,Chemical	mucopolysaccharides,177,196,Chemical	"[{""token"": ""Chondrocyte"", ""start_span"": 0, ""end_span"": 11, ""type"": ""Cell""}, {""token"": ""Oxygent"", ""start_span"": 26, ""end_span"": 33, ""type"": ""Chemical""}, {""token"": ""glycosaminoglycan"", ""start_span"": 56, ""end_span"": 73, ""type"": ""Chemical""}, {""token"": ""mucopolysaccharides"", ""start_span"": 177, ""end_span"": 196, ""type"": ""Chemical""}]"	train
We conclude that Oxygent increases TET epithelial PtO ( 2), improves epithelial metabolism, does not impair angiogenesis, and tends to slow cartilage tissue formation.	Oxygent,17,24,Chemical	TET epithelial,35,49,Tissue	epithelial,69,79,Tissue	cartilage tissue,140,156,Tissue	"[{""token"": ""Oxygent"", ""start_span"": 17, ""end_span"": 24, ""type"": ""Chemical""}, {""token"": ""TET epithelial"", ""start_span"": 35, ""end_span"": 49, ""type"": ""Tissue""}, {""token"": ""epithelial"", ""start_span"": 69, ""end_span"": 79, ""type"": ""Tissue""}, {""token"": ""cartilage tissue"", ""start_span"": 140, ""end_span"": 156, ""type"": ""Tissue""}]"	train
Loss of tumor suppressor proteins, which function as brakes on cell growth, migration, or cell survival, was recognized early on as an important mechanism for initiation and progression of melanoma.	tumor,8,13,Cancer	cell,63,67,Cell	cell,90,94,Cell	melanoma,189,197,Cancer	"[{""token"": ""tumor"", ""start_span"": 8, ""end_span"": 13, ""type"": ""Cancer""}, {""token"": ""cell"", ""start_span"": 63, ""end_span"": 67, ""type"": ""Cell""}, {""token"": ""cell"", ""start_span"": 90, ""end_span"": 94, ""type"": ""Cell""}, {""token"": ""melanoma"", ""start_span"": 189, ""end_span"": 197, ""type"": ""Cancer""}]"	train
RESULTS: The average fibrinogen levels in patients with pancreatic carcinoma, ( 476. 21 + / - 142. 05) mg / dl, were significantly higher than in patients with cholangiolithiasis, ( 403. 28 + / - 126. 41) mg / dl ( P < 0. 05).	fibrinogen,21,31,Gene_or_gene_product	patients,42,50,Organism	pancreatic carcinoma,56,76,Cancer	patients,146,154,Organism	"[{""token"": ""fibrinogen"", ""start_span"": 21, ""end_span"": 31, ""type"": ""Gene_or_gene_product""}, {""token"": ""patients"", ""start_span"": 42, ""end_span"": 50, ""type"": ""Organism""}, {""token"": ""pancreatic carcinoma"", ""start_span"": 56, ""end_span"": 76, ""type"": ""Cancer""}, {""token"": ""patients"", ""start_span"": 146, ""end_span"": 154, ""type"": ""Organism""}]"	train
In patients with pancreatic carcinoma, the levels of fibrinogen in the group with jaundice were significantly higher than in patients without jaundice ( P < 0. 05).	patients,3,11,Organism	pancreatic carcinoma,17,37,Cancer	fibrinogen,53,63,Gene_or_gene_product	patients,125,133,Organism	"[{""token"": ""patients"", ""start_span"": 3, ""end_span"": 11, ""type"": ""Organism""}, {""token"": ""pancreatic carcinoma"", ""start_span"": 17, ""end_span"": 37, ""type"": ""Cancer""}, {""token"": ""fibrinogen"", ""start_span"": 53, ""end_span"": 63, ""type"": ""Gene_or_gene_product""}, {""token"": ""patients"", ""start_span"": 125, ""end_span"": 133, ""type"": ""Organism""}]"	train
There was no significant difference of intraoperative blood loss between patients with vitamin K, ( 748. 27 + / - 448. 51) ml, and those without vitamin K, ( 767. 31 + / - 547. 89) ml ( P > 0. 05).	blood,54,59,Organism_substance	patients,73,81,Organism	vitamin K,87,96,Chemical	vitamin K,145,154,Chemical	"[{""token"": ""blood"", ""start_span"": 54, ""end_span"": 59, ""type"": ""Organism_substance""}, {""token"": ""patients"", ""start_span"": 73, ""end_span"": 81, ""type"": ""Organism""}, {""token"": ""vitamin K"", ""start_span"": 87, ""end_span"": 96, ""type"": ""Chemical""}, {""token"": ""vitamin K"", ""start_span"": 145, ""end_span"": 154, ""type"": ""Chemical""}]"	train
Chronic inflammation is a common underlying condition for human tumor development, accounting for approximately 20% of human cancers.	human,58,63,Organism	tumor,64,69,Cancer	human,119,124,Organism	cancers,125,132,Cancer	"[{""token"": ""human"", ""start_span"": 58, ""end_span"": 63, ""type"": ""Organism""}, {""token"": ""tumor"", ""start_span"": 64, ""end_span"": 69, ""type"": ""Cancer""}, {""token"": ""human"", ""start_span"": 119, ""end_span"": 124, ""type"": ""Organism""}, {""token"": ""cancers"", ""start_span"": 125, ""end_span"": 132, ""type"": ""Cancer""}]"	train
We have shown that TNFalpha can cause DNA damages through reactive oxygen species ( ROS).	TNFalpha,19,27,Gene_or_gene_product	DNA,38,41,Cellular_component	reactive oxygen species,58,81,Chemical	ROS,84,87,Chemical	"[{""token"": ""TNFalpha"", ""start_span"": 19, ""end_span"": 27, ""type"": ""Gene_or_gene_product""}, {""token"": ""DNA"", ""start_span"": 38, ""end_span"": 41, ""type"": ""Cellular_component""}, {""token"": ""reactive oxygen species"", ""start_span"": 58, ""end_span"": 81, ""type"": ""Chemical""}, {""token"": ""ROS"", ""start_span"": 84, ""end_span"": 87, ""type"": ""Chemical""}]"	train
TNFalpha treatment in cultured cells resulted in increased gene mutations, gene amplification, micronuclei formation and chromosomal instability.	TNFalpha,0,8,Gene_or_gene_product	cells,31,36,Cell	micronuclei,95,106,Cellular_component	chromosomal,121,132,Cellular_component	"[{""token"": ""TNFalpha"", ""start_span"": 0, ""end_span"": 8, ""type"": ""Gene_or_gene_product""}, {""token"": ""cells"", ""start_span"": 31, ""end_span"": 36, ""type"": ""Cell""}, {""token"": ""micronuclei"", ""start_span"": 95, ""end_span"": 106, ""type"": ""Cellular_component""}, {""token"": ""chromosomal"", ""start_span"": 121, ""end_span"": 132, ""type"": ""Cellular_component""}]"	train
PTTG overexpression promotes lymph node metastasis in human esophageal squamous cell carcinoma.	PTTG,0,4,Gene_or_gene_product	lymph node,29,39,Multi	human,54,59,Organism	esophageal squamous cell carcinoma,60,94,Cancer	"[{""token"": ""PTTG"", ""start_span"": 0, ""end_span"": 4, ""type"": ""Gene_or_gene_product""}, {""token"": ""lymph node"", ""start_span"": 29, ""end_span"": 39, ""type"": ""Multi""}, {""token"": ""human"", ""start_span"": 54, ""end_span"": 59, ""type"": ""Organism""}, {""token"": ""esophageal squamous cell carcinoma"", ""start_span"": 60, ""end_span"": 94, ""type"": ""Cancer""}]"	train
Human pituitary tumor transforming gene ( PTTG) overexpression correlates with metastasis in multiple tumors, and yet its molecular mechanisms of action remain elusive.	Human,0,5,Organism	pituitary tumor transforming gene,6,39,Gene_or_gene_product	PTTG,42,46,Gene_or_gene_product	tumors,102,108,Cancer	"[{""token"": ""Human"", ""start_span"": 0, ""end_span"": 5, ""type"": ""Organism""}, {""token"": ""pituitary tumor transforming gene"", ""start_span"": 6, ""end_span"": 39, ""type"": ""Gene_or_gene_product""}, {""token"": ""PTTG"", ""start_span"": 42, ""end_span"": 46, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumors"", ""start_span"": 102, ""end_span"": 108, ""type"": ""Cancer""}]"	train
We detected PTTG overexpression in 66% ( 111 of 169) of primary esophageal squamous cell carcinoma ( ESCC) tumor tissues by in situ hybridization.	PTTG,12,16,Gene_or_gene_product	esophageal squamous cell carcinoma,64,98,Cancer	ESCC,101,105,Cancer	tumor tissues,107,120,Tissue	"[{""token"": ""PTTG"", ""start_span"": 12, ""end_span"": 16, ""type"": ""Gene_or_gene_product""}, {""token"": ""esophageal squamous cell carcinoma"", ""start_span"": 64, ""end_span"": 98, ""type"": ""Cancer""}, {""token"": ""ESCC"", ""start_span"": 101, ""end_span"": 105, ""type"": ""Cancer""}, {""token"": ""tumor tissues"", ""start_span"": 107, ""end_span"": 120, ""type"": ""Tissue""}]"	train
Suppressing PTTG expression by siRNA decreased cell motility in both PTTG - HA / EC9706 and KYSE150 cells.	PTTG,12,16,Gene_or_gene_product	cell,47,51,Cell	PTTG,69,73,Gene_or_gene_product	KYSE150 cells,92,105,Cell	"[{""token"": ""PTTG"", ""start_span"": 12, ""end_span"": 16, ""type"": ""Gene_or_gene_product""}, {""token"": ""cell"", ""start_span"": 47, ""end_span"": 51, ""type"": ""Cell""}, {""token"": ""PTTG"", ""start_span"": 69, ""end_span"": 73, ""type"": ""Gene_or_gene_product""}, {""token"": ""KYSE150 cells"", ""start_span"": 92, ""end_span"": 105, ""type"": ""Cell""}]"	train
PTTG activated E - box transcription and induced c - Myc protein expression in EC9706 cells, which in turn may act on an E - box motif within the galectin - 1 promoter.	PTTG,0,4,Gene_or_gene_product	c - Myc,49,56,Gene_or_gene_product	EC9706 cells,79,91,Cell	galectin - 1,146,158,Gene_or_gene_product	"[{""token"": ""PTTG"", ""start_span"": 0, ""end_span"": 4, ""type"": ""Gene_or_gene_product""}, {""token"": ""c - Myc"", ""start_span"": 49, ""end_span"": 56, ""type"": ""Gene_or_gene_product""}, {""token"": ""EC9706 cells"", ""start_span"": 79, ""end_span"": 91, ""type"": ""Cell""}, {""token"": ""galectin - 1"", ""start_span"": 146, ""end_span"": 158, ""type"": ""Gene_or_gene_product""}]"	train
PTTG - induced galectin - 1 transactivation and expression were mediated by c - Myc, and both inductions were suppressed by c - Myc RNAi cotranfection.	PTTG,0,4,Gene_or_gene_product	galectin - 1,15,27,Gene_or_gene_product	c - Myc,76,83,Gene_or_gene_product	c - Myc,124,131,Gene_or_gene_product	"[{""token"": ""PTTG"", ""start_span"": 0, ""end_span"": 4, ""type"": ""Gene_or_gene_product""}, {""token"": ""galectin - 1"", ""start_span"": 15, ""end_span"": 27, ""type"": ""Gene_or_gene_product""}, {""token"": ""c - Myc"", ""start_span"": 76, ""end_span"": 83, ""type"": ""Gene_or_gene_product""}, {""token"": ""c - Myc"", ""start_span"": 124, ""end_span"": 131, ""type"": ""Gene_or_gene_product""}]"	train
These findings elucidate the molecular mechanisms of PTTG overexpression in promoting tumor metastasis, whereby up - regulated PTTG modulates expression and secretion of metastasis - related factors to facilitate cell motility.	PTTG,53,57,Gene_or_gene_product	tumor,86,91,Cancer	PTTG,127,131,Gene_or_gene_product	cell,213,217,Cell	"[{""token"": ""PTTG"", ""start_span"": 53, ""end_span"": 57, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumor"", ""start_span"": 86, ""end_span"": 91, ""type"": ""Cancer""}, {""token"": ""PTTG"", ""start_span"": 127, ""end_span"": 131, ""type"": ""Gene_or_gene_product""}, {""token"": ""cell"", ""start_span"": 213, ""end_span"": 217, ""type"": ""Cell""}]"	train
The metabolism of [ 1, 2 - ( 13) C ( 2)] - glucose by HUVEC allows us to trace many of the main glucose metabolic pathways, including glycogen synthesis, the pentose cycle and the glycolytic pathways.	HUVEC,54,59,Cell	glucose,96,103,Chemical	glycogen,134,142,Chemical	pentose,158,165,Chemical	"[{""token"": ""HUVEC"", ""start_span"": 54, ""end_span"": 59, ""type"": ""Cell""}, {""token"": ""glucose"", ""start_span"": 96, ""end_span"": 103, ""type"": ""Chemical""}, {""token"": ""glycogen"", ""start_span"": 134, ""end_span"": 142, ""type"": ""Chemical""}, {""token"": ""pentose"", ""start_span"": 158, ""end_span"": 165, ""type"": ""Chemical""}]"	train
METHODS AND RESULTS: Quiescent VEGFR2 displays endosomal localization and colocalization with the Rab5a GTPase, an early endosome fusion regulator.	VEGFR2,31,37,Gene_or_gene_product	endosomal,47,56,Cellular_component	Rab5a,98,103,Gene_or_gene_product	endosome,121,129,Cellular_component	"[{""token"": ""VEGFR2"", ""start_span"": 31, ""end_span"": 37, ""type"": ""Gene_or_gene_product""}, {""token"": ""endosomal"", ""start_span"": 47, ""end_span"": 56, ""type"": ""Cellular_component""}, {""token"": ""Rab5a"", ""start_span"": 98, ""end_span"": 103, ""type"": ""Gene_or_gene_product""}, {""token"": ""endosome"", ""start_span"": 121, ""end_span"": 129, ""type"": ""Cellular_component""}]"	train
Expression of GTP or GDP - bound Rab5a mutants block activated VEGFR2 trafficking and degradation.	GTP,14,17,Chemical	GDP,21,24,Chemical	Rab5a,33,38,Gene_or_gene_product	VEGFR2,63,69,Gene_or_gene_product	"[{""token"": ""GTP"", ""start_span"": 14, ""end_span"": 17, ""type"": ""Chemical""}, {""token"": ""GDP"", ""start_span"": 21, ""end_span"": 24, ""type"": ""Chemical""}, {""token"": ""Rab5a"", ""start_span"": 33, ""end_span"": 38, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGFR2"", ""start_span"": 63, ""end_span"": 69, ""type"": ""Gene_or_gene_product""}]"	train
To test this we generated Nestin - Bmi - 1 - GFP transgenic mice.	Nestin,26,32,Gene_or_gene_product	Bmi - 1,35,42,Gene_or_gene_product	GFP,45,48,Gene_or_gene_product	mice,60,64,Organism	"[{""token"": ""Nestin"", ""start_span"": 26, ""end_span"": 32, ""type"": ""Gene_or_gene_product""}, {""token"": ""Bmi - 1"", ""start_span"": 35, ""end_span"": 42, ""type"": ""Gene_or_gene_product""}, {""token"": ""GFP"", ""start_span"": 45, ""end_span"": 48, ""type"": ""Gene_or_gene_product""}, {""token"": ""mice"", ""start_span"": 60, ""end_span"": 64, ""type"": ""Organism""}]"	train
Analysis of two independent lines with expression in the fetal and adult CNS demonstrated that transgenic neural stem cells formed larger colonies, more self - renewing divisions, and more neurons in culture.	fetal,57,62,Anatomical_system	adult CNS,67,76,Anatomical_system	neural stem cells,106,123,Cell	neurons,189,196,Cell	"[{""token"": ""fetal"", ""start_span"": 57, ""end_span"": 62, ""type"": ""Anatomical_system""}, {""token"": ""adult CNS"", ""start_span"": 67, ""end_span"": 76, ""type"": ""Anatomical_system""}, {""token"": ""neural stem cells"", ""start_span"": 106, ""end_span"": 123, ""type"": ""Cell""}, {""token"": ""neurons"", ""start_span"": 189, ""end_span"": 196, ""type"": ""Cell""}]"	train
However, in vivo, Bmi - 1 over - expression had little effect on CNS stem cell frequency, subventricular zone proliferation, olfactory bulb neurogenesis, or neurogenesis / gliogenesis during development.	Bmi - 1,18,25,Gene_or_gene_product	CNS stem cell,65,78,Cell	subventricular zone,90,109,Immaterial_anatomical_entity	olfactory bulb,125,139,Multi	"[{""token"": ""Bmi - 1"", ""start_span"": 18, ""end_span"": 25, ""type"": ""Gene_or_gene_product""}, {""token"": ""CNS stem cell"", ""start_span"": 65, ""end_span"": 78, ""type"": ""Cell""}, {""token"": ""subventricular zone"", ""start_span"": 90, ""end_span"": 109, ""type"": ""Immaterial_anatomical_entity""}, {""token"": ""olfactory bulb"", ""start_span"": 125, ""end_span"": 139, ""type"": ""Multi""}]"	train
Erbb2 suppresses DNA damage - induced checkpoint activation and UV - induced mouse skin tumorigenesis.	Erbb2,0,5,Gene_or_gene_product	DNA,17,20,Cellular_component	mouse,77,82,Organism	skin,83,87,Organ	"[{""token"": ""Erbb2"", ""start_span"": 0, ""end_span"": 5, ""type"": ""Gene_or_gene_product""}, {""token"": ""DNA"", ""start_span"": 17, ""end_span"": 20, ""type"": ""Cellular_component""}, {""token"": ""mouse"", ""start_span"": 77, ""end_span"": 82, ""type"": ""Organism""}, {""token"": ""skin"", ""start_span"": 83, ""end_span"": 87, ""type"": ""Organ""}]"	train
Further investigation using inhibition or genetic deletion of Erbb2 in vitro revealed reduced Cdc25a levels and increased S - phase arrest in UV - irradiated cells lacking Erbb2 activity.	Erbb2,62,67,Gene_or_gene_product	Cdc25a,94,100,Gene_or_gene_product	cells,158,163,Cell	Erbb2,172,177,Gene_or_gene_product	"[{""token"": ""Erbb2"", ""start_span"": 62, ""end_span"": 67, ""type"": ""Gene_or_gene_product""}, {""token"": ""Cdc25a"", ""start_span"": 94, ""end_span"": 100, ""type"": ""Gene_or_gene_product""}, {""token"": ""cells"", ""start_span"": 158, ""end_span"": 163, ""type"": ""Cell""}, {""token"": ""Erbb2"", ""start_span"": 172, ""end_span"": 177, ""type"": ""Gene_or_gene_product""}]"	train
Examination of checkpoint pathway activation upstream of Cdc25a revealed Erbb2 activation did not alter Ataxia Telangiectasia and Rad3 - related / Ataxia Telangiectasia Mutated activity but increased inhibitory phosphorylation of Chk1 - Ser ( 280).	Cdc25a,57,63,Gene_or_gene_product	Erbb2,73,78,Gene_or_gene_product	Rad3,130,134,Gene_or_gene_product	Chk1,230,234,Gene_or_gene_product	"[{""token"": ""Cdc25a"", ""start_span"": 57, ""end_span"": 63, ""type"": ""Gene_or_gene_product""}, {""token"": ""Erbb2"", ""start_span"": 73, ""end_span"": 78, ""type"": ""Gene_or_gene_product""}, {""token"": ""Rad3"", ""start_span"": 130, ""end_span"": 134, ""type"": ""Gene_or_gene_product""}, {""token"": ""Chk1"", ""start_span"": 230, ""end_span"": 234, ""type"": ""Gene_or_gene_product""}]"	train
Erbb2 ablation reduced the UV - induced activation of PI3K while inhibition of PI3K / Akt increased UV - induced S - phase arrest.	Erbb2,0,5,Gene_or_gene_product	PI3K,54,58,Gene_or_gene_product	PI3K,79,83,Gene_or_gene_product	Akt,86,89,Gene_or_gene_product	"[{""token"": ""Erbb2"", ""start_span"": 0, ""end_span"": 5, ""type"": ""Gene_or_gene_product""}, {""token"": ""PI3K"", ""start_span"": 54, ""end_span"": 58, ""type"": ""Gene_or_gene_product""}, {""token"": ""PI3K"", ""start_span"": 79, ""end_span"": 83, ""type"": ""Gene_or_gene_product""}, {""token"": ""Akt"", ""start_span"": 86, ""end_span"": 89, ""type"": ""Gene_or_gene_product""}]"	train
A series of our studies revealed that for activation of the invasion pathway of EGFR, it is prerequisite that Arf6 and AMAP1 both are highly overexpressed, and that EGFR is activated by ligands.	EGFR,80,84,Gene_or_gene_product	Arf6,110,114,Gene_or_gene_product	AMAP1,119,124,Gene_or_gene_product	EGFR,165,169,Gene_or_gene_product	"[{""token"": ""EGFR"", ""start_span"": 80, ""end_span"": 84, ""type"": ""Gene_or_gene_product""}, {""token"": ""Arf6"", ""start_span"": 110, ""end_span"": 114, ""type"": ""Gene_or_gene_product""}, {""token"": ""AMAP1"", ""start_span"": 119, ""end_span"": 124, ""type"": ""Gene_or_gene_product""}, {""token"": ""EGFR"", ""start_span"": 165, ""end_span"": 169, ""type"": ""Gene_or_gene_product""}]"	train
Our results reveal an aspect of the precise molecular mechanisms of some breast cancers, in which full invasiveness is not acquired just by intracellular alterations of cancer cells, but extracellular factors from microenvironments may also be necessary.	breast cancers,73,87,Cancer	intracellular,140,153,Immaterial_anatomical_entity	cancer cells,169,181,Cell	extracellular,187,200,Immaterial_anatomical_entity	"[{""token"": ""breast cancers"", ""start_span"": 73, ""end_span"": 87, ""type"": ""Cancer""}, {""token"": ""intracellular"", ""start_span"": 140, ""end_span"": 153, ""type"": ""Immaterial_anatomical_entity""}, {""token"": ""cancer cells"", ""start_span"": 169, ""end_span"": 181, ""type"": ""Cell""}, {""token"": ""extracellular"", ""start_span"": 187, ""end_span"": 200, ""type"": ""Immaterial_anatomical_entity""}]"	train
Most primary human melanomas exhibit loss of expression of the CDKN2A locus in addition to activation of the canonical mitogen - activated protein kinase signaling pathway.	human,13,18,Organism	melanomas,19,28,Cancer	CDKN2A,63,69,Gene_or_gene_product	mitogen - activated protein kinase,119,153,Gene_or_gene_product	"[{""token"": ""human"", ""start_span"": 13, ""end_span"": 18, ""type"": ""Organism""}, {""token"": ""melanomas"", ""start_span"": 19, ""end_span"": 28, ""type"": ""Cancer""}, {""token"": ""CDKN2A"", ""start_span"": 63, ""end_span"": 69, ""type"": ""Gene_or_gene_product""}, {""token"": ""mitogen - activated protein kinase"", ""start_span"": 119, ""end_span"": 153, ""type"": ""Gene_or_gene_product""}]"	train
In this study, we used a Cdkn2a - deficient mouse melanocyte cell line to screen for secondary genetic events in melanoma tumor progression.	Cdkn2a,25,31,Gene_or_gene_product	mouse,44,49,Organism	melanocyte cell line,50,70,Cell	melanoma tumor,113,127,Cancer	"[{""token"": ""Cdkn2a"", ""start_span"": 25, ""end_span"": 31, ""type"": ""Gene_or_gene_product""}, {""token"": ""mouse"", ""start_span"": 44, ""end_span"": 49, ""type"": ""Organism""}, {""token"": ""melanocyte cell line"", ""start_span"": 50, ""end_span"": 70, ""type"": ""Cell""}, {""token"": ""melanoma tumor"", ""start_span"": 113, ""end_span"": 127, ""type"": ""Cancer""}]"	train
RNA interference targeting Met in these tumor cells resulted in a significant delay in tumor growth in vivo compared with the control cells.	Met,27,30,Gene_or_gene_product	tumor cells,40,51,Cell	tumor,87,92,Cancer	cells,134,139,Cell	"[{""token"": ""Met"", ""start_span"": 27, ""end_span"": 30, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumor cells"", ""start_span"": 40, ""end_span"": 51, ""type"": ""Cell""}, {""token"": ""tumor"", ""start_span"": 87, ""end_span"": 92, ""type"": ""Cancer""}, {""token"": ""cells"", ""start_span"": 134, ""end_span"": 139, ""type"": ""Cell""}]"	train
MET expression is rarely detected in primary human melanoma but is frequently observed in metastatic disease.	MET,0,3,Gene_or_gene_product	human,45,50,Organism	melanoma,51,59,Cancer	metastatic disease,90,108,Cancer	"[{""token"": ""MET"", ""start_span"": 0, ""end_span"": 3, ""type"": ""Gene_or_gene_product""}, {""token"": ""human"", ""start_span"": 45, ""end_span"": 50, ""type"": ""Organism""}, {""token"": ""melanoma"", ""start_span"": 51, ""end_span"": 59, ""type"": ""Cancer""}, {""token"": ""metastatic disease"", ""start_span"": 90, ""end_span"": 108, ""type"": ""Cancer""}]"	train
Exposure to platelets resulted in significantly increased uPA and VEGF content of SKOV3 cell conditioned medium.	platelets,12,21,Cell	uPA,58,61,Gene_or_gene_product	VEGF,66,70,Gene_or_gene_product	SKOV3 cell,82,92,Cell	"[{""token"": ""platelets"", ""start_span"": 12, ""end_span"": 21, ""type"": ""Cell""}, {""token"": ""uPA"", ""start_span"": 58, ""end_span"": 61, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF"", ""start_span"": 66, ""end_span"": 70, ""type"": ""Gene_or_gene_product""}, {""token"": ""SKOV3 cell"", ""start_span"": 82, ""end_span"": 92, ""type"": ""Cell""}]"	train
Promoting angiogenesis via delivery of vascular endothelial growth factor ( VEGF) and other angiogenic factors is both a potential therapy for cardiovascular diseases and a critical aspect for tissue regeneration.	vascular endothelial growth factor,39,73,Gene_or_gene_product	VEGF,76,80,Gene_or_gene_product	cardiovascular,143,157,Anatomical_system	tissue,193,199,Tissue	"[{""token"": ""vascular endothelial growth factor"", ""start_span"": 39, ""end_span"": 73, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF"", ""start_span"": 76, ""end_span"": 80, ""type"": ""Gene_or_gene_product""}, {""token"": ""cardiovascular"", ""start_span"": 143, ""end_span"": 157, ""type"": ""Anatomical_system""}, {""token"": ""tissue"", ""start_span"": 193, ""end_span"": 199, ""type"": ""Tissue""}]"	train
The recent demonstration that VEGF signaling is modulated by the Notch signaling pathway, however, suggests that inhibiting Notch signaling may enhance regional neovascularization, by altering the responsiveness of local endothelial cells to angiogenic stimuli.	VEGF,30,34,Gene_or_gene_product	Notch,65,70,Gene_or_gene_product	Notch,124,129,Gene_or_gene_product	endothelial cells,221,238,Cell	"[{""token"": ""VEGF"", ""start_span"": 30, ""end_span"": 34, ""type"": ""Gene_or_gene_product""}, {""token"": ""Notch"", ""start_span"": 65, ""end_span"": 70, ""type"": ""Gene_or_gene_product""}, {""token"": ""Notch"", ""start_span"": 124, ""end_span"": 129, ""type"": ""Gene_or_gene_product""}, {""token"": ""endothelial cells"", ""start_span"": 221, ""end_span"": 238, ""type"": ""Cell""}]"	train
Direct intramuscular or intraperitoneal injection of DAPT did not result in the same level of improvement, suggesting that appropriate presentation of DAPT ( gel delivery) is important for its activity.	intramuscular,7,20,Immaterial_anatomical_entity	intraperitoneal,24,39,Immaterial_anatomical_entity	DAPT,53,57,Chemical	DAPT,151,155,Chemical	"[{""token"": ""intramuscular"", ""start_span"": 7, ""end_span"": 20, ""type"": ""Immaterial_anatomical_entity""}, {""token"": ""intraperitoneal"", ""start_span"": 24, ""end_span"": 39, ""type"": ""Immaterial_anatomical_entity""}, {""token"": ""DAPT"", ""start_span"": 53, ""end_span"": 57, ""type"": ""Chemical""}, {""token"": ""DAPT"", ""start_span"": 151, ""end_span"": 155, ""type"": ""Chemical""}]"	train
PURPOSE: Tumor fibroblasts ( TF) have been suggested to play an essential role in the complex process of tumor - stroma interactions and tumorigenesis.	Tumor fibroblasts,9,26,Cell	TF,29,31,Cell	tumor,105,110,Cancer	stroma,113,119,Tissue	"[{""token"": ""Tumor fibroblasts"", ""start_span"": 9, ""end_span"": 26, ""type"": ""Cell""}, {""token"": ""TF"", ""start_span"": 29, ""end_span"": 31, ""type"": ""Cell""}, {""token"": ""tumor"", ""start_span"": 105, ""end_span"": 110, ""type"": ""Cancer""}, {""token"": ""stroma"", ""start_span"": 113, ""end_span"": 119, ""type"": ""Tissue""}]"	train
EXPERIMENTAL DESIGN: An Affymetrix expression microarray was used to compare gene expression profiles between six pairs of TFs and normal fibroblasts from esophageal squamous cell carcinoma ( ESCC).	TFs,123,126,Cell	fibroblasts,138,149,Cell	esophageal squamous cell carcinoma,155,189,Cancer	ESCC,192,196,Cancer	"[{""token"": ""TFs"", ""start_span"": 123, ""end_span"": 126, ""type"": ""Cell""}, {""token"": ""fibroblasts"", ""start_span"": 138, ""end_span"": 149, ""type"": ""Cell""}, {""token"": ""esophageal squamous cell carcinoma"", ""start_span"": 155, ""end_span"": 189, ""type"": ""Cancer""}, {""token"": ""ESCC"", ""start_span"": 192, ""end_span"": 196, ""type"": ""Cancer""}]"	train
Up - regulation of fibroblast growth factor receptor 2 ( FGFR2), which showed the most significant change, was detected in all six tested TFs compared with their paired normal fibroblasts.	fibroblast growth factor receptor 2,19,54,Gene_or_gene_product	FGFR2,57,62,Gene_or_gene_product	TFs,138,141,Cell	fibroblasts,176,187,Cell	"[{""token"": ""fibroblast growth factor receptor 2"", ""start_span"": 19, ""end_span"": 54, ""type"": ""Gene_or_gene_product""}, {""token"": ""FGFR2"", ""start_span"": 57, ""end_span"": 62, ""type"": ""Gene_or_gene_product""}, {""token"": ""TFs"", ""start_span"": 138, ""end_span"": 141, ""type"": ""Cell""}, {""token"": ""fibroblasts"", ""start_span"": 176, ""end_span"": 187, ""type"": ""Cell""}]"	train
Mechanical regulation of the proangiogenic factor CCN1 / CYR61 gene requires the combined activities of MRTF - A and CREB - binding protein histone acetyltransferase.	CCN1,50,54,Gene_or_gene_product	CYR61,57,62,Gene_or_gene_product	MRTF - A,104,112,Gene_or_gene_product	CREB - binding protein histone acetyltransferase,117,165,Gene_or_gene_product	"[{""token"": ""CCN1"", ""start_span"": 50, ""end_span"": 54, ""type"": ""Gene_or_gene_product""}, {""token"": ""CYR61"", ""start_span"": 57, ""end_span"": 62, ""type"": ""Gene_or_gene_product""}, {""token"": ""MRTF - A"", ""start_span"": 104, ""end_span"": 112, ""type"": ""Gene_or_gene_product""}, {""token"": ""CREB - binding protein histone acetyltransferase"", ""start_span"": 117, ""end_span"": 165, ""type"": ""Gene_or_gene_product""}]"	train
Desipramine inhibits the growth of a mouse skin squamous cell carcinoma cell line and affects glucocorticoid receptor - mediated transcription.	Desipramine,0,11,Chemical	mouse,37,42,Organism	skin squamous cell carcinoma cell line,43,81,Cell	glucocorticoid receptor,94,117,Gene_or_gene_product	"[{""token"": ""Desipramine"", ""start_span"": 0, ""end_span"": 11, ""type"": ""Chemical""}, {""token"": ""mouse"", ""start_span"": 37, ""end_span"": 42, ""type"": ""Organism""}, {""token"": ""skin squamous cell carcinoma cell line"", ""start_span"": 43, ""end_span"": 81, ""type"": ""Cell""}, {""token"": ""glucocorticoid receptor"", ""start_span"": 94, ""end_span"": 117, ""type"": ""Gene_or_gene_product""}]"	train
Therefore, we next examined the effect of DMI on Ca3 / 7 cells, resistant to growth inhibition by the synthetic glucocorticoid fluocinolone acetonide ( FA).	DMI,42,45,Chemical	Ca3 / 7 cells,49,62,Cell	glucocorticoid fluocinolone acetonide,112,149,Chemical	FA,152,154,Chemical	"[{""token"": ""DMI"", ""start_span"": 42, ""end_span"": 45, ""type"": ""Chemical""}, {""token"": ""Ca3 / 7 cells"", ""start_span"": 49, ""end_span"": 62, ""type"": ""Cell""}, {""token"": ""glucocorticoid fluocinolone acetonide"", ""start_span"": 112, ""end_span"": 149, ""type"": ""Chemical""}, {""token"": ""FA"", ""start_span"": 152, ""end_span"": 154, ""type"": ""Chemical""}]"	train
MEK5 / ERK5 signaling modulates endothelial cell migration and focal contact turnover.	MEK5,0,4,Gene_or_gene_product	ERK5,7,11,Gene_or_gene_product	endothelial cell,32,48,Cell	focal contact,63,76,Cellular_component	"[{""token"": ""MEK5"", ""start_span"": 0, ""end_span"": 4, ""type"": ""Gene_or_gene_product""}, {""token"": ""ERK5"", ""start_span"": 7, ""end_span"": 11, ""type"": ""Gene_or_gene_product""}, {""token"": ""endothelial cell"", ""start_span"": 32, ""end_span"": 48, ""type"": ""Cell""}, {""token"": ""focal contact"", ""start_span"": 63, ""end_span"": 76, ""type"": ""Cellular_component""}]"	train
The formation of new blood vessels from pre - existing ones requires highly coordinated restructuring of endothelial cells ( EC) and the surrounding extracellular matrix.	blood vessels,21,34,Multi	endothelial cells,105,122,Cell	EC,125,127,Cell	extracellular matrix,149,169,Cellular_component	"[{""token"": ""blood vessels"", ""start_span"": 21, ""end_span"": 34, ""type"": ""Multi""}, {""token"": ""endothelial cells"", ""start_span"": 105, ""end_span"": 122, ""type"": ""Cell""}, {""token"": ""EC"", ""start_span"": 125, ""end_span"": 127, ""type"": ""Cell""}, {""token"": ""extracellular matrix"", ""start_span"": 149, ""end_span"": 169, ""type"": ""Cellular_component""}]"	train
The area covered by spread EC was dramatically enlarged, accompanied by an increase in focal contacts and altered organization of actin filaments.	EC,27,29,Cell	focal contacts,87,101,Cellular_component	actin,130,135,Gene_or_gene_product	filaments,136,145,Cellular_component	"[{""token"": ""EC"", ""start_span"": 27, ""end_span"": 29, ""type"": ""Cell""}, {""token"": ""focal contacts"", ""start_span"": 87, ""end_span"": 101, ""type"": ""Cellular_component""}, {""token"": ""actin"", ""start_span"": 130, ""end_span"": 135, ""type"": ""Gene_or_gene_product""}, {""token"": ""filaments"", ""start_span"": 136, ""end_span"": 145, ""type"": ""Cellular_component""}]"	train
EXPERIMENTAL DESIGN: To evaluate the antiangiogenic activity of EPOX, we did cell viability, cell cycle, tube formation assay in vitro, and Matrigel plug assay in vivo.	EPOX,64,68,Chemical	cell,77,81,Cell	cell,93,97,Cell	tube,105,109,Tissue	"[{""token"": ""EPOX"", ""start_span"": 64, ""end_span"": 68, ""type"": ""Chemical""}, {""token"": ""cell"", ""start_span"": 77, ""end_span"": 81, ""type"": ""Cell""}, {""token"": ""cell"", ""start_span"": 93, ""end_span"": 97, ""type"": ""Cell""}, {""token"": ""tube"", ""start_span"": 105, ""end_span"": 109, ""type"": ""Tissue""}]"	train
Intracellular glutathione levels were determined with the use of monochlorobimane, a glutathione - specific probe.	Intracellular,0,13,Immaterial_anatomical_entity	glutathione,14,25,Chemical	monochlorobimane,65,81,Chemical	glutathione,85,96,Chemical	"[{""token"": ""Intracellular"", ""start_span"": 0, ""end_span"": 13, ""type"": ""Immaterial_anatomical_entity""}, {""token"": ""glutathione"", ""start_span"": 14, ""end_span"": 25, ""type"": ""Chemical""}, {""token"": ""monochlorobimane"", ""start_span"": 65, ""end_span"": 81, ""type"": ""Chemical""}, {""token"": ""glutathione"", ""start_span"": 85, ""end_span"": 96, ""type"": ""Chemical""}]"	train
The update information testifies about protumoral activity of neutrophils: they migrate to a tumor and promote angiogenesis and metastasis at late stages of the tumor.	protumoral,39,49,Cancer	neutrophils,62,73,Cell	tumor,93,98,Cancer	tumor,161,166,Cancer	"[{""token"": ""protumoral"", ""start_span"": 39, ""end_span"": 49, ""type"": ""Cancer""}, {""token"": ""neutrophils"", ""start_span"": 62, ""end_span"": 73, ""type"": ""Cell""}, {""token"": ""tumor"", ""start_span"": 93, ""end_span"": 98, ""type"": ""Cancer""}, {""token"": ""tumor"", ""start_span"": 161, ""end_span"": 166, ""type"": ""Cancer""}]"	train
It is interesting that certain components of neutrophil cytotoxic arsenal ( ROS, cytokines, specific enzymes) participate both in antitumoral defenses of an organism and protumoral activity.	neutrophil,45,55,Cell	ROS,76,79,Chemical	antitumoral,130,141,Cancer	protumoral,170,180,Cancer	"[{""token"": ""neutrophil"", ""start_span"": 45, ""end_span"": 55, ""type"": ""Cell""}, {""token"": ""ROS"", ""start_span"": 76, ""end_span"": 79, ""type"": ""Chemical""}, {""token"": ""antitumoral"", ""start_span"": 130, ""end_span"": 141, ""type"": ""Cancer""}, {""token"": ""protumoral"", ""start_span"": 170, ""end_span"": 180, ""type"": ""Cancer""}]"	train
This was due primarily to restoring polarity: forced proliferation of polarized, nonmalignant cells did not induce VEGF expression and EC recruitment, whereas disrupting the architecture of growth - arrested, reverted cells did.	nonmalignant cells,81,99,Cell	VEGF,115,119,Gene_or_gene_product	EC,135,137,Cell	cells,218,223,Cell	"[{""token"": ""nonmalignant cells"", ""start_span"": 81, ""end_span"": 99, ""type"": ""Cell""}, {""token"": ""VEGF"", ""start_span"": 115, ""end_span"": 119, ""type"": ""Gene_or_gene_product""}, {""token"": ""EC"", ""start_span"": 135, ""end_span"": 137, ""type"": ""Cell""}, {""token"": ""cells"", ""start_span"": 218, ""end_span"": 223, ""type"": ""Cell""}]"	train
Metronomic 5 - fluorouracil, oxaliplatin and irinotecan in colorectal cancer.	5 - fluorouracil,11,27,Chemical	oxaliplatin,29,40,Chemical	irinotecan,45,55,Chemical	colorectal cancer,59,76,Cancer	"[{""token"": ""5 - fluorouracil"", ""start_span"": 11, ""end_span"": 27, ""type"": ""Chemical""}, {""token"": ""oxaliplatin"", ""start_span"": 29, ""end_span"": 40, ""type"": ""Chemical""}, {""token"": ""irinotecan"", ""start_span"": 45, ""end_span"": 55, ""type"": ""Chemical""}, {""token"": ""colorectal cancer"", ""start_span"": 59, ""end_span"": 76, ""type"": ""Cancer""}]"	train
Low concentrations of SN - 38, but not 5 - FU and L - OHP, preferentially inhibited endothelial cell proliferation.	SN - 38,22,29,Chemical	5 - FU,39,45,Chemical	L - OHP,50,57,Chemical	endothelial cell,84,100,Cell	"[{""token"": ""SN - 38"", ""start_span"": 22, ""end_span"": 29, ""type"": ""Chemical""}, {""token"": ""5 - FU"", ""start_span"": 39, ""end_span"": 45, ""type"": ""Chemical""}, {""token"": ""L - OHP"", ""start_span"": 50, ""end_span"": 57, ""type"": ""Chemical""}, {""token"": ""endothelial cell"", ""start_span"": 84, ""end_span"": 100, ""type"": ""Cell""}]"	train
On the contrary, metronomic 5 - FU + L - OHP + CPT - 11 therapy did not affect the microvascular count.	5 - FU,28,34,Chemical	L - OHP,37,44,Chemical	CPT - 11,47,55,Chemical	microvascular,83,96,Tissue	"[{""token"": ""5 - FU"", ""start_span"": 28, ""end_span"": 34, ""type"": ""Chemical""}, {""token"": ""L - OHP"", ""start_span"": 37, ""end_span"": 44, ""type"": ""Chemical""}, {""token"": ""CPT - 11"", ""start_span"": 47, ""end_span"": 55, ""type"": ""Chemical""}, {""token"": ""microvascular"", ""start_span"": 83, ""end_span"": 96, ""type"": ""Tissue""}]"	train
Endothelial cells bound fluorescein - labeled collagen I fibrils, an interaction specifically inhibited by SMI496.	Endothelial cells,0,17,Cell	fluorescein,24,35,Chemical	collagen I fibrils,46,64,Gene_or_gene_product	SMI496,107,113,Chemical	"[{""token"": ""Endothelial cells"", ""start_span"": 0, ""end_span"": 17, ""type"": ""Cell""}, {""token"": ""fluorescein"", ""start_span"": 24, ""end_span"": 35, ""type"": ""Chemical""}, {""token"": ""collagen I fibrils"", ""start_span"": 46, ""end_span"": 64, ""type"": ""Gene_or_gene_product""}, {""token"": ""SMI496"", ""start_span"": 107, ""end_span"": 113, ""type"": ""Chemical""}]"	train
SMI activities were examined in vivo by supplementing the growth medium of zebrafish embryos expressing green fluorescent protein under the control of the vascular endothelial growth factor receptor - 2 promoter.	zebrafish,75,84,Organism	embryos,85,92,Developing_anatomical_structure	green fluorescent protein,104,129,Gene_or_gene_product	vascular endothelial growth factor receptor - 2,155,202,Gene_or_gene_product	"[{""token"": ""zebrafish"", ""start_span"": 75, ""end_span"": 84, ""type"": ""Organism""}, {""token"": ""embryos"", ""start_span"": 85, ""end_span"": 92, ""type"": ""Developing_anatomical_structure""}, {""token"": ""green fluorescent protein"", ""start_span"": 104, ""end_span"": 129, ""type"": ""Gene_or_gene_product""}, {""token"": ""vascular endothelial growth factor receptor - 2"", ""start_span"": 155, ""end_span"": 202, ""type"": ""Gene_or_gene_product""}]"	train
Because islet inflammation may originate from endothelial cells, we assessed the expression of selected genes involved in endothelial cell activation in islets from a spontaneous model of type 2 diabetes, the Goto - Kakizaki ( GK) rat.	islet,8,13,Multi	endothelial cells,46,63,Cell	endothelial cell,122,138,Cell	islets,153,159,Multi	"[{""token"": ""islet"", ""start_span"": 8, ""end_span"": 13, ""type"": ""Multi""}, {""token"": ""endothelial cells"", ""start_span"": 46, ""end_span"": 63, ""type"": ""Cell""}, {""token"": ""endothelial cell"", ""start_span"": 122, ""end_span"": 138, ""type"": ""Cell""}, {""token"": ""islets"", ""start_span"": 153, ""end_span"": 159, ""type"": ""Multi""}]"	train
Furthermore, GK rats were treated s. c twice daily with IL - 1Ra ( Kineret, Amgen, 100 mg / kg / day) or saline, from 4 weeks of age onwards ( onset of diabetes).	GK rats,13,20,Organism	IL - 1Ra,56,64,Chemical	Kineret,67,74,Chemical	saline,105,111,Chemical	"[{""token"": ""GK rats"", ""start_span"": 13, ""end_span"": 20, ""type"": ""Organism""}, {""token"": ""IL - 1Ra"", ""start_span"": 56, ""end_span"": 64, ""type"": ""Chemical""}, {""token"": ""Kineret"", ""start_span"": 67, ""end_span"": 74, ""type"": ""Chemical""}, {""token"": ""saline"", ""start_span"": 105, ""end_span"": 111, ""type"": ""Chemical""}]"	train
After IL - 1Ra treatment of GK rats in vivo, most selected genes implied in endothelium / OS / immune cells / fibrosis were significantly down - regulated.	IL - 1Ra,6,14,Chemical	GK rats,28,35,Organism	endothelium,76,87,Tissue	immune cells,95,107,Cell	"[{""token"": ""IL - 1Ra"", ""start_span"": 6, ""end_span"": 14, ""type"": ""Chemical""}, {""token"": ""GK rats"", ""start_span"": 28, ""end_span"": 35, ""type"": ""Organism""}, {""token"": ""endothelium"", ""start_span"": 76, ""end_span"": 87, ""type"": ""Tissue""}, {""token"": ""immune cells"", ""start_span"": 95, ""end_span"": 107, ""type"": ""Cell""}]"	train
Thus, metabolically - altered islet endothelium might affect the beta - cell microenvironment and contribute to progressive type 2 diabetic beta - cell dysfunction in GK rats.	islet endothelium,30,47,Tissue	beta - cell,65,76,Cell	beta - cell,140,151,Cell	GK rats,167,174,Organism	"[{""token"": ""islet endothelium"", ""start_span"": 30, ""end_span"": 47, ""type"": ""Tissue""}, {""token"": ""beta - cell"", ""start_span"": 65, ""end_span"": 76, ""type"": ""Cell""}, {""token"": ""beta - cell"", ""start_span"": 140, ""end_span"": 151, ""type"": ""Cell""}, {""token"": ""GK rats"", ""start_span"": 167, ""end_span"": 174, ""type"": ""Organism""}]"	train
VTAs can be divided into two groups: antiangiogenic agents and vascular - disrupting agents ( VDAs).	VTAs,0,4,Chemical	antiangiogenic agents,37,58,Chemical	vascular - disrupting agents,63,91,Chemical	VDAs,94,98,Chemical	"[{""token"": ""VTAs"", ""start_span"": 0, ""end_span"": 4, ""type"": ""Chemical""}, {""token"": ""antiangiogenic agents"", ""start_span"": 37, ""end_span"": 58, ""type"": ""Chemical""}, {""token"": ""vascular - disrupting agents"", ""start_span"": 63, ""end_span"": 91, ""type"": ""Chemical""}, {""token"": ""VDAs"", ""start_span"": 94, ""end_span"": 98, ""type"": ""Chemical""}]"	train
VTAs inhibit specific factors required to induce and direct the angiogenic process, with major activity against small tumor masses and at the tumor periphery, encompassing monoclonal antibodies and small molecules inhibitors of the tyrosine kinase domain of the VEGF receptor.	VTAs,0,4,Chemical	tumor masses,118,130,Cancer	tumor periphery,142,157,Tissue	VEGF receptor,262,275,Gene_or_gene_product	"[{""token"": ""VTAs"", ""start_span"": 0, ""end_span"": 4, ""type"": ""Chemical""}, {""token"": ""tumor masses"", ""start_span"": 118, ""end_span"": 130, ""type"": ""Cancer""}, {""token"": ""tumor periphery"", ""start_span"": 142, ""end_span"": 157, ""type"": ""Tissue""}, {""token"": ""VEGF receptor"", ""start_span"": 262, ""end_span"": 275, ""type"": ""Gene_or_gene_product""}]"	train
VDAs specifically target and destroy well - established tumor vessels with ischemia and destruction of large masses with central hemorrhagic necrosis and survival of a thin peripheral tumor layer.	VDAs,0,4,Chemical	tumor vessels,56,69,Multi	masses,109,115,Cancer	peripheral tumor layer,173,195,Cancer	"[{""token"": ""VDAs"", ""start_span"": 0, ""end_span"": 4, ""type"": ""Chemical""}, {""token"": ""tumor vessels"", ""start_span"": 56, ""end_span"": 69, ""type"": ""Multi""}, {""token"": ""masses"", ""start_span"": 109, ""end_span"": 115, ""type"": ""Cancer""}, {""token"": ""peripheral tumor layer"", ""start_span"": 173, ""end_span"": 195, ""type"": ""Cancer""}]"	train
Numerous products from fruits, vegetable and traditional medicinal plants have been described which can suppress TNF expression and TNF signaling but their clinical potential is yet uncertain.	fruits,23,29,Organism_subdivision	vegetable,31,40,Organism_subdivision	TNF,113,116,Gene_or_gene_product	TNF,132,135,Gene_or_gene_product	"[{""token"": ""fruits"", ""start_span"": 23, ""end_span"": 29, ""type"": ""Organism_subdivision""}, {""token"": ""vegetable"", ""start_span"": 31, ""end_span"": 40, ""type"": ""Organism_subdivision""}, {""token"": ""TNF"", ""start_span"": 113, ""end_span"": 116, ""type"": ""Gene_or_gene_product""}, {""token"": ""TNF"", ""start_span"": 132, ""end_span"": 135, ""type"": ""Gene_or_gene_product""}]"	train
RESULTS: Osteopontin small interference RNA ( siRNA) inhibited osteopontin expression and cell invasion, promoted apoptosis in U251 cells.	Osteopontin,9,20,Gene_or_gene_product	osteopontin,63,74,Gene_or_gene_product	cell,90,94,Cell	U251 cells,127,137,Cell	"[{""token"": ""Osteopontin"", ""start_span"": 9, ""end_span"": 20, ""type"": ""Gene_or_gene_product""}, {""token"": ""osteopontin"", ""start_span"": 63, ""end_span"": 74, ""type"": ""Gene_or_gene_product""}, {""token"": ""cell"", ""start_span"": 90, ""end_span"": 94, ""type"": ""Cell""}, {""token"": ""U251 cells"", ""start_span"": 127, ""end_span"": 137, ""type"": ""Cell""}]"	train
We reported earlier on the oncogenic properties of Grm1 by demonstrating that stable Grm1 - mouse - melanocytic clones proliferate in the absence of growth supplement and anchorage in vitro.	Grm1,51,55,Gene_or_gene_product	Grm1,85,89,Gene_or_gene_product	mouse,92,97,Organism	melanocytic clones,100,118,Cell	"[{""token"": ""Grm1"", ""start_span"": 51, ""end_span"": 55, ""type"": ""Gene_or_gene_product""}, {""token"": ""Grm1"", ""start_span"": 85, ""end_span"": 89, ""type"": ""Gene_or_gene_product""}, {""token"": ""mouse"", ""start_span"": 92, ""end_span"": 97, ""type"": ""Organism""}, {""token"": ""melanocytic clones"", ""start_span"": 100, ""end_span"": 118, ""type"": ""Cell""}]"	train
In addition, these clones also exhibit aggressive tumorigenic phenotypes in vivo with short latency in tumor formation in both immunodeficient and syngeneic mice.	clones,19,25,Cell	tumor,50,55,Cancer	immunodeficient,127,142,Organism	syngeneic mice,147,161,Organism	"[{""token"": ""clones"", ""start_span"": 19, ""end_span"": 25, ""type"": ""Cell""}, {""token"": ""tumor"", ""start_span"": 50, ""end_span"": 55, ""type"": ""Cancer""}, {""token"": ""immunodeficient"", ""start_span"": 127, ""end_span"": 142, ""type"": ""Organism""}, {""token"": ""syngeneic mice"", ""start_span"": 147, ""end_span"": 161, ""type"": ""Organism""}]"	train
The decreased expression of SEMA3B, SEMA3F, and plexin - A3 was confirmed in stage 3 ovarian tumors.	SEMA3B,28,34,Gene_or_gene_product	SEMA3F,36,42,Gene_or_gene_product	plexin - A3,48,59,Gene_or_gene_product	ovarian tumors,85,99,Cancer	"[{""token"": ""SEMA3B"", ""start_span"": 28, ""end_span"": 34, ""type"": ""Gene_or_gene_product""}, {""token"": ""SEMA3F"", ""start_span"": 36, ""end_span"": 42, ""type"": ""Gene_or_gene_product""}, {""token"": ""plexin - A3"", ""start_span"": 48, ""end_span"": 59, ""type"": ""Gene_or_gene_product""}, {""token"": ""ovarian tumors"", ""start_span"": 85, ""end_span"": 99, ""type"": ""Cancer""}]"	train
Ectopic expression of SEMA3B or SEMA3F reduced soft - agar colony formation, adhesion, and cell invasion of ovarian cancer cell cultures.	SEMA3B,22,28,Gene_or_gene_product	SEMA3F,32,38,Gene_or_gene_product	cell,91,95,Cell	ovarian cancer cell cultures,108,136,Cell	"[{""token"": ""SEMA3B"", ""start_span"": 22, ""end_span"": 28, ""type"": ""Gene_or_gene_product""}, {""token"": ""SEMA3F"", ""start_span"": 32, ""end_span"": 38, ""type"": ""Gene_or_gene_product""}, {""token"": ""cell"", ""start_span"": 91, ""end_span"": 95, ""type"": ""Cell""}, {""token"": ""ovarian cancer cell cultures"", ""start_span"": 108, ""end_span"": 136, ""type"": ""Cell""}]"	train
Forced expression of SEMA3F, but not SEMA3B in ovarian cancer cells, significantly inhibited endothelial cell tube formation.	SEMA3F,21,27,Gene_or_gene_product	SEMA3B,37,43,Gene_or_gene_product	ovarian cancer cells,47,67,Cell	endothelial cell tube,93,114,Tissue	"[{""token"": ""SEMA3F"", ""start_span"": 21, ""end_span"": 27, ""type"": ""Gene_or_gene_product""}, {""token"": ""SEMA3B"", ""start_span"": 37, ""end_span"": 43, ""type"": ""Gene_or_gene_product""}, {""token"": ""ovarian cancer cells"", ""start_span"": 47, ""end_span"": 67, ""type"": ""Cell""}, {""token"": ""endothelial cell tube"", ""start_span"": 93, ""end_span"": 114, ""type"": ""Tissue""}]"	train
Furthermore, gonadotropin - and / or estrogen - mediated maintenance of SEMA3 expression could control ovarian cancer angiogenesis and metastasis.	gonadotropin,13,25,Gene_or_gene_product	estrogen,37,45,Chemical	SEMA3,72,77,Gene_or_gene_product	ovarian cancer,103,117,Cancer	"[{""token"": ""gonadotropin"", ""start_span"": 13, ""end_span"": 25, ""type"": ""Gene_or_gene_product""}, {""token"": ""estrogen"", ""start_span"": 37, ""end_span"": 45, ""type"": ""Chemical""}, {""token"": ""SEMA3"", ""start_span"": 72, ""end_span"": 77, ""type"": ""Gene_or_gene_product""}, {""token"": ""ovarian cancer"", ""start_span"": 103, ""end_span"": 117, ""type"": ""Cancer""}]"	train
Chronic exposure to tobacco smoke, which contains over 60 tumor - initiating carcinogens, is the major risk factor for development of lung cancer, accounting for a large portion of cancer - related deaths worldwide.	tobacco,20,27,Organism	tumor,58,63,Cancer	lung cancer,134,145,Cancer	cancer,181,187,Cancer	"[{""token"": ""tobacco"", ""start_span"": 20, ""end_span"": 27, ""type"": ""Organism""}, {""token"": ""tumor"", ""start_span"": 58, ""end_span"": 63, ""type"": ""Cancer""}, {""token"": ""lung cancer"", ""start_span"": 134, ""end_span"": 145, ""type"": ""Cancer""}, {""token"": ""cancer"", ""start_span"": 181, ""end_span"": 187, ""type"": ""Cancer""}]"	train
It is well established that tobacco smoke is a tumor initiator, but we asked whether it also acts as a tumor promoter once malignant initiation, such as caused by K - ras activation, has taken place.	tobacco,28,35,Organism	tumor,47,52,Cancer	tumor,103,108,Cancer	K - ras,163,170,Gene_or_gene_product	"[{""token"": ""tobacco"", ""start_span"": 28, ""end_span"": 35, ""type"": ""Organism""}, {""token"": ""tumor"", ""start_span"": 47, ""end_span"": 52, ""type"": ""Cancer""}, {""token"": ""tumor"", ""start_span"": 103, ""end_span"": 108, ""type"": ""Cancer""}, {""token"": ""K - ras"", ""start_span"": 163, ""end_span"": 170, ""type"": ""Gene_or_gene_product""}]"	train
Continuous ( 24h) treatment with 5 microM doxorubicin resulted in cell cycle arrest in G0 / G1 phase that was neither accompanied by phosphorylation and activation of p53 nor enhanced expression of p21.	doxorubicin,42,53,Chemical	cell,66,70,Cell	p53,167,170,Gene_or_gene_product	p21,198,201,Gene_or_gene_product	"[{""token"": ""doxorubicin"", ""start_span"": 42, ""end_span"": 53, ""type"": ""Chemical""}, {""token"": ""cell"", ""start_span"": 66, ""end_span"": 70, ""type"": ""Cell""}, {""token"": ""p53"", ""start_span"": 167, ""end_span"": 170, ""type"": ""Gene_or_gene_product""}, {""token"": ""p21"", ""start_span"": 198, ""end_span"": 201, ""type"": ""Gene_or_gene_product""}]"	train
These results suggest that doxorubicin is able to induce cell death by apoptosis only at particular dose and treatment conditions and imply a completely different cellular response following bolus or continuous exposure to doxorubicin.	doxorubicin,27,38,Chemical	cell,57,61,Cell	cellular,163,171,Cell	doxorubicin,223,234,Chemical	"[{""token"": ""doxorubicin"", ""start_span"": 27, ""end_span"": 38, ""type"": ""Chemical""}, {""token"": ""cell"", ""start_span"": 57, ""end_span"": 61, ""type"": ""Cell""}, {""token"": ""cellular"", ""start_span"": 163, ""end_span"": 171, ""type"": ""Cell""}, {""token"": ""doxorubicin"", ""start_span"": 223, ""end_span"": 234, ""type"": ""Chemical""}]"	train
METHODS: Primary lung cancers ( n = 269) and non neoplastic lung tissue ( n = 35) were tested for LDH5 expression by immunohistochemistry using a polyclonal LDH5 antibody ( ab53010).	Primary lung cancers,9,29,Cancer	non neoplastic lung tissue,45,71,Tissue	LDH5,98,102,Gene_or_gene_product	LDH5,157,161,Gene_or_gene_product	"[{""token"": ""Primary lung cancers"", ""start_span"": 9, ""end_span"": 29, ""type"": ""Cancer""}, {""token"": ""non neoplastic lung tissue"", ""start_span"": 45, ""end_span"": 71, ""type"": ""Tissue""}, {""token"": ""LDH5"", ""start_span"": 98, ""end_span"": 102, ""type"": ""Gene_or_gene_product""}, {""token"": ""LDH5"", ""start_span"": 157, ""end_span"": 161, ""type"": ""Gene_or_gene_product""}]"	train
RESULTS: 89. 5% ( n = 238) of NSCLC revealed LDH5 expression whereas LDH5 expression was not detected in non neoplastic lung tissues ( n = 34) ( p < 0. 0001).	NSCLC,30,35,Cancer	LDH5,45,49,Gene_or_gene_product	LDH5,69,73,Gene_or_gene_product	non neoplastic lung tissues,105,132,Tissue	"[{""token"": ""NSCLC"", ""start_span"": 30, ""end_span"": 35, ""type"": ""Cancer""}, {""token"": ""LDH5"", ""start_span"": 45, ""end_span"": 49, ""type"": ""Gene_or_gene_product""}, {""token"": ""LDH5"", ""start_span"": 69, ""end_span"": 73, ""type"": ""Gene_or_gene_product""}, {""token"": ""non neoplastic lung tissues"", ""start_span"": 105, ""end_span"": 132, ""type"": ""Tissue""}]"	train
LDH5 overexpression was associated with histological type ( adenocarcinoma = 57%, squamous cell carcinoma = 45%, large cell carcinoma = 46%, p = 0. 006).	LDH5,0,4,Gene_or_gene_product	adenocarcinoma,60,74,Cancer	squamous cell carcinoma,82,105,Cancer	large cell carcinoma,113,133,Cancer	"[{""token"": ""LDH5"", ""start_span"": 0, ""end_span"": 4, ""type"": ""Gene_or_gene_product""}, {""token"": ""adenocarcinoma"", ""start_span"": 60, ""end_span"": 74, ""type"": ""Cancer""}, {""token"": ""squamous cell carcinoma"", ""start_span"": 82, ""end_span"": 105, ""type"": ""Cancer""}, {""token"": ""large cell carcinoma"", ""start_span"": 113, ""end_span"": 133, ""type"": ""Cancer""}]"	train
We examined whether betulin, a naturally abundant compound, has anticancer functions in human cancer cells.	betulin,20,27,Chemical	anticancer,64,74,Cancer	human,88,93,Organism	cancer cells,94,106,Cell	"[{""token"": ""betulin"", ""start_span"": 20, ""end_span"": 27, ""type"": ""Chemical""}, {""token"": ""anticancer"", ""start_span"": 64, ""end_span"": 74, ""type"": ""Cancer""}, {""token"": ""human"", ""start_span"": 88, ""end_span"": 93, ""type"": ""Organism""}, {""token"": ""cancer cells"", ""start_span"": 94, ""end_span"": 106, ""type"": ""Cell""}]"	train
A kinetics analysis showed that the depolarization of mitochondrial membrane potential and the release of mitochondrial cytochrome c occurred as early as 30 min after treatment with betulin.	mitochondrial membrane,54,76,Cellular_component	mitochondrial,106,119,Cellular_component	cytochrome c,120,132,Gene_or_gene_product	betulin,182,189,Chemical	"[{""token"": ""mitochondrial membrane"", ""start_span"": 54, ""end_span"": 76, ""type"": ""Cellular_component""}, {""token"": ""mitochondrial"", ""start_span"": 106, ""end_span"": 119, ""type"": ""Cellular_component""}, {""token"": ""cytochrome c"", ""start_span"": 120, ""end_span"": 132, ""type"": ""Gene_or_gene_product""}, {""token"": ""betulin"", ""start_span"": 182, ""end_span"": 189, ""type"": ""Chemical""}]"	train
Importantly, Bax and Bak were rapidly translocated to the mitochondria 30 min after betulin treatment.	Bax,13,16,Gene_or_gene_product	Bak,21,24,Gene_or_gene_product	mitochondria,58,70,Cellular_component	betulin,84,91,Chemical	"[{""token"": ""Bax"", ""start_span"": 13, ""end_span"": 16, ""type"": ""Gene_or_gene_product""}, {""token"": ""Bak"", ""start_span"": 21, ""end_span"": 24, ""type"": ""Gene_or_gene_product""}, {""token"": ""mitochondria"", ""start_span"": 58, ""end_span"": 70, ""type"": ""Cellular_component""}, {""token"": ""betulin"", ""start_span"": 84, ""end_span"": 91, ""type"": ""Chemical""}]"	train
Moreover, we showed that combination of E1A gene therapy and SAHA showed high therapeutic efficacy with low toxicity in vivo ovarian and breast xenograft models.	E1A,40,43,Gene_or_gene_product	SAHA,61,65,Chemical	ovarian,125,132,Cancer	breast xenograft,137,153,Cancer	"[{""token"": ""E1A"", ""start_span"": 40, ""end_span"": 43, ""type"": ""Gene_or_gene_product""}, {""token"": ""SAHA"", ""start_span"": 61, ""end_span"": 65, ""type"": ""Chemical""}, {""token"": ""ovarian"", ""start_span"": 125, ""end_span"": 132, ""type"": ""Cancer""}, {""token"": ""breast xenograft"", ""start_span"": 137, ""end_span"": 153, ""type"": ""Cancer""}]"	train
Constitutively nuclear FOXO3a localization predicts poor survival and promotes Akt phosphorylation in breast cancer.	nuclear,15,22,Cellular_component	FOXO3a,23,29,Gene_or_gene_product	Akt,79,82,Gene_or_gene_product	breast cancer,102,115,Cancer	"[{""token"": ""nuclear"", ""start_span"": 15, ""end_span"": 22, ""type"": ""Cellular_component""}, {""token"": ""FOXO3a"", ""start_span"": 23, ""end_span"": 29, ""type"": ""Gene_or_gene_product""}, {""token"": ""Akt"", ""start_span"": 79, ""end_span"": 82, ""type"": ""Gene_or_gene_product""}, {""token"": ""breast cancer"", ""start_span"": 102, ""end_span"": 115, ""type"": ""Cancer""}]"	train
We also established that doxorubicin treatment induces proliferation arrest and FOXO3a nuclear relocation in sensitive breast cancer cells.	doxorubicin,25,36,Chemical	FOXO3a,80,86,Gene_or_gene_product	nuclear,87,94,Cellular_component	breast cancer cells,119,138,Cell	"[{""token"": ""doxorubicin"", ""start_span"": 25, ""end_span"": 36, ""type"": ""Chemical""}, {""token"": ""FOXO3a"", ""start_span"": 80, ""end_span"": 86, ""type"": ""Gene_or_gene_product""}, {""token"": ""nuclear"", ""start_span"": 87, ""end_span"": 94, ""type"": ""Cellular_component""}, {""token"": ""breast cancer cells"", ""start_span"": 119, ""end_span"": 138, ""type"": ""Cell""}]"	train
However FOXO3a induction has little effect on cell proliferation, indicating that FOXO3a or its downstream activity is deregulated in the cytotoxic drug resistant breast cancer cells.	FOXO3a,8,14,Gene_or_gene_product	cell,46,50,Cell	FOXO3a,82,88,Gene_or_gene_product	breast cancer cells,163,182,Cell	"[{""token"": ""FOXO3a"", ""start_span"": 8, ""end_span"": 14, ""type"": ""Gene_or_gene_product""}, {""token"": ""cell"", ""start_span"": 46, ""end_span"": 50, ""type"": ""Cell""}, {""token"": ""FOXO3a"", ""start_span"": 82, ""end_span"": 88, ""type"": ""Gene_or_gene_product""}, {""token"": ""breast cancer cells"", ""start_span"": 163, ""end_span"": 182, ""type"": ""Cell""}]"	train
CONCLUSIONS / SIGNIFICANCE: Together these data suggest that lymph node metastasis and poor survival in invasive ductal breast carcinoma are linked to an uncoupling of the Akt - FOXO3a signaling axis.	lymph node,61,71,Multi	invasive ductal breast carcinoma,104,136,Cancer	Akt,172,175,Gene_or_gene_product	FOXO3a,178,184,Gene_or_gene_product	"[{""token"": ""lymph node"", ""start_span"": 61, ""end_span"": 71, ""type"": ""Multi""}, {""token"": ""invasive ductal breast carcinoma"", ""start_span"": 104, ""end_span"": 136, ""type"": ""Cancer""}, {""token"": ""Akt"", ""start_span"": 172, ""end_span"": 175, ""type"": ""Gene_or_gene_product""}, {""token"": ""FOXO3a"", ""start_span"": 178, ""end_span"": 184, ""type"": ""Gene_or_gene_product""}]"	train
Villani et al. define a key role for the IGF regulatory protein Igfbp2 in a genetic model of basal cell carcinogenesis driven by targeted constitutive activation of hedgehog signaling.	IGF,41,44,Gene_or_gene_product	Igfbp2,64,70,Gene_or_gene_product	basal cell,93,103,Cell	hedgehog,165,173,Gene_or_gene_product	"[{""token"": ""IGF"", ""start_span"": 41, ""end_span"": 44, ""type"": ""Gene_or_gene_product""}, {""token"": ""Igfbp2"", ""start_span"": 64, ""end_span"": 70, ""type"": ""Gene_or_gene_product""}, {""token"": ""basal cell"", ""start_span"": 93, ""end_span"": 103, ""type"": ""Cell""}, {""token"": ""hedgehog"", ""start_span"": 165, ""end_span"": 173, ""type"": ""Gene_or_gene_product""}]"	train
The clinical relevance of Brk1 is emphasized by correlative data showing that Von Hippel - Lindau ( VHL) patients that also lose the BRK1 gene are protected against the development of tumors.	Brk1,26,30,Gene_or_gene_product	patients,105,113,Organism	BRK1,133,137,Gene_or_gene_product	tumors,184,190,Cancer	"[{""token"": ""Brk1"", ""start_span"": 26, ""end_span"": 30, ""type"": ""Gene_or_gene_product""}, {""token"": ""patients"", ""start_span"": 105, ""end_span"": 113, ""type"": ""Organism""}, {""token"": ""BRK1"", ""start_span"": 133, ""end_span"": 137, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumors"", ""start_span"": 184, ""end_span"": 190, ""type"": ""Cancer""}]"	train
We further show that down - regulation of caspase 3 via overexpression of RASSF1C reduces breast cancer cells ' sensitivity to the apoptosis inducing agent, etoposide.	caspase 3,42,51,Gene_or_gene_product	RASSF1C,74,81,Gene_or_gene_product	breast cancer cells,90,109,Cell	etoposide,157,166,Chemical	"[{""token"": ""caspase 3"", ""start_span"": 42, ""end_span"": 51, ""type"": ""Gene_or_gene_product""}, {""token"": ""RASSF1C"", ""start_span"": 74, ""end_span"": 81, ""type"": ""Gene_or_gene_product""}, {""token"": ""breast cancer cells"", ""start_span"": 90, ""end_span"": 109, ""type"": ""Cell""}, {""token"": ""etoposide"", ""start_span"": 157, ""end_span"": 166, ""type"": ""Chemical""}]"	train
CONCLUSION: Together, our findings suggest that RASSF1C, unlike RASSF1A, is not a tumor suppressor, but instead may play a role in stimulating metastasis and survival in breast cancer cells.	RASSF1C,48,55,Gene_or_gene_product	RASSF1A,64,71,Gene_or_gene_product	tumor,82,87,Cancer	breast cancer cells,170,189,Cell	"[{""token"": ""RASSF1C"", ""start_span"": 48, ""end_span"": 55, ""type"": ""Gene_or_gene_product""}, {""token"": ""RASSF1A"", ""start_span"": 64, ""end_span"": 71, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumor"", ""start_span"": 82, ""end_span"": 87, ""type"": ""Cancer""}, {""token"": ""breast cancer cells"", ""start_span"": 170, ""end_span"": 189, ""type"": ""Cell""}]"	train
Role of stromal myofibroblasts in invasive breast cancer: stromal expression of alpha - smooth muscle actin correlates with worse clinical outcome.	stromal myofibroblasts,8,30,Cell	breast cancer,43,56,Cancer	stromal,58,65,Cell	alpha - smooth muscle actin,80,107,Gene_or_gene_product	"[{""token"": ""stromal myofibroblasts"", ""start_span"": 8, ""end_span"": 30, ""type"": ""Cell""}, {""token"": ""breast cancer"", ""start_span"": 43, ""end_span"": 56, ""type"": ""Cancer""}, {""token"": ""stromal"", ""start_span"": 58, ""end_span"": 65, ""type"": ""Cell""}, {""token"": ""alpha - smooth muscle actin"", ""start_span"": 80, ""end_span"": 107, ""type"": ""Gene_or_gene_product""}]"	train
Melanoma cells and human fibroblasts adhered to immobilized DC - 9 in a Mn ( 2 +) - dependent fashion suggesting an integrin - mediated process.	Melanoma cells,0,14,Cell	human,19,24,Organism	fibroblasts,25,36,Cell	integrin,116,124,Gene_or_gene_product	"[{""token"": ""Melanoma cells"", ""start_span"": 0, ""end_span"": 14, ""type"": ""Cell""}, {""token"": ""human"", ""start_span"": 19, ""end_span"": 24, ""type"": ""Organism""}, {""token"": ""fibroblasts"", ""start_span"": 25, ""end_span"": 36, ""type"": ""Cell""}, {""token"": ""integrin"", ""start_span"": 116, ""end_span"": 124, ""type"": ""Gene_or_gene_product""}]"	train
Furthermore, interaction of fibroblasts and high invasive melanoma cells with soluble recombinant DC - 9 resulted in enhanced expression of MMP - 1 and MMP - 2.	fibroblasts,28,39,Cell	high invasive melanoma cells,44,72,Cell	MMP - 1,140,147,Gene_or_gene_product	MMP - 2,152,159,Gene_or_gene_product	"[{""token"": ""fibroblasts"", ""start_span"": 28, ""end_span"": 39, ""type"": ""Cell""}, {""token"": ""high invasive melanoma cells"", ""start_span"": 44, ""end_span"": 72, ""type"": ""Cell""}, {""token"": ""MMP - 1"", ""start_span"": 140, ""end_span"": 147, ""type"": ""Gene_or_gene_product""}, {""token"": ""MMP - 2"", ""start_span"": 152, ""end_span"": 159, ""type"": ""Gene_or_gene_product""}]"	train
Silencing of ADAM - 9 in melanoma cells significantly reduced cell adhesion to fibroblasts.	ADAM - 9,13,21,Gene_or_gene_product	melanoma cells,25,39,Cell	cell,62,66,Cell	fibroblasts,79,90,Cell	"[{""token"": ""ADAM - 9"", ""start_span"": 13, ""end_span"": 21, ""type"": ""Gene_or_gene_product""}, {""token"": ""melanoma cells"", ""start_span"": 25, ""end_span"": 39, ""type"": ""Cell""}, {""token"": ""cell"", ""start_span"": 62, ""end_span"": 66, ""type"": ""Cell""}, {""token"": ""fibroblasts"", ""start_span"": 79, ""end_span"": 90, ""type"": ""Cell""}]"	train
Ablation of ADAM - 9 in fibroblasts almost completely abolished these cellular interactions and melanoma cell invasion in vitro.	ADAM - 9,12,20,Gene_or_gene_product	fibroblasts,24,35,Cell	cellular,70,78,Cell	melanoma cell,96,109,Cell	"[{""token"": ""ADAM - 9"", ""start_span"": 12, ""end_span"": 20, ""type"": ""Gene_or_gene_product""}, {""token"": ""fibroblasts"", ""start_span"": 24, ""end_span"": 35, ""type"": ""Cell""}, {""token"": ""cellular"", ""start_span"": 70, ""end_span"": 78, ""type"": ""Cell""}, {""token"": ""melanoma cell"", ""start_span"": 96, ""end_span"": 109, ""type"": ""Cell""}]"	train
We previously showed in colorectal cancer that sVAP - 1 expression is significantly higher relative to controls, and this decreased expression is associated with poor prognosis and lymph node and liver metastasis.	colorectal cancer,24,41,Cancer	sVAP - 1,47,55,Gene_or_gene_product	lymph node,181,191,Multi	liver,196,201,Organ	"[{""token"": ""colorectal cancer"", ""start_span"": 24, ""end_span"": 41, ""type"": ""Cancer""}, {""token"": ""sVAP - 1"", ""start_span"": 47, ""end_span"": 55, ""type"": ""Gene_or_gene_product""}, {""token"": ""lymph node"", ""start_span"": 181, ""end_span"": 191, ""type"": ""Multi""}, {""token"": ""liver"", ""start_span"": 196, ""end_span"": 201, ""type"": ""Organ""}]"	train
RESULTS: The mean sVAP - 1 level for cancer patients was significantly higher relative to controls, and decreased with disease progression.	sVAP - 1,18,26,Gene_or_gene_product	cancer,37,43,Cancer	patients,44,52,Organism	disease,119,126,Cancer	"[{""token"": ""sVAP - 1"", ""start_span"": 18, ""end_span"": 26, ""type"": ""Gene_or_gene_product""}, {""token"": ""cancer"", ""start_span"": 37, ""end_span"": 43, ""type"": ""Cancer""}, {""token"": ""patients"", ""start_span"": 44, ""end_span"": 52, ""type"": ""Organism""}, {""token"": ""disease"", ""start_span"": 119, ""end_span"": 126, ""type"": ""Cancer""}]"	train
Use of DNA microarray and small animal positron emission tomography in preclinical drug evaluation of RAF265, a novel B - Raf / VEGFR - 2 inhibitor.	DNA,7,10,Cellular_component	RAF265,102,108,Chemical	B - Raf,118,125,Gene_or_gene_product	VEGFR - 2,128,137,Gene_or_gene_product	"[{""token"": ""DNA"", ""start_span"": 7, ""end_span"": 10, ""type"": ""Cellular_component""}, {""token"": ""RAF265"", ""start_span"": 102, ""end_span"": 108, ""type"": ""Chemical""}, {""token"": ""B - Raf"", ""start_span"": 118, ""end_span"": 125, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGFR - 2"", ""start_span"": 128, ""end_span"": 137, ""type"": ""Gene_or_gene_product""}]"	train
RAF265, a novel B - Raf / vascular endothelial growth factor receptor - 2 inhibitor, was evaluated in the preclinical setting for its ability to inhibit the uptake of PET tracers in the A375M ( B - Raf ( V600E)) human melanoma cell line.	RAF265,0,6,Chemical	B - Raf,16,23,Gene_or_gene_product	vascular endothelial growth factor receptor - 2,26,73,Gene_or_gene_product	B - Raf,194,201,Gene_or_gene_product	"[{""token"": ""RAF265"", ""start_span"": 0, ""end_span"": 6, ""type"": ""Chemical""}, {""token"": ""B - Raf"", ""start_span"": 16, ""end_span"": 23, ""type"": ""Gene_or_gene_product""}, {""token"": ""vascular endothelial growth factor receptor - 2"", ""start_span"": 26, ""end_span"": 73, ""type"": ""Gene_or_gene_product""}, {""token"": ""B - Raf"", ""start_span"": 194, ""end_span"": 201, ""type"": ""Gene_or_gene_product""}]"	train
Meanwhile, knockdown of HDGF, an up - regulated protein and a target of NF - kappaB, induced cell apoptosis in the metastatic HCC cells.	HDGF,24,28,Gene_or_gene_product	NF - kappaB,72,83,Gene_or_gene_product	cell,93,97,Cell	HCC cells,126,135,Cell	"[{""token"": ""HDGF"", ""start_span"": 24, ""end_span"": 28, ""type"": ""Gene_or_gene_product""}, {""token"": ""NF - kappaB"", ""start_span"": 72, ""end_span"": 83, ""type"": ""Gene_or_gene_product""}, {""token"": ""cell"", ""start_span"": 93, ""end_span"": 97, ""type"": ""Cell""}, {""token"": ""HCC cells"", ""start_span"": 126, ""end_span"": 135, ""type"": ""Cell""}]"	train
The dual function of Id - 1, inhibition of differentiation, and stimulation of cell proliferation, might be interdependent, as cell differentiation is generally coupled with the exit from the cell cycle.	Id - 1,21,27,Gene_or_gene_product	cell,79,83,Cell	cell,127,131,Cell	cell,192,196,Cell	"[{""token"": ""Id - 1"", ""start_span"": 21, ""end_span"": 27, ""type"": ""Gene_or_gene_product""}, {""token"": ""cell"", ""start_span"": 79, ""end_span"": 83, ""type"": ""Cell""}, {""token"": ""cell"", ""start_span"": 127, ""end_span"": 131, ""type"": ""Cell""}, {""token"": ""cell"", ""start_span"": 192, ""end_span"": 196, ""type"": ""Cell""}]"	train
Fibroblast growth factor - 2 ( FGF - 2) has been reported to play multiple roles in different biological processes during development of the central nervous system ( CNS).	Fibroblast growth factor - 2,0,28,Gene_or_gene_product	FGF - 2,31,38,Gene_or_gene_product	central nervous system,141,163,Anatomical_system	CNS,166,169,Anatomical_system	"[{""token"": ""Fibroblast growth factor - 2"", ""start_span"": 0, ""end_span"": 28, ""type"": ""Gene_or_gene_product""}, {""token"": ""FGF - 2"", ""start_span"": 31, ""end_span"": 38, ""type"": ""Gene_or_gene_product""}, {""token"": ""central nervous system"", ""start_span"": 141, ""end_span"": 163, ""type"": ""Anatomical_system""}, {""token"": ""CNS"", ""start_span"": 166, ""end_span"": 169, ""type"": ""Anatomical_system""}]"	train
The induction occurs within 1 h from FGF - 2 treatment and is mediated by ERK1 / 2 pathway, which in turn stimulates expression of the early growth response - 1 ( Egr - 1) transcription factor.	FGF - 2,37,44,Gene_or_gene_product	ERK1 / 2,74,82,Gene_or_gene_product	early growth response - 1,135,160,Gene_or_gene_product	Egr - 1,163,170,Gene_or_gene_product	"[{""token"": ""FGF - 2"", ""start_span"": 37, ""end_span"": 44, ""type"": ""Gene_or_gene_product""}, {""token"": ""ERK1 / 2"", ""start_span"": 74, ""end_span"": 82, ""type"": ""Gene_or_gene_product""}, {""token"": ""early growth response - 1"", ""start_span"": 135, ""end_span"": 160, ""type"": ""Gene_or_gene_product""}, {""token"": ""Egr - 1"", ""start_span"": 163, ""end_span"": 170, ""type"": ""Gene_or_gene_product""}]"	train
Finally, inhibition of Id - 1 expression results in G ( 2) / M accumulation of FGF - 2 - treated cells and delayed cell death.	Id - 1,23,29,Gene_or_gene_product	FGF - 2,79,86,Gene_or_gene_product	cells,97,102,Cell	cell,115,119,Cell	"[{""token"": ""Id - 1"", ""start_span"": 23, ""end_span"": 29, ""type"": ""Gene_or_gene_product""}, {""token"": ""FGF - 2"", ""start_span"": 79, ""end_span"": 86, ""type"": ""Gene_or_gene_product""}, {""token"": ""cells"", ""start_span"": 97, ""end_span"": 102, ""type"": ""Cell""}, {""token"": ""cell"", ""start_span"": 115, ""end_span"": 119, ""type"": ""Cell""}]"	train
Vimentin expression, growth fractions ( GF), and estrogen receptor ( ER) levels were determined for 90 untreated primary breast carcinomas.	Vimentin,0,8,Gene_or_gene_product	estrogen receptor,49,66,Gene_or_gene_product	ER,69,71,Gene_or_gene_product	breast carcinomas,121,138,Cancer	"[{""token"": ""Vimentin"", ""start_span"": 0, ""end_span"": 8, ""type"": ""Gene_or_gene_product""}, {""token"": ""estrogen receptor"", ""start_span"": 49, ""end_span"": 66, ""type"": ""Gene_or_gene_product""}, {""token"": ""ER"", ""start_span"": 69, ""end_span"": 71, ""type"": ""Gene_or_gene_product""}, {""token"": ""breast carcinomas"", ""start_span"": 121, ""end_span"": 138, ""type"": ""Cancer""}]"	train
Sixty - eight percent of tumors in this group were vimentin positive and 88% of all vimentin - positive tumors fell into this category.	tumors,25,31,Cancer	vimentin,51,59,Gene_or_gene_product	vimentin,84,92,Gene_or_gene_product	tumors,104,110,Cancer	"[{""token"": ""tumors"", ""start_span"": 25, ""end_span"": 31, ""type"": ""Cancer""}, {""token"": ""vimentin"", ""start_span"": 51, ""end_span"": 59, ""type"": ""Gene_or_gene_product""}, {""token"": ""vimentin"", ""start_span"": 84, ""end_span"": 92, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumors"", ""start_span"": 104, ""end_span"": 110, ""type"": ""Cancer""}]"	train
Recently, it has become apparent that microRNAs ( miRNAs) also contribute to EBV ' s oncogenic properties; recombinant EBVs that lack the BHRF1 miRNA cluster display a reduced ability to transform B lymphocytes in vitro.	EBV,77,80,Organism	recombinant EBVs,107,123,Organism	BHRF1,138,143,Gene_or_gene_product	B lymphocytes,197,210,Cell	"[{""token"": ""EBV"", ""start_span"": 77, ""end_span"": 80, ""type"": ""Organism""}, {""token"": ""recombinant EBVs"", ""start_span"": 107, ""end_span"": 123, ""type"": ""Organism""}, {""token"": ""BHRF1"", ""start_span"": 138, ""end_span"": 143, ""type"": ""Gene_or_gene_product""}, {""token"": ""B lymphocytes"", ""start_span"": 197, ""end_span"": 210, ""type"": ""Cell""}]"	train
Nevertheless, using an miR - BHRF1 - 1 and miR - BHRF1 - 3 double mutant, we could directly assess and confirm the contribution of miR - BHRF1 - 2 to B - cell transformation.	miR - BHRF1 - 1,23,38,Gene_or_gene_product	miR - BHRF1 - 3,43,58,Gene_or_gene_product	miR - BHRF1 - 2,131,146,Gene_or_gene_product	B - cell,150,158,Cell	"[{""token"": ""miR - BHRF1 - 1"", ""start_span"": 23, ""end_span"": 38, ""type"": ""Gene_or_gene_product""}, {""token"": ""miR - BHRF1 - 3"", ""start_span"": 43, ""end_span"": 58, ""type"": ""Gene_or_gene_product""}, {""token"": ""miR - BHRF1 - 2"", ""start_span"": 131, ""end_span"": 146, ""type"": ""Gene_or_gene_product""}, {""token"": ""B - cell"", ""start_span"": 150, ""end_span"": 158, ""type"": ""Cell""}]"	train
In addition, silencing of S6K1 induced apoptosis accompanied by a decrease in the phosphorylation of BAD and Bcl - 2, similar to that observed with sunitinib treatment.	S6K1,26,30,Gene_or_gene_product	BAD,101,104,Gene_or_gene_product	Bcl - 2,109,116,Gene_or_gene_product	sunitinib,148,157,Chemical	"[{""token"": ""S6K1"", ""start_span"": 26, ""end_span"": 30, ""type"": ""Gene_or_gene_product""}, {""token"": ""BAD"", ""start_span"": 101, ""end_span"": 104, ""type"": ""Gene_or_gene_product""}, {""token"": ""Bcl - 2"", ""start_span"": 109, ""end_span"": 116, ""type"": ""Gene_or_gene_product""}, {""token"": ""sunitinib"", ""start_span"": 148, ""end_span"": 157, ""type"": ""Chemical""}]"	train
To evaluate the role of VEGF - C in lymph node metastasis, we developed an animal model by using an endometrial cancer cell line, HEC1A.	VEGF - C,24,32,Gene_or_gene_product	lymph node,36,46,Multi	endometrial cancer cell line,100,128,Cell	HEC1A,130,135,Cell	"[{""token"": ""VEGF - C"", ""start_span"": 24, ""end_span"": 32, ""type"": ""Gene_or_gene_product""}, {""token"": ""lymph node"", ""start_span"": 36, ""end_span"": 46, ""type"": ""Multi""}, {""token"": ""endometrial cancer cell line"", ""start_span"": 100, ""end_span"": 128, ""type"": ""Cell""}, {""token"": ""HEC1A"", ""start_span"": 130, ""end_span"": 135, ""type"": ""Cell""}]"	train
Here we demonstrate that ablation of IL - 17F significantly inhibits spontaneous intestinal tumorigenesis in the small intestine of Apc ( Min / +) mice.	IL - 17F,37,45,Gene_or_gene_product	intestinal,81,91,Organ	small intestine,113,128,Organ	Apc,132,135,Gene_or_gene_product	"[{""token"": ""IL - 17F"", ""start_span"": 37, ""end_span"": 45, ""type"": ""Gene_or_gene_product""}, {""token"": ""intestinal"", ""start_span"": 81, ""end_span"": 91, ""type"": ""Organ""}, {""token"": ""small intestine"", ""start_span"": 113, ""end_span"": 128, ""type"": ""Organ""}, {""token"": ""Apc"", ""start_span"": 132, ""end_span"": 135, ""type"": ""Gene_or_gene_product""}]"	train
IL - 17F deficient Apc ( Min / +) mice showed a significant decrease in immune cell infiltration in the lamina propria.	IL - 17F,0,8,Gene_or_gene_product	Apc,19,22,Gene_or_gene_product	immune cell,72,83,Cell	lamina propria,104,118,Tissue	"[{""token"": ""IL - 17F"", ""start_span"": 0, ""end_span"": 8, ""type"": ""Gene_or_gene_product""}, {""token"": ""Apc"", ""start_span"": 19, ""end_span"": 22, ""type"": ""Gene_or_gene_product""}, {""token"": ""immune cell"", ""start_span"": 72, ""end_span"": 83, ""type"": ""Cell""}, {""token"": ""lamina propria"", ""start_span"": 104, ""end_span"": 118, ""type"": ""Tissue""}]"	train
Interestingly, the expression of IL - 17A from CD4 T cells in the lamina propria remains unchanged in the absence of IL - 17F.	IL - 17A,33,41,Gene_or_gene_product	CD4 T,47,52,Gene_or_gene_product	lamina propria,66,80,Tissue	IL - 17F,117,125,Gene_or_gene_product	"[{""token"": ""IL - 17A"", ""start_span"": 33, ""end_span"": 41, ""type"": ""Gene_or_gene_product""}, {""token"": ""CD4 T"", ""start_span"": 47, ""end_span"": 52, ""type"": ""Gene_or_gene_product""}, {""token"": ""lamina propria"", ""start_span"": 66, ""end_span"": 80, ""type"": ""Tissue""}, {""token"": ""IL - 17F"", ""start_span"": 117, ""end_span"": 125, ""type"": ""Gene_or_gene_product""}]"	train
Collectively, our results suggest the proinflammatory and essential role of IL - 17F to develop spontaneous intestinal tumorigenesis in Apc ( Min / +) mice in the presence of IL - 17A.	IL - 17F,76,84,Gene_or_gene_product	intestinal,108,118,Organ	Apc,136,139,Gene_or_gene_product	IL - 17A,175,183,Gene_or_gene_product	"[{""token"": ""IL - 17F"", ""start_span"": 76, ""end_span"": 84, ""type"": ""Gene_or_gene_product""}, {""token"": ""intestinal"", ""start_span"": 108, ""end_span"": 118, ""type"": ""Organ""}, {""token"": ""Apc"", ""start_span"": 136, ""end_span"": 139, ""type"": ""Gene_or_gene_product""}, {""token"": ""IL - 17A"", ""start_span"": 175, ""end_span"": 183, ""type"": ""Gene_or_gene_product""}]"	train
Curcumin inhibits metastatic progression of breast cancer cell through suppression of urokinase - type plasminogen activator by NF - kappa B signaling pathways.	Curcumin,0,8,Chemical	breast cancer cell,44,62,Cell	urokinase - type plasminogen activator,86,124,Gene_or_gene_product	NF - kappa B,128,140,Gene_or_gene_product	"[{""token"": ""Curcumin"", ""start_span"": 0, ""end_span"": 8, ""type"": ""Chemical""}, {""token"": ""breast cancer cell"", ""start_span"": 44, ""end_span"": 62, ""type"": ""Cell""}, {""token"": ""urokinase - type plasminogen activator"", ""start_span"": 86, ""end_span"": 124, ""type"": ""Gene_or_gene_product""}, {""token"": ""NF - kappa B"", ""start_span"": 128, ""end_span"": 140, ""type"": ""Gene_or_gene_product""}]"	train
Curcumin also significantly decreased ( P < 0. 05) the expression of uPA and NF - kappaB DNA binding activity, respectively.	Curcumin,0,8,Chemical	uPA,69,72,Gene_or_gene_product	NF - kappaB,77,88,Gene_or_gene_product	DNA,89,92,Cellular_component	"[{""token"": ""Curcumin"", ""start_span"": 0, ""end_span"": 8, ""type"": ""Chemical""}, {""token"": ""uPA"", ""start_span"": 69, ""end_span"": 72, ""type"": ""Gene_or_gene_product""}, {""token"": ""NF - kappaB"", ""start_span"": 77, ""end_span"": 88, ""type"": ""Gene_or_gene_product""}, {""token"": ""DNA"", ""start_span"": 89, ""end_span"": 92, ""type"": ""Cellular_component""}]"	train
It is concluded that curcumin inhibits the adhesion and invasion of MCF - 7 cells through down - regulating the protein expression of uPA via of NF - kappaB activation.	curcumin,21,29,Chemical	MCF - 7 cells,68,81,Cell	uPA,134,137,Gene_or_gene_product	NF - kappaB,145,156,Gene_or_gene_product	"[{""token"": ""curcumin"", ""start_span"": 21, ""end_span"": 29, ""type"": ""Chemical""}, {""token"": ""MCF - 7 cells"", ""start_span"": 68, ""end_span"": 81, ""type"": ""Cell""}, {""token"": ""uPA"", ""start_span"": 134, ""end_span"": 137, ""type"": ""Gene_or_gene_product""}, {""token"": ""NF - kappaB"", ""start_span"": 145, ""end_span"": 156, ""type"": ""Gene_or_gene_product""}]"	train
c - MYC functions as a molecular switch to alter the response of human mammary epithelial cells to oncostatin M.	c - MYC,0,7,Gene_or_gene_product	human,65,70,Organism	mammary epithelial cells,71,95,Cell	oncostatin M,99,111,Gene_or_gene_product	"[{""token"": ""c - MYC"", ""start_span"": 0, ""end_span"": 7, ""type"": ""Gene_or_gene_product""}, {""token"": ""human"", ""start_span"": 65, ""end_span"": 70, ""type"": ""Organism""}, {""token"": ""mammary epithelial cells"", ""start_span"": 71, ""end_span"": 95, ""type"": ""Cell""}, {""token"": ""oncostatin M"", ""start_span"": 99, ""end_span"": 111, ""type"": ""Gene_or_gene_product""}]"	train
Inhibition of STAT3 activation by expressing a dominant - negative STAT3 protein or a STAT3 - shRNA prevented the OSM - mediated arrest.	STAT3,14,19,Gene_or_gene_product	STAT3,67,72,Gene_or_gene_product	STAT3,86,91,Gene_or_gene_product	OSM,114,117,Gene_or_gene_product	"[{""token"": ""STAT3"", ""start_span"": 14, ""end_span"": 19, ""type"": ""Gene_or_gene_product""}, {""token"": ""STAT3"", ""start_span"": 67, ""end_span"": 72, ""type"": ""Gene_or_gene_product""}, {""token"": ""STAT3"", ""start_span"": 86, ""end_span"": 91, ""type"": ""Gene_or_gene_product""}, {""token"": ""OSM"", ""start_span"": 114, ""end_span"": 117, ""type"": ""Gene_or_gene_product""}]"	train
Parathyroid hormone - related protein ( PTHrP) is a secreted factor expressed in almost all normal fetal and adult tissues.	Parathyroid hormone - related protein,0,37,Gene_or_gene_product	PTHrP,40,45,Gene_or_gene_product	fetal,99,104,Tissue	adult tissues,109,122,Tissue	"[{""token"": ""Parathyroid hormone - related protein"", ""start_span"": 0, ""end_span"": 37, ""type"": ""Gene_or_gene_product""}, {""token"": ""PTHrP"", ""start_span"": 40, ""end_span"": 45, ""type"": ""Gene_or_gene_product""}, {""token"": ""fetal"", ""start_span"": 99, ""end_span"": 104, ""type"": ""Tissue""}, {""token"": ""adult tissues"", ""start_span"": 109, ""end_span"": 122, ""type"": ""Tissue""}]"	train
Although PTHrP is frequently expressed by breast tumors and other solid cancers, its effects on tumor progression are unclear.	PTHrP,9,14,Gene_or_gene_product	breast tumors,42,55,Cancer	solid cancers,66,79,Cancer	tumor,96,101,Cancer	"[{""token"": ""PTHrP"", ""start_span"": 9, ""end_span"": 14, ""type"": ""Gene_or_gene_product""}, {""token"": ""breast tumors"", ""start_span"": 42, ""end_span"": 55, ""type"": ""Cancer""}, {""token"": ""solid cancers"", ""start_span"": 66, ""end_span"": 79, ""type"": ""Cancer""}, {""token"": ""tumor"", ""start_span"": 96, ""end_span"": 101, ""type"": ""Cancer""}]"	train
Here, we demonstrate in mice pleiotropic involvement of PTHrP in key steps of breast cancer - it influences the initiation and progression of primary tumors and metastases.	mice,24,28,Organism	PTHrP,56,61,Gene_or_gene_product	breast cancer,78,91,Cancer	primary tumors,142,156,Cancer	"[{""token"": ""mice"", ""start_span"": 24, ""end_span"": 28, ""type"": ""Organism""}, {""token"": ""PTHrP"", ""start_span"": 56, ""end_span"": 61, ""type"": ""Gene_or_gene_product""}, {""token"": ""breast cancer"", ""start_span"": 78, ""end_span"": 91, ""type"": ""Cancer""}, {""token"": ""primary tumors"", ""start_span"": 142, ""end_span"": 156, ""type"": ""Cancer""}]"	train
PTHrP also influenced expression of the adhesion factor CXCR4, and coexpression of PTHrP and CXCR4 was crucial for metastatic spread.	PTHrP,0,5,Gene_or_gene_product	CXCR4,56,61,Gene_or_gene_product	PTHrP,83,88,Gene_or_gene_product	CXCR4,93,98,Gene_or_gene_product	"[{""token"": ""PTHrP"", ""start_span"": 0, ""end_span"": 5, ""type"": ""Gene_or_gene_product""}, {""token"": ""CXCR4"", ""start_span"": 56, ""end_span"": 61, ""type"": ""Gene_or_gene_product""}, {""token"": ""PTHrP"", ""start_span"": 83, ""end_span"": 88, ""type"": ""Gene_or_gene_product""}, {""token"": ""CXCR4"", ""start_span"": 93, ""end_span"": 98, ""type"": ""Gene_or_gene_product""}]"	train
Aquaporins in human breast cancer: identification and involvement in carcinogenesis of breast cancer.	Aquaporins,0,10,Gene_or_gene_product	human,14,19,Organism	breast cancer,20,33,Cancer	breast cancer,87,100,Cancer	"[{""token"": ""Aquaporins"", ""start_span"": 0, ""end_span"": 10, ""type"": ""Gene_or_gene_product""}, {""token"": ""human"", ""start_span"": 14, ""end_span"": 19, ""type"": ""Organism""}, {""token"": ""breast cancer"", ""start_span"": 20, ""end_span"": 33, ""type"": ""Cancer""}, {""token"": ""breast cancer"", ""start_span"": 87, ""end_span"": 100, ""type"": ""Cancer""}]"	train
BACKGROUND AND OBJECTIVES: Aquaporins ( AQPs) play important roles in water and glycerol transport.	Aquaporins,27,37,Gene_or_gene_product	AQPs,40,44,Gene_or_gene_product	water,70,75,Chemical	glycerol,80,88,Chemical	"[{""token"": ""Aquaporins"", ""start_span"": 27, ""end_span"": 37, ""type"": ""Gene_or_gene_product""}, {""token"": ""AQPs"", ""start_span"": 40, ""end_span"": 44, ""type"": ""Gene_or_gene_product""}, {""token"": ""water"", ""start_span"": 70, ""end_span"": 75, ""type"": ""Chemical""}, {""token"": ""glycerol"", ""start_span"": 80, ""end_span"": 88, ""type"": ""Chemical""}]"	train
AQP1 was expressed in cell membranes and its expression was higher in cancer than that in normal tissues.	AQP1,0,4,Gene_or_gene_product	cell membranes,22,36,Cellular_component	cancer,70,76,Cancer	normal tissues,90,104,Tissue	"[{""token"": ""AQP1"", ""start_span"": 0, ""end_span"": 4, ""type"": ""Gene_or_gene_product""}, {""token"": ""cell membranes"", ""start_span"": 22, ""end_span"": 36, ""type"": ""Cellular_component""}, {""token"": ""cancer"", ""start_span"": 70, ""end_span"": 76, ""type"": ""Cancer""}, {""token"": ""normal tissues"", ""start_span"": 90, ""end_span"": 104, ""type"": ""Tissue""}]"	train
AQP4 was expressed in the cell membrane and cytoplasm and was detected markedly stronger in normal than in cancer tissues.	AQP4,0,4,Gene_or_gene_product	cell membrane,26,39,Cellular_component	cytoplasm,44,53,Organism_substance	cancer tissues,107,121,Tissue	"[{""token"": ""AQP4"", ""start_span"": 0, ""end_span"": 4, ""type"": ""Gene_or_gene_product""}, {""token"": ""cell membrane"", ""start_span"": 26, ""end_span"": 39, ""type"": ""Cellular_component""}, {""token"": ""cytoplasm"", ""start_span"": 44, ""end_span"": 53, ""type"": ""Organism_substance""}, {""token"": ""cancer tissues"", ""start_span"": 107, ""end_span"": 121, ""type"": ""Tissue""}]"	train
AQP5 was expressed mainly in cell membranes in carcinoma tissues, but was almost absent in normal breast tissues.	AQP5,0,4,Gene_or_gene_product	cell membranes,29,43,Cellular_component	carcinoma tissues,47,64,Tissue	breast tissues,98,112,Tissue	"[{""token"": ""AQP5"", ""start_span"": 0, ""end_span"": 4, ""type"": ""Gene_or_gene_product""}, {""token"": ""cell membranes"", ""start_span"": 29, ""end_span"": 43, ""type"": ""Cellular_component""}, {""token"": ""carcinoma tissues"", ""start_span"": 47, ""end_span"": 64, ""type"": ""Tissue""}, {""token"": ""breast tissues"", ""start_span"": 98, ""end_span"": 112, ""type"": ""Tissue""}]"	train
Nuclear factor - kappaB ( NF - kappaB) activation contributes to the development of metastasis, thus leading to a poor prognosis in many cancers, including OSCC.	Nuclear factor - kappaB,0,23,Gene_or_gene_product	NF - kappaB,26,37,Gene_or_gene_product	cancers,137,144,Cancer	OSCC,156,160,Cancer	"[{""token"": ""Nuclear factor - kappaB"", ""start_span"": 0, ""end_span"": 23, ""type"": ""Gene_or_gene_product""}, {""token"": ""NF - kappaB"", ""start_span"": 26, ""end_span"": 37, ""type"": ""Gene_or_gene_product""}, {""token"": ""cancers"", ""start_span"": 137, ""end_span"": 144, ""type"": ""Cancer""}, {""token"": ""OSCC"", ""start_span"": 156, ""end_span"": 160, ""type"": ""Cancer""}]"	train
Furthermore, the effects of a selective NF - kappaB inhibitor, NEMO - binding domain ( NBD) peptide, on metastasis in GSAS / N5 - engrafted mice were assessed, and engrafted tongue tumors were immunohistochemically examined.	NF - kappaB,40,51,Gene_or_gene_product	GSAS / N5,118,127,Cell	mice,140,144,Organism	tongue tumors,174,187,Cancer	"[{""token"": ""NF - kappaB"", ""start_span"": 40, ""end_span"": 51, ""type"": ""Gene_or_gene_product""}, {""token"": ""GSAS / N5"", ""start_span"": 118, ""end_span"": 127, ""type"": ""Cell""}, {""token"": ""mice"", ""start_span"": 140, ""end_span"": 144, ""type"": ""Organism""}, {""token"": ""tongue tumors"", ""start_span"": 174, ""end_span"": 187, ""type"": ""Cancer""}]"	train
Highly metastatic GSAS / N3 and N5 cells showed an enhanced NF - kappaB activity, thus contributing to increased migration, invasion, and a poor prognosis compared with the parent cells.	GSAS / N3,18,27,Cell	N5 cells,32,40,Cell	NF - kappaB,60,71,Gene_or_gene_product	cells,180,185,Cell	"[{""token"": ""GSAS / N3"", ""start_span"": 18, ""end_span"": 27, ""type"": ""Cell""}, {""token"": ""N5 cells"", ""start_span"": 32, ""end_span"": 40, ""type"": ""Cell""}, {""token"": ""NF - kappaB"", ""start_span"": 60, ""end_span"": 71, ""type"": ""Gene_or_gene_product""}, {""token"": ""cells"", ""start_span"": 180, ""end_span"": 185, ""type"": ""Cell""}]"	train
beta - catenin signaling controls metastasis in Braf - activated Pten - deficient melanomas.	beta - catenin,0,14,Gene_or_gene_product	Braf,48,52,Gene_or_gene_product	Pten,65,69,Gene_or_gene_product	melanomas,82,91,Cancer	"[{""token"": ""beta - catenin"", ""start_span"": 0, ""end_span"": 14, ""type"": ""Gene_or_gene_product""}, {""token"": ""Braf"", ""start_span"": 48, ""end_span"": 52, ""type"": ""Gene_or_gene_product""}, {""token"": ""Pten"", ""start_span"": 65, ""end_span"": 69, ""type"": ""Gene_or_gene_product""}, {""token"": ""melanomas"", ""start_span"": 82, ""end_span"": 91, ""type"": ""Cancer""}]"	train
Highly metastatic tumors with beta - catenin stabilization are very similar to a subset of human melanomas.	tumors,18,24,Cancer	beta - catenin,30,44,Gene_or_gene_product	human,91,96,Organism	melanomas,97,106,Cancer	"[{""token"": ""tumors"", ""start_span"": 18, ""end_span"": 24, ""type"": ""Cancer""}, {""token"": ""beta - catenin"", ""start_span"": 30, ""end_span"": 44, ""type"": ""Gene_or_gene_product""}, {""token"": ""human"", ""start_span"": 91, ""end_span"": 96, ""type"": ""Organism""}, {""token"": ""melanomas"", ""start_span"": 97, ""end_span"": 106, ""type"": ""Cancer""}]"	train
Finally, intraperitoneal injection or oral administration of HTPB efficiently inhibited A549 xenograft tumor growth in vivo without side effects.	intraperitoneal,9,24,Immaterial_anatomical_entity	oral,38,42,Organism_subdivision	HTPB,61,65,Chemical	A549 xenograft tumor,88,108,Cancer	"[{""token"": ""intraperitoneal"", ""start_span"": 9, ""end_span"": 24, ""type"": ""Immaterial_anatomical_entity""}, {""token"": ""oral"", ""start_span"": 38, ""end_span"": 42, ""type"": ""Organism_subdivision""}, {""token"": ""HTPB"", ""start_span"": 61, ""end_span"": 65, ""type"": ""Chemical""}, {""token"": ""A549 xenograft tumor"", ""start_span"": 88, ""end_span"": 108, ""type"": ""Cancer""}]"	train
Acetylation of histone and non - histone proteins, induction of apoptotic - related proteins and de - phosphorylation of focal adhesion kinase were confirmed in treated mice.	histone,15,22,Gene_or_gene_product	histone,33,40,Gene_or_gene_product	focal adhesion kinase,121,142,Gene_or_gene_product	mice,169,173,Organism	"[{""token"": ""histone"", ""start_span"": 15, ""end_span"": 22, ""type"": ""Gene_or_gene_product""}, {""token"": ""histone"", ""start_span"": 33, ""end_span"": 40, ""type"": ""Gene_or_gene_product""}, {""token"": ""focal adhesion kinase"", ""start_span"": 121, ""end_span"": 142, ""type"": ""Gene_or_gene_product""}, {""token"": ""mice"", ""start_span"": 169, ""end_span"": 173, ""type"": ""Organism""}]"	train
Expression of HER2 and bradykinin B1 receptors in precursor lesions of gallbladder carcinoma.	HER2,14,18,Gene_or_gene_product	bradykinin B1 receptors,23,46,Gene_or_gene_product	precursor lesions,50,67,Pathological_formation	gallbladder carcinoma,71,92,Cancer	"[{""token"": ""HER2"", ""start_span"": 14, ""end_span"": 18, ""type"": ""Gene_or_gene_product""}, {""token"": ""bradykinin B1 receptors"", ""start_span"": 23, ""end_span"": 46, ""type"": ""Gene_or_gene_product""}, {""token"": ""precursor lesions"", ""start_span"": 50, ""end_span"": 67, ""type"": ""Pathological_formation""}, {""token"": ""gallbladder carcinoma"", ""start_span"": 71, ""end_span"": 92, ""type"": ""Cancer""}]"	train
AIM: To determine the expression of HER2 and bradykinin B ( 1) receptors ( B ( 1) R) in the two pathogenic models of gallbladder cancer: the metaplasia - dysplasia - carcinoma and the adenoma - carcinoma pathways.	HER2,36,40,Gene_or_gene_product	gallbladder cancer,117,135,Cancer	metaplasia - dysplasia - carcinoma,141,175,Cancer	adenoma - carcinoma,184,203,Cancer	"[{""token"": ""HER2"", ""start_span"": 36, ""end_span"": 40, ""type"": ""Gene_or_gene_product""}, {""token"": ""gallbladder cancer"", ""start_span"": 117, ""end_span"": 135, ""type"": ""Cancer""}, {""token"": ""metaplasia - dysplasia - carcinoma"", ""start_span"": 141, ""end_span"": 175, ""type"": ""Cancer""}, {""token"": ""adenoma - carcinoma"", ""start_span"": 184, ""end_span"": 203, ""type"": ""Cancer""}]"	train
The distribution of basic fibroblast growth factor ( bFGF) was studied immunohistochemically in fresh frozen sections of normal human tissues.	basic fibroblast growth factor,20,50,Gene_or_gene_product	bFGF,53,57,Gene_or_gene_product	human,128,133,Organism	tissues,134,141,Tissue	"[{""token"": ""basic fibroblast growth factor"", ""start_span"": 20, ""end_span"": 50, ""type"": ""Gene_or_gene_product""}, {""token"": ""bFGF"", ""start_span"": 53, ""end_span"": 57, ""type"": ""Gene_or_gene_product""}, {""token"": ""human"", ""start_span"": 128, ""end_span"": 133, ""type"": ""Organism""}, {""token"": ""tissues"", ""start_span"": 134, ""end_span"": 141, ""type"": ""Tissue""}]"	train
The intensity of O2 adsorption by ascites tumor cells does not practically depend on the monovalent cation concentration gradient between the cells and the culture medium, whereas the rate of glycolysis decreases simultaneously with the diminution of the concentration gradient.	O2,17,19,Chemical	tumor cells,42,53,Cell	cation,100,106,Chemical	cells,142,147,Cell	"[{""token"": ""O2"", ""start_span"": 17, ""end_span"": 19, ""type"": ""Chemical""}, {""token"": ""tumor cells"", ""start_span"": 42, ""end_span"": 53, ""type"": ""Cell""}, {""token"": ""cation"", ""start_span"": 100, ""end_span"": 106, ""type"": ""Chemical""}, {""token"": ""cells"", ""start_span"": 142, ""end_span"": 147, ""type"": ""Cell""}]"	train
In synchronized cultures at the beginning of the mitotic cycle, the bulk of ATP resynthesized via glycolysis is utilized for the synthesis of biopolymers, whereas that at the end of the S - phase and in the G2 - phase is utilized for cation transport across plasma membranes.	cultures,16,24,Cell	ATP,76,79,Chemical	cation,234,240,Chemical	plasma membranes,258,274,Cellular_component	"[{""token"": ""cultures"", ""start_span"": 16, ""end_span"": 24, ""type"": ""Cell""}, {""token"": ""ATP"", ""start_span"": 76, ""end_span"": 79, ""type"": ""Chemical""}, {""token"": ""cation"", ""start_span"": 234, ""end_span"": 240, ""type"": ""Chemical""}, {""token"": ""plasma membranes"", ""start_span"": 258, ""end_span"": 274, ""type"": ""Cellular_component""}]"	train
It is concluded that the observed increase in the Na + / K + ratio in ascites tumor cells is connected with their enhanced ability to synthesize lactic acid.	Na +,50,54,Chemical	K +,57,60,Chemical	tumor cells,78,89,Cell	lactic acid,145,156,Chemical	"[{""token"": ""Na +"", ""start_span"": 50, ""end_span"": 54, ""type"": ""Chemical""}, {""token"": ""K +"", ""start_span"": 57, ""end_span"": 60, ""type"": ""Chemical""}, {""token"": ""tumor cells"", ""start_span"": 78, ""end_span"": 89, ""type"": ""Cell""}, {""token"": ""lactic acid"", ""start_span"": 145, ""end_span"": 156, ""type"": ""Chemical""}]"	train
UK infusion prior to 5 - fluorouracil increased tissue concentration of antitumor agent.	UK,0,2,Gene_or_gene_product	5 - fluorouracil,21,37,Chemical	tissue,48,54,Tissue	antitumor,72,81,Cancer	"[{""token"": ""UK"", ""start_span"": 0, ""end_span"": 2, ""type"": ""Gene_or_gene_product""}, {""token"": ""5 - fluorouracil"", ""start_span"": 21, ""end_span"": 37, ""type"": ""Chemical""}, {""token"": ""tissue"", ""start_span"": 48, ""end_span"": 54, ""type"": ""Tissue""}, {""token"": ""antitumor"", ""start_span"": 72, ""end_span"": 81, ""type"": ""Cancer""}]"	train
Elevated levels of diacylglycerol and decreased phorbol ester sensitivity in ras - transformed fibroblasts.	diacylglycerol,19,33,Chemical	phorbol ester,48,61,Chemical	ras,77,80,Gene_or_gene_product	fibroblasts,95,106,Cell	"[{""token"": ""diacylglycerol"", ""start_span"": 19, ""end_span"": 33, ""type"": ""Chemical""}, {""token"": ""phorbol ester"", ""start_span"": 48, ""end_span"": 61, ""type"": ""Chemical""}, {""token"": ""ras"", ""start_span"": 77, ""end_span"": 80, ""type"": ""Gene_or_gene_product""}, {""token"": ""fibroblasts"", ""start_span"": 95, ""end_span"": 106, ""type"": ""Cell""}]"	train
Diacylglycerol ( DG) plays a central role in phospholipid metabolism and is an endogenous activator of protein kinase C.	Diacylglycerol,0,14,Chemical	DG,17,19,Chemical	phospholipid,45,57,Chemical	protein kinase C,103,119,Gene_or_gene_product	"[{""token"": ""Diacylglycerol"", ""start_span"": 0, ""end_span"": 14, ""type"": ""Chemical""}, {""token"": ""DG"", ""start_span"": 17, ""end_span"": 19, ""type"": ""Chemical""}, {""token"": ""phospholipid"", ""start_span"": 45, ""end_span"": 57, ""type"": ""Chemical""}, {""token"": ""protein kinase C"", ""start_span"": 103, ""end_span"": 119, ""type"": ""Gene_or_gene_product""}]"	train
Epidermal growth factor ( EGF) binds with high affinity and specificity to a single site on the external domain of its transmembrane receptor to activate the tyrosine protein kinase activity of its cytoplasmic portion.	Epidermal growth factor,0,23,Gene_or_gene_product	EGF,26,29,Gene_or_gene_product	transmembrane,119,132,Cellular_component	cytoplasmic,198,209,Organism_substance	"[{""token"": ""Epidermal growth factor"", ""start_span"": 0, ""end_span"": 23, ""type"": ""Gene_or_gene_product""}, {""token"": ""EGF"", ""start_span"": 26, ""end_span"": 29, ""type"": ""Gene_or_gene_product""}, {""token"": ""transmembrane"", ""start_span"": 119, ""end_span"": 132, ""type"": ""Cellular_component""}, {""token"": ""cytoplasmic"", ""start_span"": 198, ""end_span"": 209, ""type"": ""Organism_substance""}]"	train
The EGF receptor gene is amplified and over - expressed in several human tumors, suggesting that increased concentrations of the proto - oncogene leads to constitutive activity similar to that seen with oncogene erb B.	EGF receptor,4,16,Gene_or_gene_product	human,67,72,Organism	tumors,73,79,Cancer	erb B,212,217,Gene_or_gene_product	"[{""token"": ""EGF receptor"", ""start_span"": 4, ""end_span"": 16, ""type"": ""Gene_or_gene_product""}, {""token"": ""human"", ""start_span"": 67, ""end_span"": 72, ""type"": ""Organism""}, {""token"": ""tumors"", ""start_span"": 73, ""end_span"": 79, ""type"": ""Cancer""}, {""token"": ""erb B"", ""start_span"": 212, ""end_span"": 217, ""type"": ""Gene_or_gene_product""}]"	train
Extensive regulation contributes to normal growth control, abrogation of regulatory controls contributes to uncontrolled growth as seen with erb B transformation and EGF receptor gene amplification in human tumors.	erb B,141,146,Gene_or_gene_product	EGF receptor,166,178,Gene_or_gene_product	human,201,206,Organism	tumors,207,213,Cancer	"[{""token"": ""erb B"", ""start_span"": 141, ""end_span"": 146, ""type"": ""Gene_or_gene_product""}, {""token"": ""EGF receptor"", ""start_span"": 166, ""end_span"": 178, ""type"": ""Gene_or_gene_product""}, {""token"": ""human"", ""start_span"": 201, ""end_span"": 206, ""type"": ""Organism""}, {""token"": ""tumors"", ""start_span"": 207, ""end_span"": 213, ""type"": ""Cancer""}]"	train
In extracts of growing and stationary Swiss 3T3 cells, the total amount of protein kinase C activity was similar, indicating that growth state does not alter the level of enzyme in the cell.	extracts,3,11,Organism_substance	Swiss 3T3 cells,38,53,Cell	protein kinase C,75,91,Gene_or_gene_product	cell,185,189,Cell	"[{""token"": ""extracts"", ""start_span"": 3, ""end_span"": 11, ""type"": ""Organism_substance""}, {""token"": ""Swiss 3T3 cells"", ""start_span"": 38, ""end_span"": 53, ""type"": ""Cell""}, {""token"": ""protein kinase C"", ""start_span"": 75, ""end_span"": 91, ""type"": ""Gene_or_gene_product""}, {""token"": ""cell"", ""start_span"": 185, ""end_span"": 189, ""type"": ""Cell""}]"	train
The short - term response of Swiss 3T3 cells to an activator of protein kinase C also appeared to be independent of growth state, since the 50% effective dose for PDBu inhibition of EGF binding to its receptor was approximately 7 nM for both growth conditions.	Swiss 3T3 cells,29,44,Cell	protein kinase C,64,80,Gene_or_gene_product	PDBu,163,167,Chemical	EGF,182,185,Gene_or_gene_product	"[{""token"": ""Swiss 3T3 cells"", ""start_span"": 29, ""end_span"": 44, ""type"": ""Cell""}, {""token"": ""protein kinase C"", ""start_span"": 64, ""end_span"": 80, ""type"": ""Gene_or_gene_product""}, {""token"": ""PDBu"", ""start_span"": 163, ""end_span"": 167, ""type"": ""Chemical""}, {""token"": ""EGF"", ""start_span"": 182, ""end_span"": 185, ""type"": ""Gene_or_gene_product""}]"	train
In both growth states, PDBu caused loss of protein kinase C activity, which reflected a loss in protein mass as determined by immunoblotting with antiserum to protein kinase C.	PDBu,23,27,Chemical	protein kinase C,43,59,Gene_or_gene_product	antiserum,146,155,Organism_substance	protein kinase C,159,175,Gene_or_gene_product	"[{""token"": ""PDBu"", ""start_span"": 23, ""end_span"": 27, ""type"": ""Chemical""}, {""token"": ""protein kinase C"", ""start_span"": 43, ""end_span"": 59, ""type"": ""Gene_or_gene_product""}, {""token"": ""antiserum"", ""start_span"": 146, ""end_span"": 155, ""type"": ""Organism_substance""}, {""token"": ""protein kinase C"", ""start_span"": 159, ""end_span"": 175, ""type"": ""Gene_or_gene_product""}]"	train
Further, the inhibition of EGF binding by tumor promoters following long - term treatment of Swiss 3T3 cells with PDBu also varied with growth state.	EGF,27,30,Gene_or_gene_product	tumor,42,47,Cancer	Swiss 3T3 cells,93,108,Cell	PDBu,114,118,Chemical	"[{""token"": ""EGF"", ""start_span"": 27, ""end_span"": 30, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumor"", ""start_span"": 42, ""end_span"": 47, ""type"": ""Cancer""}, {""token"": ""Swiss 3T3 cells"", ""start_span"": 93, ""end_span"": 108, ""type"": ""Cell""}, {""token"": ""PDBu"", ""start_span"": 114, ""end_span"": 118, ""type"": ""Chemical""}]"	train
Suppression and re - expression of transformed phenotype in hybrids of HA - ras - 1 - transformed rat - 1 cells and early - passage rat embryonic fibroblasts.	HA - ras - 1,71,83,Gene_or_gene_product	rat - 1 cells,98,111,Cell	rat,132,135,Organism	embryonic fibroblasts,136,157,Cell	"[{""token"": ""HA - ras - 1"", ""start_span"": 71, ""end_span"": 83, ""type"": ""Gene_or_gene_product""}, {""token"": ""rat - 1 cells"", ""start_span"": 98, ""end_span"": 111, ""type"": ""Cell""}, {""token"": ""rat"", ""start_span"": 132, ""end_span"": 135, ""type"": ""Organism""}, {""token"": ""embryonic fibroblasts"", ""start_span"": 136, ""end_span"": 157, ""type"": ""Cell""}]"	train
Four selected cell hybrids expressed the human transforming gene product p21 at levels of 10 to 30% compared to 100% in the transformed parental cells.	cell hybrids,14,26,Cell	human,41,46,Organism	p21,73,76,Gene_or_gene_product	cells,145,150,Cell	"[{""token"": ""cell hybrids"", ""start_span"": 14, ""end_span"": 26, ""type"": ""Cell""}, {""token"": ""human"", ""start_span"": 41, ""end_span"": 46, ""type"": ""Organism""}, {""token"": ""p21"", ""start_span"": 73, ""end_span"": 76, ""type"": ""Gene_or_gene_product""}, {""token"": ""cells"", ""start_span"": 145, ""end_span"": 150, ""type"": ""Cell""}]"	train
This phenomenon occurs at mast cell / tumor ratios which reflect the stoichiometry of host cell / tumor relationships in vivo.	mast cell,26,35,Cell	tumor,38,43,Cancer	host cell,86,95,Cell	tumor,98,103,Cancer	"[{""token"": ""mast cell"", ""start_span"": 26, ""end_span"": 35, ""type"": ""Cell""}, {""token"": ""tumor"", ""start_span"": 38, ""end_span"": 43, ""type"": ""Cancer""}, {""token"": ""host cell"", ""start_span"": 86, ""end_span"": 95, ""type"": ""Cell""}, {""token"": ""tumor"", ""start_span"": 98, ""end_span"": 103, ""type"": ""Cancer""}]"	train
This cellular interaction was tumor - specific, although isolated granules could enhance fibroblast proliferation.	cellular,5,13,Cell	tumor,30,35,Cancer	granules,66,74,Organism_substance	fibroblast,89,99,Cell	"[{""token"": ""cellular"", ""start_span"": 5, ""end_span"": 13, ""type"": ""Cell""}, {""token"": ""tumor"", ""start_span"": 30, ""end_span"": 35, ""type"": ""Cancer""}, {""token"": ""granules"", ""start_span"": 66, ""end_span"": 74, ""type"": ""Organism_substance""}, {""token"": ""fibroblast"", ""start_span"": 89, ""end_span"": 99, ""type"": ""Cell""}]"	train
The findings are discussed in relation to previous morphologic studies, reports of in vitro mast - cell - mediated tumor cytotoxicity, and the role of mast cells in angiogenesis and connective tissue proliferation.	mast - cell,92,103,Cell	tumor,115,120,Cancer	mast cells,151,161,Cell	connective tissue,182,199,Tissue	"[{""token"": ""mast - cell"", ""start_span"": 92, ""end_span"": 103, ""type"": ""Cell""}, {""token"": ""tumor"", ""start_span"": 115, ""end_span"": 120, ""type"": ""Cancer""}, {""token"": ""mast cells"", ""start_span"": 151, ""end_span"": 161, ""type"": ""Cell""}, {""token"": ""connective tissue"", ""start_span"": 182, ""end_span"": 199, ""type"": ""Tissue""}]"	train
They do not compete with 125I EGF for binding on the EGF receptors of the membrane of A431 cells.	EGF,30,33,Gene_or_gene_product	EGF receptors,53,66,Gene_or_gene_product	membrane,74,82,Cellular_component	A431 cells,86,96,Cell	"[{""token"": ""EGF"", ""start_span"": 30, ""end_span"": 33, ""type"": ""Gene_or_gene_product""}, {""token"": ""EGF receptors"", ""start_span"": 53, ""end_span"": 66, ""type"": ""Gene_or_gene_product""}, {""token"": ""membrane"", ""start_span"": 74, ""end_span"": 82, ""type"": ""Cellular_component""}, {""token"": ""A431 cells"", ""start_span"": 86, ""end_span"": 96, ""type"": ""Cell""}]"	train
As chicken embryo fibroblasts are devoid of EGF receptors, their activity is not potentiated by EGF.	chicken,3,10,Organism	embryo fibroblasts,11,29,Cell	EGF receptors,44,57,Gene_or_gene_product	EGF,96,99,Gene_or_gene_product	"[{""token"": ""chicken"", ""start_span"": 3, ""end_span"": 10, ""type"": ""Organism""}, {""token"": ""embryo fibroblasts"", ""start_span"": 11, ""end_span"": 29, ""type"": ""Cell""}, {""token"": ""EGF receptors"", ""start_span"": 44, ""end_span"": 57, ""type"": ""Gene_or_gene_product""}, {""token"": ""EGF"", ""start_span"": 96, ""end_span"": 99, ""type"": ""Gene_or_gene_product""}]"	train
Transformation by Rous sarcoma virus results in a dramatic increase in the rate at which the transformed cells transport glucose across the cell membrane.	Rous sarcoma virus,18,36,Organism	cells,105,110,Cell	glucose,121,128,Chemical	cell membrane,140,153,Cellular_component	"[{""token"": ""Rous sarcoma virus"", ""start_span"": 18, ""end_span"": 36, ""type"": ""Organism""}, {""token"": ""cells"", ""start_span"": 105, ""end_span"": 110, ""type"": ""Cell""}, {""token"": ""glucose"", ""start_span"": 121, ""end_span"": 128, ""type"": ""Chemical""}, {""token"": ""cell membrane"", ""start_span"": 140, ""end_span"": 153, ""type"": ""Cellular_component""}]"	train
We have examined the tyrosine phosphorylation of a major cellular protein of Mr 36, 000 in cells infected with a panel of partially transforming mutants of Rous sarcoma virus.	tyrosine,21,29,Amino_acid	cellular,57,65,Cell	cells,91,96,Cell	Rous sarcoma virus,156,174,Organism	"[{""token"": ""tyrosine"", ""start_span"": 21, ""end_span"": 29, ""type"": ""Amino_acid""}, {""token"": ""cellular"", ""start_span"": 57, ""end_span"": 65, ""type"": ""Cell""}, {""token"": ""cells"", ""start_span"": 91, ""end_span"": 96, ""type"": ""Cell""}, {""token"": ""Rous sarcoma virus"", ""start_span"": 156, ""end_span"": 174, ""type"": ""Organism""}]"	train
All of the DR alpha DNA sequences detected by a cloned DR alpha cDNA probe are contained in a BglII fragment which varies slightly in size ( 4. 0 to 4. 8 kilobases) from one individual to another.	DR alpha,11,19,Gene_or_gene_product	DNA,20,23,Cellular_component	DR alpha,55,63,Gene_or_gene_product	BglII,94,99,Gene_or_gene_product	"[{""token"": ""DR alpha"", ""start_span"": 11, ""end_span"": 19, ""type"": ""Gene_or_gene_product""}, {""token"": ""DNA"", ""start_span"": 20, ""end_span"": 23, ""type"": ""Cellular_component""}, {""token"": ""DR alpha"", ""start_span"": 55, ""end_span"": 63, ""type"": ""Gene_or_gene_product""}, {""token"": ""BglII"", ""start_span"": 94, ""end_span"": 99, ""type"": ""Gene_or_gene_product""}]"	train
After 48 h in culture, DR antigen expression was substantially increased, but no significant changes were observed in methylation of the DR alpha locus or in the amount of DR mRNA which was present.	DR antigen,23,33,Gene_or_gene_product	DR alpha,137,145,Gene_or_gene_product	locus,146,151,Cellular_component	DR,172,174,Gene_or_gene_product	"[{""token"": ""DR antigen"", ""start_span"": 23, ""end_span"": 33, ""type"": ""Gene_or_gene_product""}, {""token"": ""DR alpha"", ""start_span"": 137, ""end_span"": 145, ""type"": ""Gene_or_gene_product""}, {""token"": ""locus"", ""start_span"": 146, ""end_span"": 151, ""type"": ""Cellular_component""}, {""token"": ""DR"", ""start_span"": 172, ""end_span"": 174, ""type"": ""Gene_or_gene_product""}]"	train
In vivo glucose and alanine kinetics were examined by tracer methodology in a sarcoma - bearing rat model.	glucose,8,15,Chemical	alanine,20,27,Amino_acid	sarcoma,78,85,Cancer	rat,96,99,Organism	"[{""token"": ""glucose"", ""start_span"": 8, ""end_span"": 15, ""type"": ""Chemical""}, {""token"": ""alanine"", ""start_span"": 20, ""end_span"": 27, ""type"": ""Amino_acid""}, {""token"": ""sarcoma"", ""start_span"": 78, ""end_span"": 85, ""type"": ""Cancer""}, {""token"": ""rat"", ""start_span"": 96, ""end_span"": 99, ""type"": ""Organism""}]"	train
Both tumor - bearing ( TB) and nontumor bearing ( NTB) animals were gaining weight prior to study and the tumors were relatively small.	tumor,5,10,Cancer	nontumor,31,39,Cancer	animals,55,62,Organism	tumors,106,112,Cancer	"[{""token"": ""tumor"", ""start_span"": 5, ""end_span"": 10, ""type"": ""Cancer""}, {""token"": ""nontumor"", ""start_span"": 31, ""end_span"": 39, ""type"": ""Cancer""}, {""token"": ""animals"", ""start_span"": 55, ""end_span"": 62, ""type"": ""Organism""}, {""token"": ""tumors"", ""start_span"": 106, ""end_span"": 112, ""type"": ""Cancer""}]"	train
After inhibition of gluconeogenesis, the plasma glucose decreased and the blood lactate increased significantly more in TB than NTB animals.	plasma,41,47,Organism_substance	glucose,48,55,Chemical	blood,74,79,Organism_substance	lactate,80,87,Chemical	"[{""token"": ""plasma"", ""start_span"": 41, ""end_span"": 47, ""type"": ""Organism_substance""}, {""token"": ""glucose"", ""start_span"": 48, ""end_span"": 55, ""type"": ""Chemical""}, {""token"": ""blood"", ""start_span"": 74, ""end_span"": 79, ""type"": ""Organism_substance""}, {""token"": ""lactate"", ""start_span"": 80, ""end_span"": 87, ""type"": ""Chemical""}]"	train
The glucose turnover rate was significantly greater in TB compared with NTB animals, as was the rate of glucose recycling and the rate of gluconeogenesis ( alanine leads to glucose), both energy demanding processes.	glucose,4,11,Chemical	glucose,104,111,Chemical	alanine,156,163,Amino_acid	glucose,173,180,Chemical	"[{""token"": ""glucose"", ""start_span"": 4, ""end_span"": 11, ""type"": ""Chemical""}, {""token"": ""glucose"", ""start_span"": 104, ""end_span"": 111, ""type"": ""Chemical""}, {""token"": ""alanine"", ""start_span"": 156, ""end_span"": 163, ""type"": ""Amino_acid""}, {""token"": ""glucose"", ""start_span"": 173, ""end_span"": 180, ""type"": ""Chemical""}]"	train
We have investigated the mechanism by which the simian virus 40 large T antigen ( SVLT) interferes with the differentiation of C2 myoblasts.	simian virus 40,48,63,Organism	large T antigen,64,79,Gene_or_gene_product	SVLT,82,86,Gene_or_gene_product	C2 myoblasts,127,139,Cell	"[{""token"": ""simian virus 40"", ""start_span"": 48, ""end_span"": 63, ""type"": ""Organism""}, {""token"": ""large T antigen"", ""start_span"": 64, ""end_span"": 79, ""type"": ""Gene_or_gene_product""}, {""token"": ""SVLT"", ""start_span"": 82, ""end_span"": 86, ""type"": ""Gene_or_gene_product""}, {""token"": ""C2 myoblasts"", ""start_span"": 127, ""end_span"": 139, ""type"": ""Cell""}]"	train
It was found that wild - type ( wt) SVLT strongly inhibited the terminal differentiation of mouse C2 myoblasts, but this arrest occurred only after the synthesis of myogenin, an initial step in biochemical differentiation.	SVLT,36,40,Gene_or_gene_product	mouse,92,97,Organism	C2 myoblasts,98,110,Cell	myogenin,165,173,Gene_or_gene_product	"[{""token"": ""SVLT"", ""start_span"": 36, ""end_span"": 40, ""type"": ""Gene_or_gene_product""}, {""token"": ""mouse"", ""start_span"": 92, ""end_span"": 97, ""type"": ""Organism""}, {""token"": ""C2 myoblasts"", ""start_span"": 98, ""end_span"": 110, ""type"": ""Cell""}, {""token"": ""myogenin"", ""start_span"": 165, ""end_span"": 173, ""type"": ""Gene_or_gene_product""}]"	train
Mutations affecting nuclear transport were far more critical for the ability to interfere with myogenic differentiation than were those affecting the transforming potential; cytoplasmic SVLT expression was fully compatible with the terminal differentiation of C2 cells, despite enabling them to grow in semisolid medium, thus showing that the myogenesis - inhibiting property can be dissociated from transforming competence.	nuclear,20,27,Cellular_component	cytoplasmic,174,185,Organism_substance	SVLT,186,190,Gene_or_gene_product	C2 cells,260,268,Cell	"[{""token"": ""nuclear"", ""start_span"": 20, ""end_span"": 27, ""type"": ""Cellular_component""}, {""token"": ""cytoplasmic"", ""start_span"": 174, ""end_span"": 185, ""type"": ""Organism_substance""}, {""token"": ""SVLT"", ""start_span"": 186, ""end_span"": 190, ""type"": ""Gene_or_gene_product""}, {""token"": ""C2 cells"", ""start_span"": 260, ""end_span"": 268, ""type"": ""Cell""}]"	train
Studies with polymerase inhibitors suggest that this LTR transcript, designated let ( LTR - encoded trans activator), is a product of RNA polymerase III.	LTR,53,56,Cellular_component	let,80,83,Gene_or_gene_product	LTR - encoded trans activator,86,115,Gene_or_gene_product	RNA polymerase III,134,152,Gene_or_gene_product	"[{""token"": ""LTR"", ""start_span"": 53, ""end_span"": 56, ""type"": ""Cellular_component""}, {""token"": ""let"", ""start_span"": 80, ""end_span"": 83, ""type"": ""Gene_or_gene_product""}, {""token"": ""LTR - encoded trans activator"", ""start_span"": 86, ""end_span"": 115, ""type"": ""Gene_or_gene_product""}, {""token"": ""RNA polymerase III"", ""start_span"": 134, ""end_span"": 152, ""type"": ""Gene_or_gene_product""}]"	train
2G7 did not inhibit MDA - 231 primary tumor or metastases formation, nor did it stimulate NK cell - mediated cytotoxicity in beige NK - deficient nude mice.	MDA - 231 primary tumor,20,43,Cancer	metastases,47,57,Cancer	NK cell,90,97,Cell	beige NK - deficient nude mice,125,155,Organism	"[{""token"": ""MDA - 231 primary tumor"", ""start_span"": 20, ""end_span"": 43, ""type"": ""Cancer""}, {""token"": ""metastases"", ""start_span"": 47, ""end_span"": 57, ""type"": ""Cancer""}, {""token"": ""NK cell"", ""start_span"": 90, ""end_span"": 97, ""type"": ""Cell""}, {""token"": ""beige NK - deficient nude mice"", ""start_span"": 125, ""end_span"": 155, ""type"": ""Organism""}]"	train
Enhanced DNA - binding activity of a Stat3 - related protein in cells transformed by the Src oncoprotein.	DNA,9,12,Cellular_component	Stat3,37,42,Gene_or_gene_product	cells,64,69,Cell	Src,89,92,Gene_or_gene_product	"[{""token"": ""DNA"", ""start_span"": 9, ""end_span"": 12, ""type"": ""Cellular_component""}, {""token"": ""Stat3"", ""start_span"": 37, ""end_span"": 42, ""type"": ""Gene_or_gene_product""}, {""token"": ""cells"", ""start_span"": 64, ""end_span"": 69, ""type"": ""Cell""}, {""token"": ""Src"", ""start_span"": 89, ""end_span"": 92, ""type"": ""Gene_or_gene_product""}]"	train
Cells stably transformed by the Src oncogene tyrosine kinase were examined for STAT protein activation.	Cells,0,5,Cell	Src,32,35,Gene_or_gene_product	tyrosine,45,53,Amino_acid	STAT,79,83,Gene_or_gene_product	"[{""token"": ""Cells"", ""start_span"": 0, ""end_span"": 5, ""type"": ""Cell""}, {""token"": ""Src"", ""start_span"": 32, ""end_span"": 35, ""type"": ""Gene_or_gene_product""}, {""token"": ""tyrosine"", ""start_span"": 45, ""end_span"": 53, ""type"": ""Amino_acid""}, {""token"": ""STAT"", ""start_span"": 79, ""end_span"": 83, ""type"": ""Gene_or_gene_product""}]"	train
Assays of electrophoretic mobility, DNA - binding specificity, and antigenicity indicated that Stat3 or a closely related STAT family member was constitutively activated by the Src oncoprotein.	DNA,36,39,Cellular_component	Stat3,95,100,Gene_or_gene_product	STAT,122,126,Gene_or_gene_product	Src,177,180,Gene_or_gene_product	"[{""token"": ""DNA"", ""start_span"": 36, ""end_span"": 39, ""type"": ""Cellular_component""}, {""token"": ""Stat3"", ""start_span"": 95, ""end_span"": 100, ""type"": ""Gene_or_gene_product""}, {""token"": ""STAT"", ""start_span"": 122, ""end_span"": 126, ""type"": ""Gene_or_gene_product""}, {""token"": ""Src"", ""start_span"": 177, ""end_span"": 180, ""type"": ""Gene_or_gene_product""}]"	train
Induction of this DNA - binding activity was accompanied by tyrosine phosphorylation of Stat3 and correlated with Src transformation.	DNA,18,21,Cellular_component	tyrosine,60,68,Amino_acid	Stat3,88,93,Gene_or_gene_product	Src,114,117,Gene_or_gene_product	"[{""token"": ""DNA"", ""start_span"": 18, ""end_span"": 21, ""type"": ""Cellular_component""}, {""token"": ""tyrosine"", ""start_span"": 60, ""end_span"": 68, ""type"": ""Amino_acid""}, {""token"": ""Stat3"", ""start_span"": 88, ""end_span"": 93, ""type"": ""Gene_or_gene_product""}, {""token"": ""Src"", ""start_span"": 114, ""end_span"": 117, ""type"": ""Gene_or_gene_product""}]"	train
These findings demonstrate that Src can activate STAT signaling pathways and raise the possibility that Stat3 contributes to oncogenesis by Src.	Src,32,35,Gene_or_gene_product	STAT,49,53,Gene_or_gene_product	Stat3,104,109,Gene_or_gene_product	Src,140,143,Gene_or_gene_product	"[{""token"": ""Src"", ""start_span"": 32, ""end_span"": 35, ""type"": ""Gene_or_gene_product""}, {""token"": ""STAT"", ""start_span"": 49, ""end_span"": 53, ""type"": ""Gene_or_gene_product""}, {""token"": ""Stat3"", ""start_span"": 104, ""end_span"": 109, ""type"": ""Gene_or_gene_product""}, {""token"": ""Src"", ""start_span"": 140, ""end_span"": 143, ""type"": ""Gene_or_gene_product""}]"	train
The erbA / myb IRES virus exhibited a 5 - 10 - fold higher transformed colony forming efficiency than the erbA IRES virus in the blastoderm assay.	erbA,4,8,Gene_or_gene_product	myb,11,14,Gene_or_gene_product	erbA,106,110,Gene_or_gene_product	blastoderm,129,139,Cell	"[{""token"": ""erbA"", ""start_span"": 4, ""end_span"": 8, ""type"": ""Gene_or_gene_product""}, {""token"": ""myb"", ""start_span"": 11, ""end_span"": 14, ""type"": ""Gene_or_gene_product""}, {""token"": ""erbA"", ""start_span"": 106, ""end_span"": 110, ""type"": ""Gene_or_gene_product""}, {""token"": ""blastoderm"", ""start_span"": 129, ""end_span"": 139, ""type"": ""Cell""}]"	train
The average latency of leukemia induction was shorter for the erbA / myb IRES virus ( 3. 5 weeks) than for the erbA IRES virus ( 5 weeks).	leukemia,23,31,Cancer	erbA,62,66,Gene_or_gene_product	myb,69,72,Gene_or_gene_product	erbA,111,115,Gene_or_gene_product	"[{""token"": ""leukemia"", ""start_span"": 23, ""end_span"": 31, ""type"": ""Cancer""}, {""token"": ""erbA"", ""start_span"": 62, ""end_span"": 66, ""type"": ""Gene_or_gene_product""}, {""token"": ""myb"", ""start_span"": 69, ""end_span"": 72, ""type"": ""Gene_or_gene_product""}, {""token"": ""erbA"", ""start_span"": 111, ""end_span"": 115, ""type"": ""Gene_or_gene_product""}]"	train
Delayed addition of GM - CSF, but not FBS, permitted partial rescue of the cells, inhibiting increasing rates of accumulation of fragmented DNA.	GM - CSF,20,28,Gene_or_gene_product	FBS,38,41,Organism_substance	cells,75,80,Cell	DNA,140,143,Cellular_component	"[{""token"": ""GM - CSF"", ""start_span"": 20, ""end_span"": 28, ""type"": ""Gene_or_gene_product""}, {""token"": ""FBS"", ""start_span"": 38, ""end_span"": 41, ""type"": ""Organism_substance""}, {""token"": ""cells"", ""start_span"": 75, ""end_span"": 80, ""type"": ""Cell""}, {""token"": ""DNA"", ""start_span"": 140, ""end_span"": 143, ""type"": ""Cellular_component""}]"	train
In contrast, in the presence of GM - CSF or FBS, apoptosis was enhanced upon addition of CHX or Act D.	GM - CSF,32,40,Gene_or_gene_product	FBS,44,47,Organism_substance	CHX,89,92,Chemical	Act D,96,101,Chemical	"[{""token"": ""GM - CSF"", ""start_span"": 32, ""end_span"": 40, ""type"": ""Gene_or_gene_product""}, {""token"": ""FBS"", ""start_span"": 44, ""end_span"": 47, ""type"": ""Organism_substance""}, {""token"": ""CHX"", ""start_span"": 89, ""end_span"": 92, ""type"": ""Chemical""}, {""token"": ""Act D"", ""start_span"": 96, ""end_span"": 101, ""type"": ""Chemical""}]"	train
Cells which were grown in media containing 5 and 10 ng / ml TGF - beta demonstrated a low level of colony - forming efficiency in soft agar medium without added epidermal growth factor and tumorigenicity in isogeneic rats.	Cells,0,5,Cell	TGF - beta,60,70,Gene_or_gene_product	epidermal growth factor,161,184,Gene_or_gene_product	rats,217,221,Organism	"[{""token"": ""Cells"", ""start_span"": 0, ""end_span"": 5, ""type"": ""Cell""}, {""token"": ""TGF - beta"", ""start_span"": 60, ""end_span"": 70, ""type"": ""Gene_or_gene_product""}, {""token"": ""epidermal growth factor"", ""start_span"": 161, ""end_span"": 184, ""type"": ""Gene_or_gene_product""}, {""token"": ""rats"", ""start_span"": 217, ""end_span"": 221, ""type"": ""Organism""}]"	train
The latter phenomenon was accompanied by an increase in the mdr - 1 mRNA expression, cellular glutathione level, and glutathione S - transferase activity.	mdr - 1,60,67,Gene_or_gene_product	cellular,85,93,Cell	glutathione,94,105,Chemical	glutathione S - transferase,117,144,Gene_or_gene_product	"[{""token"": ""mdr - 1"", ""start_span"": 60, ""end_span"": 67, ""type"": ""Gene_or_gene_product""}, {""token"": ""cellular"", ""start_span"": 85, ""end_span"": 93, ""type"": ""Cell""}, {""token"": ""glutathione"", ""start_span"": 94, ""end_span"": 105, ""type"": ""Chemical""}, {""token"": ""glutathione S - transferase"", ""start_span"": 117, ""end_span"": 144, ""type"": ""Gene_or_gene_product""}]"	train
Increased expression of specific protein tyrosine phosphatases in human breast epithelial cells neoplastically transformed by the neu oncogene.	protein tyrosine phosphatases,33,62,Gene_or_gene_product	human,66,71,Organism	breast epithelial cells,72,95,Cell	neu,130,133,Gene_or_gene_product	"[{""token"": ""protein tyrosine phosphatases"", ""start_span"": 33, ""end_span"": 62, ""type"": ""Gene_or_gene_product""}, {""token"": ""human"", ""start_span"": 66, ""end_span"": 71, ""type"": ""Organism""}, {""token"": ""breast epithelial cells"", ""start_span"": 72, ""end_span"": 95, ""type"": ""Cell""}, {""token"": ""neu"", ""start_span"": 130, ""end_span"": 133, ""type"": ""Gene_or_gene_product""}]"	train
While the role of protein tyrosine kinases has been examined extensively in human breast tumorigenesis, the role of PTPases in this process is virtually unknown.	protein tyrosine kinases,18,42,Gene_or_gene_product	human,76,81,Organism	breast,82,88,Organism_subdivision	PTPases,116,123,Gene_or_gene_product	"[{""token"": ""protein tyrosine kinases"", ""start_span"": 18, ""end_span"": 42, ""type"": ""Gene_or_gene_product""}, {""token"": ""human"", ""start_span"": 76, ""end_span"": 81, ""type"": ""Organism""}, {""token"": ""breast"", ""start_span"": 82, ""end_span"": 88, ""type"": ""Organism_subdivision""}, {""token"": ""PTPases"", ""start_span"": 116, ""end_span"": 123, ""type"": ""Gene_or_gene_product""}]"	train
To address this issue, an activated neu oncogene was introduced into an immortalized nontumorigenic human breast epithelial cell line ( 184B5).	neu,36,39,Gene_or_gene_product	human,100,105,Organism	breast epithelial cell line,106,133,Cell	184B5,136,141,Cell	"[{""token"": ""neu"", ""start_span"": 36, ""end_span"": 39, ""type"": ""Gene_or_gene_product""}, {""token"": ""human"", ""start_span"": 100, ""end_span"": 105, ""type"": ""Organism""}, {""token"": ""breast epithelial cell line"", ""start_span"": 106, ""end_span"": 133, ""type"": ""Cell""}, {""token"": ""184B5"", ""start_span"": 136, ""end_span"": 141, ""type"": ""Cell""}]"	train
This resulted in a substantial increase in P185neu expression, which led to the formation of progressively growing carcinomas after such cells were inoculated into athymic nude mice.	P185neu,43,50,Gene_or_gene_product	carcinomas,115,125,Cancer	cells,137,142,Cell	nude mice,172,181,Organism	"[{""token"": ""P185neu"", ""start_span"": 43, ""end_span"": 50, ""type"": ""Gene_or_gene_product""}, {""token"": ""carcinomas"", ""start_span"": 115, ""end_span"": 125, ""type"": ""Cancer""}, {""token"": ""cells"", ""start_span"": 137, ""end_span"": 142, ""type"": ""Cell""}, {""token"": ""nude mice"", ""start_span"": 172, ""end_span"": 181, ""type"": ""Organism""}]"	train
TC - PTP PTPase expression was only slightly increased in these neu transformed cells, and no expression of CD45 PTPase was observed.	TC - PTP PTPase,0,15,Gene_or_gene_product	neu,64,67,Gene_or_gene_product	cells,80,85,Cell	CD45 PTPase,108,119,Gene_or_gene_product	"[{""token"": ""TC - PTP PTPase"", ""start_span"": 0, ""end_span"": 15, ""type"": ""Gene_or_gene_product""}, {""token"": ""neu"", ""start_span"": 64, ""end_span"": 67, ""type"": ""Gene_or_gene_product""}, {""token"": ""cells"", ""start_span"": 80, ""end_span"": 85, ""type"": ""Cell""}, {""token"": ""CD45 PTPase"", ""start_span"": 108, ""end_span"": 119, ""type"": ""Gene_or_gene_product""}]"	train
The level of neu expression, as well as the differential expression between P185neu and LAR / PTP1B, directly correlated with tumorigenicity.	neu,13,16,Gene_or_gene_product	P185neu,76,83,Gene_or_gene_product	LAR,88,91,Gene_or_gene_product	PTP1B,94,99,Gene_or_gene_product	"[{""token"": ""neu"", ""start_span"": 13, ""end_span"": 16, ""type"": ""Gene_or_gene_product""}, {""token"": ""P185neu"", ""start_span"": 76, ""end_span"": 83, ""type"": ""Gene_or_gene_product""}, {""token"": ""LAR"", ""start_span"": 88, ""end_span"": 91, ""type"": ""Gene_or_gene_product""}, {""token"": ""PTP1B"", ""start_span"": 94, ""end_span"": 99, ""type"": ""Gene_or_gene_product""}]"	train
The dynamic uptake of the glucose analogue [ 18F] FDG was measured in diseased nodes and upper arm skeletal muscle in both metabolic states.	glucose,26,33,Chemical	diseased nodes,70,84,Multi	upper arm,89,98,Organism_subdivision	skeletal muscle,99,114,Tissue	"[{""token"": ""glucose"", ""start_span"": 26, ""end_span"": 33, ""type"": ""Chemical""}, {""token"": ""diseased nodes"", ""start_span"": 70, ""end_span"": 84, ""type"": ""Multi""}, {""token"": ""upper arm"", ""start_span"": 89, ""end_span"": 98, ""type"": ""Organism_subdivision""}, {""token"": ""skeletal muscle"", ""start_span"": 99, ""end_span"": 114, ""type"": ""Tissue""}]"	train
RESULTS: In lymphomatous tissue, [ 18F] FDG uptake rates were similar in overnight fasting and euglycemic hyperinsulinemic clamp ( 38 + / - 10 versus 41 + / - 9 mumol / 100 g / minute, not significant), whereas glucose uptake in skeletal muscle was increased by insulin ( 1. 7 + / - 0. 2 versus 3. 8 + / - 0. 5 mumol / 100 g / minute, P = 0. 012).	lymphomatous tissue,12,31,Tissue	glucose,211,218,Chemical	skeletal muscle,229,244,Organ	insulin,262,269,Gene_or_gene_product	"[{""token"": ""lymphomatous tissue"", ""start_span"": 12, ""end_span"": 31, ""type"": ""Tissue""}, {""token"": ""glucose"", ""start_span"": 211, ""end_span"": 218, ""type"": ""Chemical""}, {""token"": ""skeletal muscle"", ""start_span"": 229, ""end_span"": 244, ""type"": ""Organ""}, {""token"": ""insulin"", ""start_span"": 262, ""end_span"": 269, ""type"": ""Gene_or_gene_product""}]"	train
Both basal ( 2. 3 + / - 0. 2 mumol / 100 g / minute, P = 0. 061) and insulin - stimulated ( 8. 5 + / - 1. 9 mumol / 100 g / minute, P = 0. 055) skeletal arm muscle glucose uptake rates were higher in control subjects than in patients.	insulin,69,76,Gene_or_gene_product	skeletal arm muscle,144,163,Multi	glucose,164,171,Chemical	patients,225,233,Organism	"[{""token"": ""insulin"", ""start_span"": 69, ""end_span"": 76, ""type"": ""Gene_or_gene_product""}, {""token"": ""skeletal arm muscle"", ""start_span"": 144, ""end_span"": 163, ""type"": ""Multi""}, {""token"": ""glucose"", ""start_span"": 164, ""end_span"": 171, ""type"": ""Chemical""}, {""token"": ""patients"", ""start_span"": 225, ""end_span"": 233, ""type"": ""Organism""}]"	train
The main purpose of the present investigation was to study the effect of a homologous series of 1 - alkylpyrrolidine N - oxides on ATP - producing processes in Ehrlich ascites and L1210 murine leukemia cells.	1 - alkylpyrrolidine N - oxides,96,127,Chemical	ATP,131,134,Chemical	Ehrlich ascites,160,175,Cell	L1210 murine leukemia cells,180,207,Cell	"[{""token"": ""1 - alkylpyrrolidine N - oxides"", ""start_span"": 96, ""end_span"": 127, ""type"": ""Chemical""}, {""token"": ""ATP"", ""start_span"": 131, ""end_span"": 134, ""type"": ""Chemical""}, {""token"": ""Ehrlich ascites"", ""start_span"": 160, ""end_span"": 175, ""type"": ""Cell""}, {""token"": ""L1210 murine leukemia cells"", ""start_span"": 180, ""end_span"": 207, ""type"": ""Cell""}]"	train
The effect on aerobic glucose consumption, lactic acid formation, content of total ( T - SH) and non - protein thiol groups ( NP - SH), endogenous respiration and the level of ATP in tumor cells incubated in vitro was investigated.	glucose,22,29,Chemical	lactic acid,43,54,Chemical	ATP,176,179,Chemical	tumor cells,183,194,Cell	"[{""token"": ""glucose"", ""start_span"": 22, ""end_span"": 29, ""type"": ""Chemical""}, {""token"": ""lactic acid"", ""start_span"": 43, ""end_span"": 54, ""type"": ""Chemical""}, {""token"": ""ATP"", ""start_span"": 176, ""end_span"": 179, ""type"": ""Chemical""}, {""token"": ""tumor cells"", ""start_span"": 183, ""end_span"": 194, ""type"": ""Cell""}]"	train
1 - Tetradecylpyrrolidine N - oxide ( TPNO), one of the most active compounds, immediately after addition to the suspension of Ehrlich cells in an ice bath, decreased the level of ATP to the same extent over the whole concentration range.	1 - Tetradecylpyrrolidine N - oxide,0,35,Chemical	TPNO,38,42,Chemical	Ehrlich cells,127,140,Cell	ATP,180,183,Chemical	"[{""token"": ""1 - Tetradecylpyrrolidine N - oxide"", ""start_span"": 0, ""end_span"": 35, ""type"": ""Chemical""}, {""token"": ""TPNO"", ""start_span"": 38, ""end_span"": 42, ""type"": ""Chemical""}, {""token"": ""Ehrlich cells"", ""start_span"": 127, ""end_span"": 140, ""type"": ""Cell""}, {""token"": ""ATP"", ""start_span"": 180, ""end_span"": 183, ""type"": ""Chemical""}]"	train
Transformation - associated cytokine 9E3 / CEF4 is chemotactic for chicken peripheral blood mononuclear cells.	9E3,37,40,Gene_or_gene_product	CEF4,43,47,Gene_or_gene_product	chicken,67,74,Organism	peripheral blood mononuclear cells,75,109,Cell	"[{""token"": ""9E3"", ""start_span"": 37, ""end_span"": 40, ""type"": ""Gene_or_gene_product""}, {""token"": ""CEF4"", ""start_span"": 43, ""end_span"": 47, ""type"": ""Gene_or_gene_product""}, {""token"": ""chicken"", ""start_span"": 67, ""end_span"": 74, ""type"": ""Organism""}, {""token"": ""peripheral blood mononuclear cells"", ""start_span"": 75, ""end_span"": 109, ""type"": ""Cell""}]"	train
Since the function of 9E3 / CEF4 is unknown, we examined the effect of the protein on mitogenicity and chemotaxis, as well as its expression, in fibroblasts and peripheral blood cells.	9E3,22,25,Gene_or_gene_product	CEF4,28,32,Gene_or_gene_product	fibroblasts,145,156,Cell	peripheral blood cells,161,183,Cell	"[{""token"": ""9E3"", ""start_span"": 22, ""end_span"": 25, ""type"": ""Gene_or_gene_product""}, {""token"": ""CEF4"", ""start_span"": 28, ""end_span"": 32, ""type"": ""Gene_or_gene_product""}, {""token"": ""fibroblasts"", ""start_span"": 145, ""end_span"": 156, ""type"": ""Cell""}, {""token"": ""peripheral blood cells"", ""start_span"": 161, ""end_span"": 183, ""type"": ""Cell""}]"	train
Our purpose was to examine human colon cancers for inactivation of two candidate metastasis suppressor genes, nm23 - H1 and nm23 - H2, either by mutation or by loss of gene transcription.	human,27,32,Organism	colon cancers,33,46,Cancer	nm23 - H1,110,119,Gene_or_gene_product	nm23 - H2,124,133,Gene_or_gene_product	"[{""token"": ""human"", ""start_span"": 27, ""end_span"": 32, ""type"": ""Organism""}, {""token"": ""colon cancers"", ""start_span"": 33, ""end_span"": 46, ""type"": ""Cancer""}, {""token"": ""nm23 - H1"", ""start_span"": 110, ""end_span"": 119, ""type"": ""Gene_or_gene_product""}, {""token"": ""nm23 - H2"", ""start_span"": 124, ""end_span"": 133, ""type"": ""Gene_or_gene_product""}]"	train
Pathological analysis indicated that generated tumors corresponded to well - differentiated fibrosarcomas with distinct and intersecting bundles and spindle cells.	tumors,47,53,Cancer	fibrosarcomas,92,105,Cancer	bundles,137,144,Cell	spindle cells,149,162,Cell	"[{""token"": ""tumors"", ""start_span"": 47, ""end_span"": 53, ""type"": ""Cancer""}, {""token"": ""fibrosarcomas"", ""start_span"": 92, ""end_span"": 105, ""type"": ""Cancer""}, {""token"": ""bundles"", ""start_span"": 137, ""end_span"": 144, ""type"": ""Cell""}, {""token"": ""spindle cells"", ""start_span"": 149, ""end_span"": 162, ""type"": ""Cell""}]"	train
Pancreatic somatostatin - secreting gangliocytic paraganglioma with lymph node metastases.	Pancreatic,0,10,Organ	somatostatin,11,23,Gene_or_gene_product	gangliocytic paraganglioma,36,62,Cancer	lymph node,68,78,Multi	"[{""token"": ""Pancreatic"", ""start_span"": 0, ""end_span"": 10, ""type"": ""Organ""}, {""token"": ""somatostatin"", ""start_span"": 11, ""end_span"": 23, ""type"": ""Gene_or_gene_product""}, {""token"": ""gangliocytic paraganglioma"", ""start_span"": 36, ""end_span"": 62, ""type"": ""Cancer""}, {""token"": ""lymph node"", ""start_span"": 68, ""end_span"": 78, ""type"": ""Multi""}]"	train
c - erb B2 overexpression decreases the benefit of adjuvant tamoxifen in early - stage breast cancer without axillary lymph node metastases.	c - erb B2,0,10,Gene_or_gene_product	tamoxifen,60,69,Chemical	early - stage breast cancer,73,100,Cancer	axillary lymph node,109,128,Multi	"[{""token"": ""c - erb B2"", ""start_span"": 0, ""end_span"": 10, ""type"": ""Gene_or_gene_product""}, {""token"": ""tamoxifen"", ""start_span"": 60, ""end_span"": 69, ""type"": ""Chemical""}, {""token"": ""early - stage breast cancer"", ""start_span"": 73, ""end_span"": 100, ""type"": ""Cancer""}, {""token"": ""axillary lymph node"", ""start_span"": 109, ""end_span"": 128, ""type"": ""Multi""}]"	train
Indeed, adjuvant tamoxifen significantly prolonged DFS and OAS in c - erbB2 - negative cases, whereas it had no effect on DFS and OAS in c - erbB2 - positive patients.	tamoxifen,17,26,Chemical	c - erbB2,66,75,Gene_or_gene_product	c - erbB2,137,146,Gene_or_gene_product	patients,158,166,Organism	"[{""token"": ""tamoxifen"", ""start_span"": 17, ""end_span"": 26, ""type"": ""Chemical""}, {""token"": ""c - erbB2"", ""start_span"": 66, ""end_span"": 75, ""type"": ""Gene_or_gene_product""}, {""token"": ""c - erbB2"", ""start_span"": 137, ""end_span"": 146, ""type"": ""Gene_or_gene_product""}, {""token"": ""patients"", ""start_span"": 158, ""end_span"": 166, ""type"": ""Organism""}]"	train
CONCLUSION: In early - stage breast cancer patients, overexpression of c - erbB2 is a marker of lack of efficacy of adjuvant tamoxifen.	breast cancer,29,42,Cancer	patients,43,51,Organism	c - erbB2,71,80,Gene_or_gene_product	tamoxifen,125,134,Chemical	"[{""token"": ""breast cancer"", ""start_span"": 29, ""end_span"": 42, ""type"": ""Cancer""}, {""token"": ""patients"", ""start_span"": 43, ""end_span"": 51, ""type"": ""Organism""}, {""token"": ""c - erbB2"", ""start_span"": 71, ""end_span"": 80, ""type"": ""Gene_or_gene_product""}, {""token"": ""tamoxifen"", ""start_span"": 125, ""end_span"": 134, ""type"": ""Chemical""}]"	train
We investigated the hypothesis that naked DNA encoding for VEGF could be used in a strategy of arterial gene therapy to stimulate collateral artery development.	DNA,42,45,Cellular_component	VEGF,59,63,Gene_or_gene_product	arterial,95,103,Multi	collateral artery,130,147,Multi	"[{""token"": ""DNA"", ""start_span"": 42, ""end_span"": 45, ""type"": ""Cellular_component""}, {""token"": ""VEGF"", ""start_span"": 59, ""end_span"": 63, ""type"": ""Gene_or_gene_product""}, {""token"": ""arterial"", ""start_span"": 95, ""end_span"": 103, ""type"": ""Multi""}, {""token"": ""collateral artery"", ""start_span"": 130, ""end_span"": 147, ""type"": ""Multi""}]"	train
Comparison of transformation by manganese sulfate and 5 - azacytidine in Rat 6 cells overexpressing the c - myc oncogene.	manganese sulfate,32,49,Chemical	5 - azacytidine,54,69,Chemical	Rat 6 cells,73,84,Cell	c - myc,104,111,Gene_or_gene_product	"[{""token"": ""manganese sulfate"", ""start_span"": 32, ""end_span"": 49, ""type"": ""Chemical""}, {""token"": ""5 - azacytidine"", ""start_span"": 54, ""end_span"": 69, ""type"": ""Chemical""}, {""token"": ""Rat 6 cells"", ""start_span"": 73, ""end_span"": 84, ""type"": ""Cell""}, {""token"": ""c - myc"", ""start_span"": 104, ""end_span"": 111, ""type"": ""Gene_or_gene_product""}]"	train
Rat 6 cells are not transformed by treatment with the well - known carcinogens benzo [ a] pyrene ( BP) or N - methyl - N - nitro - N ' - nitrosoguanidine ( MNNG).	Rat 6 cells,0,11,Cell	BP,99,101,Chemical	N - methyl - N - nitro - N ' - nitrosoguanidine,106,153,Chemical	MNNG,156,160,Chemical	"[{""token"": ""Rat 6 cells"", ""start_span"": 0, ""end_span"": 11, ""type"": ""Cell""}, {""token"": ""BP"", ""start_span"": 99, ""end_span"": 101, ""type"": ""Chemical""}, {""token"": ""N - methyl - N - nitro - N ' - nitrosoguanidine"", ""start_span"": 106, ""end_span"": 153, ""type"": ""Chemical""}, {""token"": ""MNNG"", ""start_span"": 156, ""end_span"": 160, ""type"": ""Chemical""}]"	train
In the current report, we tested the sensitivity of the c - myc - overexpressing cells ( Rat 6 / c - myc) to two additional chemicals: 5 - azacytidine and MnSO4.	c - myc,56,63,Gene_or_gene_product	c - myc,97,104,Gene_or_gene_product	5 - azacytidine,135,150,Chemical	MnSO4,155,160,Chemical	"[{""token"": ""c - myc"", ""start_span"": 56, ""end_span"": 63, ""type"": ""Gene_or_gene_product""}, {""token"": ""c - myc"", ""start_span"": 97, ""end_span"": 104, ""type"": ""Gene_or_gene_product""}, {""token"": ""5 - azacytidine"", ""start_span"": 135, ""end_span"": 150, ""type"": ""Chemical""}, {""token"": ""MnSO4"", ""start_span"": 155, ""end_span"": 160, ""type"": ""Chemical""}]"	train
5 - Azacytidine, a potent DNA methylation inhibitor, induced growth of large colonies in soft agar cultures of Rat 6 or Rat 6 / c - myc cells.	5 - Azacytidine,0,15,Chemical	DNA,26,29,Cellular_component	Rat 6,111,116,Cell	c - myc,128,135,Gene_or_gene_product	"[{""token"": ""5 - Azacytidine"", ""start_span"": 0, ""end_span"": 15, ""type"": ""Chemical""}, {""token"": ""DNA"", ""start_span"": 26, ""end_span"": 29, ""type"": ""Cellular_component""}, {""token"": ""Rat 6"", ""start_span"": 111, ""end_span"": 116, ""type"": ""Cell""}, {""token"": ""c - myc"", ""start_span"": 128, ""end_span"": 135, ""type"": ""Gene_or_gene_product""}]"	train
These results suggest that MnSO4 co - operates with overexpressed c - myc in inducing transformation, while 5 - azacytidine transformation is independent of c - myc overexpression and may involve alterations in the regulation of apoptosis.	MnSO4,27,32,Chemical	c - myc,66,73,Gene_or_gene_product	5 - azacytidine,108,123,Chemical	c - myc,157,164,Gene_or_gene_product	"[{""token"": ""MnSO4"", ""start_span"": 27, ""end_span"": 32, ""type"": ""Chemical""}, {""token"": ""c - myc"", ""start_span"": 66, ""end_span"": 73, ""type"": ""Gene_or_gene_product""}, {""token"": ""5 - azacytidine"", ""start_span"": 108, ""end_span"": 123, ""type"": ""Chemical""}, {""token"": ""c - myc"", ""start_span"": 157, ""end_span"": 164, ""type"": ""Gene_or_gene_product""}]"	train
Regulation of p53 - dependent apoptosis, transcriptional repression, and cell transformation by phosphorylation of the 55 - kilodalton E1B protein of human adenovirus type 5.	p53,14,17,Gene_or_gene_product	cell,73,77,Cell	E1B,135,138,Gene_or_gene_product	human adenovirus type 5,150,173,Organism	"[{""token"": ""p53"", ""start_span"": 14, ""end_span"": 17, ""type"": ""Gene_or_gene_product""}, {""token"": ""cell"", ""start_span"": 73, ""end_span"": 77, ""type"": ""Cell""}, {""token"": ""E1B"", ""start_span"": 135, ""end_span"": 138, ""type"": ""Gene_or_gene_product""}, {""token"": ""human adenovirus type 5"", ""start_span"": 150, ""end_span"": 173, ""type"": ""Organism""}]"	train
It has been shown previously that the 55 - kDa polypeptide abrogates p53 - mediated transactivation and that mutants defective in p53 binding are unable to cooperate with E1A in transformation.	55 - kDa,38,46,Gene_or_gene_product	p53,69,72,Gene_or_gene_product	p53,130,133,Gene_or_gene_product	E1A,171,174,Gene_or_gene_product	"[{""token"": ""55 - kDa"", ""start_span"": 38, ""end_span"": 46, ""type"": ""Gene_or_gene_product""}, {""token"": ""p53"", ""start_span"": 69, ""end_span"": 72, ""type"": ""Gene_or_gene_product""}, {""token"": ""p53"", ""start_span"": 130, ""end_span"": 133, ""type"": ""Gene_or_gene_product""}, {""token"": ""E1A"", ""start_span"": 171, ""end_span"": 174, ""type"": ""Gene_or_gene_product""}]"	train
We have previously mapped phosphorylation sites near the carboxy terminus of the E1B - 55kDa protein at Ser - 490 and Ser - 491, which lie within casein kinase II consensus sequences.	E1B,81,84,Gene_or_gene_product	Ser - 490,104,113,Amino_acid	Ser - 491,118,127,Amino_acid	casein kinase II,146,162,Gene_or_gene_product	"[{""token"": ""E1B"", ""start_span"": 81, ""end_span"": 84, ""type"": ""Gene_or_gene_product""}, {""token"": ""Ser - 490"", ""start_span"": 104, ""end_span"": 113, ""type"": ""Amino_acid""}, {""token"": ""Ser - 491"", ""start_span"": 118, ""end_span"": 127, ""type"": ""Amino_acid""}, {""token"": ""casein kinase II"", ""start_span"": 146, ""end_span"": 162, ""type"": ""Gene_or_gene_product""}]"	train
Conversion of these sites to alanine residues greatly reduced transforming activity, and although the mutant 55 - kDa protein was found to interact with p53 at normal levels, it was somewhat defective for suppression of p53 transactivation activity.	alanine,29,36,Amino_acid	55 - kDa,109,117,Gene_or_gene_product	p53,153,156,Gene_or_gene_product	p53,220,223,Gene_or_gene_product	"[{""token"": ""alanine"", ""start_span"": 29, ""end_span"": 36, ""type"": ""Amino_acid""}, {""token"": ""55 - kDa"", ""start_span"": 109, ""end_span"": 117, ""type"": ""Gene_or_gene_product""}, {""token"": ""p53"", ""start_span"": 153, ""end_span"": 156, ""type"": ""Gene_or_gene_product""}, {""token"": ""p53"", ""start_span"": 220, ""end_span"": 223, ""type"": ""Gene_or_gene_product""}]"	train
The E1B - 55kDa product has been shown to exhibit intrinsic transcriptional repression activity when localized to promoters, such as by fusion with the GAL4 DNA - binding domain, even in the absence of p53.	E1B,4,7,Gene_or_gene_product	GAL4,152,156,Gene_or_gene_product	DNA,157,160,Cellular_component	p53,202,205,Gene_or_gene_product	"[{""token"": ""E1B"", ""start_span"": 4, ""end_span"": 7, ""type"": ""Gene_or_gene_product""}, {""token"": ""GAL4"", ""start_span"": 152, ""end_span"": 156, ""type"": ""Gene_or_gene_product""}, {""token"": ""DNA"", ""start_span"": 157, ""end_span"": 160, ""type"": ""Cellular_component""}, {""token"": ""p53"", ""start_span"": 202, ""end_span"": 205, ""type"": ""Gene_or_gene_product""}]"	train
Use of iodine - 123 - alpha - methyl tyrosine ( 123I - IMT) allows investigation of the amino acid transport rate in gliomas.	iodine - 123 - alpha - methyl tyrosine,7,45,Chemical	123I - IMT,48,58,Chemical	amino acid,88,98,Amino_acid	gliomas,117,124,Cancer	"[{""token"": ""iodine - 123 - alpha - methyl tyrosine"", ""start_span"": 7, ""end_span"": 45, ""type"": ""Chemical""}, {""token"": ""123I - IMT"", ""start_span"": 48, ""end_span"": 58, ""type"": ""Chemical""}, {""token"": ""amino acid"", ""start_span"": 88, ""end_span"": 98, ""type"": ""Amino_acid""}, {""token"": ""gliomas"", ""start_span"": 117, ""end_span"": 124, ""type"": ""Cancer""}]"	train
The study population comprised 23 patients with histopathologically proven primary brain tumours; 14 had high - grade gliomas, and nine low - grade brain neoplasms.	patients,34,42,Organism	brain tumours,83,96,Cancer	high - grade gliomas,105,125,Cancer	low - grade brain neoplasms,136,163,Cancer	"[{""token"": ""patients"", ""start_span"": 34, ""end_span"": 42, ""type"": ""Organism""}, {""token"": ""brain tumours"", ""start_span"": 83, ""end_span"": 96, ""type"": ""Cancer""}, {""token"": ""high - grade gliomas"", ""start_span"": 105, ""end_span"": 125, ""type"": ""Cancer""}, {""token"": ""low - grade brain neoplasms"", ""start_span"": 136, ""end_span"": 163, ""type"": ""Cancer""}]"	train
Glucose metabolism was studied using an ECAT EXACT 47 positron emission tomography ( PET) camera and fluorine - 18 fluorodeoxyglucose ( 18F - FDG); 123I - IMT uptake was measured with the triple - headed single - photon emission tomography ( SPET) camera, MULTISPECT 3.	Glucose,0,7,Chemical	fluorine - 18 fluorodeoxyglucose,101,133,Chemical	18F - FDG,136,145,Chemical	123I - IMT,148,158,Chemical	"[{""token"": ""Glucose"", ""start_span"": 0, ""end_span"": 7, ""type"": ""Chemical""}, {""token"": ""fluorine - 18 fluorodeoxyglucose"", ""start_span"": 101, ""end_span"": 133, ""type"": ""Chemical""}, {""token"": ""18F - FDG"", ""start_span"": 136, ""end_span"": 145, ""type"": ""Chemical""}, {""token"": ""123I - IMT"", ""start_span"": 148, ""end_span"": 158, ""type"": ""Chemical""}]"	train
In addition suppression of WT1 expression by WT1 anti - sense oligonucleotide inhibits proliferation of leukemia cells, suggesting that WT1 is important for their proliferation.	WT1,27,30,Gene_or_gene_product	WT1,45,48,Gene_or_gene_product	leukemia cells,104,118,Cell	WT1,136,139,Gene_or_gene_product	"[{""token"": ""WT1"", ""start_span"": 27, ""end_span"": 30, ""type"": ""Gene_or_gene_product""}, {""token"": ""WT1"", ""start_span"": 45, ""end_span"": 48, ""type"": ""Gene_or_gene_product""}, {""token"": ""leukemia cells"", ""start_span"": 104, ""end_span"": 118, ""type"": ""Cell""}, {""token"": ""WT1"", ""start_span"": 136, ""end_span"": 139, ""type"": ""Gene_or_gene_product""}]"	train
We found that induction of one splicing variant of WT1 [ WT1 - 17AA ( +) - KTS ( -)] in M1 cells induces cell cycle arrest and apoptotic cell death.	WT1,51,54,Gene_or_gene_product	M1 cells,88,96,Cell	cell,105,109,Cell	cell,137,141,Cell	"[{""token"": ""WT1"", ""start_span"": 51, ""end_span"": 54, ""type"": ""Gene_or_gene_product""}, {""token"": ""M1 cells"", ""start_span"": 88, ""end_span"": 96, ""type"": ""Cell""}, {""token"": ""cell"", ""start_span"": 105, ""end_span"": 109, ""type"": ""Cell""}, {""token"": ""cell"", ""start_span"": 137, ""end_span"": 141, ""type"": ""Cell""}]"	train
Nineteen ( 79%) putative NK - cell lymphomas expressed perforin, and all 24 cases expressed granzyme B9 and TIA1.	NK - cell lymphomas,25,44,Cancer	perforin,55,63,Gene_or_gene_product	granzyme B9,92,103,Gene_or_gene_product	TIA1,108,112,Gene_or_gene_product	"[{""token"": ""NK - cell lymphomas"", ""start_span"": 25, ""end_span"": 44, ""type"": ""Cancer""}, {""token"": ""perforin"", ""start_span"": 55, ""end_span"": 63, ""type"": ""Gene_or_gene_product""}, {""token"": ""granzyme B9"", ""start_span"": 92, ""end_span"": 103, ""type"": ""Gene_or_gene_product""}, {""token"": ""TIA1"", ""start_span"": 108, ""end_span"": 112, ""type"": ""Gene_or_gene_product""}]"	train
We propose that cytolytic effector and related proteins produced by putative NK and some CD8 + CD56 + postthymic T - cell lymphomas, probably in conjunction with other mechanisms, may effect massive tumor cell apoptosis.	NK,77,79,Cell	CD8,89,92,Gene_or_gene_product	CD56,95,99,Gene_or_gene_product	tumor cell,199,209,Cell	"[{""token"": ""NK"", ""start_span"": 77, ""end_span"": 79, ""type"": ""Cell""}, {""token"": ""CD8"", ""start_span"": 89, ""end_span"": 92, ""type"": ""Gene_or_gene_product""}, {""token"": ""CD56"", ""start_span"": 95, ""end_span"": 99, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumor cell"", ""start_span"": 199, ""end_span"": 209, ""type"": ""Cell""}]"	train
The frequent expression of cytolytic effector markers in the CD2 + surface CD3 - CD56 + putative NK - cell lymphomas lends further support to their probable NK cell origin.	CD2,61,64,Gene_or_gene_product	CD3,75,78,Gene_or_gene_product	CD56,81,85,Gene_or_gene_product	NK cell,157,164,Cell	"[{""token"": ""CD2"", ""start_span"": 61, ""end_span"": 64, ""type"": ""Gene_or_gene_product""}, {""token"": ""CD3"", ""start_span"": 75, ""end_span"": 78, ""type"": ""Gene_or_gene_product""}, {""token"": ""CD56"", ""start_span"": 81, ""end_span"": 85, ""type"": ""Gene_or_gene_product""}, {""token"": ""NK cell"", ""start_span"": 157, ""end_span"": 164, ""type"": ""Cell""}]"	train
BACKGROUND: The fate of patients with multiple endocrine neoplasia of type II A ( MEN II A) is determined by medullary thyroid carcinoma, which occurs in all cases.	patients,24,32,Organism	multiple endocrine neoplasia of type II A,38,79,Cancer	MEN II A,82,90,Cancer	medullary thyroid carcinoma,109,136,Cancer	"[{""token"": ""patients"", ""start_span"": 24, ""end_span"": 32, ""type"": ""Organism""}, {""token"": ""multiple endocrine neoplasia of type II A"", ""start_span"": 38, ""end_span"": 79, ""type"": ""Cancer""}, {""token"": ""MEN II A"", ""start_span"": 82, ""end_span"": 90, ""type"": ""Cancer""}, {""token"": ""medullary thyroid carcinoma"", ""start_span"": 109, ""end_span"": 136, ""type"": ""Cancer""}]"	train
We investigated a prophylactically thyroidectomized MEN II A population to determine whether the highly specific and sensitive tumor marker calcitonin correlates with tumor spread.	MEN II A,52,60,Cancer	tumor,127,132,Cancer	calcitonin,140,150,Gene_or_gene_product	tumor,167,172,Cancer	"[{""token"": ""MEN II A"", ""start_span"": 52, ""end_span"": 60, ""type"": ""Cancer""}, {""token"": ""tumor"", ""start_span"": 127, ""end_span"": 132, ""type"": ""Cancer""}, {""token"": ""calcitonin"", ""start_span"": 140, ""end_span"": 150, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumor"", ""start_span"": 167, ""end_span"": 172, ""type"": ""Cancer""}]"	train
The indication for surgery was established on the basis of pathologic calcitonin levels in the first seven patients and on the basis of detected RET proto - oncogene mutation in the other eight patients.	calcitonin,70,80,Gene_or_gene_product	patients,107,115,Organism	RET,145,148,Gene_or_gene_product	patients,194,202,Organism	"[{""token"": ""calcitonin"", ""start_span"": 70, ""end_span"": 80, ""type"": ""Gene_or_gene_product""}, {""token"": ""patients"", ""start_span"": 107, ""end_span"": 115, ""type"": ""Organism""}, {""token"": ""RET"", ""start_span"": 145, ""end_span"": 148, ""type"": ""Gene_or_gene_product""}, {""token"": ""patients"", ""start_span"": 194, ""end_span"": 202, ""type"": ""Organism""}]"	train
RESULTS: Histology demonstrated C - cell hyperplasia in five patients ( aged 4 - 13 years), unilateral medullary microcarcinoma in six ( aged 9 - 17 years) and a bilateral medullary microcarcinoma in three cases ( aged 17 - 24 years).	C - cell,32,40,Cell	patients,61,69,Organism	medullary microcarcinoma,103,127,Cancer	medullary microcarcinoma,172,196,Cancer	"[{""token"": ""C - cell"", ""start_span"": 32, ""end_span"": 40, ""type"": ""Cell""}, {""token"": ""patients"", ""start_span"": 61, ""end_span"": 69, ""type"": ""Organism""}, {""token"": ""medullary microcarcinoma"", ""start_span"": 103, ""end_span"": 127, ""type"": ""Cancer""}, {""token"": ""medullary microcarcinoma"", ""start_span"": 172, ""end_span"": 196, ""type"": ""Cancer""}]"	train
The induction of Ets - 1 in ECs after denudation was regulated transcriptionally, and humeral factors released from injured ECs might not be responsible.	Ets - 1,17,24,Gene_or_gene_product	ECs,28,31,Cell	humeral factors,86,101,Gene_or_gene_product	ECs,124,127,Cell	"[{""token"": ""Ets - 1"", ""start_span"": 17, ""end_span"": 24, ""type"": ""Gene_or_gene_product""}, {""token"": ""ECs"", ""start_span"": 28, ""end_span"": 31, ""type"": ""Cell""}, {""token"": ""humeral factors"", ""start_span"": 86, ""end_span"": 101, ""type"": ""Gene_or_gene_product""}, {""token"": ""ECs"", ""start_span"": 124, ""end_span"": 127, ""type"": ""Cell""}]"	train
PD98059, a specific MAPK / ERK kinase ( MEK) 1 inhibitor, did not affect the induction of ets - 1 mRNA, whereas SB203580, a specific p38 inhibitor, almost completely abrogated its induction.	PD98059,0,7,Chemical	ets - 1,90,97,Gene_or_gene_product	SB203580,112,120,Chemical	p38,133,136,Gene_or_gene_product	"[{""token"": ""PD98059"", ""start_span"": 0, ""end_span"": 7, ""type"": ""Chemical""}, {""token"": ""ets - 1"", ""start_span"": 90, ""end_span"": 97, ""type"": ""Gene_or_gene_product""}, {""token"": ""SB203580"", ""start_span"": 112, ""end_span"": 120, ""type"": ""Chemical""}, {""token"": ""p38"", ""start_span"": 133, ""end_span"": 136, ""type"": ""Gene_or_gene_product""}]"	train
Since the HTR8 line has a limited in vitro lifespan of 12 - 15 passages, SV40 Tag - transformed cells were selected on the basis of extended lifespan.	HTR8 line,10,19,Cell	SV40,73,77,Organism	Tag,78,81,Gene_or_gene_product	cells,96,101,Cell	"[{""token"": ""HTR8 line"", ""start_span"": 10, ""end_span"": 19, ""type"": ""Cell""}, {""token"": ""SV40"", ""start_span"": 73, ""end_span"": 77, ""type"": ""Organism""}, {""token"": ""Tag"", ""start_span"": 78, ""end_span"": 81, ""type"": ""Gene_or_gene_product""}, {""token"": ""cells"", ""start_span"": 96, ""end_span"": 101, ""type"": ""Cell""}]"	train
Since glucose phosphorylation is the first step in glycolysis, hexokinase ( HK), the first rate limiting glycolytic enzyme, can play a key regulatory role in this process.	glucose,6,13,Chemical	hexokinase,63,73,Gene_or_gene_product	HK,76,78,Gene_or_gene_product	glycolytic enzyme,105,122,Gene_or_gene_product	"[{""token"": ""glucose"", ""start_span"": 6, ""end_span"": 13, ""type"": ""Chemical""}, {""token"": ""hexokinase"", ""start_span"": 63, ""end_span"": 73, ""type"": ""Gene_or_gene_product""}, {""token"": ""HK"", ""start_span"": 76, ""end_span"": 78, ""type"": ""Gene_or_gene_product""}, {""token"": ""glycolytic enzyme"", ""start_span"": 105, ""end_span"": 122, ""type"": ""Gene_or_gene_product""}]"	train
However, recent identification of a high - Km glucose phosphorylating activity in a range of cancer cells prompted us to characterize glucose phosphorylating enzymes of cancer cells at the molecular level.	glucose,46,53,Chemical	cancer cells,93,105,Cell	glucose,134,141,Chemical	cancer cells,169,181,Cell	"[{""token"": ""glucose"", ""start_span"": 46, ""end_span"": 53, ""type"": ""Chemical""}, {""token"": ""cancer cells"", ""start_span"": 93, ""end_span"": 105, ""type"": ""Cell""}, {""token"": ""glucose"", ""start_span"": 134, ""end_span"": 141, ""type"": ""Chemical""}, {""token"": ""cancer cells"", ""start_span"": 169, ""end_span"": 181, ""type"": ""Cell""}]"	train
In addition, we report here the identification of two RNA transcripts of type II - like tumor HK of approximately 5. 5 and approximately 4. 0 kb in these cancer cells lines, including muscle - derived L6 myoblast cells.	type II - like tumor HK,73,96,Gene_or_gene_product	cancer cells lines,154,172,Cell	muscle,184,190,Organ	L6 myoblast cells,201,218,Cell	"[{""token"": ""type II - like tumor HK"", ""start_span"": 73, ""end_span"": 96, ""type"": ""Gene_or_gene_product""}, {""token"": ""cancer cells lines"", ""start_span"": 154, ""end_span"": 172, ""type"": ""Cell""}, {""token"": ""muscle"", ""start_span"": 184, ""end_span"": 190, ""type"": ""Organ""}, {""token"": ""L6 myoblast cells"", ""start_span"": 201, ""end_span"": 218, ""type"": ""Cell""}]"	train
Some homeobox genes, located in four clusters are designated HOX A through D, while others are known as divergent homeobox genes.	homeobox,5,13,Gene_or_gene_product	HOX A,61,66,Gene_or_gene_product	D,75,76,Gene_or_gene_product	homeobox,114,122,Gene_or_gene_product	"[{""token"": ""homeobox"", ""start_span"": 5, ""end_span"": 13, ""type"": ""Gene_or_gene_product""}, {""token"": ""HOX A"", ""start_span"": 61, ""end_span"": 66, ""type"": ""Gene_or_gene_product""}, {""token"": ""D"", ""start_span"": 75, ""end_span"": 76, ""type"": ""Gene_or_gene_product""}, {""token"": ""homeobox"", ""start_span"": 114, ""end_span"": 122, ""type"": ""Gene_or_gene_product""}]"	train
Activation of Ca2 + entry is known to produce endothelial cell shape change, leading to increased permeability, leukocyte migration, and initiation of angiogenesis in conduit - vessel endothelial cells.	Ca2 +,14,19,Chemical	endothelial cell,46,62,Cell	leukocyte,112,121,Cell	conduit - vessel endothelial cells,167,201,Cell	"[{""token"": ""Ca2 +"", ""start_span"": 14, ""end_span"": 19, ""type"": ""Chemical""}, {""token"": ""endothelial cell"", ""start_span"": 46, ""end_span"": 62, ""type"": ""Cell""}, {""token"": ""leukocyte"", ""start_span"": 112, ""end_span"": 121, ""type"": ""Cell""}, {""token"": ""conduit - vessel endothelial cells"", ""start_span"": 167, ""end_span"": 201, ""type"": ""Cell""}]"	train
Both cell types were found to express Trp1, but neither expressed Trp3 nor Trp6.	cell,5,9,Cell	Trp1,38,42,Gene_or_gene_product	Trp3,66,70,Gene_or_gene_product	Trp6,75,79,Gene_or_gene_product	"[{""token"": ""cell"", ""start_span"": 5, ""end_span"": 9, ""type"": ""Cell""}, {""token"": ""Trp1"", ""start_span"": 38, ""end_span"": 42, ""type"": ""Gene_or_gene_product""}, {""token"": ""Trp3"", ""start_span"": 66, ""end_span"": 70, ""type"": ""Gene_or_gene_product""}, {""token"": ""Trp6"", ""start_span"": 75, ""end_span"": 79, ""type"": ""Gene_or_gene_product""}]"	train
The 13C enrichment of cell metabolites was examined after a 4 - h incubation in media containing 5. 5 mM glucose and 11 mM lactate, each metabolite being alternatively labelled with either [ 1 - 13C] D - glucose or [ 3 - 13C] L - lactate.	13C,4,7,Chemical	cell,22,26,Cell	glucose,105,112,Chemical	lactate,123,130,Chemical	"[{""token"": ""13C"", ""start_span"": 4, ""end_span"": 7, ""type"": ""Chemical""}, {""token"": ""cell"", ""start_span"": 22, ""end_span"": 26, ""type"": ""Cell""}, {""token"": ""glucose"", ""start_span"": 105, ""end_span"": 112, ""type"": ""Chemical""}, {""token"": ""lactate"", ""start_span"": 123, ""end_span"": 130, ""type"": ""Chemical""}]"	train
In 3 months - old mice, pigmented cells were detected in spleen and inguinal lymph nodes.	mice,18,22,Organism	pigmented cells,24,39,Cell	spleen,57,63,Organ	inguinal lymph nodes,68,88,Multi	"[{""token"": ""mice"", ""start_span"": 18, ""end_span"": 22, ""type"": ""Organism""}, {""token"": ""pigmented cells"", ""start_span"": 24, ""end_span"": 39, ""type"": ""Cell""}, {""token"": ""spleen"", ""start_span"": 57, ""end_span"": 63, ""type"": ""Organ""}, {""token"": ""inguinal lymph nodes"", ""start_span"": 68, ""end_span"": 88, ""type"": ""Multi""}]"	train
Effect of U - 995, a potent shark cartilage - derived angiogenesis inhibitor, on anti - angiogenesis and anti - tumor activities.	U - 995,10,17,Gene_or_gene_product	shark,28,33,Organism	cartilage,34,43,Tissue	tumor,112,117,Cancer	"[{""token"": ""U - 995"", ""start_span"": 10, ""end_span"": 17, ""type"": ""Gene_or_gene_product""}, {""token"": ""shark"", ""start_span"": 28, ""end_span"": 33, ""type"": ""Organism""}, {""token"": ""cartilage"", ""start_span"": 34, ""end_span"": 43, ""type"": ""Tissue""}, {""token"": ""tumor"", ""start_span"": 112, ""end_span"": 117, ""type"": ""Cancer""}]"	train
BACKGROUND: A potent angiogenesis inhibitor, U - 995, has been purified from the cartilage of the blue shark ( Prionace glauca).	U - 995,45,52,Gene_or_gene_product	cartilage,81,90,Tissue	blue shark,98,108,Organism	Prionace glauca,111,126,Organism	"[{""token"": ""U - 995"", ""start_span"": 45, ""end_span"": 52, ""type"": ""Gene_or_gene_product""}, {""token"": ""cartilage"", ""start_span"": 81, ""end_span"": 90, ""type"": ""Tissue""}, {""token"": ""blue shark"", ""start_span"": 98, ""end_span"": 108, ""type"": ""Organism""}, {""token"": ""Prionace glauca"", ""start_span"": 111, ""end_span"": 126, ""type"": ""Organism""}]"	train
In addition, when 200 micrograms U - 995 was injected i. p. into mice it suppressed sarcoma - 180 cell growth and B16 - F10 mouse melanoma cell metastasis in vivo.	U - 995,33,40,Gene_or_gene_product	mice,65,69,Organism	sarcoma - 180 cell,84,102,Cell	B16 - F10 mouse melanoma cell,114,143,Cell	"[{""token"": ""U - 995"", ""start_span"": 33, ""end_span"": 40, ""type"": ""Gene_or_gene_product""}, {""token"": ""mice"", ""start_span"": 65, ""end_span"": 69, ""type"": ""Organism""}, {""token"": ""sarcoma - 180 cell"", ""start_span"": 84, ""end_span"": 102, ""type"": ""Cell""}, {""token"": ""B16 - F10 mouse melanoma cell"", ""start_span"": 114, ""end_span"": 143, ""type"": ""Cell""}]"	train
In this model, UFT showed a strong angiogenesis - inhibitory effect, whereas 5 - fluorouracil ( 5 - FU) and doxifluridine were less effective.	UFT,15,18,Chemical	5 - fluorouracil,77,93,Chemical	5 - FU,96,102,Chemical	doxifluridine,108,121,Chemical	"[{""token"": ""UFT"", ""start_span"": 15, ""end_span"": 18, ""type"": ""Chemical""}, {""token"": ""5 - fluorouracil"", ""start_span"": 77, ""end_span"": 93, ""type"": ""Chemical""}, {""token"": ""5 - FU"", ""start_span"": 96, ""end_span"": 102, ""type"": ""Chemical""}, {""token"": ""doxifluridine"", ""start_span"": 108, ""end_span"": 121, ""type"": ""Chemical""}]"	valid
The anti - tumour effect of L - NAME after systemic administration was studied in a renal subcapsular CC531 adenocarcinoma model in rats.	tumour,11,17,Cancer	L - NAME,28,36,Chemical	renal subcapsular CC531 adenocarcinoma,84,122,Cancer	rats,132,136,Organism	"[{""token"": ""tumour"", ""start_span"": 11, ""end_span"": 17, ""type"": ""Cancer""}, {""token"": ""L - NAME"", ""start_span"": 28, ""end_span"": 36, ""type"": ""Chemical""}, {""token"": ""renal subcapsular CC531 adenocarcinoma"", ""start_span"": 84, ""end_span"": 122, ""type"": ""Cancer""}, {""token"": ""rats"", ""start_span"": 132, ""end_span"": 136, ""type"": ""Organism""}]"	valid
In combination with TNF or melphalan, L - NAME increased response rates significantly compared to perfusions without L - NAME ( 0 - 64% and 0 - 63% respectively).	TNF,20,23,Gene_or_gene_product	melphalan,27,36,Chemical	L - NAME,38,46,Chemical	L - NAME,117,125,Chemical	"[{""token"": ""TNF"", ""start_span"": 20, ""end_span"": 23, ""type"": ""Gene_or_gene_product""}, {""token"": ""melphalan"", ""start_span"": 27, ""end_span"": 36, ""type"": ""Chemical""}, {""token"": ""L - NAME"", ""start_span"": 38, ""end_span"": 46, ""type"": ""Chemical""}, {""token"": ""L - NAME"", ""start_span"": 117, ""end_span"": 125, ""type"": ""Chemical""}]"	valid
An additional anti - tumour effect was demonstrated when L - NAME was added to the synergistic combination of melphalan and TNF ( responses increased from 70 to 100%).	tumour,21,27,Cancer	L - NAME,57,65,Chemical	melphalan,110,119,Chemical	TNF,124,127,Gene_or_gene_product	"[{""token"": ""tumour"", ""start_span"": 21, ""end_span"": 27, ""type"": ""Cancer""}, {""token"": ""L - NAME"", ""start_span"": 57, ""end_span"": 65, ""type"": ""Chemical""}, {""token"": ""melphalan"", ""start_span"": 110, ""end_span"": 119, ""type"": ""Chemical""}, {""token"": ""TNF"", ""start_span"": 124, ""end_span"": 127, ""type"": ""Gene_or_gene_product""}]"	valid
A synergistic anti - tumour effect of L - NAME is observed in combination with melphalan and / or TNF using ILP.	tumour,21,27,Cancer	L - NAME,38,46,Chemical	melphalan,79,88,Chemical	TNF,98,101,Gene_or_gene_product	"[{""token"": ""tumour"", ""start_span"": 21, ""end_span"": 27, ""type"": ""Cancer""}, {""token"": ""L - NAME"", ""start_span"": 38, ""end_span"": 46, ""type"": ""Chemical""}, {""token"": ""melphalan"", ""start_span"": 79, ""end_span"": 88, ""type"": ""Chemical""}, {""token"": ""TNF"", ""start_span"": 98, ""end_span"": 101, ""type"": ""Gene_or_gene_product""}]"	valid
The efficacy of the antitumor activity of 1 ' - acetoxychavicol acetate ( ACA), reported to be a suppressor of chemically induced carcinogenesis, was evaluated in Ehrlich ascites tumor cells.	antitumor,20,29,Cancer	1 ' - acetoxychavicol acetate,42,71,Chemical	ACA,74,77,Chemical	Ehrlich ascites tumor cells,163,190,Cell	"[{""token"": ""antitumor"", ""start_span"": 20, ""end_span"": 29, ""type"": ""Cancer""}, {""token"": ""1 ' - acetoxychavicol acetate"", ""start_span"": 42, ""end_span"": 71, ""type"": ""Chemical""}, {""token"": ""ACA"", ""start_span"": 74, ""end_span"": 77, ""type"": ""Chemical""}, {""token"": ""Ehrlich ascites tumor cells"", ""start_span"": 163, ""end_span"": 190, ""type"": ""Cell""}]"	valid
Apoptosis, characterized by nuclear condensation, membrane blebbing, cell shrinkage and a significant induction of caspase - 3 - like protease activity at 8 h in a time - course study were observed.	nuclear,28,35,Cellular_component	membrane,50,58,Cellular_component	cell,69,73,Cell	caspase - 3 - like protease,115,142,Gene_or_gene_product	"[{""token"": ""nuclear"", ""start_span"": 28, ""end_span"": 35, ""type"": ""Cellular_component""}, {""token"": ""membrane"", ""start_span"": 50, ""end_span"": 58, ""type"": ""Cellular_component""}, {""token"": ""cell"", ""start_span"": 69, ""end_span"": 73, ""type"": ""Cell""}, {""token"": ""caspase - 3 - like protease"", ""start_span"": 115, ""end_span"": 142, ""type"": ""Gene_or_gene_product""}]"	valid
Vascular endothelial growth factor - B and vascular endothelial growth factor - C expression in renal cell carcinomas: regulation by the von Hippel - Lindau gene and hypoxia.	Vascular endothelial growth factor - B,0,38,Gene_or_gene_product	vascular endothelial growth factor - C,43,81,Gene_or_gene_product	renal cell carcinomas,96,117,Cancer	von Hippel - Lindau,137,156,Gene_or_gene_product	"[{""token"": ""Vascular endothelial growth factor - B"", ""start_span"": 0, ""end_span"": 38, ""type"": ""Gene_or_gene_product""}, {""token"": ""vascular endothelial growth factor - C"", ""start_span"": 43, ""end_span"": 81, ""type"": ""Gene_or_gene_product""}, {""token"": ""renal cell carcinomas"", ""start_span"": 96, ""end_span"": 117, ""type"": ""Cancer""}, {""token"": ""von Hippel - Lindau"", ""start_span"": 137, ""end_span"": 156, ""type"": ""Gene_or_gene_product""}]"	valid
We observed a significant up - regulation of VEGF - B ( P = 0. 002) but not VEGF - C ( P = 0. 3) in neoplastic kidney compared with normal tissues.	VEGF - B,45,53,Gene_or_gene_product	VEGF - C,76,84,Gene_or_gene_product	neoplastic kidney,100,117,Organ	normal tissues,132,146,Tissue	"[{""token"": ""VEGF - B"", ""start_span"": 45, ""end_span"": 53, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF - C"", ""start_span"": 76, ""end_span"": 84, ""type"": ""Gene_or_gene_product""}, {""token"": ""neoplastic kidney"", ""start_span"": 100, ""end_span"": 117, ""type"": ""Organ""}, {""token"": ""normal tissues"", ""start_span"": 132, ""end_span"": 146, ""type"": ""Tissue""}]"	valid
One of the most common signatures of highly malignant tumors is their capacity to metabolize more glucose to lactic acid than their tissues of origin.	malignant tumors,44,60,Cancer	glucose,98,105,Chemical	lactic acid,109,120,Chemical	tissues,132,139,Tissue	"[{""token"": ""malignant tumors"", ""start_span"": 44, ""end_span"": 60, ""type"": ""Cancer""}, {""token"": ""glucose"", ""start_span"": 98, ""end_span"": 105, ""type"": ""Chemical""}, {""token"": ""lactic acid"", ""start_span"": 109, ""end_span"": 120, ""type"": ""Chemical""}, {""token"": ""tissues"", ""start_span"": 132, ""end_span"": 139, ""type"": ""Tissue""}]"	valid
Membrane - anchored Cbl suppresses Hck protein - tyrosine kinase mediated cellular transformation.	Cbl,20,23,Gene_or_gene_product	Hck,35,38,Gene_or_gene_product	tyrosine,49,57,Amino_acid	cellular,74,82,Cell	"[{""token"": ""Cbl"", ""start_span"": 20, ""end_span"": 23, ""type"": ""Gene_or_gene_product""}, {""token"": ""Hck"", ""start_span"": 35, ""end_span"": 38, ""type"": ""Gene_or_gene_product""}, {""token"": ""tyrosine"", ""start_span"": 49, ""end_span"": 57, ""type"": ""Amino_acid""}, {""token"": ""cellular"", ""start_span"": 74, ""end_span"": 82, ""type"": ""Cell""}]"	valid
Activated Hck and membrane - anchored Cbl are present in similar subcellular localizations and co - immunoprecipitate, suggesting that their interaction is required for subsequent ubiquitination and degradation.	Hck,10,13,Gene_or_gene_product	membrane,18,26,Cellular_component	Cbl,38,41,Gene_or_gene_product	subcellular,65,76,Cellular_component	"[{""token"": ""Hck"", ""start_span"": 10, ""end_span"": 13, ""type"": ""Gene_or_gene_product""}, {""token"": ""membrane"", ""start_span"": 18, ""end_span"": 26, ""type"": ""Cellular_component""}, {""token"": ""Cbl"", ""start_span"": 38, ""end_span"": 41, ""type"": ""Gene_or_gene_product""}, {""token"": ""subcellular"", ""start_span"": 65, ""end_span"": 76, ""type"": ""Cellular_component""}]"	valid
The finding of retinal vasculopathy ( 32 patients in group 1 and two patients in group 2) was directly correlated with the presence of choroidal neovascularizations ( P = 0. 002).	retinal,15,22,Multi	patients,41,49,Organism	patients,69,77,Organism	choroidal,135,144,Multi	"[{""token"": ""retinal"", ""start_span"": 15, ""end_span"": 22, ""type"": ""Multi""}, {""token"": ""patients"", ""start_span"": 41, ""end_span"": 49, ""type"": ""Organism""}, {""token"": ""patients"", ""start_span"": 69, ""end_span"": 77, ""type"": ""Organism""}, {""token"": ""choroidal"", ""start_span"": 135, ""end_span"": 144, ""type"": ""Multi""}]"	valid
We undertook this study to test the hypothesis that Fas - FasL - mediated apoptosis plays a role in IL - 12 - induced tumor regression.	Fas,52,55,Gene_or_gene_product	FasL,58,62,Gene_or_gene_product	IL - 12,100,107,Gene_or_gene_product	tumor,118,123,Cancer	"[{""token"": ""Fas"", ""start_span"": 52, ""end_span"": 55, ""type"": ""Gene_or_gene_product""}, {""token"": ""FasL"", ""start_span"": 58, ""end_span"": 62, ""type"": ""Gene_or_gene_product""}, {""token"": ""IL - 12"", ""start_span"": 100, ""end_span"": 107, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumor"", ""start_span"": 118, ""end_span"": 123, ""type"": ""Cancer""}]"	valid
Fas and FasL proteins were increased approximately twofold in the RM - 9 - IL12 tumors compared with the RM - 9 control tumors as determined by Western blot and immunohistochemical analyses ( P < 0. 05).	Fas,0,3,Gene_or_gene_product	FasL,8,12,Gene_or_gene_product	RM - 9 - IL12 tumors,66,86,Cancer	RM - 9 control tumors,105,126,Cancer	"[{""token"": ""Fas"", ""start_span"": 0, ""end_span"": 3, ""type"": ""Gene_or_gene_product""}, {""token"": ""FasL"", ""start_span"": 8, ""end_span"": 12, ""type"": ""Gene_or_gene_product""}, {""token"": ""RM - 9 - IL12 tumors"", ""start_span"": 66, ""end_span"": 86, ""type"": ""Cancer""}, {""token"": ""RM - 9 control tumors"", ""start_span"": 105, ""end_span"": 126, ""type"": ""Cancer""}]"	valid
CONCLUSION: The Fas - FasL - mediated apoptosis pathway may contribute to the IL - 12 - induced rejection of prostate carcinoma.	Fas,16,19,Gene_or_gene_product	FasL,22,26,Gene_or_gene_product	IL - 12,78,85,Gene_or_gene_product	prostate carcinoma,109,127,Cancer	"[{""token"": ""Fas"", ""start_span"": 16, ""end_span"": 19, ""type"": ""Gene_or_gene_product""}, {""token"": ""FasL"", ""start_span"": 22, ""end_span"": 26, ""type"": ""Gene_or_gene_product""}, {""token"": ""IL - 12"", ""start_span"": 78, ""end_span"": 85, ""type"": ""Gene_or_gene_product""}, {""token"": ""prostate carcinoma"", ""start_span"": 109, ""end_span"": 127, ""type"": ""Cancer""}]"	valid
The dominant negative mutant of Rac1 completely inhibited ephrin - B1 - induced membrane ruffling and focal complex assembly.	Rac1,32,36,Gene_or_gene_product	ephrin - B1,58,69,Gene_or_gene_product	membrane,80,88,Cellular_component	focal complex,102,115,Cellular_component	"[{""token"": ""Rac1"", ""start_span"": 32, ""end_span"": 36, ""type"": ""Gene_or_gene_product""}, {""token"": ""ephrin - B1"", ""start_span"": 58, ""end_span"": 69, ""type"": ""Gene_or_gene_product""}, {""token"": ""membrane"", ""start_span"": 80, ""end_span"": 88, ""type"": ""Cellular_component""}, {""token"": ""focal complex"", ""start_span"": 102, ""end_span"": 115, ""type"": ""Cellular_component""}]"	valid
In contrast, rap1GAPII, a negative regulator of Rap1, did not inhibit ephrin - B1 - induced membrane ruffling.	rap1GAPII,13,22,Gene_or_gene_product	Rap1,48,52,Gene_or_gene_product	ephrin - B1,70,81,Gene_or_gene_product	membrane,92,100,Cellular_component	"[{""token"": ""rap1GAPII"", ""start_span"": 13, ""end_span"": 22, ""type"": ""Gene_or_gene_product""}, {""token"": ""Rap1"", ""start_span"": 48, ""end_span"": 52, ""type"": ""Gene_or_gene_product""}, {""token"": ""ephrin - B1"", ""start_span"": 70, ""end_span"": 81, ""type"": ""Gene_or_gene_product""}, {""token"": ""membrane"", ""start_span"": 92, ""end_span"": 100, ""type"": ""Cellular_component""}]"	valid
However, in rap1GAPII - expressing cells, ephrin - B1 did not induce membrane spreading, probably due to instability of the focal complex.	rap1GAPII,12,21,Gene_or_gene_product	ephrin - B1,42,53,Gene_or_gene_product	membrane,69,77,Cellular_component	focal complex,124,137,Cellular_component	"[{""token"": ""rap1GAPII"", ""start_span"": 12, ""end_span"": 21, ""type"": ""Gene_or_gene_product""}, {""token"": ""ephrin - B1"", ""start_span"": 42, ""end_span"": 53, ""type"": ""Gene_or_gene_product""}, {""token"": ""membrane"", ""start_span"": 69, ""end_span"": 77, ""type"": ""Cellular_component""}, {""token"": ""focal complex"", ""start_span"": 124, ""end_span"": 137, ""type"": ""Cellular_component""}]"	valid
FVIIa - induced antiapoptotic effect was dependent on its proteolytic activity and TF but independent of factor Xa and thrombin.	FVIIa,0,5,Gene_or_gene_product	TF,83,85,Gene_or_gene_product	factor Xa,105,114,Gene_or_gene_product	thrombin,119,127,Gene_or_gene_product	"[{""token"": ""FVIIa"", ""start_span"": 0, ""end_span"": 5, ""type"": ""Gene_or_gene_product""}, {""token"": ""TF"", ""start_span"": 83, ""end_span"": 85, ""type"": ""Gene_or_gene_product""}, {""token"": ""factor Xa"", ""start_span"": 105, ""end_span"": 114, ""type"": ""Gene_or_gene_product""}, {""token"": ""thrombin"", ""start_span"": 119, ""end_span"": 127, ""type"": ""Gene_or_gene_product""}]"	valid
Cloning and characterization of the latent membrane protein ( LMP) of a specific Epstein - Barr virus variant derived from the nasopharyngeal carcinoma in the Taiwanese population.	latent membrane protein,36,59,Gene_or_gene_product	LMP,62,65,Gene_or_gene_product	Epstein - Barr virus,81,101,Organism	nasopharyngeal carcinoma,127,151,Cancer	"[{""token"": ""latent membrane protein"", ""start_span"": 36, ""end_span"": 59, ""type"": ""Gene_or_gene_product""}, {""token"": ""LMP"", ""start_span"": 62, ""end_span"": 65, ""type"": ""Gene_or_gene_product""}, {""token"": ""Epstein - Barr virus"", ""start_span"": 81, ""end_span"": 101, ""type"": ""Organism""}, {""token"": ""nasopharyngeal carcinoma"", ""start_span"": 127, ""end_span"": 151, ""type"": ""Cancer""}]"	valid
A DNA fragment containing Epstein - Barr virus ( EBV) terminal fragment sequence was obtained from a genomic library of nasopharyngeal carcinoma ( NPC).	Epstein - Barr virus,26,46,Organism	EBV,49,52,Organism	nasopharyngeal carcinoma,120,144,Cancer	NPC,147,150,Cancer	"[{""token"": ""Epstein - Barr virus"", ""start_span"": 26, ""end_span"": 46, ""type"": ""Organism""}, {""token"": ""EBV"", ""start_span"": 49, ""end_span"": 52, ""type"": ""Organism""}, {""token"": ""nasopharyngeal carcinoma"", ""start_span"": 120, ""end_span"": 144, ""type"": ""Cancer""}, {""token"": ""NPC"", ""start_span"": 147, ""end_span"": 150, ""type"": ""Cancer""}]"	valid
Indeed, we would hypothesize that these angiogenic markers - - especially the angiopoietins - - do not necessarily translate into new vessel formation in congestive heart failure ( CHF), but may well reflect disturbances of endothelial integrity in CHF.	angiopoietins,78,91,Gene_or_gene_product	vessel,134,140,Multi	heart,165,170,Organ	endothelial,224,235,Tissue	"[{""token"": ""angiopoietins"", ""start_span"": 78, ""end_span"": 91, ""type"": ""Gene_or_gene_product""}, {""token"": ""vessel"", ""start_span"": 134, ""end_span"": 140, ""type"": ""Multi""}, {""token"": ""heart"", ""start_span"": 165, ""end_span"": 170, ""type"": ""Organ""}, {""token"": ""endothelial"", ""start_span"": 224, ""end_span"": 235, ""type"": ""Tissue""}]"	valid
[ Correlation between expression of vascular endothelial growth factor - C in tumor - associated macrophages and lymphatic metastasis in oral cancer].	vascular endothelial growth factor - C,36,74,Gene_or_gene_product	tumor - associated macrophages,78,108,Cell	lymphatic,113,122,Organ	oral cancer,137,148,Cancer	"[{""token"": ""vascular endothelial growth factor - C"", ""start_span"": 36, ""end_span"": 74, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumor - associated macrophages"", ""start_span"": 78, ""end_span"": 108, ""type"": ""Cell""}, {""token"": ""lymphatic"", ""start_span"": 113, ""end_span"": 122, ""type"": ""Organ""}, {""token"": ""oral cancer"", ""start_span"": 137, ""end_span"": 148, ""type"": ""Cancer""}]"	valid
In addition, the hypothesis predicts that early detection, which is designed to find more patients without involved lymph nodes, may not be a synergistic strategy with adjuvant chemotherapy, which works best with positive lymph node patients.	patients,90,98,Organism	lymph nodes,116,127,Multi	lymph node,222,232,Multi	patients,233,241,Organism	"[{""token"": ""patients"", ""start_span"": 90, ""end_span"": 98, ""type"": ""Organism""}, {""token"": ""lymph nodes"", ""start_span"": 116, ""end_span"": 127, ""type"": ""Multi""}, {""token"": ""lymph node"", ""start_span"": 222, ""end_span"": 232, ""type"": ""Multi""}, {""token"": ""patients"", ""start_span"": 233, ""end_span"": 241, ""type"": ""Organism""}]"	valid
Vascular endothelial growth factor ( VEGF) is a vascular growth factor which induces angiogenesis ( the development of new blood vessels), vascular permeability, and inflammation.	Vascular endothelial growth factor,0,34,Gene_or_gene_product	VEGF,37,41,Gene_or_gene_product	blood vessels,123,136,Multi	vascular,139,147,Multi	"[{""token"": ""Vascular endothelial growth factor"", ""start_span"": 0, ""end_span"": 34, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF"", ""start_span"": 37, ""end_span"": 41, ""type"": ""Gene_or_gene_product""}, {""token"": ""blood vessels"", ""start_span"": 123, ""end_span"": 136, ""type"": ""Multi""}, {""token"": ""vascular"", ""start_span"": 139, ""end_span"": 147, ""type"": ""Multi""}]"	valid
Eligible patients had CNV in which the central boundary of the lesion was between 1 and 199 microm from the geometric center of the foveal avascular zone ( FAZ).	patients,9,17,Organism	lesion,63,69,Pathological_formation	foveal avascular zone,132,153,Tissue	FAZ,156,159,Tissue	"[{""token"": ""patients"", ""start_span"": 9, ""end_span"": 17, ""type"": ""Organism""}, {""token"": ""lesion"", ""start_span"": 63, ""end_span"": 69, ""type"": ""Pathological_formation""}, {""token"": ""foveal avascular zone"", ""start_span"": 132, ""end_span"": 153, ""type"": ""Tissue""}, {""token"": ""FAZ"", ""start_span"": 156, ""end_span"": 159, ""type"": ""Tissue""}]"	valid
To define these roles more clearly, we examined the expression of DCC and its ligand, netrin - 1, in the normal endometrium and in endometrial cancer.	DCC,66,69,Gene_or_gene_product	netrin - 1,86,96,Gene_or_gene_product	endometrium,112,123,Multi	endometrial cancer,131,149,Cancer	"[{""token"": ""DCC"", ""start_span"": 66, ""end_span"": 69, ""type"": ""Gene_or_gene_product""}, {""token"": ""netrin - 1"", ""start_span"": 86, ""end_span"": 96, ""type"": ""Gene_or_gene_product""}, {""token"": ""endometrium"", ""start_span"": 112, ""end_span"": 123, ""type"": ""Multi""}, {""token"": ""endometrial cancer"", ""start_span"": 131, ""end_span"": 149, ""type"": ""Cancer""}]"	valid
METHODS: The expression of DCC and netrin - 1 in normal endometrial glands and in cancer cell lines was examined by RT - PCR and immunohistochemistry.	DCC,27,30,Gene_or_gene_product	netrin - 1,35,45,Gene_or_gene_product	endometrial glands,56,74,Multi	cancer cell lines,82,99,Cell	"[{""token"": ""DCC"", ""start_span"": 27, ""end_span"": 30, ""type"": ""Gene_or_gene_product""}, {""token"": ""netrin - 1"", ""start_span"": 35, ""end_span"": 45, ""type"": ""Gene_or_gene_product""}, {""token"": ""endometrial glands"", ""start_span"": 56, ""end_span"": 74, ""type"": ""Multi""}, {""token"": ""cancer cell lines"", ""start_span"": 82, ""end_span"": 99, ""type"": ""Cell""}]"	valid
CONCLUSION: Our observations suggest that DCC / netrin - 1 signaling may commit cells to the transition of endometrial gland architecture or function from a proliferating to a secretory phase.	DCC,42,45,Gene_or_gene_product	netrin - 1,48,58,Gene_or_gene_product	cells,80,85,Cell	endometrial gland,107,124,Multi	"[{""token"": ""DCC"", ""start_span"": 42, ""end_span"": 45, ""type"": ""Gene_or_gene_product""}, {""token"": ""netrin - 1"", ""start_span"": 48, ""end_span"": 58, ""type"": ""Gene_or_gene_product""}, {""token"": ""cells"", ""start_span"": 80, ""end_span"": 85, ""type"": ""Cell""}, {""token"": ""endometrial gland"", ""start_span"": 107, ""end_span"": 124, ""type"": ""Multi""}]"	valid
Group 2 was treated by Enoxaparine Na, group 3 received HBO therapy, and group 4 was given both enoxaparine Na and HBO treatment.	Enoxaparine Na,23,37,Chemical	HBO,56,59,Chemical	enoxaparine Na,96,110,Chemical	HBO,115,118,Chemical	"[{""token"": ""Enoxaparine Na"", ""start_span"": 23, ""end_span"": 37, ""type"": ""Chemical""}, {""token"": ""HBO"", ""start_span"": 56, ""end_span"": 59, ""type"": ""Chemical""}, {""token"": ""enoxaparine Na"", ""start_span"": 96, ""end_span"": 110, ""type"": ""Chemical""}, {""token"": ""HBO"", ""start_span"": 115, ""end_span"": 118, ""type"": ""Chemical""}]"	valid
Enoxaparine Na had no harmful effects on wound healing, and HBO therapy increased the process of wound healing.	Enoxaparine Na,0,14,Chemical	wound,41,46,Pathological_formation	HBO,60,63,Chemical	wound,97,102,Pathological_formation	"[{""token"": ""Enoxaparine Na"", ""start_span"": 0, ""end_span"": 14, ""type"": ""Chemical""}, {""token"": ""wound"", ""start_span"": 41, ""end_span"": 46, ""type"": ""Pathological_formation""}, {""token"": ""HBO"", ""start_span"": 60, ""end_span"": 63, ""type"": ""Chemical""}, {""token"": ""wound"", ""start_span"": 97, ""end_span"": 102, ""type"": ""Pathological_formation""}]"	valid
The results showed that thrombospondin is expressed in normal prostate but not in prostate tumours in a rat model.	thrombospondin,24,38,Gene_or_gene_product	prostate,62,70,Organ	prostate tumours,82,98,Cancer	rat,104,107,Organism	"[{""token"": ""thrombospondin"", ""start_span"": 24, ""end_span"": 38, ""type"": ""Gene_or_gene_product""}, {""token"": ""prostate"", ""start_span"": 62, ""end_span"": 70, ""type"": ""Organ""}, {""token"": ""prostate tumours"", ""start_span"": 82, ""end_span"": 98, ""type"": ""Cancer""}, {""token"": ""rat"", ""start_span"": 104, ""end_span"": 107, ""type"": ""Organism""}]"	valid
Bovine papillomavirus E7 transformation function correlates with cellular p600 protein binding.	Bovine papillomavirus,0,21,Organism	E7,22,24,Gene_or_gene_product	cellular,65,73,Cell	p600,74,78,Gene_or_gene_product	"[{""token"": ""Bovine papillomavirus"", ""start_span"": 0, ""end_span"": 21, ""type"": ""Organism""}, {""token"": ""E7"", ""start_span"": 22, ""end_span"": 24, ""type"": ""Gene_or_gene_product""}, {""token"": ""cellular"", ""start_span"": 65, ""end_span"": 73, ""type"": ""Cell""}, {""token"": ""p600"", ""start_span"": 74, ""end_span"": 78, ""type"": ""Gene_or_gene_product""}]"	valid
To address this question, we used the proteomic approach of tandem affinity purification to identify cellular proteins that are in complex with E7, and identified the 600 - kDa protein, p600, as a binding partner of E7.	cellular,101,109,Cell	E7,144,146,Gene_or_gene_product	p600,186,190,Gene_or_gene_product	E7,216,218,Gene_or_gene_product	"[{""token"": ""cellular"", ""start_span"": 101, ""end_span"": 109, ""type"": ""Cell""}, {""token"": ""E7"", ""start_span"": 144, ""end_span"": 146, ""type"": ""Gene_or_gene_product""}, {""token"": ""p600"", ""start_span"": 186, ""end_span"": 190, ""type"": ""Gene_or_gene_product""}, {""token"": ""E7"", ""start_span"": 216, ""end_span"": 218, ""type"": ""Gene_or_gene_product""}]"	valid
Epithelial - mesenchymal transitions ( EMTs) occur as key steps during embryonic morphogenesis, and are now implicated in the progression of primary tumors towards metastases.	Epithelial,0,10,Cell	mesenchymal,13,24,Cell	embryonic,71,80,Developing_anatomical_structure	tumors,149,155,Cancer	"[{""token"": ""Epithelial"", ""start_span"": 0, ""end_span"": 10, ""type"": ""Cell""}, {""token"": ""mesenchymal"", ""start_span"": 13, ""end_span"": 24, ""type"": ""Cell""}, {""token"": ""embryonic"", ""start_span"": 71, ""end_span"": 80, ""type"": ""Developing_anatomical_structure""}, {""token"": ""tumors"", ""start_span"": 149, ""end_span"": 155, ""type"": ""Cancer""}]"	valid
Single cell transplants showed that a common precursor contributes to both the hemopoietic and endothelial lineages, thus demonstrating the presence of an adult hemangioblast.	cell,7,11,Cell	hemopoietic,79,90,Cell	endothelial lineages,95,115,Cell	hemangioblast,161,174,Cell	"[{""token"": ""cell"", ""start_span"": 7, ""end_span"": 11, ""type"": ""Cell""}, {""token"": ""hemopoietic"", ""start_span"": 79, ""end_span"": 90, ""type"": ""Cell""}, {""token"": ""endothelial lineages"", ""start_span"": 95, ""end_span"": 115, ""type"": ""Cell""}, {""token"": ""hemangioblast"", ""start_span"": 161, ""end_span"": 174, ""type"": ""Cell""}]"	valid
By ruling out cell fusion, we clearly demonstrate the existence of an adult hemangioblast, but the differentiation of marrow stem cells toward the endothelial lineage is an extremely rare event.	cell,14,18,Cell	hemangioblast,76,89,Cell	marrow stem cells,118,135,Cell	endothelial lineage,147,166,Cell	"[{""token"": ""cell"", ""start_span"": 14, ""end_span"": 18, ""type"": ""Cell""}, {""token"": ""hemangioblast"", ""start_span"": 76, ""end_span"": 89, ""type"": ""Cell""}, {""token"": ""marrow stem cells"", ""start_span"": 118, ""end_span"": 135, ""type"": ""Cell""}, {""token"": ""endothelial lineage"", ""start_span"": 147, ""end_span"": 166, ""type"": ""Cell""}]"	valid
After MNNG administration, rats were investigated by endoscopic observation, visualization of microvascular structure, and estimation of lectin binding sites.	MNNG,6,10,Chemical	rats,27,31,Organism	microvascular,94,107,Tissue	lectin,137,143,Gene_or_gene_product	"[{""token"": ""MNNG"", ""start_span"": 6, ""end_span"": 10, ""type"": ""Chemical""}, {""token"": ""rats"", ""start_span"": 27, ""end_span"": 31, ""type"": ""Organism""}, {""token"": ""microvascular"", ""start_span"": 94, ""end_span"": 107, ""type"": ""Tissue""}, {""token"": ""lectin"", ""start_span"": 137, ""end_span"": 143, ""type"": ""Gene_or_gene_product""}]"	valid
Protruding and expansive ulcerating carcinomas developed at 36 weeks and had a microvascular pattern similar to that of human adenocarcinoma.	ulcerating carcinomas,25,46,Cancer	microvascular,79,92,Tissue	human,120,125,Organism	adenocarcinoma,126,140,Cancer	"[{""token"": ""ulcerating carcinomas"", ""start_span"": 25, ""end_span"": 46, ""type"": ""Cancer""}, {""token"": ""microvascular"", ""start_span"": 79, ""end_span"": 92, ""type"": ""Tissue""}, {""token"": ""human"", ""start_span"": 120, ""end_span"": 125, ""type"": ""Organism""}, {""token"": ""adenocarcinoma"", ""start_span"": 126, ""end_span"": 140, ""type"": ""Cancer""}]"	valid
We postulate that endoscopic observation is valuable in investigating the development of gastric carcinoma, and microvascular structure and lectin binding pattern may be useful to demonstrate the mechanism of growth of gastric carcinoma.	gastric carcinoma,89,106,Cancer	microvascular,112,125,Tissue	lectin,140,146,Gene_or_gene_product	gastric carcinoma,219,236,Cancer	"[{""token"": ""gastric carcinoma"", ""start_span"": 89, ""end_span"": 106, ""type"": ""Cancer""}, {""token"": ""microvascular"", ""start_span"": 112, ""end_span"": 125, ""type"": ""Tissue""}, {""token"": ""lectin"", ""start_span"": 140, ""end_span"": 146, ""type"": ""Gene_or_gene_product""}, {""token"": ""gastric carcinoma"", ""start_span"": 219, ""end_span"": 236, ""type"": ""Cancer""}]"	valid
Thus, c - myc induction is a resistance factor and our findings suggest that tumors carrying low levels of c - Myc protein could be more responsive to vinca alkaloids treatment.	c - myc,6,13,Gene_or_gene_product	tumors,77,83,Cancer	c - Myc,107,114,Gene_or_gene_product	vinca alkaloids,151,166,Chemical	"[{""token"": ""c - myc"", ""start_span"": 6, ""end_span"": 13, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumors"", ""start_span"": 77, ""end_span"": 83, ""type"": ""Cancer""}, {""token"": ""c - Myc"", ""start_span"": 107, ""end_span"": 114, ""type"": ""Gene_or_gene_product""}, {""token"": ""vinca alkaloids"", ""start_span"": 151, ""end_span"": 166, ""type"": ""Chemical""}]"	valid
Recently, it has been shown that expression of human HOX 2 genes is sequentially activated by RA beginning from Hox 2. 9 at the 3 ' end of the HOX 2 cluster ( A. Simeone, D. Acampora, L. Arcioni, P. W. Andrews, E. Boncinelli, and F. Mavilio, Nature [ London] 346: 763 - 766, 1990).	human,47,52,Organism	HOX 2,53,58,Gene_or_gene_product	RA,94,96,Chemical	HOX 2,143,148,Gene_or_gene_product	"[{""token"": ""human"", ""start_span"": 47, ""end_span"": 52, ""type"": ""Organism""}, {""token"": ""HOX 2"", ""start_span"": 53, ""end_span"": 58, ""type"": ""Gene_or_gene_product""}, {""token"": ""RA"", ""start_span"": 94, ""end_span"": 96, ""type"": ""Chemical""}, {""token"": ""HOX 2"", ""start_span"": 143, ""end_span"": 148, ""type"": ""Gene_or_gene_product""}]"	valid
However, in N - ras - transformed cell clones, RA - induced expression of these homeobox genes is delayed.	N - ras,12,19,Gene_or_gene_product	cell clones,34,45,Cell	RA,47,49,Chemical	homeobox,80,88,Gene_or_gene_product	"[{""token"": ""N - ras"", ""start_span"": 12, ""end_span"": 19, ""type"": ""Gene_or_gene_product""}, {""token"": ""cell clones"", ""start_span"": 34, ""end_span"": 45, ""type"": ""Cell""}, {""token"": ""RA"", ""start_span"": 47, ""end_span"": 49, ""type"": ""Chemical""}, {""token"": ""homeobox"", ""start_span"": 80, ""end_span"": 88, ""type"": ""Gene_or_gene_product""}]"	valid
"High - Dose celecoxib and metronomic "" low - dose "" cyclophosphamide is an effective and safe therapy in patients with relapsed and refractory aggressive histology non - Hodgkin ' s lymphoma."	celecoxib,12,21,Chemical	cyclophosphamide,52,68,Chemical	patients,105,113,Organism	non - Hodgkin ' s lymphoma,164,190,Cancer	"[{""token"": ""celecoxib"", ""start_span"": 12, ""end_span"": 21, ""type"": ""Chemical""}, {""token"": ""cyclophosphamide"", ""start_span"": 52, ""end_span"": 68, ""type"": ""Chemical""}, {""token"": ""patients"", ""start_span"": 105, ""end_span"": 113, ""type"": ""Organism""}, {""token"": ""non - Hodgkin ' s lymphoma"", ""start_span"": 164, ""end_span"": 190, ""type"": ""Cancer""}]"	valid
EXPERIMENTAL DESIGN: We assessed response, toxicity, and biomarkers of angiogenesis to low - dose cyclophosphamide ( 50 mg p. o. o. d.) and high - dose celecoxib ( 400 mg p. o. b. i. d.) in adult patients with relapsed or refractory aggressive non - Hodgkin ' s lymphoma in a multicenter phase II prospective study.	cyclophosphamide,98,114,Chemical	celecoxib,152,161,Chemical	patients,196,204,Organism	non - Hodgkin ' s lymphoma,244,270,Cancer	"[{""token"": ""cyclophosphamide"", ""start_span"": 98, ""end_span"": 114, ""type"": ""Chemical""}, {""token"": ""celecoxib"", ""start_span"": 152, ""end_span"": 161, ""type"": ""Chemical""}, {""token"": ""patients"", ""start_span"": 196, ""end_span"": 204, ""type"": ""Organism""}, {""token"": ""non - Hodgkin ' s lymphoma"", ""start_span"": 244, ""end_span"": 270, ""type"": ""Cancer""}]"	valid
Circulating endothelial cells and their precursors declined and remained low in responders, whereas plasma vascular endothelial growth factor trended to decline in responding patients but increase in nonresponders.	endothelial cells,12,29,Cell	plasma,100,106,Organism_substance	vascular endothelial growth factor,107,141,Gene_or_gene_product	patients,175,183,Organism	"[{""token"": ""endothelial cells"", ""start_span"": 12, ""end_span"": 29, ""type"": ""Cell""}, {""token"": ""plasma"", ""start_span"": 100, ""end_span"": 106, ""type"": ""Organism_substance""}, {""token"": ""vascular endothelial growth factor"", ""start_span"": 107, ""end_span"": 141, ""type"": ""Gene_or_gene_product""}, {""token"": ""patients"", ""start_span"": 175, ""end_span"": 183, ""type"": ""Organism""}]"	valid
Recent advances in stem cell biology added the new concept that cancer originates from a single cancer - initiating cell.	stem cell,19,28,Cell	cancer,64,70,Cancer	cancer,96,102,Cancer	cell,116,120,Cell	"[{""token"": ""stem cell"", ""start_span"": 19, ""end_span"": 28, ""type"": ""Cell""}, {""token"": ""cancer"", ""start_span"": 64, ""end_span"": 70, ""type"": ""Cancer""}, {""token"": ""cancer"", ""start_span"": 96, ""end_span"": 102, ""type"": ""Cancer""}, {""token"": ""cell"", ""start_span"": 116, ""end_span"": 120, ""type"": ""Cell""}]"	valid
As expected, Ang II - induced sFlt - 1 secretion resulted in the inhibition of endothelial cell migration and in vitro tube formation.	Ang II,13,19,Gene_or_gene_product	sFlt - 1,30,38,Gene_or_gene_product	endothelial cell,79,95,Cell	tube,119,123,Tissue	"[{""token"": ""Ang II"", ""start_span"": 13, ""end_span"": 19, ""type"": ""Gene_or_gene_product""}, {""token"": ""sFlt - 1"", ""start_span"": 30, ""end_span"": 38, ""type"": ""Gene_or_gene_product""}, {""token"": ""endothelial cell"", ""start_span"": 79, ""end_span"": 95, ""type"": ""Cell""}, {""token"": ""tube"", ""start_span"": 119, ""end_span"": 123, ""type"": ""Tissue""}]"	valid
The p53 protein suppresses tumorigenesis by initiating cellular functions such as cell cycle arrest and apoptosis in response to DNA damage.	p53,4,7,Gene_or_gene_product	cellular,55,63,Cell	cell,82,86,Cell	DNA,129,132,Cellular_component	"[{""token"": ""p53"", ""start_span"": 4, ""end_span"": 7, ""type"": ""Gene_or_gene_product""}, {""token"": ""cellular"", ""start_span"": 55, ""end_span"": 63, ""type"": ""Cell""}, {""token"": ""cell"", ""start_span"": 82, ""end_span"": 86, ""type"": ""Cell""}, {""token"": ""DNA"", ""start_span"": 129, ""end_span"": 132, ""type"": ""Cellular_component""}]"	valid
Concomitantly, immunostaining for apoptosis inducing factor ( AIF) showed a time - dependent translocation from the mitochondria to the nucleus.	apoptosis inducing factor,34,59,Gene_or_gene_product	AIF,62,65,Gene_or_gene_product	mitochondria,116,128,Cellular_component	nucleus,136,143,Cellular_component	"[{""token"": ""apoptosis inducing factor"", ""start_span"": 34, ""end_span"": 59, ""type"": ""Gene_or_gene_product""}, {""token"": ""AIF"", ""start_span"": 62, ""end_span"": 65, ""type"": ""Gene_or_gene_product""}, {""token"": ""mitochondria"", ""start_span"": 116, ""end_span"": 128, ""type"": ""Cellular_component""}, {""token"": ""nucleus"", ""start_span"": 136, ""end_span"": 143, ""type"": ""Cellular_component""}]"	valid
These studies have led to the hypothesis that increased consumption of glucose in metastatic lesions is not used for substantial energy production via Embden - Meyerhoff glycolysis, but rather for production of acid, which gives the cancer cells a competitive advantage for invasion.	glucose,71,78,Chemical	metastatic lesions,82,100,Cancer	acid,211,215,Chemical	cancer cells,233,245,Cell	"[{""token"": ""glucose"", ""start_span"": 71, ""end_span"": 78, ""type"": ""Chemical""}, {""token"": ""metastatic lesions"", ""start_span"": 82, ""end_span"": 100, ""type"": ""Cancer""}, {""token"": ""acid"", ""start_span"": 211, ""end_span"": 215, ""type"": ""Chemical""}, {""token"": ""cancer cells"", ""start_span"": 233, ""end_span"": 245, ""type"": ""Cell""}]"	valid
We found a decrease in corneal neovascularization in spironolactone - treated rats compared with the PBS - treated group, although the difference was not statistically significant.	corneal,23,30,Multi	spironolactone,53,67,Chemical	rats,78,82,Organism	PBS,101,104,Chemical	"[{""token"": ""corneal"", ""start_span"": 23, ""end_span"": 30, ""type"": ""Multi""}, {""token"": ""spironolactone"", ""start_span"": 53, ""end_span"": 67, ""type"": ""Chemical""}, {""token"": ""rats"", ""start_span"": 78, ""end_span"": 82, ""type"": ""Organism""}, {""token"": ""PBS"", ""start_span"": 101, ""end_span"": 104, ""type"": ""Chemical""}]"	valid
In conclusion, FAS - 1377 G - - > A polymorphism may be associated with an increased risk of lymph node metastasis in Korean cervical cancer patients.	FAS,15,18,Gene_or_gene_product	lymph node,93,103,Multi	cervical cancer,125,140,Cancer	patients,141,149,Organism	"[{""token"": ""FAS"", ""start_span"": 15, ""end_span"": 18, ""type"": ""Gene_or_gene_product""}, {""token"": ""lymph node"", ""start_span"": 93, ""end_span"": 103, ""type"": ""Multi""}, {""token"": ""cervical cancer"", ""start_span"": 125, ""end_span"": 140, ""type"": ""Cancer""}, {""token"": ""patients"", ""start_span"": 141, ""end_span"": 149, ""type"": ""Organism""}]"	valid
Survivin partially antagonized the growth suppressive function of N - myc in SH - EP neuroblastoma cells during serum deprivation whereas FLIP ( L) did not.	Survivin,0,8,Gene_or_gene_product	N - myc,66,73,Gene_or_gene_product	SH - EP neuroblastoma cells,77,104,Cell	serum,112,117,Organism_substance	"[{""token"": ""Survivin"", ""start_span"": 0, ""end_span"": 8, ""type"": ""Gene_or_gene_product""}, {""token"": ""N - myc"", ""start_span"": 66, ""end_span"": 73, ""type"": ""Gene_or_gene_product""}, {""token"": ""SH - EP neuroblastoma cells"", ""start_span"": 77, ""end_span"": 104, ""type"": ""Cell""}, {""token"": ""serum"", ""start_span"": 112, ""end_span"": 117, ""type"": ""Organism_substance""}]"	valid
In vivo, cediranib ( 6 mg / kg / d) prevented angiogenesis and lymphangiogenesis induced by VEGF - E - expressing and VEGF - C156S - expressing adenoviruses, respectively.	cediranib,9,18,Chemical	VEGF - E,92,100,Gene_or_gene_product	VEGF - C156S,118,130,Gene_or_gene_product	adenoviruses,144,156,Organism	"[{""token"": ""cediranib"", ""start_span"": 9, ""end_span"": 18, ""type"": ""Chemical""}, {""token"": ""VEGF - E"", ""start_span"": 92, ""end_span"": 100, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF - C156S"", ""start_span"": 118, ""end_span"": 130, ""type"": ""Gene_or_gene_product""}, {""token"": ""adenoviruses"", ""start_span"": 144, ""end_span"": 156, ""type"": ""Organism""}]"	valid
Cediranib may, therefore, be an effective means of preventing tumor progression, not only by inhibiting VEGFR - 2 activity and angiogenesis, but also by concomitantly inhibiting VEGFR - 3 activity and lymphangiogenesis.	Cediranib,0,9,Chemical	tumor,62,67,Cancer	VEGFR - 2,104,113,Gene_or_gene_product	VEGFR - 3,178,187,Gene_or_gene_product	"[{""token"": ""Cediranib"", ""start_span"": 0, ""end_span"": 9, ""type"": ""Chemical""}, {""token"": ""tumor"", ""start_span"": 62, ""end_span"": 67, ""type"": ""Cancer""}, {""token"": ""VEGFR - 2"", ""start_span"": 104, ""end_span"": 113, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGFR - 3"", ""start_span"": 178, ""end_span"": 187, ""type"": ""Gene_or_gene_product""}]"	valid
These data indicate that artemisinin may be useful for the prevention of lymph node metastasis by downregulating VEGF - C and reducing tumor lymphangiogenesis.	artemisinin,25,36,Chemical	lymph node,73,83,Multi	VEGF - C,113,121,Gene_or_gene_product	tumor,135,140,Cancer	"[{""token"": ""artemisinin"", ""start_span"": 25, ""end_span"": 36, ""type"": ""Chemical""}, {""token"": ""lymph node"", ""start_span"": 73, ""end_span"": 83, ""type"": ""Multi""}, {""token"": ""VEGF - C"", ""start_span"": 113, ""end_span"": 121, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumor"", ""start_span"": 135, ""end_span"": 140, ""type"": ""Cancer""}]"	valid
The authors report on a case series of 13 patients with recurrent heavily pretreated malignant glioma that was treated with the combination of bevacizumab and irinotecan.	patients,42,50,Organism	malignant glioma,85,101,Cancer	bevacizumab,143,154,Chemical	irinotecan,159,169,Chemical	"[{""token"": ""patients"", ""start_span"": 42, ""end_span"": 50, ""type"": ""Organism""}, {""token"": ""malignant glioma"", ""start_span"": 85, ""end_span"": 101, ""type"": ""Cancer""}, {""token"": ""bevacizumab"", ""start_span"": 143, ""end_span"": 154, ""type"": ""Chemical""}, {""token"": ""irinotecan"", ""start_span"": 159, ""end_span"": 169, ""type"": ""Chemical""}]"	valid
CONCLUSIONS: The combination of bevacizumab and irinotecan is safe and has excellent activity even in this relapsed, heavily pretreated population of patients with high - grade malignant glioma, most of whom would not be candidates for clinical trials.	bevacizumab,32,43,Chemical	irinotecan,48,58,Chemical	patients,150,158,Organism	malignant glioma,177,193,Cancer	"[{""token"": ""bevacizumab"", ""start_span"": 32, ""end_span"": 43, ""type"": ""Chemical""}, {""token"": ""irinotecan"", ""start_span"": 48, ""end_span"": 58, ""type"": ""Chemical""}, {""token"": ""patients"", ""start_span"": 150, ""end_span"": 158, ""type"": ""Organism""}, {""token"": ""malignant glioma"", ""start_span"": 177, ""end_span"": 193, ""type"": ""Cancer""}]"	valid
Anti - endosialin was capable of preventing pericyte tube formation in culture and inhibited migration.	Anti - endosialin,0,17,Gene_or_gene_product	pericyte,44,52,Cell	tube,53,57,Tissue	culture,71,78,Cell	"[{""token"": ""Anti - endosialin"", ""start_span"": 0, ""end_span"": 17, ""type"": ""Gene_or_gene_product""}, {""token"": ""pericyte"", ""start_span"": 44, ""end_span"": 52, ""type"": ""Cell""}, {""token"": ""tube"", ""start_span"": 53, ""end_span"": 57, ""type"": ""Tissue""}, {""token"": ""culture"", ""start_span"": 71, ""end_span"": 78, ""type"": ""Cell""}]"	valid
The data indicate that endosialin is strongly expressed by pericytes during periods of active angiogenesis during embryonic and tumor development.	endosialin,23,33,Gene_or_gene_product	pericytes,59,68,Cell	embryonic,114,123,Developing_anatomical_structure	tumor,128,133,Cancer	"[{""token"": ""endosialin"", ""start_span"": 23, ""end_span"": 33, ""type"": ""Gene_or_gene_product""}, {""token"": ""pericytes"", ""start_span"": 59, ""end_span"": 68, ""type"": ""Cell""}, {""token"": ""embryonic"", ""start_span"": 114, ""end_span"": 123, ""type"": ""Developing_anatomical_structure""}, {""token"": ""tumor"", ""start_span"": 128, ""end_span"": 133, ""type"": ""Cancer""}]"	valid
METHODS: Ovarian cancer SKOV3 cells were transfected with hPNAS - 4 - plasmid, and cell proliferation was evaluated by MTT assay; apoptosis was examined by DNA ladder, Hoechst33258 staining and flow - cytometric assays.	Ovarian cancer SKOV3 cells,9,35,Cell	hPNAS - 4,58,67,Gene_or_gene_product	cell,83,87,Cell	DNA,156,159,Cellular_component	"[{""token"": ""Ovarian cancer SKOV3 cells"", ""start_span"": 9, ""end_span"": 35, ""type"": ""Cell""}, {""token"": ""hPNAS - 4"", ""start_span"": 58, ""end_span"": 67, ""type"": ""Gene_or_gene_product""}, {""token"": ""cell"", ""start_span"": 83, ""end_span"": 87, ""type"": ""Cell""}, {""token"": ""DNA"", ""start_span"": 156, ""end_span"": 159, ""type"": ""Cellular_component""}]"	valid
Nude mice bearing ovarian cancers were treated with hPNAS - 4 - p / liposome.	Nude mice,0,9,Organism	ovarian cancers,18,33,Cancer	hPNAS - 4,52,61,Gene_or_gene_product	liposome,68,76,Chemical	"[{""token"": ""Nude mice"", ""start_span"": 0, ""end_span"": 9, ""type"": ""Organism""}, {""token"": ""ovarian cancers"", ""start_span"": 18, ""end_span"": 33, ""type"": ""Cancer""}, {""token"": ""hPNAS - 4"", ""start_span"": 52, ""end_span"": 61, ""type"": ""Gene_or_gene_product""}, {""token"": ""liposome"", ""start_span"": 68, ""end_span"": 76, ""type"": ""Chemical""}]"	valid
The objective of this study was to ascertain whether STX243 is more active in vivo than the clinically relevant drug 2 - methoxyoestradiol ( 2 - MeOE2) and the structurally similar compound 2 - MeOE2 - 3, 17 - O, O - bis - sulphamate ( STX140).	STX243,53,59,Chemical	2 - methoxyoestradiol,117,138,Chemical	2 - MeOE2,141,150,Chemical	STX140,236,242,Chemical	"[{""token"": ""STX243"", ""start_span"": 53, ""end_span"": 59, ""type"": ""Chemical""}, {""token"": ""2 - methoxyoestradiol"", ""start_span"": 117, ""end_span"": 138, ""type"": ""Chemical""}, {""token"": ""2 - MeOE2"", ""start_span"": 141, ""end_span"": 150, ""type"": ""Chemical""}, {""token"": ""STX140"", ""start_span"": 236, ""end_span"": 242, ""type"": ""Chemical""}]"	valid
Both STX243 and STX140 were capable of retarding the growth of MDA - MB - 231 xenograft tumours ( 72 and 63%, respectively), whereas no inhibition was observed for animals treated with 2 - MeOE2.	STX243,5,11,Chemical	STX140,16,22,Chemical	MDA - MB - 231 xenograft tumours,63,95,Cancer	2 - MeOE2,185,194,Chemical	"[{""token"": ""STX243"", ""start_span"": 5, ""end_span"": 11, ""type"": ""Chemical""}, {""token"": ""STX140"", ""start_span"": 16, ""end_span"": 22, ""type"": ""Chemical""}, {""token"": ""MDA - MB - 231 xenograft tumours"", ""start_span"": 63, ""end_span"": 95, ""type"": ""Cancer""}, {""token"": ""2 - MeOE2"", ""start_span"": 185, ""end_span"": 194, ""type"": ""Chemical""}]"	valid
GSE could also inhibit the VEGF receptor / mitogen - activated protein kinase - mediated signaling pathway in endothelial cells.	GSE,0,3,Organism_substance	VEGF receptor,27,40,Gene_or_gene_product	mitogen - activated protein kinase,43,77,Gene_or_gene_product	endothelial cells,110,127,Cell	"[{""token"": ""GSE"", ""start_span"": 0, ""end_span"": 3, ""type"": ""Organism_substance""}, {""token"": ""VEGF receptor"", ""start_span"": 27, ""end_span"": 40, ""type"": ""Gene_or_gene_product""}, {""token"": ""mitogen - activated protein kinase"", ""start_span"": 43, ""end_span"": 77, ""type"": ""Gene_or_gene_product""}, {""token"": ""endothelial cells"", ""start_span"": 110, ""end_span"": 127, ""type"": ""Cell""}]"	valid
Role of the interferon - inducible IFI16 gene in the induction of ICAM - 1 by TNF - alpha.	interferon,12,22,Gene_or_gene_product	IFI16,35,40,Gene_or_gene_product	ICAM - 1,66,74,Gene_or_gene_product	TNF - alpha,78,89,Gene_or_gene_product	"[{""token"": ""interferon"", ""start_span"": 12, ""end_span"": 22, ""type"": ""Gene_or_gene_product""}, {""token"": ""IFI16"", ""start_span"": 35, ""end_span"": 40, ""type"": ""Gene_or_gene_product""}, {""token"": ""ICAM - 1"", ""start_span"": 66, ""end_span"": 74, ""type"": ""Gene_or_gene_product""}, {""token"": ""TNF - alpha"", ""start_span"": 78, ""end_span"": 89, ""type"": ""Gene_or_gene_product""}]"	valid
In the current study, the impact of VEGF expression on the response of tumors to the VEGFR2 associated tyrosine kinase inhibitor vandetanib was evaluated.	VEGF,36,40,Gene_or_gene_product	tumors,71,77,Cancer	VEGFR2,85,91,Gene_or_gene_product	vandetanib,129,139,Chemical	"[{""token"": ""VEGF"", ""start_span"": 36, ""end_span"": 40, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumors"", ""start_span"": 71, ""end_span"": 77, ""type"": ""Cancer""}, {""token"": ""VEGFR2"", ""start_span"": 85, ""end_span"": 91, ""type"": ""Gene_or_gene_product""}, {""token"": ""vandetanib"", ""start_span"": 129, ""end_span"": 139, ""type"": ""Chemical""}]"	valid
RESULTS: Vandetanib treatment had no effect on tumor cell clonogenic cell survival in vitro but doses > or = 10 nM significantly reduced endothelial cell migration.	Vandetanib,9,19,Chemical	tumor cell,47,57,Cell	cell,69,73,Cell	endothelial cell,137,153,Cell	"[{""token"": ""Vandetanib"", ""start_span"": 9, ""end_span"": 19, ""type"": ""Chemical""}, {""token"": ""tumor cell"", ""start_span"": 47, ""end_span"": 57, ""type"": ""Cell""}, {""token"": ""cell"", ""start_span"": 69, ""end_span"": 73, ""type"": ""Cell""}, {""token"": ""endothelial cell"", ""start_span"": 137, ""end_span"": 153, ""type"": ""Cell""}]"	valid
c - Ski overexpression promotes tumor growth and angiogenesis through inhibition of transforming growth factor - beta signaling in diffuse - type gastric carcinoma.	c - Ski,0,7,Gene_or_gene_product	tumor,32,37,Cancer	transforming growth factor - beta,84,117,Gene_or_gene_product	gastric carcinoma,146,163,Cancer	"[{""token"": ""c - Ski"", ""start_span"": 0, ""end_span"": 7, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumor"", ""start_span"": 32, ""end_span"": 37, ""type"": ""Cancer""}, {""token"": ""transforming growth factor - beta"", ""start_span"": 84, ""end_span"": 117, ""type"": ""Gene_or_gene_product""}, {""token"": ""gastric carcinoma"", ""start_span"": 146, ""end_span"": 163, ""type"": ""Cancer""}]"	valid
c - Ski, originally identified as a proto - oncogene product, is an important negative regulator of transforming growth factor ( TGF) - beta family signaling through interaction with Smad2, Smad3, and Smad4.	c - Ski,0,7,Gene_or_gene_product	Smad2,183,188,Gene_or_gene_product	Smad3,190,195,Gene_or_gene_product	Smad4,201,206,Gene_or_gene_product	"[{""token"": ""c - Ski"", ""start_span"": 0, ""end_span"": 7, ""type"": ""Gene_or_gene_product""}, {""token"": ""Smad2"", ""start_span"": 183, ""end_span"": 188, ""type"": ""Gene_or_gene_product""}, {""token"": ""Smad3"", ""start_span"": 190, ""end_span"": 195, ""type"": ""Gene_or_gene_product""}, {""token"": ""Smad4"", ""start_span"": 201, ""end_span"": 206, ""type"": ""Gene_or_gene_product""}]"	valid
Here, we examined the function of c - Ski in human diffuse - type gastric carcinoma OCUM - 2MLN cells.	c - Ski,34,41,Gene_or_gene_product	human,45,50,Organism	gastric carcinoma,66,83,Cancer	OCUM - 2MLN cells,84,101,Cell	"[{""token"": ""c - Ski"", ""start_span"": 34, ""end_span"": 41, ""type"": ""Gene_or_gene_product""}, {""token"": ""human"", ""start_span"": 45, ""end_span"": 50, ""type"": ""Organism""}, {""token"": ""gastric carcinoma"", ""start_span"": 66, ""end_span"": 83, ""type"": ""Cancer""}, {""token"": ""OCUM - 2MLN cells"", ""start_span"": 84, ""end_span"": 101, ""type"": ""Cell""}]"	valid
We previously reported that VEGF induces DSCR - 1s expression in endothelial cells, which in turn negatively feeds back to attenuate endothelial cell activation.	VEGF,28,32,Gene_or_gene_product	DSCR - 1s,41,50,Gene_or_gene_product	endothelial cells,65,82,Cell	endothelial cell,133,149,Cell	"[{""token"": ""VEGF"", ""start_span"": 28, ""end_span"": 32, ""type"": ""Gene_or_gene_product""}, {""token"": ""DSCR - 1s"", ""start_span"": 41, ""end_span"": 50, ""type"": ""Gene_or_gene_product""}, {""token"": ""endothelial cells"", ""start_span"": 65, ""end_span"": 82, ""type"": ""Cell""}, {""token"": ""endothelial cell"", ""start_span"": 133, ""end_span"": 149, ""type"": ""Cell""}]"	valid
Collectively, these data suggest that the DSCR1s promoter directs vascular bed - specific expression in activated endothelium and that DSCR - 1s serves to dampen the host response to infection.	DSCR1s,42,48,Gene_or_gene_product	vascular bed,66,78,Multi	endothelium,114,125,Tissue	DSCR - 1s,135,144,Gene_or_gene_product	"[{""token"": ""DSCR1s"", ""start_span"": 42, ""end_span"": 48, ""type"": ""Gene_or_gene_product""}, {""token"": ""vascular bed"", ""start_span"": 66, ""end_span"": 78, ""type"": ""Multi""}, {""token"": ""endothelium"", ""start_span"": 114, ""end_span"": 125, ""type"": ""Tissue""}, {""token"": ""DSCR - 1s"", ""start_span"": 135, ""end_span"": 144, ""type"": ""Gene_or_gene_product""}]"	valid
A portion of bilateral radial bones of a rabbit were removed as free bone grafts, whose periostea were peeled off.	bilateral radial bones,13,35,Organ	rabbit,41,47,Organism	bone grafts,69,80,Multi	periostea,88,97,Tissue	"[{""token"": ""bilateral radial bones"", ""start_span"": 13, ""end_span"": 35, ""type"": ""Organ""}, {""token"": ""rabbit"", ""start_span"": 41, ""end_span"": 47, ""type"": ""Organism""}, {""token"": ""bone grafts"", ""start_span"": 69, ""end_span"": 80, ""type"": ""Multi""}, {""token"": ""periostea"", ""start_span"": 88, ""end_span"": 97, ""type"": ""Tissue""}]"	valid
Here, we demonstrate that D2 dopamine receptor ( D2DR) colocalizes with VEGFR - 2 at the cell surface.	D2 dopamine receptor,26,46,Gene_or_gene_product	D2DR,49,53,Gene_or_gene_product	VEGFR - 2,72,81,Gene_or_gene_product	cell surface,89,101,Cellular_component	"[{""token"": ""D2 dopamine receptor"", ""start_span"": 26, ""end_span"": 46, ""type"": ""Gene_or_gene_product""}, {""token"": ""D2DR"", ""start_span"": 49, ""end_span"": 53, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGFR - 2"", ""start_span"": 72, ""end_span"": 81, ""type"": ""Gene_or_gene_product""}, {""token"": ""cell surface"", ""start_span"": 89, ""end_span"": 101, ""type"": ""Cellular_component""}]"	valid
Dopamine administration leads to increased VEGF - induced phosphorylation of SHP - 2 and this increased phosphorylation parallels the increased phosphatase activity of SHP - 2.	Dopamine,0,8,Chemical	VEGF,43,47,Gene_or_gene_product	SHP - 2,77,84,Gene_or_gene_product	SHP - 2,168,175,Gene_or_gene_product	"[{""token"": ""Dopamine"", ""start_span"": 0, ""end_span"": 8, ""type"": ""Chemical""}, {""token"": ""VEGF"", ""start_span"": 43, ""end_span"": 47, ""type"": ""Gene_or_gene_product""}, {""token"": ""SHP - 2"", ""start_span"": 77, ""end_span"": 84, ""type"": ""Gene_or_gene_product""}, {""token"": ""SHP - 2"", ""start_span"": 168, ""end_span"": 175, ""type"": ""Gene_or_gene_product""}]"	valid
Glioma tumor stem - like cells promote tumor angiogenesis and vasculogenesis via vascular endothelial growth factor and stromal - derived factor 1.	Glioma tumor stem - like cells,0,30,Cell	tumor,39,44,Cancer	vascular endothelial growth factor,81,115,Gene_or_gene_product	stromal - derived factor 1,120,146,Gene_or_gene_product	"[{""token"": ""Glioma tumor stem - like cells"", ""start_span"": 0, ""end_span"": 30, ""type"": ""Cell""}, {""token"": ""tumor"", ""start_span"": 39, ""end_span"": 44, ""type"": ""Cancer""}, {""token"": ""vascular endothelial growth factor"", ""start_span"": 81, ""end_span"": 115, ""type"": ""Gene_or_gene_product""}, {""token"": ""stromal - derived factor 1"", ""start_span"": 120, ""end_span"": 146, ""type"": ""Gene_or_gene_product""}]"	valid
CSC - high C6 cell cultures also induced higher levels of endothelial cell proliferation and tubule organization in vitro compared with CSC - low cultures.	CSC - high C6 cell cultures,0,27,Cell	endothelial cell,58,74,Cell	tubule,93,99,Tissue	CSC - low cultures,136,154,Cell	"[{""token"": ""CSC - high C6 cell cultures"", ""start_span"": 0, ""end_span"": 27, ""type"": ""Cell""}, {""token"": ""endothelial cell"", ""start_span"": 58, ""end_span"": 74, ""type"": ""Cell""}, {""token"": ""tubule"", ""start_span"": 93, ""end_span"": 99, ""type"": ""Tissue""}, {""token"": ""CSC - low cultures"", ""start_span"": 136, ""end_span"": 154, ""type"": ""Cell""}]"	valid
It is hypothesized that the NO derived from inducible NOS ( iNOS) may promote survival of ischemic tissue through angiogenesis.	NO,28,30,Chemical	inducible NOS,44,57,Gene_or_gene_product	iNOS,60,64,Gene_or_gene_product	ischemic tissue,90,105,Tissue	"[{""token"": ""NO"", ""start_span"": 28, ""end_span"": 30, ""type"": ""Chemical""}, {""token"": ""inducible NOS"", ""start_span"": 44, ""end_span"": 57, ""type"": ""Gene_or_gene_product""}, {""token"": ""iNOS"", ""start_span"": 60, ""end_span"": 64, ""type"": ""Gene_or_gene_product""}, {""token"": ""ischemic tissue"", ""start_span"": 90, ""end_span"": 105, ""type"": ""Tissue""}]"	valid
In groups 1 & 2, hindlimb ischemia was induced by ligation of femoral artery and they received L - NIL and saline respectively.	hindlimb,17,25,Organism_subdivision	femoral artery,62,76,Multi	L - NIL,95,102,Chemical	saline,107,113,Chemical	"[{""token"": ""hindlimb"", ""start_span"": 17, ""end_span"": 25, ""type"": ""Organism_subdivision""}, {""token"": ""femoral artery"", ""start_span"": 62, ""end_span"": 76, ""type"": ""Multi""}, {""token"": ""L - NIL"", ""start_span"": 95, ""end_span"": 102, ""type"": ""Chemical""}, {""token"": ""saline"", ""start_span"": 107, ""end_span"": 113, ""type"": ""Chemical""}]"	valid
After 21 days, the serum concentration of nitrite, capillary density and expression of HIF1alpha were determined.	serum,19,24,Organism_substance	nitrite,42,49,Chemical	capillary,51,60,Tissue	HIF1alpha,87,96,Gene_or_gene_product	"[{""token"": ""serum"", ""start_span"": 19, ""end_span"": 24, ""type"": ""Organism_substance""}, {""token"": ""nitrite"", ""start_span"": 42, ""end_span"": 49, ""type"": ""Chemical""}, {""token"": ""capillary"", ""start_span"": 51, ""end_span"": 60, ""type"": ""Tissue""}, {""token"": ""HIF1alpha"", ""start_span"": 87, ""end_span"": 96, ""type"": ""Gene_or_gene_product""}]"	valid
The capillary density in group 1 ( ischemia + L - NIL) was significantly different from group 2 ( ischemia + saline); group 1: 360. 33 + / - 77. 02, group 2: 549 + / - 81. 85 / mm2, p < 0. 05). In addition, expression of HIF1alpha was significantly increased in ischemic groups ( p < 0. 05).	capillary,4,13,Tissue	L - NIL,46,53,Chemical	saline,109,115,Chemical	HIF1alpha,221,230,Gene_or_gene_product	"[{""token"": ""capillary"", ""start_span"": 4, ""end_span"": 13, ""type"": ""Tissue""}, {""token"": ""L - NIL"", ""start_span"": 46, ""end_span"": 53, ""type"": ""Chemical""}, {""token"": ""saline"", ""start_span"": 109, ""end_span"": 115, ""type"": ""Chemical""}, {""token"": ""HIF1alpha"", ""start_span"": 221, ""end_span"": 230, ""type"": ""Gene_or_gene_product""}]"	valid
CONCLUSION: Selective inhibition of iNOS by L - NIL inhibits angiogenesis in a hindlimb ischemic rat model.	iNOS,36,40,Gene_or_gene_product	L - NIL,44,51,Chemical	hindlimb,79,87,Organism_subdivision	rat,97,100,Organism	"[{""token"": ""iNOS"", ""start_span"": 36, ""end_span"": 40, ""type"": ""Gene_or_gene_product""}, {""token"": ""L - NIL"", ""start_span"": 44, ""end_span"": 51, ""type"": ""Chemical""}, {""token"": ""hindlimb"", ""start_span"": 79, ""end_span"": 87, ""type"": ""Organism_subdivision""}, {""token"": ""rat"", ""start_span"": 97, ""end_span"": 100, ""type"": ""Organism""}]"	valid
Treatment of cells with PKC inhibitors also potentiated anchorage - independent growth of BPDE treated cells on soft agar.	cells,13,18,Cell	PKC,24,27,Gene_or_gene_product	BPDE,90,94,Chemical	cells,103,108,Cell	"[{""token"": ""cells"", ""start_span"": 13, ""end_span"": 18, ""type"": ""Cell""}, {""token"": ""PKC"", ""start_span"": 24, ""end_span"": 27, ""type"": ""Gene_or_gene_product""}, {""token"": ""BPDE"", ""start_span"": 90, ""end_span"": 94, ""type"": ""Chemical""}, {""token"": ""cells"", ""start_span"": 103, ""end_span"": 108, ""type"": ""Cell""}]"	valid
Sequence analysis of CDC4 / FBXW7 was carried out on gastric carcinoma cell lines and xenografts.	CDC4,21,25,Gene_or_gene_product	FBXW7,28,33,Gene_or_gene_product	gastric carcinoma cell lines,53,81,Cell	xenografts,86,96,Cancer	"[{""token"": ""CDC4"", ""start_span"": 21, ""end_span"": 25, ""type"": ""Gene_or_gene_product""}, {""token"": ""FBXW7"", ""start_span"": 28, ""end_span"": 33, ""type"": ""Gene_or_gene_product""}, {""token"": ""gastric carcinoma cell lines"", ""start_span"": 53, ""end_span"": 81, ""type"": ""Cell""}, {""token"": ""xenografts"", ""start_span"": 86, ""end_span"": 96, ""type"": ""Cancer""}]"	valid
No CDC4 / FBXW7 mutations were found and loss of CDC4 / FBXW7 did not correlate with ploidy status.	CDC4,3,7,Gene_or_gene_product	FBXW7,10,15,Gene_or_gene_product	CDC4,49,53,Gene_or_gene_product	FBXW7,56,61,Gene_or_gene_product	"[{""token"": ""CDC4"", ""start_span"": 3, ""end_span"": 7, ""type"": ""Gene_or_gene_product""}, {""token"": ""FBXW7"", ""start_span"": 10, ""end_span"": 15, ""type"": ""Gene_or_gene_product""}, {""token"": ""CDC4"", ""start_span"": 49, ""end_span"": 53, ""type"": ""Gene_or_gene_product""}, {""token"": ""FBXW7"", ""start_span"": 56, ""end_span"": 61, ""type"": ""Gene_or_gene_product""}]"	valid
Overexpression of Bax inhibitor - 1 ( BI - 1) induces cell transformation in NIH3T3 cells.	Bax inhibitor - 1,18,35,Gene_or_gene_product	BI - 1,38,44,Gene_or_gene_product	cell,54,58,Cell	NIH3T3 cells,77,89,Cell	"[{""token"": ""Bax inhibitor - 1"", ""start_span"": 18, ""end_span"": 35, ""type"": ""Gene_or_gene_product""}, {""token"": ""BI - 1"", ""start_span"": 38, ""end_span"": 44, ""type"": ""Gene_or_gene_product""}, {""token"": ""cell"", ""start_span"": 54, ""end_span"": 58, ""type"": ""Cell""}, {""token"": ""NIH3T3 cells"", ""start_span"": 77, ""end_span"": 89, ""type"": ""Cell""}]"	valid
The expression of MMP - 2 / 9 of AGS cells was inhibited by 2. 0 microM of GA.	MMP - 2,18,25,Gene_or_gene_product	9,28,29,Gene_or_gene_product	AGS cells,33,42,Cell	GA,75,77,Chemical	"[{""token"": ""MMP - 2"", ""start_span"": 18, ""end_span"": 25, ""type"": ""Gene_or_gene_product""}, {""token"": ""9"", ""start_span"": 28, ""end_span"": 29, ""type"": ""Gene_or_gene_product""}, {""token"": ""AGS cells"", ""start_span"": 33, ""end_span"": 42, ""type"": ""Cell""}, {""token"": ""GA"", ""start_span"": 75, ""end_span"": 77, ""type"": ""Chemical""}]"	valid
It is possible that the suppressive effect of GA on MMP - 2 / 9 might involve the inhibition of NF - kappaB activity.	GA,46,48,Chemical	MMP - 2,52,59,Gene_or_gene_product	9,62,63,Gene_or_gene_product	NF - kappaB,96,107,Gene_or_gene_product	"[{""token"": ""GA"", ""start_span"": 46, ""end_span"": 48, ""type"": ""Chemical""}, {""token"": ""MMP - 2"", ""start_span"": 52, ""end_span"": 59, ""type"": ""Gene_or_gene_product""}, {""token"": ""9"", ""start_span"": 62, ""end_span"": 63, ""type"": ""Gene_or_gene_product""}, {""token"": ""NF - kappaB"", ""start_span"": 96, ""end_span"": 107, ""type"": ""Gene_or_gene_product""}]"	valid
p - XSC also decreases Akt phosphorylation as well as Akt - specific phosphorylation of the AR.	p - XSC,0,7,Chemical	Akt,23,26,Gene_or_gene_product	Akt,54,57,Gene_or_gene_product	AR,92,94,Gene_or_gene_product	"[{""token"": ""p - XSC"", ""start_span"": 0, ""end_span"": 7, ""type"": ""Chemical""}, {""token"": ""Akt"", ""start_span"": 23, ""end_span"": 26, ""type"": ""Gene_or_gene_product""}, {""token"": ""Akt"", ""start_span"": 54, ""end_span"": 57, ""type"": ""Gene_or_gene_product""}, {""token"": ""AR"", ""start_span"": 92, ""end_span"": 94, ""type"": ""Gene_or_gene_product""}]"	valid
It activated multicaspases, and increased the activities of caspase - 8 and caspase - 9 in both MG - 63 and SaOS - 2 cells.	caspase - 8,60,71,Gene_or_gene_product	caspase - 9,76,87,Gene_or_gene_product	MG - 63,96,103,Cell	SaOS - 2 cells,108,122,Cell	"[{""token"": ""caspase - 8"", ""start_span"": 60, ""end_span"": 71, ""type"": ""Gene_or_gene_product""}, {""token"": ""caspase - 9"", ""start_span"": 76, ""end_span"": 87, ""type"": ""Gene_or_gene_product""}, {""token"": ""MG - 63"", ""start_span"": 96, ""end_span"": 103, ""type"": ""Cell""}, {""token"": ""SaOS - 2 cells"", ""start_span"": 108, ""end_span"": 122, ""type"": ""Cell""}]"	valid
Thymosin beta - 4 ( TB4) is an actin - sequestering protein to control cytoskeletal reorganization.	Thymosin beta - 4,0,17,Gene_or_gene_product	TB4,20,23,Gene_or_gene_product	actin,31,36,Gene_or_gene_product	cytoskeletal,71,83,Cellular_component	"[{""token"": ""Thymosin beta - 4"", ""start_span"": 0, ""end_span"": 17, ""type"": ""Gene_or_gene_product""}, {""token"": ""TB4"", ""start_span"": 20, ""end_span"": 23, ""type"": ""Gene_or_gene_product""}, {""token"": ""actin"", ""start_span"": 31, ""end_span"": 36, ""type"": ""Gene_or_gene_product""}, {""token"": ""cytoskeletal"", ""start_span"": 71, ""end_span"": 83, ""type"": ""Cellular_component""}]"	valid
We also found an increase of tumor growth and lung metastasis count in TB4 - Tg mice as compared to wildtype mice.	tumor,29,34,Cancer	lung,46,50,Organ	TB4,71,74,Gene_or_gene_product	mice,80,84,Organism	"[{""token"": ""tumor"", ""start_span"": 29, ""end_span"": 34, ""type"": ""Cancer""}, {""token"": ""lung"", ""start_span"": 46, ""end_span"": 50, ""type"": ""Organ""}, {""token"": ""TB4"", ""start_span"": 71, ""end_span"": 74, ""type"": ""Gene_or_gene_product""}, {""token"": ""mice"", ""start_span"": 80, ""end_span"": 84, ""type"": ""Organism""}]"	valid
Androgen stimulates glycolysis for de novo lipid synthesis by increasing the activities of hexokinase 2 and 6 - phosphofructo - 2 - kinase / fructose - 2, 6 - bisphosphatase 2 in prostate cancer cells.	Androgen,0,8,Chemical	lipid,43,48,Chemical	hexokinase 2,91,103,Gene_or_gene_product	prostate cancer cells,179,200,Cell	"[{""token"": ""Androgen"", ""start_span"": 0, ""end_span"": 8, ""type"": ""Chemical""}, {""token"": ""lipid"", ""start_span"": 43, ""end_span"": 48, ""type"": ""Chemical""}, {""token"": ""hexokinase 2"", ""start_span"": 91, ""end_span"": 103, ""type"": ""Gene_or_gene_product""}, {""token"": ""prostate cancer cells"", ""start_span"": 179, ""end_span"": 200, ""type"": ""Cell""}]"	valid
Glucose uptake and lipogenesis were severely blocked by knocking - down of PFKFB2 using siRNA ( small interfering RNA) or by inhibition of PFK - 2 activity with LY294002 treatment.	Glucose,0,7,Chemical	PFKFB2,75,81,Gene_or_gene_product	PFK - 2,139,146,Gene_or_gene_product	LY294002,161,169,Chemical	"[{""token"": ""Glucose"", ""start_span"": 0, ""end_span"": 7, ""type"": ""Chemical""}, {""token"": ""PFKFB2"", ""start_span"": 75, ""end_span"": 81, ""type"": ""Gene_or_gene_product""}, {""token"": ""PFK - 2"", ""start_span"": 139, ""end_span"": 146, ""type"": ""Gene_or_gene_product""}, {""token"": ""LY294002"", ""start_span"": 161, ""end_span"": 169, ""type"": ""Chemical""}]"	valid
Our earlier studies showed that DATS induced apoptosis in human colon cancer HT29 and colo 205 cell lines in vitro.	DATS,32,36,Chemical	human,58,63,Organism	colon cancer HT29,64,81,Cell	colo 205 cell lines,86,105,Cell	"[{""token"": ""DATS"", ""start_span"": 32, ""end_span"": 36, ""type"": ""Chemical""}, {""token"": ""human"", ""start_span"": 58, ""end_span"": 63, ""type"": ""Organism""}, {""token"": ""colon cancer HT29"", ""start_span"": 64, ""end_span"": 81, ""type"": ""Cell""}, {""token"": ""colo 205 cell lines"", ""start_span"": 86, ""end_span"": 105, ""type"": ""Cell""}]"	valid
Tumor volume and total hemoglobin in allograft mice treated with 50 mg / kg DATS were significantly smaller than that in the control group.	Tumor,0,5,Cancer	hemoglobin,23,33,Gene_or_gene_product	mice,47,51,Organism	DATS,76,80,Chemical	"[{""token"": ""Tumor"", ""start_span"": 0, ""end_span"": 5, ""type"": ""Cancer""}, {""token"": ""hemoglobin"", ""start_span"": 23, ""end_span"": 33, ""type"": ""Gene_or_gene_product""}, {""token"": ""mice"", ""start_span"": 47, ""end_span"": 51, ""type"": ""Organism""}, {""token"": ""DATS"", ""start_span"": 76, ""end_span"": 80, ""type"": ""Chemical""}]"	valid
The high - mobility group A2 gene ( HMGA2) is one of the most frequently amplified genes in human cancers.	high - mobility group A2,4,28,Gene_or_gene_product	HMGA2,36,41,Gene_or_gene_product	human,92,97,Organism	cancers,98,105,Cancer	"[{""token"": ""high - mobility group A2"", ""start_span"": 4, ""end_span"": 28, ""type"": ""Gene_or_gene_product""}, {""token"": ""HMGA2"", ""start_span"": 36, ""end_span"": 41, ""type"": ""Gene_or_gene_product""}, {""token"": ""human"", ""start_span"": 92, ""end_span"": 97, ""type"": ""Organism""}, {""token"": ""cancers"", ""start_span"": 98, ""end_span"": 105, ""type"": ""Cancer""}]"	valid
Importantly, HMGA2 partially replaces the function of hTERT during the tumorigenic transformation of normal human fibroblasts.	HMGA2,13,18,Gene_or_gene_product	hTERT,54,59,Gene_or_gene_product	human,108,113,Organism	fibroblasts,114,125,Cell	"[{""token"": ""HMGA2"", ""start_span"": 13, ""end_span"": 18, ""type"": ""Gene_or_gene_product""}, {""token"": ""hTERT"", ""start_span"": 54, ""end_span"": 59, ""type"": ""Gene_or_gene_product""}, {""token"": ""human"", ""start_span"": 108, ""end_span"": 113, ""type"": ""Organism""}, {""token"": ""fibroblasts"", ""start_span"": 114, ""end_span"": 125, ""type"": ""Cell""}]"	valid
These findings are potentially clinically relevant, because HMGA2 expression is reported to be upregulated in a number of human cancers as telomere maintenance is essential for tumorigenesis.	HMGA2,60,65,Gene_or_gene_product	human,122,127,Organism	cancers,128,135,Cancer	telomere,139,147,Cellular_component	"[{""token"": ""HMGA2"", ""start_span"": 60, ""end_span"": 65, ""type"": ""Gene_or_gene_product""}, {""token"": ""human"", ""start_span"": 122, ""end_span"": 127, ""type"": ""Organism""}, {""token"": ""cancers"", ""start_span"": 128, ""end_span"": 135, ""type"": ""Cancer""}, {""token"": ""telomere"", ""start_span"": 139, ""end_span"": 147, ""type"": ""Cellular_component""}]"	valid
Furthermore, we found a significant association between tumour location, tumour grade and node status and the methylation status of the APC gene ( p < = 0. 05).	tumour,56,62,Cancer	tumour,73,79,Cancer	node,90,94,Multi	APC,136,139,Gene_or_gene_product	"[{""token"": ""tumour"", ""start_span"": 56, ""end_span"": 62, ""type"": ""Cancer""}, {""token"": ""tumour"", ""start_span"": 73, ""end_span"": 79, ""type"": ""Cancer""}, {""token"": ""node"", ""start_span"": 90, ""end_span"": 94, ""type"": ""Multi""}, {""token"": ""APC"", ""start_span"": 136, ""end_span"": 139, ""type"": ""Gene_or_gene_product""}]"	valid
Notably, AglRhz inhibits insulin - like growth factor ( IGF) - 1 - induced AP - 1 activity and cell transformation in JB6 Cl41 cells.	AglRhz,9,15,Chemical	AP - 1,75,81,Gene_or_gene_product	cell,95,99,Cell	JB6 Cl41 cells,118,132,Cell	"[{""token"": ""AglRhz"", ""start_span"": 9, ""end_span"": 15, ""type"": ""Chemical""}, {""token"": ""AP - 1"", ""start_span"": 75, ""end_span"": 81, ""type"": ""Gene_or_gene_product""}, {""token"": ""cell"", ""start_span"": 95, ""end_span"": 99, ""type"": ""Cell""}, {""token"": ""JB6 Cl41 cells"", ""start_span"": 118, ""end_span"": 132, ""type"": ""Cell""}]"	valid
Oral squamous cell carcinoma ( OSCC) often metastasizes to the lymph nodes, and these enzymes may be significant in the survival of patients with this disease.	Oral squamous cell carcinoma,0,28,Cancer	OSCC,31,35,Cancer	lymph nodes,63,74,Multi	patients,132,140,Organism	"[{""token"": ""Oral squamous cell carcinoma"", ""start_span"": 0, ""end_span"": 28, ""type"": ""Cancer""}, {""token"": ""OSCC"", ""start_span"": 31, ""end_span"": 35, ""type"": ""Cancer""}, {""token"": ""lymph nodes"", ""start_span"": 63, ""end_span"": 74, ""type"": ""Multi""}, {""token"": ""patients"", ""start_span"": 132, ""end_span"": 140, ""type"": ""Organism""}]"	valid
TS and DPD proteins were overexpressed in primary OSCC compared to that in normal mucosa.	TS,0,2,Gene_or_gene_product	DPD,7,10,Gene_or_gene_product	primary OSCC,42,54,Cancer	mucosa,82,88,Multi	"[{""token"": ""TS"", ""start_span"": 0, ""end_span"": 2, ""type"": ""Gene_or_gene_product""}, {""token"": ""DPD"", ""start_span"": 7, ""end_span"": 10, ""type"": ""Gene_or_gene_product""}, {""token"": ""primary OSCC"", ""start_span"": 42, ""end_span"": 54, ""type"": ""Cancer""}, {""token"": ""mucosa"", ""start_span"": 82, ""end_span"": 88, ""type"": ""Multi""}]"	valid
DPD expression did not significantly correlate with the occurrence of lymph node metastasis, nor was it different between primary oral cancer cells and cervical metastases.	DPD,0,3,Gene_or_gene_product	lymph node,70,80,Multi	oral cancer cells,130,147,Cell	cervical,152,160,Multi	"[{""token"": ""DPD"", ""start_span"": 0, ""end_span"": 3, ""type"": ""Gene_or_gene_product""}, {""token"": ""lymph node"", ""start_span"": 70, ""end_span"": 80, ""type"": ""Multi""}, {""token"": ""oral cancer cells"", ""start_span"": 130, ""end_span"": 147, ""type"": ""Cell""}, {""token"": ""cervical"", ""start_span"": 152, ""end_span"": 160, ""type"": ""Multi""}]"	valid
Simian virus 40 ( SV40) is a powerful tool to study cellular transformation in vitro, as well as tumor development and progression in vivo.	Simian virus 40,0,15,Organism	SV40,18,22,Organism	cellular,52,60,Cell	tumor,97,102,Cancer	"[{""token"": ""Simian virus 40"", ""start_span"": 0, ""end_span"": 15, ""type"": ""Organism""}, {""token"": ""SV40"", ""start_span"": 18, ""end_span"": 22, ""type"": ""Organism""}, {""token"": ""cellular"", ""start_span"": 52, ""end_span"": 60, ""type"": ""Cell""}, {""token"": ""tumor"", ""start_span"": 97, ""end_span"": 102, ""type"": ""Cancer""}]"	valid
However, tumor incidence was lower and life span was significantly longer in WAP - mutCK1delta / WAP - T bi - transgenic animals.	tumor,9,14,Cancer	WAP,77,80,Gene_or_gene_product	mutCK1delta,83,94,Gene_or_gene_product	WAP,97,100,Gene_or_gene_product	"[{""token"": ""tumor"", ""start_span"": 9, ""end_span"": 14, ""type"": ""Cancer""}, {""token"": ""WAP"", ""start_span"": 77, ""end_span"": 80, ""type"": ""Gene_or_gene_product""}, {""token"": ""mutCK1delta"", ""start_span"": 83, ""end_span"": 94, ""type"": ""Gene_or_gene_product""}, {""token"": ""WAP"", ""start_span"": 97, ""end_span"": 100, ""type"": ""Gene_or_gene_product""}]"	valid
Multi - step neoplastic transformation of normal human fibroblasts by Co - 60 gamma rays and Ha - ras oncogenes.	human,49,54,Organism	fibroblasts,55,66,Cell	Co - 60,70,77,Chemical	Ha - ras,93,101,Gene_or_gene_product	"[{""token"": ""human"", ""start_span"": 49, ""end_span"": 54, ""type"": ""Organism""}, {""token"": ""fibroblasts"", ""start_span"": 55, ""end_span"": 66, ""type"": ""Cell""}, {""token"": ""Co - 60"", ""start_span"": 70, ""end_span"": 77, ""type"": ""Chemical""}, {""token"": ""Ha - ras"", ""start_span"": 93, ""end_span"": 101, ""type"": ""Gene_or_gene_product""}]"	valid
As reported previously ( Namba et al., 1985; Namba, 1985), normal human fibroblasts were transformed into immortal cells with abnormal karyotypes by Co - 60 gamma - ray irradiation.	human,66,71,Organism	fibroblasts,72,83,Cell	immortal cells,106,120,Cell	Co - 60,149,156,Chemical	"[{""token"": ""human"", ""start_span"": 66, ""end_span"": 71, ""type"": ""Organism""}, {""token"": ""fibroblasts"", ""start_span"": 72, ""end_span"": 83, ""type"": ""Cell""}, {""token"": ""immortal cells"", ""start_span"": 106, ""end_span"": 120, ""type"": ""Cell""}, {""token"": ""Co - 60"", ""start_span"": 149, ""end_span"": 156, ""type"": ""Chemical""}]"	valid
One theoretical possibility is that mast cells may prepare the matrix, perhaps by slow release of heparin, so that capillary sprouts can more easily move through it toward their angiogenic target.	mast cells,36,46,Cell	matrix,63,69,Cellular_component	heparin,98,105,Chemical	capillary sprouts,115,132,Tissue	"[{""token"": ""mast cells"", ""start_span"": 36, ""end_span"": 46, ""type"": ""Cell""}, {""token"": ""matrix"", ""start_span"": 63, ""end_span"": 69, ""type"": ""Cellular_component""}, {""token"": ""heparin"", ""start_span"": 98, ""end_span"": 105, ""type"": ""Chemical""}, {""token"": ""capillary sprouts"", ""start_span"": 115, ""end_span"": 132, ""type"": ""Tissue""}]"	valid
Protein kinase activities in immune complexes of simian virus 40 large T - antigen and transformation - associated cellular p53 protein.	simian virus 40,49,64,Organism	large T - antigen,65,82,Gene_or_gene_product	cellular,115,123,Cell	p53,124,127,Gene_or_gene_product	"[{""token"": ""simian virus 40"", ""start_span"": 49, ""end_span"": 64, ""type"": ""Organism""}, {""token"": ""large T - antigen"", ""start_span"": 65, ""end_span"": 82, ""type"": ""Gene_or_gene_product""}, {""token"": ""cellular"", ""start_span"": 115, ""end_span"": 123, ""type"": ""Cell""}, {""token"": ""p53"", ""start_span"": 124, ""end_span"": 127, ""type"": ""Gene_or_gene_product""}]"	valid
These assays yielded mainly the viral large T - antigen and, in particular, the associated cellular p53 as endogenous substrates.	viral,32,37,Organism	large T - antigen,38,55,Gene_or_gene_product	cellular,91,99,Cell	p53,100,103,Gene_or_gene_product	"[{""token"": ""viral"", ""start_span"": 32, ""end_span"": 37, ""type"": ""Organism""}, {""token"": ""large T - antigen"", ""start_span"": 38, ""end_span"": 55, ""type"": ""Gene_or_gene_product""}, {""token"": ""cellular"", ""start_span"": 91, ""end_span"": 99, ""type"": ""Cell""}, {""token"": ""p53"", ""start_span"": 100, ""end_span"": 103, ""type"": ""Gene_or_gene_product""}]"	valid
The kinase reactions showed preference for ATP and MgCl2 instead of GTP or MnCl2.	ATP,43,46,Chemical	MgCl2,51,56,Chemical	GTP,68,71,Chemical	MnCl2,75,80,Chemical	"[{""token"": ""ATP"", ""start_span"": 43, ""end_span"": 46, ""type"": ""Chemical""}, {""token"": ""MgCl2"", ""start_span"": 51, ""end_span"": 56, ""type"": ""Chemical""}, {""token"": ""GTP"", ""start_span"": 68, ""end_span"": 71, ""type"": ""Chemical""}, {""token"": ""MnCl2"", ""start_span"": 75, ""end_span"": 80, ""type"": ""Chemical""}]"	valid
Suppressed transformation and induced differentiation of HER - 2 / neu - overexpressing breast cancer cells by emodin.	HER - 2,57,64,Gene_or_gene_product	neu,67,70,Gene_or_gene_product	breast cancer cells,88,107,Cell	emodin,111,117,Chemical	"[{""token"": ""HER - 2"", ""start_span"": 57, ""end_span"": 64, ""type"": ""Gene_or_gene_product""}, {""token"": ""neu"", ""start_span"": 67, ""end_span"": 70, ""type"": ""Gene_or_gene_product""}, {""token"": ""breast cancer cells"", ""start_span"": 88, ""end_span"": 107, ""type"": ""Cell""}, {""token"": ""emodin"", ""start_span"": 111, ""end_span"": 117, ""type"": ""Chemical""}]"	valid
These results may have chemotherapeutic implications for using emodin to target HER - 2 / neu - overexpressing cancer cells.	emodin,63,69,Chemical	HER - 2,80,87,Gene_or_gene_product	neu,90,93,Gene_or_gene_product	cancer cells,111,123,Cell	"[{""token"": ""emodin"", ""start_span"": 63, ""end_span"": 69, ""type"": ""Chemical""}, {""token"": ""HER - 2"", ""start_span"": 80, ""end_span"": 87, ""type"": ""Gene_or_gene_product""}, {""token"": ""neu"", ""start_span"": 90, ""end_span"": 93, ""type"": ""Gene_or_gene_product""}, {""token"": ""cancer cells"", ""start_span"": 111, ""end_span"": 123, ""type"": ""Cell""}]"	valid
Somatic cell hybrids between LTA and NIH 3T3 cells are tumorigenic, metastatic and ras - responsive.	Somatic cell hybrids,0,20,Cell	LTA,29,32,Cell	NIH 3T3 cells,37,50,Cell	ras,83,86,Gene_or_gene_product	"[{""token"": ""Somatic cell hybrids"", ""start_span"": 0, ""end_span"": 20, ""type"": ""Cell""}, {""token"": ""LTA"", ""start_span"": 29, ""end_span"": 32, ""type"": ""Cell""}, {""token"": ""NIH 3T3 cells"", ""start_span"": 37, ""end_span"": 50, ""type"": ""Cell""}, {""token"": ""ras"", ""start_span"": 83, ""end_span"": 86, ""type"": ""Gene_or_gene_product""}]"	valid
All four metastatic hybrids expressed 60 - 72 kDa gelatinase activity, while three of them also had 92 kDa activity and one had only minimal 92 kDa activity.	hybrids,20,27,Cell	60 - 72 kDa gelatinase,38,60,Gene_or_gene_product	92 kDa,100,106,Gene_or_gene_product	92 kDa,141,147,Gene_or_gene_product	"[{""token"": ""hybrids"", ""start_span"": 20, ""end_span"": 27, ""type"": ""Cell""}, {""token"": ""60 - 72 kDa gelatinase"", ""start_span"": 38, ""end_span"": 60, ""type"": ""Gene_or_gene_product""}, {""token"": ""92 kDa"", ""start_span"": 100, ""end_span"": 106, ""type"": ""Gene_or_gene_product""}, {""token"": ""92 kDa"", ""start_span"": 141, ""end_span"": 147, ""type"": ""Gene_or_gene_product""}]"	valid
Levels of RNA for tissue inhibitors of metalloproteinases ( TIMP - 1, TIMP - 2) were relatively constant, suggesting independent regulation of type IV collagenases and their inhibitors.	tissue,18,24,Tissue	TIMP - 1,60,68,Gene_or_gene_product	TIMP - 2,70,78,Gene_or_gene_product	type IV collagenases,143,163,Gene_or_gene_product	"[{""token"": ""tissue"", ""start_span"": 18, ""end_span"": 24, ""type"": ""Tissue""}, {""token"": ""TIMP - 1"", ""start_span"": 60, ""end_span"": 68, ""type"": ""Gene_or_gene_product""}, {""token"": ""TIMP - 2"", ""start_span"": 70, ""end_span"": 78, ""type"": ""Gene_or_gene_product""}, {""token"": ""type IV collagenases"", ""start_span"": 143, ""end_span"": 163, ""type"": ""Gene_or_gene_product""}]"	valid
Overexpression of ST3 correlated with the progression of human colorectal tumors toward local invasion and liver metastasis.	ST3,18,21,Gene_or_gene_product	human,57,62,Organism	colorectal tumors,63,80,Cancer	liver,107,112,Organ	"[{""token"": ""ST3"", ""start_span"": 18, ""end_span"": 21, ""type"": ""Gene_or_gene_product""}, {""token"": ""human"", ""start_span"": 57, ""end_span"": 62, ""type"": ""Organism""}, {""token"": ""colorectal tumors"", ""start_span"": 63, ""end_span"": 80, ""type"": ""Cancer""}, {""token"": ""liver"", ""start_span"": 107, ""end_span"": 112, ""type"": ""Organ""}]"	valid
Collagen XII is a complex multidomain protein associated with the surface of interstitial collagen fibrils.	Collagen XII,0,12,Gene_or_gene_product	interstitial,77,89,Organ	collagen,90,98,Gene_or_gene_product	fibrils,99,106,Cellular_component	"[{""token"": ""Collagen XII"", ""start_span"": 0, ""end_span"": 12, ""type"": ""Gene_or_gene_product""}, {""token"": ""interstitial"", ""start_span"": 77, ""end_span"": 89, ""type"": ""Organ""}, {""token"": ""collagen"", ""start_span"": 90, ""end_span"": 98, ""type"": ""Gene_or_gene_product""}, {""token"": ""fibrils"", ""start_span"": 99, ""end_span"": 106, ""type"": ""Cellular_component""}]"	valid
H4 cells formed tight, round spheroids whereas H5 cells formed loose, grape - like structures.	H4 cells,0,8,Cell	spheroids,29,38,Cell	H5 cells,47,55,Cell	grape - like structures,70,93,Cell	"[{""token"": ""H4 cells"", ""start_span"": 0, ""end_span"": 8, ""type"": ""Cell""}, {""token"": ""spheroids"", ""start_span"": 29, ""end_span"": 38, ""type"": ""Cell""}, {""token"": ""H5 cells"", ""start_span"": 47, ""end_span"": 55, ""type"": ""Cell""}, {""token"": ""grape - like structures"", ""start_span"": 70, ""end_span"": 93, ""type"": ""Cell""}]"	valid
Tumors of H4 cells were well perfused, unlike tumors of H5 cells which were highly necrotic.	Tumors,0,6,Cancer	H4 cells,10,18,Cell	tumors,46,52,Cancer	H5 cells,56,64,Cell	"[{""token"": ""Tumors"", ""start_span"": 0, ""end_span"": 6, ""type"": ""Cancer""}, {""token"": ""H4 cells"", ""start_span"": 10, ""end_span"": 18, ""type"": ""Cell""}, {""token"": ""tumors"", ""start_span"": 46, ""end_span"": 52, ""type"": ""Cancer""}, {""token"": ""H5 cells"", ""start_span"": 56, ""end_span"": 64, ""type"": ""Cell""}]"	valid
Human cytomegalovirus elevates levels of the cellular protein p53 in infected fibroblasts.	Human cytomegalovirus,0,21,Organism	cellular,45,53,Cell	p53,62,65,Gene_or_gene_product	fibroblasts,78,89,Cell	"[{""token"": ""Human cytomegalovirus"", ""start_span"": 0, ""end_span"": 21, ""type"": ""Organism""}, {""token"": ""cellular"", ""start_span"": 45, ""end_span"": 53, ""type"": ""Cell""}, {""token"": ""p53"", ""start_span"": 62, ""end_span"": 65, ""type"": ""Gene_or_gene_product""}, {""token"": ""fibroblasts"", ""start_span"": 78, ""end_span"": 89, ""type"": ""Cell""}]"	valid
Our results indicate that HCMV elevates cellular p53 levels on the order of 10 - to 20 - fold in infected fibroblasts.	HCMV,26,30,Organism	cellular,40,48,Cell	p53,49,52,Gene_or_gene_product	fibroblasts,106,117,Cell	"[{""token"": ""HCMV"", ""start_span"": 26, ""end_span"": 30, ""type"": ""Organism""}, {""token"": ""cellular"", ""start_span"": 40, ""end_span"": 48, ""type"": ""Cell""}, {""token"": ""p53"", ""start_span"": 49, ""end_span"": 52, ""type"": ""Gene_or_gene_product""}, {""token"": ""fibroblasts"", ""start_span"": 106, ""end_span"": 117, ""type"": ""Cell""}]"	valid
The induction of elevated p53 levels commenced at immediate - early times of the HCMV multiplication cycle ( 6 h postinfection) and reached maximal levels by 24 h postinfection, before most of the HCMV DNA synthesis was initiated.	p53,26,29,Gene_or_gene_product	HCMV,81,85,Organism	HCMV,197,201,Organism	DNA,202,205,Cellular_component	"[{""token"": ""p53"", ""start_span"": 26, ""end_span"": 29, ""type"": ""Gene_or_gene_product""}, {""token"": ""HCMV"", ""start_span"": 81, ""end_span"": 85, ""type"": ""Organism""}, {""token"": ""HCMV"", ""start_span"": 197, ""end_span"": 201, ""type"": ""Organism""}, {""token"": ""DNA"", ""start_span"": 202, ""end_span"": 205, ""type"": ""Cellular_component""}]"	valid
Point mutations of H - ras however, were identified in three distant metastatic pituitary tumor secondaries, but not in their respective primary pituitary carcinomas, or in six invasive adenomas.	H - ras,19,26,Gene_or_gene_product	pituitary tumor secondaries,80,107,Cancer	primary pituitary carcinomas,137,165,Cancer	adenomas,186,194,Cancer	"[{""token"": ""H - ras"", ""start_span"": 19, ""end_span"": 26, ""type"": ""Gene_or_gene_product""}, {""token"": ""pituitary tumor secondaries"", ""start_span"": 80, ""end_span"": 107, ""type"": ""Cancer""}, {""token"": ""primary pituitary carcinomas"", ""start_span"": 137, ""end_span"": 165, ""type"": ""Cancer""}, {""token"": ""adenomas"", ""start_span"": 186, ""end_span"": 194, ""type"": ""Cancer""}]"	valid
Overexpression of Glut - 1 glucose transporter in human breast cancer.	Glut - 1,18,26,Gene_or_gene_product	glucose,27,34,Chemical	human,50,55,Organism	breast cancer,56,69,Cancer	"[{""token"": ""Glut - 1"", ""start_span"": 18, ""end_span"": 26, ""type"": ""Gene_or_gene_product""}, {""token"": ""glucose"", ""start_span"": 27, ""end_span"": 34, ""type"": ""Chemical""}, {""token"": ""human"", ""start_span"": 50, ""end_span"": 55, ""type"": ""Organism""}, {""token"": ""breast cancer"", ""start_span"": 56, ""end_span"": 69, ""type"": ""Cancer""}]"	valid
BACKGROUND: Breast cancers have higher than normal glucose metabolism, but the mechanism of glucose entry into these tumors is not well understood.	Breast cancers,12,26,Cancer	glucose,51,58,Chemical	glucose,92,99,Chemical	tumors,117,123,Cancer	"[{""token"": ""Breast cancers"", ""start_span"": 12, ""end_span"": 26, ""type"": ""Cancer""}, {""token"": ""glucose"", ""start_span"": 51, ""end_span"": 58, ""type"": ""Chemical""}, {""token"": ""glucose"", ""start_span"": 92, ""end_span"": 99, ""type"": ""Chemical""}, {""token"": ""tumors"", ""start_span"": 117, ""end_span"": 123, ""type"": ""Cancer""}]"	valid
CONCLUSIONS: Higher expression of the glucose transporter Glut - 1 by breast cancer cells compared with the healthy breast tissue is common.	glucose,38,45,Chemical	Glut - 1,58,66,Gene_or_gene_product	breast cancer cells,70,89,Cell	healthy breast tissue,108,129,Tissue	"[{""token"": ""glucose"", ""start_span"": 38, ""end_span"": 45, ""type"": ""Chemical""}, {""token"": ""Glut - 1"", ""start_span"": 58, ""end_span"": 66, ""type"": ""Gene_or_gene_product""}, {""token"": ""breast cancer cells"", ""start_span"": 70, ""end_span"": 89, ""type"": ""Cell""}, {""token"": ""healthy breast tissue"", ""start_span"": 108, ""end_span"": 129, ""type"": ""Tissue""}]"	valid
Somatostatin receptors were detected in peritumoral veins of various human cancer tissue specimens.	Somatostatin receptors,0,22,Gene_or_gene_product	peritumoral veins,40,57,Multi	human,69,74,Organism	cancer tissue specimens,75,98,Tissue	"[{""token"": ""Somatostatin receptors"", ""start_span"": 0, ""end_span"": 22, ""type"": ""Gene_or_gene_product""}, {""token"": ""peritumoral veins"", ""start_span"": 40, ""end_span"": 57, ""type"": ""Multi""}, {""token"": ""human"", ""start_span"": 69, ""end_span"": 74, ""type"": ""Organism""}, {""token"": ""cancer tissue specimens"", ""start_span"": 75, ""end_span"": 98, ""type"": ""Tissue""}]"	valid
In colonic carcinoma specimens, the peritumoral vessels expressed a high density of somatostatin receptors, whereas the neoplastic tissue itself was receptor - negative in many cases.	colonic carcinoma specimens,3,30,Cancer	peritumoral vessels,36,55,Multi	somatostatin receptors,84,106,Gene_or_gene_product	neoplastic tissue,120,137,Tissue	"[{""token"": ""colonic carcinoma specimens"", ""start_span"": 3, ""end_span"": 30, ""type"": ""Cancer""}, {""token"": ""peritumoral vessels"", ""start_span"": 36, ""end_span"": 55, ""type"": ""Multi""}, {""token"": ""somatostatin receptors"", ""start_span"": 84, ""end_span"": 106, ""type"": ""Gene_or_gene_product""}, {""token"": ""neoplastic tissue"", ""start_span"": 120, ""end_span"": 137, ""type"": ""Tissue""}]"	valid
They exhibited specific and high - affinity binding of somatostatin - 14, somatostatin - 28 and octreotide, suggesting a preferential expression of the SSTR2 receptor subtype.	somatostatin - 14,55,72,Gene_or_gene_product	somatostatin - 28,74,91,Gene_or_gene_product	octreotide,96,106,Chemical	SSTR2 receptor,152,166,Gene_or_gene_product	"[{""token"": ""somatostatin - 14"", ""start_span"": 55, ""end_span"": 72, ""type"": ""Gene_or_gene_product""}, {""token"": ""somatostatin - 28"", ""start_span"": 74, ""end_span"": 91, ""type"": ""Gene_or_gene_product""}, {""token"": ""octreotide"", ""start_span"": 96, ""end_span"": 106, ""type"": ""Chemical""}, {""token"": ""SSTR2 receptor"", ""start_span"": 152, ""end_span"": 166, ""type"": ""Gene_or_gene_product""}]"	valid
E - cadherin is a Ca ( 2 +) - dependent cell - cell adhesion molecule, which is mainly expressed in epithelial cells.	E - cadherin,0,12,Gene_or_gene_product	cell,40,44,Cell	cell,47,51,Cell	epithelial cells,100,116,Cell	"[{""token"": ""E - cadherin"", ""start_span"": 0, ""end_span"": 12, ""type"": ""Gene_or_gene_product""}, {""token"": ""cell"", ""start_span"": 40, ""end_span"": 44, ""type"": ""Cell""}, {""token"": ""cell"", ""start_span"": 47, ""end_span"": 51, ""type"": ""Cell""}, {""token"": ""epithelial cells"", ""start_span"": 100, ""end_span"": 116, ""type"": ""Cell""}]"	valid
The data provide an example of coordinated changes in the expression of two cell adhesion molecules, syndecan - 1 and E - cadherin during epithelial cell transformation.	cell,76,80,Cell	syndecan - 1,101,113,Gene_or_gene_product	E - cadherin,118,130,Gene_or_gene_product	epithelial cell,138,153,Cell	"[{""token"": ""cell"", ""start_span"": 76, ""end_span"": 80, ""type"": ""Cell""}, {""token"": ""syndecan - 1"", ""start_span"": 101, ""end_span"": 113, ""type"": ""Gene_or_gene_product""}, {""token"": ""E - cadherin"", ""start_span"": 118, ""end_span"": 130, ""type"": ""Gene_or_gene_product""}, {""token"": ""epithelial cell"", ""start_span"": 138, ""end_span"": 153, ""type"": ""Cell""}]"	valid
Thus, 5T4 molecules can deliver signals through both the extracellular and intracellular domains, and the resultant effects are consistent with a role for 5T4 molecules in invasion processes.	5T4,6,9,Gene_or_gene_product	extracellular,57,70,Immaterial_anatomical_entity	intracellular,75,88,Immaterial_anatomical_entity	5T4,155,158,Gene_or_gene_product	"[{""token"": ""5T4"", ""start_span"": 6, ""end_span"": 9, ""type"": ""Gene_or_gene_product""}, {""token"": ""extracellular"", ""start_span"": 57, ""end_span"": 70, ""type"": ""Immaterial_anatomical_entity""}, {""token"": ""intracellular"", ""start_span"": 75, ""end_span"": 88, ""type"": ""Immaterial_anatomical_entity""}, {""token"": ""5T4"", ""start_span"": 155, ""end_span"": 158, ""type"": ""Gene_or_gene_product""}]"	valid
Certain carcinostatic agents induce the expression of E - selectin on endothelial cells and enhance the expression of carbohydrate ligands on cancer cells.	E - selectin,54,66,Gene_or_gene_product	endothelial cells,70,87,Cell	carbohydrate,118,130,Chemical	cancer cells,142,154,Cell	"[{""token"": ""E - selectin"", ""start_span"": 54, ""end_span"": 66, ""type"": ""Gene_or_gene_product""}, {""token"": ""endothelial cells"", ""start_span"": 70, ""end_span"": 87, ""type"": ""Cell""}, {""token"": ""carbohydrate"", ""start_span"": 118, ""end_span"": 130, ""type"": ""Chemical""}, {""token"": ""cancer cells"", ""start_span"": 142, ""end_span"": 154, ""type"": ""Cell""}]"	valid
In the trans - splenic hepatic metastasis model using nude mice, the augmentation of cancer metastasis was observed by the treatment of carcinostatic agents.	trans - splenic,7,22,Immaterial_anatomical_entity	hepatic,23,30,Organ	nude mice,54,63,Organism	cancer,85,91,Cancer	"[{""token"": ""trans - splenic"", ""start_span"": 7, ""end_span"": 22, ""type"": ""Immaterial_anatomical_entity""}, {""token"": ""hepatic"", ""start_span"": 23, ""end_span"": 30, ""type"": ""Organ""}, {""token"": ""nude mice"", ""start_span"": 54, ""end_span"": 63, ""type"": ""Organism""}, {""token"": ""cancer"", ""start_span"": 85, ""end_span"": 91, ""type"": ""Cancer""}]"	valid
We have, therefore, examined components of this plasminogen activating system in patients with Non - Small Cell Lung Cancer ( NSCLC).	plasminogen,48,59,Gene_or_gene_product	patients,81,89,Organism	Non - Small Cell Lung Cancer,95,123,Cancer	NSCLC,126,131,Cancer	"[{""token"": ""plasminogen"", ""start_span"": 48, ""end_span"": 59, ""type"": ""Gene_or_gene_product""}, {""token"": ""patients"", ""start_span"": 81, ""end_span"": 89, ""type"": ""Organism""}, {""token"": ""Non - Small Cell Lung Cancer"", ""start_span"": 95, ""end_span"": 123, ""type"": ""Cancer""}, {""token"": ""NSCLC"", ""start_span"": 126, ""end_span"": 131, ""type"": ""Cancer""}]"	valid
Immunohistochemically stained sections of tumour were allocated a score for stain intensity and results correlated to: survival; tumour stage ( T); nodal stage ( N); stage grouping ( I to IIIb), survival status and sex.	sections,30,38,Cancer	tumour,42,48,Cancer	tumour,129,135,Cancer	nodal,148,153,Multi	"[{""token"": ""sections"", ""start_span"": 30, ""end_span"": 38, ""type"": ""Cancer""}, {""token"": ""tumour"", ""start_span"": 42, ""end_span"": 48, ""type"": ""Cancer""}, {""token"": ""tumour"", ""start_span"": 129, ""end_span"": 135, ""type"": ""Cancer""}, {""token"": ""nodal"", ""start_span"": 148, ""end_span"": 153, ""type"": ""Multi""}]"	valid
There was a significant positive relationship between PAI - 1 levels and N - stage ( p = < 0. 05), presence of nodal metastases ( p = < 0. 05), stage grouping ( p = < 0. 01) and extent of disease ( p = < 0. 05) in the total group and the SCC subgroup, but not adenocarcinoma.	PAI - 1,54,61,Gene_or_gene_product	nodal,111,116,Multi	SCC,238,241,Cancer	adenocarcinoma,260,274,Cancer	"[{""token"": ""PAI - 1"", ""start_span"": 54, ""end_span"": 61, ""type"": ""Gene_or_gene_product""}, {""token"": ""nodal"", ""start_span"": 111, ""end_span"": 116, ""type"": ""Multi""}, {""token"": ""SCC"", ""start_span"": 238, ""end_span"": 241, ""type"": ""Cancer""}, {""token"": ""adenocarcinoma"", ""start_span"": 260, ""end_span"": 274, ""type"": ""Cancer""}]"	valid
The presence of activating mutations has been demonstrated in the TSH - R gene as well as in the Gs alpha protein gene in thyroid toxic adenoma resulting in the constitutive activation of the cAMP pathway and it has been hypothesised that these genetic alterations may play a causative role in the disease.	TSH - R,66,73,Gene_or_gene_product	Gs alpha protein,97,113,Gene_or_gene_product	thyroid toxic adenoma,122,143,Cancer	cAMP,192,196,Chemical	"[{""token"": ""TSH - R"", ""start_span"": 66, ""end_span"": 73, ""type"": ""Gene_or_gene_product""}, {""token"": ""Gs alpha protein"", ""start_span"": 97, ""end_span"": 113, ""type"": ""Gene_or_gene_product""}, {""token"": ""thyroid toxic adenoma"", ""start_span"": 122, ""end_span"": 143, ""type"": ""Cancer""}, {""token"": ""cAMP"", ""start_span"": 192, ""end_span"": 196, ""type"": ""Chemical""}]"	test
Activating mutations of the TSH - R gene have been detected in a group of differentiated carcinomas with high basal adenylyl cyclase activity, and in a few cases of hyperfunctioning thyroid carcinoma.	TSH - R,28,35,Gene_or_gene_product	carcinomas,89,99,Cancer	adenylyl cyclase,116,132,Gene_or_gene_product	thyroid carcinoma,182,199,Cancer	"[{""token"": ""TSH - R"", ""start_span"": 28, ""end_span"": 35, ""type"": ""Gene_or_gene_product""}, {""token"": ""carcinomas"", ""start_span"": 89, ""end_span"": 99, ""type"": ""Cancer""}, {""token"": ""adenylyl cyclase"", ""start_span"": 116, ""end_span"": 132, ""type"": ""Gene_or_gene_product""}, {""token"": ""thyroid carcinoma"", ""start_span"": 182, ""end_span"": 199, ""type"": ""Cancer""}]"	test
Cooccurrence of reduced expression of alpha - catenin and overexpression of p53 is a predictor of lymph node metastasis in early gastric cancer.	alpha - catenin,38,53,Gene_or_gene_product	p53,76,79,Gene_or_gene_product	lymph node,98,108,Multi	gastric cancer,129,143,Cancer	"[{""token"": ""alpha - catenin"", ""start_span"": 38, ""end_span"": 53, ""type"": ""Gene_or_gene_product""}, {""token"": ""p53"", ""start_span"": 76, ""end_span"": 79, ""type"": ""Gene_or_gene_product""}, {""token"": ""lymph node"", ""start_span"": 98, ""end_span"": 108, ""type"": ""Multi""}, {""token"": ""gastric cancer"", ""start_span"": 129, ""end_span"": 143, ""type"": ""Cancer""}]"	test
In this study, the expression of the cadherin - catenin complex and p53 was studied in early gastric cancer.	cadherin,37,45,Gene_or_gene_product	catenin,48,55,Gene_or_gene_product	p53,68,71,Gene_or_gene_product	gastric cancer,93,107,Cancer	"[{""token"": ""cadherin"", ""start_span"": 37, ""end_span"": 45, ""type"": ""Gene_or_gene_product""}, {""token"": ""catenin"", ""start_span"": 48, ""end_span"": 55, ""type"": ""Gene_or_gene_product""}, {""token"": ""p53"", ""start_span"": 68, ""end_span"": 71, ""type"": ""Gene_or_gene_product""}, {""token"": ""gastric cancer"", ""start_span"": 93, ""end_span"": 107, ""type"": ""Cancer""}]"	test
METHODS: One hundred and one specimens obtained from surgery were studied by immunohistochemistry using monoclonal anti - E - cadherin, anti - alpha - catenin and anti - p53 antibodies.	specimens,29,38,Multi	E - cadherin,122,134,Gene_or_gene_product	alpha - catenin,143,158,Gene_or_gene_product	p53,170,173,Gene_or_gene_product	"[{""token"": ""specimens"", ""start_span"": 29, ""end_span"": 38, ""type"": ""Multi""}, {""token"": ""E - cadherin"", ""start_span"": 122, ""end_span"": 134, ""type"": ""Gene_or_gene_product""}, {""token"": ""alpha - catenin"", ""start_span"": 143, ""end_span"": 158, ""type"": ""Gene_or_gene_product""}, {""token"": ""p53"", ""start_span"": 170, ""end_span"": 173, ""type"": ""Gene_or_gene_product""}]"	test
CONCLUSION: A study of both alpha - catenin and p53 expression may be helpful to predict lymph node metastases in early gastric cancer.	alpha - catenin,28,43,Gene_or_gene_product	p53,48,51,Gene_or_gene_product	lymph node,89,99,Multi	gastric cancer,120,134,Cancer	"[{""token"": ""alpha - catenin"", ""start_span"": 28, ""end_span"": 43, ""type"": ""Gene_or_gene_product""}, {""token"": ""p53"", ""start_span"": 48, ""end_span"": 51, ""type"": ""Gene_or_gene_product""}, {""token"": ""lymph node"", ""start_span"": 89, ""end_span"": 99, ""type"": ""Multi""}, {""token"": ""gastric cancer"", ""start_span"": 120, ""end_span"": 134, ""type"": ""Cancer""}]"	test
The Wilms ' tumor 1 ( WT1) gene is a tumor suppressor gene that encodes a zinc - finger transcription factor.	Wilms ' tumor 1,4,19,Gene_or_gene_product	WT1,22,25,Gene_or_gene_product	tumor,37,42,Cancer	zinc,74,78,Chemical	"[{""token"": ""Wilms ' tumor 1"", ""start_span"": 4, ""end_span"": 19, ""type"": ""Gene_or_gene_product""}, {""token"": ""WT1"", ""start_span"": 22, ""end_span"": 25, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumor"", ""start_span"": 37, ""end_span"": 42, ""type"": ""Cancer""}, {""token"": ""zinc"", ""start_span"": 74, ""end_span"": 78, ""type"": ""Chemical""}]"	test
N - myc is coexpressed with WT1 in the developing kidney and is overexpressed in many Wilms ' tumors.	N - myc,0,7,Gene_or_gene_product	WT1,28,31,Gene_or_gene_product	kidney,50,56,Organ	Wilms ' tumors,86,100,Cancer	"[{""token"": ""N - myc"", ""start_span"": 0, ""end_span"": 7, ""type"": ""Gene_or_gene_product""}, {""token"": ""WT1"", ""start_span"": 28, ""end_span"": 31, ""type"": ""Gene_or_gene_product""}, {""token"": ""kidney"", ""start_span"": 50, ""end_span"": 56, ""type"": ""Organ""}, {""token"": ""Wilms ' tumors"", ""start_span"": 86, ""end_span"": 100, ""type"": ""Cancer""}]"	test
However, mutant WT1 ( R394W) which has a mutation in the DNA binding domain could not repress the N - myc promoter.	WT1,16,19,Gene_or_gene_product	R394W,22,27,Amino_acid	DNA,57,60,Cellular_component	N - myc,98,105,Gene_or_gene_product	"[{""token"": ""WT1"", ""start_span"": 16, ""end_span"": 19, ""type"": ""Gene_or_gene_product""}, {""token"": ""R394W"", ""start_span"": 22, ""end_span"": 27, ""type"": ""Amino_acid""}, {""token"": ""DNA"", ""start_span"": 57, ""end_span"": 60, ""type"": ""Cellular_component""}, {""token"": ""N - myc"", ""start_span"": 98, ""end_span"": 105, ""type"": ""Gene_or_gene_product""}]"	test
Tumour - specific distribution of BRCA1 promoter region methylation supports a pathogenetic role in breast and ovarian cancer.	Tumour,0,6,Cancer	BRCA1,34,39,Gene_or_gene_product	breast,100,106,Cancer	ovarian cancer,111,125,Cancer	"[{""token"": ""Tumour"", ""start_span"": 0, ""end_span"": 6, ""type"": ""Cancer""}, {""token"": ""BRCA1"", ""start_span"": 34, ""end_span"": 39, ""type"": ""Gene_or_gene_product""}, {""token"": ""breast"", ""start_span"": 100, ""end_span"": 106, ""type"": ""Cancer""}, {""token"": ""ovarian cancer"", ""start_span"": 111, ""end_span"": 125, ""type"": ""Cancer""}]"	test
We suggest that the rarity of observed BRCA1 mutations in sporadic breast and ovarian cancer is due to the greater likelihood of BRCA1 inactivation by non - mutational mechanisms such as methylation.	BRCA1,39,44,Gene_or_gene_product	breast,67,73,Cancer	ovarian cancer,78,92,Cancer	BRCA1,129,134,Gene_or_gene_product	"[{""token"": ""BRCA1"", ""start_span"": 39, ""end_span"": 44, ""type"": ""Gene_or_gene_product""}, {""token"": ""breast"", ""start_span"": 67, ""end_span"": 73, ""type"": ""Cancer""}, {""token"": ""ovarian cancer"", ""start_span"": 78, ""end_span"": 92, ""type"": ""Cancer""}, {""token"": ""BRCA1"", ""start_span"": 129, ""end_span"": 134, ""type"": ""Gene_or_gene_product""}]"	test
Regulation of the resident chromosomal copy of c - myc by c - Myb is involved in myeloid leukemogenesis.	chromosomal,27,38,Cellular_component	c - myc,47,54,Gene_or_gene_product	c - Myb,58,65,Gene_or_gene_product	myeloid,81,88,Cell	"[{""token"": ""chromosomal"", ""start_span"": 27, ""end_span"": 38, ""type"": ""Cellular_component""}, {""token"": ""c - myc"", ""start_span"": 47, ""end_span"": 54, ""type"": ""Gene_or_gene_product""}, {""token"": ""c - Myb"", ""start_span"": 58, ""end_span"": 65, ""type"": ""Gene_or_gene_product""}, {""token"": ""myeloid"", ""start_span"": 81, ""end_span"": 88, ""type"": ""Cell""}]"	test
c - myb is a frequent target of retroviral insertional mutagenesis in murine leukemia virus - induced myeloid leukemia.	c - myb,0,7,Gene_or_gene_product	retroviral,32,42,Organism	murine leukemia virus,70,91,Organism	myeloid leukemia,102,118,Cancer	"[{""token"": ""c - myb"", ""start_span"": 0, ""end_span"": 7, ""type"": ""Gene_or_gene_product""}, {""token"": ""retroviral"", ""start_span"": 32, ""end_span"": 42, ""type"": ""Organism""}, {""token"": ""murine leukemia virus"", ""start_span"": 70, ""end_span"": 91, ""type"": ""Organism""}, {""token"": ""myeloid leukemia"", ""start_span"": 102, ""end_span"": 118, ""type"": ""Cancer""}]"	test
Expression of 14 - 3 - 3 final sigma ( final sigma) is induced in response to DNA damage, and causes cells to arrest in G ( 2).	14 - 3 - 3 final sigma,14,36,Gene_or_gene_product	final sigma,39,50,Gene_or_gene_product	DNA,78,81,Cellular_component	cells,101,106,Cell	"[{""token"": ""14 - 3 - 3 final sigma"", ""start_span"": 14, ""end_span"": 36, ""type"": ""Gene_or_gene_product""}, {""token"": ""final sigma"", ""start_span"": 39, ""end_span"": 50, ""type"": ""Gene_or_gene_product""}, {""token"": ""DNA"", ""start_span"": 78, ""end_span"": 81, ""type"": ""Cellular_component""}, {""token"": ""cells"", ""start_span"": 101, ""end_span"": 106, ""type"": ""Cell""}]"	test
The deregulated Bcr / Abl tyrosine kinase is responsible for the development of Philadelphia ( Ph) - positive leukemia in humans.	Bcr / Abl,16,25,Gene_or_gene_product	tyrosine,26,34,Amino_acid	leukemia,110,118,Cancer	humans,122,128,Organism	"[{""token"": ""Bcr / Abl"", ""start_span"": 16, ""end_span"": 25, ""type"": ""Gene_or_gene_product""}, {""token"": ""tyrosine"", ""start_span"": 26, ""end_span"": 34, ""type"": ""Amino_acid""}, {""token"": ""leukemia"", ""start_span"": 110, ""end_span"": 118, ""type"": ""Cancer""}, {""token"": ""humans"", ""start_span"": 122, ""end_span"": 128, ""type"": ""Organism""}]"	test
Latency was markedly increased and occurrence decreased in the p190 del C lines as compared with nonmutated p190 BCR / ABL transgenics.	p190,63,67,Gene_or_gene_product	lines,74,79,Organism	p190 BCR / ABL,108,122,Gene_or_gene_product	transgenics,123,134,Organism	"[{""token"": ""p190"", ""start_span"": 63, ""end_span"": 67, ""type"": ""Gene_or_gene_product""}, {""token"": ""lines"", ""start_span"": 74, ""end_span"": 79, ""type"": ""Organism""}, {""token"": ""p190 BCR / ABL"", ""start_span"": 108, ""end_span"": 122, ""type"": ""Gene_or_gene_product""}, {""token"": ""transgenics"", ""start_span"": 123, ""end_span"": 134, ""type"": ""Organism""}]"	test
Once in position, these cells coalesce and form cords, which lumenize and become ensheathed by supporting pericytes and smooth muscle cells.	cells,24,29,Cell	cords,48,53,Tissue	pericytes,106,115,Cell	smooth muscle cells,120,139,Cell	"[{""token"": ""cells"", ""start_span"": 24, ""end_span"": 29, ""type"": ""Cell""}, {""token"": ""cords"", ""start_span"": 48, ""end_span"": 53, ""type"": ""Tissue""}, {""token"": ""pericytes"", ""start_span"": 106, ""end_span"": 115, ""type"": ""Cell""}, {""token"": ""smooth muscle cells"", ""start_span"": 120, ""end_span"": 139, ""type"": ""Cell""}]"	test
Because many questions will require in vivo studies to be properly addressed, the zebrafish, with its unique accessibility to analysis by combined embryological, molecular, and genetic methods, should prove invaluable in identifying new molecules involved in blood vessel development and integrating pathways that influence embryonic blood vessel formation.	zebrafish,82,91,Organism	embryological,147,160,Developing_anatomical_structure	blood vessel,259,271,Multi	embryonic blood vessel,324,346,Multi	"[{""token"": ""zebrafish"", ""start_span"": 82, ""end_span"": 91, ""type"": ""Organism""}, {""token"": ""embryological"", ""start_span"": 147, ""end_span"": 160, ""type"": ""Developing_anatomical_structure""}, {""token"": ""blood vessel"", ""start_span"": 259, ""end_span"": 271, ""type"": ""Multi""}, {""token"": ""embryonic blood vessel"", ""start_span"": 324, ""end_span"": 346, ""type"": ""Multi""}]"	test
IL - 18, originally identified as interferon - gamma inducing factor ( IGIF), is related to the IL - 1 family in terms of its structure as well as its processing, receptor, signal transduction pathway and pro - inflammatory properties.	IL - 18,0,7,Gene_or_gene_product	interferon - gamma inducing factor,34,68,Gene_or_gene_product	IGIF,71,75,Gene_or_gene_product	IL - 1,96,102,Gene_or_gene_product	"[{""token"": ""IL - 18"", ""start_span"": 0, ""end_span"": 7, ""type"": ""Gene_or_gene_product""}, {""token"": ""interferon - gamma inducing factor"", ""start_span"": 34, ""end_span"": 68, ""type"": ""Gene_or_gene_product""}, {""token"": ""IGIF"", ""start_span"": 71, ""end_span"": 75, ""type"": ""Gene_or_gene_product""}, {""token"": ""IL - 1"", ""start_span"": 96, ""end_span"": 102, ""type"": ""Gene_or_gene_product""}]"	test
IL - 18 is also functionally related to IL - 12, as it induces the production of Th1 cytokines and participates in cell - mediated immune cytotoxicity.	IL - 18,0,7,Gene_or_gene_product	IL - 12,40,47,Gene_or_gene_product	Th1,81,84,Gene_or_gene_product	cell,115,119,Cell	"[{""token"": ""IL - 18"", ""start_span"": 0, ""end_span"": 7, ""type"": ""Gene_or_gene_product""}, {""token"": ""IL - 12"", ""start_span"": 40, ""end_span"": 47, ""type"": ""Gene_or_gene_product""}, {""token"": ""Th1"", ""start_span"": 81, ""end_span"": 84, ""type"": ""Gene_or_gene_product""}, {""token"": ""cell"", ""start_span"": 115, ""end_span"": 119, ""type"": ""Cell""}]"	test
Coexpression of vascular endothelial growth factor and p53 protein in squamous cell carcinoma of the esophagus.	vascular endothelial growth factor,16,50,Gene_or_gene_product	p53,55,58,Gene_or_gene_product	squamous cell carcinoma,70,93,Cancer	esophagus,101,110,Organ	"[{""token"": ""vascular endothelial growth factor"", ""start_span"": 16, ""end_span"": 50, ""type"": ""Gene_or_gene_product""}, {""token"": ""p53"", ""start_span"": 55, ""end_span"": 58, ""type"": ""Gene_or_gene_product""}, {""token"": ""squamous cell carcinoma"", ""start_span"": 70, ""end_span"": 93, ""type"": ""Cancer""}, {""token"": ""esophagus"", ""start_span"": 101, ""end_span"": 110, ""type"": ""Organ""}]"	test
Microvessel density ( MVD) was determined by counting microvessels in tumor sections stained for Factor VIII - related antigen.	Microvessel,0,11,Tissue	microvessels,54,66,Tissue	tumor sections,70,84,Multi	Factor VIII - related antigen,97,126,Gene_or_gene_product	"[{""token"": ""Microvessel"", ""start_span"": 0, ""end_span"": 11, ""type"": ""Tissue""}, {""token"": ""microvessels"", ""start_span"": 54, ""end_span"": 66, ""type"": ""Tissue""}, {""token"": ""tumor sections"", ""start_span"": 70, ""end_span"": 84, ""type"": ""Multi""}, {""token"": ""Factor VIII - related antigen"", ""start_span"": 97, ""end_span"": 126, ""type"": ""Gene_or_gene_product""}]"	test
The MVD and Ki - 67 LI were significantly higher ( p less than 0. 01 and p less than 0. 001), and the AI was significantly lower ( p less than 0. 001) in the SCC with p53 protein expression than in the SCC without it.	Ki - 67,12,19,Gene_or_gene_product	SCC,158,161,Cancer	p53,167,170,Gene_or_gene_product	SCC,202,205,Cancer	"[{""token"": ""Ki - 67"", ""start_span"": 12, ""end_span"": 19, ""type"": ""Gene_or_gene_product""}, {""token"": ""SCC"", ""start_span"": 158, ""end_span"": 161, ""type"": ""Cancer""}, {""token"": ""p53"", ""start_span"": 167, ""end_span"": 170, ""type"": ""Gene_or_gene_product""}, {""token"": ""SCC"", ""start_span"": 202, ""end_span"": 205, ""type"": ""Cancer""}]"	test
The MVD and Ki - 67 LI were higher, and the AI was lower in the SCC with VEGF / p53 coexpression than in those without the coexpression.	Ki - 67,12,19,Gene_or_gene_product	SCC,64,67,Cancer	VEGF,73,77,Gene_or_gene_product	p53,80,83,Gene_or_gene_product	"[{""token"": ""Ki - 67"", ""start_span"": 12, ""end_span"": 19, ""type"": ""Gene_or_gene_product""}, {""token"": ""SCC"", ""start_span"": 64, ""end_span"": 67, ""type"": ""Cancer""}, {""token"": ""VEGF"", ""start_span"": 73, ""end_span"": 77, ""type"": ""Gene_or_gene_product""}, {""token"": ""p53"", ""start_span"": 80, ""end_span"": 83, ""type"": ""Gene_or_gene_product""}]"	test
CONCLUSION: These results suggest that mutant p53 expression is associated with angiogenesis and distant metastasis in esophageal SCC, and that the coexpression of p53 and VEGF may play an important role in angiogenesis, and have important clinical significance.	p53,46,49,Gene_or_gene_product	esophageal SCC,119,133,Cancer	p53,164,167,Gene_or_gene_product	VEGF,172,176,Gene_or_gene_product	"[{""token"": ""p53"", ""start_span"": 46, ""end_span"": 49, ""type"": ""Gene_or_gene_product""}, {""token"": ""esophageal SCC"", ""start_span"": 119, ""end_span"": 133, ""type"": ""Cancer""}, {""token"": ""p53"", ""start_span"": 164, ""end_span"": 167, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF"", ""start_span"": 172, ""end_span"": 176, ""type"": ""Gene_or_gene_product""}]"	test
The authors concluded that, as also in the study of Northern blotting, the expression of nm23 - H1 mRNA significantly correlated inversely with lymph node metastasis in CBM, while the expression of nm23 - H2 mRNA not.	nm23 - H1,89,98,Gene_or_gene_product	lymph node,144,154,Multi	CBM,169,172,Cancer	nm23 - H2,198,207,Gene_or_gene_product	"[{""token"": ""nm23 - H1"", ""start_span"": 89, ""end_span"": 98, ""type"": ""Gene_or_gene_product""}, {""token"": ""lymph node"", ""start_span"": 144, ""end_span"": 154, ""type"": ""Multi""}, {""token"": ""CBM"", ""start_span"": 169, ""end_span"": 172, ""type"": ""Cancer""}, {""token"": ""nm23 - H2"", ""start_span"": 198, ""end_span"": 207, ""type"": ""Gene_or_gene_product""}]"	test
PLD activity has been shown to be significantly elevated in many tumours and transformed cells, suggesting the possibility that PLD might be involved in tumorigenesis.	PLD,0,3,Gene_or_gene_product	tumours,65,72,Cancer	cells,89,94,Cell	PLD,128,131,Gene_or_gene_product	"[{""token"": ""PLD"", ""start_span"": 0, ""end_span"": 3, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumours"", ""start_span"": 65, ""end_span"": 72, ""type"": ""Cancer""}, {""token"": ""cells"", ""start_span"": 89, ""end_span"": 94, ""type"": ""Cell""}, {""token"": ""PLD"", ""start_span"": 128, ""end_span"": 131, ""type"": ""Gene_or_gene_product""}]"	test
In this study, we have established stable cell lines overexpressing PLD1 and PLD2 from fibroblast cells.	cell lines,42,52,Cell	PLD1,68,72,Gene_or_gene_product	PLD2,77,81,Gene_or_gene_product	fibroblast cells,87,103,Cell	"[{""token"": ""cell lines"", ""start_span"": 42, ""end_span"": 52, ""type"": ""Cell""}, {""token"": ""PLD1"", ""start_span"": 68, ""end_span"": 72, ""type"": ""Gene_or_gene_product""}, {""token"": ""PLD2"", ""start_span"": 77, ""end_span"": 81, ""type"": ""Gene_or_gene_product""}, {""token"": ""fibroblast cells"", ""start_span"": 87, ""end_span"": 103, ""type"": ""Cell""}]"	test
Troponin I inhibits capillary endothelial cell proliferation by interaction with the cell ' s bFGF receptor.	Troponin I,0,10,Gene_or_gene_product	capillary endothelial cell,20,46,Cell	cell,85,89,Cell	bFGF receptor,94,107,Gene_or_gene_product	"[{""token"": ""Troponin I"", ""start_span"": 0, ""end_span"": 10, ""type"": ""Gene_or_gene_product""}, {""token"": ""capillary endothelial cell"", ""start_span"": 20, ""end_span"": 46, ""type"": ""Cell""}, {""token"": ""cell"", ""start_span"": 85, ""end_span"": 89, ""type"": ""Cell""}, {""token"": ""bFGF receptor"", ""start_span"": 94, ""end_span"": 107, ""type"": ""Gene_or_gene_product""}]"	test
Preliminary data suggest that TnI may be competing with bFGF for interaction with the bFGF receptor on responsive cells.	TnI,30,33,Gene_or_gene_product	bFGF,56,60,Gene_or_gene_product	bFGF receptor,86,99,Gene_or_gene_product	cells,114,119,Cell	"[{""token"": ""TnI"", ""start_span"": 30, ""end_span"": 33, ""type"": ""Gene_or_gene_product""}, {""token"": ""bFGF"", ""start_span"": 56, ""end_span"": 60, ""type"": ""Gene_or_gene_product""}, {""token"": ""bFGF receptor"", ""start_span"": 86, ""end_span"": 99, ""type"": ""Gene_or_gene_product""}, {""token"": ""cells"", ""start_span"": 114, ""end_span"": 119, ""type"": ""Cell""}]"	test
To further analyze RhoA function in thyroid cell proliferation and differentiation patterns, we combined transient and stable transfection assays to express different mutant RhoA forms in FRTL - 5 cells.	RhoA,19,23,Gene_or_gene_product	thyroid cell,36,48,Cell	RhoA,174,178,Gene_or_gene_product	FRTL - 5 cells,188,202,Cell	"[{""token"": ""RhoA"", ""start_span"": 19, ""end_span"": 23, ""type"": ""Gene_or_gene_product""}, {""token"": ""thyroid cell"", ""start_span"": 36, ""end_span"": 48, ""type"": ""Cell""}, {""token"": ""RhoA"", ""start_span"": 174, ""end_span"": 178, ""type"": ""Gene_or_gene_product""}, {""token"": ""FRTL - 5 cells"", ""start_span"": 188, ""end_span"": 202, ""type"": ""Cell""}]"	test
In addition, expression of the constitutively active form of RhoA results in TSH - independent proliferation and anchorage - independent growth and induces tumors when inoculated in nude mice.	RhoA,61,65,Gene_or_gene_product	TSH,77,80,Gene_or_gene_product	tumors,156,162,Cancer	nude mice,182,191,Organism	"[{""token"": ""RhoA"", ""start_span"": 61, ""end_span"": 65, ""type"": ""Gene_or_gene_product""}, {""token"": ""TSH"", ""start_span"": 77, ""end_span"": 80, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumors"", ""start_span"": 156, ""end_span"": 162, ""type"": ""Cancer""}, {""token"": ""nude mice"", ""start_span"": 182, ""end_span"": 191, ""type"": ""Organism""}]"	test
This effect is mediated, at least in part, by a decrease in TTF - 1 activity, since transient or stable expression of RhoA QL results in a reduction in the activity of the wild - type Tg promoter as well as an artificial promoter the activation of which depends exclusively on TTF - 1.	TTF - 1,60,67,Gene_or_gene_product	RhoA,118,122,Gene_or_gene_product	Tg,184,186,Gene_or_gene_product	TTF - 1,277,284,Gene_or_gene_product	"[{""token"": ""TTF - 1"", ""start_span"": 60, ""end_span"": 67, ""type"": ""Gene_or_gene_product""}, {""token"": ""RhoA"", ""start_span"": 118, ""end_span"": 122, ""type"": ""Gene_or_gene_product""}, {""token"": ""Tg"", ""start_span"": 184, ""end_span"": 186, ""type"": ""Gene_or_gene_product""}, {""token"": ""TTF - 1"", ""start_span"": 277, ""end_span"": 284, ""type"": ""Gene_or_gene_product""}]"	test
Taken together, these results show for the first time that active RhoA is able to transform FRTL - 5 cells and that this effect is coupled to a loss of thyroid differentiation due to impaired TTF - 1 activity.	RhoA,66,70,Gene_or_gene_product	FRTL - 5 cells,92,106,Cell	thyroid,152,159,Cell	TTF - 1,192,199,Gene_or_gene_product	"[{""token"": ""RhoA"", ""start_span"": 66, ""end_span"": 70, ""type"": ""Gene_or_gene_product""}, {""token"": ""FRTL - 5 cells"", ""start_span"": 92, ""end_span"": 106, ""type"": ""Cell""}, {""token"": ""thyroid"", ""start_span"": 152, ""end_span"": 159, ""type"": ""Cell""}, {""token"": ""TTF - 1"", ""start_span"": 192, ""end_span"": 199, ""type"": ""Gene_or_gene_product""}]"	test
The authors found that patients in the high PE group survived for a significantly shorter time than those patients in the low PE group.	patients,23,31,Organism	PE,44,46,Gene_or_gene_product	patients,106,114,Organism	PE,126,128,Gene_or_gene_product	"[{""token"": ""patients"", ""start_span"": 23, ""end_span"": 31, ""type"": ""Organism""}, {""token"": ""PE"", ""start_span"": 44, ""end_span"": 46, ""type"": ""Gene_or_gene_product""}, {""token"": ""patients"", ""start_span"": 106, ""end_span"": 114, ""type"": ""Organism""}, {""token"": ""PE"", ""start_span"": 126, ""end_span"": 128, ""type"": ""Gene_or_gene_product""}]"	test
MMP - 2 is involved in the early steps of angiogenesis leading to local dissolution of basement membrane collagen and migration of the activated endothelial cells.	MMP - 2,0,7,Gene_or_gene_product	basement membrane,87,104,Cellular_component	collagen,105,113,Gene_or_gene_product	endothelial cells,145,162,Cell	"[{""token"": ""MMP - 2"", ""start_span"": 0, ""end_span"": 7, ""type"": ""Gene_or_gene_product""}, {""token"": ""basement membrane"", ""start_span"": 87, ""end_span"": 104, ""type"": ""Cellular_component""}, {""token"": ""collagen"", ""start_span"": 105, ""end_span"": 113, ""type"": ""Gene_or_gene_product""}, {""token"": ""endothelial cells"", ""start_span"": 145, ""end_span"": 162, ""type"": ""Cell""}]"	test
BACKGROUND: Impaired expression of E - cadherin and alpha - and beta - catenin is frequently observed in several human cancers.	E - cadherin,35,47,Gene_or_gene_product	alpha - and beta - catenin,52,78,Gene_or_gene_product	human,113,118,Organism	cancers,119,126,Cancer	"[{""token"": ""E - cadherin"", ""start_span"": 35, ""end_span"": 47, ""type"": ""Gene_or_gene_product""}, {""token"": ""alpha - and beta - catenin"", ""start_span"": 52, ""end_span"": 78, ""type"": ""Gene_or_gene_product""}, {""token"": ""human"", ""start_span"": 113, ""end_span"": 118, ""type"": ""Organism""}, {""token"": ""cancers"", ""start_span"": 119, ""end_span"": 126, ""type"": ""Cancer""}]"	test
RESULTS: Abnormal E - cadherin and beta - catenin staining correlated with depth of tumour invasion in differentiated - type tumours.	E - cadherin,18,30,Gene_or_gene_product	beta - catenin,35,49,Gene_or_gene_product	tumour,84,90,Cancer	tumours,125,132,Cancer	"[{""token"": ""E - cadherin"", ""start_span"": 18, ""end_span"": 30, ""type"": ""Gene_or_gene_product""}, {""token"": ""beta - catenin"", ""start_span"": 35, ""end_span"": 49, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumour"", ""start_span"": 84, ""end_span"": 90, ""type"": ""Cancer""}, {""token"": ""tumours"", ""start_span"": 125, ""end_span"": 132, ""type"": ""Cancer""}]"	test
VEGF165 mediates formation of complexes containing VEGFR - 2 and neuropilin - 1 that enhance VEGF165 - receptor binding.	VEGF165,0,7,Gene_or_gene_product	VEGFR - 2,51,60,Gene_or_gene_product	neuropilin - 1,65,79,Gene_or_gene_product	VEGF165,93,100,Gene_or_gene_product	"[{""token"": ""VEGF165"", ""start_span"": 0, ""end_span"": 7, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGFR - 2"", ""start_span"": 51, ""end_span"": 60, ""type"": ""Gene_or_gene_product""}, {""token"": ""neuropilin - 1"", ""start_span"": 65, ""end_span"": 79, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF165"", ""start_span"": 93, ""end_span"": 100, ""type"": ""Gene_or_gene_product""}]"	test
VEGF165 also mediated the binding of a soluble NRP1 dimer to cells expressing KDR only, confirming the formation of such complexes.	VEGF165,0,7,Gene_or_gene_product	NRP1,47,51,Gene_or_gene_product	cells,61,66,Cell	KDR,78,81,Gene_or_gene_product	"[{""token"": ""VEGF165"", ""start_span"": 0, ""end_span"": 7, ""type"": ""Gene_or_gene_product""}, {""token"": ""NRP1"", ""start_span"": 47, ""end_span"": 51, ""type"": ""Gene_or_gene_product""}, {""token"": ""cells"", ""start_span"": 61, ""end_span"": 66, ""type"": ""Cell""}, {""token"": ""KDR"", ""start_span"": 78, ""end_span"": 81, ""type"": ""Gene_or_gene_product""}]"	test
Furthermore, the formation of complexes containing KDR and NRP1 markedly increased 125I - VEGF165 binding to KDR.	KDR,51,54,Gene_or_gene_product	NRP1,59,63,Gene_or_gene_product	125I - VEGF165,83,97,Gene_or_gene_product	KDR,109,112,Gene_or_gene_product	"[{""token"": ""KDR"", ""start_span"": 51, ""end_span"": 54, ""type"": ""Gene_or_gene_product""}, {""token"": ""NRP1"", ""start_span"": 59, ""end_span"": 63, ""type"": ""Gene_or_gene_product""}, {""token"": ""125I - VEGF165"", ""start_span"": 83, ""end_span"": 97, ""type"": ""Gene_or_gene_product""}, {""token"": ""KDR"", ""start_span"": 109, ""end_span"": 112, ""type"": ""Gene_or_gene_product""}]"	test
The objective of this article is to explain radiologic patterns of benign and malignant breast lesions ( masses, microcalcifications) based on histological correlations.	benign,67,73,Pathological_formation	malignant breast lesions,78,102,Pathological_formation	masses,105,111,Pathological_formation	microcalcifications,113,132,Pathological_formation	"[{""token"": ""benign"", ""start_span"": 67, ""end_span"": 73, ""type"": ""Pathological_formation""}, {""token"": ""malignant breast lesions"", ""start_span"": 78, ""end_span"": 102, ""type"": ""Pathological_formation""}, {""token"": ""masses"", ""start_span"": 105, ""end_span"": 111, ""type"": ""Pathological_formation""}, {""token"": ""microcalcifications"", ""start_span"": 113, ""end_span"": 132, ""type"": ""Pathological_formation""}]"	test
Mammographic patterns of microcalcifications depend on their physiopathological process ( necrosis, secretion), and the shape of clusters ( round, triangular) typifies their anatomical site of origin ( lobular, ductal).	microcalcifications,25,44,Pathological_formation	clusters,129,137,Pathological_formation	lobular,202,209,Multi	ductal,211,217,Multi	"[{""token"": ""microcalcifications"", ""start_span"": 25, ""end_span"": 44, ""type"": ""Pathological_formation""}, {""token"": ""clusters"", ""start_span"": 129, ""end_span"": 137, ""type"": ""Pathological_formation""}, {""token"": ""lobular"", ""start_span"": 202, ""end_span"": 209, ""type"": ""Multi""}, {""token"": ""ductal"", ""start_span"": 211, ""end_span"": 217, ""type"": ""Multi""}]"	test
In 1997, the PTEN gene ( phosphatase and tensin homolog deleted on chromosome 10) was identified as a tumor suppressor gene on the long arm of chromosome 10.	PTEN,13,17,Gene_or_gene_product	phosphatase and tensin homolog deleted on chromosome 10,25,80,Gene_or_gene_product	tumor,102,107,Cancer	chromosome 10,143,156,Cellular_component	"[{""token"": ""PTEN"", ""start_span"": 13, ""end_span"": 17, ""type"": ""Gene_or_gene_product""}, {""token"": ""phosphatase and tensin homolog deleted on chromosome 10"", ""start_span"": 25, ""end_span"": 80, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumor"", ""start_span"": 102, ""end_span"": 107, ""type"": ""Cancer""}, {""token"": ""chromosome 10"", ""start_span"": 143, ""end_span"": 156, ""type"": ""Cellular_component""}]"	test
Since then, important progress has been made with respect to the understanding of the role of the Pten protein in the normal development of the brain as well as in the molecular pathogenesis of human gliomas.	Pten,98,102,Gene_or_gene_product	brain,144,149,Organ	human,194,199,Organism	gliomas,200,207,Cancer	"[{""token"": ""Pten"", ""start_span"": 98, ""end_span"": 102, ""type"": ""Gene_or_gene_product""}, {""token"": ""brain"", ""start_span"": 144, ""end_span"": 149, ""type"": ""Organ""}, {""token"": ""human"", ""start_span"": 194, ""end_span"": 199, ""type"": ""Organism""}, {""token"": ""gliomas"", ""start_span"": 200, ""end_span"": 207, ""type"": ""Cancer""}]"	test
Besides the wealth of data elucidating the functional roles of Pten, recent studies suggest a diagnostic significance of PTEN gene alterations as a molecular marker for poor prognosis in anaplastic astrocytomas and anaplastic oligodendrogliomas.	Pten,63,67,Gene_or_gene_product	PTEN,121,125,Gene_or_gene_product	anaplastic astrocytomas,187,210,Cancer	anaplastic oligodendrogliomas,215,244,Cancer	"[{""token"": ""Pten"", ""start_span"": 63, ""end_span"": 67, ""type"": ""Gene_or_gene_product""}, {""token"": ""PTEN"", ""start_span"": 121, ""end_span"": 125, ""type"": ""Gene_or_gene_product""}, {""token"": ""anaplastic astrocytomas"", ""start_span"": 187, ""end_span"": 210, ""type"": ""Cancer""}, {""token"": ""anaplastic oligodendrogliomas"", ""start_span"": 215, ""end_span"": 244, ""type"": ""Cancer""}]"	test
[ A case report of advanced gastric cancer responding to TS - 1, a novel oral fluorouracil derivative].	gastric cancer,28,42,Cancer	TS - 1,57,63,Chemical	oral,73,77,Organism_subdivision	fluorouracil,78,90,Chemical	"[{""token"": ""gastric cancer"", ""start_span"": 28, ""end_span"": 42, ""type"": ""Cancer""}, {""token"": ""TS - 1"", ""start_span"": 57, ""end_span"": 63, ""type"": ""Chemical""}, {""token"": ""oral"", ""start_span"": 73, ""end_span"": 77, ""type"": ""Organism_subdivision""}, {""token"": ""fluorouracil"", ""start_span"": 78, ""end_span"": 90, ""type"": ""Chemical""}]"	test
We report one case of advanced gastric cancer with lung and lymph node metastases that completely responded to TS - 1.	gastric cancer,31,45,Cancer	lung,51,55,Organ	lymph node,60,70,Multi	TS - 1,111,117,Chemical	"[{""token"": ""gastric cancer"", ""start_span"": 31, ""end_span"": 45, ""type"": ""Cancer""}, {""token"": ""lung"", ""start_span"": 51, ""end_span"": 55, ""type"": ""Organ""}, {""token"": ""lymph node"", ""start_span"": 60, ""end_span"": 70, ""type"": ""Multi""}, {""token"": ""TS - 1"", ""start_span"": 111, ""end_span"": 117, ""type"": ""Chemical""}]"	test
In the distraction group, a significant postoperative increase in MMP - 1, bFGF, ALP, and BAP could be observed during the lengthening and the consolidation period when compared with the baseline levels.	MMP - 1,66,73,Gene_or_gene_product	bFGF,75,79,Gene_or_gene_product	ALP,81,84,Gene_or_gene_product	BAP,90,93,Gene_or_gene_product	"[{""token"": ""MMP - 1"", ""start_span"": 66, ""end_span"": 73, ""type"": ""Gene_or_gene_product""}, {""token"": ""bFGF"", ""start_span"": 75, ""end_span"": 79, ""type"": ""Gene_or_gene_product""}, {""token"": ""ALP"", ""start_span"": 81, ""end_span"": 84, ""type"": ""Gene_or_gene_product""}, {""token"": ""BAP"", ""start_span"": 90, ""end_span"": 93, ""type"": ""Gene_or_gene_product""}]"	test
In addition, comparison of both groups revealed a significantly higher increase in TGF - beta1, IGF - I, IGFBP - 3, and hGH in the lengthening group during the distraction period, indicating key regulatory functions in mechanotransduction.	TGF - beta1,83,94,Gene_or_gene_product	IGF - I,96,103,Gene_or_gene_product	IGFBP - 3,105,114,Gene_or_gene_product	hGH,120,123,Gene_or_gene_product	"[{""token"": ""TGF - beta1"", ""start_span"": 83, ""end_span"": 94, ""type"": ""Gene_or_gene_product""}, {""token"": ""IGF - I"", ""start_span"": 96, ""end_span"": 103, ""type"": ""Gene_or_gene_product""}, {""token"": ""IGFBP - 3"", ""start_span"": 105, ""end_span"": 114, ""type"": ""Gene_or_gene_product""}, {""token"": ""hGH"", ""start_span"": 120, ""end_span"": 123, ""type"": ""Gene_or_gene_product""}]"	test
Human papillomavirus oncoprotein E6 inactivates the transcriptional coactivator human ADA3.	Human papillomavirus,0,20,Organism	E6,33,35,Gene_or_gene_product	human,80,85,Organism	ADA3,86,90,Gene_or_gene_product	"[{""token"": ""Human papillomavirus"", ""start_span"": 0, ""end_span"": 20, ""type"": ""Organism""}, {""token"": ""E6"", ""start_span"": 33, ""end_span"": 35, ""type"": ""Gene_or_gene_product""}, {""token"": ""human"", ""start_span"": 80, ""end_span"": 85, ""type"": ""Organism""}, {""token"": ""ADA3"", ""start_span"": 86, ""end_span"": 90, ""type"": ""Gene_or_gene_product""}]"	test
hADA3 binds selectively to the high - risk HPV E6 proteins and only to immortalization - competent E6 mutants.	hADA3,0,5,Gene_or_gene_product	HPV,43,46,Organism	E6,47,49,Gene_or_gene_product	E6,99,101,Gene_or_gene_product	"[{""token"": ""hADA3"", ""start_span"": 0, ""end_span"": 5, ""type"": ""Gene_or_gene_product""}, {""token"": ""HPV"", ""start_span"": 43, ""end_span"": 46, ""type"": ""Organism""}, {""token"": ""E6"", ""start_span"": 47, ""end_span"": 49, ""type"": ""Gene_or_gene_product""}, {""token"": ""E6"", ""start_span"": 99, ""end_span"": 101, ""type"": ""Gene_or_gene_product""}]"	test
These findings reveal a novel strategy of HPV E6 - induced loss of p53 function that is independent of direct p53 degradation.	HPV,42,45,Organism	E6,46,48,Gene_or_gene_product	p53,67,70,Gene_or_gene_product	p53,110,113,Gene_or_gene_product	"[{""token"": ""HPV"", ""start_span"": 42, ""end_span"": 45, ""type"": ""Organism""}, {""token"": ""E6"", ""start_span"": 46, ""end_span"": 48, ""type"": ""Gene_or_gene_product""}, {""token"": ""p53"", ""start_span"": 67, ""end_span"": 70, ""type"": ""Gene_or_gene_product""}, {""token"": ""p53"", ""start_span"": 110, ""end_span"": 113, ""type"": ""Gene_or_gene_product""}]"	test
Given the likely role of the evolutionarily conserved hADA3 in multiple coactivator complexes, inactivation of its function may allow E6 to perturb numerous cellular pathways during HPV oncogenesis.	hADA3,54,59,Gene_or_gene_product	E6,134,136,Gene_or_gene_product	cellular,157,165,Cell	HPV,182,185,Organism	"[{""token"": ""hADA3"", ""start_span"": 54, ""end_span"": 59, ""type"": ""Gene_or_gene_product""}, {""token"": ""E6"", ""start_span"": 134, ""end_span"": 136, ""type"": ""Gene_or_gene_product""}, {""token"": ""cellular"", ""start_span"": 157, ""end_span"": 165, ""type"": ""Cell""}, {""token"": ""HPV"", ""start_span"": 182, ""end_span"": 185, ""type"": ""Organism""}]"	test
Immunohistochemical staining for thyroid transcription factor - 1: a helpful aid in discerning primary site of tumor origin in patients with brain metastases.	thyroid transcription factor - 1,33,65,Gene_or_gene_product	tumor,111,116,Cancer	patients,127,135,Organism	brain,141,146,Organ	"[{""token"": ""thyroid transcription factor - 1"", ""start_span"": 33, ""end_span"": 65, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumor"", ""start_span"": 111, ""end_span"": 116, ""type"": ""Cancer""}, {""token"": ""patients"", ""start_span"": 127, ""end_span"": 135, ""type"": ""Organism""}, {""token"": ""brain"", ""start_span"": 141, ""end_span"": 146, ""type"": ""Organ""}]"	test
Along these same lines, TTF - 1 staining might prove useful in localizing the tumor origin of adenocarcinomas encountered outside of the lung.	TTF - 1,24,31,Gene_or_gene_product	tumor,78,83,Cancer	adenocarcinomas,94,109,Cancer	lung,137,141,Organ	"[{""token"": ""TTF - 1"", ""start_span"": 24, ""end_span"": 31, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumor"", ""start_span"": 78, ""end_span"": 83, ""type"": ""Cancer""}, {""token"": ""adenocarcinomas"", ""start_span"": 94, ""end_span"": 109, ""type"": ""Cancer""}, {""token"": ""lung"", ""start_span"": 137, ""end_span"": 141, ""type"": ""Organ""}]"	test
TTF - 1 immunohistochemistry could focus the search for the primary tumor for patients presenting with brain metastasis as the initial manifestation.	TTF - 1,0,7,Gene_or_gene_product	tumor,68,73,Cancer	patients,78,86,Organism	brain,103,108,Organ	"[{""token"": ""TTF - 1"", ""start_span"": 0, ""end_span"": 7, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumor"", ""start_span"": 68, ""end_span"": 73, ""type"": ""Cancer""}, {""token"": ""patients"", ""start_span"": 78, ""end_span"": 86, ""type"": ""Organism""}, {""token"": ""brain"", ""start_span"": 103, ""end_span"": 108, ""type"": ""Organ""}]"	test
The data show that different protein expression patterns exist between primary squamous cell lung carcinomas with and without lymph node involvement and within carcinomas with lymph node involvement.	squamous cell lung carcinomas,79,108,Cancer	lymph node,126,136,Multi	carcinomas,160,170,Cancer	lymph node,176,186,Multi	"[{""token"": ""squamous cell lung carcinomas"", ""start_span"": 79, ""end_span"": 108, ""type"": ""Cancer""}, {""token"": ""lymph node"", ""start_span"": 126, ""end_span"": 136, ""type"": ""Multi""}, {""token"": ""carcinomas"", ""start_span"": 160, ""end_span"": 170, ""type"": ""Cancer""}, {""token"": ""lymph node"", ""start_span"": 176, ""end_span"": 186, ""type"": ""Multi""}]"	test
Administration of 317615 x 2HCl along with carboplatin to animals bearing the SKOV - 3 tumor produced a 1. 8 - fold increase in lifespan compared with carboplatin alone.	317615 x 2HCl,18,31,Chemical	carboplatin,43,54,Chemical	SKOV - 3 tumor,78,92,Cancer	carboplatin,151,162,Chemical	"[{""token"": ""317615 x 2HCl"", ""start_span"": 18, ""end_span"": 31, ""type"": ""Chemical""}, {""token"": ""carboplatin"", ""start_span"": 43, ""end_span"": 54, ""type"": ""Chemical""}, {""token"": ""SKOV - 3 tumor"", ""start_span"": 78, ""end_span"": 92, ""type"": ""Cancer""}, {""token"": ""carboplatin"", ""start_span"": 151, ""end_span"": 162, ""type"": ""Chemical""}]"	test
Expression of CD154 on renal cell carcinomas and effect on cell proliferation, motility and platelet - activating factor synthesis.	CD154,14,19,Gene_or_gene_product	renal cell carcinomas,23,44,Cancer	cell,59,63,Cell	platelet - activating factor,92,120,Chemical	"[{""token"": ""CD154"", ""start_span"": 14, ""end_span"": 19, ""type"": ""Gene_or_gene_product""}, {""token"": ""renal cell carcinomas"", ""start_span"": 23, ""end_span"": 44, ""type"": ""Cancer""}, {""token"": ""cell"", ""start_span"": 59, ""end_span"": 63, ""type"": ""Cell""}, {""token"": ""platelet - activating factor"", ""start_span"": 92, ""end_span"": 120, ""type"": ""Chemical""}]"	test
We have investigated the expression of the CD40 - CD154 system in 24 primary cultures derived from renal cell carcinomas, its correlation with tumor stage and its potential functional significance.	CD40,43,47,Gene_or_gene_product	CD154,50,55,Gene_or_gene_product	renal cell carcinomas,99,120,Cancer	tumor,143,148,Cancer	"[{""token"": ""CD40"", ""start_span"": 43, ""end_span"": 47, ""type"": ""Gene_or_gene_product""}, {""token"": ""CD154"", ""start_span"": 50, ""end_span"": 55, ""type"": ""Gene_or_gene_product""}, {""token"": ""renal cell carcinomas"", ""start_span"": 99, ""end_span"": 120, ""type"": ""Cancer""}, {""token"": ""tumor"", ""start_span"": 143, ""end_span"": 148, ""type"": ""Cancer""}]"	test
In contrast, doxorubicin treatment of mutant ( mut) p53 cells ( EU - 6 / ALL line) up - regulated survivin and induced G ( 2) / M arrest without inducing apoptosis.	doxorubicin,13,24,Chemical	p53,52,55,Gene_or_gene_product	EU - 6 / ALL line,64,81,Cell	survivin,98,106,Gene_or_gene_product	"[{""token"": ""doxorubicin"", ""start_span"": 13, ""end_span"": 24, ""type"": ""Chemical""}, {""token"": ""p53"", ""start_span"": 52, ""end_span"": 55, ""type"": ""Gene_or_gene_product""}, {""token"": ""EU - 6 / ALL line"", ""start_span"": 64, ""end_span"": 81, ""type"": ""Cell""}, {""token"": ""survivin"", ""start_span"": 98, ""end_span"": 106, ""type"": ""Gene_or_gene_product""}]"	test
However, treating EU - 6 with anti - survivin antisense resensitized these cells to doxorubicin, resulting in apoptosis.	EU - 6,18,24,Cell	survivin,37,45,Gene_or_gene_product	cells,75,80,Cell	doxorubicin,84,95,Chemical	"[{""token"": ""EU - 6"", ""start_span"": 18, ""end_span"": 24, ""type"": ""Cell""}, {""token"": ""survivin"", ""start_span"": 37, ""end_span"": 45, ""type"": ""Gene_or_gene_product""}, {""token"": ""cells"", ""start_span"": 75, ""end_span"": 80, ""type"": ""Cell""}, {""token"": ""doxorubicin"", ""start_span"": 84, ""end_span"": 95, ""type"": ""Chemical""}]"	test
Furthermore, our data indicate that loss of wt - p53 function in tumor cells may contribute to up - regulation of survivin and resistance to DNA - damaging agents.	p53,49,52,Gene_or_gene_product	tumor cells,65,76,Cell	survivin,114,122,Gene_or_gene_product	DNA,141,144,Cellular_component	"[{""token"": ""p53"", ""start_span"": 49, ""end_span"": 52, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumor cells"", ""start_span"": 65, ""end_span"": 76, ""type"": ""Cell""}, {""token"": ""survivin"", ""start_span"": 114, ""end_span"": 122, ""type"": ""Gene_or_gene_product""}, {""token"": ""DNA"", ""start_span"": 141, ""end_span"": 144, ""type"": ""Cellular_component""}]"	test
Effects of 4 - alkylmorpholine N - oxides on ATP - producing processes in Ehrlich ascites and L1210 leukaemia cells.	4 - alkylmorpholine N - oxides,11,41,Chemical	ATP,45,48,Chemical	Ehrlich ascites,74,89,Cell	L1210 leukaemia cells,94,115,Cell	"[{""token"": ""4 - alkylmorpholine N - oxides"", ""start_span"": 11, ""end_span"": 41, ""type"": ""Chemical""}, {""token"": ""ATP"", ""start_span"": 45, ""end_span"": 48, ""type"": ""Chemical""}, {""token"": ""Ehrlich ascites"", ""start_span"": 74, ""end_span"": 89, ""type"": ""Cell""}, {""token"": ""L1210 leukaemia cells"", ""start_span"": 94, ""end_span"": 115, ""type"": ""Cell""}]"	test
The main purpose of the present investigation was to study the effect of the homologous series of 4 - alkylmorpholine N - oxides on ATP - producing processes in Ehrlich ascites and L1210 murine leukaemia cells.	4 - alkylmorpholine N - oxides,98,128,Chemical	ATP,132,135,Chemical	Ehrlich ascites,161,176,Cell	L1210 murine leukaemia cells,181,209,Cell	"[{""token"": ""4 - alkylmorpholine N - oxides"", ""start_span"": 98, ""end_span"": 128, ""type"": ""Chemical""}, {""token"": ""ATP"", ""start_span"": 132, ""end_span"": 135, ""type"": ""Chemical""}, {""token"": ""Ehrlich ascites"", ""start_span"": 161, ""end_span"": 176, ""type"": ""Cell""}, {""token"": ""L1210 murine leukaemia cells"", ""start_span"": 181, ""end_span"": 209, ""type"": ""Cell""}]"	test
The effects on aerobic glucose consumption, lactic acid formation, content of total ( T - SH) and non - protein thiol groups ( NP - SH), endogenous and exogenous respiration and the level of ATP in tumour cells incubated in vitro were investigated.	glucose,23,30,Chemical	lactic acid,44,55,Chemical	ATP,191,194,Chemical	tumour cells,198,210,Cell	"[{""token"": ""glucose"", ""start_span"": 23, ""end_span"": 30, ""type"": ""Chemical""}, {""token"": ""lactic acid"", ""start_span"": 44, ""end_span"": 55, ""type"": ""Chemical""}, {""token"": ""ATP"", ""start_span"": 191, ""end_span"": 194, ""type"": ""Chemical""}, {""token"": ""tumour cells"", ""start_span"": 198, ""end_span"": 210, ""type"": ""Cell""}]"	test
4 - Dodecylmorpholine N - oxide ( DMNO), one of the most active compounds, decreased the level of ATP immediately after addition to the suspension of Ehrlich cells in an ice bath.	4 - Dodecylmorpholine N - oxide,0,31,Chemical	DMNO,34,38,Chemical	ATP,98,101,Chemical	Ehrlich cells,150,163,Cell	"[{""token"": ""4 - Dodecylmorpholine N - oxide"", ""start_span"": 0, ""end_span"": 31, ""type"": ""Chemical""}, {""token"": ""DMNO"", ""start_span"": 34, ""end_span"": 38, ""type"": ""Chemical""}, {""token"": ""ATP"", ""start_span"": 98, ""end_span"": 101, ""type"": ""Chemical""}, {""token"": ""Ehrlich cells"", ""start_span"": 150, ""end_span"": 163, ""type"": ""Cell""}]"	test
Fibroblast growth factor 2 promotes microvessel formation from mouse embryonic aorta.	Fibroblast growth factor 2,0,26,Gene_or_gene_product	microvessel,36,47,Tissue	mouse,63,68,Organism	embryonic aorta,69,84,Multi	"[{""token"": ""Fibroblast growth factor 2"", ""start_span"": 0, ""end_span"": 26, ""type"": ""Gene_or_gene_product""}, {""token"": ""microvessel"", ""start_span"": 36, ""end_span"": 47, ""type"": ""Tissue""}, {""token"": ""mouse"", ""start_span"": 63, ""end_span"": 68, ""type"": ""Organism""}, {""token"": ""embryonic aorta"", ""start_span"": 69, ""end_span"": 84, ""type"": ""Multi""}]"	test
Our data suggest that low oxygen upregulates FGFR1 expression in embryonic aorta in vitro and renders it more responsive to FGF2.	oxygen,26,32,Chemical	FGFR1,45,50,Gene_or_gene_product	embryonic aorta,65,80,Multi	FGF2,124,128,Gene_or_gene_product	"[{""token"": ""oxygen"", ""start_span"": 26, ""end_span"": 32, ""type"": ""Chemical""}, {""token"": ""FGFR1"", ""start_span"": 45, ""end_span"": 50, ""type"": ""Gene_or_gene_product""}, {""token"": ""embryonic aorta"", ""start_span"": 65, ""end_span"": 80, ""type"": ""Multi""}, {""token"": ""FGF2"", ""start_span"": 124, ""end_span"": 128, ""type"": ""Gene_or_gene_product""}]"	test
Our previous in vitro studies in a rat model indicated that insulin - like growth factor - I ( IGF - I) is a potent angiogenic agent for fetal lung endothelial cells.	rat,35,38,Organism	insulin - like growth factor - I,60,92,Gene_or_gene_product	IGF - I,95,102,Gene_or_gene_product	fetal lung endothelial cells,137,165,Cell	"[{""token"": ""rat"", ""start_span"": 35, ""end_span"": 38, ""type"": ""Organism""}, {""token"": ""insulin - like growth factor - I"", ""start_span"": 60, ""end_span"": 92, ""type"": ""Gene_or_gene_product""}, {""token"": ""IGF - I"", ""start_span"": 95, ""end_span"": 102, ""type"": ""Gene_or_gene_product""}, {""token"": ""fetal lung endothelial cells"", ""start_span"": 137, ""end_span"": 165, ""type"": ""Cell""}]"	test
Immunohistochemical and in situ hybridization studies revealed the presence of IGF - I / II - IGF - IR ligands and mRNA transcripts in embryonic lungs as early as 4 wk gestation.	IGF - I,79,86,Gene_or_gene_product	II,89,91,Gene_or_gene_product	IGF - IR,94,102,Gene_or_gene_product	embryonic lungs,135,150,Organ	"[{""token"": ""IGF - I"", ""start_span"": 79, ""end_span"": 86, ""type"": ""Gene_or_gene_product""}, {""token"": ""II"", ""start_span"": 89, ""end_span"": 91, ""type"": ""Gene_or_gene_product""}, {""token"": ""IGF - IR"", ""start_span"": 94, ""end_span"": 102, ""type"": ""Gene_or_gene_product""}, {""token"": ""embryonic lungs"", ""start_span"": 135, ""end_span"": 150, ""type"": ""Organ""}]"	test
Immunotargeting using an anti - IGF - IR neutralizing antibody on human fetal lung explants demonstrated a significant blockade of IGF - IR signaling.	IGF - IR,32,40,Gene_or_gene_product	human,66,71,Organism	fetal lung explants,72,91,Organ	IGF - IR,131,139,Gene_or_gene_product	"[{""token"": ""IGF - IR"", ""start_span"": 32, ""end_span"": 40, ""type"": ""Gene_or_gene_product""}, {""token"": ""human"", ""start_span"": 66, ""end_span"": 71, ""type"": ""Organism""}, {""token"": ""fetal lung explants"", ""start_span"": 72, ""end_span"": 91, ""type"": ""Organ""}, {""token"": ""IGF - IR"", ""start_span"": 131, ""end_span"": 139, ""type"": ""Gene_or_gene_product""}]"	test
The aim of the present study was to investigate the properties of VEGF expression in human gingival fibroblasts ( HGF) culture.	VEGF,66,70,Gene_or_gene_product	human,85,90,Organism	gingival fibroblasts,91,111,Cell	HGF,114,117,Cell	"[{""token"": ""VEGF"", ""start_span"": 66, ""end_span"": 70, ""type"": ""Gene_or_gene_product""}, {""token"": ""human"", ""start_span"": 85, ""end_span"": 90, ""type"": ""Organism""}, {""token"": ""gingival fibroblasts"", ""start_span"": 91, ""end_span"": 111, ""type"": ""Cell""}, {""token"": ""HGF"", ""start_span"": 114, ""end_span"": 117, ""type"": ""Cell""}]"	test
HGF constitutively produced VEGF and levels were significantly enhanced ( P less than 0. 01) by stimulation with Ve and OMP from A. actinomycetemcomitans and P. gingivalis at concentrations of 10 microg / ml or higher.	HGF,0,3,Cell	VEGF,28,32,Gene_or_gene_product	Ve,113,115,Gene_or_gene_product	OMP,120,123,Gene_or_gene_product	"[{""token"": ""HGF"", ""start_span"": 0, ""end_span"": 3, ""type"": ""Cell""}, {""token"": ""VEGF"", ""start_span"": 28, ""end_span"": 32, ""type"": ""Gene_or_gene_product""}, {""token"": ""Ve"", ""start_span"": 113, ""end_span"": 115, ""type"": ""Gene_or_gene_product""}, {""token"": ""OMP"", ""start_span"": 120, ""end_span"": 123, ""type"": ""Gene_or_gene_product""}]"	test
VEGF mRNA expression was also observed in Ve - and OMP - stimulated HGF.	VEGF,0,4,Gene_or_gene_product	Ve,42,44,Gene_or_gene_product	OMP,51,54,Gene_or_gene_product	HGF,68,71,Cell	"[{""token"": ""VEGF"", ""start_span"": 0, ""end_span"": 4, ""type"": ""Gene_or_gene_product""}, {""token"": ""Ve"", ""start_span"": 42, ""end_span"": 44, ""type"": ""Gene_or_gene_product""}, {""token"": ""OMP"", ""start_span"": 51, ""end_span"": 54, ""type"": ""Gene_or_gene_product""}, {""token"": ""HGF"", ""start_span"": 68, ""end_span"": 71, ""type"": ""Cell""}]"	test
These results suggest that Ve and OMP may be crucial heat - labile and protease - sensitive components of periodontal pathogens that enhance VEGF expression.	Ve,27,29,Gene_or_gene_product	OMP,34,37,Gene_or_gene_product	periodontal,106,117,Organism_subdivision	VEGF,141,145,Gene_or_gene_product	"[{""token"": ""Ve"", ""start_span"": 27, ""end_span"": 29, ""type"": ""Gene_or_gene_product""}, {""token"": ""OMP"", ""start_span"": 34, ""end_span"": 37, ""type"": ""Gene_or_gene_product""}, {""token"": ""periodontal"", ""start_span"": 106, ""end_span"": 117, ""type"": ""Organism_subdivision""}, {""token"": ""VEGF"", ""start_span"": 141, ""end_span"": 145, ""type"": ""Gene_or_gene_product""}]"	test
This review provides basic information for the understanding of the biology of NF - kappaB and aims at presenting experimental data illustrating the involvement of NF - kappaB / Rel in pancreatic cancer.	NF - kappaB,79,90,Gene_or_gene_product	NF - kappaB,164,175,Gene_or_gene_product	Rel,178,181,Gene_or_gene_product	pancreatic cancer,185,202,Cancer	"[{""token"": ""NF - kappaB"", ""start_span"": 79, ""end_span"": 90, ""type"": ""Gene_or_gene_product""}, {""token"": ""NF - kappaB"", ""start_span"": 164, ""end_span"": 175, ""type"": ""Gene_or_gene_product""}, {""token"": ""Rel"", ""start_span"": 178, ""end_span"": 181, ""type"": ""Gene_or_gene_product""}, {""token"": ""pancreatic cancer"", ""start_span"": 185, ""end_span"": 202, ""type"": ""Cancer""}]"	test
METHODS: Corneas of 105 rabbits were infected with viable yeast cells of C. albicans ( 2. 5 x 10 ( 5)).	Corneas,9,16,Multi	rabbits,24,31,Organism	yeast,58,63,Organism	cells,64,69,Cell	"[{""token"": ""Corneas"", ""start_span"": 9, ""end_span"": 16, ""type"": ""Multi""}, {""token"": ""rabbits"", ""start_span"": 24, ""end_span"": 31, ""type"": ""Organism""}, {""token"": ""yeast"", ""start_span"": 58, ""end_span"": 63, ""type"": ""Organism""}, {""token"": ""cells"", ""start_span"": 64, ""end_span"": 69, ""type"": ""Cell""}]"	test
The degree of corneal infiltration, ulceration, corneal clouding, hypopyon, conjunctivitis, neovascularization, and corneal perforation was monitored over a 24 - day period, as well as recultivation and resistance to fluconazole of the C. albicans pathogen.	corneal,14,21,Multi	corneal,48,55,Multi	corneal,116,123,Multi	fluconazole,217,228,Chemical	"[{""token"": ""corneal"", ""start_span"": 14, ""end_span"": 21, ""type"": ""Multi""}, {""token"": ""corneal"", ""start_span"": 48, ""end_span"": 55, ""type"": ""Multi""}, {""token"": ""corneal"", ""start_span"": 116, ""end_span"": 123, ""type"": ""Multi""}, {""token"": ""fluconazole"", ""start_span"": 217, ""end_span"": 228, ""type"": ""Chemical""}]"	test
Comparison of tissue integration between polyester and polypropylene prostheses in the preperitoneal space.	tissue,14,20,Tissue	polyester,41,50,Chemical	polypropylene,55,68,Chemical	preperitoneal space,87,106,Immaterial_anatomical_entity	"[{""token"": ""tissue"", ""start_span"": 14, ""end_span"": 20, ""type"": ""Tissue""}, {""token"": ""polyester"", ""start_span"": 41, ""end_span"": 50, ""type"": ""Chemical""}, {""token"": ""polypropylene"", ""start_span"": 55, ""end_span"": 68, ""type"": ""Chemical""}, {""token"": ""preperitoneal space"", ""start_span"": 87, ""end_span"": 106, ""type"": ""Immaterial_anatomical_entity""}]"	test
The aim of this study is to compare behavior and tissue response between two new polyester prostheses and a commonly used polypropylene ( PP) mesh.	tissue,49,55,Tissue	polyester,81,90,Chemical	polypropylene,122,135,Chemical	PP,138,140,Chemical	"[{""token"": ""tissue"", ""start_span"": 49, ""end_span"": 55, ""type"": ""Tissue""}, {""token"": ""polyester"", ""start_span"": 81, ""end_span"": 90, ""type"": ""Chemical""}, {""token"": ""polypropylene"", ""start_span"": 122, ""end_span"": 135, ""type"": ""Chemical""}, {""token"": ""PP"", ""start_span"": 138, ""end_span"": 140, ""type"": ""Chemical""}]"	test
Histological evaluation included amount of fibrous and fat encapsulation, connective tissue, foreign - body reaction, neovascularization, hemorrhage, necrosis, and exudate.	fibrous,43,50,Tissue	fat,55,58,Tissue	connective tissue,74,91,Tissue	exudate,164,171,Organism_substance	"[{""token"": ""fibrous"", ""start_span"": 43, ""end_span"": 50, ""type"": ""Tissue""}, {""token"": ""fat"", ""start_span"": 55, ""end_span"": 58, ""type"": ""Tissue""}, {""token"": ""connective tissue"", ""start_span"": 74, ""end_span"": 91, ""type"": ""Tissue""}, {""token"": ""exudate"", ""start_span"": 164, ""end_span"": 171, ""type"": ""Organism_substance""}]"	test
Here we show that transcription of the p53 gene is induced by IFN - alpha / beta, accompanied by an increase in p53 protein level.	p53,39,42,Gene_or_gene_product	IFN - alpha,62,73,Gene_or_gene_product	beta,76,80,Gene_or_gene_product	p53,112,115,Gene_or_gene_product	"[{""token"": ""p53"", ""start_span"": 39, ""end_span"": 42, ""type"": ""Gene_or_gene_product""}, {""token"": ""IFN - alpha"", ""start_span"": 62, ""end_span"": 73, ""type"": ""Gene_or_gene_product""}, {""token"": ""beta"", ""start_span"": 76, ""end_span"": 80, ""type"": ""Gene_or_gene_product""}, {""token"": ""p53"", ""start_span"": 112, ""end_span"": 115, ""type"": ""Gene_or_gene_product""}]"	test
IFN - alpha / beta signalling itself does not activate p53; rather, it contributes to boosting p53 responses to stress signals.	IFN - alpha,0,11,Gene_or_gene_product	beta,14,18,Gene_or_gene_product	p53,55,58,Gene_or_gene_product	p53,95,98,Gene_or_gene_product	"[{""token"": ""IFN - alpha"", ""start_span"": 0, ""end_span"": 11, ""type"": ""Gene_or_gene_product""}, {""token"": ""beta"", ""start_span"": 14, ""end_span"": 18, ""type"": ""Gene_or_gene_product""}, {""token"": ""p53"", ""start_span"": 55, ""end_span"": 58, ""type"": ""Gene_or_gene_product""}, {""token"": ""p53"", ""start_span"": 95, ""end_span"": 98, ""type"": ""Gene_or_gene_product""}]"	test
We show examples in which p53 gene induction by IFN - alpha / beta contributes to tumour suppression.	p53,26,29,Gene_or_gene_product	IFN - alpha,48,59,Gene_or_gene_product	beta,62,66,Gene_or_gene_product	tumour,82,88,Cancer	"[{""token"": ""p53"", ""start_span"": 26, ""end_span"": 29, ""type"": ""Gene_or_gene_product""}, {""token"": ""IFN - alpha"", ""start_span"": 48, ""end_span"": 59, ""type"": ""Gene_or_gene_product""}, {""token"": ""beta"", ""start_span"": 62, ""end_span"": 66, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumour"", ""start_span"": 82, ""end_span"": 88, ""type"": ""Cancer""}]"	test
A chemokine receptor, CXCR4, and its endogenous ligand, stromal cell - derived factor - 1 ( SDF - 1), have been recognized to be involved in the metastasis of several types of cancers.	CXCR4,22,27,Gene_or_gene_product	stromal cell - derived factor - 1,56,89,Gene_or_gene_product	SDF - 1,92,99,Gene_or_gene_product	cancers,176,183,Cancer	"[{""token"": ""CXCR4"", ""start_span"": 22, ""end_span"": 27, ""type"": ""Gene_or_gene_product""}, {""token"": ""stromal cell - derived factor - 1"", ""start_span"": 56, ""end_span"": 89, ""type"": ""Gene_or_gene_product""}, {""token"": ""SDF - 1"", ""start_span"": 92, ""end_span"": 99, ""type"": ""Gene_or_gene_product""}, {""token"": ""cancers"", ""start_span"": 176, ""end_span"": 183, ""type"": ""Cancer""}]"	test
These results suggest that T140 analogs have potential use for cancer therapy, and that small molecular CXCR4 antagonists could potentially replace neutralizing antibodies as anti - metastatic agents for breast cancer.	T140 analogs,27,39,Chemical	cancer,63,69,Cancer	CXCR4,104,109,Gene_or_gene_product	breast cancer,204,217,Cancer	"[{""token"": ""T140 analogs"", ""start_span"": 27, ""end_span"": 39, ""type"": ""Chemical""}, {""token"": ""cancer"", ""start_span"": 63, ""end_span"": 69, ""type"": ""Cancer""}, {""token"": ""CXCR4"", ""start_span"": 104, ""end_span"": 109, ""type"": ""Gene_or_gene_product""}, {""token"": ""breast cancer"", ""start_span"": 204, ""end_span"": 217, ""type"": ""Cancer""}]"	test
CCL16 induces dose - dependent random and directional migration of endothelial cells isolated from large vessels and liver capillaries without inducing their proliferation.	CCL16,0,5,Gene_or_gene_product	endothelial cells,67,84,Cell	vessels,105,112,Multi	liver capillaries,117,134,Tissue	"[{""token"": ""CCL16"", ""start_span"": 0, ""end_span"": 5, ""type"": ""Gene_or_gene_product""}, {""token"": ""endothelial cells"", ""start_span"": 67, ""end_span"": 84, ""type"": ""Cell""}, {""token"": ""vessels"", ""start_span"": 105, ""end_span"": 112, ""type"": ""Multi""}, {""token"": ""liver capillaries"", ""start_span"": 117, ""end_span"": 134, ""type"": ""Tissue""}]"	test
It also promotes endothelial differentiation into capillary - like structures in an in vitro assay and is angiogenic in the chick chorionallantoic membrane.	endothelial,17,28,Cell	capillary - like structures,50,77,Tissue	chick,124,129,Organism	chorionallantoic membrane,130,155,Multi	"[{""token"": ""endothelial"", ""start_span"": 17, ""end_span"": 28, ""type"": ""Cell""}, {""token"": ""capillary - like structures"", ""start_span"": 50, ""end_span"": 77, ""type"": ""Tissue""}, {""token"": ""chick"", ""start_span"": 124, ""end_span"": 129, ""type"": ""Organism""}, {""token"": ""chorionallantoic membrane"", ""start_span"": 130, ""end_span"": 155, ""type"": ""Multi""}]"	test
The largely restricted CCL16 expression in the liver suggests that this chemokine may play a role in hepatic vascular formation during development and in angiogenesis associated to hepatic diseases.	CCL16,23,28,Gene_or_gene_product	liver,47,52,Organ	hepatic vascular,101,117,Multi	hepatic,181,188,Organ	"[{""token"": ""CCL16"", ""start_span"": 23, ""end_span"": 28, ""type"": ""Gene_or_gene_product""}, {""token"": ""liver"", ""start_span"": 47, ""end_span"": 52, ""type"": ""Organ""}, {""token"": ""hepatic vascular"", ""start_span"": 101, ""end_span"": 117, ""type"": ""Multi""}, {""token"": ""hepatic"", ""start_span"": 181, ""end_span"": 188, ""type"": ""Organ""}]"	test
Simvastatin induces apoptosis of B - CLL cells by activation of mitochondrial caspase 9.	Simvastatin,0,11,Chemical	B - CLL cells,33,46,Cell	mitochondrial,64,77,Cellular_component	caspase 9,78,87,Gene_or_gene_product	"[{""token"": ""Simvastatin"", ""start_span"": 0, ""end_span"": 11, ""type"": ""Chemical""}, {""token"": ""B - CLL cells"", ""start_span"": 33, ""end_span"": 46, ""type"": ""Cell""}, {""token"": ""mitochondrial"", ""start_span"": 64, ""end_span"": 77, ""type"": ""Cellular_component""}, {""token"": ""caspase 9"", ""start_span"": 78, ""end_span"": 87, ""type"": ""Gene_or_gene_product""}]"	test
Addition of the caspase inhibitor Z - VAD. fmk inhibited caspase 8 and 3 significantly but did not affect caspase 9.	caspase,16,23,Gene_or_gene_product	caspase 8,57,66,Gene_or_gene_product	3,71,72,Gene_or_gene_product	caspase 9,106,115,Gene_or_gene_product	"[{""token"": ""caspase"", ""start_span"": 16, ""end_span"": 23, ""type"": ""Gene_or_gene_product""}, {""token"": ""caspase 8"", ""start_span"": 57, ""end_span"": 66, ""type"": ""Gene_or_gene_product""}, {""token"": ""3"", ""start_span"": 71, ""end_span"": 72, ""type"": ""Gene_or_gene_product""}, {""token"": ""caspase 9"", ""start_span"": 106, ""end_span"": 115, ""type"": ""Gene_or_gene_product""}]"	test
CONCLUSION: Exposure of clonal B lymphocytes from patients with CLL to simvastatin decreases viability significantly by the induction of apoptosis.	clonal B lymphocytes,24,44,Cell	patients,50,58,Organism	CLL,64,67,Cancer	simvastatin,71,82,Chemical	"[{""token"": ""clonal B lymphocytes"", ""start_span"": 24, ""end_span"": 44, ""type"": ""Cell""}, {""token"": ""patients"", ""start_span"": 50, ""end_span"": 58, ""type"": ""Organism""}, {""token"": ""CLL"", ""start_span"": 64, ""end_span"": 67, ""type"": ""Cancer""}, {""token"": ""simvastatin"", ""start_span"": 71, ""end_span"": 82, ""type"": ""Chemical""}]"	test
These data suggest that increases in endothelial cell migration and plasminogen activator after angiotensin system inhibition are at least partially pp60c - src mediated.	endothelial cell,37,53,Cell	plasminogen activator,68,89,Gene_or_gene_product	angiotensin,96,107,Gene_or_gene_product	pp60c - src,149,160,Gene_or_gene_product	"[{""token"": ""endothelial cell"", ""start_span"": 37, ""end_span"": 53, ""type"": ""Cell""}, {""token"": ""plasminogen activator"", ""start_span"": 68, ""end_span"": 89, ""type"": ""Gene_or_gene_product""}, {""token"": ""angiotensin"", ""start_span"": 96, ""end_span"": 107, ""type"": ""Gene_or_gene_product""}, {""token"": ""pp60c - src"", ""start_span"": 149, ""end_span"": 160, ""type"": ""Gene_or_gene_product""}]"	test
Elevated c - src expression with angiotensin system inhibition may act to enhance intimal wound closure and to reduce luminal thrombogenicity in vivo.	c - src,9,16,Gene_or_gene_product	angiotensin,33,44,Gene_or_gene_product	intimal wound,82,95,Pathological_formation	luminal,118,125,Immaterial_anatomical_entity	"[{""token"": ""c - src"", ""start_span"": 9, ""end_span"": 16, ""type"": ""Gene_or_gene_product""}, {""token"": ""angiotensin"", ""start_span"": 33, ""end_span"": 44, ""type"": ""Gene_or_gene_product""}, {""token"": ""intimal wound"", ""start_span"": 82, ""end_span"": 95, ""type"": ""Pathological_formation""}, {""token"": ""luminal"", ""start_span"": 118, ""end_span"": 125, ""type"": ""Immaterial_anatomical_entity""}]"	test
Depending on the cell type, expression of ANGPT1 and ANGPT2 was either activated or repressed in response to hypoxia or AdCA5.	cell,17,21,Cell	ANGPT1,42,48,Gene_or_gene_product	ANGPT2,53,59,Gene_or_gene_product	AdCA5,120,125,Organism	"[{""token"": ""cell"", ""start_span"": 17, ""end_span"": 21, ""type"": ""Cell""}, {""token"": ""ANGPT1"", ""start_span"": 42, ""end_span"": 48, ""type"": ""Gene_or_gene_product""}, {""token"": ""ANGPT2"", ""start_span"": 53, ""end_span"": 59, ""type"": ""Gene_or_gene_product""}, {""token"": ""AdCA5"", ""start_span"": 120, ""end_span"": 125, ""type"": ""Organism""}]"	test
However, the strong increase of angiogenesis in AOGEN - transgenic mice compared with mice with normal ANG II levels suggests additional stimulatory activity.	AOGEN,48,53,Gene_or_gene_product	mice,67,71,Organism	mice,86,90,Organism	ANG II,103,109,Gene_or_gene_product	"[{""token"": ""AOGEN"", ""start_span"": 48, ""end_span"": 53, ""type"": ""Gene_or_gene_product""}, {""token"": ""mice"", ""start_span"": 67, ""end_span"": 71, ""type"": ""Organism""}, {""token"": ""mice"", ""start_span"": 86, ""end_span"": 90, ""type"": ""Organism""}, {""token"": ""ANG II"", ""start_span"": 103, ""end_span"": 109, ""type"": ""Gene_or_gene_product""}]"	test
Moreover, the overexpression of IGF1 - R in these cells was associated with IGF1 - R - induced activation of Akt and up - regulation of the antiapoptotic protein Bcl - x ( L).	IGF1 - R,32,40,Gene_or_gene_product	cells,50,55,Cell	IGF1 - R,76,84,Gene_or_gene_product	Akt,109,112,Gene_or_gene_product	"[{""token"": ""IGF1 - R"", ""start_span"": 32, ""end_span"": 40, ""type"": ""Gene_or_gene_product""}, {""token"": ""cells"", ""start_span"": 50, ""end_span"": 55, ""type"": ""Cell""}, {""token"": ""IGF1 - R"", ""start_span"": 76, ""end_span"": 84, ""type"": ""Gene_or_gene_product""}, {""token"": ""Akt"", ""start_span"": 109, ""end_span"": 112, ""type"": ""Gene_or_gene_product""}]"	test
Expression of EphA2 and E - cadherin in colorectal cancer: correlation with cancer metastasis.	EphA2,14,19,Gene_or_gene_product	E - cadherin,24,36,Gene_or_gene_product	colorectal cancer,40,57,Cancer	cancer,76,82,Cancer	"[{""token"": ""EphA2"", ""start_span"": 14, ""end_span"": 19, ""type"": ""Gene_or_gene_product""}, {""token"": ""E - cadherin"", ""start_span"": 24, ""end_span"": 36, ""type"": ""Gene_or_gene_product""}, {""token"": ""colorectal cancer"", ""start_span"": 40, ""end_span"": 57, ""type"": ""Cancer""}, {""token"": ""cancer"", ""start_span"": 76, ""end_span"": 82, ""type"": ""Cancer""}]"	test
Reduced expression of E - cadherin, an intercellular adhesion molecule of epithelial cells, has been reported to be associated with aggressive clinicopathological phenotypes in various cancers.	E - cadherin,22,34,Gene_or_gene_product	intercellular,39,52,Immaterial_anatomical_entity	epithelial cells,74,90,Cell	cancers,185,192,Cancer	"[{""token"": ""E - cadherin"", ""start_span"": 22, ""end_span"": 34, ""type"": ""Gene_or_gene_product""}, {""token"": ""intercellular"", ""start_span"": 39, ""end_span"": 52, ""type"": ""Immaterial_anatomical_entity""}, {""token"": ""epithelial cells"", ""start_span"": 74, ""end_span"": 90, ""type"": ""Cell""}, {""token"": ""cancers"", ""start_span"": 185, ""end_span"": 192, ""type"": ""Cancer""}]"	test
Here we studied clusterin expression in PNT1a cells subjected to serum - starvation with the aim of defining clusterin early molecular changes following apoptosis induction.	clusterin,16,25,Gene_or_gene_product	PNT1a cells,40,51,Cell	serum,65,70,Organism_substance	clusterin,109,118,Gene_or_gene_product	"[{""token"": ""clusterin"", ""start_span"": 16, ""end_span"": 25, ""type"": ""Gene_or_gene_product""}, {""token"": ""PNT1a cells"", ""start_span"": 40, ""end_span"": 51, ""type"": ""Cell""}, {""token"": ""serum"", ""start_span"": 65, ""end_span"": 70, ""type"": ""Organism_substance""}, {""token"": ""clusterin"", ""start_span"": 109, ""end_span"": 118, ""type"": ""Gene_or_gene_product""}]"	test
On the 8th day of serum - free culturing, only the higher molecular weight protein - band of about 45 kDa was clearly induced and accumulated in detached cells and apoptotic bodies in which PARP was activated.	serum,18,23,Organism_substance	cells,154,159,Cell	apoptotic bodies,164,180,Cellular_component	PARP,190,194,Gene_or_gene_product	"[{""token"": ""serum"", ""start_span"": 18, ""end_span"": 23, ""type"": ""Organism_substance""}, {""token"": ""cells"", ""start_span"": 154, ""end_span"": 159, ""type"": ""Cell""}, {""token"": ""apoptotic bodies"", ""start_span"": 164, ""end_span"": 180, ""type"": ""Cellular_component""}, {""token"": ""PARP"", ""start_span"": 190, ""end_span"": 194, ""type"": ""Gene_or_gene_product""}]"	test
In contrast to CYR61 and CTGF, no significant association was found between expression of either WISP - 1 or NOV versus any of the pathological features.	CYR61,15,20,Gene_or_gene_product	CTGF,25,29,Gene_or_gene_product	WISP - 1,97,105,Gene_or_gene_product	NOV,109,112,Gene_or_gene_product	"[{""token"": ""CYR61"", ""start_span"": 15, ""end_span"": 20, ""type"": ""Gene_or_gene_product""}, {""token"": ""CTGF"", ""start_span"": 25, ""end_span"": 29, ""type"": ""Gene_or_gene_product""}, {""token"": ""WISP - 1"", ""start_span"": 97, ""end_span"": 105, ""type"": ""Gene_or_gene_product""}, {""token"": ""NOV"", ""start_span"": 109, ""end_span"": 112, ""type"": ""Gene_or_gene_product""}]"	test
METHODS: Using two - dimensional electrophoresis and liquid chromatography - electrospray ionization - tandem mass spectrometry ( LC - ESI - MS / MS), we analyzed differentially displayed proteomics of human hepatocellular carcinoma cell lines Hep3B, MHCC97L, MHCC97H with different metastasic potential.	human,202,207,Organism	hepatocellular carcinoma cell lines Hep3B,208,249,Cell	MHCC97L,251,258,Cell	MHCC97H,260,267,Cell	"[{""token"": ""human"", ""start_span"": 202, ""end_span"": 207, ""type"": ""Organism""}, {""token"": ""hepatocellular carcinoma cell lines Hep3B"", ""start_span"": 208, ""end_span"": 249, ""type"": ""Cell""}, {""token"": ""MHCC97L"", ""start_span"": 251, ""end_span"": 258, ""type"": ""Cell""}, {""token"": ""MHCC97H"", ""start_span"": 260, ""end_span"": 267, ""type"": ""Cell""}]"	test
RESULTS: Approximate 1, 000 protein spots were detected on silver - stained gel by ImageMaster ( 977 + / - 113 spots in Hep3B, 1092 + / - 40 in MHCC97L, and 889 + / - 14 in MHCC97H).	silver,59,65,Chemical	Hep3B,120,125,Cell	MHCC97L,144,151,Cell	MHCC97H,173,180,Cell	"[{""token"": ""silver"", ""start_span"": 59, ""end_span"": 65, ""type"": ""Chemical""}, {""token"": ""Hep3B"", ""start_span"": 120, ""end_span"": 125, ""type"": ""Cell""}, {""token"": ""MHCC97L"", ""start_span"": 144, ""end_span"": 151, ""type"": ""Cell""}, {""token"": ""MHCC97H"", ""start_span"": 173, ""end_span"": 180, ""type"": ""Cell""}]"	test
Expression of cyclooxygenase ( COX) - 2 plays a key role in tumorigenesis and development and peroxisome proliferator - activated receptor gamma ( PPARgamma) has been implicated in the control of COX - 2 expression in some tissues.	peroxisome proliferator - activated receptor gamma,94,144,Gene_or_gene_product	PPARgamma,147,156,Gene_or_gene_product	COX - 2,196,203,Gene_or_gene_product	tissues,223,230,Tissue	"[{""token"": ""peroxisome proliferator - activated receptor gamma"", ""start_span"": 94, ""end_span"": 144, ""type"": ""Gene_or_gene_product""}, {""token"": ""PPARgamma"", ""start_span"": 147, ""end_span"": 156, ""type"": ""Gene_or_gene_product""}, {""token"": ""COX - 2"", ""start_span"": 196, ""end_span"": 203, ""type"": ""Gene_or_gene_product""}, {""token"": ""tissues"", ""start_span"": 223, ""end_span"": 230, ""type"": ""Tissue""}]"	test
The frequency of COX - 2 and PPARgamma detection was significantly increased and decreased as lesions progressed to carcinoma, respectively.	COX - 2,17,24,Gene_or_gene_product	PPARgamma,29,38,Gene_or_gene_product	lesions,94,101,Pathological_formation	carcinoma,116,125,Cancer	"[{""token"": ""COX - 2"", ""start_span"": 17, ""end_span"": 24, ""type"": ""Gene_or_gene_product""}, {""token"": ""PPARgamma"", ""start_span"": 29, ""end_span"": 38, ""type"": ""Gene_or_gene_product""}, {""token"": ""lesions"", ""start_span"": 94, ""end_span"": 101, ""type"": ""Pathological_formation""}, {""token"": ""carcinoma"", ""start_span"": 116, ""end_span"": 125, ""type"": ""Cancer""}]"	test
Furthermore, in cultured ovarian carcinoma cells, Western blot revealed that PPARgamma and COX - 2 expression was regulated conversely as a result of stimulation by 15 - deoxy - Delta ( 12, 14) PGJ ( 2) ( 15 - PGJ ( 2)), a PPARgamma activator.	ovarian carcinoma cells,25,48,Cell	PPARgamma,77,86,Gene_or_gene_product	COX - 2,91,98,Gene_or_gene_product	PPARgamma,223,232,Gene_or_gene_product	"[{""token"": ""ovarian carcinoma cells"", ""start_span"": 25, ""end_span"": 48, ""type"": ""Cell""}, {""token"": ""PPARgamma"", ""start_span"": 77, ""end_span"": 86, ""type"": ""Gene_or_gene_product""}, {""token"": ""COX - 2"", ""start_span"": 91, ""end_span"": 98, ""type"": ""Gene_or_gene_product""}, {""token"": ""PPARgamma"", ""start_span"": 223, ""end_span"": 232, ""type"": ""Gene_or_gene_product""}]"	test
In addition, 15d - PGJ ( 2) suppressed tumour necrosis factor - alpha - induced - COX - 2 expression, confirming the reciprocal correlation between COX - 2 and PPARgamma.	tumour necrosis factor - alpha,39,69,Gene_or_gene_product	COX - 2,82,89,Gene_or_gene_product	COX - 2,148,155,Gene_or_gene_product	PPARgamma,160,169,Gene_or_gene_product	"[{""token"": ""tumour necrosis factor - alpha"", ""start_span"": 39, ""end_span"": 69, ""type"": ""Gene_or_gene_product""}, {""token"": ""COX - 2"", ""start_span"": 82, ""end_span"": 89, ""type"": ""Gene_or_gene_product""}, {""token"": ""COX - 2"", ""start_span"": 148, ""end_span"": 155, ""type"": ""Gene_or_gene_product""}, {""token"": ""PPARgamma"", ""start_span"": 160, ""end_span"": 169, ""type"": ""Gene_or_gene_product""}]"	test
Reactive oxygen species ( ROS) produced in the course of cellular oxidative phosphorylation, and by activated phagocytic cells during oxidative bursts, exceed the physiological buffering capacity and result in oxidative stress.	Reactive oxygen species,0,23,Chemical	ROS,26,29,Chemical	cellular,57,65,Cell	phagocytic cells,110,126,Cell	"[{""token"": ""Reactive oxygen species"", ""start_span"": 0, ""end_span"": 23, ""type"": ""Chemical""}, {""token"": ""ROS"", ""start_span"": 26, ""end_span"": 29, ""type"": ""Chemical""}, {""token"": ""cellular"", ""start_span"": 57, ""end_span"": 65, ""type"": ""Cell""}, {""token"": ""phagocytic cells"", ""start_span"": 110, ""end_span"": 126, ""type"": ""Cell""}]"	test
The excessive production of ROS can damage protein, lipids, nucleic acids, and matrix components.	ROS,28,31,Chemical	lipids,52,58,Chemical	nucleic acids,60,73,Chemical	matrix components,79,96,Cellular_component	"[{""token"": ""ROS"", ""start_span"": 28, ""end_span"": 31, ""type"": ""Chemical""}, {""token"": ""lipids"", ""start_span"": 52, ""end_span"": 58, ""type"": ""Chemical""}, {""token"": ""nucleic acids"", ""start_span"": 60, ""end_span"": 73, ""type"": ""Chemical""}, {""token"": ""matrix components"", ""start_span"": 79, ""end_span"": 96, ""type"": ""Cellular_component""}]"	test
Repetitive cycles of hypoxia and reoxygenation associated with changes in synovial perfusion are postulated to activate hypoxia - inducible factor - 1alpha and nuclear factor - kappaB, two key transcription factors that are regulated by changes in cellular oxygenation and cytokine stimulation, and that in turn orchestrate the expression of a spectrum of genes critical to the persistence of synovitis.	synovial,74,82,Multi	hypoxia - inducible factor - 1alpha,120,155,Gene_or_gene_product	nuclear factor - kappaB,160,183,Gene_or_gene_product	cellular,248,256,Cell	"[{""token"": ""synovial"", ""start_span"": 74, ""end_span"": 82, ""type"": ""Multi""}, {""token"": ""hypoxia - inducible factor - 1alpha"", ""start_span"": 120, ""end_span"": 155, ""type"": ""Gene_or_gene_product""}, {""token"": ""nuclear factor - kappaB"", ""start_span"": 160, ""end_span"": 183, ""type"": ""Gene_or_gene_product""}, {""token"": ""cellular"", ""start_span"": 248, ""end_span"": 256, ""type"": ""Cell""}]"	test
Paclitaxel treatment resulted in MAPK activation and apoptosis of MDA - MB - 231 breast cancer cells, and both processes were inhibited by Dex pretreatment.	Paclitaxel,0,10,Chemical	MAPK,33,37,Gene_or_gene_product	MDA - MB - 231 breast cancer cells,66,100,Cell	Dex,139,142,Chemical	"[{""token"": ""Paclitaxel"", ""start_span"": 0, ""end_span"": 10, ""type"": ""Chemical""}, {""token"": ""MAPK"", ""start_span"": 33, ""end_span"": 37, ""type"": ""Gene_or_gene_product""}, {""token"": ""MDA - MB - 231 breast cancer cells"", ""start_span"": 66, ""end_span"": 100, ""type"": ""Cell""}, {""token"": ""Dex"", ""start_span"": 139, ""end_span"": 142, ""type"": ""Chemical""}]"	test
ERK1 / 2 and JNK inactivation was associated with Ets - like transcription factor - 1 ( ELK - 1) dephosphorylation.	ERK1 / 2,0,8,Gene_or_gene_product	JNK,13,16,Gene_or_gene_product	Ets - like transcription factor - 1,50,85,Gene_or_gene_product	ELK - 1,88,95,Gene_or_gene_product	"[{""token"": ""ERK1 / 2"", ""start_span"": 0, ""end_span"": 8, ""type"": ""Gene_or_gene_product""}, {""token"": ""JNK"", ""start_span"": 13, ""end_span"": 16, ""type"": ""Gene_or_gene_product""}, {""token"": ""Ets - like transcription factor - 1"", ""start_span"": 50, ""end_span"": 85, ""type"": ""Gene_or_gene_product""}, {""token"": ""ELK - 1"", ""start_span"": 88, ""end_span"": 95, ""type"": ""Gene_or_gene_product""}]"	test
This approach revealed a previously unrecognized transcriptional target of ELK - 1, the human tissue plasminogen activator ( tPA).	ELK - 1,75,82,Gene_or_gene_product	human,88,93,Organism	tissue plasminogen activator,94,122,Gene_or_gene_product	tPA,125,128,Gene_or_gene_product	"[{""token"": ""ELK - 1"", ""start_span"": 75, ""end_span"": 82, ""type"": ""Gene_or_gene_product""}, {""token"": ""human"", ""start_span"": 88, ""end_span"": 93, ""type"": ""Organism""}, {""token"": ""tissue plasminogen activator"", ""start_span"": 94, ""end_span"": 122, ""type"": ""Gene_or_gene_product""}, {""token"": ""tPA"", ""start_span"": 125, ""end_span"": 128, ""type"": ""Gene_or_gene_product""}]"	test
Recent in vitro and in vivo evidence suggest that they may also have direct antitumor effects via induction of apoptosis, inhibition of the invasive potential of tumor cell lines in vitro, inhibition of angiogenesis, and reduction in tumor growth indirectly via effects on accessory cells.	antitumor,76,85,Cancer	tumor cell lines,162,178,Cell	tumor,234,239,Cancer	accessory cells,273,288,Cell	"[{""token"": ""antitumor"", ""start_span"": 76, ""end_span"": 85, ""type"": ""Cancer""}, {""token"": ""tumor cell lines"", ""start_span"": 162, ""end_span"": 178, ""type"": ""Cell""}, {""token"": ""tumor"", ""start_span"": 234, ""end_span"": 239, ""type"": ""Cancer""}, {""token"": ""accessory cells"", ""start_span"": 273, ""end_span"": 288, ""type"": ""Cell""}]"	test
METHODS: Forty patients with recurrent or metastatic advanced cancer, without bone metastases, were randomized into the trial to either receive zoledronic acid or no treatment.	patients,15,23,Organism	cancer,62,68,Cancer	bone metastases,78,93,Cancer	zoledronic acid,144,159,Chemical	"[{""token"": ""patients"", ""start_span"": 15, ""end_span"": 23, ""type"": ""Organism""}, {""token"": ""cancer"", ""start_span"": 62, ""end_span"": 68, ""type"": ""Cancer""}, {""token"": ""bone metastases"", ""start_span"": 78, ""end_span"": 93, ""type"": ""Cancer""}, {""token"": ""zoledronic acid"", ""start_span"": 144, ""end_span"": 159, ""type"": ""Chemical""}]"	test
However, as only a fraction of cells in advanced Kaposi ' s sarcoma lesions express vGPCR, it is unclear whether this unique viral oncogene contributes to Kaposi ' s sarcoma progression.	cells,31,36,Cell	advanced Kaposi ' s sarcoma lesions,40,75,Cancer	vGPCR,84,89,Gene_or_gene_product	Kaposi ' s sarcoma,155,173,Cancer	"[{""token"": ""cells"", ""start_span"": 31, ""end_span"": 36, ""type"": ""Cell""}, {""token"": ""advanced Kaposi ' s sarcoma lesions"", ""start_span"": 40, ""end_span"": 75, ""type"": ""Cancer""}, {""token"": ""vGPCR"", ""start_span"": 84, ""end_span"": 89, ""type"": ""Gene_or_gene_product""}, {""token"": ""Kaposi ' s sarcoma"", ""start_span"": 155, ""end_span"": 173, ""type"": ""Cancer""}]"	test
These mice were then treated with ganciclovir to specifically target only the vGPCR - expressing cells.	mice,6,10,Organism	ganciclovir,34,45,Chemical	vGPCR,78,83,Gene_or_gene_product	cells,97,102,Cell	"[{""token"": ""mice"", ""start_span"": 6, ""end_span"": 10, ""type"": ""Organism""}, {""token"": ""ganciclovir"", ""start_span"": 34, ""end_span"": 45, ""type"": ""Chemical""}, {""token"": ""vGPCR"", ""start_span"": 78, ""end_span"": 83, ""type"": ""Gene_or_gene_product""}, {""token"": ""cells"", ""start_span"": 97, ""end_span"": 102, ""type"": ""Cell""}]"	test
Since the intrinsic resistance of prostate carcinoma likely reflects a low susceptibility to drug - induced apoptosis, in this study we explored the possibility of sensitizing prostate carcinoma cells to apoptosis by combination of TRAIL with camptothecins.	prostate carcinoma,34,52,Cancer	prostate carcinoma cells,176,200,Cell	TRAIL,232,237,Gene_or_gene_product	camptothecins,243,256,Chemical	"[{""token"": ""prostate carcinoma"", ""start_span"": 34, ""end_span"": 52, ""type"": ""Cancer""}, {""token"": ""prostate carcinoma cells"", ""start_span"": 176, ""end_span"": 200, ""type"": ""Cell""}, {""token"": ""TRAIL"", ""start_span"": 232, ""end_span"": 237, ""type"": ""Gene_or_gene_product""}, {""token"": ""camptothecins"", ""start_span"": 243, ""end_span"": 256, ""type"": ""Chemical""}]"	test
In DU - 145 cells apoptosis was increased by lower TRAIL concentrations and was earlier than in PC - 3 cells, as shown using Annexin V - binding assay.	DU - 145 cells,3,17,Cell	TRAIL,51,56,Gene_or_gene_product	PC - 3 cells,96,108,Cell	Annexin V,125,134,Gene_or_gene_product	"[{""token"": ""DU - 145 cells"", ""start_span"": 3, ""end_span"": 17, ""type"": ""Cell""}, {""token"": ""TRAIL"", ""start_span"": 51, ""end_span"": 56, ""type"": ""Gene_or_gene_product""}, {""token"": ""PC - 3 cells"", ""start_span"": 96, ""end_span"": 108, ""type"": ""Cell""}, {""token"": ""Annexin V"", ""start_span"": 125, ""end_span"": 134, ""type"": ""Gene_or_gene_product""}]"	test
Targeting PIM kinases impairs survival of hematopoietic cells transformed by kinase inhibitor - sensitive and kinase inhibitor - resistant forms of Fms - like tyrosine kinase 3 and BCR / ABL.	hematopoietic cells,42,61,Cell	Fms - like tyrosine kinase 3,148,176,Gene_or_gene_product	BCR,181,184,Gene_or_gene_product	ABL,187,190,Gene_or_gene_product	"[{""token"": ""hematopoietic cells"", ""start_span"": 42, ""end_span"": 61, ""type"": ""Cell""}, {""token"": ""Fms - like tyrosine kinase 3"", ""start_span"": 148, ""end_span"": 176, ""type"": ""Gene_or_gene_product""}, {""token"": ""BCR"", ""start_span"": 181, ""end_span"": 184, ""type"": ""Gene_or_gene_product""}, {""token"": ""ABL"", ""start_span"": 187, ""end_span"": 190, ""type"": ""Gene_or_gene_product""}]"	test
Angiostatin inhibits both ATP synthesis and ATP hydrolysis ( Moser et al., 2001) and interferes with intracellular pH regulation ( Wahl and Grant, 2002; Wahl et al., 2002).	Angiostatin,0,11,Gene_or_gene_product	ATP,26,29,Chemical	ATP,44,47,Chemical	intracellular,101,114,Immaterial_anatomical_entity	"[{""token"": ""Angiostatin"", ""start_span"": 0, ""end_span"": 11, ""type"": ""Gene_or_gene_product""}, {""token"": ""ATP"", ""start_span"": 26, ""end_span"": 29, ""type"": ""Chemical""}, {""token"": ""ATP"", ""start_span"": 44, ""end_span"": 47, ""type"": ""Chemical""}, {""token"": ""intracellular"", ""start_span"": 101, ""end_span"": 114, ""type"": ""Immaterial_anatomical_entity""}]"	test
The loss of one allele of the p53 gene ( located on chromosome 17p13) occurred in at least 6 ( 60%) of the 10 patients who were heterozygous at the p53 locus.	p53,30,33,Gene_or_gene_product	chromosome 17p13,52,68,Cellular_component	patients,110,118,Organism	p53,148,151,Gene_or_gene_product	"[{""token"": ""p53"", ""start_span"": 30, ""end_span"": 33, ""type"": ""Gene_or_gene_product""}, {""token"": ""chromosome 17p13"", ""start_span"": 52, ""end_span"": 68, ""type"": ""Cellular_component""}, {""token"": ""patients"", ""start_span"": 110, ""end_span"": 118, ""type"": ""Organism""}, {""token"": ""p53"", ""start_span"": 148, ""end_span"": 151, ""type"": ""Gene_or_gene_product""}]"	test
High levels of allele loss also were detected for chromosomes 8q ( 4 of 9; 44%) and 16p ( 5 of 6; 83%) and may indicate the presence of additional cellular genes whose functional loss is important in the development of HCCs.	chromosomes 8q,50,64,Cellular_component	16p,84,87,Cellular_component	cellular,147,155,Cell	HCCs,219,223,Cancer	"[{""token"": ""chromosomes 8q"", ""start_span"": 50, ""end_span"": 64, ""type"": ""Cellular_component""}, {""token"": ""16p"", ""start_span"": 84, ""end_span"": 87, ""type"": ""Cellular_component""}, {""token"": ""cellular"", ""start_span"": 147, ""end_span"": 155, ""type"": ""Cell""}, {""token"": ""HCCs"", ""start_span"": 219, ""end_span"": 223, ""type"": ""Cancer""}]"	test
Because proteolytic degradation of the extracellular matrix is a critical component of endothelial invasion in angiogenesis, it is logical to assume that PSMA participates in matrix degradation.	extracellular matrix,39,59,Cellular_component	endothelial,87,98,Cell	PSMA,154,158,Gene_or_gene_product	matrix,175,181,Cellular_component	"[{""token"": ""extracellular matrix"", ""start_span"": 39, ""end_span"": 59, ""type"": ""Cellular_component""}, {""token"": ""endothelial"", ""start_span"": 87, ""end_span"": 98, ""type"": ""Cell""}, {""token"": ""PSMA"", ""start_span"": 154, ""end_span"": 158, ""type"": ""Gene_or_gene_product""}, {""token"": ""matrix"", ""start_span"": 175, ""end_span"": 181, ""type"": ""Cellular_component""}]"	test
We show that PSMA inhibition, knockdown, or deficiency decreases endothelial cell invasion in vitro via integrin and PAK, thus abrogating angiogenesis.	PSMA,13,17,Gene_or_gene_product	endothelial cell,65,81,Cell	integrin,104,112,Gene_or_gene_product	PAK,117,120,Gene_or_gene_product	"[{""token"": ""PSMA"", ""start_span"": 13, ""end_span"": 17, ""type"": ""Gene_or_gene_product""}, {""token"": ""endothelial cell"", ""start_span"": 65, ""end_span"": 81, ""type"": ""Cell""}, {""token"": ""integrin"", ""start_span"": 104, ""end_span"": 112, ""type"": ""Gene_or_gene_product""}, {""token"": ""PAK"", ""start_span"": 117, ""end_span"": 120, ""type"": ""Gene_or_gene_product""}]"	test
Finally, the inhibition of PAK activation enhances the PSMA / filamin A interaction and, thus, boosts PSMA activity.	PAK,27,30,Gene_or_gene_product	PSMA,55,59,Gene_or_gene_product	filamin A,62,71,Gene_or_gene_product	PSMA,102,106,Gene_or_gene_product	"[{""token"": ""PAK"", ""start_span"": 27, ""end_span"": 30, ""type"": ""Gene_or_gene_product""}, {""token"": ""PSMA"", ""start_span"": 55, ""end_span"": 59, ""type"": ""Gene_or_gene_product""}, {""token"": ""filamin A"", ""start_span"": 62, ""end_span"": 71, ""type"": ""Gene_or_gene_product""}, {""token"": ""PSMA"", ""start_span"": 102, ""end_span"": 106, ""type"": ""Gene_or_gene_product""}]"	test
PURPOSE: Heparin immobilized porous poly ( D, L - lactic - co - glycolic acid) ( PLGA) microspheres were prepared for sustained release of basic fibroblast growth factor ( bFGF) to induce angiogenesis.	Heparin,9,16,Chemical	PLGA,81,85,Chemical	basic fibroblast growth factor,139,169,Gene_or_gene_product	bFGF,172,176,Gene_or_gene_product	"[{""token"": ""Heparin"", ""start_span"": 9, ""end_span"": 16, ""type"": ""Chemical""}, {""token"": ""PLGA"", ""start_span"": 81, ""end_span"": 85, ""type"": ""Chemical""}, {""token"": ""basic fibroblast growth factor"", ""start_span"": 139, ""end_span"": 169, ""type"": ""Gene_or_gene_product""}, {""token"": ""bFGF"", ""start_span"": 172, ""end_span"": 176, ""type"": ""Gene_or_gene_product""}]"	test
bFGF was loaded into the heparin functionalized ( PLGA - heparin) microspheres by a simple dipping method.	bFGF,0,4,Gene_or_gene_product	heparin,25,32,Chemical	PLGA,50,54,Chemical	heparin,57,64,Chemical	"[{""token"": ""bFGF"", ""start_span"": 0, ""end_span"": 4, ""type"": ""Gene_or_gene_product""}, {""token"": ""heparin"", ""start_span"": 25, ""end_span"": 32, ""type"": ""Chemical""}, {""token"": ""PLGA"", ""start_span"": 50, ""end_span"": 54, ""type"": ""Chemical""}, {""token"": ""heparin"", ""start_span"": 57, ""end_span"": 64, ""type"": ""Chemical""}]"	test
In this review, we discuss the reported involvement of syndecans in human cancers, infectious diseases, obesity, wound healing and angiogenesis.	syndecans,55,64,Gene_or_gene_product	human,68,73,Organism	cancers,74,81,Cancer	wound,113,118,Pathological_formation	"[{""token"": ""syndecans"", ""start_span"": 55, ""end_span"": 64, ""type"": ""Gene_or_gene_product""}, {""token"": ""human"", ""start_span"": 68, ""end_span"": 73, ""type"": ""Organism""}, {""token"": ""cancers"", ""start_span"": 74, ""end_span"": 81, ""type"": ""Cancer""}, {""token"": ""wound"", ""start_span"": 113, ""end_span"": 118, ""type"": ""Pathological_formation""}]"	test
These new insights into the involvement of syndecans in disease and tissue repair coupled with the emergence of syndecan - specific molecular tools may lead to novel therapies for a variety of human diseases.	syndecans,43,52,Gene_or_gene_product	tissue,68,74,Tissue	syndecan,112,120,Gene_or_gene_product	human,193,198,Organism	"[{""token"": ""syndecans"", ""start_span"": 43, ""end_span"": 52, ""type"": ""Gene_or_gene_product""}, {""token"": ""tissue"", ""start_span"": 68, ""end_span"": 74, ""type"": ""Tissue""}, {""token"": ""syndecan"", ""start_span"": 112, ""end_span"": 120, ""type"": ""Gene_or_gene_product""}, {""token"": ""human"", ""start_span"": 193, ""end_span"": 198, ""type"": ""Organism""}]"	test
In normal gastric mucosa, C / EBPbeta expression was restricted to cells in the proliferative zone.	gastric mucosa,10,24,Multi	C / EBPbeta,26,37,Gene_or_gene_product	cells,67,72,Cell	zone,94,98,Immaterial_anatomical_entity	"[{""token"": ""gastric mucosa"", ""start_span"": 10, ""end_span"": 24, ""type"": ""Multi""}, {""token"": ""C / EBPbeta"", ""start_span"": 26, ""end_span"": 37, ""type"": ""Gene_or_gene_product""}, {""token"": ""cells"", ""start_span"": 67, ""end_span"": 72, ""type"": ""Cell""}, {""token"": ""zone"", ""start_span"": 94, ""end_span"": 98, ""type"": ""Immaterial_anatomical_entity""}]"	test
C / EBPbeta and Ki67, a marker of cell proliferation, were also co - expressed in primary GC.	C / EBPbeta,0,11,Gene_or_gene_product	Ki67,16,20,Gene_or_gene_product	cell,34,38,Cell	GC,90,92,Cancer	"[{""token"": ""C / EBPbeta"", ""start_span"": 0, ""end_span"": 11, ""type"": ""Gene_or_gene_product""}, {""token"": ""Ki67"", ""start_span"": 16, ""end_span"": 20, ""type"": ""Gene_or_gene_product""}, {""token"": ""cell"", ""start_span"": 34, ""end_span"": 38, ""type"": ""Cell""}, {""token"": ""GC"", ""start_span"": 90, ""end_span"": 92, ""type"": ""Cancer""}]"	test
Using GC cell lines we show that C / EBPbeta can regulate the expression of endogenous COX - 2 and transactivate the promoter of the COX - 2 gene, depending on its methylation status.	GC cell lines,6,19,Cell	C / EBPbeta,33,44,Gene_or_gene_product	COX - 2,87,94,Gene_or_gene_product	COX - 2,133,140,Gene_or_gene_product	"[{""token"": ""GC cell lines"", ""start_span"": 6, ""end_span"": 19, ""type"": ""Cell""}, {""token"": ""C / EBPbeta"", ""start_span"": 33, ""end_span"": 44, ""type"": ""Gene_or_gene_product""}, {""token"": ""COX - 2"", ""start_span"": 87, ""end_span"": 94, ""type"": ""Gene_or_gene_product""}, {""token"": ""COX - 2"", ""start_span"": 133, ""end_span"": 140, ""type"": ""Gene_or_gene_product""}]"	test
Lysophosphatidic acid downregulates tissue inhibitor of metalloproteinases, which are negatively involved in lysophosphatidic acid - induced cell invasion.	Lysophosphatidic acid,0,21,Chemical	tissue inhibitor of metalloproteinases,36,74,Gene_or_gene_product	lysophosphatidic acid,109,130,Chemical	cell,141,145,Cell	"[{""token"": ""Lysophosphatidic acid"", ""start_span"": 0, ""end_span"": 21, ""type"": ""Chemical""}, {""token"": ""tissue inhibitor of metalloproteinases"", ""start_span"": 36, ""end_span"": 74, ""type"": ""Gene_or_gene_product""}, {""token"": ""lysophosphatidic acid"", ""start_span"": 109, ""end_span"": 130, ""type"": ""Chemical""}, {""token"": ""cell"", ""start_span"": 141, ""end_span"": 145, ""type"": ""Cell""}]"	test
The fibrinolytic ( plasminogen / plasmin) and matrix metalloproteinase ( MMP) systems cooperate in these processes.	plasminogen,19,30,Gene_or_gene_product	plasmin,33,40,Gene_or_gene_product	matrix metalloproteinase,46,70,Gene_or_gene_product	MMP,73,76,Gene_or_gene_product	"[{""token"": ""plasminogen"", ""start_span"": 19, ""end_span"": 30, ""type"": ""Gene_or_gene_product""}, {""token"": ""plasmin"", ""start_span"": 33, ""end_span"": 40, ""type"": ""Gene_or_gene_product""}, {""token"": ""matrix metalloproteinase"", ""start_span"": 46, ""end_span"": 70, ""type"": ""Gene_or_gene_product""}, {""token"": ""MMP"", ""start_span"": 73, ""end_span"": 76, ""type"": ""Gene_or_gene_product""}]"	test
Biomaterials such as Surgisis ( Cook Biotech Incorporated, West Lafayette, IN, USA), which are derived from natural ECM, provide the extracellular components necessary to direct the healing response, allow for the proliferation of new, healthy tissue and restore tissue integrity to the damaged site.	ECM,116,119,Cellular_component	extracellular components,133,157,Cellular_component	tissue,244,250,Tissue	tissue,263,269,Tissue	"[{""token"": ""ECM"", ""start_span"": 116, ""end_span"": 119, ""type"": ""Cellular_component""}, {""token"": ""extracellular components"", ""start_span"": 133, ""end_span"": 157, ""type"": ""Cellular_component""}, {""token"": ""tissue"", ""start_span"": 244, ""end_span"": 250, ""type"": ""Tissue""}, {""token"": ""tissue"", ""start_span"": 263, ""end_span"": 269, ""type"": ""Tissue""}]"	test
Common features of this ECM - assisted tissue remodelling include angiogenesis, recruitment of circulating progenitor cells and constructive remodelling of damaged tissue structures.	ECM,24,27,Cellular_component	tissue,39,45,Tissue	progenitor cells,107,123,Cell	tissue,164,170,Tissue	"[{""token"": ""ECM"", ""start_span"": 24, ""end_span"": 27, ""type"": ""Cellular_component""}, {""token"": ""tissue"", ""start_span"": 39, ""end_span"": 45, ""type"": ""Tissue""}, {""token"": ""progenitor cells"", ""start_span"": 107, ""end_span"": 123, ""type"": ""Cell""}, {""token"": ""tissue"", ""start_span"": 164, ""end_span"": 170, ""type"": ""Tissue""}]"	test
"Based solely on cell energetics, this presents a challenge to identify curative agents that destroy only cancer cells as they must destroy both of their power plants causing "" necrotic cell death "" and leave normal cells alone."	cell,16,20,Cell	cancer cells,105,117,Cell	cell,185,189,Cell	cells,215,220,Cell	"[{""token"": ""cell"", ""start_span"": 16, ""end_span"": 20, ""type"": ""Cell""}, {""token"": ""cancer cells"", ""start_span"": 105, ""end_span"": 117, ""type"": ""Cell""}, {""token"": ""cell"", ""start_span"": 185, ""end_span"": 189, ""type"": ""Cell""}, {""token"": ""cells"", ""start_span"": 215, ""end_span"": 220, ""type"": ""Cell""}]"	test
In the mammary carcinoma experiment, vascular permeability measured by means of B22956 / 1 in the animals treated with the antiangiogenic drug ( 0. 0043317 + / - 0. 0040418 ml / min ( - 1) / ml ( - 1)) was significantly less than in untreated animals ( 0. 0090460 + / - 0. 0043680 ml / min ( - 1) / ml ( - 1)), whereas no significant difference was observed with Gd - DTPA - albumin ( 13. 14 + / - 13. 94 ml / min ( - 1) / ml ( - 1) in treated animals and 18. 07 + / - 11. 92 ml / min ( - 1) / ml ( - 1) in untreated animals).	mammary carcinoma,7,24,Cancer	vascular,37,45,Multi	B22956 / 1,80,90,Chemical	Gd - DTPA - albumin,363,382,Chemical	"[{""token"": ""mammary carcinoma"", ""start_span"": 7, ""end_span"": 24, ""type"": ""Cancer""}, {""token"": ""vascular"", ""start_span"": 37, ""end_span"": 45, ""type"": ""Multi""}, {""token"": ""B22956 / 1"", ""start_span"": 80, ""end_span"": 90, ""type"": ""Chemical""}, {""token"": ""Gd - DTPA - albumin"", ""start_span"": 363, ""end_span"": 382, ""type"": ""Chemical""}]"	test
Angiogenesis in the caprine caruncles in non - pregnant and pregnant normal and swainsonine - treated does.	caprine,20,27,Organism	caruncles,28,37,Organism_subdivision	swainsonine,80,91,Chemical	does,102,106,Organism	"[{""token"": ""caprine"", ""start_span"": 20, ""end_span"": 27, ""type"": ""Organism""}, {""token"": ""caruncles"", ""start_span"": 28, ""end_span"": 37, ""type"": ""Organism_subdivision""}, {""token"": ""swainsonine"", ""start_span"": 80, ""end_span"": 91, ""type"": ""Chemical""}, {""token"": ""does"", ""start_span"": 102, ""end_span"": 106, ""type"": ""Organism""}]"	test
Vessel density ( MVD - microvessel density), endothelial cell proliferation fraction ( ECP%) and tumour cell proliferation fraction ( TCP%) were assessed.	Vessel,0,6,Multi	microvessel,23,34,Tissue	endothelial cell,45,61,Cell	tumour cell,97,108,Cell	"[{""token"": ""Vessel"", ""start_span"": 0, ""end_span"": 6, ""type"": ""Multi""}, {""token"": ""microvessel"", ""start_span"": 23, ""end_span"": 34, ""type"": ""Tissue""}, {""token"": ""endothelial cell"", ""start_span"": 45, ""end_span"": 61, ""type"": ""Cell""}, {""token"": ""tumour cell"", ""start_span"": 97, ""end_span"": 108, ""type"": ""Cell""}]"	test
High - grade CC - RCC showed a higher ECP% ( P = 0. 049), a higher TCP% ( P = 0. 009), a higher VEGF protein expression ( P less than 0. 001), a lower MVD ( P less than 0. 001) and a lower HIF - 1alpha protein expression ( P = 0. 002) than low - grade CC - RCC.	CC - RCC,13,21,Cancer	VEGF,96,100,Gene_or_gene_product	HIF - 1alpha,189,201,Gene_or_gene_product	CC - RCC,252,260,Cancer	"[{""token"": ""CC - RCC"", ""start_span"": 13, ""end_span"": 21, ""type"": ""Cancer""}, {""token"": ""VEGF"", ""start_span"": 96, ""end_span"": 100, ""type"": ""Gene_or_gene_product""}, {""token"": ""HIF - 1alpha"", ""start_span"": 189, ""end_span"": 201, ""type"": ""Gene_or_gene_product""}, {""token"": ""CC - RCC"", ""start_span"": 252, ""end_span"": 260, ""type"": ""Cancer""}]"	test
Tip30 ( - / -) mammary glands transplanted into wild - type mammary fat pads also display mammary trees with extensive ductal hyperplasia.	Tip30,0,5,Gene_or_gene_product	mammary fat pads,60,76,Tissue	mammary trees,90,103,Multi	ductal hyperplasia,119,137,Pathological_formation	"[{""token"": ""Tip30"", ""start_span"": 0, ""end_span"": 5, ""type"": ""Gene_or_gene_product""}, {""token"": ""mammary fat pads"", ""start_span"": 60, ""end_span"": 76, ""type"": ""Tissue""}, {""token"": ""mammary trees"", ""start_span"": 90, ""end_span"": 103, ""type"": ""Multi""}, {""token"": ""ductal hyperplasia"", ""start_span"": 119, ""end_span"": 137, ""type"": ""Pathological_formation""}]"	test
Strikingly, Tip30 deletion promotes proliferation of primary MECs and results in rapid immortalization of MECs in vitro relative to wild - type cells.	Tip30,12,17,Gene_or_gene_product	MECs,61,65,Cell	MECs,106,110,Cell	wild - type cells,132,149,Cell	"[{""token"": ""Tip30"", ""start_span"": 12, ""end_span"": 17, ""type"": ""Gene_or_gene_product""}, {""token"": ""MECs"", ""start_span"": 61, ""end_span"": 65, ""type"": ""Cell""}, {""token"": ""MECs"", ""start_span"": 106, ""end_span"": 110, ""type"": ""Cell""}, {""token"": ""wild - type cells"", ""start_span"": 132, ""end_span"": 149, ""type"": ""Cell""}]"	test
Gene array analysis identified significant increases in the expression of mammary epithelial growth factors Wisp2 and Igf - 1 in Tip30 ( - / -) cells.	mammary epithelial,74,92,Tissue	Wisp2,108,113,Gene_or_gene_product	Igf - 1,118,125,Gene_or_gene_product	Tip30,129,134,Gene_or_gene_product	"[{""token"": ""mammary epithelial"", ""start_span"": 74, ""end_span"": 92, ""type"": ""Tissue""}, {""token"": ""Wisp2"", ""start_span"": 108, ""end_span"": 113, ""type"": ""Gene_or_gene_product""}, {""token"": ""Igf - 1"", ""start_span"": 118, ""end_span"": 125, ""type"": ""Gene_or_gene_product""}, {""token"": ""Tip30"", ""start_span"": 129, ""end_span"": 134, ""type"": ""Gene_or_gene_product""}]"	test
Melissoidesin G, a diterpenoid purified from Isodon melissoides, induces leukemic - cell apoptosis through induction of redox imbalance and exhibits synergy with other anticancer agents.	Melissoidesin G,0,15,Chemical	Isodon melissoides,45,63,Organism	leukemic - cell,73,88,Cell	anticancer,168,178,Cancer	"[{""token"": ""Melissoidesin G"", ""start_span"": 0, ""end_span"": 15, ""type"": ""Chemical""}, {""token"": ""Isodon melissoides"", ""start_span"": 45, ""end_span"": 63, ""type"": ""Organism""}, {""token"": ""leukemic - cell"", ""start_span"": 73, ""end_span"": 88, ""type"": ""Cell""}, {""token"": ""anticancer"", ""start_span"": 168, ""end_span"": 178, ""type"": ""Cancer""}]"	test
Melissoidesin G ( MOG) is a new diterpenoid purified from Isodon melissoides, a plant used in Chinese traditional medicine as antitumor and anti - inflammatory agents.	Melissoidesin G,0,15,Chemical	MOG,18,21,Chemical	Isodon melissoides,58,76,Organism	antitumor,126,135,Cancer	"[{""token"": ""Melissoidesin G"", ""start_span"": 0, ""end_span"": 15, ""type"": ""Chemical""}, {""token"": ""MOG"", ""start_span"": 18, ""end_span"": 21, ""type"": ""Chemical""}, {""token"": ""Isodon melissoides"", ""start_span"": 58, ""end_span"": 76, ""type"": ""Organism""}, {""token"": ""antitumor"", ""start_span"": 126, ""end_span"": 135, ""type"": ""Cancer""}]"	test
Use of exogenous Sonic hedgehog ( Shh) peptide significantly increased BrdU incorporation in endothelial cells in vitro by a factor of 2 ( P less than 0. 001).	Sonic hedgehog,17,31,Gene_or_gene_product	Shh,34,37,Gene_or_gene_product	BrdU,71,75,Chemical	endothelial cells,93,110,Cell	"[{""token"": ""Sonic hedgehog"", ""start_span"": 17, ""end_span"": 31, ""type"": ""Gene_or_gene_product""}, {""token"": ""Shh"", ""start_span"": 34, ""end_span"": 37, ""type"": ""Gene_or_gene_product""}, {""token"": ""BrdU"", ""start_span"": 71, ""end_span"": 75, ""type"": ""Chemical""}, {""token"": ""endothelial cells"", ""start_span"": 93, ""end_span"": 110, ""type"": ""Cell""}]"	test
Furthermore, mouse embryonic fibroblasts required the presence of B16F0 cells to express Patched in a co - culture assay system.	mouse,13,18,Organism	embryonic fibroblasts,19,40,Cell	B16F0 cells,66,77,Cell	Patched,89,96,Gene_or_gene_product	"[{""token"": ""mouse"", ""start_span"": 13, ""end_span"": 18, ""type"": ""Organism""}, {""token"": ""embryonic fibroblasts"", ""start_span"": 19, ""end_span"": 40, ""type"": ""Cell""}, {""token"": ""B16F0 cells"", ""start_span"": 66, ""end_span"": 77, ""type"": ""Cell""}, {""token"": ""Patched"", ""start_span"": 89, ""end_span"": 96, ""type"": ""Gene_or_gene_product""}]"	test
These studies indicate that Shh peptide produced by melanoma cells induces Patched expression in fibroblasts.	Shh,28,31,Gene_or_gene_product	melanoma cells,52,66,Cell	Patched,75,82,Gene_or_gene_product	fibroblasts,97,108,Cell	"[{""token"": ""Shh"", ""start_span"": 28, ""end_span"": 31, ""type"": ""Gene_or_gene_product""}, {""token"": ""melanoma cells"", ""start_span"": 52, ""end_span"": 66, ""type"": ""Cell""}, {""token"": ""Patched"", ""start_span"": 75, ""end_span"": 82, ""type"": ""Gene_or_gene_product""}, {""token"": ""fibroblasts"", ""start_span"": 97, ""end_span"": 108, ""type"": ""Cell""}]"	test
Expression of epidermal growth factor receptor, transforming growth factor - alpha and Ki - 67 in relationship to malignant transformation of pleomorphic adenoma.	epidermal growth factor receptor,14,46,Gene_or_gene_product	transforming growth factor - alpha,48,82,Gene_or_gene_product	Ki - 67,87,94,Gene_or_gene_product	pleomorphic adenoma,142,161,Pathological_formation	"[{""token"": ""epidermal growth factor receptor"", ""start_span"": 14, ""end_span"": 46, ""type"": ""Gene_or_gene_product""}, {""token"": ""transforming growth factor - alpha"", ""start_span"": 48, ""end_span"": 82, ""type"": ""Gene_or_gene_product""}, {""token"": ""Ki - 67"", ""start_span"": 87, ""end_span"": 94, ""type"": ""Gene_or_gene_product""}, {""token"": ""pleomorphic adenoma"", ""start_span"": 142, ""end_span"": 161, ""type"": ""Pathological_formation""}]"	test
The data support the hypothesis that increased epidermal growth factor receptor ( EGFR) and transforming growth factor ( TGF) - alpha expression is associated with early events in malignant transformation of pleomorphic adenoma ( PA).	epidermal growth factor receptor,47,79,Gene_or_gene_product	EGFR,82,86,Gene_or_gene_product	pleomorphic adenoma,208,227,Pathological_formation	PA,230,232,Pathological_formation	"[{""token"": ""epidermal growth factor receptor"", ""start_span"": 47, ""end_span"": 79, ""type"": ""Gene_or_gene_product""}, {""token"": ""EGFR"", ""start_span"": 82, ""end_span"": 86, ""type"": ""Gene_or_gene_product""}, {""token"": ""pleomorphic adenoma"", ""start_span"": 208, ""end_span"": 227, ""type"": ""Pathological_formation""}, {""token"": ""PA"", ""start_span"": 230, ""end_span"": 232, ""type"": ""Pathological_formation""}]"	test
MATERIALS AND METHODS: The tissues were stained with monoclonal antibodies to EGFR, TGF - alpha and Ki - 67.	tissues,27,34,Tissue	EGFR,78,82,Gene_or_gene_product	TGF - alpha,84,95,Gene_or_gene_product	Ki - 67,100,107,Gene_or_gene_product	"[{""token"": ""tissues"", ""start_span"": 27, ""end_span"": 34, ""type"": ""Tissue""}, {""token"": ""EGFR"", ""start_span"": 78, ""end_span"": 82, ""type"": ""Gene_or_gene_product""}, {""token"": ""TGF - alpha"", ""start_span"": 84, ""end_span"": 95, ""type"": ""Gene_or_gene_product""}, {""token"": ""Ki - 67"", ""start_span"": 100, ""end_span"": 107, ""type"": ""Gene_or_gene_product""}]"	test
There are limited mouse models for the BMP signaling SMADs ( BR - SMADs) 1, 5, and 8 because of embryonic lethality and suspected genetic redundancy.	mouse,18,23,Organism	5,76,77,Gene_or_gene_product	8,83,84,Gene_or_gene_product	embryonic,96,105,Developing_anatomical_structure	"[{""token"": ""mouse"", ""start_span"": 18, ""end_span"": 23, ""type"": ""Organism""}, {""token"": ""5"", ""start_span"": 76, ""end_span"": 77, ""type"": ""Gene_or_gene_product""}, {""token"": ""8"", ""start_span"": 83, ""end_span"": 84, ""type"": ""Gene_or_gene_product""}, {""token"": ""embryonic"", ""start_span"": 96, ""end_span"": 105, ""type"": ""Developing_anatomical_structure""}]"	test
Single conditional knockouts for Smad1 or Smad5 or mice homozygous null for Smad8 are viable and fertile.	Smad1,33,38,Gene_or_gene_product	Smad5,42,47,Gene_or_gene_product	mice,51,55,Organism	Smad8,76,81,Gene_or_gene_product	"[{""token"": ""Smad1"", ""start_span"": 33, ""end_span"": 38, ""type"": ""Gene_or_gene_product""}, {""token"": ""Smad5"", ""start_span"": 42, ""end_span"": 47, ""type"": ""Gene_or_gene_product""}, {""token"": ""mice"", ""start_span"": 51, ""end_span"": 55, ""type"": ""Organism""}, {""token"": ""Smad8"", ""start_span"": 76, ""end_span"": 81, ""type"": ""Gene_or_gene_product""}]"	test
Serum IL - 6 levels correlate with tumor stage, and survival of patients.	Serum,0,5,Organism_substance	IL - 6,6,12,Gene_or_gene_product	tumor,35,40,Cancer	patients,64,72,Organism	"[{""token"": ""Serum"", ""start_span"": 0, ""end_span"": 5, ""type"": ""Organism_substance""}, {""token"": ""IL - 6"", ""start_span"": 6, ""end_span"": 12, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumor"", ""start_span"": 35, ""end_span"": 40, ""type"": ""Cancer""}, {""token"": ""patients"", ""start_span"": 64, ""end_span"": 72, ""type"": ""Organism""}]"	test
The keratin 5 ( K5) promoter drives transgenic expression to the basal cell layer of stratified epithelia.	keratin 5,4,13,Gene_or_gene_product	K5,16,18,Gene_or_gene_product	basal cell,65,75,Cell	epithelia,96,105,Tissue	"[{""token"": ""keratin 5"", ""start_span"": 4, ""end_span"": 13, ""type"": ""Gene_or_gene_product""}, {""token"": ""K5"", ""start_span"": 16, ""end_span"": 18, ""type"": ""Gene_or_gene_product""}, {""token"": ""basal cell"", ""start_span"": 65, ""end_span"": 75, ""type"": ""Cell""}, {""token"": ""epithelia"", ""start_span"": 96, ""end_span"": 105, ""type"": ""Tissue""}]"	test
This organ is derived from an upwards growth of the primitive oropharynx, a K5 - expressing tissue.	organ,5,10,Organ	oropharynx,62,72,Anatomical_system	K5,76,78,Gene_or_gene_product	tissue,92,98,Tissue	"[{""token"": ""organ"", ""start_span"": 5, ""end_span"": 10, ""type"": ""Organ""}, {""token"": ""oropharynx"", ""start_span"": 62, ""end_span"": 72, ""type"": ""Anatomical_system""}, {""token"": ""K5"", ""start_span"": 76, ""end_span"": 78, ""type"": ""Gene_or_gene_product""}, {""token"": ""tissue"", ""start_span"": 92, ""end_span"": 98, ""type"": ""Tissue""}]"	test
Interestingly, we found that K5CDK4 mice show a decreased number of pituitary stem cells, even though CDK4 is not expressed in the stem cells but in transit - amplifying ( TA) - like cells.	K5CDK4,29,35,Gene_or_gene_product	pituitary stem cells,68,88,Cell	CDK4,102,106,Gene_or_gene_product	stem cells,131,141,Cell	"[{""token"": ""K5CDK4"", ""start_span"": 29, ""end_span"": 35, ""type"": ""Gene_or_gene_product""}, {""token"": ""pituitary stem cells"", ""start_span"": 68, ""end_span"": 88, ""type"": ""Cell""}, {""token"": ""CDK4"", ""start_span"": 102, ""end_span"": 106, ""type"": ""Gene_or_gene_product""}, {""token"": ""stem cells"", ""start_span"": 131, ""end_span"": 141, ""type"": ""Cell""}]"	test
There was a significant correlation ( P = 0. 022) between survivin and bcl - x expression; survivin and bcl - x tended to correlate with overall survival ( P = 0. 072 and 0. 075, respectively), but not with disease - free survival ( P = 0. 19 and 0. 18, respectively).	survivin,58,66,Gene_or_gene_product	bcl - x,71,78,Gene_or_gene_product	survivin,91,99,Gene_or_gene_product	bcl - x,104,111,Gene_or_gene_product	"[{""token"": ""survivin"", ""start_span"": 58, ""end_span"": 66, ""type"": ""Gene_or_gene_product""}, {""token"": ""bcl - x"", ""start_span"": 71, ""end_span"": 78, ""type"": ""Gene_or_gene_product""}, {""token"": ""survivin"", ""start_span"": 91, ""end_span"": 99, ""type"": ""Gene_or_gene_product""}, {""token"": ""bcl - x"", ""start_span"": 104, ""end_span"": 111, ""type"": ""Gene_or_gene_product""}]"	test
The microcirculation of most tumors includes cooperation of pre - existing vessels, intussusceptive microvascular growth, postnatal vasculogenesis, glomeruloid angiogenesis and vasculogenic mimicry ( VM).	tumors,29,35,Cancer	vessels,75,82,Multi	microvascular,100,113,Tissue	glomeruloid,148,159,Multi	"[{""token"": ""tumors"", ""start_span"": 29, ""end_span"": 35, ""type"": ""Cancer""}, {""token"": ""vessels"", ""start_span"": 75, ""end_span"": 82, ""type"": ""Multi""}, {""token"": ""microvascular"", ""start_span"": 100, ""end_span"": 113, ""type"": ""Tissue""}, {""token"": ""glomeruloid"", ""start_span"": 148, ""end_span"": 159, ""type"": ""Multi""}]"	test
These studies also show their clinicalpathological features of the cancers with human Paraffin - embedded tumor tissue samples.	cancers,67,74,Cancer	human,80,85,Organism	Paraffin,86,94,Chemical	tumor tissue samples,106,126,Tissue	"[{""token"": ""cancers"", ""start_span"": 67, ""end_span"": 74, ""type"": ""Cancer""}, {""token"": ""human"", ""start_span"": 80, ""end_span"": 85, ""type"": ""Organism""}, {""token"": ""Paraffin"", ""start_span"": 86, ""end_span"": 94, ""type"": ""Chemical""}, {""token"": ""tumor tissue samples"", ""start_span"": 106, ""end_span"": 126, ""type"": ""Tissue""}]"	test
Results show that the process: VEGF - a - - greater than EphA2 - - greater than MMPs - - greater than VM is the main pathway for VM formation and VEGF - a appears to play an important role in the formation of VM based on our in vitro assays and clinical immunohistochemical analyses.	VEGF - a,31,39,Gene_or_gene_product	EphA2,57,62,Gene_or_gene_product	MMPs,80,84,Gene_or_gene_product	VEGF - a,146,154,Gene_or_gene_product	"[{""token"": ""VEGF - a"", ""start_span"": 31, ""end_span"": 39, ""type"": ""Gene_or_gene_product""}, {""token"": ""EphA2"", ""start_span"": 57, ""end_span"": 62, ""type"": ""Gene_or_gene_product""}, {""token"": ""MMPs"", ""start_span"": 80, ""end_span"": 84, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF - a"", ""start_span"": 146, ""end_span"": 154, ""type"": ""Gene_or_gene_product""}]"	test
The increased migration ability and the invasive ability into tumor cluster of TGF - beta - treated NIH3T3 cells were dose dependently inhibited by TSP - 1.	tumor,62,67,Cancer	TGF - beta,79,89,Gene_or_gene_product	NIH3T3 cells,100,112,Cell	TSP - 1,148,155,Gene_or_gene_product	"[{""token"": ""tumor"", ""start_span"": 62, ""end_span"": 67, ""type"": ""Cancer""}, {""token"": ""TGF - beta"", ""start_span"": 79, ""end_span"": 89, ""type"": ""Gene_or_gene_product""}, {""token"": ""NIH3T3 cells"", ""start_span"": 100, ""end_span"": 112, ""type"": ""Cell""}, {""token"": ""TSP - 1"", ""start_span"": 148, ""end_span"": 155, ""type"": ""Gene_or_gene_product""}]"	test
However, there were no significant differences in serum IL - 8 concentrations between NHL patients and controls ( 159. 2 + / - 40. 4 vs. 99. 6 + / - 107. 1 pg / mL; P = 0. 099).	serum,50,55,Organism_substance	IL - 8,56,62,Gene_or_gene_product	NHL,86,89,Cancer	patients,90,98,Organism	"[{""token"": ""serum"", ""start_span"": 50, ""end_span"": 55, ""type"": ""Organism_substance""}, {""token"": ""IL - 8"", ""start_span"": 56, ""end_span"": 62, ""type"": ""Gene_or_gene_product""}, {""token"": ""NHL"", ""start_span"": 86, ""end_span"": 89, ""type"": ""Cancer""}, {""token"": ""patients"", ""start_span"": 90, ""end_span"": 98, ""type"": ""Organism""}]"	test
This study indicated that urine IL - 8 / Cr levels might be useful as a diagnostic marker of NHL.	urine,26,31,Organism_substance	IL - 8,32,38,Gene_or_gene_product	Cr,41,43,Chemical	NHL,93,96,Cancer	"[{""token"": ""urine"", ""start_span"": 26, ""end_span"": 31, ""type"": ""Organism_substance""}, {""token"": ""IL - 8"", ""start_span"": 32, ""end_span"": 38, ""type"": ""Gene_or_gene_product""}, {""token"": ""Cr"", ""start_span"": 41, ""end_span"": 43, ""type"": ""Chemical""}, {""token"": ""NHL"", ""start_span"": 93, ""end_span"": 96, ""type"": ""Cancer""}]"	test
The importance of NO in the vasculature is demonstrated by several experimental conditions, such as vascular endothelial growth factor ( VEGF) - induced angiogenesis.	NO,18,20,Chemical	vasculature,28,39,Anatomical_system	vascular endothelial growth factor,100,134,Gene_or_gene_product	VEGF,137,141,Gene_or_gene_product	"[{""token"": ""NO"", ""start_span"": 18, ""end_span"": 20, ""type"": ""Chemical""}, {""token"": ""vasculature"", ""start_span"": 28, ""end_span"": 39, ""type"": ""Anatomical_system""}, {""token"": ""vascular endothelial growth factor"", ""start_span"": 100, ""end_span"": 134, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF"", ""start_span"": 137, ""end_span"": 141, ""type"": ""Gene_or_gene_product""}]"	test
In EC9706 cells, the mechanism of aspirin and nimesulide induced growth inhibition was a consequence of cell cycle arrest at the G ( 0) / G ( 1) check point.	EC9706 cells,3,15,Cell	aspirin,34,41,Chemical	nimesulide,46,56,Chemical	cell,104,108,Cell	"[{""token"": ""EC9706 cells"", ""start_span"": 3, ""end_span"": 15, ""type"": ""Cell""}, {""token"": ""aspirin"", ""start_span"": 34, ""end_span"": 41, ""type"": ""Chemical""}, {""token"": ""nimesulide"", ""start_span"": 46, ""end_span"": 56, ""type"": ""Chemical""}, {""token"": ""cell"", ""start_span"": 104, ""end_span"": 108, ""type"": ""Cell""}]"	test
In conclusion, aspirin and nimesulide could inhibit cell proliferation and induce apoptosis in esophageal squamous carcinoma cells.	aspirin,15,22,Chemical	nimesulide,27,37,Chemical	cell,52,56,Cell	esophageal squamous carcinoma cells,95,130,Cell	"[{""token"": ""aspirin"", ""start_span"": 15, ""end_span"": 22, ""type"": ""Chemical""}, {""token"": ""nimesulide"", ""start_span"": 27, ""end_span"": 37, ""type"": ""Chemical""}, {""token"": ""cell"", ""start_span"": 52, ""end_span"": 56, ""type"": ""Cell""}, {""token"": ""esophageal squamous carcinoma cells"", ""start_span"": 95, ""end_span"": 130, ""type"": ""Cell""}]"	test
Neurotrophin p75 receptor ( p75NTR) promotes endothelial cell apoptosis and inhibits angiogenesis: implications for diabetes - induced impaired neovascularization in ischemic limb muscles.	Neurotrophin p75 receptor,0,25,Gene_or_gene_product	p75NTR,28,34,Gene_or_gene_product	endothelial cell,45,61,Cell	limb muscles,175,187,Organ	"[{""token"": ""Neurotrophin p75 receptor"", ""start_span"": 0, ""end_span"": 25, ""type"": ""Gene_or_gene_product""}, {""token"": ""p75NTR"", ""start_span"": 28, ""end_span"": 34, ""type"": ""Gene_or_gene_product""}, {""token"": ""endothelial cell"", ""start_span"": 45, ""end_span"": 61, ""type"": ""Cell""}, {""token"": ""limb muscles"", ""start_span"": 175, ""end_span"": 187, ""type"": ""Organ""}]"	test
Moreover, intramuscular p75 ( NTR) gene delivery impairs neovascularization and blood flow recovery in a mouse model of limb ischemia.	intramuscular,10,23,Immaterial_anatomical_entity	blood,80,85,Organism_substance	mouse,105,110,Organism	limb,120,124,Organism_subdivision	"[{""token"": ""intramuscular"", ""start_span"": 10, ""end_span"": 23, ""type"": ""Immaterial_anatomical_entity""}, {""token"": ""blood"", ""start_span"": 80, ""end_span"": 85, ""type"": ""Organism_substance""}, {""token"": ""mouse"", ""start_span"": 105, ""end_span"": 110, ""type"": ""Organism""}, {""token"": ""limb"", ""start_span"": 120, ""end_span"": 124, ""type"": ""Organism_subdivision""}]"	test
Diabetic mice, which typically show impaired postischemic muscular neovascularization and blood perfusion recovery, have these defects corrected by intramuscular gene transfer of a dominant negative mutant form of p75 ( NTR).	mice,9,13,Organism	muscular,58,66,Organ	blood,90,95,Organism_substance	intramuscular,148,161,Immaterial_anatomical_entity	"[{""token"": ""mice"", ""start_span"": 9, ""end_span"": 13, ""type"": ""Organism""}, {""token"": ""muscular"", ""start_span"": 58, ""end_span"": 66, ""type"": ""Organ""}, {""token"": ""blood"", ""start_span"": 90, ""end_span"": 95, ""type"": ""Organism_substance""}, {""token"": ""intramuscular"", ""start_span"": 148, ""end_span"": 161, ""type"": ""Immaterial_anatomical_entity""}]"	test
METHODS: To evaluate antiangiogenic activity of cRGD - HL, we performed tests on endothelial cell adhesion and migration to vitronectin, tube formation, binding affinity to purified alpha ( v) beta ( 3) integrin, and in vivo Matrigel plug assay.	cRGD - HL,48,57,Chemical	endothelial cell,81,97,Cell	vitronectin,124,135,Gene_or_gene_product	tube,137,141,Tissue	"[{""token"": ""cRGD - HL"", ""start_span"": 48, ""end_span"": 57, ""type"": ""Chemical""}, {""token"": ""endothelial cell"", ""start_span"": 81, ""end_span"": 97, ""type"": ""Cell""}, {""token"": ""vitronectin"", ""start_span"": 124, ""end_span"": 135, ""type"": ""Gene_or_gene_product""}, {""token"": ""tube"", ""start_span"": 137, ""end_span"": 141, ""type"": ""Tissue""}]"	test
The antitumor activity of cRGD - HL was also evaluated by monitoring tumor growth and microvessel formation in squamous cell carcinoma ( SCC7) tumor.	antitumor,4,13,Cancer	cRGD - HL,26,35,Chemical	tumor,69,74,Cancer	microvessel,86,97,Tissue	"[{""token"": ""antitumor"", ""start_span"": 4, ""end_span"": 13, ""type"": ""Cancer""}, {""token"": ""cRGD - HL"", ""start_span"": 26, ""end_span"": 35, ""type"": ""Chemical""}, {""token"": ""tumor"", ""start_span"": 69, ""end_span"": 74, ""type"": ""Cancer""}, {""token"": ""microvessel"", ""start_span"": 86, ""end_span"": 97, ""type"": ""Tissue""}]"	test
[ Inhibitory effect of adenovirus - mediated endostatin gene transfer on transplanted lung carcinoma in mice]	adenovirus,23,33,Organism	endostatin,45,55,Gene_or_gene_product	lung carcinoma,86,100,Cancer	mice,104,108,Organism	"[{""token"": ""adenovirus"", ""start_span"": 23, ""end_span"": 33, ""type"": ""Organism""}, {""token"": ""endostatin"", ""start_span"": 45, ""end_span"": 55, ""type"": ""Gene_or_gene_product""}, {""token"": ""lung carcinoma"", ""start_span"": 86, ""end_span"": 100, ""type"": ""Cancer""}, {""token"": ""mice"", ""start_span"": 104, ""end_span"": 108, ""type"": ""Organism""}]"	test
OBJECTIVE: To investigate the effect of adenovirus - mediated endostatin gene transfer on transplanted lung cancer in mice and its mechanism of action.	adenovirus,40,50,Organism	endostatin,62,72,Gene_or_gene_product	lung cancer,103,114,Cancer	mice,118,122,Organism	"[{""token"": ""adenovirus"", ""start_span"": 40, ""end_span"": 50, ""type"": ""Organism""}, {""token"": ""endostatin"", ""start_span"": 62, ""end_span"": 72, ""type"": ""Gene_or_gene_product""}, {""token"": ""lung cancer"", ""start_span"": 103, ""end_span"": 114, ""type"": ""Cancer""}, {""token"": ""mice"", ""start_span"": 118, ""end_span"": 122, ""type"": ""Organism""}]"	test
The inhibition of tumor growth and changes of survival were recorded and the microvessel density ( MVD) was determined by histochemical stainingwith CD31 and CD105 antibodies.	tumor,18,23,Cancer	microvessel,77,88,Tissue	CD31,149,153,Gene_or_gene_product	CD105 antibodies,158,174,Gene_or_gene_product	"[{""token"": ""tumor"", ""start_span"": 18, ""end_span"": 23, ""type"": ""Cancer""}, {""token"": ""microvessel"", ""start_span"": 77, ""end_span"": 88, ""type"": ""Tissue""}, {""token"": ""CD31"", ""start_span"": 149, ""end_span"": 153, ""type"": ""Gene_or_gene_product""}, {""token"": ""CD105 antibodies"", ""start_span"": 158, ""end_span"": 174, ""type"": ""Gene_or_gene_product""}]"	test
RESULTS: In comparison with controls, intratumoral injection of Ad - mEndostatin significantly inhibited the tumor growth and metastasis, and prolonged the survival rate of mice ( P less than 0. 05).	intratumoral,38,50,Cancer	Ad - mEndostatin,64,80,Gene_or_gene_product	tumor,109,114,Cancer	mice,173,177,Organism	"[{""token"": ""intratumoral"", ""start_span"": 38, ""end_span"": 50, ""type"": ""Cancer""}, {""token"": ""Ad - mEndostatin"", ""start_span"": 64, ""end_span"": 80, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumor"", ""start_span"": 109, ""end_span"": 114, ""type"": ""Cancer""}, {""token"": ""mice"", ""start_span"": 173, ""end_span"": 177, ""type"": ""Organism""}]"	test
p53 has a central role in skin pigmentation and may impact on melanoma at all stages, however, as it ' s mutation frequency in melanoma is low, it ' s role has been somewhat under - appreciated.	p53,0,3,Gene_or_gene_product	skin,26,30,Organ	melanoma,62,70,Cancer	melanoma,127,135,Cancer	"[{""token"": ""p53"", ""start_span"": 0, ""end_span"": 3, ""type"": ""Gene_or_gene_product""}, {""token"": ""skin"", ""start_span"": 26, ""end_span"": 30, ""type"": ""Organ""}, {""token"": ""melanoma"", ""start_span"": 62, ""end_span"": 70, ""type"": ""Cancer""}, {""token"": ""melanoma"", ""start_span"": 127, ""end_span"": 135, ""type"": ""Cancer""}]"	test
When melanin biosynthesis is genetically disrupted in skin of white complexion, we propose that this cycle operates as a promoter of melanocyte proliferation.	melanin,5,12,Chemical	skin,54,58,Organ	white complexion,62,78,Organism	melanocyte,133,143,Cell	"[{""token"": ""melanin"", ""start_span"": 5, ""end_span"": 12, ""type"": ""Chemical""}, {""token"": ""skin"", ""start_span"": 54, ""end_span"": 58, ""type"": ""Organ""}, {""token"": ""white complexion"", ""start_span"": 62, ""end_span"": 78, ""type"": ""Organism""}, {""token"": ""melanocyte"", ""start_span"": 133, ""end_span"": 143, ""type"": ""Cell""}]"	test
All - trans retinoic acid ( ATRA) could potently inhibit the growth of prostate cancer cells in vitro and its combination with various anticancer agents results in increased cytotoxicity.	All - trans retinoic acid,0,25,Chemical	ATRA,28,32,Chemical	prostate cancer cells,71,92,Cell	anticancer,135,145,Cancer	"[{""token"": ""All - trans retinoic acid"", ""start_span"": 0, ""end_span"": 25, ""type"": ""Chemical""}, {""token"": ""ATRA"", ""start_span"": 28, ""end_span"": 32, ""type"": ""Chemical""}, {""token"": ""prostate cancer cells"", ""start_span"": 71, ""end_span"": 92, ""type"": ""Cell""}, {""token"": ""anticancer"", ""start_span"": 135, ""end_span"": 145, ""type"": ""Cancer""}]"	test
Based on these data, our aim was to examine the synergistic / additive cytotoxic and apoptotic effects of combination of docetaxel and ATRA, in hormone - and drug refractory human DU - 145 prostate cancer cells.	docetaxel,121,130,Chemical	ATRA,135,139,Chemical	human,174,179,Organism	DU - 145 prostate cancer cells,180,210,Cell	"[{""token"": ""docetaxel"", ""start_span"": 121, ""end_span"": 130, ""type"": ""Chemical""}, {""token"": ""ATRA"", ""start_span"": 135, ""end_span"": 139, ""type"": ""Chemical""}, {""token"": ""human"", ""start_span"": 174, ""end_span"": 179, ""type"": ""Organism""}, {""token"": ""DU - 145 prostate cancer cells"", ""start_span"": 180, ""end_span"": 210, ""type"": ""Cell""}]"	test
Activation of signal transducer and activator of transcription 3 through a phosphomimetic serine 727 promotes prostate tumorigenesis independent of tyrosine 705 phosphorylation.	signal transducer and activator of transcription 3,14,64,Gene_or_gene_product	serine 727,90,100,Amino_acid	prostate,110,118,Organ	tyrosine 705,148,160,Amino_acid	"[{""token"": ""signal transducer and activator of transcription 3"", ""start_span"": 14, ""end_span"": 64, ""type"": ""Gene_or_gene_product""}, {""token"": ""serine 727"", ""start_span"": 90, ""end_span"": 100, ""type"": ""Amino_acid""}, {""token"": ""prostate"", ""start_span"": 110, ""end_span"": 118, ""type"": ""Organ""}, {""token"": ""tyrosine 705"", ""start_span"": 148, ""end_span"": 160, ""type"": ""Amino_acid""}]"	test
Aberrantly activated signal transducer and activator of transcription 3 ( Stat3) is implicated in the development of various human cancers.	signal transducer and activator of transcription 3,21,71,Gene_or_gene_product	Stat3,74,79,Gene_or_gene_product	human,125,130,Organism	cancers,131,138,Cancer	"[{""token"": ""signal transducer and activator of transcription 3"", ""start_span"": 21, ""end_span"": 71, ""type"": ""Gene_or_gene_product""}, {""token"": ""Stat3"", ""start_span"": 74, ""end_span"": 79, ""type"": ""Gene_or_gene_product""}, {""token"": ""human"", ""start_span"": 125, ""end_span"": 130, ""type"": ""Organism""}, {""token"": ""cancers"", ""start_span"": 131, ""end_span"": 138, ""type"": ""Cancer""}]"	test
We further show that Stat3 is phosphorylated at S727 in 65% of malignant prostate tissues ( n = 20) relative to 25% of normal prostate tissues ( n = 4).	Stat3,21,26,Gene_or_gene_product	S727,48,52,Amino_acid	malignant prostate tissues,63,89,Tissue	normal prostate tissues,119,142,Tissue	"[{""token"": ""Stat3"", ""start_span"": 21, ""end_span"": 26, ""type"": ""Gene_or_gene_product""}, {""token"": ""S727"", ""start_span"": 48, ""end_span"": 52, ""type"": ""Amino_acid""}, {""token"": ""malignant prostate tissues"", ""start_span"": 63, ""end_span"": 89, ""type"": ""Tissue""}, {""token"": ""normal prostate tissues"", ""start_span"": 119, ""end_span"": 142, ""type"": ""Tissue""}]"	test
Our data suggest for the first time that S727 phosphorylation is sufficient to activate Stat3, thereby driving prostate tumorigenesis independent of Y705 phosphorylation.	S727,41,45,Amino_acid	Stat3,88,93,Gene_or_gene_product	prostate,111,119,Organ	Y705,149,153,Amino_acid	"[{""token"": ""S727"", ""start_span"": 41, ""end_span"": 45, ""type"": ""Amino_acid""}, {""token"": ""Stat3"", ""start_span"": 88, ""end_span"": 93, ""type"": ""Gene_or_gene_product""}, {""token"": ""prostate"", ""start_span"": 111, ""end_span"": 119, ""type"": ""Organ""}, {""token"": ""Y705"", ""start_span"": 149, ""end_span"": 153, ""type"": ""Amino_acid""}]"	test
To test this hypothesis, the frequency of metastasis to the lung as a function of allergic pulmonary inflammation was assessed following the i. v. injection of B16 - F10 melanoma cells in mice.	lung,60,64,Organ	pulmonary,91,100,Organ	B16 - F10 melanoma cells,160,184,Cell	mice,188,192,Organism	"[{""token"": ""lung"", ""start_span"": 60, ""end_span"": 64, ""type"": ""Organ""}, {""token"": ""pulmonary"", ""start_span"": 91, ""end_span"": 100, ""type"": ""Organ""}, {""token"": ""B16 - F10 melanoma cells"", ""start_span"": 160, ""end_span"": 184, ""type"": ""Cell""}, {""token"": ""mice"", ""start_span"": 188, ""end_span"": 192, ""type"": ""Organism""}]"	test
3 - BrPA ( 3 - bromopyruvate) is an alkylating agent with anti - tumoral activity on hepatocellular carcinoma.	3 - BrPA,0,8,Chemical	3 - bromopyruvate,11,28,Chemical	tumoral,65,72,Cancer	hepatocellular carcinoma,85,109,Cancer	"[{""token"": ""3 - BrPA"", ""start_span"": 0, ""end_span"": 8, ""type"": ""Chemical""}, {""token"": ""3 - bromopyruvate"", ""start_span"": 11, ""end_span"": 28, ""type"": ""Chemical""}, {""token"": ""tumoral"", ""start_span"": 65, ""end_span"": 72, ""type"": ""Cancer""}, {""token"": ""hepatocellular carcinoma"", ""start_span"": 85, ""end_span"": 109, ""type"": ""Cancer""}]"	test
Additionally, 3 - BrPA treatment significantly impaired lactate production by HepG2 cells, even when glucose was withdrawn from the incubation medium.	3 - BrPA,14,22,Chemical	lactate,56,63,Chemical	HepG2 cells,78,89,Cell	glucose,101,108,Chemical	"[{""token"": ""3 - BrPA"", ""start_span"": 14, ""end_span"": 22, ""type"": ""Chemical""}, {""token"": ""lactate"", ""start_span"": 56, ""end_span"": 63, ""type"": ""Chemical""}, {""token"": ""HepG2 cells"", ""start_span"": 78, ""end_span"": 89, ""type"": ""Cell""}, {""token"": ""glucose"", ""start_span"": 101, ""end_span"": 108, ""type"": ""Chemical""}]"	test
On the other hand, when cells were pre - incubated in glucose - supplemented medium, oxygen consumption was affected only when succinate was used as the oxidizable substrate.	cells,24,29,Cell	glucose,54,61,Chemical	oxygen,85,91,Chemical	succinate,127,136,Chemical	"[{""token"": ""cells"", ""start_span"": 24, ""end_span"": 29, ""type"": ""Cell""}, {""token"": ""glucose"", ""start_span"": 54, ""end_span"": 61, ""type"": ""Chemical""}, {""token"": ""oxygen"", ""start_span"": 85, ""end_span"": 91, ""type"": ""Chemical""}, {""token"": ""succinate"", ""start_span"": 127, ""end_span"": 136, ""type"": ""Chemical""}]"	test
These results suggest that the combined action of 3 - BrPA on succinate dehydrogenase and on glycolysis, inhibiting steps downstream of the phosphorylation of glucose, play an important role in HepG2 cell death.	3 - BrPA,50,58,Chemical	succinate dehydrogenase,62,85,Gene_or_gene_product	glucose,159,166,Chemical	HepG2 cell,194,204,Cell	"[{""token"": ""3 - BrPA"", ""start_span"": 50, ""end_span"": 58, ""type"": ""Chemical""}, {""token"": ""succinate dehydrogenase"", ""start_span"": 62, ""end_span"": 85, ""type"": ""Gene_or_gene_product""}, {""token"": ""glucose"", ""start_span"": 159, ""end_span"": 166, ""type"": ""Chemical""}, {""token"": ""HepG2 cell"", ""start_span"": 194, ""end_span"": 204, ""type"": ""Cell""}]"	test
The function of p53 tumor suppressor is often altered in various human tumors predominantly through missense - mutations resulting in accumulation of mutant proteins.	p53,16,19,Gene_or_gene_product	tumor,20,25,Cancer	human,65,70,Organism	tumors,71,77,Cancer	"[{""token"": ""p53"", ""start_span"": 16, ""end_span"": 19, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumor"", ""start_span"": 20, ""end_span"": 25, ""type"": ""Cancer""}, {""token"": ""human"", ""start_span"": 65, ""end_span"": 70, ""type"": ""Organism""}, {""token"": ""tumors"", ""start_span"": 71, ""end_span"": 77, ""type"": ""Cancer""}]"	test
Stimulation of tumor angiogenesis was connected with about 2 - fold increase in intracellular level of reactive oxygen species ( ROS).	tumor,15,20,Cancer	intracellular,80,93,Immaterial_anatomical_entity	reactive oxygen species,103,126,Chemical	ROS,129,132,Chemical	"[{""token"": ""tumor"", ""start_span"": 15, ""end_span"": 20, ""type"": ""Cancer""}, {""token"": ""intracellular"", ""start_span"": 80, ""end_span"": 93, ""type"": ""Immaterial_anatomical_entity""}, {""token"": ""reactive oxygen species"", ""start_span"": 103, ""end_span"": 126, ""type"": ""Chemical""}, {""token"": ""ROS"", ""start_span"": 129, ""end_span"": 132, ""type"": ""Chemical""}]"	test
In the present study, we performed a series of molecular imaging experiments using a HIF - 1 - dependent reporter gene, 5HREp - ODD - luc, and found an essential role of the Akt / mTOR pathway.	HIF - 1,85,92,Gene_or_gene_product	5HREp - ODD - luc,120,137,Gene_or_gene_product	Akt,174,177,Gene_or_gene_product	mTOR,180,184,Gene_or_gene_product	"[{""token"": ""HIF - 1"", ""start_span"": 85, ""end_span"": 92, ""type"": ""Gene_or_gene_product""}, {""token"": ""5HREp - ODD - luc"", ""start_span"": 120, ""end_span"": 137, ""type"": ""Gene_or_gene_product""}, {""token"": ""Akt"", ""start_span"": 174, ""end_span"": 177, ""type"": ""Gene_or_gene_product""}, {""token"": ""mTOR"", ""start_span"": 180, ""end_span"": 184, ""type"": ""Gene_or_gene_product""}]"	test
Hypoxic tumor cells distant from blood vessels were dramatically reoxygenated at 24 h postirradiation, and HIF - 1 activity increased as HIF - 1alpha accumulated in the reoxygenated regions.	tumor cells,8,19,Cell	blood vessels,33,46,Multi	HIF - 1,107,114,Gene_or_gene_product	HIF - 1alpha,137,149,Gene_or_gene_product	"[{""token"": ""tumor cells"", ""start_span"": 8, ""end_span"": 19, ""type"": ""Cell""}, {""token"": ""blood vessels"", ""start_span"": 33, ""end_span"": 46, ""type"": ""Multi""}, {""token"": ""HIF - 1"", ""start_span"": 107, ""end_span"": 114, ""type"": ""Gene_or_gene_product""}, {""token"": ""HIF - 1alpha"", ""start_span"": 137, ""end_span"": 149, ""type"": ""Gene_or_gene_product""}]"	test
IL - 8 or CXCL8 has been associated with tumor angiogenesis, metastasis, and poor prognosis in breast cancer.	IL - 8,0,6,Gene_or_gene_product	CXCL8,10,15,Gene_or_gene_product	tumor,41,46,Cancer	breast cancer,95,108,Cancer	"[{""token"": ""IL - 8"", ""start_span"": 0, ""end_span"": 6, ""type"": ""Gene_or_gene_product""}, {""token"": ""CXCL8"", ""start_span"": 10, ""end_span"": 15, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumor"", ""start_span"": 41, ""end_span"": 46, ""type"": ""Cancer""}, {""token"": ""breast cancer"", ""start_span"": 95, ""end_span"": 108, ""type"": ""Cancer""}]"	test
We found a significant positive correlation between IL - 8 and estradiol in normal breast tissue and hormone - dependent breast cancer in vivo.	IL - 8,52,58,Gene_or_gene_product	estradiol,63,72,Chemical	breast tissue,83,96,Tissue	hormone - dependent breast cancer,101,134,Cancer	"[{""token"": ""IL - 8"", ""start_span"": 52, ""end_span"": 58, ""type"": ""Gene_or_gene_product""}, {""token"": ""estradiol"", ""start_span"": 63, ""end_span"": 72, ""type"": ""Chemical""}, {""token"": ""breast tissue"", ""start_span"": 83, ""end_span"": 96, ""type"": ""Tissue""}, {""token"": ""hormone - dependent breast cancer"", ""start_span"": 101, ""end_span"": 134, ""type"": ""Cancer""}]"	test
IL - 8 may present a novel therapeutic target for estrogen driven breast carcinogenesis and tumor progression.	IL - 8,0,6,Gene_or_gene_product	estrogen,50,58,Chemical	breast,66,72,Organism_subdivision	tumor,92,97,Cancer	"[{""token"": ""IL - 8"", ""start_span"": 0, ""end_span"": 6, ""type"": ""Gene_or_gene_product""}, {""token"": ""estrogen"", ""start_span"": 50, ""end_span"": 58, ""type"": ""Chemical""}, {""token"": ""breast"", ""start_span"": 66, ""end_span"": 72, ""type"": ""Organism_subdivision""}, {""token"": ""tumor"", ""start_span"": 92, ""end_span"": 97, ""type"": ""Cancer""}]"	test
In these cells, SDF - 1alpha - induced migration was observed and was blocked by AMD3100, a specific inhibitor of CXCR4.	cells,9,14,Cell	SDF - 1alpha,16,28,Gene_or_gene_product	AMD3100,81,88,Chemical	CXCR4,114,119,Gene_or_gene_product	"[{""token"": ""cells"", ""start_span"": 9, ""end_span"": 14, ""type"": ""Cell""}, {""token"": ""SDF - 1alpha"", ""start_span"": 16, ""end_span"": 28, ""type"": ""Gene_or_gene_product""}, {""token"": ""AMD3100"", ""start_span"": 81, ""end_span"": 88, ""type"": ""Chemical""}, {""token"": ""CXCR4"", ""start_span"": 114, ""end_span"": 119, ""type"": ""Gene_or_gene_product""}]"	test
SDF - 1alpha induced rapid phosphorylation of Erk1 / 2 MAPK but did not promote phosphorylation of Stat3 or Akt.	SDF - 1alpha,0,12,Gene_or_gene_product	Erk1 / 2 MAPK,46,59,Gene_or_gene_product	Stat3,99,104,Gene_or_gene_product	Akt,108,111,Gene_or_gene_product	"[{""token"": ""SDF - 1alpha"", ""start_span"": 0, ""end_span"": 12, ""type"": ""Gene_or_gene_product""}, {""token"": ""Erk1 / 2 MAPK"", ""start_span"": 46, ""end_span"": 59, ""type"": ""Gene_or_gene_product""}, {""token"": ""Stat3"", ""start_span"": 99, ""end_span"": 104, ""type"": ""Gene_or_gene_product""}, {""token"": ""Akt"", ""start_span"": 108, ""end_span"": 111, ""type"": ""Gene_or_gene_product""}]"	test
Effect of estrogen and progesterone on macrophage activation during wound healing.	estrogen,10,18,Chemical	progesterone,23,35,Chemical	macrophage,39,49,Cell	wound,68,73,Pathological_formation	"[{""token"": ""estrogen"", ""start_span"": 10, ""end_span"": 18, ""type"": ""Chemical""}, {""token"": ""progesterone"", ""start_span"": 23, ""end_span"": 35, ""type"": ""Chemical""}, {""token"": ""macrophage"", ""start_span"": 39, ""end_span"": 49, ""type"": ""Cell""}, {""token"": ""wound"", ""start_span"": 68, ""end_span"": 73, ""type"": ""Pathological_formation""}]"	test
Saline, thrombin solution, PPP, and PRP were applied to the created defects before closure.	Saline,0,6,Chemical	thrombin,8,16,Gene_or_gene_product	PPP,27,30,Organism_substance	PRP,36,39,Organism_substance	"[{""token"": ""Saline"", ""start_span"": 0, ""end_span"": 6, ""type"": ""Chemical""}, {""token"": ""thrombin"", ""start_span"": 8, ""end_span"": 16, ""type"": ""Gene_or_gene_product""}, {""token"": ""PPP"", ""start_span"": 27, ""end_span"": 30, ""type"": ""Organism_substance""}, {""token"": ""PRP"", ""start_span"": 36, ""end_span"": 39, ""type"": ""Organism_substance""}]"	test
New bone formation was detected to be more rapid considering histologic parameters, in groups 3 and 4 at 4th and 16th weeks. Study demonstrates that PRP and PPP might have favorable effects on bone healing.	bone,4,8,Organ	PRP,149,152,Organism_substance	PPP,157,160,Organism_substance	bone,193,197,Organ	"[{""token"": ""bone"", ""start_span"": 4, ""end_span"": 8, ""type"": ""Organ""}, {""token"": ""PRP"", ""start_span"": 149, ""end_span"": 152, ""type"": ""Organism_substance""}, {""token"": ""PPP"", ""start_span"": 157, ""end_span"": 160, ""type"": ""Organism_substance""}, {""token"": ""bone"", ""start_span"": 193, ""end_span"": 197, ""type"": ""Organ""}]"	test
Host - derived angiopoietin - 2 affects early stages of tumor development and vessel maturation but is dispensable for later stages of tumor growth.	angiopoietin - 2,15,31,Gene_or_gene_product	tumor,56,61,Cancer	vessel,78,84,Multi	tumor,135,140,Cancer	"[{""token"": ""angiopoietin - 2"", ""start_span"": 15, ""end_span"": 31, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumor"", ""start_span"": 56, ""end_span"": 61, ""type"": ""Cancer""}, {""token"": ""vessel"", ""start_span"": 78, ""end_span"": 84, ""type"": ""Multi""}, {""token"": ""tumor"", ""start_span"": 135, ""end_span"": 140, ""type"": ""Cancer""}]"	test
The angiopoietin / Tie2 system has been identified as the second vascular - specific receptor tyrosine kinase system controlling vessel assembly, maturation, and quiescence.	angiopoietin,4,16,Gene_or_gene_product	Tie2,19,23,Gene_or_gene_product	vascular,65,73,Multi	vessel,129,135,Multi	"[{""token"": ""angiopoietin"", ""start_span"": 4, ""end_span"": 16, ""type"": ""Gene_or_gene_product""}, {""token"": ""Tie2"", ""start_span"": 19, ""end_span"": 23, ""type"": ""Gene_or_gene_product""}, {""token"": ""vascular"", ""start_span"": 65, ""end_span"": 73, ""type"": ""Multi""}, {""token"": ""vessel"", ""start_span"": 129, ""end_span"": 135, ""type"": ""Multi""}]"	test
Angiopoietin - 2 ( Ang - 2) is prominently up - regulated in the host - derived vasculature of most tumors, making it an attractive candidate for antiangiogenic intervention.	Angiopoietin - 2,0,16,Gene_or_gene_product	Ang - 2,19,26,Gene_or_gene_product	vasculature,80,91,Multi	tumors,100,106,Cancer	"[{""token"": ""Angiopoietin - 2"", ""start_span"": 0, ""end_span"": 16, ""type"": ""Gene_or_gene_product""}, {""token"": ""Ang - 2"", ""start_span"": 19, ""end_span"": 26, ""type"": ""Gene_or_gene_product""}, {""token"": ""vasculature"", ""start_span"": 80, ""end_span"": 91, ""type"": ""Multi""}, {""token"": ""tumors"", ""start_span"": 100, ""end_span"": 106, ""type"": ""Cancer""}]"	test
To clarify the role of Ang - 2 for angiogenesis and tumor growth in a definite genetic experimental setting, the present study was aimed at comparatively studying the growth of different tumors in wild - type and Ang - 2 - deficient mice.	Ang - 2,23,30,Gene_or_gene_product	tumor,52,57,Cancer	tumors,187,193,Cancer	Ang - 2,213,220,Gene_or_gene_product	"[{""token"": ""Ang - 2"", ""start_span"": 23, ""end_span"": 30, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumor"", ""start_span"": 52, ""end_span"": 57, ""type"": ""Cancer""}, {""token"": ""tumors"", ""start_span"": 187, ""end_span"": 193, ""type"": ""Cancer""}, {""token"": ""Ang - 2"", ""start_span"": 213, ""end_span"": 220, ""type"": ""Gene_or_gene_product""}]"	test
Lewis lung carcinomas, MT - ret melanomas, and B16F10 melanomas all grew slower in Ang - 2 - deficient mice.	Lewis lung carcinomas,0,21,Cancer	MT - ret melanomas,23,41,Cancer	B16F10 melanomas,47,63,Cancer	Ang - 2,83,90,Gene_or_gene_product	"[{""token"": ""Lewis lung carcinomas"", ""start_span"": 0, ""end_span"": 21, ""type"": ""Cancer""}, {""token"": ""MT - ret melanomas"", ""start_span"": 23, ""end_span"": 41, ""type"": ""Cancer""}, {""token"": ""B16F10 melanomas"", ""start_span"": 47, ""end_span"": 63, ""type"": ""Cancer""}, {""token"": ""Ang - 2"", ""start_span"": 83, ""end_span"": 90, ""type"": ""Gene_or_gene_product""}]"	test
Liposomal honokiol inhibits VEGF - D - induced lymphangiogenesis and metastasis in xenograft tumor model.	Liposomal,0,9,Cellular_component	honokiol,10,18,Chemical	VEGF - D,28,36,Gene_or_gene_product	xenograft tumor,83,98,Cancer	"[{""token"": ""Liposomal"", ""start_span"": 0, ""end_span"": 9, ""type"": ""Cellular_component""}, {""token"": ""honokiol"", ""start_span"": 10, ""end_span"": 18, ""type"": ""Chemical""}, {""token"": ""VEGF - D"", ""start_span"": 28, ""end_span"": 36, ""type"": ""Gene_or_gene_product""}, {""token"": ""xenograft tumor"", ""start_span"": 83, ""end_span"": 98, ""type"": ""Cancer""}]"	test
Honokiol has been reported to possess potent antiangiogenesis and antitumor properties in several cell lines and xenograft tumor models.	Honokiol,0,8,Chemical	antitumor,66,75,Cancer	cell lines,98,108,Cell	xenograft tumor,113,128,Cancer	"[{""token"": ""Honokiol"", ""start_span"": 0, ""end_span"": 8, ""type"": ""Chemical""}, {""token"": ""antitumor"", ""start_span"": 66, ""end_span"": 75, ""type"": ""Cancer""}, {""token"": ""cell lines"", ""start_span"": 98, ""end_span"": 108, ""type"": ""Cell""}, {""token"": ""xenograft tumor"", ""start_span"": 113, ""end_span"": 128, ""type"": ""Cancer""}]"	test
In in vivo study, liposomal honokiol significantly inhibited the tumor - associated lymphangiogenesis and metastasis in Lewis lung carcinoma model.	liposomal,18,27,Cellular_component	honokiol,28,36,Chemical	tumor,65,70,Cancer	Lewis lung carcinoma,120,140,Cancer	"[{""token"": ""liposomal"", ""start_span"": 18, ""end_span"": 27, ""type"": ""Cellular_component""}, {""token"": ""honokiol"", ""start_span"": 28, ""end_span"": 36, ""type"": ""Chemical""}, {""token"": ""tumor"", ""start_span"": 65, ""end_span"": 70, ""type"": ""Cancer""}, {""token"": ""Lewis lung carcinoma"", ""start_span"": 120, ""end_span"": 140, ""type"": ""Cancer""}]"	test
P18 increased the production of CD95 ligand and reduced the expression of vascular endothelial growth factor receptor 2 by the endothelial cells in vivo.	P18,0,3,Gene_or_gene_product	CD95 ligand,32,43,Gene_or_gene_product	vascular endothelial growth factor receptor 2,74,119,Gene_or_gene_product	endothelial cells,127,144,Cell	"[{""token"": ""P18"", ""start_span"": 0, ""end_span"": 3, ""type"": ""Gene_or_gene_product""}, {""token"": ""CD95 ligand"", ""start_span"": 32, ""end_span"": 43, ""type"": ""Gene_or_gene_product""}, {""token"": ""vascular endothelial growth factor receptor 2"", ""start_span"": 74, ""end_span"": 119, ""type"": ""Gene_or_gene_product""}, {""token"": ""endothelial cells"", ""start_span"": 127, ""end_span"": 144, ""type"": ""Cell""}]"	test
However, we show here that VEGF, specifically through VEGFR2, induces phosphorylation of two serine residues on PLCbeta3, and this was confirmed in an ex vivo embryoid body model.	VEGF,27,31,Gene_or_gene_product	VEGFR2,54,60,Gene_or_gene_product	PLCbeta3,112,120,Gene_or_gene_product	embryoid body,159,172,Developing_anatomical_structure	"[{""token"": ""VEGF"", ""start_span"": 27, ""end_span"": 31, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGFR2"", ""start_span"": 54, ""end_span"": 60, ""type"": ""Gene_or_gene_product""}, {""token"": ""PLCbeta3"", ""start_span"": 112, ""end_span"": 120, ""type"": ""Gene_or_gene_product""}, {""token"": ""embryoid body"", ""start_span"": 159, ""end_span"": 172, ""type"": ""Developing_anatomical_structure""}]"	test
Knockdown of PLCbeta3 in HUVEC cells affects IP3 production, actin reorganization, migration and proliferation; whereas migration is inhibited, proliferation is enhanced.	PLCbeta3,13,21,Gene_or_gene_product	HUVEC cells,25,36,Cell	IP3,45,48,Gene_or_gene_product	actin,61,66,Gene_or_gene_product	"[{""token"": ""PLCbeta3"", ""start_span"": 13, ""end_span"": 21, ""type"": ""Gene_or_gene_product""}, {""token"": ""HUVEC cells"", ""start_span"": 25, ""end_span"": 36, ""type"": ""Cell""}, {""token"": ""IP3"", ""start_span"": 45, ""end_span"": 48, ""type"": ""Gene_or_gene_product""}, {""token"": ""actin"", ""start_span"": 61, ""end_span"": 66, ""type"": ""Gene_or_gene_product""}]"	test
Given that PLCbeta3 is typically known as an effector of heterotrimeric G - proteins, our data demonstrate a unique crosstalk between the G - protein and receptor tyrosine kinase ( RTK) axes and reveal a novel molecular mechanism of VEGF signaling and, thus, angiogenesis.	PLCbeta3,11,19,Gene_or_gene_product	heterotrimeric G - proteins,57,84,Gene_or_gene_product	G - protein,138,149,Gene_or_gene_product	VEGF,233,237,Gene_or_gene_product	"[{""token"": ""PLCbeta3"", ""start_span"": 11, ""end_span"": 19, ""type"": ""Gene_or_gene_product""}, {""token"": ""heterotrimeric G - proteins"", ""start_span"": 57, ""end_span"": 84, ""type"": ""Gene_or_gene_product""}, {""token"": ""G - protein"", ""start_span"": 138, ""end_span"": 149, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF"", ""start_span"": 233, ""end_span"": 237, ""type"": ""Gene_or_gene_product""}]"	test
Microtubule - binding drugs ( MBD) are widely used in cancer chemotherapy and also have clinically relevant antiangiogenic and vascular - disrupting properties.	Microtubule - binding drugs,0,27,Chemical	MBD,30,33,Chemical	cancer,54,60,Cancer	vascular,127,135,Multi	"[{""token"": ""Microtubule - binding drugs"", ""start_span"": 0, ""end_span"": 27, ""type"": ""Chemical""}, {""token"": ""MBD"", ""start_span"": 30, ""end_span"": 33, ""type"": ""Chemical""}, {""token"": ""cancer"", ""start_span"": 54, ""end_span"": 60, ""type"": ""Cancer""}, {""token"": ""vascular"", ""start_span"": 127, ""end_span"": 135, ""type"": ""Multi""}]"	test
Neurovascular effects of CD47 signaling: promotion of cell death, inflammation, and suppression of angiogenesis in brain endothelial cells in vitro.	Neurovascular,0,13,Multi	CD47,25,29,Gene_or_gene_product	cell,54,58,Cell	brain endothelial cells,115,138,Cell	"[{""token"": ""Neurovascular"", ""start_span"": 0, ""end_span"": 13, ""type"": ""Multi""}, {""token"": ""CD47"", ""start_span"": 25, ""end_span"": 29, ""type"": ""Gene_or_gene_product""}, {""token"": ""cell"", ""start_span"": 54, ""end_span"": 58, ""type"": ""Cell""}, {""token"": ""brain endothelial cells"", ""start_span"": 115, ""end_span"": 138, ""type"": ""Cell""}]"	test
The concept of the neurovascular unit emphasizes that common signals and substrates underlie the physiology and pathophysiology of neuronal and endothelial compartments in brain.	neurovascular,19,32,Multi	neuronal,131,139,Multi	endothelial compartments,144,168,Multi	brain,172,177,Organ	"[{""token"": ""neurovascular"", ""start_span"": 19, ""end_span"": 32, ""type"": ""Multi""}, {""token"": ""neuronal"", ""start_span"": 131, ""end_span"": 139, ""type"": ""Multi""}, {""token"": ""endothelial compartments"", ""start_span"": 144, ""end_span"": 168, ""type"": ""Multi""}, {""token"": ""brain"", ""start_span"": 172, ""end_span"": 177, ""type"": ""Organ""}]"	test
Finally, CD47 signaling may suppress angiogenesis because 4N1K significantly inhibited endothelial cell migration and tube formation in vitro.	CD47,9,13,Gene_or_gene_product	4N1K,58,62,Gene_or_gene_product	endothelial cell,87,103,Cell	tube,118,122,Tissue	"[{""token"": ""CD47"", ""start_span"": 9, ""end_span"": 13, ""type"": ""Gene_or_gene_product""}, {""token"": ""4N1K"", ""start_span"": 58, ""end_span"": 62, ""type"": ""Gene_or_gene_product""}, {""token"": ""endothelial cell"", ""start_span"": 87, ""end_span"": 103, ""type"": ""Cell""}, {""token"": ""tube"", ""start_span"": 118, ""end_span"": 122, ""type"": ""Tissue""}]"	test
The modulation of platelet and endothelial cell adhesion to vascular graft materials by perlecan.	platelet,18,26,Cell	endothelial cell,31,47,Cell	vascular graft,60,74,Multi	perlecan,88,96,Gene_or_gene_product	"[{""token"": ""platelet"", ""start_span"": 18, ""end_span"": 26, ""type"": ""Cell""}, {""token"": ""endothelial cell"", ""start_span"": 31, ""end_span"": 47, ""type"": ""Cell""}, {""token"": ""vascular graft"", ""start_span"": 60, ""end_span"": 74, ""type"": ""Multi""}, {""token"": ""perlecan"", ""start_span"": 88, ""end_span"": 96, ""type"": ""Gene_or_gene_product""}]"	test
Endothelialisation and platelet adhesion to purified endothelial cell - derived perlecan, the major heparan sulfate ( HS) proteoglycan in basement membranes, were investigated using in vivo and in vitro assays.	platelet,23,31,Cell	endothelial cell,53,69,Cell	perlecan,80,88,Gene_or_gene_product	basement membranes,138,156,Cellular_component	"[{""token"": ""platelet"", ""start_span"": 23, ""end_span"": 31, ""type"": ""Cell""}, {""token"": ""endothelial cell"", ""start_span"": 53, ""end_span"": 69, ""type"": ""Cell""}, {""token"": ""perlecan"", ""start_span"": 80, ""end_span"": 88, ""type"": ""Gene_or_gene_product""}, {""token"": ""basement membranes"", ""start_span"": 138, ""end_span"": 156, ""type"": ""Cellular_component""}]"	test
Perlecan was found to be anti - adhesive for platelets, however after removal of the HS chains attached to perlecan, platelet adhesion and aggregation were supported.	Perlecan,0,8,Gene_or_gene_product	platelets,45,54,Cell	perlecan,107,115,Gene_or_gene_product	platelet,117,125,Cell	"[{""token"": ""Perlecan"", ""start_span"": 0, ""end_span"": 8, ""type"": ""Gene_or_gene_product""}, {""token"": ""platelets"", ""start_span"": 45, ""end_span"": 54, ""type"": ""Cell""}, {""token"": ""perlecan"", ""start_span"": 107, ""end_span"": 115, ""type"": ""Gene_or_gene_product""}, {""token"": ""platelet"", ""start_span"": 117, ""end_span"": 125, ""type"": ""Cell""}]"	test
These results suggest a role for HS chains of perlecan in improving graft patency by selectively promoting endothelial cell proliferation while modulating platelet adhesion.	perlecan,46,54,Gene_or_gene_product	graft,68,73,Multi	endothelial cell,107,123,Cell	platelet,155,163,Cell	"[{""token"": ""perlecan"", ""start_span"": 46, ""end_span"": 54, ""type"": ""Gene_or_gene_product""}, {""token"": ""graft"", ""start_span"": 68, ""end_span"": 73, ""type"": ""Multi""}, {""token"": ""endothelial cell"", ""start_span"": 107, ""end_span"": 123, ""type"": ""Cell""}, {""token"": ""platelet"", ""start_span"": 155, ""end_span"": 163, ""type"": ""Cell""}]"	test
Regulation of thrombospondin - 1 by natural and synthetic progestins in human breast cancer cells.	thrombospondin - 1,14,32,Gene_or_gene_product	progestins,58,68,Chemical	human,72,77,Organism	breast cancer cells,78,97,Cell	"[{""token"": ""thrombospondin - 1"", ""start_span"": 14, ""end_span"": 32, ""type"": ""Gene_or_gene_product""}, {""token"": ""progestins"", ""start_span"": 58, ""end_span"": 68, ""type"": ""Chemical""}, {""token"": ""human"", ""start_span"": 72, ""end_span"": 77, ""type"": ""Organism""}, {""token"": ""breast cancer cells"", ""start_span"": 78, ""end_span"": 97, ""type"": ""Cell""}]"	test
Actinomycin - D, but not puromycin, also blocks progestin - dependent induction of TSP - 1.	Actinomycin - D,0,15,Chemical	puromycin,25,34,Chemical	progestin,48,57,Chemical	TSP - 1,83,90,Gene_or_gene_product	"[{""token"": ""Actinomycin - D"", ""start_span"": 0, ""end_span"": 15, ""type"": ""Chemical""}, {""token"": ""puromycin"", ""start_span"": 25, ""end_span"": 34, ""type"": ""Chemical""}, {""token"": ""progestin"", ""start_span"": 48, ""end_span"": 57, ""type"": ""Chemical""}, {""token"": ""TSP - 1"", ""start_span"": 83, ""end_span"": 90, ""type"": ""Gene_or_gene_product""}]"	test
Since tumor cell - derived TSP - 1 has the potential to promote angiogenesis in the tumor microenvironment, it could be a potential target for breast cancer therapy.	tumor cell,6,16,Cell	TSP - 1,27,34,Gene_or_gene_product	tumor,84,89,Cancer	breast cancer,143,156,Cancer	"[{""token"": ""tumor cell"", ""start_span"": 6, ""end_span"": 16, ""type"": ""Cell""}, {""token"": ""TSP - 1"", ""start_span"": 27, ""end_span"": 34, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumor"", ""start_span"": 84, ""end_span"": 89, ""type"": ""Cancer""}, {""token"": ""breast cancer"", ""start_span"": 143, ""end_span"": 156, ""type"": ""Cancer""}]"	test
Gene expression signatures denoting WNT / TCF activation are associated with relapse to multiple organs in primary lung adenocarcinoma.	WNT,36,39,Gene_or_gene_product	TCF,42,45,Gene_or_gene_product	organs,97,103,Organ	lung adenocarcinoma,115,134,Cancer	"[{""token"": ""WNT"", ""start_span"": 36, ""end_span"": 39, ""type"": ""Gene_or_gene_product""}, {""token"": ""TCF"", ""start_span"": 42, ""end_span"": 45, ""type"": ""Gene_or_gene_product""}, {""token"": ""organs"", ""start_span"": 97, ""end_span"": 103, ""type"": ""Organ""}, {""token"": ""lung adenocarcinoma"", ""start_span"": 115, ""end_span"": 134, ""type"": ""Cancer""}]"	test
Metastatic subpopulations isolated from independent lymph node - derived lung adenocarcinoma cell lines harbor a hyperactive WNT / TCF pathway.	lymph node,52,62,Multi	lung adenocarcinoma cell lines,73,103,Cell	WNT,125,128,Gene_or_gene_product	TCF,131,134,Gene_or_gene_product	"[{""token"": ""lymph node"", ""start_span"": 52, ""end_span"": 62, ""type"": ""Multi""}, {""token"": ""lung adenocarcinoma cell lines"", ""start_span"": 73, ""end_span"": 103, ""type"": ""Cell""}, {""token"": ""WNT"", ""start_span"": 125, ""end_span"": 128, ""type"": ""Gene_or_gene_product""}, {""token"": ""TCF"", ""start_span"": 131, ""end_span"": 134, ""type"": ""Gene_or_gene_product""}]"	test
[ Prognostic significance of cellular vascular endothelial growth factor ( VEGF) expression in the course of chronic myeloid leukaemia]	cellular,29,37,Cell	vascular endothelial growth factor,38,72,Gene_or_gene_product	VEGF,75,79,Gene_or_gene_product	chronic myeloid leukaemia,109,134,Cancer	"[{""token"": ""cellular"", ""start_span"": 29, ""end_span"": 37, ""type"": ""Cell""}, {""token"": ""vascular endothelial growth factor"", ""start_span"": 38, ""end_span"": 72, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF"", ""start_span"": 75, ""end_span"": 79, ""type"": ""Gene_or_gene_product""}, {""token"": ""chronic myeloid leukaemia"", ""start_span"": 109, ""end_span"": 134, ""type"": ""Cancer""}]"	test
INTRODUCTION: Increased angiogenesis in bone marrow is one of the characteristics of chronic myeloid leukaemia ( CML), a clonal myeloproliferative disorder that expresses a chimeric bcr / abl protein.	bone marrow,40,51,Multi	chronic myeloid leukaemia,85,110,Cancer	CML,113,116,Cancer	bcr / abl,182,191,Gene_or_gene_product	"[{""token"": ""bone marrow"", ""start_span"": 40, ""end_span"": 51, ""type"": ""Multi""}, {""token"": ""chronic myeloid leukaemia"", ""start_span"": 85, ""end_span"": 110, ""type"": ""Cancer""}, {""token"": ""CML"", ""start_span"": 113, ""end_span"": 116, ""type"": ""Cancer""}, {""token"": ""bcr / abl"", ""start_span"": 182, ""end_span"": 191, ""type"": ""Gene_or_gene_product""}]"	test
These data suggest that VEGF plays a role in the biology of CML and that VEGF inhibitors should be investigated in CML.	VEGF,24,28,Gene_or_gene_product	CML,60,63,Cancer	VEGF,73,77,Gene_or_gene_product	CML,115,118,Cancer	"[{""token"": ""VEGF"", ""start_span"": 24, ""end_span"": 28, ""type"": ""Gene_or_gene_product""}, {""token"": ""CML"", ""start_span"": 60, ""end_span"": 63, ""type"": ""Cancer""}, {""token"": ""VEGF"", ""start_span"": 73, ""end_span"": 77, ""type"": ""Gene_or_gene_product""}, {""token"": ""CML"", ""start_span"": 115, ""end_span"": 118, ""type"": ""Cancer""}]"	test
Overexpression of Evi - 1 increased Pbx1 expression in hematopoietic stem / progenitor cells.	Evi - 1,18,25,Gene_or_gene_product	Pbx1,36,40,Gene_or_gene_product	hematopoietic stem,55,73,Cell	progenitor cells,76,92,Cell	"[{""token"": ""Evi - 1"", ""start_span"": 18, ""end_span"": 25, ""type"": ""Gene_or_gene_product""}, {""token"": ""Pbx1"", ""start_span"": 36, ""end_span"": 40, ""type"": ""Gene_or_gene_product""}, {""token"": ""hematopoietic stem"", ""start_span"": 55, ""end_span"": 73, ""type"": ""Cell""}, {""token"": ""progenitor cells"", ""start_span"": 76, ""end_span"": 92, ""type"": ""Cell""}]"	test
We hypothesized that the hemolysis induced by 2 - BE would result in local tissue hypoxia, a well - documented trigger for endothelial cell proliferation leading to hemangiosarcoma.	2 - BE,46,52,Chemical	tissue,75,81,Tissue	endothelial cell,123,139,Cell	hemangiosarcoma,165,180,Cancer	"[{""token"": ""2 - BE"", ""start_span"": 46, ""end_span"": 52, ""type"": ""Chemical""}, {""token"": ""tissue"", ""start_span"": 75, ""end_span"": 81, ""type"": ""Tissue""}, {""token"": ""endothelial cell"", ""start_span"": 123, ""end_span"": 139, ""type"": ""Cell""}, {""token"": ""hemangiosarcoma"", ""start_span"": 165, ""end_span"": 180, ""type"": ""Cancer""}]"	test
Together, the results of this study identify molecular mechanisms that initiate hemangiosarcoma, a key step in understanding safety concerns that can impact drug decision processes, and identified hypoxia as a possible contributing factor for 2 - BE - induced hemangiosarcoma in mice.	hemangiosarcoma,80,95,Cancer	2 - BE,243,249,Chemical	hemangiosarcoma,260,275,Cancer	mice,279,283,Organism	"[{""token"": ""hemangiosarcoma"", ""start_span"": 80, ""end_span"": 95, ""type"": ""Cancer""}, {""token"": ""2 - BE"", ""start_span"": 243, ""end_span"": 249, ""type"": ""Chemical""}, {""token"": ""hemangiosarcoma"", ""start_span"": 260, ""end_span"": 275, ""type"": ""Cancer""}, {""token"": ""mice"", ""start_span"": 279, ""end_span"": 283, ""type"": ""Organism""}]"	test
We have previously reported that intercellular adhesion molecule - 3 ( ICAM - 3) is associated with an increase of cellular radio - resistance and cancer cell proliferation.	intercellular adhesion molecule - 3,33,68,Gene_or_gene_product	ICAM - 3,71,79,Gene_or_gene_product	cellular,115,123,Cell	cancer cell,147,158,Cell	"[{""token"": ""intercellular adhesion molecule - 3"", ""start_span"": 33, ""end_span"": 68, ""type"": ""Gene_or_gene_product""}, {""token"": ""ICAM - 3"", ""start_span"": 71, ""end_span"": 79, ""type"": ""Gene_or_gene_product""}, {""token"": ""cellular"", ""start_span"": 115, ""end_span"": 123, ""type"": ""Cell""}, {""token"": ""cancer cell"", ""start_span"": 147, ""end_span"": 158, ""type"": ""Cell""}]"	test
In this study, we hypothesized that ICAM - 3 has an additional effect on cancer cell migration and invasion because molecules induced by ICAM - 3 are known as regulators of cell migration and invasion.	ICAM - 3,36,44,Gene_or_gene_product	cancer cell,73,84,Cell	ICAM - 3,137,145,Gene_or_gene_product	cell,173,177,Cell	"[{""token"": ""ICAM - 3"", ""start_span"": 36, ""end_span"": 44, ""type"": ""Gene_or_gene_product""}, {""token"": ""cancer cell"", ""start_span"": 73, ""end_span"": 84, ""type"": ""Cell""}, {""token"": ""ICAM - 3"", ""start_span"": 137, ""end_span"": 145, ""type"": ""Gene_or_gene_product""}, {""token"": ""cell"", ""start_span"": 173, ""end_span"": 177, ""type"": ""Cell""}]"	test
ICAM - 3 also increased Akt phosphorylation, which caused an increase in cellular migration / invasion and MMP activities.	ICAM - 3,0,8,Gene_or_gene_product	Akt,24,27,Gene_or_gene_product	cellular,73,81,Cell	MMP,107,110,Gene_or_gene_product	"[{""token"": ""ICAM - 3"", ""start_span"": 0, ""end_span"": 8, ""type"": ""Gene_or_gene_product""}, {""token"": ""Akt"", ""start_span"": 24, ""end_span"": 27, ""type"": ""Gene_or_gene_product""}, {""token"": ""cellular"", ""start_span"": 73, ""end_span"": 81, ""type"": ""Cell""}, {""token"": ""MMP"", ""start_span"": 107, ""end_span"": 110, ""type"": ""Gene_or_gene_product""}]"	test
Such activities of p53 would not only help to prevent cancer development, but might also contribute to non - tumour related roles for p53, such as in the regulation of longevity.	p53,19,22,Gene_or_gene_product	cancer,54,60,Cancer	tumour,109,115,Cancer	p53,134,137,Gene_or_gene_product	"[{""token"": ""p53"", ""start_span"": 19, ""end_span"": 22, ""type"": ""Gene_or_gene_product""}, {""token"": ""cancer"", ""start_span"": 54, ""end_span"": 60, ""type"": ""Cancer""}, {""token"": ""tumour"", ""start_span"": 109, ""end_span"": 115, ""type"": ""Cancer""}, {""token"": ""p53"", ""start_span"": 134, ""end_span"": 137, ""type"": ""Gene_or_gene_product""}]"	test
The purpose of this study was to investigate the expression and significance of 14 - 3 - 3zeta and beta - catenin in stage I non - small - cell lung cancer ( NSCLC).	14 - 3 - 3zeta,80,94,Gene_or_gene_product	beta - catenin,99,113,Gene_or_gene_product	non - small - cell lung cancer,125,155,Cancer	NSCLC,158,163,Cancer	"[{""token"": ""14 - 3 - 3zeta"", ""start_span"": 80, ""end_span"": 94, ""type"": ""Gene_or_gene_product""}, {""token"": ""beta - catenin"", ""start_span"": 99, ""end_span"": 113, ""type"": ""Gene_or_gene_product""}, {""token"": ""non - small - cell lung cancer"", ""start_span"": 125, ""end_span"": 155, ""type"": ""Cancer""}, {""token"": ""NSCLC"", ""start_span"": 158, ""end_span"": 163, ""type"": ""Cancer""}]"	test
These results suggest that p24delta1 and possibly other p24 family proteins are required for normal insulin biosynthesis and subsequent secretion in pancreatic beta - cells.	p24delta1,27,36,Gene_or_gene_product	p24 family proteins,56,75,Gene_or_gene_product	insulin,100,107,Gene_or_gene_product	pancreatic beta - cells,149,172,Cell	"[{""token"": ""p24delta1"", ""start_span"": 27, ""end_span"": 36, ""type"": ""Gene_or_gene_product""}, {""token"": ""p24 family proteins"", ""start_span"": 56, ""end_span"": 75, ""type"": ""Gene_or_gene_product""}, {""token"": ""insulin"", ""start_span"": 100, ""end_span"": 107, ""type"": ""Gene_or_gene_product""}, {""token"": ""pancreatic beta - cells"", ""start_span"": 149, ""end_span"": 172, ""type"": ""Cell""}]"	test
KISS1 and matrix metalloproteinase - 9 ( MMP - 9) may play important roles as metastasis suppressor and metastasis promoter genes, respectively, in a variety of malignancies.	KISS1,0,5,Gene_or_gene_product	matrix metalloproteinase - 9,10,38,Gene_or_gene_product	MMP - 9,41,48,Gene_or_gene_product	malignancies,161,173,Cancer	"[{""token"": ""KISS1"", ""start_span"": 0, ""end_span"": 5, ""type"": ""Gene_or_gene_product""}, {""token"": ""matrix metalloproteinase - 9"", ""start_span"": 10, ""end_span"": 38, ""type"": ""Gene_or_gene_product""}, {""token"": ""MMP - 9"", ""start_span"": 41, ""end_span"": 48, ""type"": ""Gene_or_gene_product""}, {""token"": ""malignancies"", ""start_span"": 161, ""end_span"": 173, ""type"": ""Cancer""}]"	test
The mRNA and protein expressions of KISS1 and of MMP - 9 protein were detected by in situ hybridization and immunohistochemistry respectively in 85 cases of NSCLC, and their matched lymph node metastases.	KISS1,36,41,Gene_or_gene_product	MMP - 9,49,56,Gene_or_gene_product	NSCLC,157,162,Cancer	lymph node,182,192,Multi	"[{""token"": ""KISS1"", ""start_span"": 36, ""end_span"": 41, ""type"": ""Gene_or_gene_product""}, {""token"": ""MMP - 9"", ""start_span"": 49, ""end_span"": 56, ""type"": ""Gene_or_gene_product""}, {""token"": ""NSCLC"", ""start_span"": 157, ""end_span"": 162, ""type"": ""Cancer""}, {""token"": ""lymph node"", ""start_span"": 182, ""end_span"": 192, ""type"": ""Multi""}]"	test
In contrast, MMP - 9 expression was higher in stage III - IV NSCLC cases compared to stage I - II tumors ( p < 0. 05) and higher in NSCLC cases with metastasis than those without metastasis ( p < 0. 05).	MMP - 9,13,20,Gene_or_gene_product	NSCLC,61,66,Cancer	tumors,98,104,Cancer	NSCLC,132,137,Cancer	"[{""token"": ""MMP - 9"", ""start_span"": 13, ""end_span"": 20, ""type"": ""Gene_or_gene_product""}, {""token"": ""NSCLC"", ""start_span"": 61, ""end_span"": 66, ""type"": ""Cancer""}, {""token"": ""tumors"", ""start_span"": 98, ""end_span"": 104, ""type"": ""Cancer""}, {""token"": ""NSCLC"", ""start_span"": 132, ""end_span"": 137, ""type"": ""Cancer""}]"	test
Evaluation of VEGF expression level with the same tissues was used to establish the antigenic profiles, and the marker of CD34 staining was used as an indicator of microvessel density ( MVD).	VEGF,14,18,Gene_or_gene_product	tissues,50,57,Tissue	CD34,122,126,Gene_or_gene_product	microvessel,164,175,Tissue	"[{""token"": ""VEGF"", ""start_span"": 14, ""end_span"": 18, ""type"": ""Gene_or_gene_product""}, {""token"": ""tissues"", ""start_span"": 50, ""end_span"": 57, ""type"": ""Tissue""}, {""token"": ""CD34"", ""start_span"": 122, ""end_span"": 126, ""type"": ""Gene_or_gene_product""}, {""token"": ""microvessel"", ""start_span"": 164, ""end_span"": 175, ""type"": ""Tissue""}]"	test
Expression of SPARC was significantly correlated with the expression of VEGF and MVD in colon cancer tissues.	SPARC,14,19,Gene_or_gene_product	VEGF,72,76,Gene_or_gene_product	MVD,81,84,Gene_or_gene_product	colon cancer tissues,88,108,Tissue	"[{""token"": ""SPARC"", ""start_span"": 14, ""end_span"": 19, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF"", ""start_span"": 72, ""end_span"": 76, ""type"": ""Gene_or_gene_product""}, {""token"": ""MVD"", ""start_span"": 81, ""end_span"": 84, ""type"": ""Gene_or_gene_product""}, {""token"": ""colon cancer tissues"", ""start_span"": 88, ""end_span"": 108, ""type"": ""Tissue""}]"	test
Patients with low or absence expressing SPARC had significantly worse overall survival and disease - free survival in a Single Factor Analysis; Cox Regression Analysis, SPARC emerged as an overall survival and disease - free survival independent prognostic factor for colon cancer.	Patients,0,8,Organism	SPARC,40,45,Gene_or_gene_product	SPARC,169,174,Gene_or_gene_product	colon cancer,268,280,Cancer	"[{""token"": ""Patients"", ""start_span"": 0, ""end_span"": 8, ""type"": ""Organism""}, {""token"": ""SPARC"", ""start_span"": 40, ""end_span"": 45, ""type"": ""Gene_or_gene_product""}, {""token"": ""SPARC"", ""start_span"": 169, ""end_span"": 174, ""type"": ""Gene_or_gene_product""}, {""token"": ""colon cancer"", ""start_span"": 268, ""end_span"": 280, ""type"": ""Cancer""}]"	test
The neural stem cell fate determinant TLX promotes tumorigenesis and genesis of cells resembling glioma stem cells.	neural stem cell,4,20,Cell	TLX,38,41,Gene_or_gene_product	cells,80,85,Cell	glioma stem cells,97,114,Cell	"[{""token"": ""neural stem cell"", ""start_span"": 4, ""end_span"": 20, ""type"": ""Cell""}, {""token"": ""TLX"", ""start_span"": 38, ""end_span"": 41, ""type"": ""Gene_or_gene_product""}, {""token"": ""cells"", ""start_span"": 80, ""end_span"": 85, ""type"": ""Cell""}, {""token"": ""glioma stem cells"", ""start_span"": 97, ""end_span"": 114, ""type"": ""Cell""}]"	test
The neural stem cell fate determinant TLX plays a pivotal role in neurogenesis in the adult brain by maintaining neural stem cells.	neural stem cell,4,20,Cell	TLX,38,41,Gene_or_gene_product	brain,92,97,Organ	neural stem cells,113,130,Cell	"[{""token"": ""neural stem cell"", ""start_span"": 4, ""end_span"": 20, ""type"": ""Cell""}, {""token"": ""TLX"", ""start_span"": 38, ""end_span"": 41, ""type"": ""Gene_or_gene_product""}, {""token"": ""brain"", ""start_span"": 92, ""end_span"": 97, ""type"": ""Organ""}, {""token"": ""neural stem cells"", ""start_span"": 113, ""end_span"": 130, ""type"": ""Cell""}]"	test
Hereditary leiomyomatosis and renal cell carcinoma ( HLRCC) is caused by mutations in the Krebs cycle enzyme fumarate hydratase ( FH).	Hereditary leiomyomatosis and renal cell carcinoma,0,50,Cancer	HLRCC,53,58,Cancer	fumarate hydratase,109,127,Gene_or_gene_product	FH,130,132,Gene_or_gene_product	"[{""token"": ""Hereditary leiomyomatosis and renal cell carcinoma"", ""start_span"": 0, ""end_span"": 50, ""type"": ""Cancer""}, {""token"": ""HLRCC"", ""start_span"": 53, ""end_span"": 58, ""type"": ""Cancer""}, {""token"": ""fumarate hydratase"", ""start_span"": 109, ""end_span"": 127, ""type"": ""Gene_or_gene_product""}, {""token"": ""FH"", ""start_span"": 130, ""end_span"": 132, ""type"": ""Gene_or_gene_product""}]"	test
"It has been proposed that "" pseudohypoxic "" stabilization of hypoxia - inducible factor - alpha ( HIF - alpha) by fumarate accumulation contributes to tumorigenesis in HLRCC."	hypoxia - inducible factor - alpha,61,95,Gene_or_gene_product	HIF - alpha,98,109,Gene_or_gene_product	fumarate,114,122,Chemical	HLRCC,168,173,Cancer	"[{""token"": ""hypoxia - inducible factor - alpha"", ""start_span"": 61, ""end_span"": 95, ""type"": ""Gene_or_gene_product""}, {""token"": ""HIF - alpha"", ""start_span"": 98, ""end_span"": 109, ""type"": ""Gene_or_gene_product""}, {""token"": ""fumarate"", ""start_span"": 114, ""end_span"": 122, ""type"": ""Chemical""}, {""token"": ""HLRCC"", ""start_span"": 168, ""end_span"": 173, ""type"": ""Cancer""}]"	test
As predicted, these MEFs upregulated Hif - 1alpha and HIF target genes directly as a result of FH deficiency.	MEFs,20,24,Cell	Hif - 1alpha,37,49,Gene_or_gene_product	HIF,54,57,Gene_or_gene_product	FH,95,97,Gene_or_gene_product	"[{""token"": ""MEFs"", ""start_span"": 20, ""end_span"": 24, ""type"": ""Cell""}, {""token"": ""Hif - 1alpha"", ""start_span"": 37, ""end_span"": 49, ""type"": ""Gene_or_gene_product""}, {""token"": ""HIF"", ""start_span"": 54, ""end_span"": 57, ""type"": ""Gene_or_gene_product""}, {""token"": ""FH"", ""start_span"": 95, ""end_span"": 97, ""type"": ""Gene_or_gene_product""}]"	test
Correspondingly, Fh1 - deficient benign murine renal cysts and an advanced human HLRCC - related renal cell carcinoma manifested a prominent and progressive increase in the expression of HIF - alpha target genes and in genes known to be relevant to tumorigenesis and metastasis.	Fh1,17,20,Gene_or_gene_product	human,75,80,Organism	HLRCC - related renal cell carcinoma,81,117,Cancer	HIF - alpha,187,198,Gene_or_gene_product	"[{""token"": ""Fh1"", ""start_span"": 17, ""end_span"": 20, ""type"": ""Gene_or_gene_product""}, {""token"": ""human"", ""start_span"": 75, ""end_span"": 80, ""type"": ""Organism""}, {""token"": ""HLRCC - related renal cell carcinoma"", ""start_span"": 81, ""end_span"": 117, ""type"": ""Cancer""}, {""token"": ""HIF - alpha"", ""start_span"": 187, ""end_span"": 198, ""type"": ""Gene_or_gene_product""}]"	test
Experiments showed that mutant embryos and mutant cells in culture experienced genome instability, as do cells in FA patients.	mutant embryos,24,38,Developing_anatomical_structure	mutant cells,43,55,Cell	cells,105,110,Cell	patients,117,125,Organism	"[{""token"": ""mutant embryos"", ""start_span"": 24, ""end_span"": 38, ""type"": ""Developing_anatomical_structure""}, {""token"": ""mutant cells"", ""start_span"": 43, ""end_span"": 55, ""type"": ""Cell""}, {""token"": ""cells"", ""start_span"": 105, ""end_span"": 110, ""type"": ""Cell""}, {""token"": ""patients"", ""start_span"": 117, ""end_span"": 125, ""type"": ""Organism""}]"	test
Double mutants developed oocytes and became sterile females that produced only aberrant embryos and showed elevated risk for invasive ovarian tumors.	Double mutants,0,14,Organism	oocytes,25,32,Cell	embryos,88,95,Developing_anatomical_structure	ovarian tumors,134,148,Cancer	"[{""token"": ""Double mutants"", ""start_span"": 0, ""end_span"": 14, ""type"": ""Organism""}, {""token"": ""oocytes"", ""start_span"": 25, ""end_span"": 32, ""type"": ""Cell""}, {""token"": ""embryos"", ""start_span"": 88, ""end_span"": 95, ""type"": ""Developing_anatomical_structure""}, {""token"": ""ovarian tumors"", ""start_span"": 134, ""end_span"": 148, ""type"": ""Cancer""}]"	test
Mutating tp53 did not rescue the infertility phenotype in brca2 mutant males, suggesting that brca2 plays an essential role in zebrafish spermatogenesis.	tp53,9,13,Gene_or_gene_product	brca2,58,63,Gene_or_gene_product	brca2,94,99,Gene_or_gene_product	zebrafish,127,136,Organism	"[{""token"": ""tp53"", ""start_span"": 9, ""end_span"": 13, ""type"": ""Gene_or_gene_product""}, {""token"": ""brca2"", ""start_span"": 58, ""end_span"": 63, ""type"": ""Gene_or_gene_product""}, {""token"": ""brca2"", ""start_span"": 94, ""end_span"": 99, ""type"": ""Gene_or_gene_product""}, {""token"": ""zebrafish"", ""start_span"": 127, ""end_span"": 136, ""type"": ""Organism""}]"	test
KISS1 methylation and expression as tumor stratification biomarkers and clinical outcome prognosticators for bladder cancer patients.	KISS1,0,5,Gene_or_gene_product	tumor,36,41,Cancer	bladder cancer,109,123,Cancer	patients,124,132,Organism	"[{""token"": ""KISS1"", ""start_span"": 0, ""end_span"": 5, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumor"", ""start_span"": 36, ""end_span"": 41, ""type"": ""Cancer""}, {""token"": ""bladder cancer"", ""start_span"": 109, ""end_span"": 123, ""type"": ""Cancer""}, {""token"": ""patients"", ""start_span"": 124, ""end_span"": 132, ""type"": ""Organism""}]"	test
KISS1 hypermethylation was frequent in bladder cancer cells analyzed by methylation - specific PCR and bisulfite sequencing and was associated with low gene expression, being restored in vitro by demethylating azacytidine.	KISS1,0,5,Gene_or_gene_product	bladder cancer cells,39,59,Cell	bisulfite,103,112,Chemical	azacytidine,210,221,Chemical	"[{""token"": ""KISS1"", ""start_span"": 0, ""end_span"": 5, ""type"": ""Gene_or_gene_product""}, {""token"": ""bladder cancer cells"", ""start_span"": 39, ""end_span"": 59, ""type"": ""Cell""}, {""token"": ""bisulfite"", ""start_span"": 103, ""end_span"": 112, ""type"": ""Chemical""}, {""token"": ""azacytidine"", ""start_span"": 210, ""end_span"": 221, ""type"": ""Chemical""}]"	test
KISS1 hypermethylation was identified in bladder cancer, providing a potential mechanistic explanation ( epigenetic silencing) for the observed loss of KISS1 in uroepithelial malignancies.	KISS1,0,5,Gene_or_gene_product	bladder cancer,41,55,Cancer	KISS1,152,157,Gene_or_gene_product	uroepithelial malignancies,161,187,Cancer	"[{""token"": ""KISS1"", ""start_span"": 0, ""end_span"": 5, ""type"": ""Gene_or_gene_product""}, {""token"": ""bladder cancer"", ""start_span"": 41, ""end_span"": 55, ""type"": ""Cancer""}, {""token"": ""KISS1"", ""start_span"": 152, ""end_span"": 157, ""type"": ""Gene_or_gene_product""}, {""token"": ""uroepithelial malignancies"", ""start_span"": 161, ""end_span"": 187, ""type"": ""Cancer""}]"	test
Correlation of lymphatic vessel density and vascular endothelial growth factor with nodal metastasis in papillary thyroid microcarcinoma.	lymphatic vessel,15,31,Multi	vascular endothelial growth factor,44,78,Gene_or_gene_product	nodal,84,89,Multi	papillary thyroid microcarcinoma,104,136,Cancer	"[{""token"": ""lymphatic vessel"", ""start_span"": 15, ""end_span"": 31, ""type"": ""Multi""}, {""token"": ""vascular endothelial growth factor"", ""start_span"": 44, ""end_span"": 78, ""type"": ""Gene_or_gene_product""}, {""token"": ""nodal"", ""start_span"": 84, ""end_span"": 89, ""type"": ""Multi""}, {""token"": ""papillary thyroid microcarcinoma"", ""start_span"": 104, ""end_span"": 136, ""type"": ""Cancer""}]"	test
It significantly prolongs median survival of patients with advanced hepatocellular carcinoma ( HCC) but the response is disease - stabilizing and cytostatic rather than one of tumor regression.	patients,45,53,Organism	hepatocellular carcinoma,68,92,Cancer	HCC,95,98,Cancer	tumor,176,181,Cancer	"[{""token"": ""patients"", ""start_span"": 45, ""end_span"": 53, ""type"": ""Organism""}, {""token"": ""hepatocellular carcinoma"", ""start_span"": 68, ""end_span"": 92, ""type"": ""Cancer""}, {""token"": ""HCC"", ""start_span"": 95, ""end_span"": 98, ""type"": ""Cancer""}, {""token"": ""tumor"", ""start_span"": 176, ""end_span"": 181, ""type"": ""Cancer""}]"	test
Desensitization could be induced in NIH - 3T3 cells by culturing under conditions where the cells were all in the exponential growth phase, or by a 12 h exposure to a C - kinase - activating phorbol ester.	NIH - 3T3 cells,36,51,Cell	cells,92,97,Cell	C - kinase,167,177,Gene_or_gene_product	phorbol ester,191,204,Chemical	"[{""token"": ""NIH - 3T3 cells"", ""start_span"": 36, ""end_span"": 51, ""type"": ""Cell""}, {""token"": ""cells"", ""start_span"": 92, ""end_span"": 97, ""type"": ""Cell""}, {""token"": ""C - kinase"", ""start_span"": 167, ""end_span"": 177, ""type"": ""Gene_or_gene_product""}, {""token"": ""phorbol ester"", ""start_span"": 191, ""end_span"": 204, ""type"": ""Chemical""}]"	test
Perfusion thresholds were estimated at tumor blood flow values of 69. 0 + / - 0. 1 ml / 100 g / min ( estimate + / - standard error) and of 69 + / - 7. 1 ml / 100 g / min for the beginning of the decline in regional ATP and glucose content, respectively.	tumor,39,44,Cancer	blood,45,50,Organism_substance	ATP,216,219,Chemical	glucose,224,231,Chemical	"[{""token"": ""tumor"", ""start_span"": 39, ""end_span"": 44, ""type"": ""Cancer""}, {""token"": ""blood"", ""start_span"": 45, ""end_span"": 50, ""type"": ""Organism_substance""}, {""token"": ""ATP"", ""start_span"": 216, ""end_span"": 219, ""type"": ""Chemical""}, {""token"": ""glucose"", ""start_span"": 224, ""end_span"": 231, ""type"": ""Chemical""}]"	test
Metabolic thresholds were derived at tumor glucose utilization values of 70. 6 + / - 8. 3 mumol / 100 g / min for reduced protein synthesis, of 55. 0 + / - 0. 2 mumol / 100 g / min for the decrease in glucose content, and 34. 7 + / - 4. 7 mumol / 100 g / min for decline in ATP content.	tumor,37,42,Cancer	glucose,43,50,Chemical	glucose,201,208,Chemical	ATP,274,277,Chemical	"[{""token"": ""tumor"", ""start_span"": 37, ""end_span"": 42, ""type"": ""Cancer""}, {""token"": ""glucose"", ""start_span"": 43, ""end_span"": 50, ""type"": ""Chemical""}, {""token"": ""glucose"", ""start_span"": 201, ""end_span"": 208, ""type"": ""Chemical""}, {""token"": ""ATP"", ""start_span"": 274, ""end_span"": 277, ""type"": ""Chemical""}]"	test
Inactivation of androgen - induced regulator ARD1 inhibits androgen receptor acetylation and prostate tumorigenesis.	androgen,16,24,Chemical	ARD1,45,49,Gene_or_gene_product	androgen receptor,59,76,Gene_or_gene_product	prostate,93,101,Organ	"[{""token"": ""androgen"", ""start_span"": 16, ""end_span"": 24, ""type"": ""Chemical""}, {""token"": ""ARD1"", ""start_span"": 45, ""end_span"": 49, ""type"": ""Gene_or_gene_product""}, {""token"": ""androgen receptor"", ""start_span"": 59, ""end_span"": 76, ""type"": ""Gene_or_gene_product""}, {""token"": ""prostate"", ""start_span"": 93, ""end_span"": 101, ""type"": ""Organ""}]"	test
Androgen signaling through androgen receptor ( AR) is critical for prostate tumorigenesis.	Androgen,0,8,Chemical	androgen receptor,27,44,Gene_or_gene_product	AR,47,49,Gene_or_gene_product	prostate,67,75,Organ	"[{""token"": ""Androgen"", ""start_span"": 0, ""end_span"": 8, ""type"": ""Chemical""}, {""token"": ""androgen receptor"", ""start_span"": 27, ""end_span"": 44, ""type"": ""Gene_or_gene_product""}, {""token"": ""AR"", ""start_span"": 47, ""end_span"": 49, ""type"": ""Gene_or_gene_product""}, {""token"": ""prostate"", ""start_span"": 67, ""end_span"": 75, ""type"": ""Organ""}]"	test
Given that AR - mediated gene regulation is enhanced by AR coregulators, inactivation of those coregulators is emerging as a promising therapy for prostate cancer ( PCa).	AR,11,13,Gene_or_gene_product	AR,56,58,Gene_or_gene_product	prostate cancer,147,162,Cancer	PCa,165,168,Cancer	"[{""token"": ""AR"", ""start_span"": 11, ""end_span"": 13, ""type"": ""Gene_or_gene_product""}, {""token"": ""AR"", ""start_span"": 56, ""end_span"": 58, ""type"": ""Gene_or_gene_product""}, {""token"": ""prostate cancer"", ""start_span"": 147, ""end_span"": 162, ""type"": ""Cancer""}, {""token"": ""PCa"", ""start_span"": 165, ""end_span"": 168, ""type"": ""Cancer""}]"	test
Here, we show that the N - acetyltransferase arrest - defect 1 protein ( ARD1) functions as a unique AR regulator in PCa cells.	N - acetyltransferase arrest - defect 1,23,62,Gene_or_gene_product	ARD1,73,77,Gene_or_gene_product	AR,101,103,Gene_or_gene_product	PCa cells,117,126,Cell	"[{""token"": ""N - acetyltransferase arrest - defect 1"", ""start_span"": 23, ""end_span"": 62, ""type"": ""Gene_or_gene_product""}, {""token"": ""ARD1"", ""start_span"": 73, ""end_span"": 77, ""type"": ""Gene_or_gene_product""}, {""token"": ""AR"", ""start_span"": 101, ""end_span"": 103, ""type"": ""Gene_or_gene_product""}, {""token"": ""PCa cells"", ""start_span"": 117, ""end_span"": 126, ""type"": ""Cell""}]"	test
ARD1 is up - regulated in human PCa cell lines and primary tumor biopsies.	ARD1,0,4,Gene_or_gene_product	human,26,31,Organism	PCa cell lines,32,46,Cell	tumor biopsies,59,73,Cancer	"[{""token"": ""ARD1"", ""start_span"": 0, ""end_span"": 4, ""type"": ""Gene_or_gene_product""}, {""token"": ""human"", ""start_span"": 26, ""end_span"": 31, ""type"": ""Organism""}, {""token"": ""PCa cell lines"", ""start_span"": 32, ""end_span"": 46, ""type"": ""Cell""}, {""token"": ""tumor biopsies"", ""start_span"": 59, ""end_span"": 73, ""type"": ""Cancer""}]"	test
Disruption of AR - ARD1 interactions may be a potent intervention for androgen - dependent PCa therapy.	AR,14,16,Gene_or_gene_product	ARD1,19,23,Gene_or_gene_product	androgen,70,78,Gene_or_gene_product	PCa,91,94,Cancer	"[{""token"": ""AR"", ""start_span"": 14, ""end_span"": 16, ""type"": ""Gene_or_gene_product""}, {""token"": ""ARD1"", ""start_span"": 19, ""end_span"": 23, ""type"": ""Gene_or_gene_product""}, {""token"": ""androgen"", ""start_span"": 70, ""end_span"": 78, ""type"": ""Gene_or_gene_product""}, {""token"": ""PCa"", ""start_span"": 91, ""end_span"": 94, ""type"": ""Cancer""}]"	test
These results indicated that Hes genes cooperatively regulate intestinal development and homeostasis and raised the possibility that Hes1 is a promising target to induce the differentiation of tumor cells.	Hes,29,32,Gene_or_gene_product	intestinal,62,72,Multi	Hes1,133,137,Gene_or_gene_product	tumor cells,193,204,Cell	"[{""token"": ""Hes"", ""start_span"": 29, ""end_span"": 32, ""type"": ""Gene_or_gene_product""}, {""token"": ""intestinal"", ""start_span"": 62, ""end_span"": 72, ""type"": ""Multi""}, {""token"": ""Hes1"", ""start_span"": 133, ""end_span"": 137, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumor cells"", ""start_span"": 193, ""end_span"": 204, ""type"": ""Cell""}]"	test
AIM: Approximately 40 - 60% of melanomas from Caucasian populations carry activating mutations in the BRAF oncogene, with the most common being the p. Val600Glu ( V600E) hotspot mutation in exon 15.	melanomas,31,40,Cancer	BRAF,102,106,Gene_or_gene_product	Val600Glu,151,160,Amino_acid	V600E,163,168,Amino_acid	"[{""token"": ""melanomas"", ""start_span"": 31, ""end_span"": 40, ""type"": ""Cancer""}, {""token"": ""BRAF"", ""start_span"": 102, ""end_span"": 106, ""type"": ""Gene_or_gene_product""}, {""token"": ""Val600Glu"", ""start_span"": 151, ""end_span"": 160, ""type"": ""Amino_acid""}, {""token"": ""V600E"", ""start_span"": 163, ""end_span"": 168, ""type"": ""Amino_acid""}]"	test
CONCLUSION: BRAF p. Val600Lys mutations were present at a relatively high frequency in this cohort of metastatic melanoma patients ( 27 / 183, 15%).	BRAF,12,16,Gene_or_gene_product	Val600Lys,20,29,Amino_acid	melanoma,113,121,Cancer	patients,122,130,Organism	"[{""token"": ""BRAF"", ""start_span"": 12, ""end_span"": 16, ""type"": ""Gene_or_gene_product""}, {""token"": ""Val600Lys"", ""start_span"": 20, ""end_span"": 29, ""type"": ""Amino_acid""}, {""token"": ""melanoma"", ""start_span"": 113, ""end_span"": 121, ""type"": ""Cancer""}, {""token"": ""patients"", ""start_span"": 122, ""end_span"": 130, ""type"": ""Organism""}]"	test
Lactate concentrations were significantly higher ( P less than 0. 001) at baseline and all time periods of the glucose tolerance test in dogs with lymphoma when compared with controls.	Lactate,0,7,Chemical	glucose,111,118,Chemical	dogs,137,141,Organism	lymphoma,147,155,Cancer	"[{""token"": ""Lactate"", ""start_span"": 0, ""end_span"": 7, ""type"": ""Chemical""}, {""token"": ""glucose"", ""start_span"": 111, ""end_span"": 118, ""type"": ""Chemical""}, {""token"": ""dogs"", ""start_span"": 137, ""end_span"": 141, ""type"": ""Organism""}, {""token"": ""lymphoma"", ""start_span"": 147, ""end_span"": 155, ""type"": ""Cancer""}]"	test
Rise in lactate concentrations over baseline levels in the first 30 minutes of the glucose tolerance test were significantly higher in dogs with lymphoma ( P = 0. 011).	lactate,8,15,Chemical	glucose,83,90,Chemical	dogs,135,139,Organism	lymphoma,145,153,Cancer	"[{""token"": ""lactate"", ""start_span"": 8, ""end_span"": 15, ""type"": ""Chemical""}, {""token"": ""glucose"", ""start_span"": 83, ""end_span"": 90, ""type"": ""Chemical""}, {""token"": ""dogs"", ""start_span"": 135, ""end_span"": 139, ""type"": ""Organism""}, {""token"": ""lymphoma"", ""start_span"": 145, ""end_span"": 153, ""type"": ""Cancer""}]"	test
Insulin concentrations were significantly higher ( P less than 0. 001) at baseline and at the 5 -, 45 -, 60 -, and 90 - minute time periods of the glucose tolerance test in dogs with lymphoma.	Insulin,0,7,Gene_or_gene_product	glucose,147,154,Chemical	dogs,173,177,Organism	lymphoma,183,191,Cancer	"[{""token"": ""Insulin"", ""start_span"": 0, ""end_span"": 7, ""type"": ""Gene_or_gene_product""}, {""token"": ""glucose"", ""start_span"": 147, ""end_span"": 154, ""type"": ""Chemical""}, {""token"": ""dogs"", ""start_span"": 173, ""end_span"": 177, ""type"": ""Organism""}, {""token"": ""lymphoma"", ""start_span"": 183, ""end_span"": 191, ""type"": ""Cancer""}]"	test
Rise in insulin concentrations over baseline in the first 5 minutes of the glucose tolerance test were also significantly greater in dogs with lymphoma ( P = 0. 021).	insulin,8,15,Gene_or_gene_product	glucose,75,82,Chemical	dogs,133,137,Organism	lymphoma,143,151,Cancer	"[{""token"": ""insulin"", ""start_span"": 8, ""end_span"": 15, ""type"": ""Gene_or_gene_product""}, {""token"": ""glucose"", ""start_span"": 75, ""end_span"": 82, ""type"": ""Chemical""}, {""token"": ""dogs"", ""start_span"": 133, ""end_span"": 137, ""type"": ""Organism""}, {""token"": ""lymphoma"", ""start_span"": 143, ""end_span"": 151, ""type"": ""Cancer""}]"	test
BALB - / MK - 2 mouse epidermal keratinocytes required epidermal growth factor for proliferation and terminally differentiated in response to high Ca2 + concentration.	BALB - / MK - 2 mouse,0,21,Organism	epidermal keratinocytes,22,45,Cell	epidermal growth factor,55,78,Gene_or_gene_product	Ca2,147,150,Chemical	"[{""token"": ""BALB - / MK - 2 mouse"", ""start_span"": 0, ""end_span"": 21, ""type"": ""Organism""}, {""token"": ""epidermal keratinocytes"", ""start_span"": 22, ""end_span"": 45, ""type"": ""Cell""}, {""token"": ""epidermal growth factor"", ""start_span"": 55, ""end_span"": 78, ""type"": ""Gene_or_gene_product""}, {""token"": ""Ca2"", ""start_span"": 147, ""end_span"": 150, ""type"": ""Chemical""}]"	test
Four drugs with potential anti - peritumoral brain edema activity were studied using the VX2 rabbit brain tumor model.	peritumoral brain edema,33,56,Pathological_formation	VX2,89,92,Cancer	rabbit,93,99,Organism	brain tumor,100,111,Cancer	"[{""token"": ""peritumoral brain edema"", ""start_span"": 33, ""end_span"": 56, ""type"": ""Pathological_formation""}, {""token"": ""VX2"", ""start_span"": 89, ""end_span"": 92, ""type"": ""Cancer""}, {""token"": ""rabbit"", ""start_span"": 93, ""end_span"": 99, ""type"": ""Organism""}, {""token"": ""brain tumor"", ""start_span"": 100, ""end_span"": 111, ""type"": ""Cancer""}]"	test
This work does not confirm reports that NSAID ' s have anti - edema activity and suggests that there may be no correlation between ' angiostatic ' and anti - edema activity in certain steroid compounds.	NSAID,40,45,Chemical	edema,62,67,Pathological_formation	edema,158,163,Pathological_formation	steroid compounds,184,201,Chemical	"[{""token"": ""NSAID"", ""start_span"": 40, ""end_span"": 45, ""type"": ""Chemical""}, {""token"": ""edema"", ""start_span"": 62, ""end_span"": 67, ""type"": ""Pathological_formation""}, {""token"": ""edema"", ""start_span"": 158, ""end_span"": 163, ""type"": ""Pathological_formation""}, {""token"": ""steroid compounds"", ""start_span"": 184, ""end_span"": 201, ""type"": ""Chemical""}]"	test
The mutant which retains only the central region of the v - fos protein ( Met111 - Ile206) have both activities, but the mutants which have deletions in this region, and one of the mutants that has a four amino acid insertion in it, lost both activities.	v - fos,56,63,Gene_or_gene_product	Met111,74,80,Amino_acid	Ile206,83,89,Amino_acid	amino acid,205,215,Amino_acid	"[{""token"": ""v - fos"", ""start_span"": 56, ""end_span"": 63, ""type"": ""Gene_or_gene_product""}, {""token"": ""Met111"", ""start_span"": 74, ""end_span"": 80, ""type"": ""Amino_acid""}, {""token"": ""Ile206"", ""start_span"": 83, ""end_span"": 89, ""type"": ""Amino_acid""}, {""token"": ""amino acid"", ""start_span"": 205, ""end_span"": 215, ""type"": ""Amino_acid""}]"	test
The central region that is sufficient for these activities includes the evolutionarily highly conserved region among human, mouse and chicken c - fos proteins.	human,117,122,Organism	mouse,124,129,Organism	chicken,134,141,Organism	c - fos,142,149,Gene_or_gene_product	"[{""token"": ""human"", ""start_span"": 117, ""end_span"": 122, ""type"": ""Organism""}, {""token"": ""mouse"", ""start_span"": 124, ""end_span"": 129, ""type"": ""Organism""}, {""token"": ""chicken"", ""start_span"": 134, ""end_span"": 141, ""type"": ""Organism""}, {""token"": ""c - fos"", ""start_span"": 142, ""end_span"": 149, ""type"": ""Gene_or_gene_product""}]"	test
The truncated fos protein that contains only part of the central region is not phosphorylated in chicken embryo fibroblasts, indicating that phosphorylation of the fos protein is not necessary for the transforming activity.	fos,14,17,Gene_or_gene_product	chicken,97,104,Organism	embryo fibroblasts,105,123,Cell	fos,164,167,Gene_or_gene_product	"[{""token"": ""fos"", ""start_span"": 14, ""end_span"": 17, ""type"": ""Gene_or_gene_product""}, {""token"": ""chicken"", ""start_span"": 97, ""end_span"": 104, ""type"": ""Organism""}, {""token"": ""embryo fibroblasts"", ""start_span"": 105, ""end_span"": 123, ""type"": ""Cell""}, {""token"": ""fos"", ""start_span"": 164, ""end_span"": 167, ""type"": ""Gene_or_gene_product""}]"	test
Inhibition by retinoic acid of type IV collagenolysis and invasion through reconstituted basement membrane by metastatic rat mammary adenocarcinoma cells.	retinoic acid,14,27,Chemical	basement membrane,89,106,Cellular_component	rat,121,124,Organism	mammary adenocarcinoma cells,125,153,Cell	"[{""token"": ""retinoic acid"", ""start_span"": 14, ""end_span"": 27, ""type"": ""Chemical""}, {""token"": ""basement membrane"", ""start_span"": 89, ""end_span"": 106, ""type"": ""Cellular_component""}, {""token"": ""rat"", ""start_span"": 121, ""end_span"": 124, ""type"": ""Organism""}, {""token"": ""mammary adenocarcinoma cells"", ""start_span"": 125, ""end_span"": 153, ""type"": ""Cell""}]"	test
The present work supports and extends the finding of previous studies, since the results showed that the glucose metabolism depressed the oxidative processes in Ehrlich ascites tumor mitochondria, not only alone, but also in the presence of glutamine.	glucose,105,112,Chemical	Ehrlich ascites tumor,161,182,Cancer	mitochondria,183,195,Cellular_component	glutamine,241,250,Amino_acid	"[{""token"": ""glucose"", ""start_span"": 105, ""end_span"": 112, ""type"": ""Chemical""}, {""token"": ""Ehrlich ascites tumor"", ""start_span"": 161, ""end_span"": 182, ""type"": ""Cancer""}, {""token"": ""mitochondria"", ""start_span"": 183, ""end_span"": 195, ""type"": ""Cellular_component""}, {""token"": ""glutamine"", ""start_span"": 241, ""end_span"": 250, ""type"": ""Amino_acid""}]"	test
N - methyl - N - nitrosourea - induced transformation of rat urothelial cells in vitro is not mediated by activation of ras oncogenes.	N - methyl - N - nitrosourea,0,28,Chemical	rat,57,60,Organism	urothelial cells,61,77,Cell	ras,120,123,Gene_or_gene_product	"[{""token"": ""N - methyl - N - nitrosourea"", ""start_span"": 0, ""end_span"": 28, ""type"": ""Chemical""}, {""token"": ""rat"", ""start_span"": 57, ""end_span"": 60, ""type"": ""Organism""}, {""token"": ""urothelial cells"", ""start_span"": 61, ""end_span"": 77, ""type"": ""Cell""}, {""token"": ""ras"", ""start_span"": 120, ""end_span"": 123, ""type"": ""Gene_or_gene_product""}]"	test
This in vitro transformation process involves multiple steps: slow - growing ' pre - neoplastic ' epithelial foci are induced 70 - 100 days after MNU treatment and from such foci rapidly proliferating immortal cell lines were established, some of which became tumorigenic after a further latent period.	epithelial foci,98,113,Cell	MNU,146,149,Chemical	foci,174,178,Cell	cell lines,210,220,Cell	"[{""token"": ""epithelial foci"", ""start_span"": 98, ""end_span"": 113, ""type"": ""Cell""}, {""token"": ""MNU"", ""start_span"": 146, ""end_span"": 149, ""type"": ""Chemical""}, {""token"": ""foci"", ""start_span"": 174, ""end_span"": 178, ""type"": ""Cell""}, {""token"": ""cell lines"", ""start_span"": 210, ""end_span"": 220, ""type"": ""Cell""}]"	test
A series of epithelial cell lines and a single fibroblast cell line established in this way were analysed for the presence of transforming genes by DNA transfection into NIH3T3 cells.	epithelial cell lines,12,33,Cell	fibroblast cell line,47,67,Cell	DNA,148,151,Cellular_component	NIH3T3 cells,170,182,Cell	"[{""token"": ""epithelial cell lines"", ""start_span"": 12, ""end_span"": 33, ""type"": ""Cell""}, {""token"": ""fibroblast cell line"", ""start_span"": 47, ""end_span"": 67, ""type"": ""Cell""}, {""token"": ""DNA"", ""start_span"": 148, ""end_span"": 151, ""type"": ""Cellular_component""}, {""token"": ""NIH3T3 cells"", ""start_span"": 170, ""end_span"": 182, ""type"": ""Cell""}]"	test
Effects of repeated low - level X radiation on functional microvascular changes in hamster cheek pouch epithelium during and following carcinogenesis by 7, 12 - dimethylbenz [ a] anthracene ( DMBA) were studied.	microvascular,58,71,Tissue	hamster,83,90,Organism	cheek pouch epithelium,91,113,Tissue	DMBA,192,196,Chemical	"[{""token"": ""microvascular"", ""start_span"": 58, ""end_span"": 71, ""type"": ""Tissue""}, {""token"": ""hamster"", ""start_span"": 83, ""end_span"": 90, ""type"": ""Organism""}, {""token"": ""cheek pouch epithelium"", ""start_span"": 91, ""end_span"": 113, ""type"": ""Tissue""}, {""token"": ""DMBA"", ""start_span"": 192, ""end_span"": 196, ""type"": ""Chemical""}]"	test
Prior studies showed enhancement of such carcinogenesis by repeated 20 rad head and neck X - radiation exposures, and it was proposed that one possible mechanism was radiogenic alteration of the functional microvasculature in a manner which favored subsequent tumor development.	head,75,79,Organism_subdivision	neck,84,88,Organism_subdivision	microvasculature,206,222,Tissue	tumor,260,265,Cancer	"[{""token"": ""head"", ""start_span"": 75, ""end_span"": 79, ""type"": ""Organism_subdivision""}, {""token"": ""neck"", ""start_span"": 84, ""end_span"": 88, ""type"": ""Organism_subdivision""}, {""token"": ""microvasculature"", ""start_span"": 206, ""end_span"": 222, ""type"": ""Tissue""}, {""token"": ""tumor"", ""start_span"": 260, ""end_span"": 265, ""type"": ""Cancer""}]"	test
Participation of p53 cellular tumour antigen in transformation of normal embryonic cells.	p53,17,20,Gene_or_gene_product	cellular,21,29,Cell	tumour,30,36,Cancer	embryonic cells,73,88,Cell	"[{""token"": ""p53"", ""start_span"": 17, ""end_span"": 20, ""type"": ""Gene_or_gene_product""}, {""token"": ""cellular"", ""start_span"": 21, ""end_span"": 29, ""type"": ""Cell""}, {""token"": ""tumour"", ""start_span"": 30, ""end_span"": 36, ""type"": ""Cancer""}, {""token"": ""embryonic cells"", ""start_span"": 73, ""end_span"": 88, ""type"": ""Cell""}]"	test
The cellular tumour antigen p53 is found at elevated levels in a wide variety of transformed cells ( for reviews see refs 1, 2).	cellular,4,12,Cell	tumour,13,19,Cancer	p53,28,31,Gene_or_gene_product	cells,93,98,Cell	"[{""token"": ""cellular"", ""start_span"": 4, ""end_span"": 12, ""type"": ""Cell""}, {""token"": ""tumour"", ""start_span"": 13, ""end_span"": 19, ""type"": ""Cancer""}, {""token"": ""p53"", ""start_span"": 28, ""end_span"": 31, ""type"": ""Gene_or_gene_product""}, {""token"": ""cells"", ""start_span"": 93, ""end_span"": 98, ""type"": ""Cell""}]"	test
Although the increase in p53 levels could be a secondary by - product of the transformed state, it is equally possible that p53 is actively involved in altering cellular growth properties, especially as it has been implicated in the regulation of normal cell proliferation.	p53,25,28,Gene_or_gene_product	p53,124,127,Gene_or_gene_product	cellular,161,169,Cell	cell,254,258,Cell	"[{""token"": ""p53"", ""start_span"": 25, ""end_span"": 28, ""type"": ""Gene_or_gene_product""}, {""token"": ""p53"", ""start_span"": 124, ""end_span"": 127, ""type"": ""Gene_or_gene_product""}, {""token"": ""cellular"", ""start_span"": 161, ""end_span"": 169, ""type"": ""Cell""}, {""token"": ""cell"", ""start_span"": 254, ""end_span"": 258, ""type"": ""Cell""}]"	test
We sought to test whether p53 could behave in a manner similar to known genes in a biological test system, and we demonstrate here that p53 can cooperate with the activated Ha - ras oncogene to transform normal embryonic cells.	p53,26,29,Gene_or_gene_product	p53,136,139,Gene_or_gene_product	Ha - ras,173,181,Gene_or_gene_product	embryonic cells,211,226,Cell	"[{""token"": ""p53"", ""start_span"": 26, ""end_span"": 29, ""type"": ""Gene_or_gene_product""}, {""token"": ""p53"", ""start_span"": 136, ""end_span"": 139, ""type"": ""Gene_or_gene_product""}, {""token"": ""Ha - ras"", ""start_span"": 173, ""end_span"": 181, ""type"": ""Gene_or_gene_product""}, {""token"": ""embryonic cells"", ""start_span"": 211, ""end_span"": 226, ""type"": ""Cell""}]"	test
The primary site of nucleic acid synthesis, which was blocked by 3 - chloromethylthiochromone, was at orotidine monophosphate decarboxylase in the primidine pathway.	nucleic acid,20,32,Chemical	3 - chloromethylthiochromone,65,93,Chemical	orotidine monophosphate decarboxylase,102,139,Gene_or_gene_product	primidine,147,156,Chemical	"[{""token"": ""nucleic acid"", ""start_span"": 20, ""end_span"": 32, ""type"": ""Chemical""}, {""token"": ""3 - chloromethylthiochromone"", ""start_span"": 65, ""end_span"": 93, ""type"": ""Chemical""}, {""token"": ""orotidine monophosphate decarboxylase"", ""start_span"": 102, ""end_span"": 139, ""type"": ""Gene_or_gene_product""}, {""token"": ""primidine"", ""start_span"": 147, ""end_span"": 156, ""type"": ""Chemical""}]"	test
Other enzymes, in anaerobic and aerobic glycolysis, which were blocked include hexokinase, phosphofructokinase, succinic and alpha - ketoglutarate dehydrogenases, as well as States 3 and 4 of oxidative phosphorylation.	hexokinase,79,89,Gene_or_gene_product	phosphofructokinase,91,110,Gene_or_gene_product	succinic,112,120,Gene_or_gene_product	alpha - ketoglutarate dehydrogenases,125,161,Gene_or_gene_product	"[{""token"": ""hexokinase"", ""start_span"": 79, ""end_span"": 89, ""type"": ""Gene_or_gene_product""}, {""token"": ""phosphofructokinase"", ""start_span"": 91, ""end_span"": 110, ""type"": ""Gene_or_gene_product""}, {""token"": ""succinic"", ""start_span"": 112, ""end_span"": 120, ""type"": ""Gene_or_gene_product""}, {""token"": ""alpha - ketoglutarate dehydrogenases"", ""start_span"": 125, ""end_span"": 161, ""type"": ""Gene_or_gene_product""}]"	test
The E - cadherin / alpha -, beta -, gamma - catenin complex has an invasion - suppressor function as evidenced by transfections either with sense cDNA encoding these molecules or with antisense cDNA inhibiting their expression.	E - cadherin,4,16,Gene_or_gene_product	alpha -,19,26,Gene_or_gene_product	beta -,28,34,Gene_or_gene_product	gamma - catenin,36,51,Gene_or_gene_product	"[{""token"": ""E - cadherin"", ""start_span"": 4, ""end_span"": 16, ""type"": ""Gene_or_gene_product""}, {""token"": ""alpha -"", ""start_span"": 19, ""end_span"": 26, ""type"": ""Gene_or_gene_product""}, {""token"": ""beta -"", ""start_span"": 28, ""end_span"": 34, ""type"": ""Gene_or_gene_product""}, {""token"": ""gamma - catenin"", ""start_span"": 36, ""end_span"": 51, ""type"": ""Gene_or_gene_product""}]"	test
Ex vivo cultures from invasive tumors or metastases produced cells that were homogeneously E - cadherin - positive and noninvasive in vitro.	cultures,8,16,Cell	invasive tumors,22,37,Cancer	cells,61,66,Cell	E - cadherin,91,103,Gene_or_gene_product	"[{""token"": ""cultures"", ""start_span"": 8, ""end_span"": 16, ""type"": ""Cell""}, {""token"": ""invasive tumors"", ""start_span"": 22, ""end_span"": 37, ""type"": ""Cancer""}, {""token"": ""cells"", ""start_span"": 61, ""end_span"": 66, ""type"": ""Cell""}, {""token"": ""E - cadherin"", ""start_span"": 91, ""end_span"": 103, ""type"": ""Gene_or_gene_product""}]"	test
Heparin - steroid conjugates: new angiogenesis inhibitors with antitumor activity in mice.	Heparin,0,7,Chemical	steroid,10,17,Chemical	antitumor,63,72,Cancer	mice,85,89,Organism	"[{""token"": ""Heparin"", ""start_span"": 0, ""end_span"": 7, ""type"": ""Chemical""}, {""token"": ""steroid"", ""start_span"": 10, ""end_span"": 17, ""type"": ""Chemical""}, {""token"": ""antitumor"", ""start_span"": 63, ""end_span"": 72, ""type"": ""Cancer""}, {""token"": ""mice"", ""start_span"": 85, ""end_span"": 89, ""type"": ""Organism""}]"	test
The rationale was that the heparin derivative, which binds to sulfated polyanion receptors on endothelial cells, should concentrate the steroid on the surface of vascular endothelial cells.	heparin,27,34,Chemical	endothelial cells,94,111,Cell	steroid,136,143,Chemical	vascular endothelial cells,162,188,Cell	"[{""token"": ""heparin"", ""start_span"": 27, ""end_span"": 34, ""type"": ""Chemical""}, {""token"": ""endothelial cells"", ""start_span"": 94, ""end_span"": 111, ""type"": ""Cell""}, {""token"": ""steroid"", ""start_span"": 136, ""end_span"": 143, ""type"": ""Chemical""}, {""token"": ""vascular endothelial cells"", ""start_span"": 162, ""end_span"": 188, ""type"": ""Cell""}]"	test
HAH - cortisol at 10 ( - 4) M ( with respect to cortisol) did not suppress the DNA synthesis of Lewis lung carcinoma cells.	HAH - cortisol,0,14,Chemical	cortisol,48,56,Chemical	DNA,79,82,Cellular_component	Lewis lung carcinoma cells,96,122,Cell	"[{""token"": ""HAH - cortisol"", ""start_span"": 0, ""end_span"": 14, ""type"": ""Chemical""}, {""token"": ""cortisol"", ""start_span"": 48, ""end_span"": 56, ""type"": ""Chemical""}, {""token"": ""DNA"", ""start_span"": 79, ""end_span"": 82, ""type"": ""Cellular_component""}, {""token"": ""Lewis lung carcinoma cells"", ""start_span"": 96, ""end_span"": 122, ""type"": ""Cell""}]"	test
Selenoperoxidase - dependent glutathione cycle activity in peroxide - challenged leukemia cells.	Selenoperoxidase,0,16,Gene_or_gene_product	glutathione,29,40,Chemical	peroxide,59,67,Chemical	leukemia cells,81,95,Cell	"[{""token"": ""Selenoperoxidase"", ""start_span"": 0, ""end_span"": 16, ""type"": ""Gene_or_gene_product""}, {""token"": ""glutathione"", ""start_span"": 29, ""end_span"": 40, ""type"": ""Chemical""}, {""token"": ""peroxide"", ""start_span"": 59, ""end_span"": 67, ""type"": ""Chemical""}, {""token"": ""leukemia cells"", ""start_span"": 81, ""end_span"": 95, ""type"": ""Cell""}]"	test
The apparent first - order rate constant for GSH decay increased progressively for L1210 cells expressing a range of GPX activities from approximately 5% to 100%, demonstrating that peroxide detoxification is strictly dependent on enzyme content.	GSH,45,48,Chemical	L1210 cells,83,94,Cell	GPX,117,120,Gene_or_gene_product	peroxide,182,190,Chemical	"[{""token"": ""GSH"", ""start_span"": 45, ""end_span"": 48, ""type"": ""Chemical""}, {""token"": ""L1210 cells"", ""start_span"": 83, ""end_span"": 94, ""type"": ""Cell""}, {""token"": ""GPX"", ""start_span"": 117, ""end_span"": 120, ""type"": ""Gene_or_gene_product""}, {""token"": ""peroxide"", ""start_span"": 182, ""end_span"": 190, ""type"": ""Chemical""}]"	test
These results highlight the importance of selenoperoxidase action in the glutathione cycle as a means by which tumor cells cope with hydroperoxide stress.	selenoperoxidase,42,58,Gene_or_gene_product	glutathione,73,84,Chemical	tumor cells,111,122,Cell	hydroperoxide,133,146,Chemical	"[{""token"": ""selenoperoxidase"", ""start_span"": 42, ""end_span"": 58, ""type"": ""Gene_or_gene_product""}, {""token"": ""glutathione"", ""start_span"": 73, ""end_span"": 84, ""type"": ""Chemical""}, {""token"": ""tumor cells"", ""start_span"": 111, ""end_span"": 122, ""type"": ""Cell""}, {""token"": ""hydroperoxide"", ""start_span"": 133, ""end_span"": 146, ""type"": ""Chemical""}]"	test
Similar differences in NME protein levels were observed in tumors induced by the two cell lines in nude mice.	NME,23,26,Gene_or_gene_product	tumors,59,65,Cancer	cell lines,85,95,Cell	nude mice,99,108,Organism	"[{""token"": ""NME"", ""start_span"": 23, ""end_span"": 26, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumors"", ""start_span"": 59, ""end_span"": 65, ""type"": ""Cancer""}, {""token"": ""cell lines"", ""start_span"": 85, ""end_span"": 95, ""type"": ""Cell""}, {""token"": ""nude mice"", ""start_span"": 99, ""end_span"": 108, ""type"": ""Organism""}]"	test
We found a ser122 - pro mutation in the NME2 gene of metastatic IV Cl 1 cells.	ser122,11,17,Amino_acid	pro,20,23,Amino_acid	NME2,40,44,Gene_or_gene_product	IV Cl 1 cells,64,77,Cell	"[{""token"": ""ser122"", ""start_span"": 11, ""end_span"": 17, ""type"": ""Amino_acid""}, {""token"": ""pro"", ""start_span"": 20, ""end_span"": 23, ""type"": ""Amino_acid""}, {""token"": ""NME2"", ""start_span"": 40, ""end_span"": 44, ""type"": ""Gene_or_gene_product""}, {""token"": ""IV Cl 1 cells"", ""start_span"": 64, ""end_span"": 77, ""type"": ""Cell""}]"	test
The chromosomal translocation t ( 11: 14) is associated with human lymphoid neoplasia affecting centrocytic B - cells of intermediate differentiation.	chromosomal,4,15,Cellular_component	human,61,66,Organism	lymphoid neoplasia,67,85,Pathological_formation	centrocytic B - cells,96,117,Cell	"[{""token"": ""chromosomal"", ""start_span"": 4, ""end_span"": 15, ""type"": ""Cellular_component""}, {""token"": ""human"", ""start_span"": 61, ""end_span"": 66, ""type"": ""Organism""}, {""token"": ""lymphoid neoplasia"", ""start_span"": 67, ""end_span"": 85, ""type"": ""Pathological_formation""}, {""token"": ""centrocytic B - cells"", ""start_span"": 96, ""end_span"": 117, ""type"": ""Cell""}]"	test
It leads to enhanced oxygenation of the affected tissues, has an antiseptic effect, reduces edema, and accelerates collagen production and angiogenesis, thus enhancing tissue repair.	tissues,49,56,Tissue	edema,92,97,Pathological_formation	collagen,115,123,Gene_or_gene_product	tissue,168,174,Tissue	"[{""token"": ""tissues"", ""start_span"": 49, ""end_span"": 56, ""type"": ""Tissue""}, {""token"": ""edema"", ""start_span"": 92, ""end_span"": 97, ""type"": ""Pathological_formation""}, {""token"": ""collagen"", ""start_span"": 115, ""end_span"": 123, ""type"": ""Gene_or_gene_product""}, {""token"": ""tissue"", ""start_span"": 168, ""end_span"": 174, ""type"": ""Tissue""}]"	test
Synthetic vascular prostheses are foreign bodies, so that blood coagulation can occur on their luminal surfaces, causing graft occlusion very frequently in prostheses of small diameter.	vascular,10,18,Multi	blood,58,63,Organism_substance	luminal surfaces,95,111,Multi	graft,121,126,Multi	"[{""token"": ""vascular"", ""start_span"": 10, ""end_span"": 18, ""type"": ""Multi""}, {""token"": ""blood"", ""start_span"": 58, ""end_span"": 63, ""type"": ""Organism_substance""}, {""token"": ""luminal surfaces"", ""start_span"": 95, ""end_span"": 111, ""type"": ""Multi""}, {""token"": ""graft"", ""start_span"": 121, ""end_span"": 126, ""type"": ""Multi""}]"	test
To induce capillary growth into the graft, we developed a method of transplanting bone marrow cells, which are primitive, strong enough to survive, and create blood cells, resulting in the inducement of capillary growth.	capillary,10,19,Tissue	bone marrow cells,82,99,Cell	blood cells,159,170,Cell	capillary,203,212,Tissue	"[{""token"": ""capillary"", ""start_span"": 10, ""end_span"": 19, ""type"": ""Tissue""}, {""token"": ""bone marrow cells"", ""start_span"": 82, ""end_span"": 99, ""type"": ""Cell""}, {""token"": ""blood cells"", ""start_span"": 159, ""end_span"": 170, ""type"": ""Cell""}, {""token"": ""capillary"", ""start_span"": 203, ""end_span"": 212, ""type"": ""Tissue""}]"	test
In an animal experiment, marrow cells were infiltrated into the walls of long - fibril expanded polytetrafluoroethylene ( ePTFE) vascular grafts.	marrow cells,25,37,Cell	polytetrafluoroethylene,96,119,Chemical	ePTFE,122,127,Chemical	vascular grafts,129,144,Multi	"[{""token"": ""marrow cells"", ""start_span"": 25, ""end_span"": 37, ""type"": ""Cell""}, {""token"": ""polytetrafluoroethylene"", ""start_span"": 96, ""end_span"": 119, ""type"": ""Chemical""}, {""token"": ""ePTFE"", ""start_span"": 122, ""end_span"": 127, ""type"": ""Chemical""}, {""token"": ""vascular grafts"", ""start_span"": 129, ""end_span"": 144, ""type"": ""Multi""}]"	test
Four out of seven control grafts were patent with endothelial cell lining at six months, but three were occluded and one of the four grafts was still covered with a thrombus layer.	grafts,26,32,Multi	endothelial cell,50,66,Cell	grafts,133,139,Multi	thrombus,165,173,Pathological_formation	"[{""token"": ""grafts"", ""start_span"": 26, ""end_span"": 32, ""type"": ""Multi""}, {""token"": ""endothelial cell"", ""start_span"": 50, ""end_span"": 66, ""type"": ""Cell""}, {""token"": ""grafts"", ""start_span"": 133, ""end_span"": 139, ""type"": ""Multi""}, {""token"": ""thrombus"", ""start_span"": 165, ""end_span"": 173, ""type"": ""Pathological_formation""}]"	test
In the present study, the authors used molecular techniques to analyze the clonal composition of five cases of concurrent adenocarcinomas of the endometrium and ovary that were clinicopathologically diagnosed as synchronous primary tumors.	adenocarcinomas,122,137,Cancer	endometrium,145,156,Multi	ovary,161,166,Organ	synchronous primary tumors,212,238,Cancer	"[{""token"": ""adenocarcinomas"", ""start_span"": 122, ""end_span"": 137, ""type"": ""Cancer""}, {""token"": ""endometrium"", ""start_span"": 145, ""end_span"": 156, ""type"": ""Multi""}, {""token"": ""ovary"", ""start_span"": 161, ""end_span"": 166, ""type"": ""Organ""}, {""token"": ""synchronous primary tumors"", ""start_span"": 212, ""end_span"": 238, ""type"": ""Cancer""}]"	test
Cervical cancer develops from well - defined precursor lesions referred to as either cervical intraepithelial neoplasia or squamous intraepithelial lesions.	Cervical cancer,0,15,Cancer	precursor lesions,45,62,Pathological_formation	cervical intraepithelial neoplasia,85,119,Pathological_formation	squamous intraepithelial lesions,123,155,Pathological_formation	"[{""token"": ""Cervical cancer"", ""start_span"": 0, ""end_span"": 15, ""type"": ""Cancer""}, {""token"": ""precursor lesions"", ""start_span"": 45, ""end_span"": 62, ""type"": ""Pathological_formation""}, {""token"": ""cervical intraepithelial neoplasia"", ""start_span"": 85, ""end_span"": 119, ""type"": ""Pathological_formation""}, {""token"": ""squamous intraepithelial lesions"", ""start_span"": 123, ""end_span"": 155, ""type"": ""Pathological_formation""}]"	test
It is now known that specific types of human papillomaviruses ( HPV) are the principal etiologic agents for both cervical cancer and its precursors.	human papillomaviruses,39,61,Organism	HPV,64,67,Organism	cervical cancer,113,128,Cancer	precursors,137,147,Pathological_formation	"[{""token"": ""human papillomaviruses"", ""start_span"": 39, ""end_span"": 61, ""type"": ""Organism""}, {""token"": ""HPV"", ""start_span"": 64, ""end_span"": 67, ""type"": ""Organism""}, {""token"": ""cervical cancer"", ""start_span"": 113, ""end_span"": 128, ""type"": ""Cancer""}, {""token"": ""precursors"", ""start_span"": 137, ""end_span"": 147, ""type"": ""Pathological_formation""}]"	test
Expanded polytetrafluoroethylene ( PTFE) sheets were implanted adjacent to both superficial epigastric vascular pedicles of 63 rats distributed into 7 groups ( n = 7) that differed with respect to dose and timing of irradiation.	polytetrafluoroethylene,9,32,Chemical	PTFE,35,39,Chemical	epigastric vascular pedicles,92,120,Multi	rats,127,131,Organism	"[{""token"": ""polytetrafluoroethylene"", ""start_span"": 9, ""end_span"": 32, ""type"": ""Chemical""}, {""token"": ""PTFE"", ""start_span"": 35, ""end_span"": 39, ""type"": ""Chemical""}, {""token"": ""epigastric vascular pedicles"", ""start_span"": 92, ""end_span"": 120, ""type"": ""Multi""}, {""token"": ""rats"", ""start_span"": 127, ""end_span"": 131, ""type"": ""Organism""}]"	test
Vascular grade was not related to histology, grade, proliferation index ( Ki67), or EGFR or p53 expression.	Vascular,0,8,Multi	Ki67,74,78,Gene_or_gene_product	EGFR,84,88,Gene_or_gene_product	p53,92,95,Gene_or_gene_product	"[{""token"": ""Vascular"", ""start_span"": 0, ""end_span"": 8, ""type"": ""Multi""}, {""token"": ""Ki67"", ""start_span"": 74, ""end_span"": 78, ""type"": ""Gene_or_gene_product""}, {""token"": ""EGFR"", ""start_span"": 84, ""end_span"": 88, ""type"": ""Gene_or_gene_product""}, {""token"": ""p53"", ""start_span"": 92, ""end_span"": 95, ""type"": ""Gene_or_gene_product""}]"	test
In an experiment in which vitamin E inhibited carcinogenesis, it was found that tumour angiogenesis and tumour growth - factor alpha ( TGF alpha) expression were also inhibited.	vitamin E,26,35,Chemical	tumour,80,86,Cancer	tumour growth - factor alpha,104,132,Gene_or_gene_product	TGF alpha,135,144,Gene_or_gene_product	"[{""token"": ""vitamin E"", ""start_span"": 26, ""end_span"": 35, ""type"": ""Chemical""}, {""token"": ""tumour"", ""start_span"": 80, ""end_span"": 86, ""type"": ""Cancer""}, {""token"": ""tumour growth - factor alpha"", ""start_span"": 104, ""end_span"": 132, ""type"": ""Gene_or_gene_product""}, {""token"": ""TGF alpha"", ""start_span"": 135, ""end_span"": 144, ""type"": ""Gene_or_gene_product""}]"	test
Staining was effected by the standard avidin - biotin horseradish peroxidase system.	avidin,38,44,Gene_or_gene_product	biotin,47,53,Chemical	horseradish,54,65,Organism	peroxidase,66,76,Gene_or_gene_product	"[{""token"": ""avidin"", ""start_span"": 38, ""end_span"": 44, ""type"": ""Gene_or_gene_product""}, {""token"": ""biotin"", ""start_span"": 47, ""end_span"": 53, ""type"": ""Chemical""}, {""token"": ""horseradish"", ""start_span"": 54, ""end_span"": 65, ""type"": ""Organism""}, {""token"": ""peroxidase"", ""start_span"": 66, ""end_span"": 76, ""type"": ""Gene_or_gene_product""}]"	test
Mean tumour volume was significantly lower in the DMBA - vitamin E group compared to the tumour control group.	tumour,5,11,Cancer	DMBA,50,54,Chemical	vitamin E,57,66,Chemical	tumour,89,95,Cancer	"[{""token"": ""tumour"", ""start_span"": 5, ""end_span"": 11, ""type"": ""Cancer""}, {""token"": ""DMBA"", ""start_span"": 50, ""end_span"": 54, ""type"": ""Chemical""}, {""token"": ""vitamin E"", ""start_span"": 57, ""end_span"": 66, ""type"": ""Chemical""}, {""token"": ""tumour"", ""start_span"": 89, ""end_span"": 95, ""type"": ""Cancer""}]"	test
It is suggested that inhibition of tumour angiogenesis by vitamin E may be an additional mechanism for the anticancer action of vitamin E.	tumour,35,41,Cancer	vitamin E,58,67,Chemical	anticancer,107,117,Cancer	vitamin E,128,137,Chemical	"[{""token"": ""tumour"", ""start_span"": 35, ""end_span"": 41, ""type"": ""Cancer""}, {""token"": ""vitamin E"", ""start_span"": 58, ""end_span"": 67, ""type"": ""Chemical""}, {""token"": ""anticancer"", ""start_span"": 107, ""end_span"": 117, ""type"": ""Cancer""}, {""token"": ""vitamin E"", ""start_span"": 128, ""end_span"": 137, ""type"": ""Chemical""}]"	test
Curcumin, which is a widely used dietary pigment and spice, has been demonstrated to be an effective inhibitor of tumor promotion in mouse skin carcinogenesis.	Curcumin,0,8,Chemical	tumor,114,119,Cancer	mouse,133,138,Organism	skin,139,143,Organ	"[{""token"": ""Curcumin"", ""start_span"": 0, ""end_span"": 8, ""type"": ""Chemical""}, {""token"": ""tumor"", ""start_span"": 114, ""end_span"": 119, ""type"": ""Cancer""}, {""token"": ""mouse"", ""start_span"": 133, ""end_span"": 138, ""type"": ""Organism""}, {""token"": ""skin"", ""start_span"": 139, ""end_span"": 143, ""type"": ""Organ""}]"	test
Fas - signaling and effects on receptor tyrosine kinase signal transduction in human breast epithelial cells.	Fas,0,3,Gene_or_gene_product	receptor tyrosine kinase,31,55,Gene_or_gene_product	human,79,84,Organism	breast epithelial cells,85,108,Cell	"[{""token"": ""Fas"", ""start_span"": 0, ""end_span"": 3, ""type"": ""Gene_or_gene_product""}, {""token"": ""receptor tyrosine kinase"", ""start_span"": 31, ""end_span"": 55, ""type"": ""Gene_or_gene_product""}, {""token"": ""human"", ""start_span"": 79, ""end_span"": 84, ""type"": ""Organism""}, {""token"": ""breast epithelial cells"", ""start_span"": 85, ""end_span"": 108, ""type"": ""Cell""}]"	test
Anti - Fas treatment resulted in decreased p53 protein levels, while bcl - 2 and bax protein levels remained unaffected.	Fas,7,10,Gene_or_gene_product	p53,43,46,Gene_or_gene_product	bcl - 2,69,76,Gene_or_gene_product	bax,81,84,Gene_or_gene_product	"[{""token"": ""Fas"", ""start_span"": 7, ""end_span"": 10, ""type"": ""Gene_or_gene_product""}, {""token"": ""p53"", ""start_span"": 43, ""end_span"": 46, ""type"": ""Gene_or_gene_product""}, {""token"": ""bcl - 2"", ""start_span"": 69, ""end_span"": 76, ""type"": ""Gene_or_gene_product""}, {""token"": ""bax"", ""start_span"": 81, ""end_span"": 84, ""type"": ""Gene_or_gene_product""}]"	test
Immunoprecipitation experiments demonstrated that Fas associated with c - erbB2 and c - met in untreated cells.	Fas,50,53,Gene_or_gene_product	c - erbB2,70,79,Gene_or_gene_product	c - met,84,91,Gene_or_gene_product	cells,105,110,Cell	"[{""token"": ""Fas"", ""start_span"": 50, ""end_span"": 53, ""type"": ""Gene_or_gene_product""}, {""token"": ""c - erbB2"", ""start_span"": 70, ""end_span"": 79, ""type"": ""Gene_or_gene_product""}, {""token"": ""c - met"", ""start_span"": 84, ""end_span"": 91, ""type"": ""Gene_or_gene_product""}, {""token"": ""cells"", ""start_span"": 105, ""end_span"": 110, ""type"": ""Cell""}]"	test
These results show that Fas - signaling exerted a suppressive effect on p53 levels and on downstream effectors of receptor tyrosine kinase signal transduction, thereby ensuring cell death.	Fas,24,27,Gene_or_gene_product	p53,72,75,Gene_or_gene_product	receptor tyrosine kinase,114,138,Gene_or_gene_product	cell,177,181,Cell	"[{""token"": ""Fas"", ""start_span"": 24, ""end_span"": 27, ""type"": ""Gene_or_gene_product""}, {""token"": ""p53"", ""start_span"": 72, ""end_span"": 75, ""type"": ""Gene_or_gene_product""}, {""token"": ""receptor tyrosine kinase"", ""start_span"": 114, ""end_span"": 138, ""type"": ""Gene_or_gene_product""}, {""token"": ""cell"", ""start_span"": 177, ""end_span"": 181, ""type"": ""Cell""}]"	test
Prevention of hepatic tumor metastases in rats with herpes viral vaccines and gamma - interferon.	hepatic tumor,14,27,Cancer	rats,42,46,Organism	herpes viral,52,64,Organism	gamma - interferon,78,96,Gene_or_gene_product	"[{""token"": ""hepatic tumor"", ""start_span"": 14, ""end_span"": 27, ""type"": ""Cancer""}, {""token"": ""rats"", ""start_span"": 42, ""end_span"": 46, ""type"": ""Organism""}, {""token"": ""herpes viral"", ""start_span"": 52, ""end_span"": 64, ""type"": ""Organism""}, {""token"": ""gamma - interferon"", ""start_span"": 78, ""end_span"": 96, ""type"": ""Gene_or_gene_product""}]"	test
Previous studies showed that gammaIFN decreases metastatic hepatic tumor growth by stimulating Kupffer cells ( KC).	gammaIFN,29,37,Gene_or_gene_product	hepatic tumor,59,72,Cancer	Kupffer cells,95,108,Cell	KC,111,113,Cell	"[{""token"": ""gammaIFN"", ""start_span"": 29, ""end_span"": 37, ""type"": ""Gene_or_gene_product""}, {""token"": ""hepatic tumor"", ""start_span"": 59, ""end_span"": 72, ""type"": ""Cancer""}, {""token"": ""Kupffer cells"", ""start_span"": 95, ""end_span"": 108, ""type"": ""Cell""}, {""token"": ""KC"", ""start_span"": 111, ""end_span"": 113, ""type"": ""Cell""}]"	test
On day 18, half of each group was treated with 5 x 10 ( 4) U gammaIFN, or saline intraperitoneally for 3 d.	group,24,29,Organism	gammaIFN,61,69,Gene_or_gene_product	saline,74,80,Chemical	intraperitoneally,81,98,Immaterial_anatomical_entity	"[{""token"": ""group"", ""start_span"": 24, ""end_span"": 29, ""type"": ""Organism""}, {""token"": ""gammaIFN"", ""start_span"": 61, ""end_span"": 69, ""type"": ""Gene_or_gene_product""}, {""token"": ""saline"", ""start_span"": 74, ""end_span"": 80, ""type"": ""Chemical""}, {""token"": ""intraperitoneally"", ""start_span"": 81, ""end_span"": 98, ""type"": ""Immaterial_anatomical_entity""}]"	test
GM - CSF and IL - 2 vaccine therapy and pretreatment with gammaIFN represent effective strategies in reducing hepatic tumor.	GM - CSF,0,8,Gene_or_gene_product	IL - 2,13,19,Gene_or_gene_product	gammaIFN,58,66,Gene_or_gene_product	hepatic tumor,110,123,Cancer	"[{""token"": ""GM - CSF"", ""start_span"": 0, ""end_span"": 8, ""type"": ""Gene_or_gene_product""}, {""token"": ""IL - 2"", ""start_span"": 13, ""end_span"": 19, ""type"": ""Gene_or_gene_product""}, {""token"": ""gammaIFN"", ""start_span"": 58, ""end_span"": 66, ""type"": ""Gene_or_gene_product""}, {""token"": ""hepatic tumor"", ""start_span"": 110, ""end_span"": 123, ""type"": ""Cancer""}]"	test
Insulin - like growth factor I induces tumor hexokinase RNA expression in cancer cells.	Insulin - like growth factor I,0,30,Gene_or_gene_product	tumor,39,44,Cancer	hexokinase,45,55,Gene_or_gene_product	cancer cells,74,86,Cell	"[{""token"": ""Insulin - like growth factor I"", ""start_span"": 0, ""end_span"": 30, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumor"", ""start_span"": 39, ""end_span"": 44, ""type"": ""Cancer""}, {""token"": ""hexokinase"", ""start_span"": 45, ""end_span"": 55, ""type"": ""Gene_or_gene_product""}, {""token"": ""cancer cells"", ""start_span"": 74, ""end_span"": 86, ""type"": ""Cell""}]"	test
Integrins and growth factors are capable of activating the ras / MAP kinase pathway in vitro, yet how these signals influence endothelial cells during angiogenesis is unknown.	Integrins,0,9,Gene_or_gene_product	ras,59,62,Gene_or_gene_product	MAP kinase,65,75,Gene_or_gene_product	endothelial cells,126,143,Cell	"[{""token"": ""Integrins"", ""start_span"": 0, ""end_span"": 9, ""type"": ""Gene_or_gene_product""}, {""token"": ""ras"", ""start_span"": 59, ""end_span"": 62, ""type"": ""Gene_or_gene_product""}, {""token"": ""MAP kinase"", ""start_span"": 65, ""end_span"": 75, ""type"": ""Gene_or_gene_product""}, {""token"": ""endothelial cells"", ""start_span"": 126, ""end_span"": 143, ""type"": ""Cell""}]"	test
The initial wave of ERK activity ( 5 - 120 min) was refractory to integrin antagonists, whereas the sustained activity ( 4 - 20 h) depended on integrin alphavbeta3, but not beta1 integrins.	ERK,20,23,Gene_or_gene_product	integrin antagonists,66,86,Chemical	integrin alphavbeta3,143,163,Gene_or_gene_product	beta1 integrins,173,188,Gene_or_gene_product	"[{""token"": ""ERK"", ""start_span"": 20, ""end_span"": 23, ""type"": ""Gene_or_gene_product""}, {""token"": ""integrin antagonists"", ""start_span"": 66, ""end_span"": 86, ""type"": ""Chemical""}, {""token"": ""integrin alphavbeta3"", ""start_span"": 143, ""end_span"": 163, ""type"": ""Gene_or_gene_product""}, {""token"": ""beta1 integrins"", ""start_span"": 173, ""end_span"": 188, ""type"": ""Gene_or_gene_product""}]"	test
Basic fibroblast growth factor: a missing link between collagen VII, increased collagenase, and squamous cell carcinoma in recessive dystrophic epidermolysis bullosa.	Basic fibroblast growth factor,0,30,Gene_or_gene_product	collagen VII,55,67,Gene_or_gene_product	collagenase,79,90,Gene_or_gene_product	squamous cell carcinoma,96,119,Cancer	"[{""token"": ""Basic fibroblast growth factor"", ""start_span"": 0, ""end_span"": 30, ""type"": ""Gene_or_gene_product""}, {""token"": ""collagen VII"", ""start_span"": 55, ""end_span"": 67, ""type"": ""Gene_or_gene_product""}, {""token"": ""collagenase"", ""start_span"": 79, ""end_span"": 90, ""type"": ""Gene_or_gene_product""}, {""token"": ""squamous cell carcinoma"", ""start_span"": 96, ""end_span"": 119, ""type"": ""Cancer""}]"	test
BACKGROUND: Patients with recessive dystrophic epidermolysis bullosa ( RDEB) have deficiencies of collagen type VII and have elevated levels of fibroblast collagenase, and a greatly increased risk of cutaneous squamous cell carcinoma.	Patients,12,20,Organism	collagen type VII,98,115,Gene_or_gene_product	fibroblast collagenase,144,166,Gene_or_gene_product	cutaneous squamous cell carcinoma,200,233,Cancer	"[{""token"": ""Patients"", ""start_span"": 12, ""end_span"": 20, ""type"": ""Organism""}, {""token"": ""collagen type VII"", ""start_span"": 98, ""end_span"": 115, ""type"": ""Gene_or_gene_product""}, {""token"": ""fibroblast collagenase"", ""start_span"": 144, ""end_span"": 166, ""type"": ""Gene_or_gene_product""}, {""token"": ""cutaneous squamous cell carcinoma"", ""start_span"": 200, ""end_span"": 233, ""type"": ""Cancer""}]"	test
CONCLUSIONS: We have found that patients with RDEB have elevated levels of bFGF, which may contribute to increased fibroblast collagenase and the development of squamous cell carcinoma.	patients,32,40,Organism	bFGF,75,79,Gene_or_gene_product	fibroblast collagenase,115,137,Gene_or_gene_product	squamous cell carcinoma,161,184,Cancer	"[{""token"": ""patients"", ""start_span"": 32, ""end_span"": 40, ""type"": ""Organism""}, {""token"": ""bFGF"", ""start_span"": 75, ""end_span"": 79, ""type"": ""Gene_or_gene_product""}, {""token"": ""fibroblast collagenase"", ""start_span"": 115, ""end_span"": 137, ""type"": ""Gene_or_gene_product""}, {""token"": ""squamous cell carcinoma"", ""start_span"": 161, ""end_span"": 184, ""type"": ""Cancer""}]"	test
A prefabricated composite fat flap consisting of muscle woven into an anatomically distinct fat pad was studied in a rabbit model.	composite fat flap,16,34,Multi	muscle,49,55,Tissue	fat pad,92,99,Tissue	rabbit,117,123,Organism	"[{""token"": ""composite fat flap"", ""start_span"": 16, ""end_span"": 34, ""type"": ""Multi""}, {""token"": ""muscle"", ""start_span"": 49, ""end_span"": 55, ""type"": ""Tissue""}, {""token"": ""fat pad"", ""start_span"": 92, ""end_span"": 99, ""type"": ""Tissue""}, {""token"": ""rabbit"", ""start_span"": 117, ""end_span"": 123, ""type"": ""Organism""}]"	test
At 3 weeks, the endogenous blood supply of both the control and the experimental fat pads was isolated and ligated, and the composite fat / muscle flap was transferred to the chest wall.	blood,27,32,Organism_substance	fat pads,81,89,Tissue	composite fat / muscle flap,124,151,Multi	chest wall,175,185,Organism_subdivision	"[{""token"": ""blood"", ""start_span"": 27, ""end_span"": 32, ""type"": ""Organism_substance""}, {""token"": ""fat pads"", ""start_span"": 81, ""end_span"": 89, ""type"": ""Tissue""}, {""token"": ""composite fat / muscle flap"", ""start_span"": 124, ""end_span"": 151, ""type"": ""Multi""}, {""token"": ""chest wall"", ""start_span"": 175, ""end_span"": 185, ""type"": ""Organism_subdivision""}]"	test
Experimental flaps were found to be perfused fully with fluorescein and lead oxide; control fat pads were found not to be perfused.	flaps,13,18,Multi	fluorescein,56,67,Chemical	lead oxide,72,82,Chemical	fat pads,92,100,Tissue	"[{""token"": ""flaps"", ""start_span"": 13, ""end_span"": 18, ""type"": ""Multi""}, {""token"": ""fluorescein"", ""start_span"": 56, ""end_span"": 67, ""type"": ""Chemical""}, {""token"": ""lead oxide"", ""start_span"": 72, ""end_span"": 82, ""type"": ""Chemical""}, {""token"": ""fat pads"", ""start_span"": 92, ""end_span"": 100, ""type"": ""Tissue""}]"	test
The lead oxide group revealed extensive growth of blood vessels from the latissimus graft into the experimental fat pad.	lead oxide,4,14,Chemical	blood vessels,50,63,Multi	latissimus graft,73,89,Multi	fat pad,112,119,Tissue	"[{""token"": ""lead oxide"", ""start_span"": 4, ""end_span"": 14, ""type"": ""Chemical""}, {""token"": ""blood vessels"", ""start_span"": 50, ""end_span"": 63, ""type"": ""Multi""}, {""token"": ""latissimus graft"", ""start_span"": 73, ""end_span"": 89, ""type"": ""Multi""}, {""token"": ""fat pad"", ""start_span"": 112, ""end_span"": 119, ""type"": ""Tissue""}]"	test
Requirement of estrogen receptor expression and function for [ 12Val] K - Ras - mediated NIH3T3 cell transformation.	estrogen receptor,15,32,Gene_or_gene_product	12Val,63,68,Amino_acid	K - Ras,70,77,Gene_or_gene_product	NIH3T3 cell,89,100,Cell	"[{""token"": ""estrogen receptor"", ""start_span"": 15, ""end_span"": 32, ""type"": ""Gene_or_gene_product""}, {""token"": ""12Val"", ""start_span"": 63, ""end_span"": 68, ""type"": ""Amino_acid""}, {""token"": ""K - Ras"", ""start_span"": 70, ""end_span"": 77, ""type"": ""Gene_or_gene_product""}, {""token"": ""NIH3T3 cell"", ""start_span"": 89, ""end_span"": 100, ""type"": ""Cell""}]"	test
The p16 / Rb / E2F pathway is the most frequent target of genetic alterations in gliomas, and therefore constitutes a suitable target for gene therapy strategies.	p16,4,7,Gene_or_gene_product	Rb,10,12,Gene_or_gene_product	E2F,15,18,Gene_or_gene_product	gliomas,81,88,Cancer	"[{""token"": ""p16"", ""start_span"": 4, ""end_span"": 7, ""type"": ""Gene_or_gene_product""}, {""token"": ""Rb"", ""start_span"": 10, ""end_span"": 12, ""type"": ""Gene_or_gene_product""}, {""token"": ""E2F"", ""start_span"": 15, ""end_span"": 18, ""type"": ""Gene_or_gene_product""}, {""token"": ""gliomas"", ""start_span"": 81, ""end_span"": 88, ""type"": ""Cancer""}]"	test
In addition, p21 - or p16 - mediated growth arrest did not protect glioma cells from E2F - 1 - mediated apoptosis.	p21,13,16,Gene_or_gene_product	p16,22,25,Gene_or_gene_product	glioma cells,67,79,Cell	E2F - 1,85,92,Gene_or_gene_product	"[{""token"": ""p21"", ""start_span"": 13, ""end_span"": 16, ""type"": ""Gene_or_gene_product""}, {""token"": ""p16"", ""start_span"": 22, ""end_span"": 25, ""type"": ""Gene_or_gene_product""}, {""token"": ""glioma cells"", ""start_span"": 67, ""end_span"": 79, ""type"": ""Cell""}, {""token"": ""E2F - 1"", ""start_span"": 85, ""end_span"": 92, ""type"": ""Gene_or_gene_product""}]"	test
Accordingly, the rate of elimination of abnormal proteins was lower in cells lacking a functional VHL gene than in wtVHL - expressing cells.	cells,71,76,Cell	VHL,98,101,Gene_or_gene_product	wtVHL,115,120,Gene_or_gene_product	cells,134,139,Cell	"[{""token"": ""cells"", ""start_span"": 71, ""end_span"": 76, ""type"": ""Cell""}, {""token"": ""VHL"", ""start_span"": 98, ""end_span"": 101, ""type"": ""Gene_or_gene_product""}, {""token"": ""wtVHL"", ""start_span"": 115, ""end_span"": 120, ""type"": ""Gene_or_gene_product""}, {""token"": ""cells"", ""start_span"": 134, ""end_span"": 139, ""type"": ""Cell""}]"	test
